Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,pulmonary valve development (GO:0003177),-0.7041247961302726,-2.1168002277068676,0.0,0.05580658214189371,0.048,12/18,15.30%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;BMPR2;SLIT2;JAG1;STRA6;TNFRSF1A;TGFB2;HEY2
prerank,pulmonary valve morphogenesis (GO:0003184),-0.6762814059921767,-2.007213895346432,0.0,0.16686168060426218,0.233,10/17,15.30%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;SLIT2;JAG1;STRA6;TGFB2;HEY2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.46339330277341567,-2.0062743492328177,0.0,0.11124112040284147,0.233,49/91,27.56%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;SRPRA;RPS6;SRP14;RPS8;RPL11;RPL12;SSR2;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;SIL1;RPS17;RPS5;RPS15A;UBA52;RPL37A;SRP19;RPS10;RPL6;RPL9;RPS27
prerank,regulation of tube diameter (GO:0035296),-0.7369985930247631,-1.9610732862503581,0.0,0.1252299703264095,0.407,6/13,7.86%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,vascular process in circulatory system (GO:0003018),-0.7369985930247631,-1.9610732862503581,0.0,0.1252299703264095,0.407,6/13,7.86%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,somite development (GO:0061053),0.8874483173730952,1.939536741333664,0.0,0.2352200381705975,0.184,7/11,8.63%,PTCH1;MEOX1;MEOX2;SOX11;LOXL3;PPP2R3A;SMO
prerank,protein localization to cell-cell junction (GO:0150105),-0.6976375395723522,-1.9270269078534197,0.0,0.16258317597338368,0.553,7/15,11.99%,TJP1;CGNL1;CDH5;TJP2;PAK2;MPP7;ACTG1
prerank,regulation of glucose import (GO:0046324),-0.5590964970643418,-1.9078041840131228,0.0,0.18001608925199428,0.637,13/30,9.62%,PRKAG2;OSBPL8;SORBS1;IGF1;OCLN;APPL2;GRB10;CREBL2;PRKCI;INSR;RHOQ;ARPP19;GSK3A
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6437586283124758,-1.9062579701739073,0.006430868167202572,0.1614205388454276,0.645,7/18,10.10%,PTN;MTUS1;SLC8B1;LYN;SLIT2;CAMK1D;IL6R
prerank,regulation of trans-synaptic signaling (GO:0099177),0.7192271258050517,1.8895976155307146,0.0,0.35716813173035394,0.431,13/33,10.36%,RELN;CEL;NGF;NRG3;GRIK3;CACNA1A;GRIK5;GRIK2;LRRC4C;GRID2;NLGN1;GRIK1;PXK
prerank,eosinophil chemotaxis (GO:0048245),0.8327648935393424,1.8696545964804916,0.0,0.25932045191758496,0.561,3/14,4.10%,LGALS3;CCL11;CCL4
prerank,eosinophil migration (GO:0072677),0.8327648935393424,1.8696545964804916,0.0,0.25932045191758496,0.561,3/14,4.10%,LGALS3;CCL11;CCL4
prerank,regulation of chondrocyte differentiation (GO:0032330),0.7340386610471773,1.8451779561690815,0.001388888888888889,0.3308504799186437,0.726,11/24,10.85%,SOX6;ADAMTS12;EFEMP1;PKDCC;SOX9;MBOAT2;PTHLH;ZBTB16;TRPS1;SOX5;PTPN11
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6985354230859058,1.8417949124210753,0.0024479804161566705,0.2909723286386285,0.743,9/35,9.72%,DCHS1;CDH19;CDH10;CDH22;PCDHGB4;CDH8;NLGN1;CDH20;CDH7
prerank,spinal cord development (GO:0021510),0.8343603681256608,1.840472372401584,0.006211180124223602,0.25532666906808416,0.753,7/12,8.79%,RELN;VIT;GLI2;SOX11;NF1;LOXL3;SOX12
prerank,neuronal action potential (GO:0019228),0.7461953868464404,1.8326852157675926,0.0,0.2535363526183079,0.795,9/22,8.45%,ANK3;KCNA2;SCN7A;SCN2A;KCNA1;SCN5A;SCN3A;KCNMB2;KCNMB3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6946685650742936,-1.8238179702298036,0.0029411764705882353,0.38109694871564304,0.932,6/13,4.03%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,endochondral bone morphogenesis (GO:0060350),-0.6958808718121792,-1.8234105029042467,0.008522727272727272,0.3454427434583221,0.932,6/11,15.98%,COL13A1;BMP4;BMPR2;INPPL1;TMEM119;TRPV4
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.8476674975970672,1.822843700396726,0.004702194357366771,0.2666041325166745,0.838,3/12,3.45%,DCN;ADAMTS12;CADM4
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7654201387582125,1.8112421257605027,0.0028011204481792717,0.29180780964852404,0.878,6/18,5.72%,RELN;TSHZ3;CACNG7;NRXN1;CCR2;NLGN1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7767608863893981,1.7993232365877443,0.004392386530014641,0.3232084578141444,0.924,4/16,4.44%,LGALS3;FGF10;PTPN22;SOX11
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6782843900416967,-1.7981946925857661,0.009771986970684038,0.4004883267528263,0.973,5/13,7.97%,PTGIS;NAMPT;NAXD;PARP10;PTGS2
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5807391314697354,-1.7848577916792838,0.003676470588235294,0.417061190540419,0.978,6/21,4.03%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,alpha-amino acid catabolic process (GO:1901606),0.6824492920487113,1.7775937525844088,0.0012468827930174563,0.41444678173569416,0.966,8/29,9.64%,AADAT;KYNU;CBS;DAO;SARDH;GOT2;MTRR;IL4I1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.41104283538376724,-1.770948645423437,0.0,0.43975586727812244,0.989,47/87,27.56%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;RPS6;SEC61B;SRP14;RPS8;RPL11;RPL12;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;SRP19;RPS10;RPL6;RPL9;RPS27
prerank,artery development (GO:0060840),-0.5445087558483765,-1.76965572161497,0.00819672131147541,0.41328760260511,0.989,13/23,12.75%,ROBO1;NRP1;ACVRL1;SMAD7;ENG;BMPR2;TGFBR1;TBX1;EFEMP2;STRA6;HECTD1;PDE2A;SLC2A10
prerank,connective tissue development (GO:0061448),0.6627008955805879,1.768068679531262,0.0024509803921568627,0.4439666987791195,0.978,13/35,8.90%,SOX6;SULF1;SOX8;SOX9;PGRMC2;ITGB8;HOXD3;ZBTB16;RORC;CREB3L2;DYRK1B;TRIP11;SOX5
prerank,regulation of T cell activation (GO:0050863),0.6570388274629718,1.7674875411730182,0.0037174721189591076,0.41549113299806356,0.979,10/42,9.64%,LGALS3;PRKCQ;PYCARD;PTPN22;FGL1;TNFAIP8L2;CCR2;METTL3;LAX1;IL4I1
prerank,myeloid cell development (GO:0061515),-0.5907985308868566,-1.766312610163608,0.010067114093959731,0.3982357701645535,0.991,5/18,13.20%,FOXP1;KIT;ALAS1;APP;NCKAP1L
prerank,regulation of NMDA receptor activity (GO:2000310),0.6745954240140554,1.7660817057194078,0.0024906600249066002,0.3962750697704656,0.979,10/32,5.72%,RELN;CRH;GRIA1;EPHB2;GRIA3;CAPN1;GRIN2B;CCR2;DLG2;NLGN1
prerank,lysine catabolic process (GO:0006554),0.8022493713179055,1.758301848486532,0.004511278195488722,0.39167425353045243,0.987,5/12,3.36%,AADAT;GCDH;AASS;SLC25A21;DLST
prerank,lysine metabolic process (GO:0006553),0.8022493713179055,1.758301848486532,0.004511278195488722,0.39167425353045243,0.987,5/12,3.36%,AADAT;GCDH;AASS;SLC25A21;DLST
prerank,smoothened signaling pathway (GO:0007224),0.663964158356464,1.7572226473853985,0.0012578616352201257,0.37543088970307115,0.987,8/32,8.63%,PTCH1;PTCH2;GLI2;DHH;STK36;CC2D2A;GLI1;SMO
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7976905041921903,1.7528080947311762,0.004398826979472141,0.3787570286763396,0.99,5/12,13.88%,APOD;CBLB;PTPRJ;CBL;SNCA
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8077462178777192,1.7499513874661972,0.006430868167202572,0.3753880445230765,0.992,5/10,8.90%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,regulation of T cell migration (GO:2000404),0.7473306719621967,1.745738571649035,0.004081632653061225,0.37991433175251077,0.993,3/18,1.40%,APOD;CXCL10;PYCARD
prerank,myelination in peripheral nervous system (GO:0022011),0.7839458954483729,1.74195344723039,0.0030864197530864196,0.3827583892362461,0.993,4/13,5.07%,LGI4;PRX;NF1;ARHGEF10
prerank,response to sterol (GO:0036314),0.8294799268317096,1.7380713402902734,0.0,0.3861934126343346,0.993,4/11,6.38%,RORA;TGFB1;RORC;TGFBR2
prerank,blood vessel diameter maintenance (GO:0097746),-0.49110769782141395,-1.7333625646424495,0.010101010101010102,0.5053286012948476,0.994,15/34,22.90%,ROCK2;ROCK1;NOS3;KLF2;NPR1;ACE;AGTR1;ECE1;NOS1;EDNRB;EDN1;GCLC;GPER1;ACE2;AGT
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7161868663683637,1.7307532752527934,0.008298755186721992,0.4093856948488268,0.995,8/21,9.64%,LGALS3;PTPN22;FGL1;SOX11;TNFAIP8L2;SAMSN1;LAX1;IL4I1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6317013354618917,1.7291512788214571,0.00375,0.4019563406377554,0.996,10/39,9.57%,FXYD3;WNK2;ANK3;FGF13;UTRN;WNK3;FGF12;FGF14;STK39;FXYD6
prerank,cellular response to sterol (GO:0036315),0.7673193448518065,1.7241900822085097,0.007173601147776184,0.41226538531192836,0.998,8/13,16.10%,RORA;PTCH1;GRAMD1A;RORC;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,modified amino acid transport (GO:0072337),-0.6246608894276637,-1.722884423692208,0.012861736334405145,0.519263833129691,0.997,5/15,13.58%,SLC16A12;SLC6A13;PDPN;SLC5A6;MGST1
prerank,action potential (GO:0001508),0.6245111600149578,1.7182820409693114,0.0,0.42991567692959387,1.0,13/44,10.70%,ANK3;GNA14;KCNA2;SCN7A;SCN2A;KCNA1;CHRNA4;SCN5A;KCND2;SCN3A;KCNMB2;KCNMB3;AKAP6
prerank,epithelial structure maintenance (GO:0010669),-0.6643311728555823,-1.716872457856057,0.019390581717451522,0.5157768336180799,0.997,3/11,8.35%,RBP4;CXADR;STRAP
prerank,aspartate family amino acid catabolic process (GO:0009068),0.7239265068548023,1.7151368911397018,0.011157601115760111,0.4320515601584936,1.0,7/19,11.93%,AADAT;GCDH;AASS;SLC25A21;DLST;GOT2;PHYKPL
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8146778294495727,1.7142167030425062,0.004559270516717325,0.4223057327472118,1.0,3/10,2.79%,APOD;LRP1;PTPN2
prerank,pyroptosis (GO:0070269),-0.6155354170440142,-1.7105766923837806,0.013201320132013201,0.5171214132579899,0.999,10/15,36.50%,CASP4;AIM2;CASP8;GSDMD;GSDME;APIP;ZBP1;CASP1;TREM2;NLRC4
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.794896860025663,1.7102437374764443,0.006033182503770739,0.43088326391113957,1.0,3/11,1.04%,ANK3;PRKCA;PRKCQ
prerank,cartilage development (GO:0051216),0.6072384175119798,1.7096241953089648,0.003500583430571762,0.42037341036358233,1.0,13/49,9.67%,OSR2;SOX6;SULF1;FGF2;SOX9;TGFB1;ITGB8;HOXD3;ZBTB16;CREB3L2;TRIP11;SOX5;AMELX
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5823547196866542,-1.7060132525478606,0.014705882352941176,0.5106860331804693,0.999,11/20,12.46%,IGF1;NRP1;VTN;IGFBP3;SLIT2;IGFBP5;S100A11;ACE;PDGFRB;SERPINE1;CCN4
prerank,diol biosynthetic process (GO:0034312),-0.6005322748021525,-1.7049868436314448,0.011834319526627219,0.4910447737228153,0.999,8/15,25.69%,ACER2;SPTLC2;ASAH2;SPR;QDPR;SPHK1;SPHK2;SPTLC1
prerank,extracellular matrix assembly (GO:0085029),0.6829122255496599,1.7047350011594176,0.010624169986719787,0.4326928033099759,1.0,8/23,6.82%,NTN4;HAS2;PXDN;TGFB1;GPM6B;TNXB;NTNG2;NTNG1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6935161104387652,1.701422861869092,0.006596306068601583,0.43789721462708103,1.0,9/24,11.09%,RORA;SULF1;EIF2AK3;TGFB1;NOX1;CYP1B1;BRCA1;HIF1A;IL6ST
prerank,neuron migration (GO:0001764),0.6066832635169677,1.6998550952379559,0.0023781212841854932,0.4323614226209548,1.0,19/48,11.86%,RELN;FGF13;ASTN2;MAP1B;NRCAM;VEGFA;SEMA3A;AUTS2;NTRK2;CEP85L;CDKL5;NAV1;DISC1;SDCCAG8;FGFR1;GPM6A;POMGNT2;ADGRL3;CDK5R1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5255841095366901,-1.6971280758242449,0.008968609865470852,0.5013967739166686,0.999,12/25,22.44%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,aortic valve development (GO:0003176),-0.4813401921380698,-1.6969908692724287,0.0,0.4798880789575539,0.999,10/34,3.97%,ROBO1;ROCK2;SMAD6;ELN;ROCK1;NOS3;BMP4;BMPR2;SLIT2;TIE1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6195204962846503,-1.6955754193991062,0.0064516129032258064,0.4660314663699308,0.999,8/15,24.24%,PRKCD;SIRT3;RACK1;TNFRSF1A;ORMDL3;SPHK1;ORMDL1;SPHK2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6827733731202725,1.6923038576406528,0.0066050198150594455,0.4630860072321142,1.0,10/26,11.09%,RORA;SULF1;EIF2AK3;TGFB1;CCR2;NOX1;CYP1B1;BRCA1;HIF1A;IL6ST
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6325017935549638,1.6922139454535852,0.002509410288582183,0.45073129354365854,1.0,14/39,17.21%,FXYD3;CHRM3;UTRN;ANK2;WNK3;FGF12;STK39;FXYD6;FXYD1;AHCYL1;TCAF1;NEDD4L;HOMER1;RIPK1
prerank,regulation of synapse maturation (GO:0090128),0.7892136578267248,1.692178626873207,0.011608623548922056,0.43873174820056393,1.0,4/10,11.79%,RELN;NRXN1;YWHAZ;ANAPC2
prerank,endothelial cell differentiation (GO:0045446),-0.6458576169730106,-1.6909083806660916,0.020527859237536656,0.4663644456433774,0.999,7/12,12.04%,ACVRL1;BMPR2;TIE1;KDR;KDM6B;JAG1;PROX1
prerank,negative regulation of T cell activation (GO:0050868),0.6305456842474944,1.6885674079392092,0.007380073800738007,0.4462635560244802,1.0,8/35,9.64%,LGALS3;GLMN;PTPN22;FGL1;TNFAIP8L2;SDC4;LAX1;IL4I1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.817145646954438,1.6879505671604136,0.008143322475570033,0.4387016853143931,1.0,2/10,3.45%,DCN;CADM4
prerank,peripheral nervous system development (GO:0007422),0.6755553642418609,1.6875064411960077,0.004225352112676056,0.4298790800050151,1.0,7/23,11.34%,ERBB3;SOX8;NGF;NF1;PMP22;GDNF;GPC1
prerank,homocysteine metabolic process (GO:0050667),0.7813171819059666,1.6862487449645351,0.006134969325153374,0.4264009788308462,1.0,5/11,8.74%,CTH;TST;DPEP1;CBS;MTRR
prerank,stress fiber assembly (GO:0043149),-0.6051721284464634,-1.6790262828115017,0.025078369905956112,0.47427327178810863,0.999,7/15,12.85%,SORBS1;PHACTR1;ITGB5;TNFAIP1;RHOA;PDLIM1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6051721284464634,-1.6790262828115017,0.025078369905956112,0.47427327178810863,0.999,7/15,12.85%,SORBS1;PHACTR1;ITGB5;TNFAIP1;RHOA;PDLIM1;FAM171A1
prerank,sprouting angiogenesis (GO:0002040),-0.4418179494111487,-1.6719249614576552,0.006711409395973154,0.48428154745847624,0.999,18/51,5.90%,ROBO1;NRP1;TEK;CCBE1;VEGFC;ANGPT1;PIK3R3;RSPO3;CDH13;ACVRL1;VEGFD;BMP4;ENG;SLIT2;EPHB4;RNF213;KDR;THBS1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.7171932599213072,1.6715360983134775,0.020989505247376312,0.49369123741328863,1.0,8/16,11.37%,GCDH;ACACA;ACSS1;SCD5;ACLY;FASN;PPT2;DIP2A
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7174980496415072,1.6699935745288497,0.016597510373443983,0.49072926186772864,1.0,5/17,10.53%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ
prerank,positive regulation of glucose import (GO:0046326),-0.5468724361027895,-1.6640060037554816,0.010526315789473684,0.4982180729840097,1.0,9/21,9.47%,OSBPL8;SORBS1;IGF1;OCLN;CREBL2;PRKCI;INSR;RHOQ;ARPP19
prerank,acylglycerol homeostasis (GO:0055090),0.6846448790735582,1.66359486982738,0.016483516483516484,0.5176549778182478,1.0,6/20,15.20%,RORA;MLXIPL;IL18;PNPLA8;MTLN;LIPC
prerank,aortic valve morphogenesis (GO:0003180),-0.4909656650524366,-1.6555983754278583,0.009389671361502348,0.5152807751101519,1.0,9/30,3.97%,ROBO1;ROCK2;SMAD6;ELN;ROCK1;NOS3;BMP4;SLIT2;TIE1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6399941252566675,-1.6548659905257193,0.01764705882352941,0.5017551798254393,1.0,5/12,13.93%,FOXP1;MAP2K5;TLR4;KLF4;TIRAP
prerank,presynapse assembly (GO:0099054),0.7176852731157795,1.6537942062391477,0.01881331403762663,0.5666060828391742,1.0,6/16,5.72%,CEL;LRP4;PTEN;IL1RAPL1;WNT5A;NLGN1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6262858496847423,1.6534654299809346,0.005,0.5563004199250278,1.0,9/37,8.17%,DCHS1;TENM2;TENM3;IL1RAPL1;GRID2;NLGN1;CADM3;HMCN1;CADM1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5517048782817104,-1.652549589916421,0.006756756756756757,0.49521365828162933,1.0,6/19,1.98%,TJP1;ROCK2;PRKCH;ROCK1;CLDN5;OCLN
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.6440015673531416,1.649845400712652,0.01673101673101673,0.5670673522237974,1.0,5/29,7.02%,LGALS3;CXCL10;ANO6;CCR2;PLA2G7
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.7259868060128559,1.6479958705732867,0.00715307582260372,0.5665404761573075,1.0,5/16,10.41%,SEC16B;ANK2;PPP1R15A;GBF1;VAPA
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6923423848233003,1.647552754577845,0.013717421124828532,0.557811453851702,1.0,4/18,3.77%,RELN;VEGFA;CRTC1;RPS6KA4
prerank,negative regulation of cell communication (GO:0010648),0.6734886599127906,1.6454338226562202,0.010666666666666666,0.5595344858810581,1.0,6/21,9.75%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7563430073702535,1.6441226859991585,0.026200873362445413,0.5563887675628043,1.0,4/12,12.59%,PRKCQ;CCR2;CARD9;ZBTB1
prerank,cellular amino acid catabolic process (GO:0009063),0.5520226736948047,1.6438500705205845,0.001081081081081081,0.5472833186344742,1.0,35/87,22.76%,AADAT;GCDH;AASS;KYNU;CBS;IVD;SLC25A21;DLST;BCKDHB;MCCC1;DAO;HMGCLL1;SARDH;GOT2;MTRR;MCCC2;IL4I1;HIBADH;PHYKPL;HIBCH;ALDH5A1;GLS2;GLS;DBT;GSTZ1;AUH;AMT;BCKDK;ALDH7A1;ASPA;HYKK;GLUD1;DDAH1;ALDH6A1;CARNS1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6785618513120197,-1.6414450528797904,0.013888888888888888,0.5225187197031006,1.0,4/10,7.84%,IGF2;PCGF3;PRMT7;PCGF5
prerank,regulation of cholesterol esterification (GO:0010872),-0.6511253056511903,-1.6409611431973732,0.032,0.5092514757454101,1.0,6/10,22.90%,AGTR1;ABCG1;STARD4;APOE;LAMTOR1;AGT
prerank,macrophage migration (GO:1905517),0.7504703549167514,1.637046509478846,0.01355421686746988,0.5791738675709994,1.0,5/13,13.84%,LGALS3;CCR2;TAFA4;CKLF;P2RY12
prerank,protein trimerization (GO:0070206),0.745053358779903,1.6365866285806425,0.01634472511144131,0.5607596632780869,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,protein homotrimerization (GO:0070207),0.745053358779903,1.6365866285806425,0.01634472511144131,0.5607596632780869,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.6798534567955369,1.6323051519918488,0.019635343618513323,0.5753629490468296,1.0,5/19,6.26%,RELN;IL1RAPL1;OBSL1;CDKL5;CDKL3
prerank,cellular response to ATP (GO:0071318),0.7145061587737722,1.6313547986033412,0.021929824561403508,0.5708500106681174,1.0,8/14,21.50%,P2RY2;HSP90B1;P2RY12;P2RY1;SSH1;TAF1;RYR3;P2RX7
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5785642246445045,1.6280922716171042,0.008293838862559242,0.5805872776524266,1.0,11/50,8.63%,RORA;GPC3;PTCH1;PTCH2;STK36;EVC;GLI1;HHIP;UCHL5;RAB34;SMO
prerank,macrophage chemotaxis (GO:0048246),0.7784027387064845,1.6269462858651327,0.01567398119122257,0.5778053771760794,1.0,3/10,9.37%,LGALS3;TAFA4;CKLF
prerank,urogenital system development (GO:0001655),0.7448730266172348,1.6249833271432563,0.020249221183800622,0.5794864150750643,1.0,3/11,3.35%,OSR2;SOX9;EPHB2
prerank,canonical glycolysis (GO:0061621),-0.5012023423466845,-1.6241223458632739,0.02877697841726619,0.5483616768575967,1.0,10/24,23.62%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.5012023423466845,-1.6241223458632739,0.02877697841726619,0.5483616768575967,1.0,10/24,23.62%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,myelination (GO:0042552),0.5808601518732815,1.623411173101605,0.01090909090909091,0.5795161784275604,1.0,12/46,12.65%,LGI4;MPZ;SCN2A;PLP1;NF1;ARHGEF10;KLK6;EIF2B5;EPB41L3;PMP22;GPC1;MYOC
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5995542762674266,1.6229747351933093,0.01373283395755306,0.5729057064009674,1.0,13/38,18.56%,RORA;PYCARD;TLE1;OTUD7B;NLRX1;PPM1B;ESR1;RHOH;PER1;RIPK1;OTUD7A;ZMYND11;MAPKBP1
prerank,sulfur amino acid catabolic process (GO:0000098),0.7732677586703784,1.6226627691884639,0.0264797507788162,0.5655869796293017,1.0,4/10,8.74%,CTH;TST;CBS;MTRR
prerank,regulation of nervous system development (GO:0051960),0.598283196622724,1.6208535366554482,0.01,0.5666911037432262,1.0,3/37,0.75%,LGI4;NKX6-2;DOCK7
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.43056360793446713,-1.6200374631841719,0.0,0.5490161053959274,1.0,17/45,21.37%,SP100;PRKCD;TRIM25;IRF2;CAMK2G;TRIM5;ICAM1;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9;TRIM21;TRIM68;MT2A;IFNGR2
prerank,protein targeting to ER (GO:0045047),-0.37191251460062874,-1.618003282410031,0.0,0.5432623912086664,1.0,49/99,26.80%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;SPCS2;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;SRPRA;RPS6;SRP14;RPS8;RPL11;RPL12;ZFAND2A;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;GET3;SRP19;RPS10;RPL6;RPL9
prerank,chondrocyte differentiation (GO:0002062),0.6173156096734557,1.6173014856796957,0.017743979721166033,0.5786472263092076,1.0,9/32,9.67%,OSR2;SOX6;SULF1;SOX9;EIF2AK3;TGFB1;CREB3L2;SOX5;AMELX
prerank,regulation of keratinocyte migration (GO:0051547),0.7452998082812796,1.614819894163654,0.010447761194029851,0.5845737933223829,1.0,4/12,2.99%,EPB41L4B;FGF10;PTEN;MAP4K4
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6909694204780767,1.6142742867346993,0.024531024531024532,0.5701732591118165,1.0,3/16,1.66%,APOD;DLC1;PTEN
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6909694204780767,1.6142742867346993,0.024531024531024532,0.5701732591118165,1.0,3/16,1.66%,APOD;DLC1;PTEN
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7090161520885532,1.6137311906408582,0.030349013657056147,0.5650114970098082,1.0,3/14,3.54%,WNK2;ANK3;WNK3
prerank,negative regulation of signal transduction (GO:0009968),0.5081077263344282,1.613582422793152,0.0,0.5578350624202706,1.0,37/249,6.20%,APOD;DCN;GPC3;PTCH1;SOSTDC1;BMP5;UBASH3B;ADAMTS12;SULF1;PTCH2;ERBB3;PRKCQ;CREB3L1;TAX1BP3;FGF2;PTEN;RNF157;BCL2;VGLL4;ERBB2;EGFR;LRP1;PTPRT;ACVR1;FRZB;PTPN2;CADM4;IRAK3;TLE1;SOCS5;FBXW7;WIF1;SLC27A4;HHIP;SOCS1;SHISA2;METTL3
prerank,membrane depolarization (GO:0051899),0.6060742468839357,1.611075842139498,0.016581632653061226,0.5638410600964212,1.0,8/32,6.94%,CACNA1E;SCN7A;SCN2A;CACNA1A;CHRNA4;SCN5A;CACNB4;SCN3A
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6470735031824285,-1.6083305363051346,0.02459016393442623,0.5681968624846964,1.0,9/11,31.18%,ATP6V0D1;ATP6AP1;ATP6V0A2;CAV1;TMEM199;FAS;ATP6V1G1;CCDC115;ATP6V1A
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5616809874432916,-1.6078758234165806,0.03571428571428571,0.5562800107903966,1.0,7/16,19.44%,NOTCH2;ENG;BMPR2;PROX1;TGFB2;HEY2;ZFPM1
prerank,regulation of cartilage development (GO:0061035),0.6812199880364529,1.6074882237539174,0.015536723163841809,0.5768032356778996,1.0,7/18,8.90%,SOX6;SOX9;MBOAT2;PTHLH;ZBTB16;TRPS1;SOX5
prerank,cytoplasmic translation (GO:0002181),-0.37657433724637773,-1.6032682552574413,0.0,0.5616319981314191,1.0,45/91,27.56%,RPS14;GSPT1;RPL24;DRG1;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;FTSJ1;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;DRG2;RPS6;RPS8;RPL11;RPL12;RPL7A;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPL8;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;RPS10;RPL6;RPL9;RPS27
prerank,muscle organ development (GO:0007517),0.5701766140747243,1.6026066741816976,0.005995203836930456,0.5969903584986638,1.0,14/54,11.39%,LAMA2;SOX6;CXCL10;CHODL;UTRN;SGCD;EGR3;EVC;ITGB1BP2;MKX;SGCE;CHD2;MRAS;EMD
prerank,organophosphate catabolic process (GO:0046434),0.741979853153819,1.6024543291901003,0.027607361963190184,0.5895742837553573,1.0,2/11,2.67%,PLBD1;NUDT15
prerank,response to cholesterol (GO:0070723),0.6867438623109388,1.601413960740061,0.023088023088023088,0.587960120548505,1.0,8/17,16.10%,PTCH1;TGFB1;GRAMD1A;TGFBR2;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,aggrephagy (GO:0035973),0.6282076594022079,1.5999134346031358,0.01968503937007874,0.5892043784006915,1.0,15/27,22.85%,DYNLL1;PRKN;WDFY3;ACBD5;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;PARK7;PCNT;WDR81;VIM;UBQLN1;DYNC1H1
prerank,axonogenesis (GO:0007409),0.5041228797870342,1.598391882256039,0.0,0.5907793890352435,1.0,64/237,13.43%,LAMA2;RELN;GFRA1;NTN4;ANK3;PRKCA;DOCK7;LGR6;ENAH;PRKCQ;GLI2;EFNA4;PTEN;SEMA3E;IRS2;EPHB6;GFRA4;SEMA6C;EFNA5;MAP1B;NRCAM;EPHB2;MAPK7;SEMA3A;AUTS2;NRXN1;CTNNA2;WNT5A;SPTBN1;BAIAP2;NTNG2;NTNG1;PPP3CB;S100A6;CNTN6;FYN;GAB2;CNTN2;TNR;DOK6;DOK4;SPG11;DSCAM;DCC;PALLD;PIK3R1;GDNF;KIF5C;USP33;PTPN11;GPC1;MAPK1;OPHN1;EFNB1;PLPPR4;CDK5R1;PTPRA;NRP2;UNC5C;EFNB3;RAB3A;DRD2;SH3KBP1;LYPLA2
prerank,ERBB2 signaling pathway (GO:0038128),0.6061938803828371,1.597318719544568,0.0129366106080207,0.5894466835051653,1.0,16/31,22.34%,PRKCA;ERBB3;ERBB2;EGFR;ERBIN;BTC;ERBB4;PIK3R1;PTPN18;MYOC;GAB1;HBEGF;GRB2;SOS1;CPNE3;NRG1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6441757088943394,1.5956313600083525,0.03369272237196765,0.5918329451791855,1.0,3/22,8.12%,APOD;PDE3B;ASXL3
prerank,glial cell differentiation (GO:0010001),0.6187942426014662,1.5948816699080322,0.017639077340569877,0.5888936099076383,1.0,7/28,7.61%,RELN;ERBB3;SOX8;FGF10;SOX9;SOX11;EIF2B5
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6816066598312231,1.5942097923294556,0.024759284731774415,0.5852056515324048,1.0,3/18,2.35%,FFAR4;CRH;PRKN
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6899106668453274,1.5938050129914028,0.027576197387518143,0.5803849882250128,1.0,2/16,1.40%,APOD;PYCARD
prerank,muscle tissue morphogenesis (GO:0060415),-0.5462377393027459,-1.5923805403661642,0.026936026936026935,0.5933834155458785,1.0,7/16,19.44%,BMP4;MYLK;TBX1;EFEMP2;PROX1;HEY2;ZFPM1
prerank,camera-type eye morphogenesis (GO:0048593),0.7475393806586512,1.59124749045033,0.01834862385321101,0.5873532159928458,1.0,3/10,5.06%,TENM3;VEGFA;NF1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.6016558313462816,-1.5887443762641176,0.046875,0.5947424263335863,1.0,5/12,11.03%,PARP3;PARP10;PARP1;PARP6;PARP12
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7008357693786251,1.5851153698172114,0.030165912518853696,0.6162361031229705,1.0,4/14,3.66%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,cellular response to type I interferon (GO:0071357),-0.43663529612928387,-1.5850178718828145,0.005235602094240838,0.5831911848454876,1.0,18/41,21.82%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;IFNAR2;RSAD2
prerank,type I interferon signaling pathway (GO:0060337),-0.43663529612928387,-1.5850178718828145,0.005235602094240838,0.5831911848454876,1.0,18/41,21.82%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;IFNAR2;RSAD2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7385993485482811,1.5828072883667943,0.04643962848297214,0.6221195744363528,1.0,3/11,13.22%,PRKCQ;CARD9;MALT1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.697634443673107,1.57963218750331,0.01293103448275862,0.633033797922615,1.0,4/16,7.17%,RORA;PRKN;RORC;PDK3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.480771026501195,-1.5795591178330228,0.01509433962264151,0.591913726674564,1.0,10/26,9.47%,OSBPL8;SORBS1;IGF1;OCLN;CLIP3;CREBL2;PRKCI;INSR;RHOQ;ARPP19
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5787977587061317,-1.579337763075164,0.0443213296398892,0.5803172118304071,1.0,6/13,12.77%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ;ECHDC3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.43546854528826884,-1.5773041822793257,0.009615384615384616,0.576668015466235,1.0,24/39,30.62%,RPS14;NPM1;RPS16;RPS19;WDR3;RPS25;RPS15;RIOK3;RPS6;EMG1;SURF6;MRPS7;RIOK1;MRPS11;DDX52;RPS17;SNU13;RPS5;TSR3;RIOK2;PWP2;RPS27;NOL11;NOP14
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6193468823548913,1.5762221782826265,0.0215633423180593,0.6462567498692179,1.0,5/25,4.84%,ANK3;PRKN;KCNA1;TMTC2;MT3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6956398023441213,1.5751473203862236,0.02865329512893983,0.6455405369465802,1.0,1/13,0.13%,SEC16B
prerank,ephrin receptor signaling pathway (GO:0048013),0.5279964835091906,1.573571835869952,0.005567928730512249,0.6479599329251847,1.0,28/82,14.33%,SIPA1L1;MMP2;DNM1;EFNA4;ARPC1B;EPHB6;EFNA5;EPHB2;ARHGEF28;PSEN1;SDC2;GRIN2B;PAK1;RASA1;CHN1;ITSN1;ANKS1B;FYN;VAV3;NCSTN;PTPN11;EFNB1;CDK5R1;ANKS1A;APH1A;EFNB3;EPHA10;PSEN2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.69958993539908,1.5725429164134224,0.02723146747352496,0.6468872388541391,1.0,2/13,0.83%,APOD;MDFIC
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5614245706202831,1.5718581639852818,0.016203703703703703,0.6438147450810615,1.0,21/55,18.20%,DCN;GPC3;HSPG2;VCAN;LUM;FGF2;TGFB1;SDC2;SDC4;BCAN;GALNS;NCAN;GPC1;SDC3;GPC4;IDS;SPAM1;HYAL1;SLC9A1;CSPG4;SGSH
prerank,negative regulation of cartilage development (GO:0061037),0.7091516747027016,1.571752748767519,0.0365296803652968,0.6373721160817416,1.0,4/13,3.66%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,skeletal system development (GO:0001501),0.501772070464706,1.5707902150500361,0.0010384215991692627,0.6361679967656403,1.0,38/148,12.65%,SOX6;BMP5;SULF1;VCAN;ANKH;GLI2;PKDCC;SOX9;AKAP13;FRZB;PTHLH;EIF2AK3;EVC;SOX11;ITGB8;PAPSS2;EXT1;HHIP;WNT5A;HOXD3;COL9A2;ZBTB16;TRPS1;CREB3L2;BCAN;FGFR1;TRIP11;SOX5;ADAMTS4;BPNT2;SLC10A7;NCAN;MMP16;COL1A2;BMP7;KIAA1217;VKORC1;MYOC
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.519061263625476,-1.5707435343740699,0.03690036900369004,0.5916636616880364,1.0,5/20,10.63%,WNT4;CLK2;SIK1;GSK3A;C1QTNF3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5709803982929907,1.5686029665793484,0.012925969447708578,0.6420965551910145,1.0,13/46,12.69%,RELN;TSHZ3;CACNG7;GRIK3;NRXN1;CCR2;SYT1;NLGN1;GRIK1;GRM5;DGKI;OPHN1;DRD2
prerank,eye morphogenesis (GO:0048592),0.6547395319953722,1.5673878945436588,0.02664796633941094,0.6430497764827766,1.0,6/19,8.49%,EFEMP1;TENM3;COL5A2;VEGFA;NF1;RARG
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7069530348013703,1.566025434785811,0.034954407294832825,0.6446961095709756,1.0,4/14,7.90%,PTPN22;CCR2;TGFBR2;IL18
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6362882351410899,-1.5644794559392405,0.057065217391304345,0.5930160612936839,1.0,4/10,10.30%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6362882351410899,-1.5644794559392405,0.057065217391304345,0.5930160612936839,1.0,4/10,10.30%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6146406560044062,1.5642523745462384,0.0203527815468114,0.6480775177076501,1.0,10/27,6.82%,PTEN;IL1RAPL1;FRMD7;NCS1;PSEN1;CTNNA2;FBXO7;DISC1;NTNG2;NTNG1
prerank,regulation of cation channel activity (GO:2001257),0.5232309773203331,1.5642241556503411,0.005482456140350877,0.6415825246555164,1.0,18/89,6.55%,RELN;ANK3;CRH;FGF13;ANK2;GRIA1;CACNG7;GRIA3;CAPN1;HPCA;SHISA9;GRIN2B;DLG2;NLGN1;FGF12;JPH3;CACNB4;FGF14
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5494678361994018,-1.5630250656159488,0.050314465408805034,0.5880940554252868,1.0,10/15,37.46%,ATP1A2;SLC30A1;ADRA2A;NOS1;CBARP;PLN;TMBIM6;STC1;EPO;LILRB1
prerank,negative regulation of chemokine production (GO:0032682),0.6978650752229454,1.5629727881901416,0.03240058910162003,0.6430866766377961,1.0,1/14,0.03%,APOD
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5642424209389006,1.5625661648639786,0.012091898428053204,0.6393164955490854,1.0,12/46,9.88%,WNK2;PTEN;DUSP4;PTPN2;EPHB2;CNKSR3;DUSP6;LMO3;SPRED2;SPRED1;PTPN1;SPRED3
prerank,protein localization to cell junction (GO:1902414),-0.505073785202584,-1.5623104173600793,0.031496062992125984,0.5795882089468676,1.0,6/22,8.22%,TJP1;CGNL1;NLGN2;JAM3;TJP2;PAK2
prerank,nucleotide biosynthetic process (GO:0009165),-0.5376109545766168,-1.5622939705912522,0.02734375,0.5689584394888549,1.0,10/18,22.58%,NMNAT2;ME1;PRPSAP2;RRM1;NMNAT1;RRM2B;PRPS2;GART;PRPS1;PRPS1L1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5921225215951867,-1.5611322708887554,0.04371584699453552,0.5630173872526179,1.0,5/12,9.28%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5901552714849773,1.5607522329390353,0.03254067584480601,0.6439057870096108,1.0,10/32,12.65%,APOD;DLC1;PTEN;SEMA3E;HOXA7;MAP4K4;RASA1;NF2;AJAP1;MYOC
prerank,regulation of neuron projection development (GO:0010975),0.4930998940738757,1.559907996695465,0.0020491803278688526,0.642394165640289,1.0,39/163,12.50%,ROR2;RELN;SIPA1L1;ROR1;TENM3;NTRK3;PTEN;IL1RAPL1;LPAR1;FRMD7;NCS1;SEMA3A;CSMD3;PSEN1;NTRK2;MT3;TANC2;CTNNA2;LRRC4C;WNT5A;FBXO7;PAK1;ALKAL2;CHN1;CDKL5;DISC1;NTNG2;NTNG1;RAP1A;GAK;BAG5;DCC;HDAC2;PPFIA2;FKBP4;MAGI2;CDK5R1;LZTS3;MYLIP
prerank,membrane assembly (GO:0071709),0.59213732953226,1.5597876250760427,0.022641509433962263,0.6368218453432128,1.0,9/34,8.19%,ANK3;CEL;LRP4;PTEN;IL1RAPL1;NRXN1;SPTBN1;NLGN1;GAK
prerank,negative regulation of signaling (GO:0023057),0.6161289046661863,1.5592095197922464,0.024869109947643978,0.6342023877519747,1.0,6/25,9.75%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.49393121894966574,-1.5591224584261787,0.039285714285714285,0.5608162886816448,1.0,10/22,24.25%,SNX9;ROCK1;TIMP3;ADRA2A;TIMP2;NRDC;APOE;TIMP4;SNX33;SH3D19
prerank,negative regulation of cell projection organization (GO:0031345),0.560124330279831,1.5587963477339688,0.02181818181818182,0.6306688080411664,1.0,20/48,20.12%,PTEN;GORASP1;LPAR1;SEMA3A;PRNP;MT3;GRIN2B;FYN;GAK;BAG5;DCC;HDAC2;FKBP4;MYLIP;STX1B;EFNB2;RTN4RL1;KANK1;DENND5A;PTPRS
prerank,regulation of stem cell proliferation (GO:0072091),-0.5437255538075078,-1.5584593236224538,0.040625,0.5536992011320452,1.0,9/17,15.06%,GJA1;FBLN1;KDM1A;ZFP36L1;ACE;AGO3;PTPRC;HMGA2;TERT
prerank,positive regulation of sodium ion transport (GO:0010765),0.7215146004221408,1.5574440748369547,0.03582089552238806,0.6324039512167041,1.0,6/12,15.13%,ANK3;WNK3;CNKSR3;SCN5A;AHCYL1;PKP2
prerank,regulation of T cell differentiation (GO:0045580),0.5993302574900713,1.5566772684356074,0.018844221105527637,0.6309623461468307,1.0,11/33,17.76%,IL2RA;CBFB;CCR2;METTL3;ZMIZ1;RHOH;ZBTB1;GATA3;RUNX1;ABL1;MDK
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6413709745927899,1.5541366306914837,0.038135593220338986,0.639482163578398,1.0,3/19,4.08%,RAPSN;NQO1;CHRNA4
prerank,ERBB signaling pathway (GO:0038127),0.5357496332903603,1.553341820722857,0.01160092807424594,0.6377632791592704,1.0,17/64,12.63%,EFEMP1;PRKCA;ERBB3;REPS2;GAREM1;SOX9;ERBB2;EGFR;TGFB1;ERBIN;BTC;ERBB4;PIK3R1;CBL;PTPN11;MAPK1;PTPN18
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.48240011670345695,-1.5515501242529641,0.043478260869565216,0.5690924323042147,1.0,12/25,29.82%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3;ADPGK;PKM
prerank,prostanoid biosynthetic process (GO:0046457),-0.5707075335894553,-1.5500794506608189,0.04746835443037975,0.564686941334077,1.0,5/15,7.97%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,extracellular matrix organization (GO:0030198),0.4832246837399719,1.5482309845241697,0.0,0.6612014239887134,1.0,52/276,9.48%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;A2M;ADAM19;HAS2;LUM;ADAMTS20;CREB3L1;FGF2;COL5A3;COL20A1;GSN;COL28A1;LAMC1;P4HA1;COL5A2;PXDN;RECK;HTRA1;CAPN1;COL4A2;COL27A1;COL26A1;TGFB1;GPM6B;ITGB8;NF1;COLGALT2;NID1;COL9A2;MMP15;PLEC;CTSK;ADAMTS1;LOXL3;BCAN;POSTN;CYP1B1;TNR;COL18A1;TLL2;ADAMTS4;COL3A1;PLOD1;SPARC
prerank,actomyosin structure organization (GO:0031032),-0.37308360960454456,-1.5482151454199222,0.0,0.561246796601025,1.0,15/75,6.22%,TJP1;SORBS1;PHACTR1;ROCK2;FRMD5;TMOD3;PGM5;MYH9;ROCK1;ITGB5;TNFAIP1;EPB41L5;EPB41;CIT;TPM1
prerank,myotube cell development (GO:0014904),-0.6286091669070943,-1.547757473933933,0.041916167664670656,0.553857456208237,1.0,2/10,7.30%,IGF1;SIX1
prerank,indolalkylamine catabolic process (GO:0046218),0.7384688559233568,1.5465823675661527,0.032208588957055216,0.6645634810520648,1.0,3/10,9.64%,AADAT;KYNU;IL4I1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5687754925956451,1.5458983238442954,0.02014218009478673,0.6627183415890352,1.0,11/41,9.79%,RELN;ERBB3;GPRC5B;FBXW7;NCF1;NTRK2;PRNP;FYN;BTC;PTPN1;GRM5
prerank,sulfur compound catabolic process (GO:0044273),0.59207481733319,1.5451882026495054,0.02369077306733167,0.6608034860227093,1.0,8/38,7.19%,DCN;VCAN;CTH;LUM;TST;DPEP1;BCAN;GALNS
prerank,basement membrane organization (GO:0071711),0.6853425534187673,1.5433979178409998,0.0391566265060241,0.6661100671101573,1.0,5/14,6.82%,NTN4;PXDN;NID1;NTNG2;NTNG1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6213029585344295,-1.541759694875587,0.04120879120879121,0.5658787429188024,1.0,4/10,10.75%,PLPP1;GAP43;PARD3;DGKH
prerank,microtubule anchoring (GO:0034453),0.710389900457274,1.5397158522299061,0.043478260869565216,0.6817692695799963,1.0,5/12,10.80%,SAXO2;BICD1;PCM1;CLASP1;BICD2
prerank,base conversion or substitution editing (GO:0016553),0.7331621649705132,1.5385939673206448,0.038109756097560975,0.6822577817147177,1.0,4/11,13.08%,METTL3;APOBEC1;ADARB2;ADARB1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6062778177162009,-1.5380988938220863,0.0625,0.5704495677418526,1.0,6/11,15.89%,PARP3;PARP4;PARP10;PARP6;PARP12;PARP14
prerank,acyl-CoA metabolic process (GO:0006637),0.5829550755304793,1.5380251051336273,0.016414141414141416,0.6793185682727775,1.0,14/35,20.99%,ACACA;DLST;THEM4;OXSM;ACOT11;ACSF2;SUCLA2;ACSL6;HMGCS2;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,regulation of adaptive immune response (GO:0002819),0.6472330756215454,1.537800601514579,0.03910614525139665,0.6748606027063204,1.0,6/18,13.21%,PYCARD;FADD;SAMSN1;IL4I1;IL6ST;AHR
prerank,regulation of myelination (GO:0031641),0.6097600968906954,1.5354483658279157,0.03562005277044855,0.6828477564911146,1.0,5/25,8.97%,LGI4;NKX6-2;EIF2AK3;TMEM98;NSUN5
prerank,regulation of metal ion transport (GO:0010959),0.6617935238768877,1.5347263968345868,0.05224963715529753,0.6815275668798091,1.0,4/16,1.85%,IL16;BCL2;CACNA2D1;ANK2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6255072796620237,1.5333655848022032,0.03927068723702665,0.6834638326277902,1.0,2/22,0.83%,APOD;MDFIC
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6358570211623427,1.5330574302141264,0.03480589022757698,0.6796079623400489,1.0,9/21,18.76%,CREB3L1;PRKN;EIF2AK3;SELENOS;HERPUD1;NCK1;OPA1;BCL2L11;PARK7
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6740256375272805,1.5323994543281618,0.05473372781065089,0.6779309230201367,1.0,5/15,10.11%,EDA;GLI2;SCN5A;AMELX;HDAC2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6920323978150312,1.5316188557688613,0.03939393939393939,0.6767940383045137,1.0,14/14,30.86%,SEC24D;SEC31B;SEC24C;RAB1A;TBC1D20;SEC24A;SEC23B;MIA3;SEC23A;SCAP;SAR1A;SEC13;SEC31A;SEC24B
prerank,positive regulation of neuron projection development (GO:0010976),0.5096497607504481,1.531483926815199,0.006607929515418502,0.6722511569591686,1.0,10/85,7.42%,ROR2;RELN;ROR1;BMP5;TENM3;NTRK3;NTRK2;WNT5A;ALKAL2;RAP1A
prerank,smooth muscle contraction (GO:0006939),-0.5762660810312322,-1.5311028186041145,0.03426791277258567,0.5883234526739951,1.0,6/14,14.80%,ROCK2;ROCK1;PIK3C2A;MYLK;MYH11;ACTA2
prerank,cellular response to estradiol stimulus (GO:0071392),0.6428139239187306,1.5290983443908526,0.037921348314606744,0.6804426657149446,1.0,8/18,19.23%,SSTR1;EGFR;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4777795425695273,1.527455217681932,0.0,0.6841633045176292,1.0,35/214,7.42%,ROR2;FFAR4;ROR1;WNK2;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTEN;PTPN22;GAREM1;DUSP4;ERBB2;EGFR;PTPN2;EPHB2;FBXW7;TGFB1;CCL4;NTRK2;MT3;CNKSR3;DUSP6;YWHAZ;ALKAL2;LMO3;SPRED2;CARD9;ACKR3;SPRED1;RAP1A
prerank,cardiac conduction system development (GO:0003161),-0.4704589692172047,-1.5271324312016896,0.034934497816593885,0.5949153368886306,1.0,6/24,4.38%,NOTCH2;GJA1;BMP4;GJB6;MAML1;CACNA1G
prerank,bicellular tight junction assembly (GO:0070830),-0.4159711010095652,-1.5264035053619063,0.006060606060606061,0.5890131078794418,1.0,12/46,8.89%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7
prerank,positive regulation of nuclear division (GO:0051785),-0.4823926541888865,-1.5262522418921507,0.03345724907063197,0.5808548973503134,1.0,7/25,9.92%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.5413653066306555,1.5256516075690976,0.015186915887850467,0.6889856407505955,1.0,11/57,5.72%,RELN;CRH;GRIA1;CACNG7;DLGAP1;GRIA3;CAPN1;SHISA9;GRIN2B;DLG2;NLGN1
prerank,positive regulation of vascular permeability (GO:0043117),-0.5737660222998578,-1.5248770756707615,0.05309734513274336,0.5773683333597803,1.0,6/12,7.65%,BMP6;TJP1;ANGPT1;OCLN;PDE3A;TJP2
prerank,regulation of protein export from nucleus (GO:0046825),-0.4966646263639286,-1.5241250931243595,0.030418250950570342,0.5716535109839199,1.0,6/23,8.21%,SP100;PTPN14;XPO4;IFI27;GSK3B;CAMK1
prerank,positive regulation of calcium ion import (GO:0090280),0.7065064421355729,1.5236715757196782,0.04185351270553064,0.694689755634094,1.0,1/12,0.37%,LGALS3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6313941584970573,1.520957901692988,0.04207573632538569,0.7050297959984099,1.0,6/20,8.59%,BMP5;SLC27A1;ERLIN2;FBXW7;ASXL3;BRCA1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6498835420100064,1.52093943230804,0.058091286307053944,0.6997361960182581,1.0,4/18,7.73%,DCN;SPIRE1;PRKN;BNIP3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.7020130136660188,1.5201539185050372,0.048265460030165915,0.6989631207524024,1.0,5/12,6.89%,CTH;CBS;PSPH;PSAT1;PHGDH
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5059900221877216,1.5200316961837153,0.003188097768331562,0.6943456044789963,1.0,32/107,15.56%,RELN;CEL;CLSTN2;PTEN;NGF;NRG3;GRIK3;DLGAP1;CACNA1A;GRIK5;GRIK2;SLC12A2;LRRC4C;GRID2;SYT1;NLGN1;SLC8A2;GRIK1;USP46;SYN1;NMU;GRM5;MCTP1;PXK;DGKI;RIMS1;OPHN1;DRD2;CLSTN1;ITGB1;HOMER1;STX1B
prerank,ubiquinone biosynthetic process (GO:0006744),-0.5565131860860473,-1.5195104711311074,0.06451612903225806,0.5803406200624301,1.0,10/15,26.69%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;NDUFA9;FDXR;PDSS2;COQ6;COQ8A
prerank,external encapsulating structure organization (GO:0045229),0.47912138188644754,1.5189357984573169,0.0,0.6956242705783455,1.0,39/205,10.98%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;FGF2;COL5A3;COL28A1;LAMC1;TGM1;COL5A2;PXDN;RECK;COL4A2;COL27A1;ITGB8;NF1;NID1;COL9A2;MMP15;ADAMTS1;BCAN;POSTN;TNR;COL18A1;HRNR;ADAMTS4;COL3A1;SPARC;NCAN;MMP16;COL1A2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6355994260540222,1.5172851563207004,0.042582417582417584,0.6998046065791911,1.0,6/20,13.69%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;SMOC2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6230633769818965,1.517210797223912,0.040376850605652756,0.6952047879597906,1.0,4/22,4.81%,LGALS3;PTPN22;PTPN2;PRNP
prerank,sphingosine biosynthetic process (GO:0046512),-0.5997060167931879,-1.5164051633118745,0.0521978021978022,0.5755983893085154,1.0,6/11,25.69%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,sphingoid biosynthetic process (GO:0046520),-0.5997060167931879,-1.5164051633118745,0.0521978021978022,0.5755983893085154,1.0,6/11,25.69%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4821646804658032,1.5159288139663079,0.0020833333333333333,0.6976313343408983,1.0,23/151,7.42%,ROR2;FFAR4;ROR1;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;EGFR;FBXW7;TGFB1;CCL4;NTRK2;MT3;ALKAL2;CARD9;ACKR3;RAP1A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5728537316403882,1.515630398047893,0.03850931677018633,0.694378326627333,1.0,13/34,14.80%,UBASH3B;PTPN22;DUSP4;PTPRT;PTPN2;DUSP6;PTPN13;PTPN1;PTPRJ;PTPN11;PTPN18;PTPRZ1;PTPRF
prerank,lymphocyte chemotaxis (GO:0048247),0.5714403090899774,1.5154981674861652,0.03522012578616352,0.6902358497137205,1.0,6/34,10.16%,CCL11;CXCL10;CCL4;SLC12A2;CKLF;CYP7B1
prerank,negative regulation of viral genome replication (GO:0045071),-0.42644403914113893,-1.5150684453030423,0.011627906976744186,0.5727742959451021,1.0,15/40,21.82%,ZC3HAV1;PLSCR1;IFITM3;IFIH1;PARP10;TNIP1;IFITM2;OAS2;PROX1;HMGA2;TASOR;ISG15;IFIT1;BST2;RSAD2
prerank,diol metabolic process (GO:0034311),-0.5047188588010268,-1.5128029654794202,0.05017921146953405,0.5732693443375937,1.0,9/19,24.24%,PLPP1;NOS3;DEGS2;ASAH2;HSP90AA1;SPR;SPHK1;AKT1;SPHK2
prerank,T cell differentiation in thymus (GO:0033077),0.6769762541411045,1.511334480265711,0.0547112462006079,0.7096056965337992,1.0,5/14,12.08%,RAG2;FADD;RABL3;ZFP36L2;MR1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6812791620619063,1.51089668547221,0.03982300884955752,0.7071300688254386,1.0,6/13,12.80%,SOSTDC1;SOX8;SOX9;TGFB1;PRICKLE1;EID2B
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6160035781386045,1.510133998824402,0.050271739130434784,0.706698808400043,1.0,11/21,22.29%,SULF1;HS6ST1;EXT1;EXTL3;GLCE;GPC1;HS2ST1;UGDH;SGSH;XYLT1;SULF2
prerank,regulation of sodium ion transport (GO:0002028),0.5691832295842372,1.5097478078275604,0.043037974683544304,0.7038736502760019,1.0,11/34,15.13%,WNK2;ANK3;NKAIN2;WNK3;CNKSR3;SCN5A;FGF12;DRD2;PER1;AHCYL1;PKP2
prerank,cell-cell junction maintenance (GO:0045217),-0.6010798671528298,-1.508858783115596,0.06764705882352941,0.5800759374157001,1.0,2/11,3.26%,TJP1;NLGN2
prerank,sulfur amino acid metabolic process (GO:0000096),0.5992132128545763,1.5085524231702838,0.051075268817204304,0.7056400308336699,1.0,9/24,15.09%,CTH;TST;DPEP1;CBS;AHCY;SMS;MTRR;ADI1;MTR
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6925864587512853,1.5072274381844442,0.045317220543806644,0.7078673799915167,1.0,6/14,13.20%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;GATA3
prerank,positive regulation of cartilage development (GO:0061036),0.6310135338497795,1.5071230189070755,0.06060606060606061,0.7035868186442433,1.0,5/17,8.90%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.6014988849060647,-1.5051164220576823,0.0641025641025641,0.5860278562605598,1.0,3/10,8.34%,PODXL;WNK1;DPP4
prerank,positive regulation of transporter activity (GO:0032411),0.6775573413711413,1.5050788729165328,0.0581039755351682,0.7105261028111843,1.0,5/13,9.41%,SYNGR3;KMT2A;WNK3;STK39;SGK2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6527566838044392,1.504469228160061,0.05857142857142857,0.7089885770590115,1.0,5/15,10.03%,DCN;VCAN;BCAN;CSGALNACT1;NCAN
prerank,wound healing (GO:0042060),0.5155184406254423,1.502151280787096,0.02522935779816514,0.7174159404925378,1.0,19/62,13.71%,DCBLD2;PDGFRA;ERBB3;EPB41L4B;FGF2;FGF10;ERBB2;CLDN1;NF1;WNT5A;PAK1;PLEC;FZD7;PPP3CA;COL3A1;SYT11;ANXA6;RAB3A;CORO1B
prerank,triglyceride homeostasis (GO:0070328),0.5968381864078626,1.5001793739913647,0.05242463958060288,0.7237129311025359,1.0,6/26,15.20%,RORA;MLXIPL;IL18;PNPLA8;MTLN;LIPC
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5718334012130092,1.497633437184163,0.0410783055198973,0.7336293628894222,1.0,10/28,21.39%,PRKCQ;PYCARD;FGF10;CCR2;XRCC6;SH3KBP1;TICAM1;SIRPA;HSPD1;TNIP2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6753455604282085,1.4970620975279723,0.04940119760479042,0.732246676203206,1.0,5/13,13.63%,AADAT;IDH2;DLST;GOT2;GPT2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5602624389088551,1.4961649167646949,0.03523693803159174,0.7328226984760443,1.0,14/36,18.82%,RELN;EPHB2;FBXW7;NCF1;CCR2;BTC;HIF1A;HDAC2;HDAC6;ITGB1;HBEGF;NCOA3;PARK7;TAF1
prerank,negative regulation of cellular component movement (GO:0051271),-0.5514122089158481,-1.495296702532301,0.056782334384858045,0.6140753365868015,1.0,5/15,9.34%,SP100;FRMD5;FBLN1;ACTN1;CCDC125
prerank,embryonic appendage morphogenesis (GO:0035113),0.6863753485888953,1.492136745916931,0.060653188180404355,0.7507998764675137,1.0,1/12,0.46%,PTCH1
prerank,cellular lipid catabolic process (GO:0044242),0.5807841389083477,1.4913379530631194,0.049479166666666664,0.7501976791162253,1.0,6/27,8.14%,PLBD1;CEL;MT3;ACBD5;CYP1B1;ACOX1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6875998175578931,1.4911227359596082,0.058997050147492625,0.7466369974749396,1.0,7/13,21.80%,VDAC2;BMF;BNIP3;RHOT2;BCL2L11;RHOT1;BNIP3L
prerank,tight junction assembly (GO:0120192),-0.40219030065973027,-1.4910875929593252,0.01875,0.6213848280799319,1.0,12/49,8.89%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7
prerank,Golgi organization (GO:0007030),0.4903059141515428,1.4904635211954895,0.013963480128893663,0.7457005726122015,1.0,35/112,18.97%,SEC16B;TMED6;ATP8B1;GORASP1;HACE1;VAMP4;BLZF1;GOLGB1;OBSL1;YWHAZ;ARL1;GBF1;GAK;BAG5;TRIP11;TMED10;HUWE1;CLASP1;PI4K2A;GORASP2;ARHGAP21;RAB1A;ATL3;USP6NL;CSNK1A1;TBC1D20;TMED3;TMED2;SEC23IP;ARFGEF1;SURF4;HTT;STX17;RAB30;COG1
prerank,bicarbonate transport (GO:0015701),-0.48308206050379243,-1.4891411453413443,0.038461538461538464,0.6204279109314229,1.0,11/25,24.59%,SLC26A7;SLC4A10;SLC4A3;SLC39A8;CYB5R4;CA4;SLC4A8;CYB5R1;SLC26A6;CA2;CYB5RL
prerank,cellular component disassembly (GO:0022411),0.5293851619825712,1.488023998980788,0.023668639053254437,0.7548737695201978,1.0,14/53,14.87%,MMP2;A2M;GSN;LAMC1;HTRA1;CAPN1;MMP15;CTSK;TLL2;ADAMTS4;MMP16;MMP19;SCUBE1;WASHC1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6808366612413168,1.4878006255495795,0.06231454005934718,0.7514114911494697,1.0,7/13,17.54%,DCN;VCAN;BCAN;NCAN;IDS;HYAL1;CSPG4
prerank,extracellular matrix disassembly (GO:0022617),0.5289034140644914,1.4868099261556658,0.02372479240806643,0.7523426159397072,1.0,14/53,14.87%,MMP2;A2M;GSN;LAMC1;HTRA1;CAPN1;MMP15;CTSK;TLL2;ADAMTS4;MMP16;MMP19;SCUBE1;WASHC1
prerank,outer dynein arm assembly (GO:0036158),-0.5267871967961393,-1.486450006313134,0.08552631578947369,0.6224945205017535,1.0,11/15,42.14%,LRRC49;ODAD1;DNAH8;DNAAF5;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6891292380110245,1.4864208129355205,0.06351550960118169,0.7496276519389051,1.0,2/12,1.40%,CXCL10;PYCARD
prerank,extracellular structure organization (GO:0043062),0.46872070179957315,1.4861896455087624,0.0010152284263959391,0.7463154297511551,1.0,37/204,10.98%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;FGF2;COL5A3;COL28A1;LAMC1;COL5A2;PXDN;RECK;COL4A2;COL27A1;ITGB8;NF1;NID1;COL9A2;MMP15;ADAMTS1;BCAN;POSTN;TNR;COL18A1;ADAMTS4;COL3A1;SPARC;NCAN;MMP16;COL1A2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.34571813546280805,-1.4860369287426594,0.011111111111111112,0.6164215931154605,1.0,24/87,13.37%,PTPRK;GCNT2;SMAD6;CDH5;FMOD;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PARD3;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;USP15
prerank,negative regulation of viral process (GO:0048525),-0.3824940935461038,-1.4853725784951484,0.029197080291970802,0.6112590221532105,1.0,20/57,21.82%,ZC3HAV1;CHMP3;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TRIM5;TNIP1;IFITM2;LARP7;OAS2;PROX1;PML;TRIM21;ISG15;IFIT1;BST2;HEXIM1;RSAD2
prerank,covalent chromatin modification (GO:0016569),0.6557220220587767,1.4844008251090222,0.07863501483679525,0.7519506515418958,1.0,10/14,27.41%,MT3;HLCS;UFL1;MBD2;HELLS;SETD5;PARK7;CHD1;HDAC1;SIRT1
prerank,tryptophan catabolic process (GO:0006569),0.691961483540957,1.4838391734488414,0.05697151424287856,0.7507337663683534,1.0,3/11,9.64%,AADAT;KYNU;IL4I1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7253897277907528,1.4837398271487556,0.04574132492113565,0.7467155344875696,1.0,2/10,1.76%,DCN;BCL2
prerank,positive regulation of cation channel activity (GO:2001259),0.5534232346281631,1.483238119424401,0.03398058252427184,0.7450396098415086,1.0,5/40,5.23%,RELN;ANK3;ANK2;EPHB2;CCR2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5053732143300498,1.4829260853534258,0.022909507445589918,0.7422811982988315,1.0,11/72,4.52%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;IRS2;SOX9;NCF1;NTRK2
prerank,estrogen metabolic process (GO:0008210),0.6468306377378379,1.4824864092471266,0.053811659192825115,0.7402384700449702,1.0,3/15,7.15%,HSD17B7;HSD17B11;CYP1B1
prerank,dorsal/ventral pattern formation (GO:0009953),0.6080127666200029,1.481316984291624,0.055944055944055944,0.7423840112462552,1.0,4/20,5.82%,PTCH1;GLI2;ACVR1;FBXL15
prerank,negative regulation of axonogenesis (GO:0050771),0.5835646937394139,1.4801142824508797,0.040897097625329816,0.7447254675242623,1.0,11/27,16.43%,FGF13;LRP4;PTEN;RNF6;MT3;CDKL3;DCC;NGFR;EFNB3;RTN4;DIP2B
prerank,positive regulation of dendritic spine development (GO:0060999),0.6070075529946957,1.480072324173025,0.055710306406685235,0.7405958487784782,1.0,4/20,8.00%,RELN;PSEN1;NLGN1;CPEB3
prerank,vasculogenesis (GO:0001570),0.5591883975955507,1.4795776196408312,0.06012269938650307,0.7389298949774012,1.0,8/32,7.08%,HAS2;GLMN;VEGFA;TGFB1;ITGB8;RASA1;TGFBR2;SPRED1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5566103616158011,1.474974518588569,0.0622568093385214,0.7603081509549615,1.0,15/33,19.99%,FGF10;STXBP4;EGFR;UBE2E2;PLCB1;GLI1;ADAMTS1;EIF4G1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX;PHB2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5261797508385099,1.4749490588985912,0.03431952662721893,0.7561047736304869,1.0,21/51,16.91%,KIF20B;NGF;MAP4K4;GAS7;TNIK;NYAP1;PAK1;ALS2;CNTNAP2;GPM6A;EPB41L3;DCLK1;BMP7;TAOK3;WASF1;TRIO;SNX1;ANKRD27;UBB;SGK1;CTTN
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.48875071825883043,-1.4748993657954068,0.06620209059233449,0.6423942736145553,1.0,9/19,16.18%,BMP6;AFDN;TJP1;RGCC;NOTCH4;NEXMIF;PTPRU;FLOT1;PPM1F
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.600448886416735,1.4747344526358408,0.07489597780859916,0.7529465034498816,1.0,6/21,10.03%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,regulation of lymphocyte migration (GO:2000401),-0.6180816620445966,-1.4730534931594432,0.04748603351955307,0.641935142009326,1.0,5/10,22.44%,WASL;SLC8B1;STK10;MSN;AKT1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7022338395446122,1.4728625135710967,0.07511737089201878,0.7596450413050444,1.0,3/10,5.93%,GCDH;IVD;ETFA
prerank,embryonic limb morphogenesis (GO:0030326),0.5602396654840885,1.4724664719003977,0.05056890012642225,0.7575590619908983,1.0,4/34,1.94%,OSR2;PTCH1;AFF3;WDPCP
prerank,regulation of Rac protein signal transduction (GO:0035020),0.633896316205512,1.471380689755188,0.06966618287373004,0.7598616742376015,1.0,4/16,6.14%,ARHGAP24;CADM4;AUTS2;ALS2
prerank,axon guidance (GO:0007411),0.46502901040821376,1.470689379381617,0.0010152284263959391,0.759402690775745,1.0,53/201,13.43%,LAMA2;RELN;GFRA1;NTN4;PRKCA;LGR6;ENAH;PRKCQ;GLI2;EFNA4;SEMA3E;IRS2;EPHB6;PLXNC1;GFRA4;SEMA6C;EFNA5;VEGFA;EPHB2;MAPK7;SEMA3A;NRXN1;WNT5A;SPTBN1;CHN1;CNTN6;FYN;GAB2;CNTN2;TNR;DOK6;SMO;DOK4;DSCAM;DCC;PALLD;PIK3R1;GDNF;KIF5C;USP33;PTPN11;GPC1;MAPK1;OPHN1;EFNB1;CDK5R1;PTPRA;NRP2;UNC5C;RHOH;EFNB3;SH3KBP1;LYPLA2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.605255938217954,1.4705876601045884,0.07832167832167833,0.7556765065080405,1.0,8/20,15.26%,GCDH;ACACA;SCD5;ACLY;FASN;PPT2;FAR1;ACSL3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.47267318256446683,1.4705390127204316,0.006141248720573183,0.7517837792739828,1.0,31/159,10.12%,DCHS1;CDH19;MPZ;TENM2;CLDN19;TENM3;IL1RAPL1;PTPRT;ACVR1;DSG2;CDH10;CLDN1;CDH22;PCDHGB4;LRRC4C;GRID2;OBSL1;CDH8;NLGN1;CADM3;TGFBR2;KIRREL3;NTNG1;HMCN1;CNTN6;CADM1;CNTN2;CDH20;CDH7;DSCAM;PALLD
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6709626425786036,1.4701093752047005,0.09653092006033183,0.7500154693947096,1.0,3/11,7.26%,SOX6;TGFB1;FZD7
prerank,positive regulation of behavior (GO:0048520),0.6923430683567424,1.4668110646707622,0.06327160493827161,0.7645862846044267,1.0,3/10,5.72%,SGIP1;CRH;NLGN1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.47349231031812045,-1.4657802141591398,0.05776173285198556,0.6619711118868912,1.0,9/22,4.56%,ROBO1;CDH5;NRP1;MYH9;PIK3R3;ID1;SLIT2;EPHB4;KDR
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.6704544489447992,1.4654157567448363,0.06504065040650407,0.7687822416473806,1.0,8/12,28.91%,H6PD;KPNB1;CLCN2;SREBF2;MBTPS1;SEC14L2;DGKQ;MBTPS2
prerank,odontogenesis (GO:0042476),0.5509399795709412,1.4647670711899763,0.05972045743329098,0.7679043182323904,1.0,7/35,10.98%,OSR2;EDA;GLI2;SCN5A;AMELX;HDAC2;COL1A2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5154380097064164,-1.4643601999803915,0.06349206349206349,0.6592184961198486,1.0,8/16,22.90%,NOS3;GUCY1B1;DDAH2;NOS1;APOE;NDNF;KCNC2;AGT
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5268611162863314,1.4639413751653467,0.04257907542579075,0.7683678362160508,1.0,17/45,20.76%,EFEMP1;REPS2;GAREM1;SOX9;EGFR;TGFB1;ERBIN;BTC;PIK3R1;CBL;PTPN11;IQGAP1;GAB1;HBEGF;GRB2;AAMP;SOS1
prerank,protein heterotetramerization (GO:0051290),0.6535864318263254,1.462336019682678,0.05830903790087463,0.773326859077131,1.0,5/13,14.69%,FARSA;CPSF6;GRIN2B;FARSB;PKD1
prerank,sphingosine metabolic process (GO:0006670),-0.5096185771810471,-1.4621964729792967,0.0756578947368421,0.6595568263211259,1.0,7/17,25.69%,PLPP1;ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.46557670259609024,1.4620435687818134,0.007238883143743537,0.7707978923475333,1.0,44/173,15.86%,SEC16B;TMED6;DYNLL1;ANK3;ANK1;ANK2;GORASP1;PGAP1;GRIA1;SEC24D;VAMP4;COG5;COPZ2;GOLGB1;SPTBN1;TRAPPC6B;GBF1;COPB2;COPG2;TRIP11;TMED10;SEC24C;KDELR2;CUL3;DYNC1I1;VAPA;ARF4;BET1L;RAB1A;ATL3;PROS1;DCTN4;KLHL12;TBC1D20;TMED3;DYNC1I2;TMED2;COPA;ARFGAP3;ARFGAP1;COPG1;TRAPPC6A;KDELR3;CNIH4
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5680037355672465,-1.4618353002450828,0.05934718100890208,0.6533301937979743,1.0,4/12,5.29%,CDH5;MAP2;CLIP3;EML2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4875209778152469,1.4617416989522607,0.022975929978118162,0.7682140773039733,1.0,14/85,5.51%,OSR2;BMP5;EPB41L4B;FGF2;MYC;FGF10;SOX9;ERBB2;LAMC1;CDKN2B;EGFR;VEGFA;TGFB1;SCN5A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6572860622326764,1.4612986793622589,0.07863501483679525,0.7666062555494374,1.0,1/13,0.13%,SEC16B
prerank,RNA interference (GO:0016246),-0.5201254169615604,-1.4599089098352873,0.04713804713804714,0.6534762656741119,1.0,10/17,30.18%,AGO1;NRDE2;AGO3;TERT;TARBP2;CLP1;MRPL44;AGO2;DICER1;AGO4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5578738574894753,1.4591892472912702,0.04738154613466334,0.7747816153002727,1.0,8/34,13.40%,RORA;TGFB1;WNT5A;ZFP36L2;WWTR1;ZFPM2;GATA3;TRIO
prerank,neuron cell-cell adhesion (GO:0007158),0.6308961419868495,1.4583341589538297,0.07195301027900147,0.7757772557569341,1.0,5/14,5.72%,CEL;ASTN2;NRXN1;NCAM2;NLGN1
prerank,neutrophil chemotaxis (GO:0030593),0.5077673570381174,1.4580110110692917,0.04738760631834751,0.7736507532525164,1.0,8/53,11.59%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5802887616435322,1.4579338485612627,0.06693989071038252,0.7700554262122482,1.0,6/24,14.76%,GFPT2;MYC;MT3;PID1;COX10;MTLN
prerank,serine family amino acid metabolic process (GO:0009069),0.6317718687420747,1.4578071681057732,0.0670391061452514,0.766813369496456,1.0,4/16,5.58%,CTH;CBS;PSPH;DAO
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.5148828232138167,1.4577200290457644,0.03537735849056604,0.76339290156529,1.0,17/53,15.16%,GLMN;RAD23B;XPO1;PRKN;NUDT15;ARAF;FBXW7;UCHL5;UFL1;OPHN1;TMF1;PRKACA;TMTC3;PKD1;USP14;GABARAPL2;UBB
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6369174762407448,1.4577027168432182,0.06782106782106782,0.759610786909871,1.0,2/16,4.63%,CLDN19;CLDN1
prerank,protein heterooligomerization (GO:0051291),0.61820749478626,1.4574010234336885,0.061196105702364396,0.7575563387803055,1.0,8/17,21.49%,FARSA;CPSF6;GRIN2B;FARSB;TMEM120A;PKD1;MAT2A;PKD2
prerank,embryonic organ morphogenesis (GO:0048562),0.527914574608977,1.456932860552345,0.05745721271393643,0.7563654473137458,1.0,7/42,8.49%,OSR2;EFEMP1;PDGFRA;ACVR1;SOX11;HOXD3;RARG
prerank,negative regulation of neurogenesis (GO:0050768),0.5471902863690071,1.4566792746044996,0.04236200256739409,0.7540007244054999,1.0,9/34,14.55%,CCL11;LRP4;PTEN;GORASP1;PCM1;NF1;NGFR;EFNB3;RTN4
prerank,glial cell development (GO:0021782),0.5752803252874193,1.456246561668086,0.06809078771695594,0.7525851788104045,1.0,7/25,8.97%,MXRA8;SOX11;MT3;NF1;CDK6;EIF2B5;NSUN5
prerank,mesonephros development (GO:0001823),0.6706288636108922,1.4562386210300653,0.0724191063174114,0.7488881437633197,1.0,5/11,13.20%,OSR2;FGF10;ZBTB16;BMP7;GATA3
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6213507713665107,1.4552684718159605,0.06231884057971015,0.750456016556193,1.0,3/18,6.17%,APOD;MDFIC;OTUD7B
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.6014688343481263,-1.4549070720832433,0.09631728045325778,0.6657477220273956,1.0,10/10,39.90%,NAF1;DKC1;RPUSD4;GAR1;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3;NOP10
prerank,epithelium development (GO:0060429),0.479030003621851,1.4544359943964866,0.019251336898395723,0.7511295617811088,1.0,22/107,9.87%,LGALS3;PTCH1;MEOX1;MEOX2;SOX8;FGF10;TST;CD34;SOX9;VEGFA;CNN3;TGFB1;SOX11;UPK1B;CASP6;LOXL3;GATA6;CTSB;PPP2R3A;SMO;RCN3;PIH1D1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6892606976772,1.4542243295269752,0.08634222919937205,0.7485376896425304,1.0,3/10,6.38%,PRKCQ;SOCS1;TGFBR2
prerank,positive regulation of protein secretion (GO:0050714),-0.36806069697445853,-1.4541381610035,0.028037383177570093,0.6612282746926664,1.0,19/69,13.12%,BMP6;WLS;IGF1;MYRIP;RBP4;NLGN2;TLR4;EXOC1;PPIA;NNAT;ABCG1;C1QTNF3;UNC13B;APBB1;SYTL4;AACS;TGFB2;LRRC8A;MYH10
prerank,regulation of lamellipodium organization (GO:1902743),-0.5445323654893217,-1.4540203210321263,0.08125,0.6545141535989492,1.0,6/14,27.66%,CAPZB;PDPN;CDC42;EPHA2;DMTN;TWF2
prerank,positive regulation of B cell proliferation (GO:0030890),0.5611054055846527,1.4539337309003884,0.06501950585175553,0.7463313175943299,1.0,6/29,8.66%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3
prerank,quinone biosynthetic process (GO:1901663),-0.5443734143622897,-1.4535020555287306,0.08766233766233766,0.6492765793282689,1.0,9/14,26.69%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5073289376675265,-1.4534243353367309,0.07357859531772576,0.6425593615299405,1.0,6/17,10.76%,CACNA1C;ATP1A2;GJA1;ATP1A1;GJC1;GJD3
prerank,negative regulation of cell junction assembly (GO:1901889),0.5718811316159007,1.4519431748803509,0.06865284974093264,0.753083208847169,1.0,3/25,1.66%,APOD;DLC1;PTEN
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.47884550711537355,1.4515838029966885,0.024096385542168676,0.751335033257285,1.0,22/100,12.65%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;PTEN;IRS2;SOX9;EGFR;NCF1;NTRK2;PTPN13;FGFR1;IL18;PIK3R1;CBL;MAPK1;MYDGF;FBXL2;MYOC
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.36555864586537357,-1.4508221547976559,0.03571428571428571,0.645347315888859,1.0,10/56,4.03%,BMP6;DAB2;RBPMS;SMAD6;ACVRL1;SMAD7;BMP4;ENG;BMPR2;TGFBR1
prerank,dopaminergic neuron differentiation (GO:0071542),0.6139850168764841,1.4506517271076467,0.07313642756680731,0.7525786616188465,1.0,3/19,5.30%,CDNF;VEGFA;PHOX2A
prerank,endodermal cell fate commitment (GO:0001711),-0.6022177008233454,-1.4505835900110695,0.07799442896935933,0.6395085522322632,1.0,5/10,16.80%,CTR9;LEO1;SOX17;RTF1;PAF1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5544076376233399,1.450348047641998,0.06572164948453608,0.7506475535061691,1.0,8/31,12.44%,RELN;SIPA1L1;PTEN;TANC2;NLGN1;PPFIA2;CDK5R1;LZTS3
prerank,cellular response to alcohol (GO:0097306),0.526029078748628,1.4500122073546973,0.05811138014527845,0.7488398321085277,1.0,14/42,16.10%,PTCH1;PTGFR;GRAMD1A;BRCA1;SMO;GRAMD1C;GNAI1;GRAMD1B;AHR;JUP;KLF9;BLM;SPIDR;GPLD1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6991588796580556,1.4492538338443404,0.06583072100313479,0.7490635954957539,1.0,3/10,2.99%,EPB41L4B;FGF10;MAP4K4
prerank,secretory granule organization (GO:0033363),-0.5768227855332758,-1.449163807176197,0.07807807807807808,0.6383812736561367,1.0,3/10,9.40%,ABCA1;DTNBP1;SRGN
prerank,kidney development (GO:0001822),0.499505653714396,1.4484851020736704,0.030716723549488054,0.7497695290428985,1.0,11/65,6.27%,OSR2;SULF1;HAS2;GLI2;LRP4;FGF10;PRKX;VEGFA;ARL3;NF1;ZBTB16
prerank,establishment of endothelial barrier (GO:0061028),-0.4299631272242466,-1.447925117723937,0.034934497816593885,0.6362861492047587,1.0,10/29,14.23%,AFDN;TJP1;PECAM1;RAP1B;PPP1R16B;TJP2;ICAM1;PDE2A;ROBO4;MSN
prerank,regulation of cell junction assembly (GO:1901888),-0.43226464813156595,-1.4477991239605315,0.03418803418803419,0.6302648824364497,1.0,8/27,1.98%,TJP1;ROCK2;PRKCH;PDLIM5;RAP1B;ROCK1;CLDN5;OCLN
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6778335989522494,1.4469074612341624,0.09233176838810642,0.7549060440598424,1.0,4/10,13.88%,PRKN;MT3;HDAC6;SNCA
prerank,positive regulation of DNA replication (GO:0045740),0.6219363375307395,1.4468094231389683,0.08781869688385269,0.7519015223206634,1.0,4/16,6.05%,GLI2;EGFR;GLI1;STN1
prerank,cellular response to oxygen levels (GO:0071453),-0.5961916550362686,-1.4463549328027308,0.0918918918918919,0.6295317305098462,1.0,8/10,31.18%,ATP6V0D1;NDUFS2;ATP6AP1;ATP6V0A2;TMEM199;ATP6V1G1;CCDC115;ATP6V1A
prerank,endomembrane system organization (GO:0010256),0.45946170285244914,1.4459752244393511,0.012371134020618556,0.7529103145746362,1.0,54/178,19.15%,SEC16B;TMED6;USP50;ANK3;DNM1;ATP8B1;GORASP1;SPAG4;HACE1;EIF2AK3;BLZF1;GOLGB1;OBSL1;SPTBN1;ALS2;LAPTM4B;NUP155;ARL1;GBF1;SEC31B;GAK;BAG5;TRIP11;TMED10;VPS11;HUWE1;VAPA;CLASP1;PI4K2A;GORASP2;ARHGAP21;PHETA2;RAB22A;SNX10;RAB1A;ATL3;USP6NL;AKTIP;CSNK1A1;OTOF;TBC1D20;TMED3;TMED2;SEC23IP;BNIP1;ARFGEF1;SURF4;DYSF;HTT;STX17;REEP5;RAB30;COG1;HOOK2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5430638399080686,-1.443792081926714,0.09202453987730061,0.6327803366390051,1.0,8/13,23.61%,PRPF3;SRSF10;PRPF31;DDX20;SRSF12;SART3;USP4;AAR2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6835481387722744,1.4433506825295255,0.09202453987730061,0.7634255854707007,1.0,6/10,19.39%,SMOX;COMT;SARDH;LRTOMT;SLC44A1;ALDH7A1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6539521699885091,1.4422325004644676,0.09037037037037036,0.7658713500308716,1.0,4/12,10.03%,DCN;VCAN;BCAN;NCAN
prerank,response to ATP (GO:0033198),0.5969225777191914,1.4421590481425304,0.09375,0.7628408221964257,1.0,8/18,21.50%,P2RY2;HSP90B1;P2RY12;P2RY1;SSH1;TAF1;RYR3;P2RX7
prerank,negative regulation of neuron projection development (GO:0010977),0.5070911450778044,1.4421408711046402,0.04863582443653618,0.7594872931423368,1.0,21/56,20.12%,LRP4;PTEN;LPAR1;SEMA3A;MT3;NLGN1;GAK;BAG5;DCC;HDAC2;NGFR;FKBP4;MYLIP;EFNB3;RTN4;STX1B;EFNB2;RTN4RL1;KANK1;DENND5A;PTPRS
prerank,regulation of leukocyte activation (GO:0002694),-0.5251092387143833,-1.4414650547928936,0.07516339869281045,0.6352102143797902,1.0,4/14,3.82%,CD200;MFHAS1;PLSCR1;LYN
prerank,chordate embryonic development (GO:0043009),0.513264332517004,1.4408729026631004,0.049596309111880045,0.7630430905917237,1.0,19/55,17.16%,PTCH1;BMP5;SULF1;SOX8;VEGFA;TGFB1;WNT5A;FGFR1;EGFL8;BRCA1;BMP7;KIAA1217;DVL1;GATA3;COL1A1;PKD1;DACT1;TGFB3;MYH6
prerank,sodium-independent organic anion transport (GO:0043252),-0.5692526918290177,-1.4407011242574637,0.1092896174863388,0.6315029490258524,1.0,4/10,8.78%,SLCO3A1;SLCO2A1;SLCO1C1;SLC16A2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5889200325700468,1.4401659857633669,0.06818181818181818,0.7631710838208199,1.0,7/22,12.45%,NTRK3;NGF;NTRK2;RAP1A;MAGI2;WASF1;ACAP2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5407473839945514,1.4391798502465607,0.06327543424317618,0.7649276790806173,1.0,11/35,13.16%,GCDH;ACACA;ACSS3;HMGCLL1;SCD5;ACLY;FASN;PPT2;FAR1;ALOX5AP;GGTA1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6834791264647199,1.4382592739066458,0.08744038155802862,0.7664060680901368,1.0,5/10,17.62%,KLF15;BRCA1;SNCA;TAF7;CTBP1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.541447053869545,1.4375826029242418,0.055970149253731345,0.7662346299882207,1.0,12/37,20.80%,APOD;PYCARD;CARD9;HIF1A;MAPK14;CHID1;PER1;TICAM1;ABCD2;PDCD4;STAT3;SIRPA
prerank,sphingoid metabolic process (GO:0046519),-0.5611679824329778,-1.4371914085151398,0.0748502994011976,0.637751181496545,1.0,9/12,37.22%,PLPP1;KDSR;DEGS2;ASAH2;SPHK1;SPHK2;PLPP2;SPTLC3;NAAA
prerank,inositol lipid-mediated signaling (GO:0048017),-0.37043000469054976,-1.436765390587478,0.02040816326530612,0.6331442765938315,1.0,17/50,10.57%,IGF1;IGF1R;ADAP2;PITPNM2;PLCL1;PI4KA;PIK3C2A;PLCB3;PLCD1;EXOC1;PLCL2;OGT;RPS6KB1;RHOA;PDGFRB;PIK3C2B;TNFAIP8L3
prerank,mesonephric tubule development (GO:0072164),-0.5149494399925909,-1.4364220994099481,0.06857142857142857,0.6286137648813311,1.0,6/15,8.66%,OSR1;BMP4;SLIT2;SIX1;FGFR2;SALL1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5499198631046096,-1.433635981512436,0.09850746268656717,0.6329509528575643,1.0,2/12,0.13%,DAB2;FOXP1
prerank,regulation of protein localization to membrane (GO:1905475),0.5596965956353598,1.4333667120173745,0.05919395465994962,0.784624160402807,1.0,9/28,13.44%,GPC3;GSN;PRKN;SLC5A3;SPTBN1;FYN;GPC1;GPC4;STX8
prerank,tryptophan metabolic process (GO:0006568),0.6718085717190109,1.432913454748124,0.07228915662650602,0.783537363373864,1.0,3/11,9.64%,AADAT;KYNU;IL4I1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6813570329107299,1.4328456318304643,0.07628524046434494,0.7804897851248072,1.0,3/10,14.57%,ANK3;SUMO1;KCNRG
prerank,embryonic digestive tract development (GO:0048566),0.6092763500355888,1.4327295544429934,0.08357771260997067,0.7777214040350992,1.0,5/18,8.79%,PDGFRA;GLI2;PKDCC;SOX11;RARB
prerank,embryonic skeletal system development (GO:0048706),0.5432663254957415,1.432628989463796,0.055900621118012424,0.7748723114168367,1.0,6/35,5.53%,OSR2;SULF1;PDGFRA;SOX11;WNT5A;HOXD3
prerank,response to UV-A (GO:0070141),0.6365735917521737,1.431825158502496,0.08784773060029283,0.7757036373394007,1.0,3/14,8.91%,MMP2;EGFR;PPID
prerank,SNARE complex assembly (GO:0035493),0.6835436675324897,1.4318226447605953,0.0875,0.772368397665954,1.0,2/10,3.39%,STXBP6;VAMP4
prerank,positive regulation of telomere capping (GO:1904355),0.6167141380893599,1.4303029614221965,0.0698005698005698,0.7768525298498892,1.0,5/17,14.20%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1
prerank,regulation of leukocyte migration (GO:0002685),0.6313516423771877,1.4298914625390697,0.05738880918220947,0.7756584273280427,1.0,4/16,12.13%,BST1;HOXA7;VEGFA;RHOH
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6158063102947643,1.4297023146624934,0.09379509379509379,0.7733750982941793,1.0,5/17,19.82%,ANK3;AKAP6;SUMO1;KCNRG;NOS1AP
prerank,negative regulation of MAPK cascade (GO:0043409),0.4791775339150354,1.428961764589438,0.031938325991189426,0.7741379680803514,1.0,19/87,11.41%,WNK2;MYC;PTEN;DUSP4;PTPN2;EPHB2;IRAK3;NF1;CNKSR3;DUSP6;LMO3;SPRED2;SPRED1;FOXM1;UCHL1;PTPN1;SPRED3;PTPRJ;BMP7
prerank,cell proliferation in forebrain (GO:0021846),0.6791487333881272,1.4279621103640368,0.09886547811993517,0.7763424587618178,1.0,3/10,5.45%,DOCK7;PCM1;NUMBL
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5342558448343655,-1.4268332865260853,0.07871720116618076,0.6500226673260798,1.0,3/13,6.72%,ATP1A2;ATP1B3;ATP1A1
prerank,central nervous system development (GO:0007417),0.44526747596621613,1.42617725391762,0.0010111223458038423,0.7821333601492921,1.0,50/250,14.69%,APOD;RELN;VIT;SOX6;PTCH1;HSPG2;VCAN;SOX8;PTEN;SOX9;GSN;PRKN;ADAM23;NRCAM;CHST8;THOC6;SOX11;GBA2;GRIN2B;EML1;NF1;ZBTB16;TGFBR2;PHGDH;LOXL3;BCAN;PAFAH1B3;CNTN6;KLK6;EIF2B5;DHX30;CNTNAP2;GRIK1;SMO;SOX12;NHEJ1;NCAN;PTPN11;DCLK1;ADGRL3;CDK5R1;PHF8;JARID2;PTPRZ1;ALDH5A1;GRIN2D;ZFHX2;GRIN2A;NES;PKD1
prerank,cellular response to cadmium ion (GO:0071276),0.5715310906716128,1.4259739707930263,0.0738255033557047,0.7798248521797185,1.0,16/24,28.17%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4946705059350393,-1.42584942836665,0.09747292418772563,0.6476635450412436,1.0,8/18,20.69%,ANKRD17;DDX60;BIRC3;NOP53;USP15;UFD1;GPATCH3;RNF125
prerank,nervous system development (GO:0007399),0.44004966753198343,1.4255175758063596,0.0,0.7790619413138672,1.0,95/429,15.53%,DCHS1;RELN;MPZ;GFRA1;PRX;PCDHA4;SOX6;CHRM3;VCAN;RBFOX1;ERBB3;FGF13;FGF2;SOX8;LSAMP;PTEN;WDPCP;GSN;NGF;NAB1;PRKN;ADAM23;GFRA4;LPAR1;EFNA5;SCN2A;ATXN10;NRCAM;VEGFA;PCDHA1;CHST8;EPHB2;THOC6;MAB21L2;TGFB1;GPM6B;NRXN1;GBA2;GSS;NF1;ACVR1C;NUMBL;OBSL1;NLGN1;APAF1;FGF12;NAV1;ZBTB16;KIRREL3;BCAN;PAFAH1B3;BPNT1;LIMK1;CNTN6;KLK6;DHX30;SCD5;GRIK1;GPM6A;SMO;LDB2;PMP22;NHEJ1;DSCAM;NCAN;ERBB4;GDNF;DCLK1;OPHN1;ADGRL3;APC2;DVL1;JARID2;MYLIP;WWTR1;EFNB3;DRD2;BTBD1;PTPRZ1;ALDH5A1;NRSN2;TRPC5;APBA1;MSI1;RBM45;NES;PKD1;MET;MTR;ZEB2;POU3F1;NDUFV2;GFRA2;DACT1;FZD9
prerank,androgen metabolic process (GO:0008209),0.5978828511427816,1.424842293849132,0.08592592592592592,0.7794013804745665,1.0,2/18,4.64%,HSD17B7;HSD17B11
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6595431950418769,1.4242411492835196,0.0847723704866562,0.7794432324327347,1.0,5/12,10.49%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,dermatan sulfate metabolic process (GO:0030205),0.6381019208964275,1.4239972626026882,0.09615384615384616,0.7774575281731881,1.0,4/13,10.03%,DCN;VCAN;BCAN;NCAN
prerank,positive regulation of cellular component movement (GO:0051272),-0.44689558529012463,-1.4236792679467298,0.06882591093117409,0.649629202736837,1.0,14/24,26.77%,ETS1;LYN;TGFBR1;CCDC25;RPS19;PDPN;SPOCK2;CAVIN1;TWIST1;ACTN4;TUBB2B;CSF1R;STK11;CCL19
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5816789673689476,1.423295404313858,0.07972972972972973,0.778103587702737,1.0,7/22,17.76%,IL2RA;CBFB;SOCS1;SOX12;IL4I1;RUNX1;MDK
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6384492854253385,1.4232800233908913,0.097953216374269,0.7750299584888356,1.0,6/14,18.76%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;PARK7
prerank,granulocyte chemotaxis (GO:0071621),0.4940229612016125,1.4230157903183207,0.06498194945848375,0.7731961357338383,1.0,8/55,11.59%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48888535625486157,-1.4219746648464195,0.0707395498392283,0.6495182294514639,1.0,6/18,4.22%,ROCK2;CDH5;TEK;RAP1B;ROCK1;CYRIB
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6526530632447215,1.4217560962941294,0.11251980982567353,0.7764626417642784,1.0,4/11,6.38%,MYC;SOX9;WNT5A;TGFBR2
prerank,apical junction assembly (GO:0043297),-0.3745901960792034,-1.4215958626432086,0.043478260869565216,0.6448948839550657,1.0,13/53,9.33%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7;RHOA
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5760066090717869,-1.4215245192727501,0.10277777777777777,0.6393952722784686,1.0,2/10,1.73%,ROCK2;ROCK1
prerank,cellular response to copper ion (GO:0071280),0.6123171379842155,1.4213873558027548,0.09415121255349501,0.7753180845676014,1.0,12/16,28.17%,PRNP;MT3;AOC1;SNCA;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,myelin maintenance (GO:0043217),0.6845343892674236,1.4203133458447934,0.08132530120481928,0.7780852454298478,1.0,3/10,8.51%,PRX;PTEN;EPB41L3
prerank,DNA packaging (GO:0006323),0.610881804726619,1.4202891123010204,0.08734939759036145,0.7750538818383182,1.0,6/16,17.73%,BANF2;HAT1;RBBP4;TP53;NAA10;AIFM1
prerank,regulation of cellular pH (GO:0030641),-0.4239822130824873,-1.4196455634415055,0.06224066390041494,0.6405224941906965,1.0,14/29,25.90%,SLC4A10;SLC9A6;SLC9A2;SLC9A8;SLC4A3;SLC4A8;SLC9A9;SLC9A7;ATP6AP1;TM9SF4;SLC26A6;SLC9B1;CA2;LACC1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5538295121150718,1.4191598325478418,0.06623376623376623,0.7747326654031584,1.0,11/29,20.99%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5538295121150718,1.4191598325478418,0.06623376623376623,0.7747326654031584,1.0,11/29,20.99%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,renal absorption (GO:0070293),0.6725450830115416,1.4181155255730724,0.10764430577223089,0.7770773563868574,1.0,2/10,2.24%,HAS2;GSN
prerank,V(D)J recombination (GO:0033151),0.6576524413590348,1.4179387869612756,0.09230769230769231,0.7749402645176994,1.0,1/11,0.19%,RAG2
prerank,metanephros development (GO:0001656),0.5587405753678284,1.4178538538911953,0.07848443843031123,0.7723209138216951,1.0,6/26,11.41%,OSR2;PTCH1;FGF10;NF1;GDNF;BMP7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5710662556922314,1.4177556602492558,0.0796812749003984,0.7698651230096263,1.0,4/23,5.28%,GPC3;PTCH1;PTCH2;HHIP
prerank,negative regulation of angiogenesis (GO:0016525),0.47331434321798,1.4171878607389237,0.04148471615720524,0.7699228831208803,1.0,13/84,7.08%,DCN;HSPG2;SULF1;CXCL10;CREB3L1;SEMA3E;COL4A2;E2F2;CCR2;SLC12A2;PDE3B;ADAMTS1;SPRED1
prerank,retinoid metabolic process (GO:0001523),0.48545486844112956,1.417073306822536,0.04190260475651189,0.7674954241395282,1.0,14/71,12.81%,GPC3;CYP2S1;HSPG2;RHO;LRP1;SDC2;AKR1B10;SDC4;CYP1B1;RDH10;DHRS3;GPC1;SDC3;GPC4
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4514951911587717,-1.4165600498779296,0.07473309608540925,0.6458034740385404,1.0,8/24,8.22%,PHLDB2;TJP1;CGNL1;ARHGAP28;WASF2;RHPN2;ARAP1;PAK2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5588563777477339,1.416490153927282,0.07835325365205843,0.7674167268500187,1.0,7/27,14.27%,FXYD3;UTRN;SCN5A;FGF12;FXYD6;FXYD1;NEDD4L
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5744168201390377,1.4164536881480472,0.09243697478991597,0.7646319730726903,1.0,8/21,13.71%,USP50;PYCARD;NGF;MT3;GRIN2B;FYN;NGFR;TTBK1
prerank,positive chemotaxis (GO:0050918),0.6195947015893442,1.415866742845089,0.06843575418994413,0.7645907047544261,1.0,7/17,15.00%,LGALS3;FGF10;VEGFA;PTPRJ;FGF7;SCRIB;MET
prerank,positive regulation of cell communication (GO:0010647),0.5532792568001018,1.4151835522412524,0.07905138339920949,0.765201014550533,1.0,11/28,15.49%,ANK3;CLSTN2;SOX11;GRIK2;SYT1;NMU;RIMS1;EDN3;GATA3;CLSTN1;HOMER1
prerank,negative regulation of lipid storage (GO:0010888),-0.4661448763857318,-1.4140197128989584,0.05818181818181818,0.6492422304493828,1.0,9/19,20.71%,OSBPL8;ABCA1;NFKBIA;PPARD;ABCG1;NR1H2;TTC39B;PNPLA2;NR1H3
prerank,organelle fission (GO:0048285),0.5691931340381461,1.413420510207706,0.0968586387434555,0.7707880462922445,1.0,3/24,2.35%,SEC16B;DNM1;PRKN
prerank,regulation of AMPA receptor activity (GO:2000311),0.5649422903405588,1.4129859659876205,0.09491978609625669,0.7701652370633885,1.0,4/25,5.72%,RELN;CACNG7;SHISA9;NLGN1
prerank,neuropeptide signaling pathway (GO:0007218),0.4968682652005309,1.412613020334128,0.056778679026651215,0.7691287814768777,1.0,4/58,2.34%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,actin filament-based transport (GO:0099515),-0.47418981969229956,-1.4124124591260754,0.0683453237410072,0.649435982744588,1.0,11/21,27.07%,SYNE2;MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,negative regulation of phosphorylation (GO:0042326),0.47036645065135624,1.412313875589249,0.03943044906900329,0.7677268341856132,1.0,20/85,12.78%,DYNLL1;NTRK3;PIP5KL1;PTEN;IRS2;PRKN;CDKN2B;NPRL2;EPHB2;CADM4;TGFB1;PRNP;PTPN13;NIBAN1;CBFA2T3;MEN1;PID1;BMP7;WWTR1;PRDX3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5675198427845694,1.4117070281230866,0.09592641261498029,0.7679673564641164,1.0,8/24,15.90%,CREB3L1;VEGFA;MAPK7;MT3;HIF1A;NFE2L2;GCN1;TP53
prerank,response to cadmium ion (GO:0046686),0.5585369271452196,1.411476738227869,0.07611548556430446,0.7662708565471267,1.0,16/26,28.17%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,axoneme assembly (GO:0035082),0.54209422092685,1.4112475081519396,0.07387862796833773,0.7645654677845408,1.0,10/31,18.07%,DNAI4;CCDC39;RSPH1;CFAP46;CFAP74;CCDC65;FOXJ1;DNAAF2;RSPH9;DCX
prerank,positive regulation of developmental process (GO:0051094),0.44732633607269223,1.4109155412613221,0.021761658031088083,0.7633582902379136,1.0,33/164,15.06%,RELN;DCN;SOX6;BMP5;PHLDB1;SOX8;SPIRE1;SOX9;PRKN;ACVR1;VEGFA;PSEN1;NRXN1;PLCB1;WNT5A;NLGN1;ZBTB16;BNIP3;FGFR1;CPEB3;PPP1R13L;SOX5;GDNF;CLASP1;BMP7;EDN3;ANAPC2;DVL1;CORO1B;COBL;RTN4;BMPR1A;LMNA
prerank,regulation of small molecule metabolic process (GO:0062012),0.5601366908194225,1.4106277315857785,0.08194622279129321,0.7620390750248558,1.0,4/28,7.17%,RORA;PRKN;RORC;PDK3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6537367338138982,1.410487342041277,0.08056872037914692,0.7599498406553739,1.0,3/12,3.54%,WNK2;ANK3;WNK3
prerank,anterograde trans-synaptic signaling (GO:0098916),0.43875530940028645,1.409991002503966,0.011270491803278689,0.7595920733627433,1.0,42/224,14.50%,MPZ;SLC6A2;CHRM3;RAPSN;CRH;SLC1A3;CEL;CACNA1E;HRH1;PDE7B;GRIA1;KCNA1;DLGAP1;GRIA3;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;GRIK2;PRKAR1B;DLG2;SYT1;NLGN1;CACNB4;KCND2;GRIK1;PMP22;SYN1;SPG11;GRM5;HTR2C;SLC12A4;MAPK1;PRKACA;PENK;APBA1;SNCA;RPS6KA2;NOVA1;GRIN2A;CALM1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.49342849433797253,1.4098986690944078,0.05052878965922444,0.7571998168445836,1.0,5/53,9.86%,SSTR1;CHRM3;HRH1;TSHR;HTR2C
prerank,collagen fibril organization (GO:0030199),0.46229053385154223,1.409326859354006,0.046637744034707156,0.7573559401884213,1.0,23/88,11.55%,COL15A1;LUM;COL5A3;COL20A1;COL28A1;P4HA1;COL5A2;PXDN;COL4A2;COL27A1;COL26A1;NF1;COLGALT2;COL9A2;PLEC;LOXL3;CYP1B1;COL18A1;TLL2;COL3A1;PLOD1;COL1A2;COL14A1
prerank,protein alkylation (GO:0008213),-0.4614910715671582,-1.4089261186424669,0.09433962264150944,0.6562664885031982,1.0,10/22,14.77%,CAMKMT;GSPT1;FAM98A;METTL21A;PRMT2;LCMT1;SNRPD3;PCMT1;PRMT8;SNRPB
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5530832891863097,1.4088317175827278,0.082010582010582,0.7570324167423275,1.0,7/25,13.73%,WNK2;ANK3;ANK2;WNK3;STK39;NDUFA4;TCAF1
prerank,response to axon injury (GO:0048678),0.5938426178450062,1.4077718731489508,0.09735744089012517,0.759582397630323,1.0,1/18,0.03%,APOD
prerank,regulation of protein import into nucleus (GO:0042306),0.5222324871098254,1.4073965326562157,0.06751592356687898,0.7587226369803395,1.0,6/36,10.37%,APOD;MDFIC;TGFB1;PSEN1;FLNA;PIK3R1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6472417100328507,1.4072809236358301,0.09104258443465492,0.7566251471667123,1.0,3/12,3.35%,PTEN;EPHB6;EPHB2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5732479640263065,-1.4070476072562264,0.0718232044198895,0.6571107806489199,1.0,6/10,30.86%,KIT;LYN;CD40;BTLA;BAG6;FGR
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.643482037052403,1.4066088147829157,0.1076923076923077,0.7573004153390873,1.0,4/12,14.80%,TGFB1;SELENOS;HDAC2;TAF7
prerank,regulation of glucose metabolic process (GO:0010906),0.5356063667149444,1.4062174522645436,0.08104738154613467,0.7565231371755414,1.0,6/34,9.85%,RORA;IRS2;PRKN;RORC;PDK3;SELENOS
prerank,protein localization to chromatin (GO:0071168),0.5899357055316714,1.4058171968070259,0.11510791366906475,0.7558641820704106,1.0,5/18,10.72%,FAM47E;LRWD1;MRNIP;PIH1D1;ESR1
prerank,regulation of histone methylation (GO:0031060),0.6389952133538096,1.4055565701847377,0.0990990990990991,0.7544332203816676,1.0,4/13,12.25%,FAM47E;AASS;PIH1D1;JARID2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6295008775643413,1.4042264400216353,0.10909090909090909,0.7582567216962389,1.0,5/13,11.46%,FGF2;FGFR1;AKT3;SP1;SIRT6
prerank,copper ion transport (GO:0006825),0.6699197580065221,1.4026650949699127,0.10461538461538461,0.7630444680861985,1.0,3/11,2.60%,STEAP4;STEAP2;STEAP3
prerank,positive regulation of cellular component organization (GO:0051130),0.45638056871151467,1.402455507228167,0.035106382978723406,0.761421393479123,1.0,30/107,17.04%,RELN;GPC3;LGALS3;CLDN19;HRK;LRP4;LRP1;VEGFA;TGFB1;NRXN1;PPP1R15A;NOX1;BMF;BNIP3;BRK1;PIH1D1;SLF2;BMP7;ANAPC2;RHOC;SNCA;NEDD4L;SUMO1;MTLN;RUNX1;SPIDR;BCL2L11;TGFB3;HYAL1;SURF4
prerank,peptide biosynthetic process (GO:0043043),-0.30196231933279,-1.4020940684680903,0.0,0.6693255440158259,1.0,66/153,26.80%,RPS14;GSPT1;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;SARS1;MRPL10;RPL19;RPL5;RPL34;RPS25;RPS15;TNIP1;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;EEF1A1;RPS6;RPS8;EIF4EBP2;RPL11;RPL12;RPS6KB2;RPL7A;RPL13;MRPS7;COPS5;MRPL43;IGF2BP3;YARS2;RPS21;RPL35A;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RPS23;RPLP2;MRPS11;RPL8;MRPS16;PCSK1;RSL24D1;DMD;RPL41;RPS17;DHPS;RPS5;RPS15A;RPL37A;GGT5;RPS10;MRPL55;RPL6;WARS1;RPL9
prerank,positive regulation of synaptic transmission (GO:0050806),0.4813876962743976,1.4016761061728693,0.04740406320541761,0.7625538856680953,1.0,19/72,15.56%,RELN;TSHZ3;CLSTN2;CACNG7;EPHB2;NRXN1;GRIN2B;GRIK2;CCR2;MPP2;SYT1;NLGN1;SLC8A2;NMU;RIMS1;GRIN2D;CLSTN1;GRIN2A;STX1B
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5307287429030582,1.399930051127622,0.07512953367875648,0.7685889726289263,1.0,8/30,11.65%,RELN;FGF10;IRS2;NGF;ERBIN;SHOC2;STK19;MMD2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4575708508360712,1.399342279350741,0.031385281385281384,0.7686414172047848,1.0,26/108,11.58%,GPC3;SOSTDC1;SULF1;LGR6;MDFIC;TAX1BP3;CBFB;VGLL4;PRKN;DEPDC1B;LRP1;FRZB;TLE1;PSEN1;WIF1;SHISA2;DISC1;FZD7;OTULIN;SPIN1;FAM53B;DAAM2;SFRP4;ESR1;EMD;PPP1CA
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5816216067484902,1.399221196493889,0.10335195530726257,0.7639814593936776,1.0,10/20,22.13%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5816216067484902,1.399221196493889,0.10335195530726257,0.7639814593936776,1.0,10/20,22.13%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.42035615532531173,-1.3992024178673808,0.08333333333333333,0.6741804091878889,1.0,11/31,13.32%,CDH2;BOC;CTNNB1;CDON;IGF2;BNIP2;CAMK1;FGFR2;MAPK12;ID2;CDC42
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.38658191175204465,-1.3990777411068593,0.06629834254143646,0.6690843254012127,1.0,15/38,22.44%,ROCK2;PTGIS;TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;CAV1;EDN1;HSP90AB1;CLU;AKT1
prerank,B cell activation (GO:0042113),0.48116278248145233,1.398322661215754,0.0547945205479452,0.7657989003768778,1.0,13/68,13.22%,RAG2;FCRL1;BCL2;PTPN2;EPHB2;DNAJB9;CHRNA4;RABL3;LAX1;NHEJ1;PTPRJ;DCAF1;MALT1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6102381865657976,1.3978704298060762,0.09544159544159544,0.7653139850437555,1.0,4/17,7.02%,CXCL10;ANO6;CCR2;PLA2G7
prerank,negative regulation of cilium assembly (GO:1902018),-0.5400775267735758,-1.3976931201372573,0.0990990990990991,0.6682634041069302,1.0,6/12,17.85%,ODF2L;EVI5L;CCP110;TBC1D7;TBC1D30;CDK10
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4280677186463866,-1.397259592275342,0.0752212389380531,0.6644583699539668,1.0,12/26,22.44%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5869497217774765,1.3964862428794296,0.09510086455331412,0.7695770349430886,1.0,4/18,5.72%,RELN;PTEN;NRXN1;NLGN1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5102844198521813,1.3964850787659562,0.07063197026022305,0.7669682992314171,1.0,7/42,9.96%,VIT;BST1;FBLN2;NF1;TSC1;FZD7;ARL2
prerank,protein ADP-ribosylation (GO:0006471),-0.41798712761703805,-1.395313673391657,0.05333333333333334,0.6660805772862153,1.0,10/28,16.87%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP12;PARP14;SIRT4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5474332152394342,1.3947240609829357,0.09296148738379814,0.7730012300586113,1.0,6/27,10.03%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,homologous chromosome segregation (GO:0045143),0.5765301901714067,1.3945311127355153,0.10828877005347594,0.7714469408853872,1.0,7/20,23.00%,MEIOB;FMN2;PRDM9;SGO1;CENPC;PTTG1;MEI4
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5029759331780431,1.3932643694313933,0.08004926108374384,0.7751728246588081,1.0,6/42,9.18%,CCL11;CXCL10;CCL4;CCR2;ACKR3;STK39
prerank,positive regulation of cell projection organization (GO:0031346),0.45329514191490167,1.3932078614013121,0.03404255319148936,0.7728639973401813,1.0,16/115,7.42%,ROR2;RELN;ROR1;TENM3;NTRK3;CHODL;NGF;PLXNC1;IL1RAPL1;NTRK2;WNT5A;OBSL1;ALKAL2;CDKL5;CDKL3;RAP1A
prerank,endothelial tube morphogenesis (GO:0061154),-0.5705268946011758,-1.3931777616857555,0.12352941176470589,0.6680756537396003,1.0,4/10,9.33%,ACVRL1;CTNNB1;BMP4;RHOA
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6482949113237645,1.3927514052853807,0.11353032659409021,0.767504010662009,1.0,8/12,23.62%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6482949113237645,1.3927514052853807,0.11353032659409021,0.767504010662009,1.0,8/12,23.62%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6482949113237645,1.3927514052853807,0.11353032659409021,0.767504010662009,1.0,8/12,23.62%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,T cell migration (GO:0072678),0.6299848432067139,1.3925348013216474,0.1043872919818457,0.7661099971775036,1.0,2/13,5.24%,CXCL10;SLC12A2
prerank,regulation of ion transmembrane transport (GO:0034765),0.5204154959819535,1.3917505953348541,0.08041504539559015,0.7673476603828645,1.0,9/33,16.10%,CHRM3;ANO6;WNK3;AKAP6;AHCYL1;KCNJ3;NEDD4L;KCNJ10;KCNH2
prerank,oligodendrocyte differentiation (GO:0048709),0.5736385385764436,1.3899751698803777,0.12066574202496533,0.773567968853304,1.0,6/19,13.02%,SOX6;SOX8;SOX9;EIF2B5;NSUN5;PTPRZ1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.649489385502359,1.3899375158460956,0.11526479750778816,0.7712352925697721,1.0,2/11,1.18%,DLC1;FAP
prerank,cellular response to inorganic substance (GO:0071241),0.564331150829123,1.3899279291187445,0.11065006915629322,0.7687482464454375,1.0,9/21,15.98%,DDX11;DPEP1;NSMCE3;MT3;AOC1;ATRX;MTR;BLM;SPIDR
prerank,positive regulation of T cell migration (GO:2000406),0.5794103806230554,1.3895386389824764,0.10754189944134078,0.768092705811943,1.0,5/20,9.18%,CXCL10;PYCARD;CCR2;WNT5A;STK39
prerank,metal ion homeostasis (GO:0055065),0.5095201202021699,1.3889128652913636,0.07598039215686274,0.7685146175228676,1.0,11/40,16.10%,ANK3;SLC12A3;LETM1;KCNA1;TMTC2;MT3;SLC12A2;SLC12A4;SLC7A8;SNCA;KCNH2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.516813030163108,-1.3884592216789087,0.10606060606060606,0.6793199023341666,1.0,6/13,22.44%,NOS3;FPGS;HSP90AA1;SPR;QDPR;AKT1
prerank,cellular response to chemokine (GO:1990869),0.49761562226691164,1.3877131850782176,0.08009708737864078,0.7717729914486897,1.0,7/46,9.18%,CCL11;CXCL10;CCL4;CCR2;SLC12A2;ACKR3;STK39
prerank,negative regulation of nervous system development (GO:0051961),0.5864974434584477,1.3873061192030074,0.11473087818696884,0.7712566361470012,1.0,2/17,4.93%,CCL11;PCM1
prerank,xenobiotic transport (GO:0042908),-0.47795529810749077,-1.3872358889483292,0.08737864077669903,0.6782854070424198,1.0,6/17,3.59%,ABCG2;ABCA3;SLC47A1;GJA1;SLC22A4;SLC7A5
prerank,chemical synaptic transmission (GO:0007268),0.4299311641429499,1.3870951027475487,0.005055611729019211,0.7698938967407826,1.0,56/284,14.50%,MPZ;SLC6A2;CHRM3;RAPSN;CRH;SLC1A3;CEL;CACNA1E;PTEN;NQO1;HRH1;PDE7B;GRIA1;GRIK3;KCNA1;DLGAP1;GRIA3;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;GRIK5;GRIK2;PRKAR1B;GRID2;DLG2;CDH8;SYT1;NLGN1;CACNB4;KCND2;GRIK1;PDLIM4;PMP22;SYN1;SPG11;GRM5;HTR2C;RIMS1;SLC12A4;MAPK1;TSPOAP1;DVL1;PRKACA;RAB3A;DRD2;GRIN2D;PENK;APBA1;SNCA;RPS6KA2;CHAT;NOVA1;GRIN2A;CALM1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6673123589474852,1.3867952500812823,0.12324492979719189,0.7688232180419162,1.0,1/10,0.03%,APOD
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6023304324955304,1.3855570128939074,0.1048951048951049,0.7722908507603107,1.0,3/15,9.64%,AADAT;KYNU;IL4I1
prerank,glutamate receptor signaling pathway (GO:0007215),0.5203591984718022,1.3829212020021873,0.09014423076923077,0.782665144442167,1.0,12/37,15.49%,GRIK3;GRIA3;PLCB1;GRIN2B;GRIK2;GRID2;GRIK1;GRM5;CDK5R1;HOMER2;GRIN2A;HOMER1
prerank,iron ion transmembrane transport (GO:0034755),0.6674248024794911,1.3822719297728754,0.10371517027863777,0.783306156371074,1.0,1/10,0.17%,SCARA5
prerank,myoblast differentiation (GO:0045445),-0.5304467221985211,-1.3813834689204312,0.10616438356164383,0.693161011118709,1.0,4/14,9.50%,IGF1;DDX5;JAG1;MAPK12
prerank,neurotransmitter uptake (GO:0001504),0.6355555485433267,1.3803287226043535,0.12828438948995363,0.7899796314786974,1.0,3/12,5.90%,SLC22A3;SLC1A3;SLC29A1
prerank,neutrophil migration (GO:1990266),0.4755653642907116,1.3797479634141032,0.06954436450839328,0.7903723109578071,1.0,8/58,11.59%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5454790798494659,-1.3794051445242712,0.10140845070422536,0.6947490195264675,1.0,5/11,5.89%,DAB2;WNT5B;RSPO3;MLLT3;NKD1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4886026581306371,-1.3785805524070096,0.10231023102310231,0.6872157813636772,1.0,4/15,12.82%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4886026581306371,-1.3785805524070096,0.10231023102310231,0.6872157813636772,1.0,4/15,12.82%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,regulation of steroid metabolic process (GO:0019218),0.564040561500891,1.3785184286144134,0.10312075983717775,0.7940111736098395,1.0,2/23,6.31%,RORA;RORC
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6567632092400524,1.3784416243710493,0.11509715994020926,0.7919426082777259,1.0,6/11,19.25%,ZRANB3;TIPIN;FBH1;BLM;FBXO5;LIG3
prerank,cyclooxygenase pathway (GO:0019371),-0.5785147592642856,-1.3781598018484633,0.11452513966480447,0.6833830682046362,1.0,5/10,13.34%,PTGIS;PTGDS;PTGS1;PTGS2;HPGDS
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6212414528283249,1.3773579741245214,0.12682215743440234,0.7947280361202852,1.0,2/13,3.35%,RELN;EPHB2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5219547582305523,1.3772799042454842,0.09620253164556962,0.7926102159346193,1.0,6/33,12.73%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ;NECTIN2
prerank,negative regulation of complement activation (GO:0045916),0.6565656523550091,1.3757491473658097,0.1274658573596358,0.7975789433142345,1.0,1/10,0.82%,A2M
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5409666984698588,1.3754467842070124,0.09326424870466321,0.7966317380073654,1.0,9/27,15.41%,FGF13;ANK2;PDE4B;DSG2;SCN5A;CTNNA3;PDE4D;PKP2;JUP
prerank,amino acid transmembrane transport (GO:0003333),-0.3718477549688237,-1.3750457814554387,0.05732484076433121,0.6898776367018429,1.0,14/45,14.82%,SLC7A11;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;SLC38A7;SLC16A2;SLC38A5;SLC25A12;SLC38A10;SLC36A4;SFXN3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6103656234516309,1.374511467545932,0.12205882352941176,0.7986832622680108,1.0,6/14,16.77%,DNAJB9;UFL1;PTPN1;TMEM33;BCL2L11;FICD
prerank,response to interleukin-1 (GO:0070555),0.47012018679024725,1.374461241415772,0.06243032329988852,0.7964669249832638,1.0,8/73,4.10%,CCL11;ADAMTS12;PRKCA;HAS2;PYCARD;SOX9;IRAK3;CCL4
prerank,T cell differentiation (GO:0030217),0.5097006448470196,1.3744477755770919,0.0989010989010989,0.7941078959475254,1.0,10/40,13.20%,RAG2;PTPN22;FADD;PTPN2;RABL3;NHEJ1;ZFP36L2;MR1;RHOH;GATA3
prerank,pinocytosis (GO:0006907),0.6576913447636624,1.37405543096891,0.1130298273155416,0.7937324313827956,1.0,4/10,7.70%,PYCARD;MAPKAPK3;MAPKAPK2;RAB34
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4515025815269983,1.3739207082030658,0.042735042735042736,0.791952781362708,1.0,19/113,5.52%,OSR2;BMP5;CCL11;PRKCA;FGF2;MYC;FGF10;SOX9;STXBP4;ERBB2;LAMC1;EGFR;TGM1;VEGFA;EGR3;SOX11;CLDN1;SCN5A;WNT5A
prerank,carnitine metabolic process (GO:0009437),-0.5287482543862585,-1.3738913761461868,0.11641791044776119,0.6888599146759384,1.0,5/12,12.61%,CPT1C;CPT1A;ACADM;TMLHE;ALDH9A1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.53847973923396,-1.3737967283876658,0.10086455331412104,0.6840655943048921,1.0,4/11,13.95%,NBL1;SLIT2;RIN3;PADI2
prerank,embryonic eye morphogenesis (GO:0048048),0.6359638678781073,1.3719744884713383,0.13023255813953488,0.7987227667224324,1.0,5/11,23.45%,EFEMP1;RARG;ALDH1A3;FBN2;TBX2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5388565159625391,1.3719303625463,0.12117177097203728,0.7965893009280698,1.0,8/25,14.38%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A
prerank,anterior/posterior pattern specification (GO:0009952),-0.3577237403685943,-1.371409776551458,0.045454545454545456,0.6877896473233712,1.0,16/53,20.26%,WLS;LRP5;HOXB9;HOXA3;BMPR2;TGFBR1;HOXC6;HOXC5;TBX1;HOXC4;HOXA9;HEY2;HOXB3;HOXA6;HOXD4;HHEX
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.424123303913906,-1.3711984184095571,0.06349206349206349,0.6835901916859212,1.0,9/27,8.22%,PHLDB2;TJP1;CGNL1;ARHGAP28;SHANK3;WASF2;RHPN2;ARAP1;PAK2
prerank,COPII-coated vesicle budding (GO:0090114),0.4722573327029563,1.3710035796071964,0.05875706214689266,0.7989229083840202,1.0,27/68,24.23%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;SEC31B;TMED10;SEC24C;CUL3;VAPA;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;SEC23B;TRAPPC3;PEF1;TRAPPC2L;LMAN1;TRAPPC10;MIA3;PPP6R1
prerank,regulation of calcium ion import (GO:0090279),0.5663384161995674,1.3709551264403832,0.11005434782608696,0.7968045501166157,1.0,6/21,14.33%,LGALS3;WNK3;PRNP;FYN;PLPP4;PSEN2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.647080894559121,1.3707116520542284,0.13224368499257058,0.7955012616617898,1.0,3/11,15.06%,MLIP;GLRX3;LMNA
prerank,blood circulation (GO:0008015),-0.36143182677936003,-1.3704191143941322,0.043209876543209874,0.681410412538596,1.0,15/49,11.94%,MYOF;ROCK2;ELN;TBC1D8;ROCK1;ACVRL1;NOS3;COL4A3;NPR1;ACE;AGTR1;GUCY1B1;ADORA2A;SOD1;GPX1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5553928080006302,1.3696950141180404,0.08575197889182058,0.798064697894421,1.0,10/24,17.33%,TTLL10;TTLL5;TTLL11;AGBL4;TTLL4;VKORC1;CFAP20;TPGS1;VKORC1L1;NAA10
prerank,secretion (GO:0046903),-0.5097294696975087,-1.369390816391017,0.11475409836065574,0.6803061534163166,1.0,4/14,6.39%,SLC22A4;SLC22A6;PRKCI;NPR1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5577675204354442,1.3693773593657552,0.0993006993006993,0.7973564506253304,1.0,6/21,8.63%,STK36;EVC;GLI1;UCHL5;RAB34;SMO
prerank,DNA catabolic process (GO:0006308),0.6423594865100622,1.3681933208263137,0.11514195583596215,0.8006915501306257,1.0,4/11,10.68%,SETMAR;XRN2;REXO4;FBH1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3813518976248705,-1.3674036709706014,0.05,0.6820593395282454,1.0,14/39,16.18%,BMP6;PODXL;MAP2K5;CDH1;WNK1;RGCC;KLF4;JAG1;NOTCH4;NEXMIF;FXYD5;AKNA;ASS1;PPM1F
prerank,response to reactive oxygen species (GO:0000302),0.49013086754632534,1.3672445868140053,0.08045977011494253,0.8029259618506698,1.0,12/54,12.83%,APOD;PDGFRA;EGFR;APTX;NCF1;FYN;MAPK9;HIF1A;MAPK1;ERCC6L2;PRDX3;SOD2
prerank,negative regulation of transferase activity (GO:0051348),0.5355403082093468,1.3655249726987642,0.10646900269541779,0.8089520706807394,1.0,14/28,20.38%,IRS2;NPRL2;ERCC4;LIMK1;MEN1;BAG5;PRDX3;ABL1;TP53;HNRNPU;EIF4A2;FBXO5;PARK7;ZFP36
prerank,nuclear membrane organization (GO:0071763),-0.4520677685684567,-1.3651192881999668,0.10069444444444445,0.6848725241929049,1.0,11/19,27.60%,UBXN2A;TOR1B;VPS4A;DCTN1;TMEM43;UBXN2B;GPER1;CHMP7;TARDBP;NSFL1C;TOR1AIP1
prerank,regulation of cellular metabolic process (GO:0031323),0.49314018930986137,1.3646629240197181,0.08543922984356198,0.8106500228220511,1.0,14/45,14.53%,PRKN;PARL;ACACA;MKLN1;CYP1B1;PDK3;FOXM1;EIF6;ACLY;FASN;ARF4;PID1;SSH1;NCOR2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.585094124408314,1.364236164559899,0.12552891396332863,0.8104382534800735,1.0,6/18,8.05%,GRIK3;GRIK5;GRIK2;GRID2;CDH8;GRIK1
prerank,L-serine metabolic process (GO:0006563),0.6534080345889683,1.3641695665224765,0.14423076923076922,0.8083419708831678,1.0,5/10,13.39%,CBS;PSPH;PSAT1;PHGDH;SRR
prerank,ubiquinone metabolic process (GO:0006743),-0.49823884927762013,-1.3641343935501353,0.12080536912751678,0.6831193961150799,1.0,9/15,26.69%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6239043970213042,1.3639109511173337,0.1255539143279173,0.8072134964266493,1.0,4/13,15.46%,BMP5;ERLIN2;DKK3;ERLIN1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5066731850221314,1.3634482773576888,0.09492847854356307,0.8070555994180134,1.0,9/35,15.00%,ARHGAP24;DLC1;EPHB2;SYNGAP1;MAPKAP1;CUL3;MYOC;ARHGAP44;MET
prerank,diterpenoid metabolic process (GO:0016101),0.4805969584415209,1.363077483734583,0.09307875894988067,0.8065158053852725,1.0,12/55,12.81%,GPC3;HSPG2;RHO;LRP1;SDC2;AKR1B10;SDC4;RDH10;DHRS3;GPC1;SDC3;GPC4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4959554021217587,1.362290488555312,0.09876543209876543,0.8080409010489948,1.0,7/40,6.81%,GLMN;PTEN;RAD23B;XPO1;ARAF;FBXW7;UFL1
prerank,metanephric mesenchyme development (GO:0072075),-0.5544070327362571,-1.3617843394966649,0.1271186440677966,0.6860644182927195,1.0,3/10,7.30%,WNT4;OSR1;SIX1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6474353061529307,1.3614495734336836,0.13192182410423453,0.8098516899777312,1.0,4/11,9.18%,CXCL10;CCR2;WNT5A;STK39
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5663520738160761,1.3608307992907092,0.11468531468531469,0.8104886038236888,1.0,11/20,21.21%,HM13;TGFB1;PSEN1;NGFR;NCSTN;APH1A;PSEN2;SPPL2B;MBTPS1;NFKB1;RHBDD1
prerank,muscle contraction (GO:0006936),-0.30391768319828966,-1.360805869625442,0.0,0.6845735700399059,1.0,24/126,15.74%,CALD1;MYOF;SORBS1;ROCK2;TMOD3;TPM3;ROCK1;ITGB5;SNTA1;MYL6;TPM1;MYLK;ACTN2;MYL12B;MYL12A;GJC1;MYH11;ITGA1;LMOD1;ACTA2;TPM2;TMOD1;NOS1;DES
prerank,positive regulation of dendrite extension (GO:1903861),0.5736290958045285,1.3598958838964665,0.12693935119887165,0.8126245181723475,1.0,9/17,23.56%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;CPNE5;SYT3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5126135262492231,-1.3590288560447943,0.10410094637223975,0.6862221971760203,1.0,5/14,19.29%,PELP1;SERPINB9;SRA1;ARID5A;RARA
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.47702768844224286,1.3580045036209685,0.0689252336448598,0.8193947870665755,1.0,19/55,19.23%,BST1;PRKN;PARL;MT3;TGFBR2;CYP1B1;PDK3;FOXM1;EIF6;BRCA1;MAPK14;ARF4;PID1;SNCA;TP53;PAX2;RIPK1;AATF;GRB2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5293156331333889,-1.3574198780581563,0.12465373961218837,0.6873017172879403,1.0,4/12,5.85%,SORBS1;IGF1;IGF2;INSR
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5200414184300411,-1.3573164198865957,0.12951807228915663,0.6830197754066449,1.0,7/12,22.32%,IGF1R;INSR;IRGM;UVRAG;SMCR8;JMJD4;ADRB2
prerank,regulation of dendrite extension (GO:1903859),0.5682382274343465,1.3571887856333136,0.12693935119887165,0.8208669584371352,1.0,9/18,23.56%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;CPNE5;SYT3
prerank,regulation of nuclear division (GO:0051783),0.5567363138477752,1.357080201806764,0.13911845730027547,0.8190251743575651,1.0,5/20,10.81%,KIF20B;OBSL1;CDK13;RCC1;PKMYT1
prerank,COPII vesicle coating (GO:0048208),0.47254749286322717,1.355965587878233,0.07542857142857143,0.8173801282543064,1.0,21/61,22.16%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,vesicle coating (GO:0006901),0.47254749286322717,1.355965587878233,0.07542857142857143,0.8173801282543064,1.0,21/61,22.16%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.47254749286322717,1.355965587878233,0.07542857142857143,0.8173801282543064,1.0,21/61,22.16%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5247710961999944,1.3540382860851237,0.1235370611183355,0.8241393732389769,1.0,7/29,14.70%,BMP5;PTEN;SPRED2;SPRED1;SPRED3;GATA3;LDLRAD4
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4322714651663868,1.353745124132444,0.03657262277951933,0.823235029352978,1.0,29/140,13.66%,RELN;ARHGAP24;DLC1;ARHGAP32;ARHGAP19;A2M;RHOJ;RHOD;DEPDC1B;AKAP13;FGD4;CHN1;ITSN1;FOXM1;ARHGAP9;RABL3;ARHGEF11;VAV3;ARHGAP11A;RHOT2;MYO9B;MYO9A;ARHGAP21;OPHN1;RHOH;RHOC;TRIO;ARHGAP4;ARHGEF3
prerank,platelet degranulation (GO:0002576),-0.3149133397805025,-1.3532481090278459,0.07317073170731707,0.6927282277497859,1.0,33/118,14.90%,IGF1;ABCC4;VWF;PECAM1;VEGFC;STXBP1;VEGFD;VTI1B;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;HABP4;ACTN1;TIMP3;CD109;APP;ACTN2;FN1;SRGN;MANF;TMX3;SOD1;TMSB4X;SERPINE1;SYTL4;TGFB2;BRPF3;LGALS3BP;QSOX1
prerank,calcium-mediated signaling (GO:0019722),0.44961511255340886,1.3531099235585495,0.053610503282275714,0.823975642915718,1.0,24/93,17.45%,CHRM3;ANK2;PPP1R9A;EGFR;EIF2AK3;PTGFR;PRNP;CCR2;PPP3CB;ACKR3;RCAN1;PPP3CA;RCAN3;GRM5;MCTP1;PTPRJ;PRKACA;TPCN2;P2RY12;PPP3CC;ACKR4;LAT2;STIMATE;SLC9A1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5791733586316528,1.3529696824805086,0.11773049645390071,0.8223141728958179,1.0,3/16,8.90%,SOX6;SOX9;SOX5
prerank,regulation of secretion (GO:0051046),0.6136631287571067,1.352580749107935,0.12957317073170732,0.8218910543660137,1.0,6/13,16.79%,ERBB3;FGF10;ACSL3;GPLD1;OPRK1;SGK1
prerank,histone lysine methylation (GO:0034968),0.5136041655292177,1.3524115765192513,0.09923664122137404,0.8204127992248722,1.0,14/33,20.48%,SUV39H1;KMT2A;SETD3;CXXC1;SETMAR;MEN1;PRDM9;TRMT112;KDM6A;WDR5B;ASH2L;N6AMT1;SETDB1;KMT2D
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5408677630730072,-1.3523288870389456,0.10682492581602374,0.6912054446542578,1.0,4/11,8.33%,USP7;CHMP3;ATP9A;MAP2K1
prerank,adherens junction organization (GO:0034332),0.48732417505004955,1.3514689088324405,0.09058823529411765,0.8227987774387248,1.0,11/48,9.72%,DCHS1;CDH19;CDH10;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5613442004237044,-1.3505964974289975,0.11602209944751381,0.6926003381824614,1.0,3/10,4.56%,TLR4;NAMPT;KDR
prerank,chromatin organization (GO:0006325),0.4379121734000691,1.3504262084672125,0.03549060542797495,0.8257399280637248,1.0,42/132,20.29%,FAM47E;DDX11;PRDM16;MYC;KAT2B;LRWD1;SOX9;HMGN1;SUV39H1;SATB1;KDM5B;BAZ1A;EZH1;PAK1;KDM4B;MTA2;MCM3AP;ATRX;SETD2;PIH1D1;HDAC2;MYSM1;ESR1;SMARCC2;JARID2;ZBTB1;SETD5;RBBP4;SMARCC1;BAZ2B;KDM6A;BAZ1B;PHF19;SMARCE1;PBRM1;NUDT5;RUVBL2;HMG20A;TOP1;HP1BP3;SMARCA4;SETDB1
prerank,proteolysis (GO:0006508),0.4246040247671805,1.3502332182202414,0.013171225937183385,0.824395702370989,1.0,59/252,19.66%,HGFAC;KLK12;PTCH1;MMP2;ADAMTS12;ADAM19;FAP;BACE2;CAPN5;HTRA3;HM13;PARL;HTRA1;CAPN1;MIPEP;NAALAD2;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;CASP6;TRHDE;CTSB;UFSP2;SPCS3;LNPEP;CAPN6;THOP1;MMP16;NCSTN;RSPRY1;UBA3;FBXL2;APH1A;YME1L1;MALT1;MMP19;CPD;NEDD8;TYSND1;ADAM33;PSEN2;PAPPA2;CASP2;RNPEPL1;USP25;FAM111A;ATG4C;SUFU;MDM2;CASP7;ERMP1;CAPN11;SENP1;CPNE1;SPPL2B;MBTPS1
prerank,camera-type eye development (GO:0043010),0.5273272742183034,1.350164159826906,0.10435931307793923,0.8224408152500717,1.0,5/25,7.15%,EFEMP1;TENM3;VEGFA;NF1;CYP1B1
prerank,organic anion transport (GO:0015711),-0.3207431837209113,-1.3500152291433434,0.019417475728155338,0.6898574709298199,1.0,20/76,13.58%,SLCO3A1;ABCC4;ABCG2;SLC26A7;SLCO2A1;SLCO1C1;SLC4A10;SLC22A6;SLC35B4;SLC4A3;SLC39A8;SLC16A2;CYB5R4;ABCC6;CA4;SLC4A8;LRRC8C;SLC2A10;LRRC8A;MGST1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.593627850365195,1.3494685138454539,0.12835820895522387,0.8235177225470602,1.0,5/15,10.49%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,transition metal ion transport (GO:0000041),-0.3838840806407842,-1.3494330880857421,0.08333333333333333,0.6874860271417262,1.0,9/35,10.28%,SLC30A10;SLC31A1;ATP7A;SLC31A2;FTH1;SLC39A8;SLC30A1;TRPC6;TFRC
prerank,neuron development (GO:0048666),0.43480775723971005,1.3490970787191692,0.04179728317659352,0.8230048320397675,1.0,28/141,13.05%,LGI4;ETV1;TENM2;CDNF;TENM3;DOCK7;GLI2;PPP1R9A;ATXN10;HS6ST1;ARL3;GPM6B;PLP1;NTRK2;GBA2;NLGN1;UNK;CNTNAP2;GPM6A;VAPA;GDNF;PRMT1;OPHN1;STMN4;CDK5R1;ATP8A2;MYOC;CDK16
prerank,DNA alkylation (GO:0006305),0.5712607596123664,1.3486614946672668,0.12482065997130559,0.8206785227096103,1.0,6/19,11.02%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,DNA methylation or demethylation (GO:0044728),0.5712607596123664,1.3486614946672668,0.12482065997130559,0.8206785227096103,1.0,6/19,11.02%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,cation transmembrane transport (GO:0098655),-0.3667707106965329,-1.3478858243869192,0.053691275167785234,0.6882328623628866,1.0,16/44,24.09%,TRPM3;SLC7A2;ATP1A2;SLC7A5;ABCC9;SLC38A5;SLC25A20;SLC36A4;SFXN3;SLC6A5;SLC25A19;ATP1B1;TRPM2;KCNJ8;SLC25A29;ATP13A2
prerank,endoderm development (GO:0007492),0.5975015620139038,1.3477518929391992,0.13538461538461538,0.8228167852736344,1.0,2/13,2.38%,DUSP4;LAMC1
prerank,ion homeostasis (GO:0050801),0.516728475666904,1.347655151602279,0.12046632124352331,0.8209991080860544,1.0,4/30,7.95%,P2RY2;WNK2;WNK3;SLC30A4
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.427753365527936,-1.3475762074084587,0.10566037735849057,0.6847071582098385,1.0,9/23,13.93%,MOSPD2;SLIT2;MPP1;JAM3;DAPK2;CAMK1D;DPP4;NCKAP1L;TIRAP
prerank,regulation of intracellular transport (GO:0032386),-0.3733938134097815,-1.3467225921368766,0.04145077720207254,0.6831584216969974,1.0,11/38,10.96%,MAP2;RAB11B;GAS1;LAMP1;ATP9A;SCFD1;ATPSCKMT;WWC1;DYNLT2B;NUMA1;NUP214
prerank,positive regulation of protein localization to membrane (GO:1905477),0.44272436388825864,1.34638043735955,0.049019607843137254,0.8246876525561883,1.0,17/98,8.27%,LGALS3;ANK3;BCL2;ERBB2;PRKN;EGFR;SLC5A3;LRP1;C2CD5;EPHB2;WNK3;PRNP;SPTBN1;YWHAZ;DPP10;FYN;ZDHHC8
prerank,neuron projection morphogenesis (GO:0048812),0.4339046504680912,1.3457983349938305,0.04569055036344756,0.8252162581602528,1.0,49/137,19.93%,ANK3;DOCK7;LRP4;KIF20B;PTEN;NGF;MAP4K4;MAP1B;GAS7;NRCAM;EPHB2;SDC2;CTNNA2;TNIK;NYAP1;NLGN1;PAK1;ALS2;BAIAP2;DOCK10;NTNG2;NTNG1;S100A6;CNTNAP2;GPM6A;EPB41L3;DCC;DCLK1;DIP2A;BMP7;TAOK3;PLPPR4;DVL1;RAB3A;DRD2;TRIO;IQGAP1;ANKRD27;UBB;LRP2;SGK1;CTTN;PAX2;KLF7;CNTN4;NCKAP1;CPNE1;MAP6;SHTN1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6027239185893241,1.344863475844299,0.15805022156573117,0.8273530272201103,1.0,5/13,14.61%,FGF2;GLI1;ERBB4;ZFPM2;BMPR1A
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5429068259763739,1.3446278554248656,0.12696335078534032,0.8262598702571176,1.0,5/23,8.06%,UBASH3B;CACNA2D1;ANK2;PRNP;FYN
prerank,aminoglycan catabolic process (GO:0006026),0.5311769411536106,1.3437547840340813,0.10863874345549739,0.8282337932794496,1.0,9/28,15.41%,GPC3;HSPG2;SDC2;SDC4;GPC1;CTBS;SDC3;GPC4;IDS
prerank,positive regulation of nervous system development (GO:0051962),0.4882556141804231,1.343334318825921,0.1003584229390681,0.8279725909849649,1.0,13/42,16.58%,CLSTN2;IL1RAPL1;EPHB2;SOX11;NRXN1;GRID2;NUMBL;NLGN1;SYNDIG1;CLSTN1;LRP2;IL1RAP;FAIM
prerank,regulation of platelet activation (GO:0010543),0.5561844193178596,1.3430753080546767,0.13399153737658676,0.8270088856132906,1.0,4/21,4.19%,PRKCA;PDGFRA;PRKCQ;TEC
prerank,actin filament bundle organization (GO:0061572),-0.38152485355399457,-1.342408840279909,0.0821256038647343,0.6935869520394365,1.0,12/33,20.86%,PAWR;CALD1;BAIAP2L1;NEDD9;EPS8;FAM107A;LIMA1;SHROOM2;AIF1L;ADD2;LCP1;RFLNA
prerank,cAMP-mediated signaling (GO:0019933),0.5347460866150523,1.3413275260417754,0.13096862210095497,0.8329993243709409,1.0,7/24,13.21%,SOX9;PDE7B;MAPK7;KSR1;AKAP6;PDE4D;AHR
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6262406733292645,1.3405762967160215,0.15062111801242237,0.8342447009517721,1.0,2/11,3.68%,GFPT2;NAGK
prerank,stabilization of membrane potential (GO:0030322),0.5829725706590223,1.3405687351074742,0.14644351464435146,0.832093035721579,1.0,2/16,3.10%,KCNK15;KCNK1
prerank,regulation of interleukin-2 production (GO:0032663),0.4864403866631477,1.340449658035979,0.11837237977805179,0.8305053049282549,1.0,11/43,16.02%,GLMN;CD34;PDE4B;PRNP;CCR2;SPTBN1;PDE4D;MALT1;HOMER2;RUNX1;NAV3
prerank,generation of neurons (GO:0048699),0.4249187912988235,1.3403166321577964,0.027522935779816515,0.8289913075341045,1.0,27/190,8.16%,RELN;DOCK7;LHX5;FGF13;ASTN2;ERBB2;IL1RAPL1;OTP;MAP1B;NRCAM;SEMA3A;AUTS2;SOX11;NTRK2;EML1;CEP85L;WNT5A;NGRN;CDKL5;NAV1;DISC1;SDCCAG8;FZD7;TAFA1;CDK6;FGFR1;GPM6A
prerank,bone morphogenesis (GO:0060349),0.5914006900830932,1.3399441448148723,0.14326647564469913,0.828680174391337,1.0,1/14,0.11%,OSR2
prerank,receptor clustering (GO:0043113),0.5280224078449375,1.339901467586736,0.11357702349869452,0.8267405931766574,1.0,9/27,12.72%,LRP4;SAV1;NRXN1;DLG2;NLGN1;FLNA;MAGI2;DVL1;SCRIB
prerank,regulation of macrophage migration (GO:1905521),-0.5445267203761461,-1.3390666202151673,0.11343283582089553,0.700994248821081,1.0,2/10,1.32%,CD200;MTUS1
prerank,morphogenesis of an epithelium (GO:0002009),0.5302726830934952,1.338410779289317,0.1290743155149935,0.8316216137597778,1.0,4/25,7.60%,SOX8;SOX9;PRKX;TBX18
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6081458442754923,1.3381853407093753,0.1618320610687023,0.8305563051950176,1.0,4/12,14.76%,UBASH3B;ANK2;ANXA6;MTLN
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6441007083568596,1.3373227273517634,0.14175654853620956,0.8324183525059993,1.0,3/10,11.41%,BMP5;SOX11;BMP7
prerank,limb development (GO:0060173),0.5277463263980234,1.3365230785568332,0.11345646437994723,0.8339833560781429,1.0,4/28,2.04%,PTCH1;LRP4;FGF10;KAT2B
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4810838309151536,-1.3360026085281205,0.12666666666666668,0.7070027086270577,1.0,7/15,29.37%,MKNK2;HNRNPA1;PPIF;ZFAND1;VCP;GSTO2;ATF3
prerank,energy reserve metabolic process (GO:0006112),0.5576557300251236,1.33600120242312,0.14166666666666666,0.834205541844955,1.0,6/19,11.37%,PYGL;GFPT2;MYC;MT3;PHKB;PID1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5554922411425225,1.3357386964710374,0.13892709766162312,0.8333664194583612,1.0,7/19,18.76%,PXDN;NOX1;ACOX1;GPX3;PRDX3;CAT;PARK7
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4977604880312091,1.335365020255147,0.1027479091995221,0.8329668612914147,1.0,7/38,9.79%,RELN;ERBB3;RAP2B;GPRC5B;PRNP;PTPN1;GRM5
prerank,superoxide anion generation (GO:0042554),0.6002712928276615,1.3350031218649943,0.13439306358381503,0.8324883885447939,1.0,4/13,9.76%,NCF1;NOX1;TAFA4;NCF2
prerank,regulation of protein targeting to membrane (GO:0090313),0.5281205923734678,1.3338886704351602,0.12550607287449392,0.8357509671527646,1.0,5/28,8.06%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5473395959053775,1.3336638792967552,0.13286713286713286,0.8346308855963039,1.0,5/24,8.06%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,regulation of feeding behavior (GO:0060259),0.6279673708742469,1.3331852459652396,0.1465648854961832,0.8347141785490698,1.0,3/11,19.75%,SGIP1;CFAP20;STAT3
prerank,amino sugar biosynthetic process (GO:0046349),0.6079460095565432,1.3330503537733267,0.15267175572519084,0.833221115514991,1.0,2/12,3.68%,GFPT2;NAGK
prerank,regulation of double-strand break repair (GO:2000779),0.49562552341009974,1.3322925755813122,0.11964735516372796,0.8346808923068457,1.0,12/39,16.41%,DDX11;SPIRE1;FMN2;MRNIP;FOXM1;SETD2;SLF2;SIRT6;RPA2;RTEL1;SPIDR;TERF2IP
prerank,neuron maturation (GO:0042551),0.5726546136652315,1.3322516106408235,0.14949201741654572,0.8327870789353753,1.0,4/18,12.08%,LGI4;ADGRB3;FARP2;ANKS1A
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4983726839095786,-1.3321770914329187,0.15,0.7154194555907742,1.0,4/13,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,regulation of actin filament-based movement (GO:1903115),0.6354762804040078,1.3305905483318796,0.1642512077294686,0.8383449423958318,1.0,4/10,12.05%,ANK2;PDE4B;SCN5A;PDE4D
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4825218611843023,-1.3305036283566893,0.11526479750778816,0.7170972492866442,1.0,7/14,16.08%,NRP1;VEGFC;VEGFD;KDR;MYO1C;NUS1;FLT4
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2835197120099112,-1.3300921014221,0.0,0.7140279942517826,1.0,33/128,14.79%,BMP6;PTPRK;GCNT2;SMAD6;CDH5;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;BMP4;ENG;ID1;USP9X;SMAD9;BMPR2;TGFBR1;PARD3;DDX5;ACVR1B;TWSG1;STUB1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;INHBA;USP15;TMEM100;GDF1;HPGD
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5890207000766986,1.3296218189232998,0.14032496307237813,0.8407137846841876,1.0,3/15,8.59%,OSR2;FGFR1;BRCA1
prerank,positive regulation of kinase activity (GO:0033674),0.42548148913002903,1.3293879643030395,0.0669500531349628,0.8397447447853305,1.0,17/107,7.80%,ROR2;RELN;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2;TRAF4;MRNIP;ALS2;VAC14;RAP1A;FGFR1
prerank,regulation of filopodium assembly (GO:0051489),-0.37058456808489615,-1.3291311087210789,0.08181818181818182,0.7130506288053939,1.0,10/38,3.56%,CAPZB;NRP1;MYO10;RAB5A;WASL;PPP1R16B;PRKCD;GAP43;AGRN;FNBP1L
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5035024587826796,-1.3284532199965555,0.1511627906976744,0.7112140553139413,1.0,4/13,5.85%,SORBS1;IGF1;IGF2;INSR
prerank,positive regulation of synapse assembly (GO:0051965),0.5154769811277774,1.3283601744140572,0.12419146183699871,0.8422394915140748,1.0,10/27,18.85%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;SYNDIG1;CLSTN1;IL1RAP;SEMA4D
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3643488020839634,-1.3278387181222029,0.0962566844919786,0.7090615216094039,1.0,8/39,7.76%,TJP1;SNCAIP;ROCK2;RAP1B;ROCK1;TIE1;PARP10;IRGM
prerank,muscle tissue development (GO:0060537),0.5939712210185253,1.3276343979547405,0.15233785822021115,0.8435502738382443,1.0,4/13,8.63%,PTCH1;CSRP1;NF1;SMO
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5397052818995056,-1.3275430103068302,0.16022099447513813,0.7057717246108794,1.0,5/10,21.89%,ABCA3;ABCB4;APOE;ABCA7;TMEM30A
prerank,response to interferon-beta (GO:0035456),-0.4328414956025264,-1.3274997693249628,0.12857142857142856,0.7016725316564066,1.0,14/22,28.37%,PLSCR1;IFITM3;AIM2;IRGM;IRF1;IFITM2;UBE2G2;BST2;HTRA2;IFNAR2;CDC34;IKBKE;XAF1;TRIM6
prerank,central nervous system myelination (GO:0022010),0.6153638734384121,1.3273491249058185,0.15698587127158556,0.842871803444641,1.0,2/11,4.28%,PTEN;PLP1
prerank,defense response to tumor cell (GO:0002357),0.6348920225621513,1.3272970940868798,0.15942028985507245,0.8410094627698738,1.0,2/10,1.48%,DLEC1;RBMS3
prerank,ear morphogenesis (GO:0042471),0.554173329687184,1.327111734818425,0.1474269819193324,0.8397673701324985,1.0,2/20,3.35%,OSR2;EPHB2
prerank,negative regulation of transport (GO:0051051),0.4682844180618791,1.3270639228187802,0.10295857988165681,0.8379005024129095,1.0,14/51,18.12%,LGALS3;ERBB3;PTEN;PRKN;CRYAB;SYT11;MCTP1;PXK;ARL6IP5;NDFIP1;SNCA;SNX12;DYSF;RAB7A
prerank,negative regulation of cell development (GO:0010721),0.5265943962929166,1.3265117830298703,0.14492753623188406,0.8384115573536338,1.0,4/25,4.93%,CCL11;PTHLH;FBXW7;PCM1
prerank,cellular response to hormone stimulus (GO:0032870),-0.3239475866024535,-1.326377280152484,0.03759398496240601,0.701189773690701,1.0,20/69,19.29%,THRB;ATP1A2;CTSH;TFPI;SLIT2;RAMP1;LMO2;STAT5B;ZFP36L1;ATP1A1;SLC5A5;PELP1;SERPINB9;ADRA2A;SRA1;CTSS;CAV1;ARID5A;GPER1;RARA
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4410077131595728,1.3255311701501977,0.08287292817679558,0.8409233927592749,1.0,23/88,18.76%,LGALS3;CLDN19;PRKCA;HRK;VEGFA;TGFB1;SDC4;BMF;LIMK1;BRK1;PIH1D1;SLF2;BMP7;RHOC;SUMO1;PDCD6IP;MTLN;SPIDR;BCL2L11;HYAL1;RAB7A;FNIP1;PARK7
prerank,regulation of mitochondrial fission (GO:0090140),0.5379843656549657,1.325289945263379,0.14150943396226415,0.8400102458026629,1.0,5/24,11.05%,DCN;SPIRE1;PRKN;BNIP3;MYO19
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5926416341259303,1.3238021695181639,0.1598173515981735,0.8448598925916012,1.0,2/13,3.68%,GFPT2;NAGK
prerank,protein localization to vacuole (GO:0072665),-0.5016996707641411,-1.3236124551226565,0.13649025069637882,0.706366034672928,1.0,8/13,25.91%,LMBRD1;MFSD1;RNF128;KPTN;SH3GLB1;SH3BP4;ATP13A2;SZT2
prerank,glycoprotein catabolic process (GO:0006516),0.5685350816088078,1.3226049349337081,0.14446002805049088,0.8483532373380237,1.0,4/17,11.73%,ADAMTS12;FBXO27;EDEM2;FBXO17
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3720299196039903,-1.3225184591923944,0.09545454545454546,0.7058022580491597,1.0,11/34,9.20%,ROCK2;LZTFL1;MFHAS1;TTBK2;LATS2;COMMD1;LEPROTL1;GSK3B;ACTN2;GOPC;FLCN
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4714738383775181,-1.3223796718466587,0.13993174061433447,0.7021186012869599,1.0,11/16,28.53%,PARP1;ATPSCKMT;FLCN;TMSB4X;ENO1;PINK1;AK4;SPHK2;ANTKMT;DNAJC30;VCP
prerank,response to laminar fluid shear stress (GO:0034616),-0.5279988075261637,-1.321692206548234,0.15548780487804878,0.7002493122690572,1.0,6/10,8.81%,SMAD6;ABCA1;SMAD7;MAP2K5;KLF2;KLF4
prerank,peptidyl-tyrosine modification (GO:0018212),0.4574188064270544,1.3216083183488585,0.09580838323353294,0.8511497716446932,1.0,10/56,8.06%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,positive regulation of cell junction assembly (GO:1901890),0.4655524363216125,1.321473258148912,0.10520231213872833,0.8497933648417276,1.0,17/56,16.54%,CLDN19;CLSTN2;IL1RAPL1;MAP4K4;VEGFA;EPHB2;NRXN1;GRID2;NLGN1;TSC1;CNTNAP2;PTPRJ;MYOC;SYNDIG1;CLSTN1;ABL1;IL1RAP
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5228842658010135,-1.3211270219809037,0.14714714714714713,0.6980338907332012,1.0,4/11,17.18%,CLK2;SIK1;C1QTNF3;PGP
prerank,cellular response to UV-A (GO:0071492),0.6194223554025804,1.3208498685557897,0.162406015037594,0.8507330185312785,1.0,2/11,8.91%,MMP2;PPID
prerank,nerve growth factor signaling pathway (GO:0038180),0.6325134497705371,1.3205469905235558,0.16611842105263158,0.8500522240775564,1.0,3/10,11.52%,NGF;RAP1A;MAGI2
prerank,regulation of pH (GO:0006885),-0.5234728157771114,-1.3200143257175743,0.1638888888888889,0.6977939569128303,1.0,7/11,27.81%,CLCN3;SLC9A7;ATP6V0A4;ATP6AP1;PDK2;LACC1;PDK4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.42630865950988683,-1.3190559126298838,0.11929824561403508,0.6969189756830706,1.0,6/21,17.77%,FOXP1;PRKCH;PRKCB;PTPRC;IKBKG;SLC39A10
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3850381578559643,-1.318824640135932,0.0967741935483871,0.6937138659661083,1.0,13/34,17.75%,FLT1;NRP1;VEGFC;VEGFD;GAS1;MAP2K3;KDR;ERN1;NUS1;FLT4;ANXA1;SPHK1;HSPB1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.47083212074259007,1.3184812762040805,0.10482921083627797,0.8575065586759457,1.0,8/57,7.73%,DCN;HRK;PYCARD;SPIRE1;PRKN;FBXO7;BMF;BNIP3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.43411322749443126,1.318060046050606,0.0890557939914163,0.8574731646961571,1.0,20/95,12.81%,DCN;GPC3;HSPG2;VCAN;HAS2;LUM;ST3GAL4;HS6ST1;SDC2;EXT1;SDC4;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GPC1;SDC3;GPC4
prerank,T-helper cell differentiation (GO:0042093),-0.4704015228189778,-1.3180027773590473,0.132890365448505,0.6925186964957121,1.0,3/14,5.12%,FOXP1;LEF1;ATP7A
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6187351974423461,1.3169463993183124,0.1953125,0.8606785662874152,1.0,3/11,4.08%,PRKCA;FADD;TGFB1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5566428314620342,1.3167077385971653,0.16332378223495703,0.8597630831349287,1.0,7/17,15.54%,CADM4;SPRED2;SPRED1;SPRED3;EIF4G1;CALM1;CALM2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5267177293373614,1.3165530949180138,0.1380697050938338,0.8584361780730272,1.0,11/26,19.13%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;EIF4G1;CCND2;HYAL1;RPTOR;KMT2E;RDX
prerank,cilium-dependent cell motility (GO:0060285),0.5340976480420614,1.3159106762656319,0.15214384508990317,0.8592669217894002,1.0,7/22,17.71%,EFHC1;DNAH2;CCDC39;RFX3;CCDC65;DNAAF2;RSPH9
prerank,gastrulation (GO:0007369),0.5784013537700997,1.3154824899126156,0.14390602055800295,0.8592752422855152,1.0,1/15,0.27%,GPC3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4635215775879049,-1.315180315495215,0.14814814814814814,0.6982532098398718,1.0,5/18,7.97%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3280590079517997,-1.3143053731288348,0.058394160583941604,0.6970772116168565,1.0,19/61,17.46%,PRKAG2;PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;PANK2;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;FGFR4;CAV1;PSMC4;PDK2;PSMB6
prerank,alpha-amino acid metabolic process (GO:1901605),0.4770678484179736,1.3141094232965356,0.11071428571428571,0.8635614888335843,1.0,18/45,22.10%,AADAT;DPEP1;CBS;NAALAD2;GOT2;MTRR;ASNS;OAT;SRR;GPT2;KYAT3;GLS2;GLS;ASPA;RIMKLB;GLUD1;NAT8L;DDAH1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5647236005793126,1.3140508808456195,0.1504297994269341,0.8617855365993189,1.0,5/18,9.64%,PTPN22;FGL1;TNFAIP8L2;LAX1;IL4I1
prerank,substantia nigra development (GO:0021762),0.4825980926396996,1.3138450537001036,0.14039408866995073,0.8607222894424098,1.0,9/37,17.10%,DYNLL1;SYNGR3;NDRG2;PLP1;MAPKAP1;TTBK1;CALM1;CALM2;CNP
prerank,negative regulation of developmental growth (GO:0048640),0.5159707239969675,1.3136412229894472,0.14192708333333334,0.8596257203531776,1.0,7/30,10.02%,PTCH1;FGF13;PTEN;RNF6;MT3;CDKL3;DCC
prerank,membrane repolarization (GO:0086009),-0.4720675895858621,-1.3115987678018721,0.14423076923076922,0.701798774091059,1.0,4/15,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.46927621234916583,1.3112170772678673,0.12530413625304138,0.8690215950319318,1.0,11/48,16.89%,UBASH3B;CXCL10;ANK2;JPH3;AKAP6;PDE4D;PRKACA;SNCA;CALM1;CALM2;APLNR
prerank,phasic smooth muscle contraction (GO:0014821),0.6189183049863685,1.3109973886117305,0.15650741350906094,0.8680430975916108,1.0,4/10,12.69%,PTGER3;GDNF;EDN3;DRD2
prerank,negative regulation of ion transport (GO:0043271),0.5184808230662434,1.310785898468486,0.14189189189189189,0.8669617792707481,1.0,6/24,13.88%,WNK2;WNK3;GPM6B;SYT11;PXK;SNCA
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4488922150827748,1.3106977387999532,0.09222222222222222,0.8653588283824551,1.0,18/75,12.69%,ANK3;DOCK7;LRP4;MAP1B;NRCAM;SDC2;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;UNK;DCC;OPHN1;PLPPR4;DVL1;RAB3A;DRD2
prerank,renal filtration (GO:0097205),0.624872583430514,1.3102993081025283,0.17073170731707318,0.8651191384194582,1.0,2/10,1.88%,SULF1;CD34
prerank,regulation of dendrite development (GO:0050773),0.48224197639831634,1.3094904064020372,0.12625,0.8669862850214655,1.0,11/37,14.73%,BMP5;CSMD3;SDC2;TNIK;CDKL5;ADGRB3;DCC;BMP7;COBL;NEDD4L;RTN4IP1
prerank,axon development (GO:0061564),0.4467081896501002,1.3094811103215849,0.09438202247191012,0.8650375357018703,1.0,23/78,18.89%,ANK3;DOCK7;MAP1B;NRCAM;EPHB2;PLP1;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;DCC;PLPPR4;CDK5R1;RAB3A;DRD2;RTN4;MTR;PAX2;NREP;RTN4RL1;KLF7;CNTN4
prerank,negative regulation of histone modification (GO:0031057),0.5868020953717091,1.3091870615223675,0.17410714285714285,0.8644951073872363,1.0,6/14,17.62%,AASS;BRCA1;JARID2;SNCA;TAF7;CTBP1
prerank,mesoderm formation (GO:0001707),-0.445925594967301,-1.3088705827570999,0.13503649635036497,0.7071958084376728,1.0,4/17,14.55%,ITGA3;BMPR2;KDM6B;HMGA2
prerank,regulation of cholesterol storage (GO:0010885),-0.46810036435376917,-1.3087908833347037,0.15210355987055016,0.7036351445290615,1.0,7/15,20.81%,ABCA1;PPARD;ABCG1;NR1H2;TTC39B;NR1H3;LPL
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.29590228969829674,-1.308353648776491,0.015384615384615385,0.7012539229430069,1.0,52/110,26.80%,RPS14;GSPT1;RPL24;RPL18A;UPF3B;RPS16;RPL38;RPL28;RPS19;RPL37;CTIF;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;RPS6;RPS8;RPL11;RPL12;PNRC2;SMG9;RPL7A;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SMG5;RPL41;SMG8;RPS17;RPS5;RPS15A;UBA52;RPL37A;PPP2CA;RPS10;EIF3E;RPL6;RPL9
prerank,positive regulation of cell adhesion (GO:0045785),0.44467365362457956,1.307833254078182,0.10638297872340426,0.8688723077826952,1.0,19/74,18.36%,VIT;PRKCA;EPB41L4B;RHOD;ERBB2;FBLN2;VEGFA;PPP3CA;MAGI1;ARL2;PTPRJ;P2RY12;CITED2;ATM;HYAL1;RELL2;RAC3;MDK;MEGF10
prerank,regulation of axon regeneration (GO:0048679),-0.4958807990769565,-1.3077008671250643,0.153125,0.699371726961917,1.0,3/12,7.20%,EPHA4;PTN;SCARF1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.45651888538936564,-1.3076414071319853,0.13703703703703704,0.6958145655771769,1.0,5/17,10.65%,PRKAG2;PPARD;PANK2;PRKAA2;ADIPOR2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6106835448136547,1.307020909200028,0.18524332810047095,0.8707204367908175,1.0,3/11,14.80%,TMEM106A;HDAC2;TAF7
prerank,phagolysosome assembly (GO:0001845),0.5999496843720299,1.3052918972468832,0.15269461077844312,0.8768773591452879,1.0,5/12,18.12%,RAB14;RAB39A;RAB34;RAB7A;RAB7B
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4054981626037407,-1.305211081231415,0.1347517730496454,0.7001025740316924,1.0,8/23,18.16%,CLK2;SIK1;NUPR1;GSK3A;C1QTNF3;HDAC4;PGP;GIT1
prerank,regulation of dopamine secretion (GO:0014059),0.514195354235966,1.304735953882107,0.16304347826086957,0.8774763460074745,1.0,9/25,13.88%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;GDNF;DRD2;SNCA
prerank,autonomic nervous system development (GO:0048483),0.5502505682156128,1.3045730674680311,0.1697841726618705,0.8762167205690444,1.0,7/17,13.20%,SOX8;SEMA3A;SOX11;NF1;PHOX2A;GDNF;GATA3
prerank,zinc ion transmembrane transport (GO:0071577),-0.4140098673046923,-1.3040362098710583,0.11284046692607004,0.7000831278878376,1.0,10/22,26.20%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC30A6;SLC39A3;SLC39A10;TRPM2;SLC39A13;SLC39A1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6065159579403794,1.303180516630027,0.17040358744394618,0.881002074943947,1.0,3/12,12.00%,PTEN;GORASP1;RAB1A
prerank,regulation of interleukin-1 production (GO:0032652),-0.475060608746997,-1.3031311046552603,0.15081967213114755,0.6989774413272188,1.0,4/15,16.22%,FOXP1;TLR4;CEACAM1;ANXA1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.448224436010585,1.3027327595686498,0.11862527716186252,0.8810980699323006,1.0,18/65,15.90%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;TSC1;KCND2;GATA6;BNIP3;TBL2;HIF1A;BMP7;CPEB1;MDM4;LMNA;TP53
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5422888844920132,1.3025441155151198,0.15870786516853932,0.8799603861136536,1.0,7/19,16.74%,HS6ST1;EXT1;EXTL3;CSGALNACT1;GLCE;HS2ST1;UGDH
prerank,neuron apoptotic process (GO:0051402),0.5435345943679281,1.302182060614984,0.16869095816464239,0.8797831667132855,1.0,7/19,13.69%,ERBB3;BCL2;SCN2A;BNIP3;NAE1;NGFR;TRPC5
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.4564097744141151,-1.301617412377396,0.15845070422535212,0.7001511511897268,1.0,4/17,1.86%,ROCK2;CDH5;ROCK1;CLDN5
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5743668943773913,1.3014366184481718,0.1816860465116279,0.8812170387220227,1.0,3/15,3.14%,IL16;NTRK3;VEGFA
prerank,regulation of neuroinflammatory response (GO:0150077),-0.44131202646714396,-1.3013742081822213,0.13432835820895522,0.6973179298056309,1.0,6/19,17.29%,IGF1;CD200;PTGS2;NUPR1;SPHK1;DAGLA
prerank,regulation of stress fiber assembly (GO:0051492),-0.3310036966747202,-1.3012420010915065,0.07766990291262135,0.6940410423466571,1.0,20/74,9.33%,PHLDB2;TJP1;CGNL1;ROCK2;ARHGAP28;NRP1;CCN2;ROCK1;LIMCH1;WASF2;TGFBR1;RHPN2;TPM1;FHOD1;ARAP1;RGCC;PAK2;PFN2;ARHGEF15;RHOA
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5570792353059073,1.3006334176455814,0.14385474860335196,0.8829701473191588,1.0,3/17,5.51%,CACNA2D1;ANK2;SCN5A
prerank,myelin assembly (GO:0032288),0.6131696121445005,1.3003417671938495,0.18660287081339713,0.8823742464889219,1.0,5/10,20.23%,EPB41L3;PMP22;GPC1;CD9;NCMAP
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5334446536401989,1.3002486664186774,0.15258855585831063,0.8809050116927822,1.0,8/24,16.89%,FFAR4;RNF157;PRKAR1B;PDE3B;PDE4D;GNAI1;CGAS;APLNR
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4245526165268687,1.3000787133796,0.08315565031982942,0.8796929511320384,1.0,32/113,17.08%,LGALS3;USP50;HRK;VEGFA;GTF2H2;TGFB1;ERCC5;ERCC4;DDB2;RPA3;BMF;BRK1;XPA;PIH1D1;EIF4G1;SLF2;ESR1;RHOC;DDB1;TTBK1;RPA2;SNCA;SUMO1;DHX33;MTLN;MED25;ATM;TP53;SPIDR;BCL2L11;FSCN1;CUL4B
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4221907268449431,-1.2998633145349745,0.11428571428571428,0.6943966510430717,1.0,4/22,11.86%,ALDH1A2;RBP1;CUBN;LGMN
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3650440765365683,-1.2996685881720769,0.09090909090909091,0.6915447563844344,1.0,9/38,14.03%,BMP6;SASH1;ANKRD17;DDX60;PLSCR1;RIOK3;CYBA;USP15;NMI
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.47221754260783794,1.29904790263269,0.1385176184690158,0.8824641697740601,1.0,12/44,17.39%,WNK2;ANK2;ANO6;WNK3;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6086354027816793,1.2980440949486722,0.1774960380348653,0.8851996658069385,1.0,4/11,18.05%,PXDN;GPX3;PRDX3;CAT
prerank,response to peptide (GO:1901652),0.4903631007285735,1.2980184095711016,0.13181242078580482,0.88337113889885,1.0,12/33,23.66%,MMP2;CACNA1A;PRNP;EIF2B5;FYN;ERBIN;GNAI1;EIF2B2;STAT3;STAT5A;STAT6;KAT7
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.43842902149042395,1.2975682148535765,0.11764705882352941,0.8834871938130223,1.0,10/75,7.08%,DCN;HSPG2;SULF1;CXCL10;SEMA3E;COL4A2;CCR2;PDE3B;ADAMTS1;SPRED1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6010233830625331,1.2973523567962268,0.20610687022900764,0.8825200738550696,1.0,2/10,4.08%,FAP;TGFB1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3178310705119023,-1.2972864901367414,0.072,0.6955801437236324,1.0,16/65,14.48%,FOXP1;LEF1;KIT;MYH9;IL31RA;BMP4;GLO1;PARP1;TNFRSF11A;SBNO2;CASP8;CAMK4;OSTM1;CDC42;PML;CDK2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.46611756815901245,1.2970291073852476,0.12907268170426064,0.8820540024259274,1.0,8/40,10.72%,PDGFRA;NTRK3;FGF2;EGFR;LPAR1;NTRK2;FGFR1;ESR1
prerank,negative regulation of response to stimulus (GO:0048585),0.4542734125895779,1.2968640659829096,0.11325028312570781,0.8808896348223834,1.0,13/60,9.97%,UBASH3B;ERBB3;CD34;ACVR1;MAP3K3;MAPK7;SOCS5;HHIP;CDK6;COL3A1;AKT3;PTPN1;MCTP1
prerank,histone H4-K16 acetylation (GO:0043984),0.5513106582456931,1.2961044613661785,0.18220338983050846,0.882439280395481,1.0,11/19,23.66%,JADE1;KMT2A;JADE3;KAT8;PHF20;ING4;KANSL1;MSL3;MCRS1;KANSL2;KAT7
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5855030750626778,1.2960493566175033,0.1806853582554517,0.8807162788526556,1.0,6/13,18.98%,TRIM44;WNT5A;AGPAT2;TAF9;CD74;AXL
prerank,membrane protein proteolysis (GO:0033619),0.4860421682289777,1.2954105673652814,0.13670886075949368,0.8817461200998905,1.0,11/37,14.33%,ADAM19;PRKCQ;BACE2;HM13;PARL;TGFB1;PSEN1;NGFR;NCSTN;APH1A;PSEN2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.534307565650525,1.2952750133646191,0.16734143049932523,0.8804607813685758,1.0,8/21,14.33%,ADAM19;PRKCQ;BACE2;HM13;PSEN1;NCSTN;APH1A;PSEN2
prerank,spermatid development (GO:0007286),0.4848462739618255,1.2952699800290317,0.14393939393939395,0.8785821481083591,1.0,7/32,14.94%,RSPH1;RFX2;CEP57;CDYL;DDX25;NECTIN2;DPY19L2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.38736452091384793,-1.294908280630703,0.1072961373390558,0.6993051261300519,1.0,9/28,9.67%,FOXP1;ERAP1;APPL2;BIRC3;TRIM5;CD55;SAMHD1;CASP8;IRF1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4710660835792714,-1.2947324677543701,0.16374269005847952,0.696449061483239,1.0,7/15,27.31%,DAB2;WASL;SNAP91;HIP1R;TNK2;PIK3CB;BMP2K
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5540861910282653,1.293947594797741,0.1820689655172414,0.8827351717494853,1.0,6/18,15.54%,CCR2;METTL3;IL4I1;ZFP36L2;XRCC6;ABL1
prerank,cellular response to organic cyclic compound (GO:0071407),0.4207291986937505,1.293238203068795,0.072992700729927,0.8839637014238795,1.0,42/141,21.50%,RORA;P2RY2;SSTR1;HRH1;EGFR;TGFB1;AOC1;URI1;RORC;CASP6;CYP1B1;RAP1A;IL18;BRCA1;AKAP6;ESR1;ARL6IP5;NRIP1;GNAI1;HSP90B1;AHR;P2RY12;P2RY1;SSH1;LCOR;JUP;BLM;GABRG2;SPIDR;NCOA3;CASP7;FAM210B;TAF1;EGR1;RYR3;RUVBL2;HCN1;UBE2L3;ADCY8;TIPARP;PKD2;P2RX7
prerank,vesicle transport along actin filament (GO:0030050),-0.441331873000793,-1.2930144441494675,0.1564625850340136,0.6981998318450894,1.0,10/19,27.07%,MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,negative regulation of leukocyte migration (GO:0002686),0.6077231215049209,1.2921563350297076,0.18923076923076923,0.8871191265071747,1.0,2/10,2.97%,BMP5;HOXA7
prerank,vesicle organization (GO:0016050),0.4625722459108456,1.2917766907811845,0.1431980906921241,0.8869303938748633,1.0,12/46,12.88%,USP50;DNM1;CD34;ALS2;LAPTM4B;EPS15;VPS11;PI4K2A;PHETA2;RAB22A;SNX10;AKTIP
prerank,negative regulation of protein polymerization (GO:0032272),-0.3928044941902656,-1.2914781421659,0.1044776119402985,0.6998821844013373,1.0,8/27,5.29%,CDH5;MAP2;PRKCD;SLIT2;CLIP3;CYRIB;KANK3;EML2
prerank,ameboidal-type cell migration (GO:0001667),0.4607602933147191,1.290704636320529,0.1413427561837456,0.8899111320548211,1.0,16/51,18.85%,GPC3;SOX8;SEMA3E;SEMA6C;SEMA3A;PKN1;ERBB4;GDNF;ANXA6;PDXDC1;SEMA6D;ITGB7;SEMA4B;CENPV;PKN2;SEMA4D
prerank,regulation of integrin activation (GO:0033623),-0.4701148332776275,-1.2901505982486567,0.1525974025974026,0.7005773234936484,1.0,3/15,6.05%,RAP1B;JAM3;RASIP1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5460615095813901,1.2895485143857708,0.1657142857142857,0.8933734994989051,1.0,7/17,16.41%,MBD4;ERCC5;MPG;MUTYH;NEIL1;SMUG1;TERF2IP
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4958963495961276,1.2894760001174748,0.16005121638924455,0.8917872501721086,1.0,11/30,18.14%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN;IDS;HYAL1;UGDH;CSPG4;CHSY3
prerank,negative regulation of secretion (GO:0051048),0.608770440917404,1.2893998205781203,0.20278637770897834,0.8902672327146741,1.0,2/10,3.40%,ERBB3;PTGER3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.39576704838395527,1.289262718318271,0.013026052104208416,0.888972671320407,1.0,87/390,15.29%,ROR2;SIPA1L1;SHC4;ROR1;MMP2;UBASH3B;SULF1;PDGFRA;DNM1;ERBB3;NTRK3;EFNA4;FGF2;FGF10;ARPC1B;IRS2;EPHB6;NGF;ERBB2;EGFR;PTPRT;PTPN2;EFNA5;VEGFA;EPHB2;RAB14;EIF2AK3;COL4A2;ARHGEF28;MAPKAPK3;PSEN1;ATP6V1B2;NCF1;NTRK2;SDC2;MAPKAPK2;PLCB1;GRIN2B;PAK1;RASA1;POLR2B;CHN1;BAIAP2;SPRED2;ITSN1;SPRED1;FGFR1;ANKS1B;FYN;BRK1;CEP57;VAV3;GRB14;SHOC2;POLR2K;DOCK1;SHCBP1;NCF2;NCBP1;ERBB4;PIK3R1;PTPRJ;NGFR;NCSTN;CBL;MAPK14;PTPN11;STYK1;MAPK1;EFNB1;CDK5R1;FGF7;NRP2;ANKS1A;APH1A;EFNB3;PRLR;POLR2G;NCK1;EPHA10;PSEN2;COL1A1;GALNT3;CYFIP1;MET;ELMO1;GFRA2
prerank,mononuclear cell differentiation (GO:1903131),-0.40198689078097327,-1.2891845880892177,0.13524590163934427,0.7001996054761263,1.0,5/24,4.34%,MYH9;IL31RA;BMP4;LYN;RELB
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5380892524105613,1.2891563838820495,0.17073170731707318,0.887634577565105,1.0,7/21,19.82%,CACNA2D1;ANK2;SCN5A;FLNA;KCNH2;KCNA5;NOS1AP
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4969139170926527,1.289146348902933,0.16512549537648613,0.885808923941811,1.0,8/29,9.43%,GCDH;ACACA;SCD5;ELOVL6;ACLY;FASN;PPT2;ELOVL5
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5796797696867387,1.288947400353347,0.1935483870967742,0.884812624734968,1.0,4/13,15.54%,ANK3;PDE4D;CALM1;CALM2
prerank,cellular response to metal ion (GO:0071248),0.41788127289826754,1.2886832426666655,0.08544303797468354,0.8842000385665276,1.0,44/123,23.56%,ANK3;CPNE8;DPEP1;PRKN;EGFR;KCNA1;HPCA;NCF1;PRNP;MT3;SLC12A2;DLG2;SCN5A;WNT5A;AOC1;SYT1;NLGN1;BNIP3;MAPK9;SYT11;SYT12;MAPK1;ALOX5AP;SNCA;SUMO1;IQGAP1;GPLD1;SLC25A24;CHUK;CPNE7;SYT2;RYR3;CPNE1;JUN;SYT13;ADCY8;CPNE3;PKD2;CACNA1H;PRKAA1;DLG4;CAMK2D;CPNE5;SYT3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.48942733181246845,1.2884123934025167,0.14754098360655737,0.8835231932094125,1.0,2/33,1.66%,APOD;PTEN
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5176995981104252,-1.2882788649979016,0.16304347826086957,0.6996757177157107,1.0,5/10,16.18%,BMP6;RGCC;NOTCH4;NEXMIF;PPM1F
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4492168382929264,1.2878938096183359,0.13142857142857142,0.8840819952026974,1.0,9/63,11.09%,FGF10;BCL2;IRS2;BST1;EPHB2;CD320;IL18;VAV3;IL6ST
prerank,positive regulation of ion transport (GO:0043270),0.46261922263402244,1.2877894497323528,0.14523809523809525,0.8827205098676935,1.0,12/48,15.13%,ANK3;ANK2;ANO6;WNK3;CCL4;CNKSR3;SCN5A;GDNF;DRD2;ATP2B1;AHCYL1;PKP2
prerank,hexose metabolic process (GO:0019318),0.4734618400539194,1.28740941133332,0.14041514041514042,0.8826889741370543,1.0,6/39,13.35%,APOD;IRS2;PGM1;GALM;FUCA2;BRAT1
prerank,regulation of postsynapse organization (GO:0099175),0.5091267039363603,1.287102056710374,0.15915119363395225,0.8821856033694143,1.0,10/28,15.49%,SIPA1L1;IL1RAPL1;TANC2;WNT5A;CDKL5;PPFIA2;CDK5R1;LZTS3;ARHGAP44;HOMER1
prerank,negative regulation of wound healing (GO:0061045),0.507137613578473,1.2869696825139927,0.17420212765957446,0.880952795389361,1.0,8/28,11.17%,CLDN19;FGF2;PTEN;CD34;SLC12A2;SERPINE2;CLASP1;AJAP1
prerank,DNA methylation (GO:0006306),0.5210080594774,1.2867939091023703,0.17721518987341772,0.8798571050612835,1.0,8/23,19.52%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS;KMT2E;N6AMT1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.49709520948159325,1.2865751185439755,0.1625806451612903,0.8790813029227237,1.0,5/31,6.38%,OSR2;PDGFRA;SOX11;HOXD3;TGFBR2
prerank,positive regulation of immune effector process (GO:0002699),-0.3924164840052943,-1.2863635143144307,0.1276595744680851,0.70251093729551,1.0,4/27,4.51%,ANKRD17;APPL2;DDX60;RPS19
prerank,detection of calcium ion (GO:0005513),0.56787889086495,1.2862313895110644,0.17921686746987953,0.8788484761752678,1.0,5/13,15.54%,SYT1;KCNMB2;KCNMB3;CALM1;CALM2
prerank,negative regulation of metabolic process (GO:0009892),-0.3330954814419605,-1.286198900293024,0.05,0.6995726199003084,1.0,21/54,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;ZDHHC7;CCDC3;NR1H2;NOVA2;PGAM5;RHEB;NRDC;PCTP;NR1H3;ATF4;FOXC2
prerank,positive regulation of neuron migration (GO:2001224),0.6064943498175912,1.285112545169598,0.18478260869565216,0.8820294268909835,1.0,5/11,19.93%,KIF20B;SEMA3A;PLAA;MDK;SHTN1
prerank,positive regulation of endocytosis (GO:0045807),0.4619324159230682,1.2846439709891186,0.14372716199756394,0.882366728392482,1.0,11/45,14.27%,GPC3;SGIP1;BICD1;LRP1;ANO6;NLGN1;RAB21;HIP1;CBL;SNCA;NEDD4L
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5059110759354158,1.2845914344674223,0.1629139072847682,0.8807845090729615,1.0,6/26,10.95%,RELN;PTEN;NRXN1;NLGN1;SLC8A2;RIMS1
prerank,endosome organization (GO:0007032),0.471073263297821,1.284503038172397,0.1471698113207547,0.8792956937838381,1.0,10/41,12.88%,USP50;DNM1;ALS2;LAPTM4B;VPS11;PI4K2A;PHETA2;RAB22A;SNX10;AKTIP
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3038632694679074,-1.2844257552454934,0.03571428571428571,0.702167170482976,1.0,26/75,20.85%,GRK5;ROCK2;CAMKMT;ROCK1;ZDHHC3;RGS3;RGS5;MGRN1;GNG7;GRK4;ZDHHC7;MGLL;KCTD8;CAMK2A;RGS12;RGS4;FNTB;RPGRIP1L;FRMPD1;EDN1;GIT1;NMT1;RGS6;GPER1;ADCYAP1;MRAP2
prerank,positive regulation of calcium ion transport (GO:0051928),0.4828541769981473,1.2840452680992687,0.1415929203539823,0.879415719160625,1.0,4/36,4.10%,LGALS3;ANK2;WNK3;CCL4
prerank,regulation of macrophage differentiation (GO:0045649),0.5715644582268928,1.2835536549623614,0.18507890961262555,0.8797752750850281,1.0,3/15,2.79%,PRKCA;FADD;PTPN2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3536989906544071,-1.2823669040926018,0.11875,0.705329863738346,1.0,8/45,4.03%,BMP6;DAB2;RBPMS;ACVRL1;BMP4;ENG;BMPR2;TGFBR1
prerank,serine family amino acid catabolic process (GO:0009071),0.6128984995980096,1.280593870724599,0.18345864661654135,0.891640700433046,1.0,2/10,5.58%,CBS;DAO
prerank,dicarboxylic acid metabolic process (GO:0043648),0.45261681427512135,1.2802455573657843,0.1425233644859813,0.891437076219668,1.0,11/52,15.44%,AADAT;IDH2;DLST;ALDH1L1;GOT2;ACLY;MTRR;MTHFD2L;ALDH5A1;GPT2;ALDH1L2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.43710396991548656,1.279968511288168,0.13528748590755355,0.890874482844523,1.0,12/70,11.42%,RELN;NTN4;PEAK1;LAMC1;RILPL2;METTL3;MEGF9;NTNG2;NTNG1;UNK;PIK3R1;OPHN1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5985211079633705,1.279263032166727,0.20933977455716588,0.892257811879156,1.0,3/10,6.38%,MYC;SOX9;TGFBR2
prerank,regulation of kinase activity (GO:0043549),0.42089262302519115,1.2788969847974787,0.11576626240352811,0.8921009152584874,1.0,16/89,10.17%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;IRS2;EPHB6;ERBB2;EGFR;NPRL2;EPHB2;NTRK2;VAC14;FGFR1;LDB2;ERBB4
prerank,interstrand cross-link repair (GO:0036297),0.45512911104821285,1.2787472646778173,0.1607981220657277,0.8909961833896336,1.0,13/53,16.45%,UBE2T;POLN;ERCC4;RPA3;XPA;FANCC;MSH6;ERCC6L2;XRCC3;RPA2;UBB;FANCI;USP1
prerank,presynaptic endocytosis (GO:0140238),0.5152208863505243,1.278430385587613,0.17096336499321574,0.8906814639281014,1.0,9/24,18.62%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;SNCA;SYT2;SNCB
prerank,striated muscle cell development (GO:0055002),-0.47034870616523217,-1.2782891730995214,0.1687116564417178,0.7151098780580428,1.0,5/14,19.72%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,acetyl-CoA metabolic process (GO:0006084),0.5545615728093526,1.2780531104532067,0.19710144927536233,0.8906545032784272,1.0,6/15,17.51%,ACACA;ACSS1;ACLY;DIP2A;PPCS;HMGCS2
prerank,protein K11-linked ubiquitination (GO:0070979),0.5046665241234333,1.2780077158659584,0.16,0.8890686098943775,1.0,14/27,25.08%,UBE2T;PRKN;UBE2E2;ANAPC7;ANAPC2;CDC23;RNF4;UBE2L3;CDC27;ANAPC4;UBE2D3;ANAPC5;CDC16;ANAPC13
prerank,heart development (GO:0007507),0.4088221101160553,1.2768641986282103,0.08539094650205761,0.8925192984411351,1.0,33/150,15.27%,GPC3;DLC1;BMP5;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;SGCD;VEGFA;TGFB1;NF1;SGCZ;FGF12;TGFBR2;PDLIM4;COL3A1;ERBB4;PTPN11;DAND5;SMYD4;BMP7;ZFPM2;KDM6A;SCUBE1;LDB3;PKD1;CITED2;PKP2;NDUFV2
prerank,protein polyglutamylation (GO:0018095),0.5996895843521912,1.276648135151093,0.1895734597156398,0.8916902942370417,1.0,5/11,14.55%,TTLL5;TTLL11;TTLL4;CFAP20;TPGS1
prerank,positive regulation of cell killing (GO:0031343),0.5706779930227375,1.2758981960342626,0.2162962962962963,0.8932995987852499,1.0,3/13,7.26%,NOX1;WNT5A;FZD7
prerank,positive regulation of ossification (GO:0045778),0.47039465387275264,1.2758705059716207,0.16044776119402984,0.8916405638165766,1.0,16/39,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;SOX11;WNT5A;ZBTB16;PTPN11;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,muscle cell development (GO:0055001),-0.3737258265349551,-1.275533695220605,0.12206572769953052,0.7204656714219997,1.0,6/30,3.87%,NEBL;MYOF;IGF1;CXADR;ENG;KDM1A
prerank,pentose-phosphate shunt (GO:0006098),0.5936139737751743,1.2753721913193303,0.21339563862928349,0.8921093312759864,1.0,8/11,25.67%,H6PD;RPE;SHPK;PGLS;TALDO1;RBKS;RPIA;PGM2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5415376140787755,1.2753701414466636,0.18668596237337193,0.8903523228630623,1.0,6/18,9.87%,SUV39H1;KMT2A;SETD3;SETMAR;PRDM9;SETD2
prerank,brain development (GO:0007420),0.41172217706420333,1.274245746327035,0.09599156118143459,0.8935004539097551,1.0,24/136,15.55%,APOD;RELN;SOX6;PTCH1;HSPG2;PTEN;GRIN2B;EML1;CTNNA2;NF1;TGFBR2;PHGDH;PAFAH1B3;CNTNAP2;PTPN11;ADGRL3;CDK5R1;PHF8;GRIN2D;ZFHX2;GRIN2A;NES;SCYL2;MEIS3
prerank,response to tumor necrosis factor (GO:0034612),0.4254644985892655,1.2741771468168737,0.12108108108108108,0.8920176333553618,1.0,17/91,17.26%,AFF3;CCL11;ADAMTS12;HAS2;PYCARD;CCL4;BRCA1;ERBIN;ZFP36L2;NFE2L2;PID1;GATA3;ZFAND6;CCL14;HYAL1;RIPK1;CHUK
prerank,toxin transport (GO:1901998),0.6022005492313026,1.2733873052035314,0.19571865443425077,0.8937609973014689,1.0,4/10,19.51%,SLC22A3;ANTXR2;ANTXR1;RAB40B
prerank,digestive tract morphogenesis (GO:0048546),0.5582540358964332,1.2730343616096063,0.212298682284041,0.8935656901105047,1.0,3/14,4.96%,PDGFRA;SOX11;GLI1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5605569143927838,1.2727407524228602,0.18413173652694612,0.893087614550717,1.0,3/14,12.72%,SLC27A1;SELENOI;ETNK1
prerank,regulation of ossification (GO:0030278),0.4754447281832997,1.2723402496137288,0.16666666666666666,0.893054744549327,1.0,9/36,10.85%,ANKH;LRP4;SOX9;ACVR1;SOX11;WNT5A;ZBTB16;CHSY1;PTPN11
prerank,NAD biosynthetic process (GO:0009435),-0.4348194372170636,-1.27232837155014,0.1553030303030303,0.7274119681320164,1.0,7/20,10.07%,PTGIS;NMNAT2;NAMPT;NAXD;PARP10;PTGS2;NMNAT1
prerank,negative regulation of response to external stimulus (GO:0032102),0.4235087507944421,1.2722186799394415,0.10223642172523961,0.8918565220003344,1.0,17/105,13.20%,RORA;FFAR4;CLDN19;FGF2;PTEN;PTPN2;MAPK7;IRAK3;TNFAIP8L2;CTNNA2;GRID2;OTULIN;PPM1B;SELENOS;AJAP1;DRD2;GATA3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5069803269131361,1.2717659510772121,0.1856368563685637,0.8921475187876042,1.0,12/22,25.65%,DDX11;ERBB2;EIF2AK3;HEATR1;PIH1D1;PHF8;DHX33;UBTF;SMARCA4;WDR75;MTOR;SMARCB1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4935343234148246,-1.2716557027467486,0.1751412429378531,0.7260196021234882,1.0,7/12,23.41%,CYP26B1;KLF2;SNW1;CNOT1;TRIM16;CTBP2;CALR
prerank,Golgi to plasma membrane transport (GO:0006893),0.4608824406844897,1.2702337917045847,0.1581450653983353,0.8973212336727571,1.0,9/47,7.70%,STXBP6;ANK3;STEAP2;VAMP4;ARL3;BLZF1;OSBPL5;SPTBN1;RAB34
prerank,carbohydrate derivative transport (GO:1901264),0.5369434803201645,1.2702264146669793,0.1792717086834734,0.8956219155115425,1.0,3/18,9.65%,SLC28A1;SLC29A1;SLC10A7
prerank,regulation of myotube differentiation (GO:0010830),-0.3989816313583694,-1.269853975712693,0.1336206896551724,0.7281749136125991,1.0,9/24,23.02%,SIK1;MAML1;HDAC4;ATP11A;TMEM119;HDAC3;DMPK;HDAC5;SMYD1
prerank,cognition (GO:0050890),0.4574329804091004,1.2695093344261785,0.1724137931034483,0.8970958661262352,1.0,14/42,14.94%,ST3GAL4;CHRNA4;NF1;RP9;GPR155;SLC8A2;NSUN5;MGAT3;GRM5;MAGT1;CBR3;SETD5;TUSC3;CYFIP1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5439675043027086,1.2693603014545127,0.1879382889200561,0.8960300751693309,1.0,4/15,10.67%,FAP;LRP1;TGFB1;CLASP1
prerank,regulation of cytoplasmic translation (GO:2000765),0.5734280923100336,1.26885113408926,0.2125748502994012,0.896628443178462,1.0,7/14,26.28%,UNK;CPEB3;CPEB1;CNBP;YBX3;FMR1;CPEB4
prerank,positive regulation of telomere maintenance (GO:0032206),0.47920009653301227,1.2686844672380084,0.18032786885245902,0.8955936642380508,1.0,14/31,26.14%,PRKCQ;ATRX;MAPK1;SIRT6;NEK7;MAP3K4;RTEL1;ATM;RAD50;GNL3;PKIB;SLX4;HNRNPA2B1;NABP2
prerank,protein K48-linked deubiquitination (GO:0071108),0.5065362267831749,1.267877569066358,0.18435754189944134,0.8974159834286884,1.0,8/23,19.06%,USP50;OTUD7B;USP33;USP25;OTUD4;USP37;OTUD7A;USP5
prerank,regulation of proteolysis (GO:0030162),0.4604912154580276,1.2668295604988755,0.1606280193236715,0.9002878396857366,1.0,11/48,13.90%,TBC1D10A;FADD;PARL;CSTB;SPOP;GSAP;SERPINE2;AURKAIP1;HDAC2;HDAC6;NEDD8
prerank,negative regulation of immune system process (GO:0002683),0.55203646589301,1.2667952336013935,0.21029411764705883,0.8986924245876635,1.0,4/16,9.11%,SOX9;FADD;HOXA7;COL3A1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5071703649813283,1.2665972331033009,0.18860244233378562,0.8978754296895819,1.0,7/23,17.45%,PRKN;PDE4B;MAPK1;PRKACA;SNCA;ABL1;SLC9A1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.43512240909386823,-1.2662772929198998,0.1563517915309446,0.7363453700377282,1.0,2/17,5.68%,PLA2G4A;CRLS1
prerank,neurotransmitter transport (GO:0006836),0.42988078008526825,1.2661619491121463,0.133032694475761,0.8981488313006132,1.0,17/73,17.00%,SLC6A2;SLC22A3;SLC1A3;NRXN1;SYT1;SLC29A1;SYN1;PPFIA2;RIMS1;TSPOAP1;DVL1;RAB3A;APBA1;CHAT;GLS2;GLS;SLC6A15
prerank,neural tube development (GO:0021915),0.5506089611466154,1.2657085682104923,0.21545319465081725,0.8983385613917078,1.0,6/15,15.38%,PTCH1;TGFB1;SOX11;DVL1;PKD1;DACT1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4328092003583078,-1.2657015250018508,0.14545454545454545,0.7347463016170325,1.0,8/19,26.77%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.44708162872074375,-1.2654431612660884,0.1694915254237288,0.7321037568817275,1.0,8/17,26.77%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3902882596882945,-1.2650937791506967,0.12987012987012986,0.729819705205358,1.0,4/26,3.06%,DAB2;FOXP1;KANK2;CLOCK
prerank,anion transport (GO:0006820),0.4833856764180247,1.26413910177828,0.18508997429305912,0.90371236631061,1.0,5/33,5.60%,SLC22A3;VDAC2;SLC17A5;LRRC8D;SLCO2B1
prerank,skeletal system morphogenesis (GO:0048705),0.4657292180549806,1.2639714825918307,0.1668711656441718,0.9027438774795669,1.0,7/42,10.31%,OSR2;PDGFRA;SOX11;HHIP;HOXD3;FGFR1;SFRP4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4779537069168378,-1.2633609374713821,0.18862275449101795,0.7323380970006462,1.0,3/13,9.33%,ETS1;NFAT5;RHOA
prerank,transcription preinitiation complex assembly (GO:0070897),0.5826820281614923,1.2623457621890706,0.2102728731942215,0.9082587820447063,1.0,7/12,28.18%,GTF2B;TAF11;TAF7;TAF1;TBP;DR1;BDP1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4342859611964577,1.2616316963990544,0.1275395033860045,0.9097309373948846,1.0,18/69,18.76%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;MT3;RASA1;HIF1A;SNX6;GDNF;GRN;SOD2;PTPRZ1;FZD9;TGFB3;MDK;PARK7
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4718753898479561,1.2613852569051267,0.18239795918367346,0.9091185357125866,1.0,6/35,10.65%,SGIP1;BICD1;MKLN1;RAB21;HIP1;CBL
prerank,regulation of smooth muscle contraction (GO:0006940),0.5121977910608029,1.2607927245497008,0.22085048010973937,0.9099989445591314,1.0,5/20,16.91%,CHRM3;SETD3;NMU;ATP2B1;CTTN
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5166020557660256,-1.2604294977708612,0.19491525423728814,0.7383365835656266,1.0,7/10,30.56%,ATP7A;GIPC1;APPL1;OPN3;CDH3;MFSD12;RAPGEF2
prerank,epithelial cell morphogenesis (GO:0003382),0.5354823018553009,1.2603967576918282,0.18556701030927836,0.9099990059849343,1.0,3/17,8.42%,COL15A1;RILPL2;COL18A1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4405708458263678,1.2596646086554901,0.1580161476355248,0.9114749349188986,1.0,14/54,12.65%,APOD;DLC1;PTEN;PEAK1;EFNA5;MAP4K4;VEGFA;GPM6B;TSC1;SLK;PTPRJ;CLASP1;PTPRA;MYOC
prerank,pharyngeal system development (GO:0060037),0.5565143031899118,1.2596266372872955,0.20605187319884727,0.9099612173831649,1.0,5/15,14.61%,PTCH1;BMP5;BMP7;GATA3;BMPR1A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5293591477430875,1.2596153367290424,0.2129120879120879,0.908296393296463,1.0,7/19,15.48%,FGF2;VGLL4;GLI1;ERBB4;ZFPM2;BMPR1A;RUNX1
prerank,neuron fate commitment (GO:0048663),-0.455211073848363,-1.2593784799482084,0.1761006289308176,0.7386116874414951,1.0,10/14,45.96%,TGFBR1;ID2;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,response to estradiol (GO:0032355),0.4842367964500092,1.258933976190067,0.17752234993614305,0.9095981753464683,1.0,10/31,19.75%,SSTR1;EGFR;TGFB1;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2;STAT3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5149443704854805,1.2585986259491313,0.20516304347826086,0.9094158732229152,1.0,4/22,7.90%,PRKCQ;TGFB1;CARD9;IL18
prerank,cell projection organization (GO:0030030),0.4810763501435629,1.2584228460568176,0.19788918205804748,0.9085533449196093,1.0,10/30,20.39%,RHOJ;GSN;PACSIN2;RHOH;P2RY12;CYFIP1;ITGB1;RAC3;NCKAP1;RHOU
prerank,artery morphogenesis (GO:0048844),-0.3641930012613636,-1.2583947932283965,0.14347826086956522,0.7384951573145773,1.0,13/30,15.30%,NRP1;SMAD7;BMP4;ENG;BMPR2;TGFBR1;TBX1;JAG1;PDGFRB;STRA6;TGFB2;HPGD;HEY2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4162631436538079,1.2579237666835983,0.12595837897042717,0.9090586638967572,1.0,27/93,21.48%,DOCK7;NTRK3;PTEN;NGF;EGFR;VEGFA;ARAF;TGFB1;CNKSR3;PAK1;MLXIPL;EIF4G1;HDAC6;PDE4D;TBK1;SNCA;NCK1;SH2D3C;RASSF2;TERF2IP;RPTOR;FNIP1;PARK7;INPP5J;BCAR3;NSD1;PRKD2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5725208741541766,1.2565845174670345,0.2217125382262997,0.9132146629166815,1.0,5/12,14.08%,SETMAR;NAE1;STK33;ORC1;TOPBP1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3902884796756792,-1.256424414450531,0.16141732283464566,0.741498744199854,1.0,8/24,8.69%,ROBO1;SMAD6;NRP1;BMP4;ENG;BMPR2;FGFR2;TBX1
prerank,regulation of protein neddylation (GO:2000434),-0.5133028429230457,-1.255894917907844,0.19428571428571428,0.7398380061063835,1.0,4/10,13.12%,DCUN1D3;RPL5;DCUN1D1;RPL11
prerank,intestinal lipid absorption (GO:0098856),0.5819572614212886,1.2554445951017044,0.21818181818181817,0.9165908558406017,1.0,1/11,1.19%,CEL
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5270519078865752,-1.2553670294755306,0.21005917159763313,0.7382832039665693,1.0,5/10,12.97%,APPL2;GRB10;PRKCB;GSK3A;ENPP1
prerank,histone H4-K5 acetylation (GO:0043981),0.5535706289942092,1.2545128874697449,0.22254335260115607,0.9174472715739931,1.0,9/15,23.66%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,histone H4-K8 acetylation (GO:0043982),0.5535706289942092,1.2545128874697449,0.22254335260115607,0.9174472715739931,1.0,9/15,23.66%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4186349950979957,-1.2544868738322492,0.16731517509727625,0.7378132921159628,1.0,8/20,20.80%,ROCK2;ROCK1;FHOD1;RHOQ;NCKAP1L;IKBKB;LLGL2;LCP1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.522809601545122,1.2540653310344254,0.1926729986431479,0.9159837619676121,1.0,9/21,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.522809601545122,1.2540653310344254,0.1926729986431479,0.9159837619676121,1.0,9/21,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,regulation of axonogenesis (GO:0050770),0.44505635542934735,1.2539548632405433,0.16159250585480095,0.9148216906683396,1.0,10/51,6.05%,SIPA1L1;CHODL;LRP4;PTEN;NGF;PLXNC1;NTRK2;LRRC4C;PAK1;CHN1
prerank,regulation of endopeptidase activity (GO:0052548),-0.3076896090053133,-1.253692619709856,0.08181818181818182,0.7370773206913113,1.0,18/59,24.09%,VTN;BIRC3;TIMP3;SERPIND1;SPOCK2;SERPINB9;APH1B;SERPINE1;TIMP2;SERPINI1;NRDC;PSENEN;TIMP4;AKT1;AGT;SERPINC1;PSMB9;ATP13A2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4939709309940398,1.2536888684995484,0.19738562091503267,0.9143600045240962,1.0,4/27,5.23%,HAS2;PRKCQ;PYCARD;CCR2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5677498111191311,1.2536279158465264,0.23922734026745915,0.9129359868159013,1.0,5/13,14.00%,DNAJB9;PPP1R15A;UFL1;PTPN1;NCK1
prerank,chromatin remodeling (GO:0006338),0.4198784576959986,1.253456417020396,0.13127001067235858,0.9120263822859969,1.0,36/100,22.04%,MYC;KAT2B;SOX9;SATB1;KDM5B;BAZ1A;EZH1;PAK1;KDM4B;MTA2;CHD3;ATRX;MBD2;PIH1D1;POLE3;HDAC2;MYSM1;ESR1;SMARCC2;JARID2;ZBTB1;RBBP4;SMARCC1;BAZ2B;KDM6A;BAZ1B;SMARCE1;PBRM1;NUDT5;RUVBL2;TOP1;SMARCA4;HNRNPC;GATAD2B;NPM3;ACTR5
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4808685587351914,1.2526396461843259,0.1925,0.9139893492128423,1.0,8/32,8.91%,GORASP1;IL1RAPL1;SDC2;TNIK;OBSL1;CDKL5;CDKL3;ADGRB3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4300547725675454,1.2526087656818015,0.1672394043528064,0.9124652837412051,1.0,14/62,11.65%,FGF10;IRS2;NGF;AKAP13;LPAR1;MAP4K4;GPR65;AUTS2;ALS2;ERBIN;SHOC2;COL3A1;STK19;MMD2
prerank,signal peptide processing (GO:0006465),0.5839929168971127,1.2524656130587386,0.20982142857142858,0.9114374805548202,1.0,3/11,8.76%,HM13;PARL;SPCS3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40224074712178576,-1.2524566724633757,0.1593625498007968,0.7379872387905122,1.0,8/24,13.32%,CDH2;BOC;CTNNB1;CDON;BNIP2;CAMK1;MAPK12;CDC42
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4051066372740523,-1.251615484552445,0.15053763440860216,0.7374554596409196,1.0,4/20,8.85%,DAB2;LZTFL1;NUMB;RHOQ
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4319418846717853,1.2506750900384511,0.14236902050113895,0.9177524717289518,1.0,20/68,20.99%,ADSS1;THEM4;PTHLH;OXSM;NT5C2;ACOT11;BPNT1;PDE9A;ACLY;BPNT2;ACSF2;HINT1;AK3;OPA1;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,regulation of B cell proliferation (GO:0030888),0.4530426574798747,1.2505188272516694,0.18863361547763,0.916777998833327,1.0,10/44,17.21%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3;AHR;ATM;CD74;RC3H1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4908896770744905,1.2504428514342905,0.19768934531450577,0.9154266418320581,1.0,10/29,17.08%,RAD23B;GTF2H2;ERCC5;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2997707455124723,-1.250412031431471,0.07476635514018691,0.7381235363137427,1.0,19/73,16.15%,DAB2;PTN;NRP1;MYH9;FBLN1;NEDD9;ITGB5;SEMA7A;FYB1;BCAR1;ITGA10;FN1;ADAM10;LAMA3;CDC42;ADAM15;CEACAM1;PTK2B;ITGA11
prerank,aorta morphogenesis (GO:0035909),-0.43627723127164847,-1.2499190827283166,0.19285714285714287,0.7363666221424165,1.0,9/17,15.30%,ACVRL1;ENG;MYLK;TBX1;EFEMP2;JAG1;PDGFRB;PROX1;HEY2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5918259812108904,1.2498427057399641,0.2374631268436578,0.9162977306604628,1.0,3/11,8.27%,PTPRT;SOCS1;NF2
prerank,gliogenesis (GO:0042063),0.5445061868189923,1.248361934165606,0.20906432748538012,0.9211515626427556,1.0,3/15,7.57%,RELN;METTL3;CDK6
prerank,regulation of interleukin-17 production (GO:0032660),0.4796516763576334,1.2481162563179573,0.1865482233502538,0.9206444432760484,1.0,5/31,7.90%,PRKCQ;TGFB1;PRNP;CARD9;IL18
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5150606328227307,-1.247886891027079,0.20334261838440112,0.739559596235666,1.0,4/10,16.31%,ERRFI1;ENG;ENPP1;CAV1
prerank,negative regulation of DNA binding (GO:0043392),-0.38887129158203754,-1.247511747534807,0.17040358744394618,0.7375290669251964,1.0,11/28,18.78%,SP100;LEF1;NFKBIA;KDM1A;HABP4;MDFI;SUMO3;HMGA2;HEY2;TFAP4;SIN3A
prerank,gas transport (GO:0015669),0.5925347628899498,1.2466937532575513,0.2476038338658147,0.9253334457107197,1.0,2/10,14.42%,MYC;MB
prerank,ganglioside biosynthetic process (GO:0001574),-0.4505006990665639,-1.2455696261548326,0.1930379746835443,0.7404562900974654,1.0,3/15,5.04%,ST6GALNAC3;ST8SIA4;ST3GAL1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5700177321572077,1.2451168933151773,0.23088923556942278,0.9307338784949083,1.0,8/12,24.42%,BICD1;PCM1;BICD2;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,cell-substrate junction assembly (GO:0007044),0.47239035811290553,1.2447245587130928,0.19029850746268656,0.9307983610635967,1.0,7/33,9.12%,DLC1;RHOD;PEAK1;LAMC1;TESK2;PLEC;TRIP6
prerank,isotype switching (GO:0045190),0.5985073238919069,1.2446131446320456,0.24427480916030533,0.9296241444967863,1.0,6/10,27.55%,MSH6;BATF;HSPD1;EXOSC3;LIG4;RNF168
prerank,microvillus organization (GO:0032528),0.5688872722167558,1.244071194041244,0.22869318181818182,0.9303444620404564,1.0,4/13,7.42%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,heterochromatin assembly (GO:0031507),0.5174772008268255,1.2438859719530493,0.19478737997256515,0.9295050992436523,1.0,6/20,11.02%,SUV39H1;EZH1;ZNFX1;MBD2;POLE3;HELLS
prerank,regulation of phospholipase C activity (GO:1900274),0.5353537349466165,1.2438823215142136,0.22633136094674555,0.9278667823710078,1.0,6/15,10.72%,PDGFRA;NTRK3;FGF2;BICD1;FGFR1;ESR1
prerank,manganese ion transport (GO:0006828),-0.44306111551528626,-1.2434730653253265,0.19384615384615383,0.7441312475403384,1.0,5/14,17.61%,SLC30A10;SLC39A8;TRPC6;TRPC3;TRPC7
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5471547183547728,1.2425237441629688,0.22334293948126802,0.9321392817742953,1.0,3/15,3.61%,PIEZO2;LHFPL5;KCNA1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.44443345095458564,1.2421715840598613,0.1873508353221957,0.9320237819446081,1.0,6/51,9.17%,USP50;IL16;PYCARD;WNT5A;TMEM106A;TMED10
prerank,glycine transport (GO:0015816),0.5798900439990976,1.2419957246719209,0.22473604826546004,0.9311720986941668,1.0,4/10,19.24%,SLC36A2;SLC25A38;SLC7A8;SLC6A9
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.49540784109574926,-1.2418759686692107,0.20699708454810495,0.7462302214821912,1.0,2/11,0.18%,AFDN;TJP1
prerank,negative regulation of bone remodeling (GO:0046851),0.5766373210396286,1.2416144324188496,0.2153846153846154,0.9313094505905284,1.0,1/11,0.55%,UBASH3B
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4435191502032754,1.2415671479253563,0.17577197149643706,0.9298937465279739,1.0,8/48,12.72%,PYCARD;PTPN22;FADD;PDE4B;CCR2;IL18;PDE4D;SCRIB
prerank,MAPK cascade (GO:0000165),0.386294723331857,1.2413208995299256,0.05628140703517588,0.9293187072645707,1.0,53/295,11.99%,GFRA1;PDGFRA;ERBB3;PRKCQ;IL2RA;FGF13;FGF2;MYC;FGF10;IRS2;SOX9;ERBB2;EGFR;GFRA4;MAP4K4;MAP3K3;ARAF;TGFB1;MT3;MAPKAPK2;GRIN2B;NF1;DUSP6;TNIK;DLG2;SPTBN1;PAK1;SYNGAP1;RASA1;KSR1;SPRED1;MEN1;FGFR1;RGL1;IL18;LYPLA1;FYN;LAMTOR2;SHOC2;PSMB7;BTC;CUL3;ARL2;ZFP36L2;MRAS;ERBB4;PIK3R1;GDNF;MAPK1;TAOK3;CCM2;PTPRA;FGF7
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4366575090993936,1.2401154914593755,0.17289719626168223,0.9329775764544442,1.0,22/56,23.62%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;CUL3;ANAPC7;EIF4G1;CDC25B;CDC23;CCND2;HYAL1;FBXO5;RPTOR;KMT2E;RDX;CDC27;PHB2;ANAPC4;ANAPC5;RB1;CDC16
prerank,embryonic digit morphogenesis (GO:0042733),0.5348403919986557,1.239708311604309,0.2244039270687237,0.9331225954197471,1.0,2/18,1.94%,OSR2;WDPCP
prerank,ceramide transport (GO:0035627),-0.4749204664243416,-1.2393633672639661,0.19444444444444445,0.7515733486467431,1.0,5/12,25.76%,PLTP;GLTP;ABCB4;CERT1;PLEKHA8
prerank,platelet aggregation (GO:0070527),0.4723724241472044,1.2393406307093635,0.20610687022900764,0.9330874056589737,1.0,4/33,2.62%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4385722771702782,-1.2391368574820343,0.20350877192982456,0.7491914407715595,1.0,8/18,26.77%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5211471377828936,1.2390827978690153,0.20056899004267426,0.932544343489345,1.0,7/18,14.37%,ERBB2;EIF2AK3;FLNA;HEATR1;POLR2K;PHF8;DHX33
prerank,cell-cell junction assembly (GO:0007043),0.4331374552546014,1.2384607339841693,0.16303099885189437,0.9336249239606406,1.0,17/63,16.62%,DCHS1;CDH19;PRKCA;CDH10;CDH22;CDH8;PATJ;EPB41L3;CDH20;CDH7;RHOC;FBF1;CD9;PKP2;JUP;CDH18;FSCN1
prerank,actin filament bundle assembly (GO:0051017),-0.3520742545911611,-1.2377983589584356,0.13592233009708737,0.7503254337682016,1.0,4/33,2.13%,PAWR;CALD1;BAIAP2L1;NEDD9
prerank,regulation of blood coagulation (GO:0030193),0.48676745012184247,1.237618381253055,0.2193211488250653,0.9357810564774814,1.0,5/27,8.22%,FAP;ST3GAL4;CD34;EPHB2;SERPINE2
prerank,synaptic vesicle endocytosis (GO:0048488),0.4719436998704981,1.237170863631598,0.20178799489144317,0.9361568051577208,1.0,10/33,13.88%,DNM1;CEL;STON2;SYT1;NLGN1;STON1;ITSN1;GAK;OPHN1;SNCA
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.46735368699642593,-1.2371264484103957,0.20760233918128654,0.7494492925660569,1.0,6/13,18.86%,PLPP1;BMP4;CALCOCO1;NR3C2;ABHD2;GPER1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4641452638081869,-1.237048873282149,0.22522522522522523,0.7466120089828913,1.0,3/14,13.37%,ANKRD17;DDX60;USP15
prerank,regulation of endocytosis (GO:0030100),0.43211495620258317,1.2363756956296423,0.1707035755478662,0.9379914329690204,1.0,17/61,15.54%,GPC3;LGALS3;LRP1;STON2;PACSIN2;STON1;HIP1;SYT11;PTPN1;MCTP1;OPHN1;RAB4B;RAB4A;SNCA;NEDD4L;ARFGAP1;ABL1
prerank,postsynaptic membrane organization (GO:0001941),0.5292295946051077,1.2357498188408498,0.22525107604017217,0.9391565575751054,1.0,6/17,13.53%,CEL;LRP4;NRXN1;NLGN1;LHFPL4;GPHN
prerank,negative regulation of cell differentiation (GO:0045596),0.39049078526380004,1.2353963590335575,0.11270491803278689,0.9390301037097296,1.0,31/181,13.40%,RORA;PTCH1;SOSTDC1;BMP5;ADAMTS12;EFEMP1;SOX8;PTEN;HOXB8;SOX9;EGFR;COL5A2;PTHLH;TGFB1;WNT5A;ZBTB16;SPRED2;TWIST2;SPRED1;CDK6;MEN1;SPRED3;ZFP36L2;PTPN11;ABCA5;BMP7;WWTR1;EID2B;ZFPM2;GATA3;TRIO
prerank,receptor recycling (GO:0001881),-0.508277908060444,-1.235331075017852,0.20821917808219179,0.7489337116017164,1.0,7/10,22.21%,RAB11B;EHD3;NSG1;ARFGEF2;PHETA1;PLEKHJ1;REP15
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5000393483188491,1.2353153587162446,0.20291777188328913,0.937800931434579,1.0,7/23,11.46%,FGF2;SOX8;SOX9;VEGFA;SMO;GDNF;SIRT6
prerank,cellular response to BMP stimulus (GO:0071773),0.4253156891861629,1.235267064712608,0.16162790697674417,0.9363825111460741,1.0,8/66,4.73%,BMP5;ADAMTS12;RGMB;SOX9;HIVEP1;ACVR1;TGFB1;GDF9
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4913171898493667,1.2351304939742984,0.20316622691292877,0.9353750239258006,1.0,8/25,15.41%,FGF13;ANK2;DSG2;CTNNA3;TBX18;CALM1;PKP2;JUP
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.510135137565834,1.2349830552440477,0.21161825726141079,0.9344171220693517,1.0,9/21,18.76%,PRKN;MT3;BRCA1;HDAC6;ABCD2;PAX2;TRAP1;AATF;PARK7
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5400376825008679,1.2348327898813836,0.21823204419889503,0.9334953910912481,1.0,3/15,8.24%,DPEP1;SARDH;GOT2
prerank,embryonic axis specification (GO:0000578),0.5450848447497623,1.2344357773638999,0.2268326417704011,0.9337116139426558,1.0,2/15,2.36%,PTCH1;RIPPLY2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5470590389343591,1.23422590902777,0.2134502923976608,0.9330434195047982,1.0,5/15,12.86%,ERBB2;MVB12B;EGFR;PTPN18;MVB12A
prerank,histone H3-K4 methylation (GO:0051568),0.48988262652757886,1.2333226262348924,0.21333333333333335,0.9355543295019011,1.0,11/26,20.48%,KMT2A;CXXC1;SETMAR;MEN1;PRDM9;KDM6A;TET3;WDR5B;ASH2L;SETD4;KMT2D
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4888602283398867,1.2332721609525508,0.21216216216216216,0.934182688550261,1.0,9/26,18.13%,PRKCA;CCDC57;CUL3;ASNS;CDC25B;SMOC2;USP2;PKN2;MDM2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4521076079878315,1.2328118538019806,0.21153846153846154,0.9345659258387631,1.0,11/40,17.24%,DDX11;ZRANB3;TIPIN;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5082835587384881,1.2315366603790547,0.21030042918454936,0.9385743293130836,1.0,2/18,7.26%,SOX6;FZD7
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4834101942815744,1.231510041939563,0.21494102228047182,0.9371021181766228,1.0,6/26,10.85%,GAREM1;SOX9;ERBB2;EGFR;ZFP36L2;PTPN11
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.46664450689859777,1.2308504853524636,0.19551681195516812,0.9383500149698274,1.0,9/32,23.35%,CXCL10;AKAP6;SNCA;CALM1;CALM2;APLNR;HTT;PKD2;CEMIP
prerank,cellular response to misfolded protein (GO:0071218),-0.4056928294878238,-1.2307475624751012,0.18050541516245489,0.7609776200854879,1.0,13/20,30.73%,POMT2;RNF185;DNAJB12;STUB1;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;RNF126;VCP;BAG6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4727139539082353,1.2305326190716916,0.21273885350318472,0.938208449672724,1.0,5/32,3.25%,RHOJ;MEOX2;FGF2;VEGFA;MAP3K3
prerank,magnesium ion transport (GO:0015693),0.5723932020714605,1.2303725896727808,0.23384615384615384,0.9373686091760337,1.0,5/12,13.78%,MRS2;NIPA1;NIPAL2;MAGT1;TUSC3
prerank,DNA biosynthetic process (GO:0071897),-0.4320650009541162,-1.230334795826738,0.1986754966887417,0.7591927434583221,1.0,11/16,34.56%,POLD3;PPIA;POLH;POLA1;TERT;RFC3;POLD2;POLE;POLD4;POLD1;POLL
prerank,protein methylation (GO:0006479),-0.3421660160355363,-1.230198579616234,0.13114754098360656,0.756487166256057,1.0,15/40,14.77%,CAMKMT;GSPT1;PRMT7;FAM98A;ATPSCKMT;NTMT1;METTL21A;NSD3;PRMT5;PRMT2;LCMT1;SNRPD3;PCMT1;PRMT8;SNRPB
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5254933039458755,1.230007925439057,0.2140845070422535,0.9373761059265465,1.0,4/18,3.25%,RHOJ;FGF2;VEGFA;MAP3K3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5207609857964439,1.2298010796982257,0.22770919067215364,0.9366420264121004,1.0,8/18,18.76%,PRKN;MAPK7;BAG5;HIF1A;NFE2L2;SOD2;TRAP1;PARK7
prerank,selective autophagy (GO:0061912),0.4374831060183804,1.2293316748509877,0.1691948658109685,0.937069149026105,1.0,20/56,22.85%,DYNLL1;PRKN;WDFY3;ACBD5;UFL1;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;ATM;NBR1;RAB7A;PARK7;PHB2;PCNT;WDR81;VIM;UBQLN1;DYNC1H1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3792704034413177,-1.2290466254948265,0.20077220077220076,0.7571754046956061,1.0,4/24,8.85%,DAB2;LZTFL1;NUMB;RHOQ
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2945568713592582,-1.2285349200829627,0.08108108108108109,0.7557818819028842,1.0,17/82,8.90%,BMP6;RANBP3L;CRIM1;SMOC1;IGF1;WNT4;SMAD6;LRP5;TMEM64;BMP4;NOCT;BMPR2;SUCO;ZHX3;DDX5;FGFR2;CCN1
prerank,amyloid-beta metabolic process (GO:0050435),0.5356832101611982,1.2283900637389102,0.23348017621145375,0.939696019020288,1.0,6/16,14.33%,BACE2;PSEN1;MGAT3;NCSTN;APH1A;PSEN2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.48825259402315246,1.2283404360157921,0.21858638743455497,0.9383441956684807,1.0,5/27,7.57%,PDGFRA;MYC;WNT5A;S100A6;CDK6
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.4293173624620563,1.2269464106416845,0.1940828402366864,0.9428658346123743,1.0,8/56,6.92%,RTKN;ANK3;EFHC1;SPIRE1;ARL3;SPTBN1;RASA1;SON
prerank,muscle cell differentiation (GO:0042692),0.4648948086866371,1.226573262321273,0.22042341220423411,0.9428545481037849,1.0,5/32,7.60%,RORA;GLMN;SGCZ;GATA6;TBX18
prerank,monocarboxylic acid transport (GO:0015718),-0.32222995202629373,-1.2263274666805934,0.15822784810126583,0.7599255479221854,1.0,10/51,5.22%,SLCO3A1;ABCC4;ABCG2;SLC16A12;SLC16A6;SLC6A12;SLCO2A1;SLCO1C1;SLC6A13;SLC16A11
prerank,neuron differentiation (GO:0030182),0.3924728634378505,1.2263205248858537,0.11419753086419752,0.9423836354472683,1.0,16/165,7.26%,TENM2;CDNF;TENM3;LHX5;GLI2;ERBB2;IL1RAPL1;OTP;VEGFA;HS6ST1;SOX11;NTRK2;PHOX2A;WNT5A;NGRN;FZD7
prerank,peptide hormone secretion (GO:0030072),0.48044195818084307,1.2249875881615848,0.2325268817204301,0.9465463392135826,1.0,6/26,18.76%,FFAR4;EDN3;RAB1A;CDK16;RIMS2;PARK7
prerank,actin cytoskeleton reorganization (GO:0031532),0.42918478033286334,1.2248088228356602,0.20180383314543404,0.9457193248684187,1.0,15/63,10.30%,SIPA1L1;CLDN19;FGF10;GSN;GPR65;AUTS2;TNIK;THSD7A;PAK1;MKLN1;PDLIM4;FLNA;THSD7B;PTPN1;FARP2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.480985452341601,1.2237431776513152,0.21532364597093792,0.9487653951373352,1.0,6/27,13.50%,SLC27A1;SELENOI;PLAAT5;PLAAT3;ETNK1;PNPLA8
prerank,glutamate metabolic process (GO:0006536),0.5172953139913224,1.223124661217991,0.2327823691460055,0.949833773500103,1.0,6/19,16.78%,AADAT;GOT2;OAT;ALDH5A1;GLS2;GLS
prerank,regulation of lipase activity (GO:0060191),0.5407725209663201,1.2226038309899168,0.21460506706408347,0.9504949909811882,1.0,6/13,21.03%,PCSK6;LMF1;RHOC;SNCA;LIPC;FURIN
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5850231616596734,1.2223962060369378,0.25673534072900156,0.9498707922762661,1.0,1/10,1.69%,RHO
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.44803620892140894,1.222255180895983,0.20221948212083848,0.9489614829090394,1.0,8/39,6.38%,GLI2;FGF2;MYC;FGF10;SEMA3E;VEGFA;PAK1;TGFBR2
prerank,microvillus assembly (GO:0030033),0.5541124384173748,1.2219101587577443,0.24216524216524216,0.9489577292637333,1.0,4/14,7.42%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4881522045668241,1.2217507355691102,0.21174863387978143,0.9480670297345095,1.0,7/25,15.48%,GLMN;PDE4B;CCR2;SPTBN1;PDE4D;MALT1;RUNX1
prerank,negative regulation of blood pressure (GO:0045776),-0.4394409486245142,-1.2214154315677805,0.20121951219512196,0.7728551058945293,1.0,3/13,15.26%,NOS3;BMPR2;NOS1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.35567953865394986,-1.2210244543167392,0.14601769911504425,0.7710337205375022,1.0,11/33,19.60%,TOMM70;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;HSP90AA1;FLOT1;POLR3D;ISG15
prerank,sensory perception of pain (GO:0019233),0.5097484452375024,1.220898101480816,0.24594594594594596,0.9501717649660819,1.0,7/21,21.50%,KCNA2;CHRNA4;CCR2;NIPSNAP1;OPRK1;PTGES;P2RX7
prerank,retinoic acid metabolic process (GO:0042573),0.5420989992492209,1.2197715101144726,0.2543604651162791,0.9532712922381581,1.0,1/14,0.28%,CYP2S1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.32504701026855154,-1.2194493652432998,0.07643312101910828,0.7730499470855555,1.0,19/46,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;NR1H2;NOVA2;PGAM5;RHEB;NRDC;PCTP;NR1H3;ATF4;FOXC2
prerank,negative regulation of axon extension (GO:0030517),0.4678315652110861,1.2192255882506418,0.22066326530612246,0.9542026736062929,1.0,12/30,20.12%,SEMA3E;SEMA6C;SEMA3A;RNF6;MT3;CDKL3;RTN4;SEMA6D;DIP2B;SEMA4B;SEMA4D;PTPRS
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.4602452674506581,-1.219059217167107,0.22699386503067484,0.771255966262607,1.0,4/13,7.84%,ZC3HAV1;MOV10;CNOT1;GTPBP1
prerank,phospholipid transport (GO:0015914),-0.3218253359230365,-1.2187251025116208,0.152317880794702,0.7693643335142566,1.0,22/52,20.42%,OSBPL8;ATP10A;ABCA3;ABCA1;PLTP;PITPNA;ATP9A;ABCA4;OSBPL2;ABCG1;TNFAIP8L3;ATP11A;ATP8B2;ATP11B;MFSD2A;ABCB4;PRELID2;ATP10B;ATP8A1;APOE;ABCA7;PCTP
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.41267973874962677,-1.2186099419189855,0.1827956989247312,0.7666663609387645,1.0,6/19,7.52%,IL34;MPP1;JAM3;THBS1;CAMK1D;AKIRIN1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4704309359566514,1.2183655128350155,0.2111251580278129,0.9563481653952053,1.0,5/33,5.21%,RHOJ;CREB3L1;FGF2;VEGFA;E2F2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.48829721779983365,-1.2181311546294364,0.24705882352941178,0.7652838873800722,1.0,4/10,24.29%,ADGRV1;SOD1;PDZD7;TSKU
prerank,response to fatty acid (GO:0070542),0.5117285304770948,1.2180022899120333,0.254957507082153,0.9563792925522971,1.0,3/17,11.37%,SOX9;PDK3;PID1
prerank,regulation of mononuclear cell migration (GO:0071675),0.5006969291021355,1.2179591647528987,0.22086720867208673,0.9549931057922576,1.0,2/23,0.52%,LGALS3;BMP5
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4291395170642194,1.2175365012101762,0.20606060606060606,0.9552673222566399,1.0,17/54,19.82%,DPP10;BIN1;KCNMB2;KCNMB3;FLNA;STK39;AKAP6;KCNAB2;KCNJ3;KCNIP4;NEDD4L;KCNJ10;KCNH2;KCNMA1;CD63;CAB39;NOS1AP
prerank,protein import into peroxisome matrix (GO:0016558),-0.48027825864005586,-1.2174879091299882,0.2087227414330218,0.7642091351197435,1.0,8/12,27.26%,PEX13;PEX7;PEX14;PEX26;PEX2;PEX10;PEX6;PEX16
prerank,positive regulation of integrin activation (GO:0033625),-0.46946718653907393,-1.2173004677065584,0.23835616438356164,0.7617973447307784,1.0,2/11,6.05%,RAP1B;RASIP1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.33544728747577063,-1.217237908234155,0.15463917525773196,0.7589783055678871,1.0,5/41,2.50%,AFDN;TJP1;GCNT2;PODXL;SMAD7
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4842273261119952,-1.217040292596971,0.2265193370165746,0.756746007817748,1.0,5/11,22.44%,NOS3;HSP90AA1;SPR;QDPR;AKT1
prerank,cellular response to cytokine stimulus (GO:0071345),0.37786759686084076,1.2167517541815915,0.042042042042042045,0.9570728364694963,1.0,86/416,17.35%,RORA;MMP2;CCL11;ADAMTS12;CXCL10;IL16;HAS2;IL2RA;FGF2;PYCARD;MYC;BCL2;SOX9;CRLF1;IL20RB;IL1RAPL1;PTPRT;PTPN2;EPRS1;VEGFA;NPR2;IRAK3;SOCS5;TGFB1;CCL4;TEC;CCR2;SLC12A2;AQP4;ZEB1;PTPN13;NUMBL;WNT5A;SOCS1;YWHAZ;RORC;CSK;IL1RL2;CSF3R;IL18;FYN;GAB2;BRCA1;UBE2K;ERBIN;STK39;HIF1A;NDN;ZFP36L2;PIK3R1;PTPRJ;TYK2;CBL;AKAP6;NFE2L2;PTPN11;COL1A2;IL6ST;PID1;UPF1;TBK1;PRKACA;PTPN18;PRLR;HSP90B1;PTPRZ1;SHPK;GATA3;TXLNA;KHSRP;ZFAND6;UBB;CCL14;ITGB1;TP53;BCL2L11;NDUFA13;PNPT1;HNRNPU;HYAL1;IL1RAP;FSCN1;RC3H1;RIPK1;CHUK;SELPLG
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.39964457054033364,-1.215604648074779,0.18604651162790697,0.7585509677636904,1.0,6/20,12.43%,WTIP;MOV10;AGO1;CNOT1;NRDE2;AGO3
prerank,cell differentiation in spinal cord (GO:0021515),0.5822541141074671,1.215422924282807,0.2647058823529412,0.9612329908383668,1.0,2/10,6.66%,SOX6;MDGA2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.43140609934369234,1.215323839182073,0.20146520146520147,0.9601016833125715,1.0,12/52,12.87%,LGALS3;GPSM2;EGFR;LRP1;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1;EPB41L2;GNAI1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.4835985532092024,1.2152333112656781,0.22935779816513763,0.9589152956363856,1.0,8/26,12.83%,PRKN;MAPK7;FBXO7;FYN;BAG5;GPR37;NFE2L2;SOD2
prerank,regulation of macrophage cytokine production (GO:0010935),0.5540431071055889,1.2147703002356223,0.25037707390648567,0.959336827939763,1.0,6/13,17.14%,IRAK3;GPRC5B;TGFB1;WNT5A;TGFB3;CD74
prerank,cellular protein catabolic process (GO:0044257),0.4202363191678522,1.2147419458302313,0.18823529411764706,0.9579521773979877,1.0,19/59,22.26%,ADAMTS12;FAP;PRKN;CTSK;CTSO;BNIP3;CTSB;RSPRY1;AFG1L;MYLIP;YME1L1;MALT1;RIPK1;RAB7A;MDM2;MAGEC2;UBE2G1;BNIP3L;RNF123
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.49719349087099923,-1.2146753685767566,0.23056300268096513,0.7585786539085274,1.0,4/10,5.11%,VTN;GRB10;PRKCB;ARNT
prerank,regulation of endothelial cell migration (GO:0010594),-0.2920311755682648,-1.2142684553380385,0.06896551724137931,0.7568886670514405,1.0,18/85,6.74%,FOXP1;PTPRM;ANXA3;SP100;PTN;ROCK2;SASH1;ETS1;NRP1;TEK;ANGPT1;ACVRL1;BMP4;BMPR2;SLIT2;KDR;THBS1;BCAR1
prerank,response to steroid hormone (GO:0048545),-0.36511841221772773,-1.2140942591466055,0.1598360655737705,0.7545739407757213,1.0,11/31,20.71%,ATP1A2;PAQR7;TFPI;THBS1;ATP1A1;PAQR8;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5504685882382638,1.213613957464785,0.2368815592203898,0.9612920884339055,1.0,7/12,24.46%,FADS2;ACOX1;ELOVL5;ACOT8;SCP2;ELOVL1;HSD17B4
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4420615862095343,1.2134975274743405,0.23522167487684728,0.9602602624630089,1.0,10/41,17.39%,ANK3;ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3982652560625416,-1.213299464633253,0.21839080459770116,0.7541744438795626,1.0,4/21,7.52%,MTUS1;IL34;THBS1;AKIRIN1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5474662298495496,1.2132337531104627,0.24661654135338346,0.9597957206611065,1.0,7/13,19.83%,CBLB;RANBP2;KPNB1;KPNA6;KPNA1;IPO5;KPNA3
prerank,myeloid dendritic cell activation (GO:0001773),0.5484478104009459,1.2131578622580186,0.2503725782414307,0.9585966346101754,1.0,2/12,6.38%,PYCARD;TGFBR2
prerank,histone mRNA metabolic process (GO:0008334),-0.3774942175411895,-1.2121648928174618,0.19291338582677164,0.7549711145011975,1.0,12/27,15.65%,XRN1;LSM1;MTPAP;ERI1;SLBP;DCP2;CPSF2;TUT7;SNRPD3;SNRPE;SNRPB;EXOSC10
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.38919445579134354,-1.2113798546583665,0.17153284671532848,0.7546029715804843,1.0,4/21,4.25%,OSBPL8;PLA2G4A;PLA1A;OSBPL10
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.47220378643908634,1.2112759010329945,0.22903629536921152,0.9652525077065225,1.0,7/29,10.85%,FADD;PTPN2;WNT5A;METTL3;UBE2K;PTPN1;PTPN11
prerank,phospholipid catabolic process (GO:0009395),0.4765698474389273,1.2111428295500535,0.2358490566037736,0.9643109410094454,1.0,2/24,1.15%,PRDX6;PLBD1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.44308036038033105,-1.2110712923544742,0.21725239616613418,0.752722575007103,1.0,6/14,26.45%,MOXD1;ALDH9A1;NOS1;DAGLA;SLC22A2;DAGLB
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.45061993203983175,-1.210956977874468,0.22356495468277945,0.7501968915279038,1.0,5/13,18.89%,FEZ2;SCFD1;NUPR1;SMCR8;PINK1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.42053504887991333,1.2109171014467197,0.20795454545454545,0.9637972475363974,1.0,17/62,18.76%,CREB3L1;BCL2;PRKN;MAPK7;URI1;ACKR3;BAG5;SELENOS;HERPUD1;NFE2L2;RTKN2;SOD2;OPA1;NDUFA13;DNAJA1;MDM2;PARK7
prerank,response to copper ion (GO:0046688),0.504230452016424,1.2107328673364586,0.24447513812154695,0.9630206021820672,1.0,12/20,28.17%,PRNP;MT3;AOC1;SNCA;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4101715812021649,1.2104389953165955,0.20301624129930396,0.9628491030655494,1.0,10/67,8.06%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5395854919071338,1.2103276227778754,0.2450532724505327,0.9618429653943922,1.0,2/13,9.14%,FAM47E;ZMIZ1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.39599637615939115,-1.2098221863401812,0.19444444444444445,0.7508744038560399,1.0,5/22,10.05%,EPHA4;ROCK2;LYN;GSK3A;ABCG1
prerank,regulation of ion transport (GO:0043269),0.4055869070148762,1.2095422150800375,0.20346820809248556,0.9637789508240331,1.0,17/76,14.64%,ANK3;KCNA2;NKAIN2;PRKN;CHRNA4;SYT1;SYT11;SYT12;SNX6;PXK;GDNF;DRD2;PER1;KCNJ3;SNCA;NEDD4L;KCNJ10
prerank,positive regulation of MAPK cascade (GO:0043410),0.37597462446314694,1.2095039800933511,0.09898989898989899,0.9624269802706057,1.0,39/245,11.86%,ROR2;FFAR4;ROR1;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;ERBB2;EGFR;LPAR1;VEGFA;FBXW7;TGFB1;CCL4;NTRK2;MT3;TMEM106A;ALKAL2;KSR1;CARD9;ACKR3;RAP1A;FGFR1;HTR2C;ERBB4;GPR37;PTPRJ;PTPN11;MTURN;ARL6IP5;EDN3;TAOK3;MYDGF
prerank,phagosome-lysosome fusion (GO:0090385),0.5724852043591633,1.2094663561332004,0.24695121951219512,0.9610716980714152,1.0,5/10,23.59%,RAB39A;RAB34;RAB7A;RAB7B;ARL8B
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4187981187192389,1.2088088716252974,0.21788990825688073,0.9623189769861945,1.0,9/62,8.35%,LGALS3;PRKCQ;CBFB;HOXB8;KAT2B;KMT2A;ZBTB16;CDK6;EIF6
prerank,axonal transport (GO:0098930),-0.33740579645354046,-1.2086979263313729,0.18274111675126903,0.7517314453857871,1.0,10/36,12.82%,KIF3B;PAFAH1B1;DTNBP1;KIF1B;BLOC1S5;DCTN1;SOD1;SNAPIN;MAPT;AP3D1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5233936060932609,1.2086913074855512,0.23385939741750358,0.9613470812741373,1.0,4/16,15.46%,SOX9;ERLIN2;BRCA1;ERLIN1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4560135083258232,1.208661308036067,0.22831632653061223,0.959998312671589,1.0,13/34,21.86%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A;GABRG2;GABRA3;GABRA2;RAB3GAP1;ARRB2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49628868966653295,1.2086485823856665,0.24324324324324326,0.9585532896808029,1.0,6/20,13.39%,BCL2;PACS2;PSEN1;THADA;HERPUD1;CCDC47
prerank,negative regulation of binding (GO:0051100),-0.28933974370321036,-1.2079952158263905,0.12048192771084337,0.7511482350932389,1.0,15/81,9.44%,DAB2;SP100;ARHGAP28;LEF1;ROCK1;WAPL;PRKCD;NFKBIA;IFIT2;KDM1A;HABP4;PEX19;GSK3B;CAMK1;RACK1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4034396931102796,1.2076523752898363,0.1794871794871795,0.9612203031168038,1.0,19/86,11.65%,DLC1;FGF10;IRS2;NGF;AKAP13;EPHB2;CADM4;ARHGEF28;SYNGAP1;MAPKAP1;EPS8L1;FOXM1;RABL3;ERBIN;SHOC2;MYO9B;STK19;OPHN1;MMD2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4316931839367035,-1.2074164008731119,0.21621621621621623,0.7502570268431246,1.0,2/14,0.89%,IGF1;CD200
prerank,mitotic cytokinesis (GO:0000281),0.42866626438443156,1.2071696596650499,0.2342449464922711,0.9617148669542042,1.0,7/47,6.92%,RTKN;ANK3;EFHC1;ARL3;SPTBN1;RASA1;SON
prerank,cell junction assembly (GO:0034329),0.4026156344788324,1.2067689617483466,0.1648590021691974,0.9619407804973271,1.0,20/100,12.69%,DCHS1;CDH19;PTEN;NRCAM;CDH10;NRXN1;CDH22;OBSL1;CDH8;NLGN1;KIRREL3;GPM6A;FLNA;CDH20;CDH7;DSCAM;MYO9A;OPHN1;ADGRL3;DRD2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4834109814328519,1.206350573129183,0.2483130904183536,0.9622851940356649,1.0,5/25,16.89%,CXCL10;ANK2;AKAP6;SNCA;APLNR
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4083899808871474,1.2061883960225477,0.20681818181818182,0.9614279869214882,1.0,17/73,18.76%,DOCK7;NTRK3;NGF;EGFR;VEGFA;ARAF;TGFB1;PAK1;EIF4G1;HDAC6;TBK1;SNCA;SH2D3C;TERF2IP;RPTOR;FNIP1;PARK7
prerank,hyaluronan metabolic process (GO:0030212),0.49825277169890914,1.2059904812043793,0.25205479452054796,0.9607932587959254,1.0,3/23,4.08%,HAS2;FGF2;TGFB1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4104596387347166,1.205816492891142,0.19337016574585636,0.9600551834106853,1.0,15/79,16.36%,SOSTDC1;ADAMTS12;SULF1;CREB3L1;FGF2;HTRA3;CADM4;SHISA2;PTPN1;DAND5;GPC1;BMPER;BMPR1A;LRP2;VWC2
prerank,positive regulation of neuron differentiation (GO:0045666),0.43349106968746237,1.205444908722132,0.23414634146341465,0.9601456754380464,1.0,12/40,20.21%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;FGFR1;MMD2;VWC2;HEYL;CPNE1;PCP4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.41153021871864565,1.2049788893689135,0.20658342792281498,0.9607075482865066,1.0,20/70,20.02%,SLC27A1;PLBD1;MBOAT2;SLC44A2;PLA2G7;PLA2G12A;PCYT1B;PLAAT3;CHPT1;PNPLA8;CHAT;LIPC;GPLD1;GPAT4;SLC44A1;CSNK2A2;LPCAT2;DBI;PLA2G4E;STARD7
prerank,regulation of potassium ion transport (GO:0043266),0.45813887322712743,1.2048830517927558,0.23066485753052918,0.9596423063308105,1.0,9/31,19.20%,ANK3;ANK2;DPP10;DRD2;KCNAB2;KCNIP4;KCNH2;KCNA5;CD63
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.5150418329900024,1.2046999341931166,0.2543103448275862,0.9590181093280585,1.0,1/19,0.29%,FFAR4
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5238600582259675,1.204183538469518,0.23579545454545456,0.9597528003451453,1.0,3/16,9.98%,MEIOB;ERCC4;HFM1
prerank,regulation of fat cell differentiation (GO:0045598),0.4112896243037724,1.2040216171821614,0.21364653243847875,0.9590024881901856,1.0,24/74,23.34%,RORA;FRZB;WDFY2;TGFB1;WNT5A;ZBTB16;RORC;LMO3;CARM1;ZFP36L2;WWTR1;ZFPM2;GATA3;TRIO;ASXL2;CCDC85B;PPARG;TAF8;CCDC71L;ZFP36;RARRES2;TRPM4;CEBPB;BMP2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.40642381454291643,1.2039377620443132,0.17467248908296942,0.9579125790309458,1.0,17/86,11.99%,RELN;FGF10;BST1;EGFR;RAP2B;ACVR1;EFNA5;VEGFA;CADM4;TGFB1;TEC;PRNP;SAMSN1;FYN;PTPRJ;PTPN11;FGF7
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5208841907345666,1.2032898121256637,0.26842837273991654,0.9591407944418096,1.0,4/16,12.97%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,ether lipid biosynthetic process (GO:0008611),-0.49801523189902197,-1.202497045874776,0.23163841807909605,0.7628905000386088,1.0,4/10,8.32%,PLA2G4A;PEX7;DHRS7B;GNPAT
prerank,monocyte chemotaxis (GO:0002548),0.4564952181679979,1.2024824787512423,0.23097112860892388,0.9611230373822875,1.0,3/32,4.10%,LGALS3;CCL11;CCL4
prerank,sympathetic nervous system development (GO:0048485),0.5243894714635029,1.202219529265578,0.2517985611510791,0.9607491180278609,1.0,6/15,13.20%,SEMA3A;SOX11;NF1;GDNF;NRP2;GATA3
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.4661124752067214,-1.2015275223120856,0.23125,0.7632356202979348,1.0,5/12,22.58%,PRPSAP2;PRPS2;GART;PRPS1;PRPS1L1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.49536521026871283,-1.2012919824294892,0.256198347107438,0.7611358833442664,1.0,2/10,2.98%,EPHA4;RIC1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5480497554829559,1.201242419387063,0.25401459854014596,0.9634054713100585,1.0,3/13,6.38%,CBFB;SOCS1;TGFBR2
prerank,focal adhesion assembly (GO:0048041),0.4984656279242164,1.2003026573517923,0.2407152682255846,0.9658994402103048,1.0,5/21,9.12%,DLC1;RHOD;PEAK1;TESK2;TRIP6
prerank,inner dynein arm assembly (GO:0036159),0.5563038016258739,1.200271414553286,0.23919753086419754,0.964542905823776,1.0,1/11,2.93%,CCDC39
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.40654541672890154,1.1998743010425752,0.20135746606334842,0.964656807859162,1.0,18/72,14.75%,FGF2;FGF10;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;CBL;PTPN11;MAPK1;FGF7;POLR2G;GALNT3
prerank,inositol phosphate-mediated signaling (GO:0048016),0.49915371614252735,1.1993972874606924,0.24745269286754004,0.9652270067503992,1.0,6/19,13.96%,HRH1;PPP3CB;PPP3CA;NFATC3;EDN3;PPP3CC
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.37950838457314046,1.199382595897586,0.1273100616016427,0.9638153512301988,1.0,47/208,19.55%,RORA;ROR1;PYCARD;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TLE1;TNFRSF10B;TRAF4;SLC44A2;WNT5A;TMEM106A;OTUD7B;NLRX1;UFL1;CARD9;PELI1;PPM1B;FLNA;VAPA;MID2;ESR1;RHOH;RHOC;TBK1;PER1;MALT1;NDFIP1;GOLT1B;ZFAND6;TICAM1;PIM2;TERF2IP;CD74;RIPK1;CHUK;OTUD7A;ZMYND11;MAPKBP1;TAB3;CPNE1;BCL10
prerank,alcohol catabolic process (GO:0046164),0.5723144488489142,1.1993310877638546,0.26395173453996984,0.9626001537492402,1.0,3/10,14.24%,CEL;MT3;CYP27A1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4440900246776679,1.1987182714783111,0.23192019950124687,0.9637033888146419,1.0,11/36,19.28%,PRKN;FADD;TRIM44;WNT5A;AGPAT2;UBE2K;HIF1A;CD74;RIPK1;AXL;CPNE1
prerank,granulocyte differentiation (GO:0030851),-0.4229844913791435,-1.1983909919862494,0.22377622377622378,0.7676523647630079,1.0,8/18,23.59%,LEF1;LBR;PML;CDK2;CDK4;TAL1;RARA;E2F1
prerank,actin filament organization (GO:0007015),-0.2656474259906767,-1.1983555470166776,0.08823529411764706,0.7649303960134821,1.0,41/151,15.98%,NEBL;CGNL1;RHOBTB1;BAIAP2L1;TMOD3;TPM3;MYO1D;NEDD9;WASL;ARHGAP17;SHROOM4;SHROOM3;TPM1;ACTN1;FHOD1;BCAR1;INPPL1;VILL;EPS8;RHOA;ABI2;MYO1E;DSTN;ARPC4;EVL;EFS;PROX1;WHAMM;CDC42EP2;CDC42;MYO5B;MYO1C;GAS2;SHROOM2;AVIL;LMOD1;MPRIP;TPM2;TMOD1;HIP1R;TRPV4
prerank,regulation of cardiac conduction (GO:1903779),0.42962825744502214,1.1981134816493775,0.234192037470726,0.9648724928251309,1.0,12/54,13.52%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;FXYD1;PRKACA;ATP2B1;AHCYL1
prerank,polyamine metabolic process (GO:0006595),0.5353927013284018,1.1977483116018872,0.2598187311178248,0.9649935159054206,1.0,5/13,11.21%,SMOX;SMS;AOC1;PAOX;HDAC6
prerank,regulation of fatty acid oxidation (GO:0046320),-0.41929107897606155,-1.1976757867539627,0.26013513513513514,0.7641998566531262,1.0,3/16,5.48%,PRKAG2;APPL2;LONP2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5078320889698438,1.1975712236450653,0.2780203784570597,0.9643053238385528,1.0,5/17,16.10%,ANK2;SCN5A;NEDD4L;PKP2;KCNH2
prerank,digestive tract development (GO:0048565),0.44640166861807296,1.1974940887824284,0.23753280839895013,0.9631959881733506,1.0,9/33,14.69%,GLI2;PKDCC;CCDC39;GLI1;GATA6;SMO;RARB;COBL;PKD1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.3798932092877551,-1.1972351288217675,0.24696356275303644,0.7627197194496897,1.0,6/21,8.98%,FOXP1;PRKCH;LYN;PRKCB;GPS2;ELF1
prerank,regulation of receptor binding (GO:1900120),-0.4886432893213925,-1.1971920604412338,0.2552552552552553,0.7600694729516817,1.0,5/10,22.56%,GREM2;ADAM15;ATP2A3;HFE;ATP2A2
prerank,limb morphogenesis (GO:0035108),0.4949576172625382,1.1971301350086525,0.2538787023977433,0.9633275573676227,1.0,1/20,0.46%,PTCH1
prerank,motile cilium assembly (GO:0044458),0.5509093253593473,1.1970367394958996,0.2916666666666667,0.9623044908139108,1.0,3/12,8.05%,CCDC39;SPATA6;BBS5
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4566151086210961,1.19661403025419,0.23096129837702872,0.9626754957456655,1.0,12/33,19.16%,CBFB;RNF6;PKN1;UFL1;UFSP2;CARM1;NCOA2;ESR1;HDAC6;RUNX1;PARK7;KLK2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.3133125310307451,-1.196092233133356,0.16666666666666666,0.7608794319265241,1.0,14/46,12.60%,FOXP1;IGF1;ELN;CDH13;CTNNB1;BMP4;IGFBP3;IGFBP5;THBS1;OGN;PDGFRB;IL6R;CCN4;ID2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3346190760340823,-1.1958774029238515,0.1674641148325359,0.758824982096869,1.0,4/36,3.05%,PDGFD;EPHA7;ERRFI1;ENG
prerank,amino sugar metabolic process (GO:0006040),0.5584799470466069,1.1946709559929867,0.2839506172839506,0.9695154371817691,1.0,3/10,15.43%,GFPT2;CSGALNACT1;GNE
prerank,regulation of lipid metabolic process (GO:0019216),0.4001144403624944,1.1945971308147496,0.19477693144722524,0.9683738477268115,1.0,16/88,11.00%,RORA;IRS2;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;RORC;ELOVL6;FASN;CARM1;NCOA2;CHD9;SIN3B;TGS1;SP1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3837883368124064,-1.1945803580789218,0.2265625,0.7603496799139089,1.0,8/24,12.97%,SORBS1;IGF1;IGF2;INSR;GSK3B;PPP1R3B;GSK3A;ENPP1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4307471508641726,1.1943456521801232,0.2182254196642686,0.9679934736110805,1.0,11/48,11.00%,PRKCA;RHOJ;FGF2;VEGFA;MAP3K3;TGFB1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,regulation of myoblast differentiation (GO:0045661),0.4610761593761176,1.1942879374780455,0.24283935242839352,0.9667950187868826,1.0,6/32,4.92%,SOSTDC1;SOX8;SOX9;XKR8;TGFB1;PLCB1
prerank,lipid transport (GO:0006869),0.39735340595299673,1.1942445727995503,0.2046908315565032,0.965560394030702,1.0,14/97,9.19%,ABCA6;ABCA9;SLC27A1;ATP8B1;NCOA1;PITPNB;SLC27A4;OSBPL5;SLCO2B1;PEX3;GM2A;GOT2;MTTP;NCOA2
prerank,activation of GTPase activity (GO:0090630),0.3977910355751172,1.1941754007371315,0.21719955898566704,0.9644440579530128,1.0,11/89,6.35%,ARHGAP24;SIPA1L1;DOCK7;NTRK3;TAX1BP3;TBC1D10A;GPR65;SLC27A4;ARHGEF10;MTSS2;TSC1
prerank,endoplasmic reticulum organization (GO:0007029),0.4117372060555314,1.1941642527397185,0.21484814398200225,0.9630779765816682,1.0,27/72,24.85%,SEC16B;EIF2AK3;WDR83OS;PRNP;SEC31B;GAK;VAPA;TMEM33;UBE2J2;EMD;ATL3;OTOF;CCDC47;RTN4;SEC61G;BNIP1;REEP5;CYB5A;SHTN1;SGTA;LMAN1;RAB18;ZBED3;STX18;MIA3;REEP3;ATL1
prerank,glycerol metabolic process (GO:0006071),-0.4847089121605876,-1.1940456082204192,0.26239067055393583,0.7592405776715865,1.0,5/10,27.49%,COQ3;PGP;GOT1;ANGPTL3;TKFC
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5605519156400898,1.1935000880475553,0.2688,0.9644131657660515,1.0,6/10,21.94%,KLF15;DIP2A;SETD5;DIP2B;PARK7;PRKAA1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.49415815557753356,1.1934225441415207,0.24366197183098592,0.9633372282756355,1.0,6/18,17.23%,MYC;NF1;EMD;MED25;TP53;CDC73
prerank,positive regulation of dendrite development (GO:1900006),0.5674299462856986,1.1932197589106466,0.25673534072900156,0.9627738832903833,1.0,3/10,14.10%,BMP5;BMP7;COBL
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.413919169016402,-1.192533826296375,0.19387755102040816,0.7614083243493363,1.0,8/17,12.46%,DOCK4;IGF1;NRP1;VTN;IGFBP5;S100A11;PDGFRB;CCN4
prerank,negative regulation of secretion by cell (GO:1903531),0.44251272996672547,1.1921546528708085,0.22409326424870465,0.9657998399695811,1.0,6/38,13.88%,STXBP6;IL1RAPL1;PNKD;SYT11;DRD2;SNCA
prerank,negative regulation of hippo signaling (GO:0035331),-0.45406797826559975,-1.191932789767659,0.25,0.7606278829395029,1.0,6/12,9.58%,WWC2;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,cholesterol homeostasis (GO:0042632),0.41325671488401855,1.1912502542449714,0.2300578034682081,0.9681939549289758,1.0,11/64,16.66%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;GRAMD1B;LIPC;TMEM97;ABCG4
prerank,regulation of hippo signaling (GO:0035330),-0.41492873372223515,-1.1910642190584728,0.2323943661971831,0.7608073876087738,1.0,8/17,9.58%,WWC2;SCHIP1;MOB3B;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,bone development (GO:0060348),0.44398776756844904,1.190530512799805,0.21085080147965474,0.9697880384971631,1.0,7/39,12.65%,OSR2;SULF1;AKAP13;SLC10A7;SFRP4;VKORC1;MYOC
prerank,placenta development (GO:0001890),0.546952752160394,1.1905197415095237,0.27555555555555555,0.9684014959859164,1.0,1/12,1.00%,ADAM19
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.2953990807458933,-1.1903257207816598,0.15172413793103448,0.7604157722162487,1.0,7/66,1.35%,FLT1;PDGFD;ROBO1;SASH1;MAP3K5;KIT;IL34
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2865698338161057,-1.1900721910305831,0.13402061855670103,0.758519148221241,1.0,21/80,10.67%,EPHA4;ROCK2;SAMD4A;PRKCD;LARP4B;ZCCHC4;YTHDF1;NPM1;UPF3B;THBS1;RBM3;METTL14;SIRT3;RPL5;RPS6KB1;RACK1;GSK3A;ABCG1;EIF4A3;TNFRSF1A;ELAVL1
prerank,peptidyl-arginine modification (GO:0018195),-0.42127981459542385,-1.1899808854673295,0.23839009287925697,0.7562026033718102,1.0,5/15,13.95%,PRMT7;PRMT5;KRTCAP2;PRMT8;PADI2
prerank,sodium ion transport (GO:0006814),0.39930637308023564,1.1897235961540913,0.21195652173913043,0.9704251642480447,1.0,11/85,7.96%,SLC6A2;FGF13;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5023871804312788,1.18970956013146,0.2748299319727891,0.9690835659564333,1.0,10/19,26.81%,ZMIZ1;RHOH;ZBTB1;XRCC6;GATA3;MDK;AXL;PRKDC;SYK;MMP14
prerank,regulation of lipid storage (GO:0010883),0.4798091239865957,1.1885494428768106,0.25591098748261476,0.9723109928534611,1.0,3/22,5.00%,PTPN2;FBXW7;MEST
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4594475629755691,-1.188505441373262,0.2869822485207101,0.7582383925692893,1.0,4/12,11.12%,ABCA1;NFKBIA;ABCG1;NR1H2
prerank,negative regulation of defense response (GO:0031348),0.4062001590762467,1.1883207110543927,0.23355263157894737,0.9718399684603383,1.0,9/77,9.85%,RORA;FFAR4;PTPN2;MAPK7;IRAK3;TNFAIP8L2;OTULIN;PPM1B;SELENOS
prerank,amyloid fibril formation (GO:1990000),0.42509195912359904,1.1873714471005112,0.2293144208037825,0.9744429306048518,1.0,4/51,2.35%,TGFBI;HSPG2;GSN;PRKN
prerank,negative regulation of T cell proliferation (GO:0042130),0.46249615935363525,1.1871058074328782,0.24415584415584415,0.9741324818194563,1.0,6/28,17.21%,GLMN;PRNP;SDC4;IL4I1;SCRIB;RC3H1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.40444853985093576,1.1870012617128465,0.22477064220183487,0.9731373099096078,1.0,26/71,23.02%,ADAMTS12;FAP;HM13;PRKN;OTUD7B;CTSK;CTSO;CTSB;RSPRY1;HDAC6;YME1L1;DDB1;MALT1;NEDD8;PDCD6IP;UBB;CHMP4C;CUL4B;MDM2;ZER1;OTUD7A;PSMA8;RHBDD1;FBXO44;RNF123;ZYG11B
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4954673364049478,1.1868081507340307,0.27113702623906705,0.9725350261071992,1.0,3/19,6.19%,CCDC39;AQP4;RFX3
prerank,tRNA wobble uridine modification (GO:0002098),-0.4335619842351604,-1.1865477118248673,0.2336182336182336,0.7618722344925516,1.0,6/14,16.43%,TRMT9B;URM1;ELP3;ELP1;MTO1;DPH3
prerank,T cell mediated immunity (GO:0002456),-0.44292576265443867,-1.1865305563868571,0.2507462686567164,0.7592746188591116,1.0,3/13,9.23%,CTSH;CD55;JAG1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.46943318027407666,1.1862994062345134,0.2663115845539281,0.9733321539324167,1.0,4/25,7.77%,HAS2;EXT1;B3GNT9;CSGALNACT1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4838510597836419,1.1861613276301768,0.2653061224489796,0.9724954822810132,1.0,5/23,13.50%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.4430765855129931,1.1859039964883236,0.2518796992481203,0.9721363235624828,1.0,4/36,4.25%,BCL2L14;PYCARD;BCL2;DEPTOR
prerank,actin nucleation (GO:0045010),0.48900925000297224,1.1852366247874377,0.27600554785020803,0.9733747989835349,1.0,3/21,4.87%,SPIRE1;ARPC1B;IQGAP2
prerank,regulation of DNA recombination (GO:0000018),0.4483398335759633,1.184964012198521,0.2571428571428571,0.9731705873745075,1.0,10/32,16.41%,ZRANB3;SETD2;MSH6;SIRT6;RPA2;RTEL1;BLM;KPNA1;SPIDR;TERF2IP
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3764658936535602,1.1848065303029565,0.1917808219178082,0.9724102131822183,1.0,14/138,4.52%,ROR2;SHC4;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;NGF;ERBB2;EGFR;PTPRT;NPR2;EPHB2;NTRK2
prerank,maintenance of blood-brain barrier (GO:0035633),0.45510353726449854,1.1847453948006947,0.2509505703422053,0.9712877542542993,1.0,5/30,5.24%,LAMA2;LAMC1;WNK3;CLDN1;SLC12A2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4567423442687485,1.184534823713636,0.2583547557840617,0.9708289334986464,1.0,8/29,10.72%,CBFB;PAK1;UFL1;UFSP2;BRCA1;CARM1;VPS11;ESR1
prerank,positive regulation of metabolic process (GO:0009893),0.3924847432437293,1.184349616564074,0.2101293103448276,0.9702785610661089,1.0,17/103,13.94%,EBF2;FFAR4;PRDM16;VEGFA;ACACA;CCR2;PTH2R;PRKAB2;IL18;TSHR;ELOVL6;ACLY;FASN;SIRT6;CNOT3;PRLR;PIGA
prerank,lipid catabolic process (GO:0016042),0.5019569545090234,1.183977421911119,0.2492836676217765,0.9703733322777133,1.0,4/18,15.20%,CEL;MT3;PLAAT3;LIPC
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4078724986583092,1.1839016254451022,0.22789115646258504,0.9693268105356138,1.0,18/64,12.65%,UTRN;SEMA3E;PEAK1;BST1;EFNA5;HOXA7;MAP4K4;GPM6B;NF1;RASA1;TSC1;CDK6;NF2;SLK;CLASP1;AJAP1;PTPRA;MYOC
prerank,sterol homeostasis (GO:0055092),0.4109797977131085,1.183789209719916,0.23897911832946636,0.968408331905042,1.0,11/65,16.66%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;GRAMD1B;LIPC;TMEM97;ABCG4
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2689292532235375,-1.1833832231306294,0.12,0.7667131614931677,1.0,27/128,14.03%,BMP6;PTN;SASH1;ETS1;ANKRD17;DDX60;THBD;NFKBIA;PLSCR1;GPR4;TLR4;THBS1;APP;SCARF1;AGTR1;RIOK3;TNIP1;PDGFRB;TNFRSF1A;CYBA;OPTN;LRSAM1;SERPINE1;PDE2A;CCN4;USP15;NMI
prerank,protein localization to kinetochore (GO:0034501),-0.4304861346641936,-1.1833127983854026,0.22018348623853212,0.7642855255729617,1.0,7/14,34.36%,BUB3;IK;CENPT;KNL1;ZW10;TTK;SPDL1
prerank,regulation of dephosphorylation (GO:0035303),-0.41581643110229094,-1.1824917365078487,0.228125,0.7643208332255527,1.0,6/15,25.32%,PPP1R16B;MTMR2;IGBP1;MTMR9;SMG5;MTMR3
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4476826396344067,-1.1823360988831475,0.25,0.7622264883059537,1.0,4/12,22.42%,HDAC4;TMEM119;HDAC3;HDAC5
prerank,proteoglycan metabolic process (GO:0006029),0.4655889110909786,1.1818798746232972,0.28157894736842104,0.9749791831523531,1.0,4/26,7.77%,ADAMTS12;SULF1;CHST8;CSGALNACT1
prerank,monocyte differentiation (GO:0030224),-0.4720647340046361,-1.1814487993309266,0.26330532212885155,0.7624166175777028,1.0,3/10,2.72%,MYH9;IL31RA;BMP4
prerank,regulation of signal transduction (GO:0009966),0.374499626835664,1.1807543301550827,0.1470888661899898,0.9782354550251888,1.0,29/190,10.72%,RORA;PTCH1;UBASH3B;SULF1;MDFIC;ERBB3;ZFAND2B;CBFB;BST1;ACVR1;PTPN2;SIK2;SOCS5;TGFB1;PRNP;PLCB1;GLI1;HHIP;RGS11;CSK;FRRS1L;SLC8A2;FYN;DHRS3;CASTOR2;PTPN1;GDNF;USP33;ESR1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3102024555595887,-1.180646256684255,0.12666666666666668,0.7623443965379286,1.0,21/54,24.42%,NXN;DCUN1D3;CTNNB1;SMAD7;HDAC8;OGT;RPL5;SH3RF2;SQSTM1;RPL11;PINX1;CAV1;TRIM21;ISG15;AKT1;COPS9;TNFAIP3;U2AF2;USP4;VPS28;SIRT7
prerank,aminoglycan biosynthetic process (GO:0006023),0.41984165096691384,1.1804174085805923,0.2569767441860465,0.9781965292711945,1.0,10/49,12.81%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;B3GNT9;SDC4;GPC1;SDC3;GPC4
prerank,regulation of viral life cycle (GO:1903900),-0.3875974173815227,-1.1802630197294106,0.23166023166023167,0.7609868496598838,1.0,10/21,28.37%,TSG101;TRIM25;PPIA;TRIM5;VPS4A;TRIM21;TRIM68;KPNA2;TYRO3;TRIM6
prerank,insulin secretion (GO:0030073),-0.39563494043611225,-1.1802064431028798,0.2462686567164179,0.7586275374008042,1.0,6/19,20.11%,RAB11B;SELENOT;CAMK2G;CYB5R4;ANXA1;ADCYAP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4438473401558639,1.1801359172483403,0.2809278350515464,0.9778900054451551,1.0,9/32,20.02%,SLC27A1;SLC44A2;PCYT1B;CHPT1;CHAT;GPAT4;SLC44A1;CSNK2A2;STARD7
prerank,mesenchymal cell differentiation (GO:0048762),-0.30749826725620294,-1.1799853820708928,0.1696969696969697,0.7567672171096583,1.0,17/51,15.30%,RANBP3L;ROCK2;LEF1;WNT4;ROCK1;CTNNB1;ENG;TGFBR1;DDX5;GSK3B;FBXL17;FGFR2;NOTCH4;TGFB2;AKNA;HMGA2;HEY2
prerank,response to interferon-alpha (GO:0035455),-0.41094548842353523,-1.179966498263978,0.24610591900311526,0.754318346470972,1.0,7/16,22.46%,IFITM3;KLHL20;IFITM2;BST2;IFNAR1;IFNAR2;PDE12
prerank,response to light stimulus (GO:0009416),0.41874267463113873,1.1792273838726006,0.23853211009174313,0.9801712529877727,1.0,14/55,17.26%,RHO;ZRANB3;GTF2H2;ERCC5;ERCC4;DDB2;MEN1;MSH6;GPR88;DRD2;CRY1;FECH;USP1;REV1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4855348519571534,1.17899032524088,0.28060522696011003,0.9797185593059269,1.0,2/22,2.40%,DYNLL1;CDKN2B
prerank,protein localization to organelle (GO:0033365),0.3876240483225297,1.178651236875309,0.1891891891891892,0.9797679878921238,1.0,34/133,15.34%,BICD1;ANK2;ARL3;PACSIN2;IFT140;WDR83OS;PRNP;PPP1R15A;OBSL1;BBS9;FAM83H;ARL1;GBF1;LAMP5;GAK;XPA;WDR35;VAPA;BICD2;UBE2J2;TSPAN17;TOLLIP;EMD;BMP7;SNX10;SYS1;DVL1;OTOF;CCDC47;RPA2;COL1A1;GABARAPL2;LMNA;SEC61G
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4153223767783514,-1.1781107322717224,0.22796352583586627,0.7574739007283519,1.0,4/17,6.72%,ATP1A2;TFPI;BMP4;ATP1A1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43348057587765054,1.1780029849027718,0.27103960396039606,0.9811429694225454,1.0,3/39,1.98%,FFAR4;CRH;IRS2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4143520562578234,1.1779619464574074,0.2261072261072261,0.9799510184226314,1.0,13/57,14.38%,USP50;PYCARD;MYC;TBC1D10A;FADD;GRIN2B;ACVR1C;CARD9;FYN;ARL6IP5;MALT1;TTBK1;GRIN2A
prerank,lung development (GO:0030324),0.44165528756573325,1.1778381304526873,0.27023661270236615,0.9790881910995194,1.0,9/33,11.99%,GLI2;FGF2;FGF10;CCDC39;VEGFA;SOX11;LOXL3;RCN3;FGF7
prerank,adipose tissue development (GO:0060612),0.5454988572120887,1.1776964519939137,0.29027355623100304,0.9782773002583405,1.0,4/11,7.04%,SOX8;PGRMC2;RORC;DYRK1B
prerank,neuron projection regeneration (GO:0031102),-0.4837064041800387,-1.1776318492186675,0.2814207650273224,0.7564109429318869,1.0,2/10,2.86%,PTN;GAP43
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4914331360652503,1.177525357977501,0.28067700987306066,0.9776170718564385,1.0,8/19,18.93%,PRKN;FBXW7;FBXO7;HDAC6;SREBF2;HTT;PARK7;CSNK2A2
prerank,regulation of ruffle assembly (GO:1900027),0.4778201503196897,1.1768677473946847,0.2700534759358289,0.9789815048532506,1.0,3/23,6.47%,ARHGAP24;NLGN1;EPS8L1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5311553780978807,1.1764396264653383,0.290625,0.9793808136474945,1.0,4/14,9.18%,CCL4;CCR2;WNT5A;STK39
prerank,Ras protein signal transduction (GO:0007265),0.38037821301677827,1.1760458095981077,0.18592436974789917,0.9796804873004681,1.0,43/137,20.76%,USP50;RTKN;TAX1BP3;FGF2;RHOD;GPSM2;RAP2B;HACE1;CTNNAL1;PLD1;NF1;KSR1;EPS8L1;RALB;LIMK1;RAP1A;BRK1;ARHGEF11;SHOC2;MRAS;MYO9B;FARP2;NGFR;MAPK14;COL1A2;RHOH;WASF1;KPNB1;ARHGAP4;ARHGEF3;CYFIP1;CDC42EP1;ELMO1;TP53;NRAS;KRAS;PARK7;NCKAP1;GRB2;JUN;SHTN1;SETDB1;SOS1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.548572881336053,1.1759385753480853,0.27694610778443113,0.9787812943896524,1.0,1/12,0.67%,PRKCA
prerank,excitatory postsynaptic potential (GO:0060079),0.4897934238373297,1.1758719603531829,0.281767955801105,0.9777172699368762,1.0,8/19,21.86%,GRIN2B;GRID2;MPP2;DRD2;GRIN2D;GRIN2A;RAB3GAP1;ARRB2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3768421937685421,-1.1757757680180942,0.21153846153846154,0.7597567225599681,1.0,10/24,28.68%,PECAM1;ROCK1;ICAM1;TNIP1;MSN;VCAM1;GFUS;CERCAM;FERMT3;ITGB2
prerank,GTP metabolic process (GO:0046039),-0.4166156881094668,-1.1757214596805932,0.22847682119205298,0.7574113531531195,1.0,7/15,19.64%,GTPBP1;RHOQ;ENTPD7;GNAI3;IMPDH1;AK4;IMPDH2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.39444210797905005,1.1755712206886717,0.22161572052401746,0.9776148851188573,1.0,10/90,8.18%,EBF2;FFAR4;PRDM16;VEGFA;CCR2;PTH2R;PRKAB2;IL18;TSHR;ELOVL6
prerank,macrophage differentiation (GO:0030225),-0.4485026206768828,-1.1754955320456448,0.2639751552795031,0.75570189488592,1.0,5/13,13.32%,IL31RA;BMP4;PARP1;CASP8;CDC42
prerank,regulation of acrosome reaction (GO:0060046),0.5497854797853516,1.1752938078515616,0.3118279569892473,0.9774068456932087,1.0,1/10,4.92%,PLCB1
prerank,zymogen activation (GO:0031638),0.4408992702102636,1.1752401337029676,0.2397094430992736,0.9762895781366058,1.0,4/39,7.58%,HGFAC;TBC1D10A;FADD;KLK1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4745519968076947,1.1748732117345158,0.26238286479250333,0.9764510428023272,1.0,1/23,0.29%,FFAR4
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5353406264706011,1.1744592116564523,0.2921511627906977,0.9768072427895954,1.0,3/12,3.35%,GLI2;EPHB6;EPHB2
prerank,positive regulation of ATPase activity (GO:0032781),0.4343288119197102,1.174195475689135,0.2569360675512666,0.9765922247904258,1.0,12/41,21.51%,DYNLL1;FGF10;SETMAR;TNNT3;MSH6;AHSA1;GABARAPL2;HNRNPU;DNAJC10;SSBP1;VMP1;DNAJC9
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5629447836018685,1.1732040412153506,0.2803738317757009,0.9792553762962151,1.0,4/10,16.49%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.25339790754640573,-1.1721306116523278,0.11904761904761904,0.7639244097343528,1.0,76/168,27.90%,SAMD4A;RPS14;GSPT1;RPL24;RPL18A;XRN1;UPF3B;RPS16;LSM1;RPL38;RPL28;RPS19;RPL37;AGO1;MTPAP;CTIF;ERI1;ZFP36L1;DCP2;RPS2;EXOSC7;DDX5;CNOT1;RPL19;RPL5;PATL1;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;TUT7;RPS6;PAN2;RPS8;RPL11;RPL12;PNRC2;SMG9;EXOSC10;RPL7A;RPL13;CNOT11;CNOT9;RPS21;TENT4B;RPL35A;RPL26;RPS9;RPL32;RPS29;RC3H2;RPS23;RPLP2;PDE12;POLR2D;RPL8;SMG5;RPL41;SMG8;RPS17;RPS5;RPS15A;UBA52;RPL37A;PPP2CA;RPS10;EIF3E;RPL6;RPL9;RPS27;PAN3;PELO
prerank,synaptic vesicle recycling (GO:0036465),0.44475626751878616,1.1717085766466926,0.2644415917843389,0.9840258034727053,1.0,10/31,18.62%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;RAB3A;SNCA;SYT2;SNCB
prerank,Golgi inheritance (GO:0048313),0.538352350599326,1.1713354650962151,0.29057187017001546,0.9841979412441182,1.0,2/11,7.30%,YWHAZ;GBF1
prerank,cellular response to hydroxyurea (GO:0072711),0.5648088627115766,1.1709587291221801,0.3040650406504065,0.9843866387160821,1.0,5/10,15.98%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,regulated exocytosis (GO:0045055),-0.2513595656140375,-1.1706664902731116,0.05555555555555555,0.765721019322215,1.0,40/173,12.58%,IGF1;ABCC4;VWF;MYH9;PECAM1;VEGFC;RAB11B;SYT9;STXBP1;VEGFD;RAB31;VTI1B;ARHGAP17;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;HABP4;ACTN1;TIMP3;CD109;APP;ACTN2;SDF4;FN1;SRGN;MANF;CPLX1;TMX3;SOD1;SYT10;TMSB4X;SERPINE1;SYTL4;SNAPIN;TGFB2;SYT6
prerank,B cell differentiation (GO:0030183),0.4273467261756858,1.1700421264833867,0.2702702702702703,0.9867762350462593,1.0,10/46,18.68%,RAG2;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;ITGB1;MS4A1;FNIP1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5589795485009302,1.1700162541296535,0.297583081570997,0.9855540903597325,1.0,3/11,8.10%,SESTD1;CACNA2D1;BIN1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5621880012353608,1.1695455781989101,0.2763578274760383,0.9861837125751709,1.0,3/10,12.94%,SLC1A3;ARL6IP5;PRAF2
prerank,cell-cell junction organization (GO:0045216),0.39445025384317545,1.1693814055504543,0.25193370165745854,0.9855466870684959,1.0,14/79,9.72%,DCHS1;CDH19;TGFB1;DSG2;CDH10;CLDN1;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,positive regulation of T cell differentiation (GO:0045582),0.44053402540643893,1.1690820137511035,0.27552275522755226,0.985474699641593,1.0,10/36,18.11%,GLI2;SOCS1;SOX12;ZMIZ1;IL4I1;RHOH;ZBTB1;GATA3;MDK;SART1
prerank,skeletal muscle tissue development (GO:0007519),-0.3277815244488369,-1.1690712174582094,0.2,0.76828758032387,1.0,22/32,50.30%,MYL6;SIX1;LEMD2;CAV1;CFLAR;MYH14;SIX4;FOXL2;KLHL41;MSC;MEF2C;MYORG;POPDC3;RYR1;POPDC2;ACTA1;MYLK2;LMOD3;MYOZ2;CSRP3;MYL6B;EGR2
prerank,regulation of synapse assembly (GO:0051963),0.41943674123001695,1.1677172938486262,0.25178997613365156,0.9895785790154534,1.0,13/46,14.19%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;LHFPL4;EIF4G1;SETD5;GPC4;SYNDIG1;SNCA;CLSTN1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4375941319577502,1.167546252101321,0.2665832290362954,0.9889732905752343,1.0,11/38,16.10%,CACNA2D1;ANK2;DSG2;SCN5A;CTNNA3;KCND3;BIN1;KCNJ3;PKP2;JUP;KCNH2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45625458386323164,1.1672742929344426,0.27622841965471445,0.9887803728651122,1.0,5/28,6.95%,BCL2;NGF;FADD;TNFRSF10B;DEDD
prerank,apoptotic process (GO:0006915),0.3671018780247492,1.1672550741700372,0.17791411042944785,0.9875476115701808,1.0,59/203,21.06%,DLC1;BCL2L14;ERBB3;IL2RA;MAGI3;FAP;PYCARD;MYC;BCL2;FADD;EFNA5;SCN2A;JADE1;PAK4;TNFRSF10B;PAK5;PPP1R15A;BNIPL;APAF1;ZBTB16;TGFBR2;BMF;CASP6;BNIP3;NAE1;HIP1;DCC;NGFR;ING4;CASP12;YARS1;RFK;AHR;BRAT1;AHCYL1;TRPC5;PAX3;TRAF7;RTN4;ELMO1;CASP2;BNIP1;IFT57;BCL2L11;AKAP1;RIPK1;AIFM1;MRPS30;MDM2;IRF3;CASP7;NCKAP1;HK2;PDCD4;TRAIP;IER3;HSPD1;DPF2;KREMEN1
prerank,entry into host (GO:0044409),-0.4478541128188641,-1.1666234960717683,0.2664576802507837,0.7734393666422599,1.0,4/13,7.58%,CTNNB1;CDH1;PPIA;CTNND1
prerank,histone H4 acetylation (GO:0043967),0.41927955167528697,1.1665969068410063,0.2649164677804296,0.98891557251097,1.0,15/47,15.62%,JADE1;KMT2A;HAT1;JADE3;KAT8;BRD8;MORF4L2;ATF2;PHF20;ING4;EPC1;PER1;KANSL1;TRRAP;MSL3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4933012009357002,1.166421256085319,0.26814814814814814,0.9882860214150186,1.0,2/19,3.45%,DCN;CADM4
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.47247009982435645,1.1664113325918621,0.2695883134130146,0.9870111799369177,1.0,8/26,12.38%,CBLB;SOCS5;FBXW7;NCF1;BTC;SNX6;CBL;ZGPAT
prerank,Rac protein signal transduction (GO:0016601),0.495540601286069,1.1663469714929577,0.2738944365192582,0.9859263679417125,1.0,8/18,19.02%,HACE1;BRK1;FARP2;RHOH;WASF1;CYFIP1;ELMO1;NCKAP1
prerank,histone H3-K36 demethylation (GO:0070544),0.559160322427708,1.1658433404514779,0.3068362480127186,0.9866503731152686,1.0,4/10,19.50%,KDM8;KDM4B;PHF8;RIOX2
prerank,protein K48-linked ubiquitination (GO:0070936),0.4096688628823699,1.16466697553215,0.24381625441696114,0.9901784956892103,1.0,9/54,9.84%,UBE2T;PRKN;UBE2E2;HACE1;RNF6;FBXO38;PELI1;UBE2K;CUL3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.26167130859656773,-1.163909741163647,0.1206896551724138,0.7796450430961105,1.0,27/112,12.51%,PTPRK;GCNT2;WNT4;SMAD6;CDH5;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PDCD5;PARD3;ZFP36L1;PDE3A;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;PDE2A;TGFB2
prerank,carboxylic acid catabolic process (GO:0046395),0.5357682906660959,1.1638345237016006,0.29057187017001546,0.9921832674778389,1.0,5/12,20.96%,NAGK;IL4I1;GNPDA1;BCKDK;ACOT8
prerank,lymphocyte migration (GO:0072676),0.4429630467041374,1.1628229180288143,0.27496757457846954,0.9949700587015252,1.0,5/32,15.17%,CCL11;CCL4;CKLF;GATA3;CCL14
prerank,RNA biosynthetic process (GO:0032774),-0.34006359163163746,-1.162742562529034,0.2026431718061674,0.781007716438821,1.0,13/31,24.58%,NCOA6;BRF1;PRIM2;POLA1;TAF13;PRMT5;HELB;POLA2;TERT;SMARCA5;BRF2;TAF10;TBPL1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.513887950294637,1.1624964299275435,0.30280649926144754,0.9950415175179276,1.0,1/15,0.50%,USP50
prerank,negative regulation of protein modification process (GO:0031400),0.39050249889978234,1.1623739846559924,0.2419889502762431,0.9942292116056551,1.0,18/79,12.61%,NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;PRNP;PPP1R15A;PTPN13;NIBAN1;MEN1;ENSA;PPP1R8;CDYL;PID1;FXYD1;WWTR1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.37150128968755314,-1.1615692280669025,0.2631578947368421,0.7820781076385425,1.0,20/26,39.37%,APPL2;BIRC3;GPS2;LGR4;GPR108;IRF1;LRRC14;FLOT1;APPL1;CACTIN;NLRP2B;TYRO3;SMPDL3B;TLR3;BIRC2;IRF7;TREM2;CD36;NFKBIL1;TLR5
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.46961708792887374,1.1609525780994328,0.2903225806451613,0.9987134947501609,1.0,8/23,20.96%,RAD23B;DDB2;XPA;DDB1;UBB;CUL4B;COPS6;COPS7A
prerank,nuclear transport (GO:0051169),0.5018367676655149,1.1608673441812,0.29036827195467424,0.9977443944284524,1.0,6/16,16.73%,XPO1;RSRC1;PSIP1;NUP205;NXT1;AAAS
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.4113616048517495,-1.1607794700493022,0.22653721682847897,0.7820469697834312,1.0,6/16,25.48%,KIF5B;TUBB4B;PLEKHM2;CEBPG;VAMP7;ULBP1
prerank,long-term synaptic potentiation (GO:0060291),0.4805239111587966,1.16074138051807,0.30939226519337015,0.9969368248051321,1.0,7/21,18.10%,TSHZ3;GRIN2B;MPP2;SLC8A2;GRIN2D;GRIN2A;SLC24A2
prerank,rRNA modification (GO:0000154),-0.3689176590114074,-1.1599954390565614,0.24210526315789474,0.7819661080711648,1.0,11/21,30.33%,ZCCHC4;NSUN3;DKC1;BUD23;DIMT1;GAR1;METTL5;TFB2M;TSR3;MRM2;NHP2
prerank,inhibitory synapse assembly (GO:1904862),0.5460931445338627,1.1592997161777743,0.3072100313479624,1.0,1.0,5/11,20.49%,FGF13;WNT5A;GABRG2;CBLN4;GABRA2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4517345314987245,1.1591444005816178,0.2862796833773087,1.0,1.0,13/26,26.92%,SUV39H1;KMT2A;SETD3;PRDM9;SETD2;SETD5;TET3;SETD4;KMT2D;TET2;KMT5B;VCPKMT;KMT5C
prerank,cellular response to calcium ion (GO:0071277),0.39865381716422726,1.1589735719055916,0.2519954389965792,0.9999765207092343,1.0,26/67,24.07%,CPNE8;DPEP1;HPCA;SCN5A;WNT5A;SYT1;NLGN1;SYT11;SYT12;ALOX5AP;IQGAP1;GPLD1;SLC25A24;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;CPNE3;PKD2;PRKAA1;CAMK2D;CPNE5;SYT3;MEF2A
prerank,metal ion transport (GO:0030001),0.3833736894796405,1.1584521480688563,0.24588364434687157,1.0,1.0,17/86,14.33%,CACNA1E;CACNA2D1;MRS2;CACNG7;NIPA1;CACNA1A;CHRNA4;PSEN1;MT3;NIPAL2;SLC8A2;FYN;MAGT1;NDFIP1;TRPC5;TUSC3;PSEN2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4518481865968187,-1.1580340062479566,0.2740963855421687,0.7857886675922123,1.0,3/12,4.61%,THRB;CTSH;LMO2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.48043485934802543,1.1579549584821998,0.30703012912482064,1.0,1.0,5/20,15.00%,RNF157;BICD1;SNCA;CRY1;MET
prerank,cellular response to heat (GO:0034605),-0.326531972965,-1.1575001938393397,0.21962616822429906,0.7850232186211414,1.0,23/35,39.78%,ANO1;THBS1;STUB1;MAPT;HSP90AA1;TRPV4;HSP90AB1;HTRA2;TCIM;PDCD6;POLR2D;IER5;ZFAND1;VCP;SLU7;FGF1;HSPA1B;HMOX1;BAG3;ATXN3;HSF1;HSBP1L1;IL1A
prerank,coenzyme A biosynthetic process (GO:0015937),-0.46035002806158276,-1.1569178076265465,0.3021978021978022,0.7793863025586474,1.0,5/11,18.20%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.46035002806158276,-1.1569178076265465,0.3021978021978022,0.7793863025586474,1.0,5/11,18.20%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.46035002806158276,-1.1569178076265465,0.3021978021978022,0.7793863025586474,1.0,5/11,18.20%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,aorta development (GO:0035904),-0.43159771584964435,-1.1567020483331891,0.2625,0.7775658797682601,1.0,7/14,12.42%,ROBO1;TBX1;EFEMP2;JAG1;PDGFRB;HECTD1;PDE2A
prerank,organelle transport along microtubule (GO:0072384),0.4485345359936705,1.1565894419720746,0.2913992297817715,1.0,1.0,13/31,18.46%,BICD1;NDE1;COPG2;RHOT2;DYNC1I1;BICD2;ARHGAP21;RAB1A;COPG1;UBB;TRAK2;RHOT1;HTT
prerank,response to histamine (GO:0034776),0.5438689359369092,1.1564216364946802,0.30141287284144425,1.0,1.0,4/10,15.81%,HRH1;AOC1;DRD2;GABRG2
prerank,protein processing (GO:0016485),0.3845049476294463,1.1561707543343127,0.24812030075187969,1.0,1.0,20/102,15.30%,HGFAC;PTCH1;ADAM19;HM13;PARL;PSEN1;PCSK4;PCSK6;ATP23;KLK1;KLK6;SPCS3;MMP16;NCSTN;APH1A;YME1L1;CPD;TYSND1;PSEN2;CASP2
prerank,carboxylic acid transport (GO:0046942),-0.3059098849173009,-1.156087324179976,0.22058823529411764,0.7770752651234151,1.0,17/55,18.91%,SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC7A5;SLC16A11;SLC16A2;SLC6A11;SLC66A1;SLC38A5;SLC16A9;SLC36A4;SLC6A7;SLC16A7;LLGL2
prerank,cytoskeleton organization (GO:0007010),0.3793893967246296,1.1552798297696798,0.23945147679324894,1.0,1.0,24/114,13.64%,CCL11;ANK1;RHOD;WDPCP;RND3;FGD4;RHOBTB3;PAK4;FMNL2;MAST2;PACSIN2;PAK5;TNIK;OBSL1;PDZD8;BIN1;EPB41L3;PALLD;ZMYM6;RHOH;RHOC;NECTIN2;SH3KBP1;ARHGAP4
prerank,intracellular sterol transport (GO:0032366),-0.4286431418242934,-1.1544711493243414,0.2578616352201258,0.7798700383294382,1.0,6/13,12.30%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.39814571574182456,-1.154317699103629,0.25925925925925924,0.7779090925846184,1.0,9/16,28.53%,ATP7A;SLC25A33;NUPR1;PINK1;AK4;PDE12;COX7A2;PPIF;VCP
prerank,positive regulation of axon extension (GO:0045773),-0.3753588079318683,-1.1533614651423618,0.27450980392156865,0.7784966376055342,1.0,4/22,3.01%,MACF1;NRP1;GOLGA4;SEMA7A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4342945233952612,1.1530172289794793,0.2894736842105263,1.0,1.0,9/35,13.21%,SOX9;PDE7B;MAPK7;KSR1;PDE9A;HTR2C;AKAP6;PDE4D;AHR
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3951107738705946,1.1529376250124534,0.24857468643101482,1.0,1.0,15/67,17.76%,VIT;UTRN;OLFM4;FBLN2;DOCK5;CDK6;FLNA;DOCK1;ARL2;MYOC;JUP;ABL1;RELL2;RAC3;MDK
prerank,regulation of actin filament-based process (GO:0032970),0.39766341337051675,1.1528419649540822,0.24575311438278596,1.0,1.0,11/70,6.44%,DLC1;RHOD;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4172542113027369,-1.1527818196590423,0.26198083067092653,0.7779713138639943,1.0,6/15,20.71%,CD200;IL31RA;CD300A;GPER1;HAVCR2;NR1H3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.43250767944399743,-1.1526105669646793,0.29512893982808025,0.7761236019173704,1.0,4/12,18.69%,NOTCH2;PTK2B;LFNG;MFNG
prerank,positive regulation of transferase activity (GO:0051347),0.36548123118053616,1.1525679042798893,0.20829015544041452,1.0,1.0,15/142,4.52%,ROR2;ROR1;PDGFRA;ERBB3;PRKCQ;NTRK3;MYC;EPHB6;ERBB2;EGFR;EPHB2;FBXW7;CHTF18;TGFB1;NTRK2
prerank,pre-miRNA processing (GO:0031054),-0.4227894135181349,-1.1525287886498596,0.23692307692307693,0.7739345828071912,1.0,9/14,30.18%,AGO1;TUT7;AGO3;TARBP2;LIN28B;MRPL44;AGO2;DICER1;AGO4
prerank,mRNA splice site selection (GO:0006376),0.44153656772514044,1.152470426814425,0.2986198243412798,1.0,1.0,11/30,20.54%,CELF5;LUC7L2;PSIP1;CELF6;SRSF6;YTHDC1;LUC7L;PRPF39;SF3A1;SF1;CELF4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4528527732637575,1.152225974113439,0.3036649214659686,1.0,1.0,4/26,7.57%,MYC;PTPN2;HOXA7;CDK6
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5567454890045616,1.151988609485079,0.3228228228228228,1.0,1.0,3/10,8.27%,PTPN2;SOCS1;NF2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.24631742748292582,-1.151553164457366,0.05263157894736842,0.7744758964979883,1.0,45/182,12.99%,FOXP1;NOTCH2;IGF1;ROBO1;ROCK2;WNT4;CLDN5;OCLN;ACVRL1;BMP4;ENG;NOCT;REL;SLC7A5;ANXA7;MOV10;SETDB2;KDR;AGO1;ERP29;TERF2;APP;PARP10;RIN3;MAP2K1;MTMR2;TET1;KLF4;FLCN;RACK1;ADAM10;XDH;SLC24A3;PRKAA2;CCDC3;OPTN;ATOH8;LGMN;GATA2;AGO3;MAPT;TGFB2;ID2;SLC2A10;VHL
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.43472007325862944,1.1511981622330245,0.28498727735368956,1.0,1.0,4/34,5.52%,PTPN22;EPHB2;DNAJB9;WNT5A
prerank,global genome nucleotide-excision repair (GO:0070911),0.4622565718168265,1.1506613023938914,0.30278884462151395,1.0,1.0,9/26,17.08%,RAD23B;GTF2H2;ERCC4;DDB2;XPA;DDB1;UBB;RNF111;CUL4B
prerank,negative regulation of RNA metabolic process (GO:0051253),0.4762127208656153,1.1505341848652193,0.29608938547486036,1.0,1.0,5/18,14.53%,KAT2B;TGFB1;SHQ1;ESR1;NCOR2
prerank,regulation of neuron apoptotic process (GO:0043523),0.38355002673728883,1.1502727538929174,0.2494553376906318,1.0,1.0,19/96,13.02%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;PRNP;MT3;NF1;GRID2;RASA1;TRIM2;NAE1;SNX6;GDNF;CDK5R1;GRN;SOD2;PTPRZ1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4447652002135348,1.149636323453975,0.29458388375165123,1.0,1.0,2/30,1.88%,PYCARD;CD34
prerank,activation of phospholipase C activity (GO:0007202),0.43863124323668906,1.149452793067423,0.2804232804232804,1.0,1.0,3/29,4.52%,EGFR;LPAR1;NTRK2
prerank,positive regulation of neurogenesis (GO:0050769),0.39302660937764367,1.1494194439780725,0.2742663656884876,1.0,1.0,13/68,6.62%,CHODL;SOX8;NGF;PLXNC1;IL1RAPL1;VEGFA;SOX11;NTRK2;NUMBL;OBSL1;CDKL5;CDKL3;DISC1
prerank,inner ear morphogenesis (GO:0042472),0.46791276296771955,1.1494073276741381,0.32421340629274964,1.0,1.0,4/22,7.60%,SOX9;EPHB2;TTC39C;TBX18
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3728819640844431,-1.148682223039677,0.2620689655172414,0.781036936958424,1.0,11/22,23.14%,APPL2;MFHAS1;LYN;WDFY1;TIRAP;FLOT1;APPL1;IFI35;NINJ1;NR1H3;TNFAIP3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.46952901361788457,1.1483168421887795,0.2828146143437077,1.0,1.0,8/22,21.49%,ANK2;AKAP6;CALM1;CALM2;SLC9A1;HTT;VMP1;PKD2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3251560033665202,-1.1481819131991267,0.20202020202020202,0.780301540747276,1.0,19/38,32.26%,PRPF3;PRMT7;SRSF10;STRAP;PRMT5;PRPF31;SNRPD3;SNRPE;DDX20;SNRPB;SRSF12;SART3;USP4;AAR2;SNRPD1;SNRPC;PRPF19;LSM4;SNRPG
prerank,neurogenesis (GO:0022008),0.4176897783585604,1.1480490576947742,0.2773809523809524,1.0,1.0,4/43,7.57%,DCHS1;LPAR1;METTL3;CDK6
prerank,positive regulation of phospholipase activity (GO:0010518),0.4662610831202418,1.1479653710553115,0.3044077134986226,1.0,1.0,7/22,10.80%,PDGFRA;NTRK3;FGF2;ARL1;FGFR1;ESR1;ARF4
prerank,protein localization to condensed chromosome (GO:1903083),-0.44555688796543047,-1.147780885114365,0.27218934911242604,0.779198557601916,1.0,10/12,47.91%,BUB3;IK;KNL1;ZW10;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4952937259169295,1.1472518499789928,0.32581100141043723,1.0,1.0,4/17,10.31%,FGF2;SOX9;RFX3;SFRP4
prerank,positive regulation of signaling (GO:0023056),0.438461403825385,1.1470746662860472,0.29908972691807545,1.0,1.0,12/37,15.49%,CLSTN2;SOX11;GRIK2;SYT1;NMU;RIMS1;EDN3;SCRIB;GATA3;SNCA;CLSTN1;HOMER1
prerank,positive regulation of chromosome organization (GO:2001252),0.5006816892767713,1.1470482323233437,0.3103448275862069,1.0,1.0,4/15,14.20%,DDX11;ATRX;SIRT6;RTEL1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.5064491948785294,1.1467536109066385,0.32521489971346706,1.0,1.0,5/14,14.33%,ADAM19;PSEN1;NCSTN;APH1A;PSEN2
prerank,response to hydroxyurea (GO:0072710),0.5380280480676412,1.1465939332621986,0.3181818181818182,1.0,1.0,5/11,15.98%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,protein homooligomerization (GO:0051260),0.3780225486570949,1.1463938208278779,0.2375923970432946,1.0,1.0,30/114,20.21%,SCARA5;STEAP4;CTH;PYCARD;SLC1A5;ACACA;LETM1;AQP4;MPP2;ALS2;CARD9;PRMT1;ATL3;ALOX5AP;ZBTB1;SOD2;TMEM120A;NACC2;PDCD6IP;BLM;PNPT1;ALDH1A3;GLS;FUS;RYR3;MLKL;HCN1;BCL10;ADCY8;DISP1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4427657781737122,1.1462646888869532,0.32349165596919127,1.0,1.0,8/29,19.94%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8;LPCAT2;DBI;PLA2G4E
prerank,homotypic cell-cell adhesion (GO:0034109),0.425614297342779,1.1459119796823296,0.29244114002478316,1.0,1.0,4/39,2.62%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,lamellipodium assembly (GO:0030032),-0.35171182953695107,-1.145765086130007,0.24045801526717558,0.7831197734016726,1.0,9/26,14.82%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.39110435258102905,1.145653677524163,0.26136363636363635,1.0,1.0,12/69,8.26%,PDGFRA;ERBB3;PTEN;IRS2;NGF;ERBB2;PLCB1;NF1;NYAP1;PI4KB;FGFR1;GAB2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4874754521182365,1.1451539742229226,0.31556195965417866,1.0,1.0,3/18,7.73%,BCL2;THEM4;BNIP3
prerank,negative regulation of endothelial cell migration (GO:0010596),0.42822841739611245,1.1445556770626637,0.28815628815628813,1.0,1.0,3/36,4.08%,DCN;FGF2;TGFB1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5065150813757998,1.144461134350472,0.3255131964809384,1.0,1.0,5/15,15.00%,FGF2;VEGFA;FGFR1;SMOC2;MET
prerank,response to thyroid hormone (GO:0097066),-0.4412726868717194,-1.1441978610371835,0.28440366972477066,0.7853734265359251,1.0,3/13,4.61%,THRB;CTSH;LMO2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5266243030851152,1.1440475864011066,0.3201219512195122,1.0,1.0,5/12,24.33%,SNAP23;SNAP29;STX1B;STX2;SNAP47
prerank,negative regulation of cell population proliferation (GO:0008285),0.35546898510881364,1.1440204515419514,0.15315315315315314,1.0,1.0,64/351,16.21%,APOD;ROR2;DLC1;SSTR1;WNK2;BMP5;CLDN19;FAP;GLMN;MYC;PTEN;KAT2B;SOX9;NGF;VGLL4;CDKN2B;FRZB;PTPN2;PTHLH;TGFB1;SOX11;NUPR2;NF1;ACVR1C;WNT5A;PAK1;BNIPL;PODN;TSC1;ADAMTS1;CYP1B1;CBFA2T3;GATA6;CDK6;MEN1;NF2;COL18A1;RARG;ERBB4;SFRP4;PTPRJ;EMD;ATRAID;MAGI2;ING4;ATP8A2;DRD2;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;NACC2;RPS6KA2;PDS5B;MDM4;CD164;LMNA;MED25;PIM2;TP53;GPLD1;TGFB3
prerank,epithelial cell-cell adhesion (GO:0090136),-0.46326585520708574,-1.143990227184773,0.2849002849002849,0.7836484278991698,1.0,2/11,2.17%,KIT;ITGB5
prerank,anterior/posterior axis specification (GO:0009948),-0.4148152687854889,-1.143639778493875,0.29073482428115016,0.7822712714576243,1.0,2/15,3.72%,WLS;TBX3
prerank,chloride transport (GO:0006821),0.38917738113318967,1.1436020576868684,0.26914414414414417,1.0,1.0,14/74,15.81%,FXYD3;ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;TTYH3;TTYH1;SLC12A4;FXYD1;ANO10;CLIC1;CLCN2;GABRG2
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2724256764713724,-1.1429294639603638,0.13274336283185842,0.7820917666858587,1.0,24/71,21.94%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB;ASAH2;CERS1;SPHK1;A4GALT;SPTSSB;ST6GALNAC5;CERT1;CLN8;LARGE1;ALDH3B1
prerank,protein localization to plasma membrane (GO:0072659),0.37046550895125274,1.1426761063777715,0.2617801047120419,1.0,1.0,30/129,15.41%,PTCH1;ANK3;ANK1;FGF13;ANK2;GORASP1;C2CD5;WNK3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;GORASP2;RAB3A;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,regulation of bone mineralization (GO:0030500),0.4002624532210652,1.142449838836825,0.28321678321678323,1.0,1.0,7/55,4.11%,OSR2;ANKH;PKDCC;ACVR1;ANO6;TGFB1;GPM6B
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5472194055552644,1.1423011164748436,0.32164634146341464,1.0,1.0,4/10,17.28%,FBXW7;NCF1;BTC;HBEGF
prerank,regulation of interleukin-6 production (GO:0032675),0.3772564051032191,1.1420799384110025,0.26185344827586204,1.0,1.0,22/96,20.89%,IL16;PYCARD;PTPN22;IRAK3;MAPKAPK2;WNT5A;TMEM106A;CARD9;SYT11;SELENOS;TLR1;PTPN11;IL33;FOXJ1;CD74;RAB7B;LBP;SETD4;BCL10;STAT3;SIRPA;HSPD1
prerank,steroid hormone biosynthetic process (GO:0120178),0.4375924107105126,1.1416818988163493,0.31048387096774194,1.0,1.0,3/29,11.54%,HSD17B7;HSD17B11;TSPOAP1
prerank,natural killer cell mediated immunity (GO:0002228),-0.4157745285023802,-1.1416005813134664,0.2585669781931464,0.783740331595951,1.0,5/15,25.48%,KIF5B;TUBB4B;PLEKHM2;CEBPG;ULBP1
prerank,histone acetylation (GO:0016573),0.38909323230600895,1.1411911176415228,0.2698412698412698,1.0,1.0,18/69,15.62%,KAT2B;JADE1;HAT1;TADA1;TAF5L;JADE3;KAT8;BRD8;MORF4L2;POLE3;ATF2;PHF20;TAF9;ING4;EPC1;PER1;TRRAP;MSL3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3721702166939945,1.1411815263876328,0.2663101604278075,1.0,1.0,24/110,16.07%,LGALS3;HRK;GSN;VEGFA;TGFB1;ATF7IP;RALB;BMF;BRK1;ANKRA2;CRYAB;PIH1D1;FARP2;SLF2;PTPN11;HDAC6;RHOC;HJURP;SUMO1;GFAP;MTLN;STX1B;SPIDR;BCL2L11
prerank,hippo signaling (GO:0035329),0.44907855798796387,1.140818786536869,0.30892143808255657,1.0,1.0,2/26,3.17%,DCHS1;SAV1
prerank,linoleic acid metabolic process (GO:0043651),0.4937116861693375,1.1406700831929844,0.307909604519774,1.0,1.0,3/17,13.50%,FADS2;ELOVL5;PNPLA8
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38573432085501363,1.1406491774010932,0.26460859977949286,1.0,1.0,13/87,6.44%,DLC1;PDGFRA;SEMA3E;RHOD;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5017941562383775,1.1405257844897712,0.30694444444444446,1.0,1.0,3/17,3.73%,MAML3;KAT2B;MAML2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5433936249417339,1.1399566241302737,0.3136,1.0,1.0,3/10,9.87%,KMT2A;BRCA1;PIH1D1
prerank,protein insertion into membrane (GO:0051205),0.4401346015018508,1.1396897830707935,0.31056701030927836,1.0,1.0,12/32,20.59%,EGFR;WDR83OS;PRNP;COX18;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;CYB5A;SGTA
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5231502722117143,1.139478340895984,0.3225331369661267,1.0,1.0,5/13,12.38%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.41461779393945014,1.1393864839007681,0.2919621749408983,1.0,1.0,14/43,19.23%,CBLB;EGFR;PTPN2;SOCS5;EPS15;BTC;SNX6;PTPRJ;CBL;ZGPAT;SH3KBP1;HBEGF;RAB7A;GRB2
prerank,negative regulation of neuron death (GO:1901215),0.3813240518992399,1.1391403245146972,0.24699453551912567,1.0,1.0,22/93,19.35%,ERBB3;BCL2;CD34;CRLF1;NGF;PRKN;NTRK2;MT3;FBXO7;RASA1;SNX6;EIF4G1;GDNF;GRN;SOD2;PTPRZ1;SNCA;FZD9;TGFB3;MDK;PARK7;BTBD10
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3895292788945186,1.1386876893421505,0.26741573033707866,1.0,1.0,18/72,15.16%,RNASE6;GTF2H2;ERCC5;DXO;ERCC4;DDB2;RPA3;SETMAR;XRN2;XPA;DCP1B;REXO4;EDC4;FBH1;DDB1;EXD2;RPA2;UBB
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4509116275230925,1.1384882471849596,0.30606860158311344,1.0,1.0,8/27,14.00%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,regulation of neurogenesis (GO:0050767),0.4002873686323657,1.1383741086364516,0.2828638497652582,1.0,1.0,5/55,5.45%,CCL11;DOCK7;SOX11;PCM1;NUMBL
prerank,transport along microtubule (GO:0010970),0.509303821905206,1.1376503917416745,0.31137724550898205,1.0,1.0,7/13,15.04%,COPG2;SPG11;DYNC1I1;ARHGAP21;APBA1;DYNC1I2;COPG1
prerank,neural tube closure (GO:0001843),0.42839194642745937,1.1373073023014806,0.2893401015228426,1.0,1.0,10/34,21.45%,DLC1;TGFB1;PRICKLE1;DVL1;SCRIB;COBL;LRP2;PAX2;BCL10;DVL3
prerank,regulation of hemopoiesis (GO:1903706),0.5523727878404328,1.1370959661869635,0.3153961136023916,1.0,1.0,2/10,1.89%,LGALS3;CBFB
prerank,positive regulation of bone mineralization (GO:0030501),0.4281037131307267,1.1366855192478778,0.3081761006289308,1.0,1.0,12/35,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,protein localization to membrane (GO:0072657),0.36173056244820256,1.1366003300547576,0.24974411463664278,1.0,1.0,42/187,15.41%,PTCH1;ANK3;ANK1;HPS6;FGF13;ANK2;RAB38;C2CD5;SAV1;WNK3;ARL3;PACS2;NPC1;NRXN1;TSPAN32;TNIK;DLG2;SPTBN1;NLGN1;NUP155;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;ARL5C;NDC1;TSPAN17;MAGI2;DVL1;RAB3A;SCRIB;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,response to calcium ion (GO:0051592),0.37380017243215463,1.1360390447064066,0.2510775862068966,1.0,1.0,36/102,24.07%,CPNE8;DPEP1;HPCA;SCN5A;WNT5A;SYT1;NLGN1;PPP3CA;KCNMB2;KCNMB3;ANXA11;SYT11;SYT12;ALOX5AP;AHCYL1;CALM1;IQGAP1;HOMER1;CALM2;GPLD1;SLC25A24;KCNMA1;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;PEF1;CPNE3;PKD2;PRKAA1;CAMK2D;CPNE5;SYT3;MEF2A
prerank,regulation of cellular component organization (GO:0051128),0.3649310805295017,1.1360118471770655,0.2518440463645943,1.0,1.0,40/135,18.85%,PTCH2;PRKCQ;ANGPTL7;STON2;NRG3;PAK4;IRAK3;PACSIN2;PAK5;WNT5A;URI1;STON1;RAP1A;LAMTOR2;ARHGEF11;BAG5;HIP1;ANKRA2;SGK3;SGK2;PTPN1;PTPN11;OPHN1;HJURP;RAB4B;CHPT1;SETD5;ATF5;RAB4A;ARFGAP1;GFAP;PAPPA2;TMEM97;ABL1;HNRNPU;SGK1;SNX12;RPTOR;PARK7;SEMA4D
prerank,positive regulation of biomineral tissue development (GO:0070169),0.41403211553215313,1.1359164144808773,0.31143552311435524,1.0,1.0,13/40,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;AMELX;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.37861030915732713,1.1358894584878463,0.25869565217391305,1.0,1.0,27/87,21.61%,FGF2;FGF10;EGR3;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;ZFP36L2;CBL;PTPN11;MAPK1;FGF7;POLR2G;GALNT3;HYAL1;POLR2A;GRB2;ZFP36;FLRT1;RBFOX2;FGF9
prerank,regulation of mitochondrial fusion (GO:0010635),0.5469293000038632,1.1358112162666099,0.3291338582677165,1.0,1.0,5/11,17.55%,PRKN;BNIP3;HUWE1;PID1;ADCK1
prerank,positive regulation of embryonic development (GO:0040019),-0.37579854931878354,-1.1357354488817861,0.25666666666666665,0.7994582688617813,1.0,4/19,14.72%,WNT4;OSR1;RACK1;RBM19
prerank,lipid oxidation (GO:0034440),0.525141179921707,1.1355843631763707,0.33534743202416917,1.0,1.0,2/12,8.14%,PLA2G7;ACOX1
prerank,mitochondrion disassembly (GO:0061726),0.4302144031994613,1.1352731362763313,0.2920353982300885,1.0,1.0,8/34,14.97%,PRKN;FBXO7;WIPI1;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,positive regulation of B cell activation (GO:0050871),0.40173368089464795,1.1351685059701928,0.3014354066985646,1.0,1.0,5/50,3.90%,BCL2;IRS2;BST1;EPHB2;CD320
prerank,cell-matrix adhesion (GO:0007160),0.37854212116924496,1.1350028562840058,0.2811158798283262,1.0,1.0,21/95,17.75%,DLC1;ADAMTS12;RHOD;CD34;PEAK1;ITGB8;TESK2;HOXD3;TSC1;MKLN1;COL3A1;TRIP6;SGCE;PPFIA2;TMEM8B;PKD1;ITGB1;ZYX;CTTN;ITGB7;PIP5K1A
prerank,regulation of neutrophil migration (GO:1902622),0.5585152042444939,1.1348988704811787,0.33070866141732286,1.0,1.0,3/10,12.13%,OLFM4;BST1;RHOH
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5084962615546857,1.1348185401497437,0.32158590308370044,1.0,1.0,4/14,16.10%,IRS2;PTPN2;DDB1;GPLD1
prerank,lymphocyte differentiation (GO:0030098),0.39191556986626336,1.1346489035191507,0.2937853107344633,1.0,1.0,21/68,25.77%,RAG2;PTPN22;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;RHOH;GATA3;ITGB1;MS4A1;AXL;PBX1;CR2;KAT7;NFAM1;LMBR1L;SOX4;TPD52;ITGA4
prerank,protein localization to cell periphery (GO:1990778),0.3656306243898982,1.1343170402623306,0.26479750778816197,1.0,1.0,29/133,15.41%,PTCH1;ANK3;ANK1;FGF13;ANK2;C2CD5;WNK3;ARL3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;RAB3A;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.27977937873416037,-1.134108928791672,0.24166666666666667,0.802386377603223,1.0,18/75,13.06%,ATP1A2;ATP1B3;SLC8A3;SLC12A7;SLC9A6;SLC9A2;KCNJ2;ABCC9;ATP1A1;SLC12A9;SLC39A8;SLC39A6;SLC9A9;SLC9A7;KCNK9;SLC6A1;TRPV2;SLC12A8
prerank,atrioventricular valve development (GO:0003171),0.49927396332174534,1.1338660740085018,0.31759656652360513,1.0,1.0,6/14,17.57%,ACVR1;TGFBR2;MDM4;BMPR1A;APLNR;HEYL
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.37461288755391675,-1.133630152947064,0.2787456445993031,0.8015537255913034,1.0,9/20,18.71%,BIRC3;OGT;STUB1;NUPR1;CASP8;HSP90AA1;FLOT1;SPATA2;CFLAR
prerank,renal system development (GO:0072001),0.40569000844349945,1.1335905690628167,0.30210772833723654,1.0,1.0,6/52,3.63%,SULF1;HAS2;GLI2;LRP4;VEGFA;ARL3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4806136756593152,1.1333853096254047,0.31631205673758866,1.0,1.0,3/18,11.86%,CHRM3;PLCB1;CDK5R1
prerank,inflammatory response (GO:0006954),0.35687036120969123,1.1330665433867093,0.22075279755849442,1.0,1.0,20/195,10.43%,HSPG2;CCL11;CXCL10;CRH;IL2RA;TAC1;HRH1;PTGER3;NFX1;TGFB1;CCL4;PTGFR;MAPKAPK2;CCR2;NOX1;LOXL3;IL18;NFATC3;PXK;TLR1
prerank,primary neural tube formation (GO:0014020),0.43637114087788736,1.131680767702631,0.3140604467805519,1.0,1.0,8/30,19.55%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,regulation of T cell proliferation (GO:0042129),0.3975307625077656,1.1306808080474278,0.28685714285714287,1.0,1.0,6/61,14.00%,LGALS3;GLMN;SDC4;IL4I1;IL6ST;NCK1
prerank,positive regulation of axonogenesis (GO:0050772),-0.3014383459763411,-1.1305240464205133,0.24598930481283424,0.8091494826956949,1.0,12/43,13.22%,MACF1;PLXNA2;ROBO1;GOLGA4;SEMA7A;SLIT2;RHOA;PLXNB1;ZFYVE27;MAPT;PLXNA1;PLXNA4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.48369494995027207,1.1301112840134568,0.3289665211062591,1.0,1.0,2/16,7.59%,PRKCA;KLK6
prerank,copper ion homeostasis (GO:0055070),-0.3930041400303338,-1.1297904167246775,0.292358803986711,0.8091463443576273,1.0,5/17,7.07%,SLC31A1;ATP7A;COMMD1;APP;SLC31A2
prerank,potassium ion export across plasma membrane (GO:0097623),0.5022514074087324,1.1297606063676213,0.33875739644970415,1.0,1.0,4/13,19.16%,KCND3;KCNT2;KCNH2;KCNA5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5276180437888228,1.129005769062999,0.32286995515695066,1.0,1.0,1/11,1.22%,CREB3L1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4658294799464759,1.1287287176016867,0.3098995695839311,1.0,1.0,11/21,27.68%,H6PD;RPE;SHPK;PGLS;HK2;TALDO1;HK1;RBKS;RPIA;PGM2;GCK
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.49837817724383804,1.128465298228532,0.33236994219653176,1.0,1.0,2/15,5.23%,HSPH1;CCR2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.31858187966552226,-1.1284224282653148,0.24102564102564103,0.8112025198888778,1.0,6/39,3.20%,AFDN;EPHA7;PTPRG;PODXL;SMAD7;CDH1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3922947826681796,1.1282729906996276,0.32045454545454544,1.0,1.0,7/63,4.25%,LGALS3;BCL2L14;PYCARD;FADD;ACVR1;TNFRSF10B;DEPTOR
prerank,positive regulation of leukocyte migration (GO:0002687),0.44556602168929166,1.1281681810972919,0.31469440832249673,1.0,1.0,2/27,3.14%,LGALS3;VEGFA
prerank,negative regulation of anoikis (GO:2000811),0.5033173103403923,1.1280480592892212,0.3343195266272189,1.0,1.0,2/14,3.82%,BCL2;TLE1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4127197179762879,1.1279120331254948,0.2971014492753623,1.0,1.0,21/42,28.05%,MTA2;CHD3;VPS72;MBD2;HDAC2;SMARCC2;ANP32E;RBBP4;SMARCC1;SMARCE1;PBRM1;NASP;SMARCA4;HNRNPC;GATAD2B;ACTR5;SMARCB1;SPTY2D1;HDAC1;SMARCA1;INO80B
prerank,tRNA aminoacylation (GO:0043039),0.42135915135451935,1.127785358511897,0.3037974683544304,1.0,1.0,9/37,14.03%,IARS2;EPRS1;FARSA;GATB;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.39762239206848654,1.1271381000332257,0.3142857142857143,1.0,1.0,9/52,10.37%,LGALS3;EGFR;LRP1;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1
prerank,regulation of isotype switching (GO:0045191),-0.4244551713483621,-1.127062447021927,0.29819277108433734,0.8131946416086185,1.0,5/14,24.28%,RIF1;PARP3;TFRC;PAXIP1;MAD2L2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.46610729503424153,1.1270543449008261,0.3310344827586207,1.0,1.0,2/19,3.68%,GFPT2;NAGK
prerank,protein destabilization (GO:0031648),0.4279292207309833,1.1268896207327845,0.31546134663341646,1.0,1.0,10/32,18.46%,GSN;PRKN;KDM8;PRNP;CUL3;SNCA;SENP2;CDC73;MDM2;HTT
prerank,amino acid import across plasma membrane (GO:0089718),-0.3551219009163543,-1.1268265832927793,0.3024193548387097,0.8115639762297601,1.0,6/24,3.59%,SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5
prerank,tube closure (GO:0060606),0.4325409540169947,1.1265953042323396,0.29986962190352023,1.0,1.0,8/31,19.55%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.41300348961820454,1.1262644311544125,0.30864197530864196,1.0,1.0,4/38,3.96%,LGALS3;BMP5;FADD;TNFRSF10B
prerank,T cell homeostasis (GO:0043029),0.5454449885113319,1.126214575838458,0.32857142857142857,1.0,1.0,2/10,7.55%,FADD;ZC3H8
prerank,actin-myosin filament sliding (GO:0033275),-0.31507450940009973,-1.1258305055723874,0.2,0.8098470554847803,1.0,20/38,41.94%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1
prerank,muscle filament sliding (GO:0030049),-0.31507450940009973,-1.1258305055723874,0.2,0.8098470554847803,1.0,20/38,41.94%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.449133945897392,1.125549057519954,0.331151832460733,1.0,1.0,7/26,13.71%,USP50;PYCARD;GRIN2B;FYN;NCSTN;APH1A;TTBK1
prerank,negative regulation of blood coagulation (GO:0030195),0.42089923399561097,1.1254938184523693,0.3135802469135803,1.0,1.0,3/38,1.88%,A2M;PDGFRA;CD34
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3508062257675948,1.1251593067071455,0.20361083249749248,1.0,1.0,34/308,8.90%,EBF2;FFAR4;SOX6;ETV4;GLIPR2;CRH;SLC27A1;GLMN;FGF2;SOX8;PRDM16;SOX9;LRP1;ACVR1;VEGFA;TGFB1;SOX11;PLCB1;CCR2;WNT5A;NLGN1;AGPAT2;RFX3;PTH2R;ZBTB16;TGFBR2;PRKAB2;CARD9;IL18;TSHR;CADM1;ELOVL6;SMO;SOX5
prerank,mitochondrial protein processing (GO:0034982),0.518887912541828,1.125090976659843,0.3258426966292135,1.0,1.0,6/11,22.66%,MIPEP;ATP23;PMPCB;YME1L1;PMPCA;IMMP2L
prerank,snRNA 3'-end processing (GO:0034472),0.4769378586692187,1.125050344673846,0.3351278600269179,1.0,1.0,6/19,13.91%,USB1;INTS6;EXOSC8;EXOSC2;INTS2;INTS8
prerank,response to organonitrogen compound (GO:0010243),0.4121694362229774,1.1248123466817663,0.31047865459249674,1.0,1.0,14/38,25.62%,KYNU;PRKN;IRAK3;HLCS;RCN3;DRD2;CCDC47;GLRB;UBXN6;RHBDD1;KAT7;MTOR;IRF5;ERLEC1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.40468716971029356,-1.1233059663712155,0.3153153153153153,0.8156349094982699,1.0,6/15,24.25%,SNX9;ADRA2A;NRDC;APOE;SNX33;SH3D19
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5124894902477708,1.1233056471529292,0.35119047619047616,1.0,1.0,3/13,12.73%,FADD;MR1;NECTIN2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5120222978554368,1.1230562486662783,0.34142640364188165,1.0,1.0,2/12,5.04%,SLC22A3;SMS
prerank,cochlea morphogenesis (GO:0090103),0.5277677256964267,1.1227193846994632,0.32909379968203495,1.0,1.0,3/10,16.98%,SOX9;TBX18;PAX2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5105358322127425,1.122712435137826,0.35198821796759944,1.0,1.0,3/12,15.46%,ERLIN2;BRCA1;ERLIN1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5124954051621808,1.1225588027124267,0.340625,1.0,1.0,4/12,16.07%,PTPN1;PIK3R1;TMEM33;BCL2L11
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5104413317320442,1.1222280104300428,0.3282674772036474,1.0,1.0,5/13,18.98%,AP1G1;IL18;ZBTB1;TICAM1;AXL
prerank,response to retinoic acid (GO:0032526),-0.2840143661647775,-1.1220573890987766,0.265625,0.8172168354216471,1.0,11/59,8.69%,WNT5B;CTSH;RBP4;EPHA3;ACER2;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,anterograde axonal transport (GO:0008089),-0.3215721102063695,-1.1219674908617554,0.2552083333333333,0.8152014445682024,1.0,10/37,12.82%,KIF3B;KIF1C;TRAK1;DTNBP1;KIF1B;KIF5B;BLOC1S5;SOD1;SNAPIN;AP3D1
prerank,negative regulation of cell migration (GO:0030336),0.3609344293071697,1.121854129660634,0.26288659793814434,1.0,1.0,30/137,14.77%,DLC1;CLDN19;SULF1;FGF2;PIP5KL1;PTEN;DPEP1;LRP1;PTPRT;RAP2B;HOXA7;RECK;NF1;ACVR1C;PODN;CYP1B1;NF2;COL3A1;MCTP1;PTPRJ;NGFR;CLASP1;MAGI2;DRD2;ADARB1;ARHGAP4;TCAF1;BMPR1A;LDLRAD4;CITED2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5246635038652825,1.1215411099857417,0.3298662704309064,1.0,1.0,3/11,9.47%,PRKN;FBXO7;HIF1A
prerank,organic substance transport (GO:0071702),0.3683165305008105,1.1215077761474865,0.2627118644067797,1.0,1.0,15/121,11.36%,ABCA6;SLC6A2;ABCA9;SLC22A3;RAB38;CD320;SCAMP2;SLCO2B1;PEX3;GM2A;SLC50A1;RCN3;ABCA5;NDC1;ARL6IP5
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.27365819271182457,-1.1211184564962398,0.18888888888888888,0.8155382577363289,1.0,21/84,12.04%,FOXP1;ANXA3;ROCK2;SASH1;ETS1;NRP1;TEK;ANGPT1;NOS3;BMP4;MAP2K3;BMPR2;KDR;THBS1;BCAR1;GPI;ATOH8;TMSB4X;LGMN;GATA2;PROX1
prerank,chromosome organization (GO:0051276),0.3678795452611726,1.1208690351258814,0.2904608788853162,1.0,1.0,24/99,20.96%,MYC;RAD23B;LRWD1;HMGN1;SUV39H1;SATB1;EZH1;DDB2;NUP155;XPA;POLE3;HDAC2;MSH6;DDB1;UBB;ABL1;PHF19;CUL4B;CENPV;NUF2;HMG20A;COPS6;SMARCA4;COPS7A
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5242496118771091,1.1208362581347364,0.33116883116883117,1.0,1.0,4/10,17.23%,CPEB3;NCBP1;CPEB1;CDC73
prerank,positive regulation of double-strand break repair (GO:2000781),0.41993705123217767,1.1204525350960526,0.3093167701863354,1.0,1.0,7/39,10.55%,DDX11;SPIRE1;FMN2;MRNIP;SETMAR;FOXM1;SLF2
prerank,negative regulation of DNA replication (GO:0008156),-0.4243653402578317,-1.1202962105542147,0.2967741935483871,0.8159717274702438,1.0,2/13,6.24%,WAPL;S100A11
prerank,cell projection assembly (GO:0030031),0.45145285578946553,1.1201517955469664,0.3194444444444444,1.0,1.0,7/22,20.39%,RHOJ;GSN;RHOH;CYFIP1;RAC3;NCKAP1;RHOU
prerank,regulation of telomere capping (GO:1904353),0.4514168007173027,1.1200807941729432,0.3293010752688172,1.0,1.0,7/23,16.25%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1;ATM;SMG6
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.46563417814172303,-1.1196937835554488,0.3185595567867036,0.8154831940340143,1.0,3/10,6.89%,SHANK3;RAB5A;APP
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4431366838231263,1.1194166990319032,0.30294906166219837,1.0,1.0,10/27,24.04%,KAT2B;KAT8;BRD8;MORF4L2;PHF20;TRRAP;MSL3;RUVBL2;KAT7;ATAT1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.43093243612893817,1.1192882849402228,0.32169576059850374,1.0,1.0,4/30,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,intracellular cholesterol transport (GO:0032367),-0.3970948172503067,-1.1190555925251127,0.28421052631578947,0.8151555207932929,1.0,6/15,12.30%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4462146435920258,1.119022750517005,0.3364864864864865,1.0,1.0,7/25,13.88%,GLMN;EGFR;PSEN1;FZD7;DSCAM;KCTD20;SNCA
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.47959053670675494,1.118947803415841,0.35714285714285715,1.0,1.0,6/16,14.61%,FGF2;GLI1;ERBB4;AKAP6;ZFPM2;BMPR1A
prerank,regulation of axon guidance (GO:1902667),-0.4509015865971493,-1.1189054676533603,0.31926121372031663,0.8133289116330534,1.0,4/10,8.49%,NRP1;YTHDF1;ZSWIM6;ZSWIM4
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.47902252328971795,1.1187353710353425,0.3237822349570201,1.0,1.0,5/17,13.00%,HM13;DERL2;SELENOS;HERPUD1;HSP90B1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5118070198931113,1.1182500149179164,0.3412112259970458,1.0,1.0,2/12,1.89%,PTPN22;CBFB
prerank,potassium ion transport (GO:0006813),0.36266524302598313,1.1181065406769515,0.2857142857142857,1.0,1.0,33/120,22.90%,KCNK15;SLC1A3;KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNMB2;KCNMB3;KCNAB2;KCNJ3;KCNJ10;SLC9A5;KCNH2;KCNMA1;SLC9A1;SLC24A4;SLC24A2;KCNA5;HCN1;KCNS3;KCNH7;KCNK10;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13
prerank,regulation of interleukin-1 beta production (GO:0032651),0.38463270903862895,1.118098467150875,0.3170454545454545,1.0,1.0,5/66,5.57%,FFAR4;USP50;PYCARD;WNT5A;TMEM106A
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5204206710311507,1.1180209316835457,0.3464447806354009,1.0,1.0,5/11,17.97%,HAT1;ATRX;ASF1A;RBBP4;NASP
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.36403353647167197,1.1178822477522672,0.25945378151260506,1.0,1.0,29/118,14.82%,SIPA1L1;PHLDB1;FGF2;ERBB2;EFNA5;FMNL2;TGFB1;SDC2;TANC2;NF1;TNIK;LRRC4C;PAK1;CHN1;PDZD8;ADGRB3;SPARC;BCL9L;PPFIA2;GDNF;CLASP1;MYO19;PID1;ZMYM6;CDK5R1;LZTS3;BMPER;NEDD4L;ARHGAP44
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.42036705474004893,1.1178129453221102,0.3367088607594937,1.0,1.0,12/33,20.22%,FGF2;TGFB1;KLF5;HIF1A;NGFR;GATA3;TP53;EGR1;PPARG;JUN;STAT3;SMARCA4
prerank,second-messenger-mediated signaling (GO:0019932),0.3765323572625792,1.1176343555527528,0.29751131221719457,1.0,1.0,13/82,14.06%,CHRM3;HRH1;PPP1R9A;EIF2AK3;CCR2;ACKR3;RCAN1;RCAN3;MCTP1;EDN3;TPCN2;P2RY12;ACKR4
prerank,response to muramyl dipeptide (GO:0032495),0.5270434097629749,1.1175274728354863,0.335832083958021,1.0,1.0,3/12,11.27%,PTPN22;ERBIN;TRIM41
prerank,mitochondrion transport along microtubule (GO:0047497),0.5100789497237969,1.1174403966916369,0.34277198211624443,1.0,1.0,6/13,22.73%,HIF1A;RHOT2;OPA1;UBB;RHOT1;SYBU
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3560157608547082,-1.1173921680020737,0.29537366548042704,0.8158356383241451,1.0,8/21,15.38%,ROCK2;ROCK1;NOS3;ASPN;SRGN;ENPP1;HEY2;PTK2B
prerank,ribosomal small subunit assembly (GO:0000028),-0.3957240097630395,-1.116777660575512,0.31475409836065577,0.8155724403876057,1.0,8/16,27.56%,RPS14;RPS19;RPS15;MRPS7;MRPS11;RPS5;PWP2;RPS27
prerank,vasodilation (GO:0042311),-0.41587567894815725,-1.116411871093169,0.279874213836478,0.8144353195823784,1.0,6/13,22.32%,NOS3;KLF2;SOD1;NOS1;GPER1;ADRB2
prerank,regulation of platelet aggregation (GO:0090330),0.47370145789760454,1.116343215381396,0.3487394957983193,1.0,1.0,3/17,8.22%,PRKCA;PRKCQ;SERPINE2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4882734098176531,1.1162282117741957,0.34285714285714286,1.0,1.0,2/16,1.34%,BMP5;ZFAND2B
prerank,epithelial cell differentiation (GO:0030855),0.3782544170128588,1.1157387532106138,0.30528586839266453,1.0,1.0,18/88,14.13%,LGALS3;TST;VEGFA;CNN3;GLI1;UPK1B;CASP6;FZD7;GATA6;CTSB;PIH1D1;HDAC2;ERBB4;TOLLIP;SCRIB;GATA3;SCUBE1;PTER
prerank,carnitine shuttle (GO:0006853),-0.44426792683178695,-1.1155455984709084,0.3106508875739645,0.8148696298562437,1.0,5/11,12.84%,PRKAG2;CPT1A;ACACB;PRKAA2;SLC25A20
prerank,regulation of wound healing (GO:0061041),0.4083865197339494,1.1153356463415107,0.3199513381995134,1.0,1.0,10/42,17.28%,CLDN19;FGF2;EPHB2;CADM4;CLDN1;AJAP1;SRSF6;ITGB1;ARFGEF1;HBEGF
prerank,organophosphate ester transport (GO:0015748),-0.34413123228130443,-1.113956053373393,0.2677165354330709,0.8177047789584261,1.0,6/24,10.57%,OSBPL8;ABCA3;PLTP;PITPNA;OSBPL2;TNFAIP8L3
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5285205544572292,1.1139479807901094,0.3469055374592834,1.0,1.0,1/10,0.88%,GFPT2
prerank,regulation of catecholamine secretion (GO:0050433),0.4308100337979173,1.1134480688487318,0.31382978723404253,1.0,1.0,8/29,13.88%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;DRD2;SNCA
prerank,membrane lipid catabolic process (GO:0046466),0.5308032490580918,1.1133011227102534,0.34194528875379937,1.0,1.0,3/10,12.21%,NAGA;CYP1B1;PDXDC1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4583348257242451,1.1130048957619239,0.329700272479564,1.0,1.0,6/21,11.40%,MYC;FGF10;SOX9;MT3;ZFP36L2;MAPK1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3465984237626077,1.1128053208662476,0.22622622622622623,1.0,1.0,86/336,18.82%,UBE2T;DDX11;MYC;BCL2;STXBP4;SUV39H1;UBE2E2;ZRANB3;FMN2;APTX;MBD4;WAC;POLE2;CHRNA4;PSEN1;NUPR2;NSMCE3;MAPKAPK2;PPP1R15A;MRNIP;ERCC4;PAK1;DDB2;METTL3;NUDT1;UFL1;MUTYH;MEN1;BRCA1;VAV3;XPA;TLK2;REXO4;TDP1;POLE3;ZBTB38;FBXO45;ENDOV;ATF2;SLF2;FBH1;MAPK14;FANCC;TAF9;ASF1A;MSH6;UPF1;TAOK3;STK33;ZBTB1;AKTIP;DDB1;HPF1;BRAT1;XRCC3;TOPBP1;PDS5B;RTEL1;SUMO1;CRY1;BAZ1B;CGAS;CASP2;ATM;TRRAP;ABL1;CSNK1E;RAD52;BLM;TP53;SPIDR;BCL2L11;XIAP;FAM111A;CUL4B;CEP63;WRN;NSMCE4A;UBA1;FBXO31;IRF3;ASH2L;AATF;PARK7;BATF;TAF1
prerank,snRNA metabolic process (GO:0016073),0.48737864715350593,1.1126803350330352,0.3338048090523338,1.0,1.0,7/17,15.73%,INTS11;INTS6;INTS4;INTS2;INTS8;RBM7;MEPCE
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4199524009660981,-1.1121213945722144,0.3553459119496855,0.8213612759643917,1.0,7/13,22.11%,USP19;NUPR1;MANF;NR1H2;AQP11;NR1H3;CLU
prerank,neuromuscular process controlling balance (GO:0050885),0.5049858564280755,1.1116493966328929,0.3586309523809524,1.0,1.0,2/12,4.74%,PCDH15;NRXN1
prerank,regulation of microtubule depolymerization (GO:0031114),0.4460927139183082,1.1108956095818487,0.3390501319261214,1.0,1.0,8/25,18.72%,FGF13;MAP1B;CLASP1;APC2;KATNB1;NAV3;ATXN7;CAMSAP1
prerank,regulation of B cell activation (GO:0050864),0.43643032345110205,1.1107256702941513,0.3285528031290743,1.0,1.0,7/25,21.39%,SAMSN1;IL4I1;ZFP36L2;AHR;SH3KBP1;FOXJ1;TNIP2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.38509506381819936,-1.1104659104640875,0.3219178082191781,0.824468821433135,1.0,6/17,4.56%,ROBO1;NRP1;PIK3R3;SLIT2;EPHB4;KDR
prerank,regulation of DNA repair (GO:0006282),-0.3007325804099793,-1.1101771906010833,0.29012345679012347,0.8230946715710311,1.0,13/44,15.19%,EYA1;EYA2;PARG;ERCC8;EYA4;NPAS2;BABAM1;POLH;ABRAXAS1;WRAP53;PML;PCNA;UBE2N
prerank,regulation of cellular component movement (GO:0051270),-0.2987215951556654,-1.1100796532946469,0.2608695652173913,0.8211285179330892,1.0,16/49,9.33%,SP100;ROCK2;ETS1;ROCK1;DIAPH1;LYN;YTHDF1;TGFBR1;ABL2;RPS19;ZSWIM6;PDPN;ACTN1;ARAP1;ZSWIM4;RHOA
prerank,regulation of protein kinase activity (GO:0045859),0.36534783554227646,1.1100661838685777,0.32199787460148777,1.0,1.0,24/106,18.76%,RELN;UBASH3B;RAP2B;DEPTOR;TRAF4;NF1;MRNIP;ALS2;SPRED1;RAP1A;MMD2;DVL1;WWTR1;XRCC6;SNCA;TAF7;IQGAP1;RASSF2;PYDC1;DBNDD2;JTB;PPM1E;MAPRE3;PARK7
prerank,positive regulation of gene expression (GO:0010628),0.3439421341141545,1.1094860878084185,0.184,1.0,1.0,63/442,11.41%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;GLMN;FGF2;MYC;RBMS3;FGF10;PTPN22;ANK2;CD34;KAT2B;SOX9;GSN;NGF;ERBB2;PRKN;EGFR;VEGFA;EPHB2;ELAVL4;EIF2AK3;TLE1;UPF3A;PLD1;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;MT3;TAF1A;NIBAN1;WNT5A;HOXD3;AGPAT2;METTL3;CARD9;EIF3C;CPEB3;CADM1;EIF6;BRCA1;SMO;NSUN5;PASK;POLR2K;MAPK9;HIF1A;SFRP4;PIK3R1;ATF2;NFE2L2;MAPK14;RIMS1;SP1;PID1;MAPK1;BMP7
prerank,regulation of extracellular matrix organization (GO:1903053),0.49048395085474805,1.1091273476751957,0.3356741573033708,1.0,1.0,3/15,2.97%,FAP;LRP1;ANGPTL7
prerank,response to amyloid-beta (GO:1904645),0.40266521426425017,1.1088942501490182,0.3252720677146312,1.0,1.0,10/44,10.58%,MMP2;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.45871707498503617,1.108317871057117,0.35054347826086957,1.0,1.0,7/22,17.08%,RAD23B;GTF2H2;DDB2;XPA;DDB1;UBB;CUL4B
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.30512429116219664,-1.1082720665171693,0.2616279069767442,0.8245729141037005,1.0,8/40,9.23%,DAB2;GCNT2;LEF1;CTNNB1;TGFBR1;PDPN;RGCC;JAG1
prerank,regulation of urine volume (GO:0035809),0.5248245424476593,1.108238461321544,0.3641791044776119,1.0,1.0,1/10,1.04%,HAS2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.35432967977915064,1.1075921656261547,0.29387331256490135,1.0,1.0,40/150,18.98%,UBASH3B;NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;DEPTOR;PRNP;NF1;CNKSR3;PTPN13;NIBAN1;MLXIPL;SPRED2;SPRED1;SAMSN1;MEN1;SPRED3;EIF4G1;PID1;PDE4D;DVL1;WWTR1;SNCA;NCK1;CALM1;LDLRAD4;TAF7;RASSF2;CALM2;TERF2IP;PYDC1;DBNDD2;PPM1E;PARK7;SEMA4D;DNAJC10;TESK1
prerank,positive regulation of catabolic process (GO:0009896),0.3868291278304877,1.1073150131498624,0.32954545454545453,1.0,1.0,12/65,16.25%,GPC3;PRKN;HACE1;WNT5A;ASB5;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;NDUFA13
prerank,cellular response to dsRNA (GO:0071359),-0.405960117251031,-1.107284551379023,0.3125,0.8253533577718569,1.0,9/15,23.11%,NPM1;IFIH1;RIOK3;FLOT1;CAV1;IFIT1;COLEC12;PDE12;MUL1
prerank,regulation of exocytosis (GO:0017157),0.40187854042016236,1.1071668801744672,0.3144578313253012,1.0,1.0,12/46,18.87%,STXBP6;IL1RAPL1;SYT1;RAB21;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;UNC13D;RIMS2;RAB3B
prerank,phosphatidylinositol metabolic process (GO:0046488),0.35934749636808916,1.1068583839489423,0.3233724653148346,1.0,1.0,18/109,12.35%,PLEKHA4;INPP4B;SLC27A1;PLBD1;FGF2;PTEN;PGAP1;RAB14;MTMR14;PLCB1;PTPN13;PI4KB;VAC14;PLA2G12A;PIK3R1;PI4K2A;MTMR12;PLAAT3
prerank,positive regulation of histone methylation (GO:0031062),0.4476239494717659,1.1067407632637298,0.3527080581241744,1.0,1.0,5/24,12.25%,FAM47E;KMT2A;AUTS2;BRCA1;JARID2
prerank,N-terminal protein amino acid modification (GO:0031365),0.4853959138405537,1.1063518489674387,0.3432203389830508,1.0,1.0,8/14,27.25%,NAA35;NAA16;NAA10;NAA15;METAP1;METAP1D;NAA40;NAA50
prerank,glucose metabolic process (GO:0006006),0.38810297826356155,1.1062862929847863,0.33179190751445087,1.0,1.0,9/58,16.03%,APOD;IRS2;PGM1;GOT2;GALM;SLC25A10;BRAT1;CRY1;SLC25A11
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4677151108716581,1.1059346843230604,0.3448275862068966,1.0,1.0,5/18,20.38%,CD34;PRNP;HOMER2;NAV3;ZFP36
prerank,ceramide metabolic process (GO:0006672),-0.2841155009666833,-1.1058877496182093,0.2602739726027397,0.8276146627042915,1.0,14/49,18.51%,SGMS1;ST6GALNAC3;PLPP1;CERS5;ACER2;SPTLC2;DEGS2;CERS4;SGPL1;ASAH2;CERS1;ORMDL3;PLA2G15;SPTSSB
prerank,P-body assembly (GO:0033962),0.5083553597266761,1.1051475370859865,0.36048265460030166,1.0,1.0,7/12,22.85%,ATXN2;LSM3;EIF4ENIF1;RC3H1;LIMD1;DDX6;DYNC1H1
prerank,leukotriene metabolic process (GO:0006691),0.46797744862707846,1.1050896448646228,0.3598901098901099,1.0,1.0,6/19,17.07%,DPEP1;MAPKAPK2;LTA4H;DPEP2;ALOX5AP;ABCC1
prerank,lymphocyte mediated immunity (GO:0002449),-0.4310805425728266,-1.104974901716688,0.33236994219653176,0.828151431601896,1.0,4/12,29.97%,CD55;JAG1;GNL1;MSH2
prerank,hemopoiesis (GO:0030097),-0.2617889200710274,-1.1047200892810671,0.21739130434782608,0.8266865584059535,1.0,21/87,14.37%,FLT1;NOTCH2;MECOM;TEK;KIT;NCOA6;BMP4;ETV6;KDR;KITLG;FLT3LG;MKNK2;FGFR2;FLCN;JAG1;NOTCH4;TGFB2;INHBA;PTPRC;TIRAP;BMI1
prerank,regulation of neuron migration (GO:2001222),0.439604768514834,1.104560453734739,0.339699863574352,1.0,1.0,6/26,9.11%,KIF20B;SEMA3A;CTNNA2;NTNG2;NTNG1;COL3A1
prerank,regulation of protein catabolic process (GO:0042176),0.36624328042774745,1.1045473958698704,0.3351235230934479,1.0,1.0,26/99,21.27%,GPC3;PRKN;EGFR;FMN2;HACE1;IRAK3;WNT5A;ASB5;FLNA;HUWE1;APC2;DDB1;MDM4;NEDD4L;GFAP;AREL1;DACT1;NDUFA13;SNX12;AZIN2;RAB7A;MDM2;SF3B3;FURIN;AGAP2;TIPARP
prerank,fat cell differentiation (GO:0045444),0.39241018502841085,1.104388974022387,0.3399532710280374,1.0,1.0,10/57,14.36%,FFAR4;STEAP4;SOX8;PRDM16;BBS9;FAM120B;PID1;TMEM120A;ATF5;SENP2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3842441454363683,-1.1042289372437728,0.2875816993464052,0.8260372323510126,1.0,4/17,7.73%,BMP6;SASH1;TRIM5;CD55
prerank,Rho protein signal transduction (GO:0007266),0.3927885238297963,1.1039236247556177,0.336094674556213,1.0,1.0,14/53,15.07%,RTKN;RHOJ;TAX1BP3;RHOD;CTNNAL1;EPS8L1;LIMK1;ARHGEF11;MYO9B;NGFR;COL1A2;ARHGAP4;ARHGEF3;CDC42EP1
prerank,regulation of phospholipase activity (GO:0010517),0.5275090732596344,1.1038874002919794,0.3605220228384992,1.0,1.0,3/10,13.88%,LRP1;FGFR1;SNCA
prerank,positive regulation of blood coagulation (GO:0030194),0.4690506897297664,1.103712774072196,0.355463347164592,1.0,1.0,2/17,3.48%,ST3GAL4;ANO6
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5080223393035191,1.1035941161830605,0.364741641337386,1.0,1.0,2/12,4.92%,BMP5;PLCB1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4569866209920031,1.1035072552488507,0.34782608695652173,1.0,1.0,4/20,10.76%,VEGFA;MT3;HIF1A;NFE2L2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.4594965486742314,1.1034059231731075,0.33861671469740634,1.0,1.0,2/20,4.92%,CHRM3;PLCB1
prerank,negative regulation of immune effector process (GO:0002698),0.5068679310947978,1.1033399671395205,0.37116564417177916,1.0,1.0,1/13,0.37%,LGALS3
prerank,positive regulation of viral process (GO:0048524),0.3910908831867518,1.1028565848474776,0.3367816091954023,1.0,1.0,16/60,18.98%,MDFIC;FKBP6;PABPC1;POLR2B;PPID;POLR2K;ADARB1;DDB1;TBC1D20;KPNA6;POLR2G;PPIH;PKN2;RAB7A;POLR2A;AXL
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4600696035234164,1.1028511137706813,0.35397039030955585,1.0,1.0,9/20,26.58%,PTPN22;TGFB1;IL18;TICAM1;LBP;BCL10;PRKCE;HCK;IRAK1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5162943479103423,1.1023136315734754,0.36818181818181817,1.0,1.0,2/12,7.90%,CCR2;IL18
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.32864185751819924,-1.101733718322446,0.3008849557522124,0.8319222945632442,1.0,16/31,29.31%,TOMM70;TIMM23;PEX7;DNAJC15;PEX14;PEX26;TIMM17A;PEX2;PEX10;ROMO1;GRPEL1;PEX6;PEX16;DNLZ;TOMM40L;TOMM40
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4339784279823934,1.1016467291506435,0.34986595174262736,1.0,1.0,9/28,18.72%,MAP1B;GBA2;ARL2;CLASP1;FKBP4;STMN4;ABL1;MAPRE3;CAMSAP1
prerank,mitochondrial gene expression (GO:0140053),0.398302564035469,1.1010089365084348,0.34306569343065696,1.0,1.0,10/42,14.97%,MRPL47;IARS2;MRPS18A;MRPL16;GATB;MRPS28;TFAM;POLRMT;HARS1;MRPL51
prerank,epithelial tube morphogenesis (GO:0060562),0.41728114042660913,1.1008907086656714,0.33984375,1.0,1.0,10/32,15.00%,GLI2;FGF10;ACVR1;PRKX;PAK1;CCM2;SCRIB;GATA3;PKD1;MET
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4142098172704351,1.1007428888317925,0.33455882352941174,1.0,1.0,14/38,22.16%,PRKN;PARL;FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3;LMAN1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3725093633208385,1.1003968122002845,0.33223684210526316,1.0,1.0,28/80,20.43%,PITPNB;ATP9B;COPZ2;GBF1;COPB2;COPG2;TMED10;KDELR2;NBAS;ARF4;BICD2;RAB1A;TMED3;TMED2;COPA;ARFGAP3;ARFGAP1;KIF22;COPG1;BNIP1;KDELR3;SURF4;HTT;KIF3A;KIF2A;ERGIC3;RINT1;COG4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2810888085813374,-1.1002414508301808,0.25,0.8345265150000326,1.0,26/65,29.99%,PSMD14;FBXL7;USP47;PSMB3;PSMD12;VPS4A;PSMD6;PSMA1;PSMD7;NABP1;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;CHFR;PSMB1;PSMB9;AVEN;ZFYVE19;PSMC6;PSMD3;PSMD10;PSME3;CHEK1
prerank,cellular response to glucose starvation (GO:0042149),-0.2974427286600465,-1.1000844968925718,0.27071823204419887,0.8328262282052844,1.0,17/41,25.91%,PRKAG2;NUAK1;SIK1;NIM1K;BECN1;PRKAA2;SESN2;PRKAG3;ATG14;KPTN;ATF4;NUAK2;HNRNPA1;SH3GLB1;BRSK2;MTMR3;SZT2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.34240432420358,-1.0999073344788766,0.2809917355371901,0.8310871812692602,1.0,8/26,14.50%,ROCK2;SHANK3;ROCK1;FHOD1;PFN2;ACTG1;CDC42;SYNPO2
prerank,regulation of cation transmembrane transport (GO:1904062),0.42053345150392374,1.099894036196272,0.3360544217687075,1.0,1.0,9/29,19.20%,WNK3;SCN5A;FGF12;DPP10;KCNAB2;KCNIP4;HOMER1;KCNH2;CD63
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3859433315615881,-1.099757450978159,0.35313531353135313,0.8293574340494714,1.0,7/16,21.70%,SOX13;SIX1;PTGS2;FLCN;RREB1;VSTM2A;ZBTB7B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.32073054266613243,-1.099507138292704,0.27380952380952384,0.8279553817102778,1.0,6/30,6.81%,FLT1;KIT;MLLT3;BMP4;KDR;ACE
prerank,regulation of establishment of cell polarity (GO:2000114),-0.39666256252905563,-1.099105403040304,0.33112582781456956,0.827074326389407,1.0,5/16,4.22%,ROCK2;CDH5;RAP1B;ROCK1;CYRIB
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4398753284690828,1.0988891843518755,0.35501355013550134,1.0,1.0,8/24,18.85%,SEMA3E;SEMA6C;VEGFA;SEMA3A;DSCAM;SEMA6D;SEMA4B;SEMA4D
prerank,epiboly involved in wound healing (GO:0090505),-0.3876628040602838,-1.0988733756866347,0.34355828220858897,0.8256324778771826,1.0,6/16,14.78%,PDPN;ARHGAP35;CCN1;RHOA;DDR1;CEACAM1
prerank,regulation of innate immune response (GO:0045088),-0.2858022604823351,-1.0980946894867616,0.2642857142857143,0.8258458810943974,1.0,25/57,27.49%,ERAP1;APPL2;BIRC3;PLSCR1;ABCE1;SAMHD1;CASP8;RIOK3;IRF1;TIRAP;NMI;TRIM21;APPL1;USP18;IFI35;POLR3D;HSP90AB1;IFNAR2;CACTIN;MUL1;TNFAIP3;TYRO3;LYAR;PTPN6;TKFC
prerank,hyaluronan catabolic process (GO:0030214),0.47275911753814087,1.0979420833911775,0.3659217877094972,1.0,1.0,8/18,25.74%,FGF2;TGFB1;SPAM1;HYAL1;SLC9A1;CEMIP;HEXB;CEMIP2
prerank,presynapse organization (GO:0099172),0.5187745006044215,1.0969561805793822,0.3500784929356358,1.0,1.0,4/10,16.30%,WNT5A;NLGN1;DVL1;LRRTM3
prerank,clathrin coat assembly (GO:0048268),0.4778713681902231,1.0967890989731317,0.3672883787661406,1.0,1.0,3/15,8.71%,SGIP1;EPS15;HIP1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3616921726499186,1.096726783067239,0.33798283261802575,1.0,1.0,37/100,23.12%,GLMN;RAD23B;XPO1;PRKN;ARAF;WAC;SOCS5;UCHL5;UFL1;CBFA2T3;BAG5;TLK2;HERPUD1;TAF9;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;N4BP1;FBXO22;MDM2;ZER1;PARK7;TAF1;USP5;NKD2;BBS7;UBQLN4;CAMLG;ELOB;ZYG11B;COP1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.4427327305519488,1.0967260983956595,0.34358288770053474,1.0,1.0,4/24,7.02%,CXCL10;ANO6;CCR2;PLA2G7
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3573440789067725,-1.0967244354103187,0.3041825095057034,0.8281902935543038,1.0,4/22,8.81%,GCNT2;MAP2K5;WNK1;KLF4
prerank,regulation of membrane repolarization (GO:0060306),0.4925989725571944,1.0966904073715191,0.37404580152671757,1.0,1.0,4/13,16.10%,CACNA2D1;AKAP6;NEDD4L;KCNH2
prerank,regulation of angiogenesis (GO:0045765),0.345899350301423,1.0965922884236896,0.31243680485338726,1.0,1.0,40/192,16.89%,DCN;HSPG2;SULF1;PRKCA;CXCL10;RHOJ;FGF2;SEMA3E;CD34;ERBB2;VEGFA;PAK4;COL4A2;ITGB8;NF1;HSPB6;CCR2;PDE3B;WNT5A;ADAMTS1;SPRED1;CYP1B1;GATA6;BRCA1;HIF1A;SPARC;ATF2;SP1;MYDGF;GRN;SMOC2;PDCL3;BMPER;ITGB1;JUP;RUNX1;GAB1;HTATIP2;HYAL1;APLNR
prerank,negative regulation of double-strand break repair (GO:2000780),-0.318024607520418,-1.0965427468469005,0.33191489361702126,0.8265160418411824,1.0,16/30,28.93%,RIF1;HELB;HMGA2;POLQ;KLHL15;TWIST1;TRIP12;OGG1;ERCC6;FANCB;MAD2L2;RNF169;UBR5;NUDT16L1;RMI2;PARPBP
prerank,regulation of protein localization (GO:0032880),-0.2819441792217804,-1.096466363476442,0.2966101694915254,0.8245781372688543,1.0,21/58,20.11%,AFDN;MAP2;KDM1A;TRIM25;RABGAP1L;PARP1;TRIM5;CAMK1;RACK1;ZDHHC7;VPS4A;RAB9A;HSP90AA1;ATCAY;PPM1F;TRIM21;PLEKHM2;TRIM17;HSP90AB1;TRIM68;ADCYAP1
prerank,nuclear membrane disassembly (GO:0051081),0.4917086191821157,1.0963036591195772,0.3564213564213564,1.0,1.0,1/14,0.67%,PRKCA
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.36101281980578837,-1.0961288188901908,0.3076923076923077,0.8235473746428507,1.0,8/21,11.99%,MACF1;ROCK2;ROCK1;LIMCH1;EPHA3;DUSP3;RHOA;ACTG1
prerank,negative regulation of locomotion (GO:0040013),-0.4162477296452526,-1.0959415244519581,0.3507246376811594,0.8219479007677944,1.0,4/12,9.34%,FRMD5;FBLN1;DUSP3;CCDC125
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4382053968712669,1.0956858990473928,0.34815756035578144,1.0,1.0,9/25,21.56%,CBLB;EPHB2;SOCS5;SNX6;CBL;ZGPAT;SLC6A9;PPARG;CNRIP1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3512347369320812,1.0948279450070115,0.3139896373056995,1.0,1.0,30/148,15.54%,RELN;ERBB3;SLC27A1;MAP4K4;VEGFA;PAK4;GPRC5B;PAK5;TRAF4;PRNP;MRNIP;TNIK;PAK1;ALS2;TGFBR2;RALB;RAP1A;SLC8A2;PTPN1;GRM5;PIH1D1;MMD2;TAOK3;XRCC6;TTBK1;SNCA;CALM1;IQGAP1;RASSF2;CALM2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4064897307492748,-1.094790605757042,0.3474320241691843,0.8233302019405854,1.0,4/12,14.92%,ZDHHC7;LAMA3;ACTG1;FUZ
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.31216260207040725,-1.0944719295292102,0.29207920792079206,0.8221802556763441,1.0,13/36,18.75%,WASL;NOS3;NPR3;NOSTRIN;TERF2;DNM2;DDAH2;HSP90AA1;TERT;NUS1;SPR;CAV1;APOE
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33958070394722006,1.094159152965718,0.2637913741223671,1.0,1.0,47/348,11.52%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;FGF2;MYC;RBMS3;FGF10;PTPN22;ANK2;CD34;SOX9;GSN;NGF;PRKN;VEGFA;EPHB2;MAPK7;EIF2AK3;TLE1;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;MT3;ATF7IP;WNT5A;HOXD3;BRCA1;SMO;MAPK9;HIF1A;PTPN1;SFRP4;ATF2;NFE2L2;MAPK14;RIMS1;SP1;PID1;MAPK1;BMP7;MAGI2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3984111527443158,1.0941271248965523,0.3381468110709988,1.0,1.0,19/39,28.75%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RAB3B;TANGO2;TVP23A;MIA3;MON1A;SCG2;SEL1L;LTBP2;PREB;RAB13
prerank,development of primary male sexual characteristics (GO:0046546),0.41227758062985914,1.0938040737613504,0.34328358208955223,1.0,1.0,12/34,21.61%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;LHFPL2;NR5A1;CSDE1;MEA1;FGF9
prerank,cellular response to growth factor stimulus (GO:0071363),0.35081715225814686,1.093509307999014,0.3184647302904564,1.0,1.0,28/151,11.52%,SOX6;ADAMTS12;HAS2;NTRK3;GAREM1;SOX9;ERBB2;EGFR;ACVR1;VEGFA;EGR3;MAPK7;TGFB1;NTRK2;MAPKAPK2;ACVR1C;WNT5A;URI1;MTSS2;TGFBR2;RAP1A;SOX5;ZFP36L2;MAPK14;PTPN11;EMD;BMP7;MAGI2
prerank,regulation of developmental growth (GO:0048638),-0.33304027371458944,-1.0932463850681935,0.3317972350230415,0.8236964778160908,1.0,12/29,18.78%,IGF1;LATS2;INSR;STAT5B;APP;SIX1;GSK3B;SOD1;DNM2;MFSD2A;APOE;SIN3A
prerank,epithelial cell migration (GO:0010631),-0.3044510036472471,-1.0930591457837386,0.2925531914893617,0.8221016144468632,1.0,10/37,9.33%,KANK2;NRP1;KIT;ROCK1;CDH13;NOS3;GIPC1;DPP4;TNFSF12;RHOA
prerank,cranial nerve development (GO:0021545),0.5216879394482634,1.0919868539408564,0.38580246913580246,1.0,1.0,1/11,1.00%,ERBB3
prerank,negative regulation of vascular permeability (GO:0043116),-0.42511984549831616,-1.091480703676059,0.3323615160349854,0.8248097775454073,1.0,6/12,14.78%,CLDN5;ANGPT1;SLIT2;PDE3A;PDE2A;CEACAM1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.33480573724053475,-1.0914148855259125,0.31063829787234043,0.8228673363739691,1.0,6/27,11.12%,PRKCH;ABCA1;NFKBIA;AGTR1;ABCG1;NR1H2
prerank,sulfur compound biosynthetic process (GO:0044272),0.3612379292812244,1.091294013271489,0.33619763694951665,1.0,1.0,17/104,13.26%,DCN;VCAN;CTH;LUM;ST3GAL4;CBS;GSS;PAPSS2;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GGCT;GGTA1;SLC35B3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2974588739363046,-1.090943767791529,0.2708333333333333,0.822317142550822,1.0,10/39,12.07%,CDH5;TEK;ANGPT1;KDR;PRKCI;THBS1;ICAM1;RGCC;GATA2;SERPINE1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.40575140594153264,1.090593703603411,0.36488169364881695,1.0,1.0,15/37,19.41%,CADM4;WNK3;TGFB1;SPRED2;SPRED1;UBE2K;SPRED3;EIF4G1;MAPK1;BMP7;CALM1;CALM2;RPTOR;S1PR2;CAB39
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.45084970638088767,1.090010821901846,0.3442622950819672,1.0,1.0,7/24,18.76%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;USP25;PARK7
prerank,chloride transmembrane transport (GO:1902476),0.3891144626204421,1.0899901365937326,0.3524390243902439,1.0,1.0,5/48,5.24%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.33616269920549036,-1.089331201428246,0.31225296442687744,0.825278013118197,1.0,7/24,12.07%,CDH5;TEK;ANGPT1;KDR;ICAM1;GATA2;SERPINE1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4701718074779096,1.0889551978423557,0.37280701754385964,1.0,1.0,5/15,15.64%,GPC3;DAAM2;SFRP4;DACT1;CSNK1E
prerank,protein acetylation (GO:0006473),0.42432135791143305,1.08880867563692,0.3684863523573201,1.0,1.0,8/30,18.52%,KAT2B;HAT1;NAA35;NAA16;GTF2B;ING4;NAA10;NAA15
prerank,positive regulation of mRNA processing (GO:0050685),0.4444063931116255,1.0887705967402999,0.36689655172413793,1.0,1.0,4/21,12.97%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.35632009733416126,1.0887238444334024,0.33762057877813506,1.0,1.0,16/112,10.85%,PYCARD;PTPN22;CD34;FADD;EPHB2;IRAK3;PSEN1;MAPKAPK2;CCR2;WNT5A;TMEM106A;SYT11;SELENOS;TLR1;PTPRJ;PTPN11
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.41292389034766663,-1.0879421635923607,0.36182336182336183,0.8275575149469013,1.0,3/12,19.97%,GCNT2;FLOT1;SKAP1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4932807269067152,1.0878663494195913,0.38088445078459343,1.0,1.0,2/13,2.66%,TBC1D10A;FADD
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3376222343058654,1.0876761714065226,0.29435483870967744,1.0,1.0,73/291,21.50%,RORA;P2RY2;SSTR1;CXCL10;PDGFRA;PYCARD;DPEP1;SOX9;EGFR;NCF1;PDE4B;MT3;WNT5A;AOC1;RORC;PDK3;FZD7;RAP1A;CPEB3;LAMTOR2;TSHR;MAPK9;SELENOS;AKAP6;ESR1;MAPK14;TRIM41;PID1;MAPK1;UPF1;ERCC6L2;NRIP1;PRDX3;HSP90B1;SHPK;AHR;CPEB1;P2RY12;P2RY1;SSH1;LCOR;TICAM1;PLAA;MTR;ATM;GPLD1;NDUFA13;PAX2;CDC73;CHUK;NCOA3;SPAAR;RPTOR;LBP;FAM210B;TAF1;AXL;EGR1;RYR3;RUVBL2;IPO5;PDCD4;HCN1;BCL10;JUN;RRAGA;ZFP36;SIRPA;NFKB1;TNIP2;PKD2;PXN;P2RX7
prerank,regulation of transmembrane transport (GO:0034762),0.41473196165751114,1.0876478566661505,0.3684210526315789,1.0,1.0,6/31,14.64%,FFAR4;BCL2;KCNJ3;SNCA;NEDD4L;KCNJ10
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4082149987804226,1.0873052096808626,0.3640897755610973,1.0,1.0,14/36,23.71%,MYC;PTPN22;PRKN;MEN1;FOXM1;TAOK3;PER1;DACT1;FKTN;ZMYND11;DUSP1;SIRPA;CYLD;AIDA
prerank,glycoprotein biosynthetic process (GO:0009101),-0.25688385660111074,-1.086833870400541,0.22,0.8287888054440709,1.0,18/79,16.54%,IGF1;GCNT2;ST3GAL6;ST8SIA4;FAM20B;BMPR2;ATP7A;CHST11;MGAT1;ST6GALNAC2;TNIP1;SERP1;FOXL1;CHST12;B4GALT7;NUS1;B3GALT1;B3GALT2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.30882632463890025,-1.0867681735888066,0.3211009174311927,0.8268779124142963,1.0,12/31,18.00%,IGF1;FAM20B;BMPR2;NDST3;PXYLP1;CHST11;FOXL1;CHST12;B4GALT7;HS3ST3B1;B3GAT1;CHST10
prerank,ESCRT complex disassembly (GO:1904896),-0.4582252978372807,-1.086758676525564,0.35755813953488375,0.8227299464839929,1.0,5/10,23.97%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),-0.4582252978372807,-1.086758676525564,0.35755813953488375,0.8227299464839929,1.0,5/10,23.97%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3489733892014244,1.086500038368502,0.34169278996865204,1.0,1.0,25/129,14.59%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;CDC25B;TAF2;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,oligodendrocyte development (GO:0014003),0.473826171808367,1.0862612870328048,0.37518037518037517,1.0,1.0,5/15,20.63%,PLP1;EIF2B5;NSUN5;EIF2B2;B4GALT6
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.30000490306915656,-1.0857439251439769,0.2777777777777778,0.8238991400298571,1.0,13/39,17.41%,PI4KA;PIK3R3;PIK3C2A;TTC7B;IP6K1;SOCS7;SOCS4;PIK3C2B;EFR3B;TMEM150A;ITPKC;PIP4K2B;ITPKB
prerank,organelle organization (GO:0006996),0.33862402103543227,1.0856804832233946,0.26926926926926925,1.0,1.0,109/388,21.74%,SEC16B;TMED6;CCL11;ANK1;HPS6;MYC;ATP8B1;WDPCP;GORASP1;PRKN;RAB38;FGD4;PAK4;HACE1;PITPNB;RAB14;EIF2AK3;FMNL2;MAST2;PACSIN2;BLZF1;PAK5;GOLGB1;TNIK;OBSL1;PEX3;ARL1;PDZD8;GBF1;EPS15;RAB34;SEC31B;BIN1;GAK;TFAM;BAG5;TRIP11;PPID;TMED10;VPS11;RHOT2;PALLD;HUWE1;VAPA;KIF5C;CLASP1;PI4K2A;AFG1L;GORASP2;ARHGAP21;MREG;ZMYM6;HPS3;RAB1A;PLAAT3;ATL3;USP6NL;NECTIN2;PRDX3;CSNK1A1;YME1L1;SH3KBP1;POLRMT;TBC1D20;ARHGAP4;TMED3;TMED2;POLG2;PDCD6IP;SEC23IP;OPA1;CHMP4C;CFAP61;BNIP1;DIAPH3;ARFGEF1;ABCD2;GABPB1;SURF4;ADCK1;MDK;RAB7A;PEX1;RHOT1;CLUH;HTT;KIF3A;ATXN7;STX17;CAMSAP1;PARK7;REEP5;RAB30;PEX11A;COG1;CHMP1B;PHB2;CEP78;RHOU;COG4;RAB3GAP1;LIMD1;SSBP1;VMP1;TANGO2;WDR81;PKD2;CDC42BPB;MTFR1
prerank,smooth muscle tissue development (GO:0048745),0.5225767794685815,1.0851409112904107,0.375,1.0,1.0,3/10,8.63%,PTCH1;NF1;SMO
prerank,protein localization to chromosome (GO:0034502),0.40916992585770223,1.084695865302579,0.37361282367447596,1.0,1.0,7/34,16.41%,FAM47E;MRNIP;ATRX;SLF2;ESR1;RPA2;TERF2IP
prerank,membrane lipid biosynthetic process (GO:0046467),-0.27819304603963363,-1.0846874302834526,0.32231404958677684,0.8251297626519433,1.0,14/58,9.45%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4464466227453949,1.0846120021864756,0.3737931034482759,1.0,1.0,4/22,2.73%,EPB41L4B;FGF10;STXBP4;TGM1
prerank,photoreceptor cell development (GO:0042461),0.4813792706166484,1.08428325783275,0.3796711509715994,1.0,1.0,2/14,3.63%,VEGFA;ARL3
prerank,regulation of gastrulation (GO:0010470),-0.39392141068887276,-1.083303528358854,0.33045977011494254,0.8273220902945251,1.0,2/14,1.38%,PHLDB2;OSR1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3562562052872176,1.0832422416681002,0.3440514469453376,1.0,1.0,33/107,21.75%,CREB3L1;BCL2;PRKN;DNAJB9;EIF2AK3;TNFRSF10B;PPP1R15A;NIBAN1;CREB3L2;UFL1;EIF2B5;RCN3;SELENOS;HERPUD1;PIK3R1;TMEM33;GORASP2;HSP90B1;CCDC47;TMTC3;NCK1;TMEM117;TP53;BCL2L11;QRICH1;FICD;AIFM1;DNAJC10;MBTPS1;JUN;UBXN6;RHBDD1;ERO1A
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4165540595689484,-1.0831669326202682,0.3446327683615819,0.8257197700296737,1.0,2/12,3.82%,IL34;LYN
prerank,metal ion export (GO:0070839),-0.31713599626337996,-1.0831171332309557,0.31336405529953915,0.8238137038708866,1.0,5/31,7.25%,ATP1A2;ATP1B3;ATP7A;ATP1A1;SLC40A1
prerank,cellular response to drug (GO:0035690),0.43218201391921296,1.082572170009565,0.38088829071332436,1.0,1.0,7/25,18.15%,MYC;DPEP1;PDE4B;TP53;KCNH2;GPLD1;PPM1E
prerank,organonitrogen compound catabolic process (GO:1901565),0.3785043363438752,1.0823302394521386,0.37697516930022573,1.0,1.0,21/57,23.94%,CTH;TST;NAGK;LTA4H;PLA2G7;TRHDE;IL4I1;LNPEP;UCHL3;PDXDC1;PNPLA8;LIPC;GNPDA1;TXN2;BCKDK;NPEPPS;RIDA;SIAH1;TPP1;CLN6;MTOR
prerank,regulation of MAPK cascade (GO:0043408),0.3418808360755152,1.0821574636021725,0.3391572456320658,1.0,1.0,30/157,14.88%,ROR2;ROR1;NTRK3;FGF2;FGF10;ERBB2;EGFR;LPAR1;MAP4K4;PAK4;PAK5;NTRK2;NF1;TNIK;TMEM106A;PAK1;YWHAZ;KSR1;SPRED1;FGFR1;GPR37;PTPRJ;MAPK1;TAOK3;MYDGF;MYOC;PRDM11;DHX33;TRAF7;IQGAP1
prerank,icosanoid metabolic process (GO:0006690),0.40532979911209455,1.081991538382222,0.3719806763285024,1.0,1.0,8/40,13.50%,CYP2S1;DPEP1;MAPKAPK2;LTA4H;CYP1B1;DPEP2;ALOX5AP;PNPLA8
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.30333331322834084,-1.08137104297299,0.33,0.827422814776938,1.0,10/36,12.43%,LEF1;CTNNB1;PLCB3;MOV10;AGO1;FZD6;NLK;CAMK2A;MAP3K7;AGO3
prerank,cell cycle G2/M phase transition (GO:0044839),0.34776064447691474,1.0813383751705732,0.34623430962343094,1.0,1.0,25/130,14.59%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;CDC25B;TAF2;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.47613041886604174,1.0809714819022103,0.3787425149700599,1.0,1.0,5/15,18.13%,BCL2;PRKN;TAF9;CD74;MDM2
prerank,C-terminal protein amino acid modification (GO:0018410),0.5096230509966694,1.0806624579969175,0.3829457364341085,1.0,1.0,4/11,16.10%,ATG5;AGBL4;AGBL1;GPLD1
prerank,regulation of dendritic spine development (GO:0060998),0.4536723018910998,1.0805664421138954,0.369901547116737,1.0,1.0,5/19,10.41%,PSEN1;TANC2;NLGN1;CPEB3;PPFIA2
prerank,negative regulation by host of viral process (GO:0044793),0.5233500296307236,1.0802832546304648,0.386046511627907,1.0,1.0,2/10,10.41%,PRKN;VAPA
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.39883771805758605,1.0794191186989153,0.38166047087980176,1.0,1.0,9/39,12.65%,SEMA3E;EFNA5;HOXA7;MAP4K4;RASA1;FZD7;NF2;AJAP1;MYOC
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4616272593872704,1.079338993807384,0.36971350613915416,1.0,1.0,5/16,18.52%,KAT2B;NAA35;NAA16;NAA10;NAA15
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3474463608401459,-1.0790735561229292,0.3275862068965517,0.8304295692922407,1.0,10/23,20.21%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3474463608401459,-1.0790735561229292,0.3275862068965517,0.8304295692922407,1.0,10/23,20.21%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.291783533001986,-1.0788767130756804,0.2981366459627329,0.8289688843595866,1.0,8/43,5.92%,BMP6;IGF1;WNT4;LRP5;BMP4;BMPR2;SUCO;ZHX3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.45528009138551145,1.078796245572864,0.3702664796633941,1.0,1.0,6/19,17.24%,PTGFR;PRNP;GRM5;PTPRJ;PRKACA;STIMATE
prerank,prostanoid metabolic process (GO:0006692),0.48868339161366636,1.0776516225703343,0.4043795620437956,1.0,1.0,4/13,17.78%,CYP2S1;ACOX1;PLAA;PTGES
prerank,retinol metabolic process (GO:0042572),0.4824507334673629,1.0775317804707574,0.39741750358680056,1.0,1.0,3/14,8.29%,CYP1B1;RDH10;DHRS3
prerank,sodium ion transmembrane transport (GO:0035725),0.3626431321490922,1.0771364797296459,0.3684210526315789,1.0,1.0,10/84,7.96%,SLC6A2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,skin development (GO:0043588),0.37355915485770963,1.0771295026322834,0.3608597285067873,1.0,1.0,13/65,15.00%,COL5A3;CERS3;TGM1;COL5A2;CLDN1;WNT5A;GATA6;HRNR;COL3A1;COL1A2;COL1A1;PKD1;MET
prerank,ureteric bud morphogenesis (GO:0060675),0.4725633911494255,1.0771275796430784,0.40229885057471265,1.0,1.0,7/16,23.34%,FGF2;MYC;GDNF;GATA3;PAX2;PKD2;BMP2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4077756156483849,1.0771140611271592,0.36742424242424243,1.0,1.0,9/37,12.38%,NUDT15;RNASE6;ENTPD2;NUDT1;XRN2;PPP1R8;NCBP1;NUDT9;RNASEH2C
prerank,negative regulation of cell motility (GO:2000146),0.35453615181472475,1.0769395961505757,0.3468085106382979,1.0,1.0,24/108,14.77%,DLC1;CLDN19;SULF1;PIP5KL1;PTEN;DPEP1;PTPRT;RAP2B;RECK;NF1;PODN;CYP1B1;NF2;MCTP1;PTPRJ;NGFR;MAGI2;DRD2;ADARB1;GATA3;ARHGAP4;TCAF1;LDLRAD4;CITED2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.37721771700057005,-1.076678816045462,0.3521594684385382,0.8339620173390511,1.0,4/18,10.05%,EPHA4;ROCK2;GSK3A;ABCG1
prerank,sphingolipid catabolic process (GO:0030149),-0.3852752025789725,-1.0765027340738038,0.3438485804416404,0.832453211236594,1.0,7/15,30.07%,ACER2;SGPL1;ASAH2;SPHK1;SMPDL3A;PPT1;GLA
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4230738362741658,-1.0757723102473422,0.3804034582132565,0.8326424124073692,1.0,8/11,30.73%,POMT2;RNF185;AUP1;UFD1;UGGT1;RNF5;VCP;BAG6
prerank,"wound healing, spreading of cells (GO:0044319)",0.4394777949068928,1.075600389476647,0.39348710990502034,1.0,1.0,1/24,0.13%,ARHGAP24
prerank,atrial septum morphogenesis (GO:0060413),-0.4375655897561529,-1.0754317548049268,0.35185185185185186,0.8318155270904249,1.0,5/10,19.44%,NOTCH2;BMPR2;TGFB2;HEY2;ZFPM1
prerank,ribosome assembly (GO:0042255),-0.2831556312551503,-1.0753971685244423,0.3825136612021858,0.8298901550790527,1.0,24/47,27.56%,RPS14;RPL24;NPM1;RPS19;RPL5;EIF2A;RPS15;RPL3;MRPL20;NOP53;RPL11;MRPS7;DHX37;MRPS11;MRPL22;RSL24D1;NLE1;PPAN;MPV17L2;RPS5;RPF2;RPL6;PWP2;RPS27
prerank,regulation of intracellular signal transduction (GO:1902531),0.332512141785252,1.0753456428093862,0.2672672672672673,1.0,1.0,100/420,18.30%,ARHGAP24;DLC1;ARHGAP32;ARHGAP19;A2M;RHOJ;NTRK3;PYCARD;PTEN;RHOD;PTPN22;BST1;DEPDC1B;EGFR;AKAP13;FGD4;MAP4K4;VEGFA;PAK4;ARAF;PAK5;NTRK2;TRAF4;PRKAR1B;TNIK;PTPN13;NOP2;WNT5A;NLGN1;PAK1;CHN1;MAPKAP1;MTA2;RPA3;PRKAB2;UFL1;ITSN1;SPRED1;ARHGAP9;CHD3;NF2;ARHGEF11;CASTOR2;TBCK;PPP1R13L;BRCA1;VAV3;RCN3;ARHGAP11A;RHOT2;HDAC2;MYO9B;PHF20;AKAP6;MAPK14;TAF9;MYO9A;ARHGAP21;TAF11;TAF2;MAPK1;OPHN1;TAOK3;CDK5R1;FBXL2;RHOH;RHOC;MYOC;GNAI1;RBBP4;TRIO;PRDM11;ARHGAP4;ARHGEF3;RPA2;TOPBP1;MDM4;TAF7;ARHGAP44;ZFAND6;RASSF2;ATM;GPAT3;TAF4;BLM;TP53;TAF4B;TTI1;XIAP;SGK1;USP2;ARHGEF4;WRN;RAC3;PLEKHG2;PIP5K1A;TP53RK;BOP1;MDM2;RHOT1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.43433772755806654,-1.0748637164328452,0.36033519553072624,0.8296714327533167,1.0,10/11,56.60%,RTP4;PKD2L1;PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,cellular copper ion homeostasis (GO:0006878),-0.3900918467165019,-1.0746960070041538,0.34394904458598724,0.8281778061578592,1.0,4/14,7.07%,SLC31A1;ATP7A;APP;SLC31A2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.41298865211011876,1.0744809952854382,0.3794466403162055,1.0,1.0,14/29,21.37%,MYC;TLE1;MEN1;BCL9L;BCL9;TRRAP;PYGO1;TLE3;CDC73;TLE4;ASH2L;SMARCA4;KMT2D;PYGO2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.40593363157144374,1.074378062557218,0.3732484076433121,1.0,1.0,2/33,1.66%,DCN;PTEN
prerank,positive regulation of bone resorption (GO:0045780),0.4969251238454268,1.0742663682565226,0.3859375,1.0,1.0,1/11,0.67%,PRKCA
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.36122147002193616,1.0740412499010092,0.3696837513631407,1.0,1.0,12/88,7.60%,STXBP6;STEAP2;SNAP23;SORCS1;RAB14;ARL3;GOLGB1;OSBPL5;SCAMP2;AP1G1;GBF1;EPS15
prerank,regulation of calcium ion transport (GO:0051924),0.3779121031190832,1.0740296750331013,0.3707602339181287,1.0,1.0,6/54,4.10%,IL16;BCL2;CACNA2D1;ANK2;WNK3;CCL4
prerank,positive regulation of response to wounding (GO:1903036),-0.34348970952080493,-1.0736835332155676,0.3157894736842105,0.8294695804874097,1.0,7/24,11.99%,PTN;VTN;OCLN;SCARF1;MYLK;ADRA2A;ACTG1
prerank,pyruvate metabolic process (GO:0006090),-0.28522726386819,-1.0735780448462404,0.32592592592592595,0.8277518036121764,1.0,10/52,10.55%,BSG;ME1;GLO1;HAGH;PDHX;PGK1;PGAM1;PGAM4;GPI;PDHA1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3306833723467687,1.0734496860499891,0.2932932932932933,1.0,1.0,70/423,12.89%,OSR2;BMP5;PDGFRA;ERBB3;HAS2;NTRK3;FGF2;SOX8;MYC;FGF10;KIF20B;PTEN;BCL2;GAREM1;IRS2;SOX9;CRLF1;BST1;ERBB2;LAMC1;EGFR;VEGFA;MAP3K3;PTHLH;CAPN1;SAAL1;TGFB1;TIPIN;PTGFR;SOX11;NTRK2;GDF9;GLI1;NOX1;NOP2;SCN5A;WNT5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;S100A6;CDK6;FOXM1;FGFR1;IL18;TSHR;GAB2;BTC;DERL2;CUL3;HDAC2;ERBB4;GDNF;IL6ST;PRMT1;CDC25B;PID1;SIRT6;S1PR3;EDN3;FGF7;GRN;RTKN2;WWTR1;GLP2R;PRLR;PRDX3;ZFPM2
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3891088109872482,-1.073340325273296,0.33444816053511706,0.8263919367786766,1.0,11/14,51.69%,ATP6AP1;TYROBP;CSF1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.41212784971905825,-1.0731877164474923,0.3504531722054381,0.8249259213987051,1.0,5/12,24.37%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,bile acid and bile salt transport (GO:0015721),0.4309397188095789,1.0730872490216583,0.3739946380697051,1.0,1.0,5/24,14.49%,ATP8B1;NCOA1;SLCO2B1;NCOA2;SLC10A1
prerank,regulation of fibroblast proliferation (GO:0048145),0.3885356359005788,1.0729102145924518,0.35322777101096225,1.0,1.0,11/45,17.23%,PDGFRA;MYC;NF1;WNT5A;S100A6;CDK6;EMD;MED25;TP53;CD74;CDC73
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4948455201398538,1.0728255697539053,0.40536512667660207,1.0,1.0,7/12,25.22%,WAC;RPA2;RPS27L;TP53;FBXO31;PLK5;PRKDC
prerank,cation transport (GO:0006812),0.3436466558515166,1.0727991710220177,0.34831460674157305,1.0,1.0,19/167,8.45%,SLC22A3;PIEZO2;FGF13;KCNA2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;KCNA6;SLC36A2;SLC12A2;SCN5A;SCN3A;KCND3;SLC8A2;KCNMB2;KCNMB3
prerank,amino acid transport (GO:0006865),-0.28051907750508626,-1.0727204711936693,0.34394904458598724,0.8244760059230738,1.0,12/49,14.59%,SLC7A11;SLC7A2;SLC6A12;SLC6A6;SLC7A5;SLC38A11;PDPN;SLC38A7;SLC38A5;SLC25A47;SLC38A10;SLC36A4
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.37903688292767174,-1.0726497086519557,0.3300970873786408,0.8227305398554139,1.0,8/16,27.84%,NPR3;TERF2;TERT;NUS1;APOE;AKT1;PIK3CB;HTR2B
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.39150409968905253,1.072646248998683,0.3654320987654321,1.0,1.0,4/45,5.57%,USP50;PYCARD;WNT5A;TMEM106A
prerank,regulation of interferon-gamma production (GO:0032649),0.3663190462200603,1.072534573835574,0.3788049605411499,1.0,1.0,9/71,12.72%,PYCARD;PTPN22;FADD;PDE4B;PRNP;CCR2;IL18;PDE4D;SCRIB
prerank,negative regulation of innate immune response (GO:0045824),0.41331374023902917,1.0724839826283634,0.3856041131105398,1.0,1.0,4/34,6.20%,A2M;PTPN2;IRAK3;METTL3
prerank,cGMP-mediated signaling (GO:0019934),-0.40021787514129986,-1.0724008604303155,0.3333333333333333,0.8214941995180375,1.0,6/13,19.52%,IRAG1;PDE3A;GUCY1B1;PDE2A;APOE;KCNC2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.42040155666332824,1.072357724511105,0.37027379400260757,1.0,1.0,8/28,14.00%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.33270516319962556,-1.0723072423660496,0.34306569343065696,0.8198438684213907,1.0,4/24,5.68%,PLA2G4A;ABCA3;GPAM;CRLS1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4898915977219841,1.072298118742545,0.39565217391304347,1.0,1.0,4/12,14.44%,IDH2;IDH3B;ACLY;IDH3A
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.29909810233654394,-1.071919602205167,0.3333333333333333,0.819060348047957,1.0,9/44,7.84%,ROCK2;ZC3HAV1;ROCK1;YTHDF1;MOV10;ZFP36L1;METTL14;CNOT1;GTPBP1
prerank,protein-DNA complex disassembly (GO:0032986),0.46304172801262716,1.071730468179384,0.40412979351032446,1.0,1.0,5/16,20.22%,MYC;SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,peroxisome organization (GO:0007031),0.43306255283123646,1.071607314688191,0.3761348897535668,1.0,1.0,7/25,20.96%,SEC16B;PEX3;PLAAT3;ABCD2;PEX1;PEX11A;ACOT8
prerank,small GTPase mediated signal transduction (GO:0007264),0.3567542674780503,1.0714177825310813,0.37189189189189187,1.0,1.0,14/103,10.78%,ARHGAP32;USP50;FGF2;RAB38;ARL3;PLD1;NUCB1;NF1;KSR1;RALB;RGL1;SHOC2;MRAS;MAPK14
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3995701851328848,-1.0713876049943878,0.3611111111111111,0.8187989339369478,1.0,3/13,4.56%,TLR4;NAMPT;KDR
prerank,protein localization to Golgi apparatus (GO:0034067),0.42780387850606383,1.0707970969398999,0.4030808729139923,1.0,1.0,8/27,11.98%,OBSL1;ARL1;GBF1;GAK;TMED10;ARL5C;BICD2;SYS1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.42696535752861714,-1.070463524550524,0.3667621776504298,0.8198633375869944,1.0,4/11,10.55%,MAP3K5;PRKCD;DIABLO;GSKIP
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35768137799769495,1.070056481387029,0.36909871244635195,1.0,1.0,30/84,26.10%,PRDX6;RBFOX1;CELF5;QKI;TRA2B;SON;KHDRBS3;NCBP1;PCBP4;DAZAP1;CELF6;RBM7;NOVA1;SRSF6;YTHDC1;HNRNPU;RNPS1;SF1;RBFOX3;CELF4;HNRNPL;RBFOX2;SRSF3;RBM25;FMR1;CIRBP;NSRP1;RBM4;RBM15;TRA2A
prerank,regulation of cardiac muscle contraction (GO:0055117),0.40398247851420865,1.069795466662017,0.3778337531486146,1.0,1.0,8/34,17.45%,ANK2;PDE4B;SCN5A;PDE4D;PRKACA;CALM1;CALM2;SLC9A1
prerank,positive regulation of cytokine production (GO:0001819),0.33714690908086414,1.069675878136151,0.3326633165829146,1.0,1.0,56/292,19.03%,RORA;SULF1;IL16;PRKCQ;GLMN;PYCARD;PTPN22;CD34;FADD;EIF2AK3;TGFB1;PDE4B;PLCB1;CCR2;NOX1;WNT5A;SPTBN1;TMEM106A;AGPAT2;CARD9;CYP1B1;LRRFIP1;IL18;CADM1;BRCA1;TMED10;POLR2K;HIF1A;TLR1;MAPK14;PTPN11;IL6ST;RAB1A;PDE4D;TBK1;XRCC6;DRD2;SCRIB;GATA3;MALT1;DHX33;TICAM1;CGAS;IL33;RUNX1;CD74;RIPK1;POLR1C;MDK;RAB7B;IRF3;LBP;PARK7;BATF;SETD4;EGR1
prerank,cholesterol biosynthetic process (GO:0006695),0.41175222933401534,1.069509692844857,0.37405541561712846,1.0,1.0,4/31,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.45706282433903833,1.0694072812149642,0.39511494252873564,1.0,1.0,7/17,21.94%,ERLIN2;KPNB1;ERLIN1;SREBF2;MBTPS1;SEC14L2;PRKAA1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.34534130468898455,1.0693329672506269,0.36886102403343785,1.0,1.0,19/144,11.39%,SEC16B;ANK3;KIF20B;BCL2;ERBB2;C2CD5;FBXW7;TGFB1;PSEN1;PRNP;PCM1;YWHAZ;FYN;FLNA;VPS11;HUWE1;PIK3R1;UBE2J2;EMD
prerank,inositol phosphate metabolic process (GO:0043647),0.3832227471623764,1.0691258808673494,0.37365269461077844,1.0,1.0,5/46,4.92%,ITPK1;INPP4B;FGF2;PTEN;PLCB1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3667050423640074,1.0683755945407245,0.38764044943820225,1.0,1.0,14/65,15.16%,PRDM16;HTRA3;TGFB1;TGFBR2;SPRED2;SPRED1;PEG10;BCL9L;SPRED3;SNX6;DAND5;LTBP1;LDLRAD4;UBB
prerank,regulation of macrophage activation (GO:0043030),-0.31298020873702415,-1.0680696133079643,0.29310344827586204,0.8252714220546544,1.0,5/30,5.90%,CD200;IL31RA;MFHAS1;TLR4;THBS1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.39442767794779665,-1.0679956992638246,0.3742138364779874,0.8235397023120011,1.0,8/14,23.36%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF12;SRSF7;U2AF2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.40570408477650544,1.0679644008450229,0.38181818181818183,1.0,1.0,7/33,13.20%,ERBB3;PTEN;ERBB2;NF1;NYAP1;PIK3R1;GATA3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4399923311922356,1.0679250856407478,0.3961218836565097,1.0,1.0,3/20,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.39788609720840534,-1.0676966890471604,0.34626865671641793,0.8225864007441828,1.0,5/13,24.37%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4213976243206292,-1.0673893907822998,0.36363636363636365,0.8216297226147885,1.0,4/11,13.93%,MFHAS1;LYN;CYBA;TIRAP
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4132900197207173,1.067387842665761,0.36923076923076925,1.0,1.0,6/31,17.21%,GLMN;SOX11;SDC4;IL4I1;ATM;RC3H1
prerank,response to growth factor (GO:0070848),0.387428877178947,1.067210081790917,0.3711843711843712,1.0,1.0,10/41,11.39%,MYC;ERBB2;ACVR1;MAPK7;ACVR1C;URI1;TGFBR2;GATA6;HDAC6;EMD
prerank,DNA double-strand break processing (GO:0000729),0.44899514679071223,1.0669656893391701,0.41086350974930363,1.0,1.0,10/18,25.96%,SETMAR;BRCA1;EXD2;ATM;RAD52;BLM;RAD50;BARD1;SLX4;RBBP8
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3090886024532575,-1.0669260697423832,0.3644859813084112,0.8211364849652969,1.0,7/34,9.92%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,neurotrophin signaling pathway (GO:0038179),0.43199271063553224,1.0665648452095715,0.40714285714285714,1.0,1.0,5/21,11.52%,NGF;NTRK2;RAP1A;NGFR;MAGI2
prerank,cardiac muscle cell development (GO:0055013),0.4492665165832048,1.0665085214147831,0.3980309423347398,1.0,1.0,3/20,5.55%,PDGFRA;VEGFA;OBSL1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.37492923055210814,-1.0663308399437834,0.35906040268456374,0.821061819665812,1.0,8/17,34.48%,BUB3;IK;BOD1;KNL1;ZW10;TTK;SPDL1;CENPA
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3479261147363262,1.0661048644776634,0.3594566353187043,1.0,1.0,20/122,9.18%,GLI2;FGF2;MYC;IRS2;HSPH1;ERBB2;EGFR;UPF3A;PLD1;GLI1;NOX1;NIBAN1;TMEM106A;STN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK
prerank,regulation of defense response to virus (GO:0050688),0.48183556403719946,1.0660151643163844,0.41642228739002934,1.0,1.0,2/14,8.38%,ELMOD2;PPM1B
prerank,respiratory tube development (GO:0030323),0.4134793252759125,1.0659229429725934,0.40797940797940796,1.0,1.0,5/28,6.98%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,translation (GO:0006412),-0.2200698006857651,-1.06527257937821,0.25,0.8224332814725128,1.0,88/208,26.80%,RPS14;GSPT1;RPL24;DRG1;RPL18A;RPS16;GTPBP2;RPL38;RPL28;RPS19;RPL37;ABCE1;RARS2;RPS2;FTSJ1;SARS1;MRPL10;GTPBP1;RPL19;RPL5;RPL34;RPS25;MRPS24;RPS15;TNIP1;EEF1G;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;QRSL1;EEF1A1;DRG2;FASTKD2;RPS6;GFM2;LARS1;RPS8;EIF4EBP2;AARS1;RARS1;RPL11;RPL12;KARS1;RPS6KB2;TSFM;RPL7A;RPL13;EEF1B2;MRPS7;COPS5;MRPL43;IGF2BP3;YARS2;RPS21;NOA1;RPL35A;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RPS23;EEF1E1;RPLP2;MRPS11;MRPL2;RPL8;MRPS16;RSL24D1;RPL41;VARS1;RPS17;GATC;DHPS;RPS5;RPS15A;UBA52;RPL37A;MRPL57;RPS10;MRPL55;RPL6;WARS1;RPL9
prerank,erythrocyte development (GO:0048821),-0.4346258696419739,-1.0652399253318698,0.38328530259365995,0.8206234896417827,1.0,7/10,42.06%,ALAS1;NCKAP1L;DMTN;LYAR;ALAS2;ZBTB7A;SH2B3
prerank,potassium ion homeostasis (GO:0055075),-0.3461309880153258,-1.0651516058441115,0.33969465648854963,0.8189848456748494,1.0,6/23,7.72%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ATP1A1;SLC12A9
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.31422037291846544,-1.0651203809746634,0.3212669683257919,0.8171913772146946,1.0,9/32,12.28%,SNCAIP;RAB5A;DTNBP1;GSK3B;SLC30A1;CPLX1;CAMK2A;MCTP2;SNAPIN
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4739687230389012,1.0651044479430836,0.40611353711790393,1.0,1.0,4/14,9.88%,ZEB1;SPRED2;SPRED1;SPRED3
prerank,plasma membrane repair (GO:0001778),-0.3986595417821957,-1.0650926944940067,0.38292011019283745,0.8153804562671941,1.0,4/13,12.26%,MYOF;MYH9;AHNAK2;SYTL4
prerank,replication fork processing (GO:0031297),0.39795470850396797,1.0644692388323493,0.39655172413793105,1.0,1.0,10/38,17.24%,DDX11;ZRANB3;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3542494461794266,-1.0644156605622763,0.35691318327974275,0.8155432794123574,1.0,6/19,8.81%,MAP2K5;SLCO1C1;MTPN;KLF2;APP;KLF4
prerank,cellular response to organonitrogen compound (GO:0071417),0.3521720905484954,1.0640842723001875,0.3845327604726101,1.0,1.0,26/99,19.79%,P2RY2;SOX9;HRH1;AOC1;RAP1A;CPEB3;LAMTOR2;TSHR;BRCA1;AKAP6;HSP90B1;AHR;CPEB1;P2RY12;P2RY1;SSH1;JUP;GABRG2;SPAAR;RPTOR;TAF1;EGR1;RYR3;IPO5;HCN1;RRAGA
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.34836819518475703,-1.0637295492148662,0.37,0.8138464152487809,1.0,5/21,6.61%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.34836819518475703,-1.0637295492148662,0.37,0.8138464152487809,1.0,5/21,6.61%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,synapse organization (GO:0050808),0.3434766301920475,1.0634054015792778,0.3793466807165437,1.0,1.0,29/125,14.94%,ANK3;PDZRN3;LRP4;PTEN;SEMA3E;NRCAM;PSEN1;NRXN1;LRRC4C;OBSL1;NLGN1;APBB2;CACNB4;KIRREL3;NTNG1;SLC8A2;GPM6A;CNTN2;DSCAM;GRM5;PPFIA2;ADGRL3;DVL1;DRD2;GPC4;GPHN;SNCA;PTPRF;CYFIP1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.41291094344133883,-1.0633549771392663,0.39204545454545453,0.8130483886464335,1.0,9/11,26.73%,UQCRB;UQCR11;CYC1;UQCR10;UQCRH;UQCRFS1;UQCRC1;CYCS;UQCC3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49952626162376124,1.0630021308618505,0.41294298921417566,1.0,1.0,3/11,6.38%,ACVR1;TGFB1;TGFBR2
prerank,defense response to fungus (GO:0050832),0.46511012553731146,1.062234572377189,0.4220314735336195,1.0,1.0,5/17,26.37%,CARD9;BCL10;RARRES2;FAM3A;RNASE7
prerank,female gamete generation (GO:0007292),0.40860649088551326,1.0621729349081055,0.39095744680851063,1.0,1.0,11/29,23.39%,FMN2;GDF9;METTL3;DIAPH2;PRDM9;MDK;MARF1;KMT2D;SPO11;MEI4;TOB2
prerank,protein localization to phagophore assembly site (GO:0034497),0.4985977734473605,1.0619197289643956,0.4084507042253521,1.0,1.0,2/11,5.78%,PACS2;WIPI1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4536215241608663,1.0616241418869323,0.40802213001383125,1.0,1.0,6/18,14.33%,ADAM19;PSEN1;KLK6;NCSTN;APH1A;PSEN2
prerank,positive regulation of cellular respiration (GO:1901857),-0.4339685390729442,-1.0612148558876078,0.39634146341463417,0.8176770245665868,1.0,7/11,36.47%,NUPR1;IL10RB;PINK1;IFNAR1;VCP;IFNLR1;ISCU
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36853364742286066,1.061207583884766,0.39198218262806234,1.0,1.0,19/69,15.66%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;POLR2G;INTS8;ELL;GTF2E2;GTF2E1
prerank,detection of mechanical stimulus (GO:0050982),0.44253045615802816,1.0598258827677836,0.4190871369294606,1.0,1.0,4/19,15.41%,PIEZO2;LHFPL5;PKD1;JUP
prerank,snRNA transcription (GO:0009301),0.36745090706418154,1.0593275531598207,0.38666666666666666,1.0,1.0,19/70,15.66%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;POLR2G;INTS8;ELL;GTF2E2;GTF2E1
prerank,cobalamin metabolic process (GO:0009235),0.44923149462202705,1.0591972487970178,0.3968705547652916,1.0,1.0,5/17,17.07%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4815112880487638,1.0587128515458042,0.4134328358208955,1.0,1.0,5/12,25.70%,TIPIN;BLM;WRNIP1;KAT7;WDR18
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.26800988629994354,-1.0587036083628856,0.3548387096774194,0.8231825998724771,1.0,24/67,19.66%,CAPZB;PODXL;TBC1D8;MYO10;RAB5A;TBC1D14;PPP1R16B;TBC1D1;GAP43;TBC1D15;DCDC2;TBC1D13;DYNC2LI1;DYNLT2B;CDC42;RABEP2;CAV1;TBC1D10B;FXR2;TBC1D2;ABITRAM;TBC1D22B;TBC1D16;EPHA2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4769561377996876,1.058225374039228,0.40532544378698226,1.0,1.0,3/13,11.09%,CRLF1;TYK2;IL6ST
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5003701948996997,1.0579388209090188,0.4393939393939394,1.0,1.0,2/11,5.21%,CREB3L1;E2F2
prerank,peptidyl-serine modification (GO:0018209),0.3380493693598529,1.0579271312915348,0.3664278403275333,1.0,1.0,49/166,19.42%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;GALNT1;PDK3;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;GALNT13;PRKACA;CSNK1A1;HPF1;TTBK1;RPS6KA2;PKD1;GALNT3;ATM;CSNK1E;CSNK1G2;SGK1;CHUK;NAA10;POGLUT2;PKN2;VRK3;TAF1;CSNK2A2;CSNK1G3;CAB39;TOP1
prerank,circulatory system development (GO:0072359),0.34643840090722006,1.0578825153102924,0.3793466807165437,1.0,1.0,25/118,15.13%,HSPG2;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;FBXW7;TGFB1;NF1;FGF12;TGFBR2;PDLIM4;COL3A1;ERBB4;PTPN11;SMYD4;ZFPM2;KDM6A;LDB3;PKD1;CITED2;PKP2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3583403598370984,-1.05741348121433,0.3527397260273973,0.8252515388854939,1.0,4/16,9.62%,PLCB3;BMPR2;ACE;GSK3A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33211411111396144,1.0569492232698439,0.3751263902932255,1.0,1.0,52/260,15.42%,DYNLL1;PTPDC1;RHOD;RHO;WDPCP;GSN;STK36;RAP2B;CC2D2A;FGD4;MAP4K4;ANO6;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;EMP1;PCM1;TNIK;RILPL2;SNAP29;BBS9;RFX3;DISC1;GBF1;RAP1A;CPLANE1;BBS5;FLNA;PMP22;SPATA13;WDR35;ARF4;HDAC6;OPHN1;SNX10;RAB1A;CEP89;CFAP20;FBF1;TRAPPC14;P2RY12;CCDC28B;RAB11FIP3;PKD1;EHD2;CYFIP1;CCDC65;ITGB1;CDC14A
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.43302804993399163,-1.0569311313977259,0.4112676056338028,0.8247985573947784,1.0,4/10,16.66%,ABCA3;MTMR2;MTMR9;MFSD2A
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.40232777286905497,-1.056842572236627,0.3704819277108434,0.8232012555101355,1.0,3/12,2.81%,WAPL;CTNNB1;HDAC8
prerank,establishment of apical/basal cell polarity (GO:0035089),0.47331239550638343,1.0568106992101771,0.41509433962264153,1.0,1.0,6/14,16.83%,PATJ;MYO9A;OPHN1;SCRIB;FSCN1;FOXJ1
prerank,protein complex oligomerization (GO:0051259),0.35516407338089984,1.0567536921638645,0.3881081081081081,1.0,1.0,34/85,24.99%,PYCARD;LETM1;LRRC8D;CLDN1;CPSF6;MPP2;ALS2;CARD9;PRMT1;ATL3;ZBTB1;TMEM120A;YME1L1;NACC2;SNCA;PDCD6IP;OPA1;HOMER1;BLM;PNPT1;UGDH;SLC9A1;FUS;MS4A1;BCL10;ADCY8;MAT2A;PKD2;CARD11;KCNC1;G3BP2;ALAD;ATL1;CPSF7
prerank,skeletal muscle organ development (GO:0060538),-0.3245643483950206,-1.056638501941587,0.3562231759656652,0.8219957616100049,1.0,12/26,36.69%,MYL6;SIX1;STRA6;CAV1;CFLAR;LARGE1;MYH14;SIX4;FOXL2;MSC;MEF2C;FXR1
prerank,response to nitric oxide (GO:0071731),0.46966117083814696,1.0566294894501473,0.4110787172011662,1.0,1.0,2/13,4.84%,DPEP1;MT3
prerank,positive regulation of transport (GO:0051050),0.35440757752087354,1.0564532725044427,0.39933993399339934,1.0,1.0,6/85,3.06%,GPC3;SYNGR3;PYCARD;LRP1;C2CD5;KMT2A
prerank,myotube differentiation (GO:0014902),-0.3613241946502823,-1.0560235809451586,0.3630573248407643,0.8219519478787475,1.0,4/17,15.26%,IGF1;MYEF2;SORT1;NOS1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5121365668455625,1.0559631075701497,0.41479099678456594,1.0,1.0,5/11,19.41%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,cellular response to lipopolysaccharide (GO:0071222),0.34583514498126905,1.0558360233208604,0.39050701186623515,1.0,1.0,27/101,24.32%,CXCL10;PYCARD;PTPN22;TGFB1;PDE4B;WNT5A;IL18;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;VIM;CARD16;PRKCE;HCK
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.38155648119206287,1.0557557583136175,0.39855072463768115,1.0,1.0,6/46,6.82%,NTN4;PEAK1;LAMC1;MEGF9;NTNG2;NTNG1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.38048964221035303,-1.055723978204411,0.39285714285714285,0.8210524628596245,1.0,3/15,6.72%,ATP1A2;ATP1B3;ATP1A1
prerank,regulation of cellular component size (GO:0032535),0.40582112907323287,1.055646405246301,0.39690721649484534,1.0,1.0,13/30,23.94%,PTEN;PPP1R15A;RARG;VAV3;RAB22A;PPP1CA;RPTOR;PEX11A;RAB3B;RDX;HP1BP3;VAV2;MTOR
prerank,negative regulation of kinase activity (GO:0033673),0.3645403345736482,1.055240280614382,0.39215686274509803,1.0,1.0,16/62,18.76%,UBASH3B;IRS2;NPRL2;DEPTOR;NF1;SPRED1;DVL1;WWTR1;PRDX3;SNCA;TAF7;HNRNPU;PYDC1;DBNDD2;PPM1E;PARK7
prerank,regulation of microtubule-based process (GO:0032886),-0.30277041695376294,-1.0551815635760338,0.37037037037037035,0.820758764632363,1.0,12/36,12.62%,PHLDB2;MACF1;ROCK1;DIAPH1;EPHA3;TRIM36;KLHL42;GSK3B;PRKAA2;MARK2;MAPT;FAM107A
prerank,positive regulation of T cell activation (GO:0050870),0.36986416956097923,1.0547687400978458,0.3941109852774632,1.0,1.0,9/62,14.00%,PRKCQ;PYCARD;CCR2;ZMIZ1;IL6ST;RHOH;ZBTB1;GATA3;NCK1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.35152164273983355,-1.0546564083026,0.36231884057971014,0.8204489380009827,1.0,4/20,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,negative regulation of endocytosis (GO:0045806),0.41934578768759284,1.054627441751545,0.39280958721704395,1.0,1.0,3/24,9.97%,LGALS3;SYT11;MCTP1
prerank,RNA transport (GO:0050658),0.35888145744194927,1.054527797834307,0.40293453724604966,1.0,1.0,19/71,20.38%,RBFOX1;TST;THOC6;ATXN2;TGFBR2;NUP155;SRSF11;CASC3;NCBP1;KIF5C;CKAP5;SRSF6;POM121;PNPT1;NXF1;RNPS1;THOC7;SRRM1;ZFP36
prerank,potassium ion transmembrane transport (GO:0071805),0.3389468460356245,1.054487044611714,0.3918067226890756,1.0,1.0,34/135,22.90%,KCNK15;SLC1A3;KCNA2;KCNH8;SLC12A3;KCNK1;KCNA1;KCNA6;SLC12A2;KCND1;KCND2;KCND3;KCNT2;SLC12A4;KCNAB2;KCNJ3;KCNJ10;SLC9A5;KCNH2;SLC9A1;SLC24A4;SLC24A2;KCNA5;HCN1;KCNS3;KCNH7;KCNK10;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13
prerank,protein dephosphorylation (GO:0006470),0.34087414027255986,1.054486888190308,0.3786610878661088,1.0,1.0,30/135,14.80%,PTPRH;UBASH3B;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PPP1R15A;DUSP6;PTPN13;RPRD1A;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;DUSP11;PTPRJ;PTPN11;PPP1CA;PTPRA;PTPN18;PTPRZ1;PTPN21;PPP3CC;NCK1;SSH1;PTPRF
prerank,lipoprotein transport (GO:0042953),0.5071889170110143,1.0539386493223448,0.42342342342342343,1.0,1.0,6/10,25.41%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,ncRNA transcription (GO:0098781),0.46412592248514056,1.0538928727450756,0.41641337386018235,1.0,1.0,6/13,23.02%,SNAPC2;SPIN1;GTF3C1;NIFK;POLR1G;SNAPC3
prerank,autophagy of mitochondrion (GO:0000422),0.39258867124791436,1.0534277849049944,0.40296662546353523,1.0,1.0,8/38,14.97%,PRKN;FBXO7;WIPI1;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,dopamine metabolic process (GO:0042417),0.4455284177892423,1.0534096109469888,0.42043795620437957,1.0,1.0,6/18,13.89%,PRKN;COMT;DAO;DRD2;SNCA;LRTOMT
prerank,cilium assembly (GO:0060271),0.3274890089753442,1.0530320487066611,0.3525252525252525,1.0,1.0,56/297,15.65%,DYNLL1;PTPDC1;RHO;WDPCP;GSN;STK36;CC2D2A;CCDC39;RSPH1;HAUS3;CNTRL;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;NDE1;BBS9;RFX3;DISC1;SDCCAG8;GBF1;SPATA6;CPLANE1;BBS5;FLNA;CEP57;TRIP11;CFAP46;WDR35;CFAP74;CLASP1;ARF4;HDAC6;SNX10;RAB1A;CEP89;PRKACA;CFAP20;CKAP5;FBF1;TRAPPC14;CEP76;DYNC1I2;CCDC28B;RAB11FIP3;PKD1;EHD2;CCDC65;CDC14A;CSNK1E;IFT57
prerank,regulation of T cell mediated immunity (GO:0002709),0.507419586156613,1.052891293325439,0.4086687306501548,1.0,1.0,2/10,12.59%,CCR2;ZBTB1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.48244124788106996,1.0528741108435797,0.40294117647058825,1.0,1.0,5/12,15.41%,DSG2;CTNNA3;BIN1;PKP2;JUP
prerank,regulation of macromolecule metabolic process (GO:0060255),0.33470885253268345,1.0528502014207943,0.38699690402476783,1.0,1.0,42/170,20.80%,AFF3;MYC;DHH;HNRNPDL;C1D;PTHLH;TRIM44;PSEN1;RFXANK;HNRNPAB;RASA1;UBAP2;MKLN1;TRIM11;CDK6;SLC8A2;ZNF462;ANKRA2;HIF1A;ZFP64;PRDM9;GDNF;PCBP4;POGZ;ATRAID;EDN3;AHR;PRDM11;KDM6A;NOVA1;KHSRP;STX1B;ZUP1;APLNR;FUBP1;CGGBP1;MARF1;HMG20A;PRDM2;FUBP3;AFF1;SIRPA
prerank,neural crest cell development (GO:0014032),0.38373256322818533,1.0527898191411278,0.4004884004884005,1.0,1.0,10/44,14.85%,SOX8;SEMA3E;SEMA6C;SEMA3A;SOX11;ERBB4;GDNF;ANXA6;KLHL12;SEMA6D
prerank,regulation of pseudopodium assembly (GO:0031272),-0.4299946854624843,-1.05229308161421,0.38482384823848237,0.8239507013757755,1.0,4/10,13.32%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.4299946854624843,-1.05229308161421,0.38482384823848237,0.8239507013757755,1.0,4/10,13.32%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.31551149068131146,-1.052283097324694,0.3394495412844037,0.822158406789576,1.0,12/30,19.33%,ACVRL1;DACH1;BMPR2;XRN1;TERF2;DCP2;CERS1;PINX1;EXOSC10;TEN1;TINF2;TENT4B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4884092215634543,1.052104893191491,0.4252696456086287,1.0,1.0,1/11,1.09%,IL2RA
prerank,cellular response to interleukin-2 (GO:0071352),0.4884092215634543,1.052104893191491,0.4252696456086287,1.0,1.0,1/11,1.09%,IL2RA
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4313053254148146,1.051575744448345,0.40939597315436244,1.0,1.0,6/21,15.43%,PTEN;CNKSR3;MLXIPL;PDE4D;NCK1;RASSF2
prerank,positive regulation of phosphorylation (GO:0042327),0.32759179034505775,1.0514272329343677,0.38244197780020184,1.0,1.0,30/240,7.80%,ROR2;ROR1;CLDN19;PDGFRA;ERBB3;NTRK3;GLMN;FGF2;FGF10;ZBTB20;SOX9;EPHB6;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;TGFB1;PSEN1;NTRK2;MT3;TNIK;NIBAN1;PAK1;VAC14;MLXIPL;RALB;FZD7;FGFR1
prerank,negative regulation of response to wounding (GO:1903035),0.45098380832702417,1.0512764700103934,0.40902872777017785,1.0,1.0,2/19,1.27%,CLDN19;FGF2
prerank,protein localization to lysosome (GO:0061462),-0.311784194170625,-1.0510902778797313,0.3723849372384937,0.8239076364734501,1.0,14/28,32.73%,LMBRD1;M6PR;MFSD1;VPS4A;RNF128;KPTN;LAPTM5;SH3BP4;ATP13A2;SZT2;NAGPA;LAMTOR4;NEDD4;SORL1
prerank,positive regulation of lyase activity (GO:0051349),-0.3861602851353898,-1.050882594442324,0.375,0.8226629367743503,1.0,5/14,15.85%,CACNA1C;NOS3;STIM1;NOS1;FXN
prerank,neuron projection development (GO:0031175),0.3357580250836203,1.0505974825969204,0.38035527690700105,1.0,1.0,34/168,13.40%,CDNF;DOCK7;KIF20B;PTEN;NGF;PPP1R9A;MAP4K4;GAS7;ATXN10;EPHB2;GPM6B;PLP1;TNIK;NYAP1;NLGN1;PAK1;ALS2;DOCK10;CNTNAP2;GPM6A;EPB41L3;VAPA;GDNF;DCLK1;PRMT1;DIP2A;BMP7;OPHN1;STMN4;TAOK3;CDK5R1;MYOC;CDK16;TRIO
prerank,secondary alcohol metabolic process (GO:1902652),0.3846135456394582,1.0503940668181742,0.41169590643274856,1.0,1.0,8/42,14.44%,IDH2;SQLE;GBA2;OSBPL5;IDH3B;ABCA5;CYP27A1;IDH3A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.40969163763814753,1.0501699288198818,0.43281653746770027,1.0,1.0,3/28,3.89%,PTEN;PRKN;FBXW7
prerank,cilium organization (GO:0044782),0.33178587858776115,1.050071779149216,0.39263803680981596,1.0,1.0,39/210,15.58%,DYNLL1;PTPDC1;RHO;WDPCP;GSN;STK36;CC2D2A;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;BBS9;RFX3;DISC1;GBF1;CPLANE1;BBS5;FLNA;WDR35;ARF4;HDAC6;SNX10;RAB1A;CEP89;CFAP20;FBF1;TRAPPC14;CCDC28B;RAB11FIP3;PKD1;EHD2;CCDC65;CDC14A;CFAP61
prerank,positive regulation of secretion by cell (GO:1903532),-0.2553456656745961,-1.0496917752897426,0.3391304347826087,0.8244426843369314,1.0,22/70,19.65%,BMP6;IGF1;RAB5A;DTNBP1;EXOC1;PPIA;RGCC;GRK2;ABCG1;UNC13B;RAB9A;KCNB1;APBB1;SYTL4;TGFB2;MYH10;ATP6AP1;STX1A;EDN1;DNM1L;GPER1;BAIAP3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.323937655115405,1.0494277681313429,0.358,1.0,1.0,91/417,17.68%,NKX6-2;MDFIC;TSHZ3;SCML4;CREB3L1;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;NAB1;VGLL4;SUV39H1;HOXA7;KDM8;TLE1;FOXP2;TGFB1;GATAD2A;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;EED;CIPC;RFX3;ZBTB16;MLXIPL;MLX;TWIST2;LOXL3;CBFA2T3;KAT8;GATA6;CBX4;ZC3H8;MEN1;FOXM1;KCTD1;BRCA1;MBD2;CRYAB;DKK3;LANCL2;SNX6;HDAC2;ZBTB38;MBTD1;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;JARID2;ZGPAT;PATZ1;XRCC6;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;SUMO1;CRY1;NCOR2;CITED2;TAF7;TP53;SP3;MTA3;NDUFA13;EIF4A2;PAX2;SMARCE1;CCDC85B;HEYL;CTBP1;SFMBT2
prerank,regulation of DNA binding (GO:0051101),-0.2900808224979951,-1.04941308606261,0.3576158940397351,0.82346475482974,1.0,20/44,24.40%,IGF1;SP100;LEF1;NFKBIA;KDM1A;HABP4;DOT1L;MDFI;SUMO3;HMGA2;NME1;CEBPG;TFAP4;HMGB2;TXN;CSNK2B;EGF;E2F1;PLAUR;MAPK8
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3676641299692683,-1.0492291022370075,0.4013605442176871,0.8222316628332362,1.0,4/16,7.52%,RANBP3L;BOC;IGFBP3;AKIRIN1
prerank,Notch signaling involved in heart development (GO:0061314),-0.4176740511136766,-1.0490285341483545,0.4011627906976744,0.8209648904816071,1.0,3/11,15.30%,NOTCH2;JAG1;HEY2
prerank,response to lipid (GO:0033993),-0.23549311455000316,-1.0488501813935414,0.2638888888888889,0.8197475153227165,1.0,16/105,7.39%,FOXP1;SMAD6;CTSH;RBP4;CTNNB1;PAQR7;NOS3;ACER2;NOCT;TLR4;PPARD;OTUD5;STAT5B;ALPL;LIAS;TNFRSF11A
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.34534062405314275,-1.048772572658488,0.35094339622641507,0.8181974439807396,1.0,5/21,6.07%,ROCK2;ROCK1;ERRFI1;BMP4;ZFP36L1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.36679758923293715,-1.0487070578756532,0.3680555555555556,0.8166298483480138,1.0,9/17,25.06%,COX7B;COX6B1;COX6A1;COX4I1;COX7C;COX5B;COX5A;COX6C;CYCS
prerank,snRNA processing (GO:0016180),0.4630946180384865,1.048621241020595,0.42134831460674155,1.0,1.0,5/16,13.91%,INTS11;INTS6;INTS4;INTS2;INTS8
prerank,positive regulation of cell migration (GO:0030335),0.3300530091073385,1.0483926609791938,0.3838383838383838,1.0,1.0,47/253,15.48%,ROR2;CCL11;PRKCA;LGR6;PDGFRA;GLIPR2;HAS2;NTRK3;FGF10;KIF20B;SEMA3E;RHOD;SOX9;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;DOCK5;CCR2;PAK1;FAM83H;TWIST2;PPP3CA;SMO;TRIP6;DOCK1;HIF1A;CLASP1;HDAC6;GRN;RHOC;MYOC;SOD2;RTN4;SPAG9;ELP5;COL1A1;SEMA6D;WASHC1;PLAA;ITGB1;ATM
prerank,glucose import (GO:0046323),0.4744536551270442,1.0483748362366776,0.41262848751835535,1.0,1.0,3/13,12.41%,SLC27A1;SLC27A4;RAB4B
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3612953166997597,1.0477132891181926,0.4188422247446084,1.0,1.0,15/68,20.89%,IL16;PYCARD;WNT5A;TMEM106A;CARD9;TLR1;PTPN11;IL33;CD74;RAB7B;LBP;SETD4;BCL10;STAT3;HSPD1
prerank,"phagocytosis, engulfment (GO:0006911)",0.4002999470543697,1.0471876871761958,0.4156171284634761,1.0,1.0,4/36,2.81%,XKR7;GULP1;GSN;XKR8
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4523040213364416,1.0471020487856226,0.3974358974358974,1.0,1.0,3/16,12.73%,AP1G1;CADM1;NECTIN2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.35078771228596106,-1.0468241032826935,0.3835125448028674,0.8207126606344215,1.0,9/19,22.04%,XRN1;TERF2;DCP2;PINX1;EXOSC10;TEN1;TINF2;TENT4B;HNRNPA1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.37962425974831904,1.0468238631149447,0.4128329297820823,1.0,1.0,6/44,8.10%,CCL11;PYCARD;SPIRE1;GSN;BAIAP2;BIN1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.476619992418738,1.0467289013206285,0.42201834862385323,1.0,1.0,2/12,7.77%,GFPT2;CSGALNACT1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.47065846644137344,1.0465832987038264,0.43010752688172044,1.0,1.0,2/13,9.75%,CADM4;PTPN1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.24144029771465875,-1.0460582233836613,0.2875,0.8213400163140518,1.0,18/102,9.75%,SORBS1;TBC1D4;ADCY9;SLC30A10;PRKCD;RAB31;PRKAR1A;PRKCI;INSR;LPIN2;ZFP36L1;PARP1;SLC25A33;RHOQ;RPS6KB1;GSK3A;ADCY4;INSIG2
prerank,negative regulation of synaptic transmission (GO:0050805),0.4201785112884145,1.0458556877000533,0.44086021505376344,1.0,1.0,5/23,12.69%,PTEN;GRIK3;PNKD;SYT11;DRD2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.33467189559754007,1.045521323617986,0.40145228215767637,1.0,1.0,36/150,19.28%,PDGFRA;ERBB3;FGF2;FGF10;IRS2;ERBB2;EGFR;THEM4;TGFB1;FGFR1;IL18;FYN;GAB2;HIP1;BTC;ERBB4;PIK3R1;PTPRJ;ESR1;PTPN11;MYDGF;FGF7;MYOC;STRN;GATA3;P2RY12;RTN4;MET;ITGB1;GAB1;LRP2;HBEGF;PARK7;AXL;GRB2;CPNE1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3495210079304195,-1.0453805882614167,0.3977272727272727,0.8215837790975103,1.0,5/20,4.03%,ACVRL1;BMP4;ENG;TBX3;TGFBR1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3318082559042156,1.045237892907797,0.40122824974411464,1.0,1.0,37/193,16.12%,PDGFRA;ERBB3;NTRK3;FGF2;FGF10;PTEN;IRS2;ERBB2;EGFR;THEM4;TGFB1;NTRK2;FGFR1;IL18;FYN;GAB2;HIP1;BTC;RCN3;ERBB4;PIK3R1;PTPRJ;ESR1;PTPN11;MAGI2;MYDGF;FGF7;MYOC;DRD2;STRN;GATA3;P2RY12;RTN4;MET;ITGB1;GAB1;LRP2
prerank,regulation of telomerase activity (GO:0051972),0.3768381110051208,1.0451962987160188,0.39492753623188404,1.0,1.0,11/45,16.25%,PRKCQ;MYC;ERCC4;MEN1;PARM1;MAPK1;NEK7;MAP3K4;ATM;TP53;SMG6
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3798517268569168,-1.0449738237700792,0.4101796407185629,0.8210519343064844,1.0,3/14,7.52%,IL34;THBS1;AKIRIN1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.38468939802659635,1.0448548374364166,0.4036363636363636,1.0,1.0,9/39,13.38%,ERBB2;EGFR;PTPN2;EPS15;BTC;PTPRJ;CBL;PTPN18;SH3KBP1
prerank,organic hydroxy compound transport (GO:0015850),0.3885526873458639,1.0446297072070612,0.4200743494423792,1.0,1.0,7/36,14.49%,ATP8B1;NCOA1;SLC5A3;SLCO2B1;NCOA2;SLC16A1;SLC10A1
prerank,ventricular septum morphogenesis (GO:0060412),-0.31010912925778544,-1.0441415724959608,0.39111111111111113,0.8217513219686093,1.0,6/27,4.03%,ROBO1;SMAD7;BMP4;BMPR2;SLIT2;TGFBR1
prerank,regulation of protein dephosphorylation (GO:0035304),0.38471162827286076,1.0441023905896294,0.4086845466155811,1.0,1.0,11/37,18.46%,DLC1;TGFB1;PPP1R15A;TSC1;ENSA;PPP1R8;HSP90B1;CALM1;CALM2;TIPRL;HTT
prerank,cardiac muscle cell contraction (GO:0086003),0.4426288673316538,1.0440979553541498,0.41422594142259417,1.0,1.0,4/19,6.08%,CACNA2D1;GSN;SCN5A;FGF12
prerank,modulation by host of viral genome replication (GO:0044827),0.47626446713665077,1.0440249181482488,0.41140215716486905,1.0,1.0,4/13,13.56%,PRKN;VAPA;FBXL2;TBC1D20
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.41832786277225653,1.0437997807821413,0.41688654353562005,1.0,1.0,4/25,7.73%,HRK;PYCARD;BMF;BNIP3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5070461686661115,1.0436340278443554,0.4717607973421927,1.0,1.0,3/10,9.18%,CCR2;WNT5A;STK39
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2172185294064644,-1.0432048358821546,0.3333333333333333,0.8226656650044979,1.0,125/306,28.00%,THRB;RPS14;POLD3;GSPT1;RPL24;RRAGC;DRG1;RPL18A;RECQL5;RPS16;ALAS1;GTPBP2;RPL38;RPL28;RPS19;CREBL2;RPL37;MMS19;RPS2;SARS1;MRPL10;GTPBP1;RPL19;RPL5;RPL34;PTMS;RPS25;RPS15;POLA1;PWP1;TNIP1;EEF1G;MCM6;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;RMI1;EEF1A1;RPS6;HELB;RPS8;HUS1;MED20;EIF4EBP2;RPL11;RPL12;INHBA;ORC6;CDK2;RPS6KB2;TSFM;POLA2;TERT;RPL7A;RPL13;BAZ2A;POLR2C;EEF1B2;CLSPN;CDC7;MRPS7;KAT5;NT5M;DTX1;COPS5;MRPL43;IGF2BP3;APOE;YARS2;RPS21;RPL35A;DONSON;POLR2E;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RNASEH2A;LARGE1;RPS23;RPLP2;MRPS11;POLR2J;XAB2;DNA2;PTMA;GAL3ST2;POLR2D;RPL8;MRPS16;NBN;RFC3;TIMELESS;RSL24D1;ING5;E2F1;RPL41;TOP1MT;RPS17;RAD9B;DHPS;RPS5;RPS15A;THAP1;RPL37A;INHA;RPS10;MRPL55;POLD2;TBRG1;RPL6;WARS1;RPL9;MCM8;RAD9A;RPS27;RMI2;MRE11;CDC45;MRPL36
prerank,microtubule polymerization (GO:0046785),0.40511195143329914,1.0431786098131175,0.4046997389033943,1.0,1.0,7/29,13.07%,FGF13;CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2;CKAP5
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.2986592161712263,-1.0430175434079656,0.35294117647058826,0.821432259068872,1.0,8/33,12.07%,CDH5;TEK;ANGPT1;KDR;ICAM1;NUPR1;GATA2;SERPINE1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.36657878056080334,1.042965335577827,0.3947065592635213,1.0,1.0,12/54,16.74%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;SDC4;GPC1;SDC3;GPC4;IDS;HS2ST1;UGDH
prerank,negative regulation of histone methylation (GO:0031061),0.4933919346666046,1.0429053647110846,0.4211332312404288,1.0,1.0,3/10,12.25%,AASS;BRCA1;JARID2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.40840634703966827,1.0428991018692488,0.4027027027027027,1.0,1.0,3/27,8.08%,CSTF3;RNASE6;ZC3H12B
prerank,regulation of cell communication (GO:0010646),-0.30158037350687017,-1.0428563018862906,0.36312849162011174,0.8200944188518373,1.0,8/35,11.22%,GRK5;IGFBP7;CXADR;SCG5;GRK4;GRK2;MGLL;UGCG
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.32596636615459235,1.0428544214533284,0.4030456852791878,1.0,1.0,60/248,19.45%,GPC3;WNK2;TPBGL;LGR6;PLEKHA4;RBMS3;LRP4;FGF10;SOX9;PRKN;EGFR;FRZB;JADE1;GPRC5B;TLE1;TGFB1;PSEN1;GLI1;WNT5A;LGR5;FZD7;OTULIN;FAM53B;PPM1B;PSMB7;DKK3;CUL3;DAAM2;SFRP4;TMEM131L;EMD;PRICKLE1;PPP1CA;APC2;DVL1;CSNK1G1;WWTR1;CSNK1A1;KLHL12;COL1A1;PSMD2;ZEB2;SCYL2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;CSNK1G3;KANK1;NKD2;PSME4
prerank,peptidyl-proline modification (GO:0018208),-0.31913296931804996,-1.0424737230514212,0.3650190114068441,0.8194905060615455,1.0,6/25,8.48%,PPIC;PPIL2;OGFOD1;CWC27;PPIA;NTMT1
prerank,protein-containing complex assembly (GO:0065003),0.3268059475504396,1.0422733331952903,0.4084507042253521,1.0,1.0,77/259,23.01%,SEC16B;MYC;REPS2;SOX9;GORASP1;LAMC1;FADD;GRIA1;WIPF1;ANKRD28;EPRS1;KMT2A;SEC24D;ANO6;TLE1;CLDN1;TRAPPC6B;MEN1;PPID;TMED10;MAGI1;SEC24C;BCL9L;CUL3;FARP2;RIMS1;FANCC;BCL9;RAB1A;WASF1;CSNK1A1;KLHL12;TBC1D20;DET1;TMED2;MDM4;SEC23IP;OPA1;TRRAP;TRAPPC6A;NIFK;BLM;TP53;LPXN;PYGO1;PPIH;IL1RAP;TLE3;CD74;RIPK1;CDC73;SLC9A1;CNIH3;TLE4;RSPH9;SEC24A;MDM2;ASH2L;SKAP2;TRAPPC3;KPNA3;ADCY8;SMARCA4;NAPG;KMT2D;PEF1;TRAPPC2L;MITF;PYGO2;P2RX7;LMAN1;LLGL1;DLG4;SH3PXD2B;ELOB;KIFAP3;WASF3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4333419334498226,1.042110257639004,0.4301675977653631,1.0,1.0,3/21,6.93%,MMP2;FGF2;ADAMTS1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4545959714451766,1.0420570410608962,0.41354466858789624,1.0,1.0,2/16,1.47%,FGF2;MYC
prerank,negative regulation of protein depolymerization (GO:1901880),0.4182491965269264,1.0420145496682112,0.42105263157894735,1.0,1.0,12/24,27.16%,FGF13;CLASP1;APC2;PLEKHH2;KATNB1;NAV3;ATXN7;CAMSAP1;TAOK1;CIB1;APC;PIK3CA
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4826495053674929,1.041898439191981,0.4332344213649852,1.0,1.0,1/11,0.52%,BMP5
prerank,cAMP biosynthetic process (GO:0006171),-0.4304070231615382,-1.0418315399890863,0.42329545454545453,0.8195802148322036,1.0,3/10,18.27%,ADCY9;ADCY4;ADCY3
prerank,mRNA catabolic process (GO:0006402),0.3773013456538844,1.0418261126895638,0.42193087008343266,1.0,1.0,9/44,11.47%,DHX34;DXO;METTL3;XRN2;TUT4;MRTO4;ZFP36L2;NBAS;UPF1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.47829999779367266,1.0417730711436237,0.44613050075872535,1.0,1.0,8/12,26.01%,METTL3;BRCA1;CDYL;YTHDC1;HNRNPU;LRIF1;SMCHD1;RBM15
prerank,endoderm formation (GO:0001706),0.38765268234105205,1.0417481376354527,0.40875,1.0,1.0,5/35,9.87%,MMP2;DUSP4;COL4A2;MMP15;SETD2
prerank,glycolipid metabolic process (GO:0006664),0.3793690358163483,1.0417065705008592,0.41433778857837184,1.0,1.0,8/47,9.90%,ST3GAL4;PGAP1;GBA2;NAGA;GM2A;ST6GALNAC6;SCCPDH;GALC
prerank,DNA duplex unwinding (GO:0032508),0.3779571201291459,1.0416319609056965,0.4280618311533888,1.0,1.0,12/50,17.24%,DDX11;RAD23B;GTF2H2;DDB2;XPA;MCM4;DDB1;RTEL1;UBB;BLM;CUL4B;WRN
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.24732399379070474,-1.041550541133756,0.35714285714285715,0.8187595754746428,1.0,29/91,20.45%,BMP6;ABCG2;SLC30A10;SLC31A1;FLVCR1;ATP7A;FBXL5;ATP6V0D1;APP;SLC31A2;SLC40A1;FTH1;SLC39A8;FTL;SLC39A6;SLC30A1;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC39A10;SLC22A17;ACO1;ABCB7;HFE;TMEM199
prerank,regulation of autophagosome maturation (GO:1901096),-0.3941581292692201,-1.0414370880840953,0.39,0.8174103591236003,1.0,6/13,22.32%,IRGM;TBC1D25;UVRAG;SMCR8;RUBCN;ADRB2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4982955851480715,1.0414000941969386,0.4416796267496112,1.0,1.0,2/11,15.48%,CBFB;RUNX1
prerank,cholesterol metabolic process (GO:0008203),0.3626558183962051,1.0411356419613826,0.41731409544950054,1.0,1.0,9/68,10.88%,CEL;HSD17B7;SQLE;GBA2;MT3;OSBPL5;IDI1;ACLY;ABCA5
prerank,cellular response to chemical stress (GO:0062197),0.34923847281614173,1.041057256222833,0.41431670281995664,1.0,1.0,25/96,18.84%,PRDX6;SRXN1;LRRC8D;NCF1;MT3;NOX1;GPX3;MGAT3;NCF2;SELENOS;NFE2L2;FANCC;PRDX3;SOD2;SNCA;ATM;ABL1;VKORC1L1;RAD52;PNPT1;SLC25A24;TXNRD1;CAT;PARK7;ERMP1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.47232551781404203,1.040616825395977,0.4170471841704718,1.0,1.0,5/13,22.13%,MBD4;NEIL1;SMUG1;NT5C;TDG
prerank,monosaccharide transmembrane transport (GO:0015749),0.4474956725100764,1.0405108166640014,0.4317862165963432,1.0,1.0,3/16,10.56%,SLC5A3;SLC50A1;SLC2A2
prerank,regulation of peptide hormone secretion (GO:0090276),0.35598342843941017,1.04030070591876,0.39485458612975394,1.0,1.0,10/67,10.56%,PRKCA;CACNA1E;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA;PASK;HTR2C;SLC2A2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3616490837658414,-1.0402107313037268,0.3938356164383562,0.8192736614518786,1.0,6/17,14.57%,ATP5MC3;ATP5PD;STOML2;VPS9D1;ATP5F1D;ATP5MF
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.38724303849317127,-1.03991797015985,0.4294117647058823,0.8184565080432844,1.0,6/13,21.70%,SOX13;SIX1;PTGS2;RREB1;VSTM2A;ZBTB7B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.33547598513605836,1.03908677818892,0.4166666666666667,1.0,1.0,30/129,19.45%,GPC3;WNK2;LGR6;PLEKHA4;FGF10;EGFR;GPRC5B;TGFB1;LGR5;FAM53B;PPM1B;PSMB7;DAAM2;SFRP4;CSNK1G1;COL1A1;PSMD2;ZEB2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;PSMB2;PSMD9;CSNK1G3;KANK1;PSME4
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.38740027343761485,1.0387597176271284,0.43647798742138366,1.0,1.0,5/37,10.01%,DYNLL1;IFT140;PCM1;TRIP11;WDR35
prerank,regulation of cell death (GO:0010941),0.34762546712835596,1.0387448991049746,0.4265658747300216,1.0,1.0,20/94,16.37%,FGF2;OLFM4;PRKN;LRP1;SOX11;MT3;TSC1;BNIP3;ATG5;PACRG;CRYAB;DCC;EIF4G1;BMP7;TBK1;SNCA;NCK1;SRSF6;UBB;SLC25A24
prerank,regulation of microtubule-based movement (GO:0060632),-0.41249312992517406,-1.038615499781939,0.4101123595505618,0.8207585648772593,1.0,5/11,15.59%,MAP2;LAMP1;DYNLT2B;NEFH;IGBP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3414312792381955,1.0383514980844517,0.41658031088082903,1.0,1.0,19/121,11.99%,RELN;ERBB3;FGF10;CRLF1;ACVR1;EFNA5;VEGFA;GPRC5B;TGFB1;TEC;PRNP;IL18;PTPN1;GRM5;ERBB4;PTPRJ;PTPN11;IL6ST;FGF7
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.37045561485193607,1.0381749000153022,0.41504854368932037,1.0,1.0,12/49,20.48%,PRKCQ;CBFB;KAT2B;KMT2A;EIF6;MTURN;PRMT1;RUNX1;RAB7B;ASH2L;KMT2E;KMT2D
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.40588084763825544,1.0381275779693961,0.4263157894736842,1.0,1.0,8/27,15.54%,ANK2;HPCA;JPH3;CACNB4;PDE4D;PRKACA;CALM1;CALM2
prerank,positive regulation of apoptotic process (GO:0043065),0.32352142477398055,1.0379885902372408,0.41146881287726356,1.0,1.0,71/293,18.00%,DLC1;HRK;FAP;PIP5KL1;PYCARD;NGF;AKAP13;FADD;FRZB;FGD4;ANO6;TNFRSF10B;PSEN1;SLC27A4;FANK1;PRNP;NF1;DUSP6;ACVR1C;APAF1;BMF;ITSN1;CYP1B1;SHQ1;PHLDA1;BNIP3;BIN1;ARHGEF11;RARG;VAV3;PPID;UBE2Z;SFRP4;NGFR;NCSTN;ARL6IP5;ING4;CDK5R1;GRN;APH1A;SCRIB;TRIO;PRDM11;ARHGEF3;SNCA;RPS6KA2;PSEN2;ITGB3BP;TRAF7;UBB;ITGB1;CASP2;CRADD;RASSF2;ATM;FZD9;ABL1;TP53;BCL2L11;GPLD1;TGFB3;QRICH1;ARHGEF4;RIPK1;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;CSRNP3;AIFM1;DNAJA1
prerank,positive regulation of chemotaxis (GO:0050921),0.3815951872697533,1.0378701736372289,0.42039800995024873,1.0,1.0,10/43,15.00%,NTRK3;FGF2;VEGFA;TGFB1;CCR2;DSCAM;EDN3;SMOC2;P2RY12;MET
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3609945019188024,1.0377942852725548,0.4215456674473068,1.0,1.0,18/66,19.13%,FGF10;PTEN;CDKN2B;EGFR;UBE2E2;JADE1;PLCB1;ADAMTS1;CDK6;EIF4G1;PKD1;DACT1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX
prerank,protein import into mitochondrial matrix (GO:0030150),-0.35512811951405565,-1.0376722443801325,0.38782051282051283,0.8218574386862918,1.0,9/18,29.31%,TOMM70;TIMM23;DNAJC15;TIMM17A;ROMO1;GRPEL1;DNLZ;TOMM40L;TOMM40
prerank,cellular response to lipid (GO:0071396),0.32718098592614875,1.037503921411789,0.4246153846153846,1.0,1.0,43/191,21.39%,RORA;SSTR1;CXCL10;PYCARD;SOX9;EGFR;PDE4B;WNT5A;URI1;RORC;PDK3;FZD7;SELENOS;ESR1;MAPK14;TRIM41;PID1;UPF1;NRIP1;GNAI1;SHPK;AHR;LCOR;TICAM1;PLAA;ATM;GPLD1;NDUFA13;PAX2;CDC73;NCOA3;LBP;FAM210B;AXL;RUVBL2;PDCD4;BCL10;UBE2L3;ADCY8;ZFP36;SIRPA;NFKB1;TNIP2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4249510004712225,-1.037489671999009,0.3960674157303371,0.8189674304408825,1.0,3/10,8.81%,MAP2K5;WNK1;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4249510004712225,-1.037489671999009,0.3960674157303371,0.8189674304408825,1.0,3/10,8.81%,MAP2K5;WNK1;KLF4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3876838528916423,1.0374780428943648,0.4145141451414514,1.0,1.0,11/37,19.70%,MMP2;FGF2;PTEN;ADAMTS1;SOD2;BMPR1A;TGFB3;TAFA5;PDCD4;PPARG;JUN
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3167384803799792,1.0372548023480823,0.294,1.0,1.0,351/1645,20.36%,EBF2;RORA;OSR2;FAM47E;ETV1;MLF2;SOX6;NKX6-2;EFEMP1;KLF15;MDFIC;MEOX1;EBF4;ETV4;MEOX2;TSHZ3;PRKCQ;SCML4;LHX5;TLX3;GLI2;CREB3L1;RCOR2;FGF2;IFRD1;SOX8;PRDM16;CRLF3;MYC;DMRT2;TGIF2;ATP8B1;RGMB;EBF1;CBFB;HOXB8;ZNF25;ZBTB20;SOX9;SSBP2;NAB1;VGLL4;ERBB2;NCOA1;EGFR;SUV39H1;HIVEP1;ACVR1;ZBTB37;HOXA7;KMT2A;SATB1;VEGFA;CCNC;TFCP2;EGR3;WAC;KDM8;RPS6KA4;NFX1;TRIM44;TLE1;ZNF326;FOXP2;KDM5B;GTF2H2;TGFB1;BAZ1A;RFX2;GATAD2A;PSEN1;FANK1;NCF1;SOX11;NUPR2;MED31;SETD3;BICRAL;RFXANK;ZNF276;RNF6;MT3;PLCB1;MBD1;GLI1;RAI1;E2F2;ATF7IP;ZEB1;PHOX2A;CXXC1;NOP2;WNT5A;HOXD3;PGBD1;URI1;EED;HNRNPAB;CIPC;PKN1;APBB2;ZFP14;RFX3;ZBTB16;MAMLD1;RORC;MLXIPL;MLX;TRPS1;CREB3L2;TADA1;TAF5L;TWIST2;DRAP1;PPP3CB;LOXL3;DYRK1B;NAA16;E2F6;CBFA2T3;FZD7;KAT8;LRRFIP1;GATA6;CBX4;ZC3H8;TBX18;MEN1;BICRA;FOXM1;ZSCAN20;CHD3;SPIN1;MKX;ZBTB41;ATMIN;CDK15;ARHGEF11;ATRX;KCTD1;TFAM;PPP1R13L;BRCA1;MBD2;SOX12;SOX5;CRYAB;CARM1;ZMIZ1;NCOA2;POLR2K;DKK3;ZNF569;BBX;LANCL2;KLF5;REXO4;HIF1A;DBX2;PIAS2;ARID4B;ZBTB6;CHD2;SNX6;HDAC2;ERBB4;ZSCAN26;ZBTB38;MBTD1;MED13;NFATC3;ELP2;HINT1;ZNF260;PSIP1;ATF2;ZKSCAN8;PHF20;ESR1;NFE2L2;MAPK14;MYT1;LIN9;SMARCC2;SP1;ZNF112;SFPQ;HDAC6;RBAK;NSD2;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;FGF7;ZFHX4;L3MBTL4;EPC1;RHOH;PHF8;DVL1;JARID2;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;WWTR1;SETD5;XRCC6;EID2B;SOD2;ZFPM2;ATF5;CDK16;PER1;SCML2;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;PRDM11;SMARCC1;BAZ2B;ELP4;NACC2;ORC1;TGFBRAP1;PAX3;LCOR;ZFHX2;MDM4;HIVEP3;SUMO1;PCBD2;CRY1;NCOR2;COL1A1;BAZ1B;CITED2;TAF7;CREM;MED12;SLTM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;TRRAP;ABL1;MEIS3;PIM2;PURG;MSL3;KLF9;BLM;MED21;TP53;ZFX;LCORL;SP3;PHF19;KCNH2;ZXDB;MTA3;HTATIP2;TGFB3;NDUFA13;SREBF2;RNF111;TERF2IP;ING1;QRICH1;USP21;NFIA;FOXJ1;PAX2;CD74;RNF10;SMARCE1;CHUK;NFIX;CCDC85B;ZKSCAN1;HEYL;NR5A1;CTBP1;PCID2;SFMBT2;CSRNP3;SUFU;TCEA2;MLF1;FBXO5;FUS;APBB3;KLF16;MDM2;IRF3;MED30;ELOC;ZNF496;EPC2;EID2;KLF7;ZMYND11;NAA15;AATF;RNF4;MAPRE3;PSMD9;RFX7;BATF;POLR2A;KMT2E;EGR1;PHC2;MED8;RUVBL2;HMG20A;CNBP;PDCD4;BCL10;PRRX1;BCOR;UBE2L3;FOXJ3;PPARG;JUN;STAT3;PRDM2;YEATS2;ONECUT2;PHB2;POLR3G;TFE3;HP1BP3;CTDSP1;SMARCA4;JDP2;BBS7;USP13;FUBP3
prerank,angiogenesis involved in wound healing (GO:0060055),0.4910475968086902,1.037160799293537,0.43684992570579495,1.0,1.0,2/11,3.14%,CD34;VEGFA
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3125477886551659,-1.0371420459762148,0.35807860262008734,0.818189737803501,1.0,15/31,24.40%,PPP1R13B;YWHAQ;GSK3B;CASP8;GSK3A;TFDP2;BID;HIP1R;BOK;NMT1;BBC3;E2F1;BAK1;PPP3R1;MAPK8
prerank,GPI anchor metabolic process (GO:0006505),0.41902160596560023,1.0371303723360448,0.4397905759162304,1.0,1.0,9/26,19.95%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;GPLD1;DPM1;PIGO
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.47711359686364674,1.0365720391222548,0.4339622641509434,1.0,1.0,2/12,7.90%,CARD9;IL18
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.437829493116413,1.0362670402181111,0.42921013412816694,1.0,1.0,6/18,17.21%,EGFR;TGFB1;ESR1;NCOR2;TP53;RIPK1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.42918367370770555,1.0360721146860294,0.4190871369294606,1.0,1.0,10/21,26.32%,FGF13;CLASP1;APC2;KATNB1;NAV3;ATXN7;CAMSAP1;TAOK1;CIB1;APC
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4303759998983702,-1.0358159648278795,0.42136498516320475,0.8204055882452117,1.0,4/10,12.21%,ATP5MC3;ATP5PD;VPS9D1;ATP5F1D
prerank,regulation of amyloid-beta formation (GO:1902003),-0.292763117133218,-1.0357937783796365,0.4105263157894737,0.8187626152017844,1.0,4/34,1.73%,EPHA4;IGF1;ROCK2;ROCK1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.34555150439875965,1.0356988814842187,0.4250269687162891,1.0,1.0,24/92,16.48%,PRKCA;GLIPR2;EPB41L4B;FGF2;FGF10;SOX9;MAP4K4;VEGFA;DOCK5;WNT5A;DOCK1;HIF1A;SPARC;CLASP1;HDAC6;FGF7;NRP2;GRN;GATA3;SMOC2;RTN4;ABL1;GPLD1;HYAL1
prerank,synapse assembly (GO:0007416),0.35399574706896025,1.0355462149259624,0.425,1.0,1.0,17/67,16.30%,FGF13;PTEN;NRCAM;NRXN1;GRID2;WNT5A;OBSL1;NLGN1;KIRREL3;GPM6A;DSCAM;ADGRL3;DVL1;DRD2;GABRG2;CBLN4;LRRTM3
prerank,regulation of cell morphogenesis (GO:0022604),0.39816567270570896,1.0353625943034785,0.4112271540469974,1.0,1.0,9/30,11.82%,EFNA5;FMNL2;NTNG2;NTNG1;PDZD8;SPARC;BCL9L;MYO9A;ZMYM6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3644982256165678,-1.0351856608871195,0.3864406779661017,0.8189372788612327,1.0,4/17,9.23%,TLR4;BACH2;CD55;JAG1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.36366001469589976,1.0347913105187359,0.42,1.0,1.0,19/56,28.10%,ALPK1;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;UBB;LBP;TAB3;BCL10;RPS6KA3;TAB2;IRAK2;IRAK1;TRAF6;TAB1;CTSL
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.49123858729604014,1.034390718451383,0.4279141104294479,1.0,1.0,3/11,18.76%,GSN;PIH1D1;PARK7
prerank,regulation of glucose transmembrane transport (GO:0010827),0.43773032653785965,1.0340291240562847,0.43380281690140843,1.0,1.0,2/18,2.59%,FFAR4;C2CD5
prerank,regulation of cellular catabolic process (GO:0031329),-0.2668946595021391,-1.0339563962887386,0.3798449612403101,0.820830477955365,1.0,21/62,20.00%,DAPK1;ITPR1;ROCK1;ACER2;RRAGC;ABL2;LONP2;DAPK2;NUPR1;KEAP1;RAB8A;MAPT;RMC1;DRAM2;PIP4K2B;BOK;OSBPL7;SMCR8;HSPB1;GPR137;RRAGB
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.40324673007908374,-1.0336367944450175,0.40782122905027934,0.820091560917808,1.0,4/12,10.96%,PTPN14;BMP4;IFI27;NUP214
prerank,polyol metabolic process (GO:0019751),0.36962109500854334,1.0331855005725104,0.4342105263157895,1.0,1.0,5/46,4.92%,ITPK1;INPP4B;PTEN;SLC5A3;PLCB1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4263984777213282,1.0329079821149914,0.43105756358768405,1.0,1.0,7/21,17.76%,VEGFA;DISC1;DRD2;NES;FZD9;LRP2;MDK
prerank,protein kinase B signaling (GO:0043491),0.4266010774447051,1.0328653645040373,0.4351851851851852,1.0,1.0,4/23,4.84%,PTEN;THEM4;TGFB1;MT3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.4162081256629575,-1.0322607792999121,0.425,0.8225591038408806,1.0,6/11,23.29%,TOMM70;TIMM9;TIMM22;TIMM10B;TIMM8B;ROMO1
prerank,negative regulation of RNA splicing (GO:0033119),-0.3405395139357189,-1.0321891678759885,0.40213523131672596,0.8210893624118979,1.0,9/19,23.36%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;PTBP3;SRSF12;SRSF7;U2AF2
prerank,RNA processing (GO:0006396),0.3263721536374893,1.0318638442434043,0.42636457260556127,1.0,1.0,60/176,25.66%,CSTF3;BICD1;DHX8;USB1;ELAVL4;CPSF6;RNGTT;RSRC1;RP9;METTL3;XRN2;SON;IVNS1ABP;RNPC3;TUT4;DDX54;SRSF11;APOBEC1;AURKAIP1;ALKBH5;NCBP1;ADARB2;DUSP11;SFPQ;SNRNP40;LSM3;PRKACA;PRPF6;PRPF18;ADARB1;NOVA1;TSEN2;KHSRP;SF3A1;HNRNPU;RNPS1;FUS;DDX23;TENT2;PRMT9;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;HNRNPC;TSEN34;HNRNPL;SNRPN;RBMS1;SF3B2;WBP4;PPP2R1A;TUT1;TFIP11;MAGOHB;SCAF11;SNRPA1;NONO;DROSHA;RBM4
prerank,melanocyte differentiation (GO:0030318),0.4785301705987291,1.0317728546854037,0.4265842349304482,1.0,1.0,5/11,21.26%,HPS6;SLC24A5;MREG;USP13;MITF
prerank,fatty acid transport (GO:0015908),0.44408569304694234,1.0315765552551888,0.4380165289256198,1.0,1.0,3/17,8.24%,SLC27A1;SLC27A4;GOT2
prerank,amino acid import (GO:0043090),-0.3378370086983499,-1.0315184126543635,0.39015151515151514,0.8213124595290889,1.0,8/21,14.82%,SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC16A2;SLC6A1;SFXN3
prerank,regulation of muscle contraction (GO:0006937),0.4005595509908356,1.0315101342682909,0.43832020997375326,1.0,1.0,4/26,11.40%,MYBPH;KCNA1;TNNT3;ANXA6
prerank,protein monoubiquitination (GO:0006513),0.38838078498124445,1.031351126918192,0.4396551724137931,1.0,1.0,9/36,17.23%,UBE2T;PRKN;WAC;CUL3;HUWE1;KLHL12;KLHL22;UBE2O;CDC73
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3355674755909992,-1.0312500260004398,0.3993055555555556,0.8186312042711434,1.0,7/22,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3355674755909992,-1.0312500260004398,0.3993055555555556,0.8186312042711434,1.0,7/22,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,regulation of cell migration (GO:0030334),0.32262920172220105,1.0308708641309308,0.41624874623871616,1.0,1.0,76/382,15.19%,ROR2;DLC1;CLDN19;CCL11;SULF1;PRKCA;LGR6;PDGFRA;HAS2;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SEMA3E;RHOD;DPEP1;PLXNC1;EGFR;PTPRT;RAP2B;ACVR1;SEMA6C;PRKX;MAP4K4;VEGFA;HACE1;EPHB2;RECK;SEMA3A;TGFB1;CLDN1;CTNNA2;NF1;PAK1;PODN;FAM83H;DOCK10;TWIST2;NTNG2;NTNG1;CYP1B1;PPP3CA;SERPINE2;NF2;FLNA;SMO;TRIP6;LDB2;SGK3;MGAT3;SPATA13;MCTP1;ERBB4;SLK;PTPRJ;NGFR;MAGI2;FGF7;GRN;RHOC;MYOC;DRD2;SOD2;ADARB1;ARHGAP4;TCAF1;SPAG9;ELP5;COL1A1;LDLRAD4;CITED2;SEMA6D;WASHC1;LMNA;ITGB1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3991533213005873,1.0307760721108996,0.4410994764397906,1.0,1.0,8/31,15.61%,ANK1;DLG2;ERBIN;MYO9A;OPHN1;SCRIB;PDCD6IP;PARD3B
prerank,inorganic anion transport (GO:0015698),0.3669026294633875,1.0302227689025454,0.444047619047619,1.0,1.0,11/53,16.03%,FXYD3;ANO6;TTYH3;TTYH1;FXYD1;SLC25A10;ANO10;XPR1;CLIC1;CLCN2;SLC25A11
prerank,regulation of multicellular organism growth (GO:0040014),0.4555358291193742,1.029964152612352,0.44847605224963716,1.0,1.0,1/15,0.46%,PTCH1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3480754482791539,-1.0298084617328178,0.4340277777777778,0.8212564962591458,1.0,4/18,8.41%,DAB2;CHMP3;MAP2K1;MTMR2
prerank,cellular response to reactive oxygen species (GO:0034614),0.3618889666280481,1.0294442529891623,0.4412442396313364,1.0,1.0,21/59,21.49%,PDGFRA;EGFR;MAPK7;NCF1;CYP1B1;MAPK9;NFE2L2;HDAC6;MAPK1;ERCC6L2;PRDX3;ABL1;PAX2;RIPK1;CHUK;PARK7;OSER1;JUN;SIRPA;PKD2;PXN
prerank,regulation of synapse organization (GO:0050807),0.4091578801276312,1.0293257272999747,0.422103861517976,1.0,1.0,5/26,6.15%,IL1RAPL1;CTNNA2;WNT5A;YWHAZ;CDKL5
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.44269617367541436,1.0291245127546724,0.4228571428571429,1.0,1.0,3/17,12.73%,AP1G1;CADM1;NECTIN2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4709135174299557,1.0286892117753157,0.4424778761061947,1.0,1.0,3/12,16.67%,IRS2;MTLN;ABCD2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.38994007430704,1.0283483631114274,0.4258312020460358,1.0,1.0,4/33,4.96%,PTEN;STXBP4;FBXW7;GLI1
prerank,regulation of cellular response to heat (GO:1900034),0.349295674626465,1.0282647344407492,0.4326710816777042,1.0,1.0,19/77,18.03%,CD34;HSPH1;RANBP2;MAPKAPK2;RPA3;NUP155;BAG5;CRYAB;NUP205;FKBP4;NDC1;NUP160;MAPK1;DNAJB6;RPA2;ATM;POM121;AAAS;RPTOR
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.46683269888010387,1.0282224131776239,0.44574780058651026,1.0,1.0,3/14,8.56%,BST1;LOXL3;FLNA
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3297552466010325,1.0278819296538941,0.43106995884773663,1.0,1.0,44/153,19.42%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;PDK3;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;PRKACA;CSNK1A1;TTBK1;RPS6KA2;PKD1;ATM;CSNK1E;CSNK1G2;SGK1;RIPK1;CHUK;PKN2;VRK3;TAF1;CSNK2A2;CSNK1G3;CAB39;TOP1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.41042351733402566,-1.02773251602538,0.4092140921409214,0.8256419022304365,1.0,5/10,12.73%,ACER2;WNK1;JAM3;SERPINE1;NEXMIF
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.45016307575579284,1.02769928879536,0.43575418994413406,1.0,1.0,6/16,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,dicarboxylic acid transport (GO:0006835),-0.3135278251316344,-1.0276661068119943,0.40772532188841204,0.8241497902232867,1.0,6/28,6.63%,SLC13A3;SLC26A7;GJA1;SLC22A6;PDPN;GIPC1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3176015441520037,1.0272517943900132,0.407,1.0,1.0,117/476,21.45%,RORA;OSR2;MDFIC;GLI2;FGF2;SOX8;PRDM16;CRLF3;MYC;RGMB;SOX9;NCOA1;EGFR;ACVR1;KMT2A;WAC;KDM8;TRIM44;TGFB1;PSEN1;FANK1;NCF1;SOX11;SETD3;BICRAL;RNF6;MT3;PLCB1;GLI1;RAI1;ATF7IP;CXXC1;WNT5A;HNRNPAB;RFX3;ZBTB16;RORC;MLXIPL;CREB3L2;PPP3CB;DYRK1B;NAA16;FZD7;KAT8;GATA6;BICRA;FOXM1;SPIN1;ATMIN;ARHGEF11;TFAM;BRCA1;ZMIZ1;HIF1A;HDAC2;ERBB4;MED13;ESR1;SMARCC2;SP1;BMP7;FGF7;EPC1;PHF8;XRCC6;ATF5;GATA3;AHR;PRDM11;SMARCC1;PAX3;HIVEP3;PCBD2;COL1A1;CITED2;MED12;POU3F1;RUNX1;PIM2;BLM;TP53;SP3;KCNH2;TGFB3;RNF111;ING1;QRICH1;USP21;PAX2;CD74;RNF10;CHUK;PCID2;MED30;ZNF496;NAA15;RNF4;MAPRE3;PSMD9;KMT2E;EGR1;CNBP;BCL10;PPARG;JUN;STAT3;TFE3;SMARCA4;FUBP3;CD38;NR1D2;SEC14L2;NFKB1;MITF;ZXDC;NSD1;DVL3
prerank,regulation of lymphocyte activation (GO:0051249),-0.3994626042561388,-1.026694767923074,0.4254658385093168,0.8253080351793192,1.0,7/12,44.26%,KAT2A;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,lipoxygenase pathway (GO:0019372),-0.38007190556917614,-1.0264000618296576,0.41776315789473684,0.8245704933439199,1.0,5/14,22.01%,PTGS2;GPX1;HPGD;GPX4;ALOX12
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.46021902066130954,1.0263504122890401,0.4560117302052786,1.0,1.0,4/14,9.84%,KMT2A;AUTS2;BRCA1;PRDM9
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.37199504699507113,1.026244813303956,0.43050430504305043,1.0,1.0,8/40,11.52%,SGIP1;BICD1;VEGFA;RAB21;HIP1;SFRP4;CBL;MAGI2
prerank,cytoplasmic translational initiation (GO:0002183),0.43401736693021464,1.0261118919131405,0.45558739255014324,1.0,1.0,10/17,29.67%,EIF3M;EIF4G1;EIF4A2;DENR;DHX29;RBM4;MCTS1;EIF2S2;EIF3I;EIF2D
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3488431532852751,1.0260343136399992,0.44114285714285717,1.0,1.0,10/69,10.85%,PYCARD;FADD;EPHB2;PSEN1;CCR2;WNT5A;TMEM106A;TLR1;PTPRJ;PTPN11
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.37079075690042407,1.0259566653914978,0.4361078546307151,1.0,1.0,11/48,16.07%,PYCARD;BCL2;BRCA1;MSH6;CASP2;AEN;ATM;ABL1;RPS27L;TP53;BCL2L11
prerank,cellular response to peptide (GO:1901653),0.3611912713243018,1.025927301515823,0.44779582366589327,1.0,1.0,12/56,11.27%,DDX11;PTPN22;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR;TRIM41
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4785612975361218,1.025911814819174,0.456656346749226,1.0,1.0,3/12,15.28%,IL18;TTBK1;IL33
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.31781091954751084,1.0258939888337966,0.4371859296482412,1.0,1.0,75/327,21.43%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;RFX3;MLXIPL;MLX;TAF5L;DRAP1;FZD7;CHD3;SPIN1;ATRX;SOX12;CARM1;ZMIZ1;NCOA2;REXO4;HIF1A;ZSCAN26;ZBTB38;HINT1;ATF2;ESR1;MYT1;SP1;SFPQ;RBAK;NSD2;RHOH;DVL1;PATZ1;WWTR1;ATF5;AHR;TGFBRAP1;CREM;HOXB7;TRRAP;ABL1;MSL3;TP53;SP3;PHF19;TERF2IP;NFIA;SUFU;MLF1;FUS;APBB3;POLR2A;HMG20A;CNBP;UBE2L3;STAT3;PRDM2;HP1BP3;USP13;KMT2D;NR1D2;ZSCAN21;LIMD1;MITF;NSD1
prerank,positive regulation of DNA repair (GO:0045739),0.3698833112679708,1.0258332644189576,0.44619105199516323,1.0,1.0,8/46,10.55%,DDX11;FGF10;SPIRE1;EGFR;FMN2;FOXM1;BRCA1;SLF2
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.293878773851779,-1.0258301413549367,0.36923076923076925,0.8245845288602235,1.0,11/32,18.86%,PRKAG2;SORBS1;CREBL2;PRKAA2;ADIPOR2;AVIL;CEACAM1;SIRT4;MID1IP1;APOE;GPER1
prerank,peptidyl-asparagine modification (GO:0018196),0.3940741854078941,1.0257025406762479,0.43170103092783507,1.0,1.0,13/31,27.07%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1;HIF1AN;UBE2J1
prerank,respiratory system development (GO:0060541),0.3905349874291259,1.0254418436252446,0.4466501240694789,1.0,1.0,5/32,6.98%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,tetrapyrrole metabolic process (GO:0033013),0.4364126335003164,1.0254225150123715,0.42613636363636365,1.0,1.0,5/18,17.07%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,positive regulation of GTPase activity (GO:0043547),0.32413545040269004,1.0252879622810838,0.45,1.0,1.0,22/188,8.53%,ARHGAP24;SIPA1L1;CCL11;DOCK7;NTRK3;TAX1BP3;TBC1D10A;ERBB2;MAP4K4;GPR65;CCL4;SLC27A4;NF1;ARHGEF10;ALS2;CDKL5;MTSS2;TSC1;DOCK10;RAP1A;ZC3H15;TBCK
prerank,catecholamine metabolic process (GO:0006584),0.4528403842500919,1.0250134813087306,0.4490106544901065,1.0,1.0,4/14,13.89%,PRKN;COMT;DRD2;LRTOMT
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4448706000345681,1.0248039897564603,0.45092460881934565,1.0,1.0,6/16,22.11%,RSRC1;CDK13;SFPQ;SRSF6;CELF4;RBM17
prerank,neuromuscular junction development (GO:0007528),0.4133550168308986,1.0247479412406493,0.44154057771664373,1.0,1.0,6/24,13.53%,ANK3;PDZRN3;LRP4;CACNB4;DVL1;GPHN
prerank,glycolipid biosynthetic process (GO:0009247),0.3862810806721798,1.0247435136548482,0.437046004842615,1.0,1.0,11/38,20.63%,ST3GAL4;SCCPDH;PIGC;PIGP;ST8SIA1;PIGN;PIGA;PIGU;DPM1;PIGO;B4GALT6
prerank,respiratory chain complex IV assembly (GO:0008535),0.41984368889240675,1.0242712922626807,0.453804347826087,1.0,1.0,5/21,13.41%,COX20;COX18;SCO1;COX19;COX10
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3275971105067802,1.0238587919500388,0.45483193277310924,1.0,1.0,22/142,15.54%,PDGFRA;TAC1;LPAR1;PTGER3;ATP2B3;CACNA1A;PTGFR;CCR2;WNT5A;ACKR3;CD52;SLC8A2;ESR1;S1PR3;PRKACA;DRD2;ATP2B1;TRPC5;P2RY1;ACKR4;FZD9;ABL1
prerank,mRNA stabilization (GO:0048255),0.37861784235256235,1.0237609815860729,0.43403205918618987,1.0,1.0,15/40,22.57%,ELAVL4;PABPC1;MAPKAPK2;GDNF;MAPK14;EIF4ENIF1;HNRNPU;FUS;TENT5D;SYNCRIP;TENT5A;HNRNPC;ZFP36;TENT5C;YBX3
prerank,DNA geometric change (GO:0032392),0.4189295571027083,1.0234880649310378,0.4539385847797063,1.0,1.0,10/24,26.68%,DDX11;ZRANB3;RTEL1;BLM;WRN;RAD50;SUPV3L1;RECQL;HNRNPA2B1;DDX1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.37626600756722683,-1.0234209096978397,0.40773809523809523,0.8300058955594037,1.0,7/14,30.76%,SAP30BP;ING2;ZBTB7B;FNTA;BRMS1;NIPBL;NNMT
prerank,spliceosomal complex assembly (GO:0000245),0.37004405785980576,1.0232963839797988,0.43611793611793614,1.0,1.0,22/46,29.75%,CELF5;LUC7L2;TXNL4A;NCBP1;PRPF6;CELF6;SRSF6;YTHDC1;LUC7L;SF3A1;SF1;DDX23;CELF4;SNRNP200;SCAF11;DDX1;SRSF5;RBM5;CELF2;CELF1;USP39;SRSF9
prerank,mitotic cell cycle phase transition (GO:0044772),0.3222494659465628,1.0228179356496512,0.44263959390862945,1.0,1.0,48/204,20.14%,DYNLL1;CRLF3;MYC;CDKN2B;ACVR1;CCNJ;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;CDK6;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CUL3;ANAPC7;RCC1;CLASP1;PKMYT1;CDC25B;TAF2;PHF8;PRKACA;CKAP5;CEP76;DYNC1I2;NES;PIM2;CSNK1E;CDC23;CCND2;CUL4B;CEP63;NASP;USP37;TUBA1A;DBF4;FBXL12;CDC27;CEP78;SSNA1
prerank,negative regulation of cellular process (GO:0048523),0.3164433528420807,1.0227111924932342,0.433,1.0,1.0,100/521,17.87%,ROR2;TGFBI;DLC1;DCBLD2;SSTR1;WNK2;BMP5;CLDN19;ERBB3;GLMN;FGF2;CRLF3;MYC;PTEN;BCL2;CD34;KAT2B;NGF;VGLL4;PRKN;CDKN2B;PLXNC1;FRZB;PTPN2;JADE1;EPHB2;PTHLH;EIF2AK3;TGFB1;SOX11;NUPR2;MT3;PDE3B;BNIPL;APBB2;RASA1;PODN;TSC1;TMEM98;ADAMTS1;CYP1B1;CBFA2T3;CDK6;MEN1;BNIP3;FOXM1;ATG5;NF2;COL18A1;PACRG;RARG;CRYAB;TEX15;SYT11;DSCAM;ERBB4;SFRP4;PTPRJ;ANXA6;BMP7;MAGI2;ING4;ATP8A2;DRD2;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;PRDM11;NACC2;CD9;RPS6KA2;NCK1;PDS5B;MDM4;SRSF6;RTN4;CD164;LMNA;PIM2;BLM;TP53;LPXN;GPLD1;TGFB3;NDUFA13;ING1;HYAL1;DYSF;CDC73;CCDC85B;FKTN;RNF167;NUDT6;CTBP1;MDK;PBRM1;FBXO5
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.27771668383416365,-1.02252474258793,0.4,0.8308780386663113,1.0,11/39,13.86%,ROBO1;TSPAN5;NOS3;MAML1;PRKCI;SNW1;JAG1;JAG2;NOTCH4;TGFB2;NEPRO
prerank,sulfur compound transport (GO:0072348),-0.3183928210252205,-1.0224449006655962,0.42272727272727273,0.829431490461441,1.0,9/27,13.58%,ABCG2;SLC26A7;SLC6A6;SLC6A13;SLC25A26;SLC25A30;SLC13A4;SLC5A6;MGST1
prerank,chemical homeostasis (GO:0048878),0.35558897508875337,1.0223832531178854,0.45011600928074247,1.0,1.0,8/61,9.74%,WNK2;IRS2;ZBTB20;WNK3;FBXW7;AQP4;ACOX1;THADA
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4604010789804338,1.0220014543939258,0.44298245614035087,1.0,1.0,3/13,10.21%,CPSF6;NCBP1;FIP1L1
prerank,negative regulation of protein secretion (GO:0050709),-0.2929461956402249,-1.0215461070773117,0.4153846153846154,0.8304847015314688,1.0,14/38,23.90%,CD200;MIDN;ERP29;OPRM1;ADRA2A;KCNB1;RHBDF2;DPH3;SIRT4;APOE;NR1H3;RSAD2;RAB11FIP1;SERGEF
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4010087938851521,1.0212400326516669,0.46114649681528663,1.0,1.0,6/29,23.00%,MEIOB;TEX11;PRDM9;SYCE2;SYCP2;MEI4
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.449926143868214,1.0210178754658825,0.45702592087312416,1.0,1.0,4/15,15.49%,GRIK3;GRM5;HOMER2;HOMER1
prerank,folic acid metabolic process (GO:0046655),0.4335334480255899,1.0209224728237278,0.4623338257016248,1.0,1.0,5/18,20.80%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,apical protein localization (GO:0045176),0.49198343625717733,1.0208506314868693,0.4563253012048193,1.0,1.0,2/10,3.59%,ATP8B1;INSC
prerank,positive regulation of protein catabolic process (GO:0045732),0.3446253381916574,1.0205543433285815,0.4440789473684211,1.0,1.0,15/84,16.25%,GPC3;VGLL4;PRKN;HACE1;WNT5A;ASB5;VPS11;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;GPLD1;NDUFA13
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3614623875819096,-1.0204617833154999,0.4253968253968254,0.8318841650930672,1.0,5/15,7.23%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,protein insertion into ER membrane (GO:0045048),0.38535733363804203,1.0203881628356268,0.45066991473812423,1.0,1.0,17/37,23.28%,WDR83OS;PRNP;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;EMC10;CYB5A;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC6;EMC2
prerank,cellular response to interleukin-1 (GO:0071347),0.3288116195818617,1.020169050721163,0.4364012409513961,1.0,1.0,32/143,21.39%,CCL11;ADAMTS12;HAS2;PYCARD;SOX9;MAP3K3;IRAK3;RPS6KA4;CCL4;PLCB1;PELI1;PSMB7;HIF1A;TOLLIP;UPF1;PSMD2;UBB;CCL14;PSMC1;HYAL1;IL1RAP;PSMB2;RC3H1;CHUK;PSMD9;TAB3;EGR1;PSME4;PSMA8;SIRPA;NFKB1;TNIP2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.42593104613039867,1.020119408947768,0.45767575322812054,1.0,1.0,5/19,20.80%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4434516490959033,1.0199931996301541,0.4472140762463343,1.0,1.0,5/15,19.99%,STXBP4;GLI1;CUL3;CDC73;PHB2
prerank,insulin receptor signaling pathway (GO:0008286),-0.25351818628294565,-1.0194865410654865,0.4,0.8330084772456705,1.0,14/69,9.62%,SORBS1;IGF1R;PIK3R3;PIK3C2A;GRB10;NAMPT;IGF2;INSR;ATP6V0C;ATP6V0D1;BCAR1;GSK3B;RHOQ;GSK3A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.45183023098988984,1.0193562871077482,0.45241581259150804,1.0,1.0,2/13,4.44%,PSEN1;SOX11
prerank,regulation of cell projection organization (GO:0031344),-0.37567092950092884,-1.0192008478825774,0.43142857142857144,0.8322562326899576,1.0,2/13,3.91%,MACF1;MOV10
prerank,regulation of neuron differentiation (GO:0045664),0.3382760748916172,1.0186605440873449,0.43564356435643564,1.0,1.0,19/76,20.21%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;NLGN1;FGFR1;BIN1;BMP7;MMD2;CDK5R1;ZFHX2;VWC2;NREP;HEYL;CNTN4;CPNE1;PCP4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.3798138633805349,-1.0185686714511313,0.43302180685358255,0.8324700032875314,1.0,6/14,12.07%,IGFBP3;SLIT2;IGFBP5;TPM1;PRKG1;SERPINE1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.39171097077959594,1.0181291148041642,0.42893725992317544,1.0,1.0,12/29,25.29%,DHX34;PABPC1;GDNF;NBAS;EIF4ENIF1;HNRNPU;FUS;TENT5D;TENT5A;TENT5C;FMR1;CIRBP
prerank,response to interleukin-4 (GO:0070670),-0.41067947966528373,-1.018005298478087,0.43440233236151604,0.8324969036486098,1.0,1/10,0.63%,LEF1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2895907490815941,-1.0178676479403996,0.3981042654028436,0.8312882171006418,1.0,13/35,20.36%,ETS1;LYN;ARNT;STAT5B;ZFP36L1;ACVR1B;NCKAP1L;INHBA;TAL1;MAFB;ANKRD54;ZFPM1;HMGB2
prerank,regulation of response to oxidative stress (GO:1902882),0.48113678891995243,1.017821297239238,0.4583333333333333,1.0,1.0,2/11,9.97%,PRKN;MCTP1
prerank,regulation of telomere maintenance (GO:0032204),0.3964281974225806,1.017694644041485,0.4306864064602961,1.0,1.0,8/26,16.41%,MYC;ERCC4;ATRX;SIRT6;UPF1;RTEL1;SMG6;TERF2IP
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3629048605504889,-1.0171055299309424,0.4533762057877814,0.8318401198032565,1.0,5/16,9.92%,PDGFD;NRP1;PIK3C2A;BCAR1;PDGFRB
prerank,ceramide biosynthetic process (GO:0046513),-0.27145241056866226,-1.016919805679716,0.4011299435028249,0.8307343601768391,1.0,7/40,7.92%,SGMS1;ST6GALNAC3;ST8SIA4;CERS5;SPTLC2;DEGS2;CERS4
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3811724272411248,-1.0168225953999752,0.4325153374233129,0.8293824834479989,1.0,3/13,17.25%,ADRA1B;CAV1;TBXA2R
prerank,response to alcohol (GO:0097305),0.3902864077017653,1.0166061551136707,0.44559585492227977,1.0,1.0,5/27,14.38%,TGFB1;GRIN2B;TGFBR2;GOT2;GRIN2A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3245952442311233,1.0165280376877124,0.4652631578947368,1.0,1.0,31/152,17.23%,GPC3;WNK2;SULF1;LGR6;PLEKHA4;FGF10;DEPDC1B;EGFR;GPRC5B;TGFB1;DISC1;LGR5;SPIN1;FAM53B;PPM1B;PSMB7;DAAM2;SFRP4;CSNK1G1;COL1A1;PSMD2;ZEB2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;PSMB2;CDC73
prerank,cardiac muscle cell differentiation (GO:0055007),0.4214611925205325,1.0164910191001642,0.4556291390728477,1.0,1.0,3/21,3.14%,AKAP13;ACVR1;VEGFA
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4815027363039891,1.0164517751518918,0.458528951486698,1.0,1.0,4/10,21.34%,ATF7IP;ESR1;TP53;THRA
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3732743101078196,1.0163916344049897,0.4560975609756098,1.0,1.0,8/40,15.54%,PIP5KL1;BCL2;ARL6IP5;PID1;PRDX3;MTLN;UBB;ABL1
prerank,negative regulation of catabolic process (GO:0009895),0.36474003557875573,1.0163792706614458,0.4505882352941176,1.0,1.0,15/47,24.09%,EGFR;FMN2;IRAK3;PDE3B;CBFA2T3;FLNA;MDM4;SNX12;AZIN2;SF3B3;PFKFB1;AGAP2;PRKAA1;PRKCG;HMGCR
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.43910188997004723,1.0161345697535882,0.4684813753581662,1.0,1.0,3/17,12.35%,PLBD1;PLA2G12A;PLAAT3
prerank,sphingolipid metabolic process (GO:0006665),-0.2320921267323458,-1.0158669819208677,0.4166666666666667,0.8305006179568946,1.0,31/108,19.90%,SGMS1;ST6GALNAC3;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;ESYT2;DEGS2;CERS4;SPNS2;ALDH3A2;ESYT1;GLTP;SGPL1;SUMF2;VAPB;GAL3ST1;UGCG;ASAH2;CERS1;ORMDL3;ESYT3;PLA2G15;SPHK1;SERINC1;SPTSSB;CTSA;CERT1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.48861113796149797,1.0156723010325786,0.47208931419457734,1.0,1.0,4/10,17.59%,GALNT1;GALNT13;GALNT3;POGLUT2
prerank,heart morphogenesis (GO:0003007),0.3654428918394181,1.015526345219539,0.44970414201183434,1.0,1.0,4/50,3.14%,DLC1;SOX9;ACVR1;VEGFA
prerank,regulation of response to interferon-gamma (GO:0060330),0.4544682013476038,1.015393260412277,0.45390070921985815,1.0,1.0,3/14,14.35%,PTPN2;SOCS1;SUMO1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4328195437985861,1.0151751985379631,0.44923504867872044,1.0,1.0,6/19,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,negative regulation of ATPase activity (GO:0032780),0.4410946316100083,1.0150808475533035,0.45750708215297453,1.0,1.0,5/16,17.48%,TSC1;THADA;PXK;TP53;PAM16
prerank,response to organophosphorus (GO:0046683),-0.3608437526364653,-1.0150307363119715,0.41324921135646686,0.8312751511448927,1.0,5/16,25.43%,ABCC9;TRIM16;TRPC3;RFC3;VGF
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.34263885012224543,1.0146115713662045,0.45413363533408835,1.0,1.0,16/73,19.75%,PYCARD;FADD;EPHB2;PSEN1;CCR2;WNT5A;TMEM106A;TLR1;PTPRJ;PTPN11;IL33;RIPK1;LBP;SETD4;BCL10;STAT3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.35299970840306244,1.014500459824216,0.44661308840413316,1.0,1.0,12/60,15.48%,PRKCQ;FGF2;MYC;CCT7;CHTF18;PARM1;MAPK1;NEK7;SMOC2;MAP3K4;POLG2;ATM
prerank,tRNA 5'-leader removal (GO:0001682),0.4585169563299467,1.0144733671445925,0.472809667673716,1.0,1.0,7/13,27.32%,RPP38;PRORP;POP1;RPP21;SSB;RPP30;RPP14
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.29868746989618056,-1.0143378356184014,0.4055299539170507,0.8316556791852512,1.0,6/30,11.45%,DAB2;FOXP1;KDM1A;DDX5;KDM4C;PRMT2
prerank,regulation of gene expression (GO:0010468),0.3103801273590123,1.0142199360014192,0.446,1.0,1.0,141/903,15.62%,RORA;OSR2;SEC16B;RAG2;PRX;MLF2;SOX6;NKX6-2;AFF3;CLDN19;ANK3;EFEMP1;ADAM19;PRKCQ;NTRK3;EPB41L4B;GLMN;CREB3L1;FGF2;MYC;RBMS3;TGIF2;FGF10;DHH;PTPN22;ANK2;CD34;SOX9;SSBP2;GSN;NGF;NAB1;PRKN;HNRNPDL;C1D;VEGFA;EPHB2;TRA2B;PTHLH;EIF2AK3;RPS6KA4;NFX1;TRIM44;TLE1;ZNF326;FBXW7;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;RFXANK;RNF6;MT3;CXXC1;WNT5A;HOXD3;HNRNPAB;APBB2;UBAP2;RFX3;MLXIPL;MLX;TAF5L;DRAP1;SON;FZD7;TRIM11;CDK6;CHD3;SPIN1;SLC8A2;ATRX;ZNF462;BRCA1;SMO;SOX12;ANKRA2;CARM1;NCOA2;MAPK9;REXO4;HIF1A;ZFP64;PRDM9;ZSCAN26;ZBTB38;SFRP4;HINT1;GDNF;ATF2;PCBP4;ESR1;NFE2L2;MAPK14;MYT1;RIMS1;SP1;SFPQ;HDAC6;POGZ;RBAK;NSD2;PID1;DIP2A;MAPK1;BMP7;ATRAID;EDN3;FGF7;RHOH;DVL1;PATZ1;WWTR1;ATF5;PER1;GATA3;AHR;SPOUT1;NDFIP1;PRDM11;TTBK1;TGFBRAP1;KDM6A;PDCL3;NOVA1;YTHDC1;BMPR1A;CITED2;CREM;KHSRP;TICAM1;HOXB7;POU3F1;IL33;ATM;RUNX1;TRRAP;ABL1;STX1B;MSL3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.36495334605685237,1.0139687318235013,0.4520383693045564,1.0,1.0,12/47,18.73%,MYC;EGFR;MAP4K4;CARD9;FOXM1;ARL6IP5;MAPK1;TAOK3;PER1;KLHDC10;NBR1;MID1
prerank,O-glycan processing (GO:0016266),0.3569396527724516,1.0138738227435593,0.4668192219679634,1.0,1.0,11/54,15.02%,ST3GAL4;GALNT9;GALNT1;GALNT15;GALNT7;C1GALT1;GALNT13;GALNT6;GALNT3;MUC3B;MUC3A
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4285522101786545,1.013840805335644,0.45143638850889195,1.0,1.0,7/18,20.38%,ZFP36L2;KLF9;BCL2L11;HNRNPU;PCK2;UBE2L3;ZFP36
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4777779085888239,1.013816756874617,0.4660347551342812,1.0,1.0,3/10,17.21%,PRNP;SCRIB;RC3H1
prerank,protein deacetylation (GO:0006476),0.3662752939753955,1.01365754319473,0.46953405017921146,1.0,1.0,11/41,16.15%,RCOR2;MTA2;FLNA;MORF4L2;HDAC2;SIN3B;HDAC6;SIRT6;MIDEAS;MSL3;MTA3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3445372214866524,1.0135888429922284,0.45685840707964603,1.0,1.0,19/73,19.67%,DLC1;PYCARD;NGF;FADD;EIF2AK3;TNFRSF10B;APAF1;HIP1;NGFR;CASP12;SNCA;CASP2;CRADD;IFT57;RPS27L;RIPK1;AIFM1;SENP1;PPARG
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.32532788188684436,1.0134858549833987,0.46645702306079667,1.0,1.0,18/140,14.06%,PDGFRA;TAC1;CACNA2D1;LPAR1;PTGER3;GPR65;CACNA1A;PTGFR;CCR2;JPH3;ACKR3;CD52;HTR2C;ESR1;S1PR3;DRD2;P2RY1;ACKR4
prerank,positive regulation of protein transport (GO:0051222),-0.24887595520679773,-1.0133672618054619,0.43820224719101125,0.8327453827324149,1.0,14/67,13.12%,BMP6;IGF1;OAZ1;EXOC1;PPIA;RACK1;ABCG1;CNST;UNC13B;OAZ2;APBB1;SYTL4;TGFB2;MYH10
prerank,response to gamma radiation (GO:0010332),0.4096687513006969,1.013141999144423,0.4479166666666667,1.0,1.0,9/24,18.13%,MYC;MEN1;CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,nucleosome organization (GO:0034728),0.35908622546550095,1.0128341821581444,0.44683393070489846,1.0,1.0,13/55,17.97%,SOX9;VPS72;MCM3AP;ATRX;PRDM9;SETD2;POLE3;SMARCC2;ASF1A;ANP32E;SMARCC1;SMARCE1;NASP
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3653952206180611,-1.0122079009754021,0.42038216560509556,0.8345270603899371,1.0,5/13,13.22%,PLXNA2;NRP1;PLXNB1;PLXNA1;PLXNA4
prerank,positive regulation of catalytic activity (GO:0043085),0.38370580930459175,1.0121464550633268,0.46925972396486826,1.0,1.0,12/37,17.96%,SLC5A3;PSEN1;MT3;NHEJ1;NCSTN;MAPK14;MSH6;APH1A;PSEN2;ABL1;WRN;AZIN2
prerank,nuclear body organization (GO:0030575),0.4620803922921477,1.0118475507033142,0.46096096096096095,1.0,1.0,1/12,0.50%,USP50
prerank,peptide metabolic process (GO:0006518),0.3490281421589759,1.0115527627595446,0.4826038159371493,1.0,1.0,15/75,15.28%,BACE2;DPEP1;HM13;PARL;MIPEP;PSEN1;LTA4H;TRHDE;SPCS3;MGAT3;LNPEP;THOP1;CPD;PSEN2;ABCB9
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.4393675576496471,1.0114589993555851,0.4623188405797101,1.0,1.0,2/15,3.89%,SLC27A1;FBXW7
prerank,extracellular transport (GO:0006858),-0.3924510650258767,-1.0111273218970094,0.45821325648414984,0.8359348283140846,1.0,10/13,42.06%,TSG101;ARRDC1;CABYR;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.41876742913266274,1.0110613261726855,0.47035040431266845,1.0,1.0,2/21,2.13%,PTEN;GORASP1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.29135914970736615,-1.0109024856780693,0.4099099099099099,0.834922817236349,1.0,9/34,16.91%,CAPZB;OCLN;SLIT2;WASF2;AKIRIN1;ABI2;CDC42;AVIL;ABI3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.29790756201577595,-1.0108192348113265,0.4425531914893617,0.8335491739386829,1.0,12/29,18.96%,TERF2;PPIA;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;GAR1;HSP90AB1;TINF2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31171157158434115,1.0107456878627656,0.467,1.0,1.0,84/509,16.12%,ROR2;RELN;DCN;FFAR4;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;S100A4;FGF10;BCL2;IRS2;SOX9;ERBB2;PRKN;EGFR;AKAP13;FADD;LPAR1;ALPK1;VEGFA;MIOS;MAP3K3;THEM4;GPRC5B;TRIM44;TNFRSF10B;TGFB1;CCL4;NCF1;SOX11;NTRK2;SLC44A2;WNT5A;TMEM106A;NLGN1;KSR1;CARD9;BMF;FGFR1;IL18;PELI1;FYN;LAMTOR2;GAB2;FLNA;HIP1;BTC;TRIP6;ERBB4;PIK3R1;VAPA;MID2;GPR37;PTPRJ;CBL;ESR1;PTPN11;MYDGF;FGF7;RHOC;TBK1;RTKN2;MYOC;STRN;GATA3;MALT1;NDFIP1;P2RY12;DHX33;GOLT1B;TRAF7;RTN4;IQGAP1;TICAM1;MET;ITGB1;CGAS;PIM2;GAB1;TP53;BCL2L11;LRP2
prerank,histone deacetylation (GO:0016575),0.3664069917808299,1.0106333590116603,0.463030303030303,1.0,1.0,12/43,16.15%,RCOR2;MTA2;MORF4L2;HDAC2;SIN3B;SFPQ;HDAC6;SIRT6;MIDEAS;PER1;MSL3;MTA3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4612201880886208,1.0105826694554279,0.44916540212443096,1.0,1.0,3/12,6.93%,DOCK7;DOCK5;ADAMTS1
prerank,regulation of cell motility (GO:2000145),0.3315315729769607,1.0105220267104758,0.4900105152471083,1.0,1.0,25/121,13.20%,ERBB3;FGF2;FGF10;ERBB2;PLXNC1;EGFR;PRKX;HACE1;CADM4;TGFB1;PKN1;DOCK10;CDK6;SERPINE2;FLNA;BTC;LDB2;SGK3;MGAT3;SPATA13;ERBB4;SLK;FGF7;CFAP20;GATA3
prerank,RNA destabilization (GO:0050779),-0.34601890999143825,-1.0103178905294719,0.4444444444444444,0.8334955914864397,1.0,4/18,6.60%,ROCK2;ROCK1;YTHDF1;METTL14
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3782698826595156,-1.0101040286210246,0.4264705882352941,0.8325156973710387,1.0,5/13,18.89%,NOS3;TMSB4X;NOS1;ENO1;PINK1
prerank,cytosolic transport (GO:0016482),0.3294194996540056,1.0097060545725152,0.4729011689691817,1.0,1.0,36/108,23.29%,TBC1D10A;DENND2A;RHOBTB3;RAB14;VPS29;ARL1;CCDC91;AP1G1;GBF1;EPS15;GAK;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SYS1;AKTIP;STX8;SPAG9;SNX1;WASHC1;ANKRD27;UBE2O;AP4M1;RBSN;RAB7A;SNX16;HOOK2;DENND5A;WDR81;CORO7;RAB6A;HOOK1;HOOK3;ERC1
prerank,neural crest cell migration (GO:0001755),0.3801068994745191,1.0096045785150578,0.45627376425855515,1.0,1.0,10/36,18.85%,SOX8;SEMA3E;SEMA6C;SEMA3A;ERBB4;GDNF;ANXA6;SEMA6D;SEMA4B;SEMA4D
prerank,plasma membrane organization (GO:0007009),0.3490025529426092,1.0087761865344025,0.4531791907514451,1.0,1.0,15/61,17.09%,ANK3;ANK2;PLSCR4;ANO6;PACSIN2;SPTBN1;BIN1;EPB41L3;SYT11;ANXA6;RAB3A;OTOF;EHD2;ABCD2;DYSF
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4379701295111027,1.0081505720481077,0.47599451303155005,1.0,1.0,6/17,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,Golgi to endosome transport (GO:0006895),0.42975092727679504,1.0080764980639436,0.4483260553129549,1.0,1.0,7/16,17.58%,RAB14;WIPI1;GBF1;EPS15;SYS1;AP4M1;AP1AR
prerank,establishment of protein localization to membrane (GO:0090150),-0.24927551991361072,-1.0080476892720756,0.4418604651162791,0.8368342153806811,1.0,21/66,18.07%,AFDN;RAB11B;ZDHHC14;ZDHHC3;RFTN1;PRKCI;SYNE3;PARD3;NECTIN3;VPS37C;ZDHHC18;ZDHHC7;AQP11;OXA1L;ZDHHC20;MYO1C;BID;ZDHHC4;MICALL1;FRMPD1;TAOK2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.48605287989560675,1.0078232195491081,0.45425867507886436,1.0,1.0,4/10,13.96%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),0.48605287989560675,1.0078232195491081,0.45425867507886436,1.0,1.0,4/10,13.96%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.34074799864213423,-1.0077975845613139,0.45209580838323354,0.8359826004855678,1.0,8/18,15.65%,DCP2;NAF1;DKC1;RUVBL1;CCT8;CCT6A;CCT4;EXOSC10
prerank,positive regulation of programmed cell death (GO:0043068),0.3148375086806734,1.0077876171392022,0.47628657921291623,1.0,1.0,68/272,18.70%,HRK;PIP5KL1;PYCARD;NGF;AKAP13;FADD;FRZB;FGD4;ANO6;TNFRSF10B;PSEN1;SLC27A4;FANK1;NF1;DUSP6;ACVR1C;APAF1;BMF;ITSN1;CYP1B1;SHQ1;PHLDA1;BNIP3;BIN1;ARHGEF11;RARG;VAV3;PPID;UBE2Z;SFRP4;NGFR;NCSTN;HDAC6;ARL6IP5;ING4;APH1A;SCRIB;TRIO;ARHGEF3;SNCA;RPS6KA2;PSEN2;ITGB3BP;UBB;ITGB1;CASP2;CRADD;RASSF2;ATM;FZD9;ABL1;TP53;BCL2L11;GPLD1;HTATIP2;TGFB3;QRICH1;ARHGEF4;RIPK1;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;CSRNP3;AIFM1;DNAJA1;HTT;MAP3K11
prerank,peptidyl-threonine modification (GO:0018210),0.34806728743342275,1.007409909257595,0.4668192219679634,1.0,1.0,15/66,14.75%,PRKCA;GALNTL6;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;GALNT1;STK39;MAPK1;CDK5R1;TBK1;GALNT13;TTBK1;GALNT3
prerank,regulation of cell growth (GO:0001558),0.31471927499857144,1.0072877318905964,0.5,1.0,1.0,39/204,16.79%,DCBLD2;PTCH2;PRKCQ;CRLF3;BCL2;VGLL4;ERBB2;EGFR;FRZB;JADE1;NRG3;PAK4;TGFB1;PAK5;MT3;URI1;APBB2;LAMTOR2;ARHGEF11;DERL2;SGK3;SGK2;NCBP1;EIF4G1;EXOSC2;PTPRJ;AKAP6;CHPT1;BRAT1;PRDM11;RTN4;PAPPA2;KLHL22;TMEM97;TP53;NDUFA13;ING1;HYAL1;SGK1
prerank,male gonad development (GO:0008584),0.38111275691081076,1.0071467999302361,0.45901639344262296,1.0,1.0,11/34,21.61%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;NR5A1;CSDE1;MEA1;FGF9
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3110052378071663,1.0070886178547607,0.485456369107322,1.0,1.0,82/366,20.97%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;ATXN2;RFX3;TSC1;MLXIPL;MLX;TAF5L;DRAP1;FZD7;CHD3;SPIN1;RABL3;ATRX;SOX12;CARM1;NCOA2;REXO4;HIF1A;GRM5;ZSCAN26;ZBTB38;HINT1;ATF2;ESR1;MYT1;SP1;SFPQ;RBAK;NSD2;DDX25;RHOH;DVL1;PATZ1;WWTR1;ATF5;AHR;RBM4B;TGFBRAP1;CREM;CYFIP1;HOXB7;TRRAP;ABL1;MSL3;TP53;SP3;PHF19;TERF2IP;NFIA;SUFU;MLF1;FBXO5;FUS;APBB3;USP37;POLR2A;HMG20A;CNBP;UBE2L3;STAT3;PRDM2;HP1BP3;USP13;CCDC88A;KMT2D;NR1D2;ZSCAN21;LIMD1
prerank,cellular component maintenance (GO:0043954),-0.3863111992744679,-1.0070784916461994,0.4561933534743202,0.8364539036744821,1.0,4/12,8.41%,IGF1R;ITGA3;INSR;MTMR2
prerank,negative chemotaxis (GO:0050919),0.3773126411746262,1.0068430785071578,0.4691046658259773,1.0,1.0,4/33,3.81%,LGR6;SEMA3E;SEMA6C;SEMA3A
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.26126390442947045,-1.0066784019188102,0.44666666666666666,0.8359868768520156,1.0,21/55,29.32%,PSMD14;FBXL7;USP47;PSMB3;PSMD12;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;PSMB1;PSMB9;AVEN;PSMC6;PSMD3;PSMD10;PSME3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.392825692660986,1.0066539375328452,0.4820971867007673,1.0,1.0,14/29,26.90%,COG5;COPZ2;COPB2;COPG2;COPA;GABARAPL2;COPG1;COG1;TRAPPC3;NAPG;RAB6A;TRAPPC10;GOSR1;COG6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.287622136922133,-1.0066489393759621,0.43434343434343436,0.8344588567131276,1.0,7/35,11.14%,FLT1;PTPRM;COL4A3;THBS1;RGCC;XDH;ATOH8
prerank,cellular response to amino acid stimulus (GO:0071230),0.3736317434765637,1.006582207618824,0.4544287548138639,1.0,1.0,14/33,26.28%,CPEB3;FYN;LAMTOR2;CASTOR2;CPEB1;KLHL22;SPAAR;RPTOR;IPO5;RRAGA;MTOR;SESN1;SLC38A9;CPEB4
prerank,substrate-dependent cell migration (GO:0006929),-0.3804666709957618,-1.006486345001844,0.44761904761904764,0.8332881223783352,1.0,5/14,16.15%,NRP1;VEGFC;EPHA8;PTPRC;ITGA11
prerank,positive regulation of hemostasis (GO:1900048),0.48319521967176504,1.006215599003813,0.46656534954407297,1.0,1.0,1/10,1.60%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.48319521967176504,1.006215599003813,0.46656534954407297,1.0,1.0,1/10,1.60%,ST3GAL4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3185543842730797,-1.0060550751145252,0.4362934362934363,0.832921210836641,1.0,6/26,6.83%,EYA1;EYA2;MAP2K5;EYA4;MCL1;PPP2R1B
prerank,regulation of interleukin-12 production (GO:0032655),0.3610898128697022,1.0051679412862107,0.4546525323910483,1.0,1.0,4/47,4.92%,IL16;IRAK3;MAST2;PLCB1
prerank,defense response to bacterium (GO:0042742),-0.23273985546011317,-1.0048954538487613,0.4533333333333333,0.8345587899678032,1.0,23/105,21.76%,ANXA3;ANKRD17;PRKCD;TLR4;RPS19;DEFA6;IRGM;IL6R;PGLYRP1;PPP1R11;OPTN;STAB1;OAS2;SERPINE1;TIRAP;CFP;GSDMD;MPEG1;ISG15;HMGB2;NOD1;FCER1G;COLEC12
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3456388522424373,1.0046767674403398,0.46179775280898877,1.0,1.0,19/72,19.47%,PYCARD;CBFB;FADD;PTPN2;IRAK3;TRIM44;SOCS1;AGPAT2;OTULIN;PTPN1;PTPN11;TAX1BP1;SUMO1;RUNX1;CD74;RIPK1;CHUK;AXL;SPPL2B
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.33680040557290625,1.004617999811398,0.4906284454244763,1.0,1.0,20/80,18.12%,TBC1D10A;DENND2A;RHOBTB3;VPS29;ARL1;GBF1;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SPAG9;SNX1;WASHC1;UBE2O;SNX12;SURF4;RBSN;RAB7A;RAB7B
prerank,positive regulation of potassium ion transport (GO:0043268),0.37273491590802643,1.0044674758850067,0.47117794486215536,1.0,1.0,10/38,19.82%,ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1;NOS1AP
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4184070127008084,-1.0044589064213914,0.4320652173913043,0.834235335579797,1.0,2/10,1.38%,ATP1A2;OSR1
prerank,negative regulation of organelle assembly (GO:1902116),-0.28132673092278476,-1.0039550365028664,0.39603960396039606,0.8340927866812173,1.0,14/35,22.58%,ODF2L;FEZ2;SCFD1;EVI5L;CCP110;NUPR1;RBM14;TBC1D7;TBC1D30;SMCR8;CDK10;PINK1;KAT2A;STYXL1
prerank,protein phosphorylation (GO:0006468),0.3103567537552281,1.0036547486357028,0.5165165165165165,1.0,1.0,83/479,13.05%,RELN;WNK2;CCL11;EFEMP1;PRKCA;PDGFRA;STK32B;PRKCQ;PKDCC;PEAK1;STK36;ERBB2;EGFR;ACVR1;PRKX;MAP4K4;PAK4;MAP3K3;EPHB2;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;NEK1;TGFB1;TEC;PAK5;NTRK2;MAPKAPK2;DYRK4;TESK2;PRKAR1B;TNIK;EEF2K;ACVR1C;PAK1;PKN1;YWHAZ;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;LIMK1;CDK6;FGFR1;FYN;CDK15;TBCK;CDK19;STK39;PASK;TLK2;MAPK9;AKT3;SGK3;SGK2;ERBB4;SLK;PXK;TYK2;MAPK14;DCLK1;STK32A;STK19;CDC25B;MAPK1;TAOK3;CDK5R1;TBK1;STK33;CSNK1G1;PRKACA;CSNK1A1;NEK7;CDK16
prerank,mitochondrial fission (GO:0000266),0.4404792933388715,1.003622081584891,0.4751066856330014,1.0,1.0,2/16,2.35%,DNM1;PRKN
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4274310953702042,1.0035179866699107,0.48463687150837986,1.0,1.0,4/18,11.11%,CD34;ITGB8;HIF1A;LTBP1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3880256776710968,1.0033993024746635,0.4577373211963589,1.0,1.0,11/30,24.96%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1
prerank,lysosome organization (GO:0007040),0.3738717809777544,1.0033227939314415,0.4674185463659148,1.0,1.0,16/36,23.94%,GNPTAB;VPS33A;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLVS2;HOOK1;HOOK3;TPP1;CLN6;MTOR
prerank,cellular response to organic substance (GO:0071310),0.32889326251270135,1.0029657352426096,0.49148936170212765,1.0,1.0,23/116,12.63%,ERBB2;NCOA1;IL1RAPL1;ACVR1;PTPN2;MAPK7;TGFB1;PTPN13;ACVR1C;URI1;TGFBR2;IL1RL2;CYP1B1;IL18;NCOA2;AKAP6;PTPN11;HDAC6;ARL6IP5;PID1;EMD;TBK1;PTPN18
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2599901045403673,-1.002941908376028,0.4591194968553459,0.835497325858247,1.0,17/47,23.29%,MTX2;TOMM70;MICOS10;DNAJC11;ATP5MC3;SPG7;IMMT;TMEM11;ATP5PD;ATP5F1D;ATP5MF;TIMM9;TIMM22;MTX1;TIMM10B;TIMM8B;ROMO1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3261163759127249,1.0027923768819438,0.5072916666666667,1.0,1.0,20/125,14.45%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;NDE1;SETD2;DYNC1I1;RCC1;CLASP1;NUP160;SGO1;ZWINT;CKAP5;KPNB1;BUB1B;DYNC1I2;ITGB3BP
prerank,activin receptor signaling pathway (GO:0032924),0.4421555684556476,1.00233910515398,0.4607703281027104,1.0,1.0,2/15,5.43%,ACVR1;ACVR1C
prerank,tRNA wobble base modification (GO:0002097),-0.3742351696061542,-1.002125021677408,0.4316109422492401,0.8362479449893369,1.0,5/14,16.43%,TRMT9B;URM1;ELP3;MTO1;DPH3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.32899184861770797,1.0020261565481992,0.5015940488841658,1.0,1.0,20/104,16.36%,SOSTDC1;PRDM16;HTRA3;ACVR1;TGFB1;TGFBR2;SPRED2;SPRED1;PEG10;BCL9L;SPRED3;SNX6;DAND5;MAGI2;BMPER;BMPR1A;LDLRAD4;UBB;LRP2;VWC2
prerank,dendritic spine morphogenesis (GO:0060997),0.439465114667225,1.0020037176224068,0.48840579710144927,1.0,1.0,4/15,11.37%,PTEN;EPHB2;DOCK10;DIP2A
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.30686706384525236,1.0016458218972082,0.483,1.0,1.0,192/834,21.49%,RORA;OSR2;DCN;ETV1;BMP5;MLIP;KLF15;CXCL10;ETV4;MEOX2;MAML3;GLI2;MACC1;FGF2;SOX8;CRLF3;MYC;KAT2B;SOX9;SSBP2;PRKN;NCOA1;CDKN2B;EGFR;FADD;HIVEP1;ACVR1;HOXA7;KMT2A;VEGFA;CCNC;TFCP2;MAPK7;MAML2;CRTC1;RPS6KA4;TGFB1;AUTS2;SOX11;SETD3;RFXANK;GLI1;E2F2;PHOX2A;WNT5A;HOXD3;CDK8;RFX3;CDK13;MLXIPL;MLX;DRAP1;PPP3CB;KAT8;GATA6;MEN1;FOXM1;IL18;ASXL3;PPP3CA;ATMIN;ATRX;ZNF462;RARG;BRCA1;RARB;SOX12;ZMIZ1;NCOA2;LDB2;KLF5;BRD8;HIF1A;ZFP64;IL4I1;BCL9L;HDAC2;ZBTB38;MED13;NFATC3;PIK3R1;MYSM1;GDNF;ATF2;NGFR;ESR1;NFE2L2;ARF4;SP1;TAF9;SFPQ;POGZ;PID1;MYDGF;BCL9;EPC1;TMF1;DVL1;TBK1;WWTR1;XRCC6;NRIP1;PRPF6;ZFPM2;ATF5;PER1;GATA3;AHR;SALL2;NCK1;PAX3;BMPR1A;PKD1;CITED2;TAF7;MED12;MET;HOXB7;ELL;ZEB2;UBB;IL33;MED25;JUP;ATM;RUNX1;ABL1;MEIS3;GCN1;MEPCE;MED21;TP53;SP3;TET3;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ASXL2;NFIA;WWOX;FOXJ1;PAX2;GABPB2;GABPB1;RNF10;RIPK1;CDC73;CHUK;NFIX;NCOA3;SLC9A1;HEYL;NR5A1;CSRNP3;IRF3;MED30;KLF7;AATF;RNF4;PARK7;EGR1;SENP1;RUVBL2;CNBP;FOXJ3;PPARG;JUN;STAT3;PRDM2;ONECUT2;MCRS1;TFE3;SMARCA4;FUBP3;KMT2D;PBX1;ZBED4;NR1D2;MEIS1;ZSCAN21;DPF2;NFKB1;MITF;THRA;DCAF6;TNIP2;RPS6KA3;DVL3;PRKD2;PKD2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4079627910692431,-1.0015396342738898,0.47696476964769646,0.8363882754517971,1.0,4/10,17.28%,APPL2;RAB31;NCKAP1L;CD300A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.451263663961885,1.0014784616442927,0.47238372093023256,1.0,1.0,4/14,12.35%,NUDT15;ENTPD2;NUDT1;NUDT9
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.35644980124447734,1.0014453731715296,0.47368421052631576,1.0,1.0,10/54,11.00%,PRKCA;FGF2;VEGFA;TGFB1;NF1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,cellular component assembly (GO:0022607),0.3160124172978065,1.0013920630096453,0.4994944388270981,1.0,1.0,53/253,18.13%,ANK3;RHOJ;HAS2;RHOD;REPS2;SOX9;GSN;LAMC1;WIPF1;EPRS1;KMT2A;RSPH1;TGFB1;GPM6B;WNT5A;SPTBN1;NLGN1;YWHAZ;BAIAP2;FLNA;TEX11;PPID;CFAP46;MAGI1;CFAP74;RIMS1;FANCC;MYO9A;GORASP2;OPHN1;RHOH;DVL1;WASF1;RBBP4;DET1;CORO1B;MDM4;RTN4;CYFIP1;PKP2;NIFK;TP53;LPXN;PPIH;LRRTM3;IL1RAP;FSCN1;FOXJ1;CD74;RAC3;RSPH9;DCX;MDM2
prerank,regulation of hormone secretion (GO:0046883),0.42823140768242085,1.0013358344836605,0.4593437945791726,1.0,1.0,3/15,11.59%,SOX11;SNX6;EDN3
prerank,intraciliary retrograde transport (GO:0035721),-0.3840966185549753,-1.0011373287616534,0.48,0.8359112687640331,1.0,6/12,13.39%,WDR19;IFT43;DYNC2LI1;DYNLT2B;IFT122;DYNC2I2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2731500321082138,-1.0011078090521,0.45989304812834225,0.8344371874416384,1.0,9/41,13.06%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ABCC9;ATP1A1;SLC12A9;KCNK9;SLC12A8
prerank,regulation of immunoglobulin production (GO:0002637),0.39752361915787215,1.0010101969207983,0.47106325706594887,1.0,1.0,2/23,3.65%,EPHB2;DNAJB9
prerank,muscle cell migration (GO:0014812),-0.4184195793627786,-1.0009617176490315,0.44285714285714284,0.8332654260741649,1.0,3/10,13.64%,ROCK1;SIX1;DDR1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3787248802191757,1.0003389752725493,0.4639580602883355,1.0,1.0,2/32,3.93%,CXCL10;RNASE6
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3899691117197548,-1.0001171004613856,0.43823529411764706,0.8340048569390065,1.0,5/11,36.55%,LYN;ANXA1;PIK3CB;RAPGEF2;MEF2C
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4054517908836907,-0.9999050744200476,0.47513812154696133,0.8331152249777548,1.0,5/10,29.54%,TERT;TARBP2;MRPL44;AGO2;DICER1
prerank,negative regulation of mRNA processing (GO:0050686),-0.365040771880198,-0.999688122863106,0.45751633986928103,0.8321540818894646,1.0,8/15,23.36%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF12;SRSF7;U2AF2
prerank,regulation of cell population proliferation (GO:0042127),0.3074080416736034,0.9996185179541408,0.511,1.0,1.0,120/691,16.21%,ROR2;OSR2;DLC1;SSTR1;WNK2;BMP5;CLDN19;CXCL10;PDGFRA;ERBB3;HAS2;NTRK3;GLMN;FGF2;MYC;FGF10;KIF20B;PTEN;BCL2;GAREM1;IRS2;KAT2B;SOX9;CRLF1;NGF;BST1;ERBB2;CDKN2B;EGFR;SQLE;FRZB;PTPN2;VEGFA;CADM4;PTHLH;CAPN1;TGFB1;TIPIN;PTGFR;SOX11;NUPR2;NTRK2;GDF9;GLI1;NOX1;NOP2;PAK1;BNIPL;KSR1;CDK13;PODN;TSC1;TGFBR2;MLXIPL;UFL1;ADAMTS1;CYP1B1;CBFA2T3;CDK6;MEN1;FOXM1;FGFR1;TSHR;GAB2;NF2;COL18A1;RARG;BTC;DERL2;SGK3;SGK2;AMELX;SHCBP1;CUL3;HDAC2;ERBB4;SFRP4;GDNF;PTPRJ;IL6ST;PRMT1;CDC25B;MAGI2;S1PR3;EDN3;ING4;FGF7;ATP8A2;RTKN2;WWTR1;XRCC6;DRD2;GLP2R;PRLR;PRDX3;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;TRAPPC14;NACC2;RPS6KA2;PDS5B;MDM4;BMPR1A;CD164;LMNA;CCL14;JUP;RUNX1;MEIS3;PIM2;TP53;CCND2;GPLD1;XIAP;TRNP1;TGFB3
prerank,mRNA destabilization (GO:0061157),-0.2773605958376029,-0.9992391998634987,0.46842105263157896,0.8318417105987568,1.0,7/38,7.64%,ROCK2;ROCK1;YTHDF1;MOV10;ZFP36L1;METTL14;CNOT1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.36976663592380843,0.9987685508988445,0.47006369426751593,1.0,1.0,12/41,21.75%,FGF2;CACNA2D1;GRIN2B;SLC8A2;HTR2C;DRD2;GRIN2D;GRIN2A;SLC24A2;RYR3;PKD2;ERO1A
prerank,positive regulation of lipid localization (GO:1905954),0.4605235978593221,0.9986903475193457,0.46601941747572817,1.0,1.0,1/11,2.55%,LRP1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3438614509518602,0.9984030984476596,0.49193548387096775,1.0,1.0,14/68,15.44%,ACP5;MMAB;PDXK;CD320;ALDH1L1;MCCC1;HLCS;PNPO;MTRR;MCCC2;MTHFD2L;RFK;MTR;ALDH1L2
prerank,gene silencing by miRNA (GO:0035195),-0.28807841201146656,-0.9983241517060997,0.44559585492227977,0.8328951194475878,1.0,7/32,12.43%,WTIP;MOV10;AGO1;ZC3H7B;CNOT1;NOTCH4;AGO3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30506689314782254,0.9980582297713525,0.515,1.0,1.0,252/1082,21.49%,RORA;OSR2;DCN;ETV1;BMP5;MLIP;KLF15;CXCL10;MDFIC;ETV4;MEOX2;MAML3;GLI2;MACC1;FGF2;SOX8;PRDM16;CRLF3;MYC;RGMB;KAT2B;SOX9;SSBP2;HMGN1;ERBB2;PRKN;NCOA1;CDKN2B;EGFR;FADD;HIVEP1;ACVR1;HOXA7;KMT2A;VEGFA;CCNC;TFCP2;MAPK7;WAC;KDM8;EIF2AK3;MAML2;CRTC1;RPS6KA4;TRIM44;TGFB1;AUTS2;PSEN1;FANK1;NCF1;SOX11;SETD3;BICRAL;RFXANK;RNF6;MT3;PLCB1;GLI1;RAI1;E2F2;ATF7IP;PHOX2A;CXXC1;WNT5A;HOXD3;HNRNPAB;CDK8;RFX3;ZBTB16;RORC;MLXIPL;MLX;CREB3L2;DRAP1;PPP3CB;DYRK1B;NAA16;FZD7;KAT8;GATA6;ZC3H8;MEN1;BICRA;FOXM1;SPIN1;IL18;ASXL3;PPP3CA;ATMIN;ARHGEF11;ATRX;ZNF462;TFAM;RARG;BRCA1;HEATR1;RARB;SOX12;ZMIZ1;NCOA2;LDB2;KLF5;BRD8;HIF1A;ZFP64;IL4I1;BCL9L;HDAC2;ERBB4;ZBTB38;MED13;NFATC3;PIK3R1;MYSM1;GDNF;ATF2;ESR1;NFE2L2;ARF4;SMARCC2;SP1;TAF9;ASF1A;SFPQ;POGZ;PID1;BMP7;MYDGF;BCL9;FGF7;EPC1;TMF1;PHF8;DVL1;TBK1;WWTR1;XRCC6;NRIP1;PRPF6;ZFPM2;ATF5;PER1;GATA3;AHR;SALL2;PRDM11;SMARCC1;NCK1;PAX3;HIVEP3;DHX33;PCBD2;BMPR1A;COL1A1;PKD1;CITED2;TAF7;MED12;MET;HOXB7;ELL;ZEB2;UBB;POU3F1;IL33;MED25;JUP;ATM;RUNX1;ABL1;MEIS3;PIM2;BLM;MED21;TP53;SP3;TET3;KCNH2;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ING1;ASXL2;QRICH1;USP21;NFIA;WWOX;FOXJ1;PAX2;GABPB2;GABPB1;CD74;RNF10;RIPK1;CHUK;NFIX;NCOA3;SLC9A1;HEYL;NR5A1;PCID2;CSRNP3;RPTOR;IRF3;MED30;ZNF496;KLF7;NAA15;AATF;RNF4;MAPRE3;PSMD9;PARK7;KMT2E;EGR1;SENP1;RUVBL2;CNBP;BCL10;FOXJ3;PPARG;JUN;STAT3;PRDM2;ONECUT2;MCRS1;UBTF;TFE3;SMARCA4;FUBP3;KMT2D;CD38;PBX1;ZBED4;NR1D2;MEIS1;ZSCAN21;DPF2;SEC14L2;NFKB1;MITF;ZXDC;THRA;DCAF6;TNIP2;RPS6KA3;NSD1;DVL3;PRKD2;PKD2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33816420529211855,0.9979348901768393,0.47742663656884876,1.0,1.0,13/76,16.76%,GNA14;HRH1;LPAR1;PTGER3;GPR65;GRM5;HTR2C;ESR1;DRD2;P2RY12;P2RY1;HOMER1;OPRK1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.21501166836607802,-0.9975580290185565,0.5128205128205128,0.8336118541997621,1.0,27/137,12.38%,AFDN;PKP4;CD200;CTSH;SNX9;CCL25;AGRN;RIC1;MTCL1;ITGA6;CCL15;SNX18;NET1;ARAP1;EVI5L;ARHGAP27;GSK3B;TGM2;FLCN;RHOA;RACK1;MAPK12;PLXNB1;RSU1;LARS1;RALBP1;RASGRF1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3405319122548136,0.9973232032110426,0.4811529933481153,1.0,1.0,15/74,14.70%,BMP5;GLIPR2;PHLDB1;PTEN;TGFB1;TGFBR2;SPRED2;SPRED1;BCL9L;SPRED3;CLASP1;WWTR1;GATA3;COL1A1;LDLRAD4
prerank,histone mRNA catabolic process (GO:0071044),-0.3646245291493694,-0.99716003674136,0.42592592592592593,0.8331953660133423,1.0,8/15,19.33%,XRN1;LSM1;MTPAP;ERI1;DCP2;TUT7;EXOSC10;TENT4B
prerank,regulation of programmed cell death (GO:0043067),0.32158612694977406,0.9968110733774916,0.4963655244029076,1.0,1.0,36/161,17.24%,BCL2L14;RTKN;CXCL10;OLFM4;SOX9;PRKN;STEAP3;TNFRSF10B;FANK1;APAF1;CASP6;BNIP3;NAE1;NF2;CTSB;RARG;HIP1;SLK;ANP32E;MALT1;TM7SF3;DDX42;RTN4;CASP2;CRADD;ATM;ABL1;IFT57;TP53;BCL2L11;HTATIP2;GLS2;SGK1;PAX2;RIPK1;WRN
prerank,gland development (GO:0048732),0.35151224691523386,0.9968089843106187,0.48711943793911006,1.0,1.0,14/59,16.21%,GLI2;FGF10;SOX9;FADD;PRKCSH;NF1;HOXD3;DKK3;IGSF3;ZBTB1;COBL;CITED2;MET;TGFB3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4096826661256436,0.9965695001698518,0.48435374149659866,1.0,1.0,3/21,8.27%,PTCH1;LRP1;ZDHHC8
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.35858380784814137,0.9965618759609653,0.47002398081534774,1.0,1.0,14/43,20.22%,FGF2;SOX9;TGFB1;KLF5;HIF1A;NFATC3;NGFR;GATA3;TP53;EGR1;PPARG;JUN;STAT3;SMARCA4
prerank,epidermal cell differentiation (GO:0009913),0.3684176491726279,0.9964728379214957,0.47911547911547914,1.0,1.0,6/41,10.11%,CERS3;TGM1;GLI1;WNT5A;GATA6;HDAC2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.23873655335818264,-0.9964696576044985,0.49504950495049505,0.8337009143965193,1.0,22/80,14.92%,NRP1;OCLN;WASL;AGRN;PLEKHM1;FNBP1L;CDC42EP4;WASF2;ARHGAP35;ARAP1;FAM98A;AKIRIN1;CCP110;RHOQ;EPS8;CDC42EP3;ABI2;EPS8L2;CDC42EP2;CDC42;AVIL;FUZ
prerank,iron ion homeostasis (GO:0055072),-0.25171835983938007,-0.9962193175673789,0.45,0.8329075858673626,1.0,21/58,20.45%,BMP6;ABCG2;FLVCR1;FBXL5;ATP6V0D1;SLC40A1;FTH1;FTL;BDH2;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC22A17;ACO1;ABCB7;HFE;TMEM199
prerank,osteoclast differentiation (GO:0030316),-0.3108634695253727,-0.9960677226549478,0.45907473309608543,0.8318483996393944,1.0,5/22,12.36%,FOXP1;GLO1;TNFRSF11A;SBNO2;OSTM1
prerank,negative regulation of JNK cascade (GO:0046329),0.38426137012016104,0.9960318742437004,0.493167701863354,1.0,1.0,13/31,23.71%,PTPN22;PRKN;MEN1;TAOK3;PER1;DACT1;FKTN;DNAJA1;ZMYND11;PDCD4;SIRPA;CYLD;AIDA
prerank,thymus development (GO:0048538),0.4505318733014678,0.9959676172784044,0.47214076246334313,1.0,1.0,2/13,2.66%,FGF10;FADD
prerank,histone H2A acetylation (GO:0043968),0.42367624500625584,0.9957380864839241,0.48,1.0,1.0,6/16,19.23%,BRD8;MORF4L2;EPC1;TRRAP;MSL3;RUVBL2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42368113984162975,0.9956792691563852,0.484,1.0,1.0,5/19,15.48%,CBFB;MAPK7;WNT5A;TAF9;RUNX1
prerank,histone monoubiquitination (GO:0010390),0.392900448153619,0.9955045404458698,0.47248322147651006,1.0,1.0,12/24,27.83%,WAC;DDB2;DDB1;CUL4B;CDC73;BCOR;UBE2E1;RNF2;PCGF1;RNF20;RNF168;TRIM37
prerank,regulation of cilium assembly (GO:1902017),-0.25539539393293514,-0.995006650691318,0.4645669291338583,0.8332506378955759,1.0,22/62,19.25%,TBC1D8;ODF2L;TBC1D14;TBC1D1;TBC1D15;DCDC2;ARHGAP35;EVI5L;CCP110;TBC1D13;DYNC2LI1;DYNLT2B;RABEP2;TBC1D7;FUZ;TBC1D30;TBC1D10B;CDK10;CROCC;TBC1D2;TBC1D22B;TBC1D16
prerank,apoptotic mitochondrial changes (GO:0008637),0.38592416891590525,0.9949615128756203,0.47736093143596375,1.0,1.0,11/32,21.72%,BCL2;THEM4;BNIP3;ERBB4;ATG3;SOD2;GGCT;FZD9;HK2;HSPD1;AIFM2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.24167613626086995,-0.9949126112448561,0.4649122807017544,0.8319616646953443,1.0,32/72,33.18%,PSMD14;BIRC3;REL;RELB;PSMB3;PSMD12;ZFP91;PSMD6;MAP3K7;PSMA1;TIRAP;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;NFKB2;PSMA4;AKT1;PSMB1;PSMB9;PSMC6;PSMD3;PSMD10;PSME3;DICER1;TLR3;BTRC;FBXW11;BIRC2;PSMA6;PSME2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3481525751116076,-0.9948447103356177,0.4902597402597403,0.8306080287355952,1.0,6/16,20.01%,TRIM25;TRIM5;EXOC2;CAV1;TRIM21;TRIM68
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.31639100196622905,-0.9946633507048926,0.45228215767634855,0.82956484353925,1.0,10/25,24.37%,RECQL5;WDR43;EAF2;EAF1;LEO1;LARP7;CDK12;NELFCD;HEXIM1;EAPP
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.43484050331845137,0.9943412436390169,0.47863247863247865,1.0,1.0,3/17,10.31%,SULF1;PCSK6;SFRP4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3256298960154542,0.994078598204328,0.47927736450584485,1.0,1.0,27/108,19.67%,DLC1;PYCARD;MYC;GSN;NGF;FADD;EIF2AK3;TNFRSF10B;ACVR1C;APAF1;CARD9;HIP1;NGFR;ARL6IP5;CASP12;MALT1;SNCA;CASP2;CRADD;IFT57;RPS27L;NDUFA13;RIPK1;AIFM1;SENP1;BCL10;PPARG
prerank,heart process (GO:0003015),0.43826332530055195,0.9934682406701059,0.4682080924855491,1.0,1.0,3/14,8.06%,SGCD;SGCZ;FYN
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3031781129428791,0.9929498458040575,0.551,1.0,1.0,294/1667,17.62%,EBF2;RORA;OSR2;DCN;ETV1;SOX6;NKX6-2;PTCH1;TENM2;BMP5;MLIP;KLF15;CXCL10;MEOX1;EBF4;ETV4;MEOX2;TSHZ3;LHX5;TLX3;MAML3;GLI2;MACC1;CREB3L1;RCOR2;FGF2;IFRD1;SOX8;AASS;PRDM16;CRLF3;MYC;DMRT2;TGIF2;PTEN;EBF1;CBFB;HOXB8;ZNF25;ZBTB20;KAT2B;SOX9;SSBP2;ERBB2;PRKN;RIPPLY2;NCOA1;CDKN2B;EGFR;SUV39H1;FADD;HIVEP1;ACVR1;OTP;ZBTB37;HOXA7;KMT2A;SATB1;VEGFA;CCNC;TFCP2;EGR3;MAPK7;MAML2;CRTC1;RPS6KA4;NFX1;FOXP2;KDM5B;GTF2H2;TGFB1;AUTS2;BAZ1A;RFX2;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;MED31;SETD3;RFXANK;ZNF276;GLI1;RAI1;E2F2;ZEB1;PHOX2A;NOP2;WNT5A;HOXD3;RPRD1A;PGBD1;URI1;EED;PKN1;ZFP14;OTUD7B;CDK8;RFX3;ZBTB16;MAMLD1;CDK13;RORC;MTA2;MLXIPL;MLX;TRPS1;CREB3L2;TADA1;TWIST2;DRAP1;PPP3CB;E2F6;KAT8;LRRFIP1;GATA6;CBX4;TBX18;MEN1;FOXM1;ZSCAN20;CHD3;VPS72;IL18;MKX;CPEB3;ASXL3;PPP3CA;ZBTB41;ATMIN;ATRX;KCTD1;ZNF462;RARG;PPP1R13L;BRCA1;MBD2;RARB;SOX12;SOX5;PPID;ZMIZ1;NCOA2;ZNF569;BBX;LDB2;KLF5;BRD8;HIF1A;ZFP64;DBX2;PIAS2;IL4I1;ARID4B;BCL9L;ZBTB6;CHD2;HDAC2;ZSCAN26;ZBTB38;MED13;NFATC3;ELP2;PIK3R1;ZNF260;PSIP1;MYSM1;GDNF;ATF2;ZKSCAN8;PHF20;ESR1;NFE2L2;MAPK14;ARF4;MYT1;SIN3B;LIN9;SMARCC2;SP1;ZNF112;TAF9;SFPQ;POGZ;RBAK;PID1;SIRT6;DCAF1;CREBZF;MYDGF;BCL9;MIDEAS;ZFHX4;EPC1;TMF1;PHF8;DVL1;PER3;TBK1;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;WWTR1;XRCC6;NRIP1;PRPF6;SOD2;ZFPM2;ATF5;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;SMARCC1;BAZ2B;ELP4;NACC2;SNCA;NCK1;PAX3;LCOR;ZFHX2;MDM4;NEDD4L;HIVEP3;SUMO1;CRY1;NCOR2;BMPR1A;PKD1;BAZ1B;CITED2;TAF7;CREM;MED12;SLTM;MET;IRX5;HOXB7;ZNF235;ZEB2;UBB;POU3F1;IL33;MED25;DACT1;JUP;ATM;RUNX1;ABL1;MEIS3;PURG;KLF9;MED21;TP53;ZFX;LCORL;SP3;TET3;ZXDB;MTA3;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ASXL2;NFIA;WWOX;FOXJ1;USP2;PAX2;GABPB2;GABPB1;RNF10;SMARCE1;RIPK1;CDC73;CHUK;NFIX;NCOA3;ZKSCAN1;SLC9A1;HEYL;NR5A1;CTBP1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4619209218132339,0.9928359414545368,0.48302469135802467,1.0,1.0,2/11,4.11%,TAX1BP3;GPM6B
prerank,positive regulation of cell cycle process (GO:0090068),-0.22896458770656905,-0.9927696305337461,0.5774647887323944,0.8333803263456181,1.0,17/91,11.27%,IGF1;PKP4;LRP5;MAP3K20;PLSCR1;USP19;CIT;IGF2;INSR;GIPC1;TGFA;RGCC;RHOA;DYNC1LI1;PDGFRB;NUMA1;WIZ
prerank,determination of left/right symmetry (GO:0007368),0.36986077240962945,0.9926695306808536,0.493167701863354,1.0,1.0,10/37,21.49%,CCDC39;RFX3;SMO;DAND5;ENKUR;CITED2;FOXJ1;GALNT11;BBS7;PKD2
prerank,cellular protein localization (GO:0034613),0.31069183782838306,0.9923889122991354,0.5192307692307693,1.0,1.0,64/285,17.14%,TMED6;HPS6;FGF10;TBC1D10A;BICD1;ANK2;ARMCX3;RAB38;EGFR;RAB14;PACS2;VPS33A;COPZ2;SNX15;VPS29;GRID2;WNT5A;WIPI1;ARL1;ITSN1;RAB21;COPB2;SEC31B;CNTNAP2;LAMTOR2;RABL3;CNTN2;EPB41L3;TBCK;FLNA;TMED10;SNX6;COX18;VPS26B;ARL5C;NGFR;ARF4;BICD2;HDAC6;RAB22A;FGF7;RAB1A;USP6NL;STX8;SYNDIG1;CORO1B;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;SEC23IP;UNC93B1;SGSM1;RIC3;STX1B;PIGU;FOXJ1;TM9SF2;CTTN;AP4M1;CD74
prerank,intracellular lipid transport (GO:0032365),-0.3273222324063395,-0.9920868186544972,0.4496124031007752,0.8337016332736592,1.0,5/21,12.84%,PRKAG2;CPT1A;ACACB;PRKAA2;SLC25A20
prerank,positive regulation of cellular protein localization (GO:1903829),0.3432409271241891,0.9918202183156555,0.49318181818181817,1.0,1.0,24/69,26.59%,BICD1;PRKN;SLC5A3;EIF2AK3;TGFB1;FYN;SYT11;NGFR;WWTR1;RTN4;RIC3;PARK7;TESK1;CCDC88A;PRKAA1;LIMK2;GNL3L;KAT7;GPR137B;GNL3;CARD10;ENTR1;APC;CDK5RAP3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3746292658468569,0.9914814870402111,0.49002493765586036,1.0,1.0,15/33,28.36%,AADAT;GOT2;OAT;ALDH5A1;GLS2;GLS;RIMKLB;GLUD1;DDAH1;DGLUCY;GCLM;NIT2;CAD;RIMKLA;PYCR2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2822264300180884,-0.9912850031871365,0.47577092511013214,0.8345018523350878,1.0,12/34,23.42%,MFHAS1;LYN;TLR4;GPS2;LGR4;GPR108;LRRC14;CD300A;GRAMD4;CACTIN;TNFAIP3;NLRP2B
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.41720036798107435,0.9908849763917702,0.47540983606557374,1.0,1.0,3/18,7.90%,PYCARD;FADD;IL18
prerank,cellular response to mechanical stimulus (GO:0071260),0.3587789216547644,0.9906619070577027,0.49287410926365793,1.0,1.0,9/46,17.45%,PIEZO2;SOX9;FADD;TNFRSF10B;BNIP3;MAP2K4;CASP2;CRADD;SLC9A1
prerank,histone H3 acetylation (GO:0043966),0.3618264429356025,0.9906271140925056,0.46307884856070086,1.0,1.0,9/40,13.12%,KAT2B;JADE1;TADA1;TAF5L;JADE3;POLE3;TAF9;ING4;PER1
prerank,regulation of heart contraction (GO:0008016),0.33293317436773795,0.9901862873663629,0.49396267837541163,1.0,1.0,17/90,17.16%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;PDE4D;FXYD1;PRKACA;ATP2B1;AHCYL1;CALM1;CALM2;NPPC;MYH6
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2661441760054998,-0.990180602352491,0.45962732919254656,0.8360553916796659,1.0,18/48,23.42%,ROBO1;SLIT2;GPS2;SAMHD1;CCDC3;NR1H2;PTPRC;PADI2;PARP14;STAT2;USP18;PELI3;ISG15;NR1H3;RFFL;CACTIN;MUL1;NLRP2B
prerank,nucleic acid-templated transcription (GO:0097659),-0.26871644250406473,-0.9898761485295436,0.44516129032258067,0.8352923346232703,1.0,17/42,23.59%,THRB;RRAGC;DRG1;CREBL2;MMS19;PWP1;MED20;TERT;BAZ2A;POLR2C;DTX1;POLR2E;POLR2J;XAB2;PTMA;POLR2D;E2F1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4524979016747728,0.9897842122553765,0.4774494556765163,1.0,1.0,4/12,19.75%,TGFB1;ESR1;NCOR2;STAT3
prerank,regulation of mRNA processing (GO:0050684),0.37563333338006444,0.9892632688590846,0.4831038798498123,1.0,1.0,9/32,17.61%,QKI;SON;KHDRBS3;NCBP1;AHCYL1;YTHDC1;SLTM;PAPOLA;SF1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4160602761647354,0.9891926853125587,0.4877384196185286,1.0,1.0,2/20,1.76%,ERBB3;BCL2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3637719617537687,0.9891647912059576,0.47342398022249693,1.0,1.0,8/42,14.03%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,regulation of gluconeogenesis (GO:0006111),-0.30472813425909484,-0.9887552327671747,0.4576271186440678,0.8368448826933921,1.0,8/27,17.18%,USP7;CLK2;SIK1;OGT;ARPP19;C1QTNF3;PDK2;PGP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.48264261104008854,0.9886145786235959,0.5046439628482973,1.0,1.0,2/10,3.52%,MAPK7;IRAK3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4755112780227749,0.9884561952352992,0.5054773082942097,1.0,1.0,2/10,5.68%,CBFB;SOCS1
prerank,epidermis development (GO:0008544),0.3478627388808192,0.9884232001212881,0.5115740740740741,1.0,1.0,8/56,11.99%,CERS3;PTHLH;EMP1;GLI1;GATA6;PLOD1;HDAC2;FGF7
prerank,organelle disassembly (GO:1903008),-0.27677471359468825,-0.9883552547811428,0.4951923076923077,0.836535638686974,1.0,10/33,21.18%,MTIF2;TEX264;KIF5B;KLC1;UFM1;GFM2;MTIF3;UFC1;UBA5;ULK1
prerank,synaptic vesicle transport (GO:0048489),-0.39548481633436733,-0.9881048665061379,0.47126436781609193,0.83568750812676,1.0,5/11,14.87%,SYNJ1;KIF5B;DNM2;SNAPIN;TMEM230
prerank,regulation of cell adhesion (GO:0030155),0.3227231127540338,0.9876059316467395,0.5164021164021164,1.0,1.0,18/129,10.85%,TGFBI;PRKCA;ERBB3;EPB41L4B;RHOD;ERBB2;PLXNC1;PRKX;EFNA5;VEGFA;EPHB2;PDE3B;RASA1;IL18;PPP3CA;DSCAM;PTPRJ;PTPN11
prerank,negative regulation of cell activation (GO:0050866),-0.3660558199346118,-0.9875446940122122,0.4702194357366771,0.8356459575484103,1.0,3/14,2.67%,CD200;THBD;NOS3
prerank,apoptotic cell clearance (GO:0043277),0.3917105374090265,0.9874929680191156,0.4909560723514212,1.0,1.0,3/30,2.81%,XKR7;LRP1;XKR8
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3330947285312148,0.9873836225844352,0.4920091324200913,1.0,1.0,16/70,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.33276370927815246,-0.9870632492797767,0.4639175257731959,0.8355065443368306,1.0,6/19,13.59%,CENPJ;DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3299451408092696,-0.9870165809149433,0.468013468013468,0.8341496687357912,1.0,11/19,34.56%,POLD3;AMPD3;TERT;DCK;APRT;CDA;POLD2;POLD1;PNP;ADA;POLL
prerank,nucleic acid metabolic process (GO:0090304),0.3372749594941366,0.9869215975431349,0.4966887417218543,1.0,1.0,23/69,21.25%,DXO;ATXN2;POLR2B;METTL3;SETMAR;XRN2;DDX54;DDX24;POLR2K;NCBP1;DUSP11;HNRNPA3;EXD2;POLR2G;TOPBP1;POLG;HNRNPU;WRN;POLR2A;HNRNPC;HNRNPH2;HNRNPL;RBFOX2
prerank,regulation of viral release from host cell (GO:1902186),-0.3181149778983646,-0.9868496479368846,0.4715447154471545,0.8330866374908473,1.0,7/21,17.26%,CHMP3;TSG101;TRIM25;TRIM5;VPS4A;PML;TRIM21
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3505147932716385,0.9867694342924809,0.4874551971326165,1.0,1.0,13/49,24.51%,PYCARD;FADD;TLR1;RAB1A;CD74;RIPK1;LBP;PARK7;BCL10;STAT3;PRKD2;MAVS;HSPA1A
prerank,cellular glucose homeostasis (GO:0001678),0.35914970635774246,0.9859734724614309,0.5085995085995086,1.0,1.0,14/41,22.83%,ZBTB20;TRA2B;LRRC8D;PDK3;HIF1A;PIK3R1;NGFR;PRKACA;PAX2;PCK2;HK2;ADCY8;PRKAA1;HK1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.32386212687899874,0.9857194182807313,0.509719222462203,1.0,1.0,32/109,22.71%,PRKCQ;TEC;PAK1;PPP3CB;PPP3CA;GAB2;VAV3;PSMB7;MAPK9;NFATC3;PIK3R1;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;PSMB2;CHUK;PSMD9;TAB3;GRB2;PSME4;BCL10;JUN;PSMA8;SOS1;NFKB1;VAV2;CARD11;TAB2
prerank,inorganic cation transmembrane transport (GO:0098662),0.3071395046600626,0.9855927282740184,0.5347432024169184,1.0,1.0,23/268,7.96%,SCARA5;KCNK15;SLC6A2;SLC1A3;KCNA2;SCN7A;KCNH8;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;CACNA1A;KCNA6;SLC36A2;SLC12A2;SCN5A;KCND1;KCND2;SCN3A;KCND3;SLC30A4;SLC8A2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3487997203951322,0.9853145245968805,0.49539170506912444,1.0,1.0,20/52,26.01%,RBFOX1;CELF5;TRA2B;KHDRBS3;CELF6;RBM7;NOVA1;SRSF6;YTHDC1;HNRNPU;RNPS1;RBFOX3;CELF4;HNRNPL;RBFOX2;RBM25;FMR1;NSRP1;RBM4;RBM15
prerank,nitrogen compound transport (GO:0071705),0.32014697505900797,0.9852882054259023,0.5119418483904465,1.0,1.0,28/141,18.47%,SLC6A2;SLC22A3;SLC1A5;RAB38;SLC38A4;SLC16A10;CD320;LRRC8D;SLC44A2;SLC36A2;SLC12A2;SCAMP2;SLC43A1;SEC14L1;RCN3;SLC7A7;NDC1;ARL6IP5;SLC7A8;HSP90B1;LRP2;SLC6A15;ABCC1;DENND10;RAB7A;SLC44A1;SLC6A4;KIF3A
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.45277207752090903,0.9852354689832018,0.49404761904761907,1.0,1.0,4/12,19.67%,TGFB1;ESR1;NCOR2;PPARG
prerank,autophagy of nucleus (GO:0044804),0.42400585018231823,0.9848522898526499,0.4834054834054834,1.0,1.0,3/16,12.66%,WIPI1;ATG5;ATG3
prerank,negative regulation of histone acetylation (GO:0035067),0.45654158598476435,0.9843339992878122,0.48992248062015503,1.0,1.0,4/11,17.62%,BRCA1;SNCA;TAF7;CTBP1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3809773773359792,-0.9842873886088468,0.49707602339181284,0.8386485833757689,1.0,2/12,3.82%,FOXP1;LYN
prerank,positive regulation of cell motility (GO:2000147),0.3123467052235274,0.9842805702253475,0.5416666666666666,1.0,1.0,21/205,6.75%,ROR2;CCL11;PRKCA;LGR6;PDGFRA;HAS2;NTRK3;SEMA3E;RHOD;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;PAK1;FAM83H;TWIST2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.39170125563947494,0.984180457256247,0.4859437751004016,1.0,1.0,11/26,23.62%,CUL3;ANAPC7;CDC23;FBXO5;CDC27;DUSP1;ANAPC4;CDK5RAP2;ANAPC5;RB1;CDC16
prerank,erythrocyte differentiation (GO:0030218),-0.27538905422335247,-0.9840272083422817,0.49673202614379086,0.8378534118869082,1.0,15/44,19.44%,KIT;RPS14;MFHAS1;FLVCR1;LYN;ALAS1;RPS19;ACIN1;ID2;NCKAP1L;INHBA;TAL1;CEBPG;UBA5;ZFPM1
prerank,regulation of neuroblast proliferation (GO:1902692),0.4391973877843638,0.9837414620028483,0.5141579731743666,1.0,1.0,5/15,12.69%,VEGFA;NF1;DISC1;TAFA1;DRD2
prerank,hemidesmosome assembly (GO:0031581),0.46814517265096334,0.9837389378649195,0.5171339563862928,1.0,1.0,2/11,6.45%,LAMC1;PLEC
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.36526192620405024,0.9837204506328393,0.501840490797546,1.0,1.0,5/41,9.85%,PTPN22;CD34;IRAK3;SYT11;SELENOS
prerank,recombinational repair (GO:0000725),0.33389503557269995,0.9833007843505687,0.503919372900336,1.0,1.0,18/77,17.24%,POLN;MEIOB;AP5S1;ERCC5;REV3L;ERCC4;RPA3;BRCA1;FBH1;SFPQ;HELQ;XRCC3;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3007033162473109,0.9828761017913108,0.576,1.0,1.0,155/807,17.79%,OSR2;NKX6-2;PTCH1;TENM2;MLIP;MDFIC;TSHZ3;SCML4;GLI2;CREB3L1;RCOR2;SOX8;AASS;PRDM16;MYC;TGIF2;ATP8B1;CBFB;ZNF25;SOX9;NAB1;VGLL4;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;KDM8;NFX1;TLE1;FOXP2;TGFB1;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;URI1;EED;CIPC;OTUD7B;RFX3;ZBTB16;RORC;MTA2;MLXIPL;MLX;TRPS1;TWIST2;DRAP1;LOXL3;E2F6;CBFA2T3;KAT8;LRRFIP1;GATA6;CBX4;ZC3H8;MEN1;FOXM1;CHD3;VPS72;CPEB3;KCTD1;RARG;FLNA;BRCA1;MBD2;RARB;PPID;CRYAB;DKK3;LDB2;LANCL2;SNX6;HDAC2;ZBTB38;MBTD1;ESR1;SIN3B;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;SIRT6;PRICKLE1;ING4;DCAF1;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;PER3;JARID2;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;XRCC6;NRIP1;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;SNCA;LCOR;MDM4;NEDD4L;SUMO1;CRY1;NCOR2;CITED2;TAF7;CREM;ZEB2;UBB;IL33;MED25;DACT1;RUNX1;TP53;SP3;MTA3;NDUFA13;SREBF2;HNRNPU;WWOX;FOXJ1;USP2;PAX2;SMARCE1;CDC73;NFIX;CCDC85B;HEYL;CTBP1;SFMBT2;SUFU
prerank,cellular response to hypoxia (GO:0071456),0.32085681817773504,0.9826409131869771,0.5234131113423517,1.0,1.0,35/126,23.11%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;KCND2;GATA6;BNIP3;TBL2;PSMB7;HIF1A;BMP7;CPEB1;MDM4;PSMD2;LMNA;UBB;PSMC1;TP53;PSMB2;MDM2;ELOC;PSMD9;ACAA2;PSME4;HP1BP3;NPEPPS;PSMA8;LIMD1;BNIP3L;ELOB;UBQLN1;CARD16
prerank,negative regulation of cation channel activity (GO:2001258),0.3888770785932934,0.9825342392775871,0.48663101604278075,1.0,1.0,8/26,25.00%,EPHB2;DRD2;CALM1;CALM2;SLC6A9;PKD2;UBQLN1;FMR1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2933065588693077,-0.982357585170298,0.4851063829787234,0.8409982542269174,1.0,5/28,9.11%,ARHGAP28;FCHSD2;ESAM;ARHGAP35;PFN2
prerank,sulfate transport (GO:0008272),-0.366391713747403,-0.9822809841526562,0.4713375796178344,0.8397426184312982,1.0,7/14,26.34%,SLC26A7;SLC26A2;SLC25A30;SLC13A4;SLC26A6;RACGAP1;SLC26A8
prerank,cellular response to insulin stimulus (GO:0032869),-0.22573522552291483,-0.9822051795256582,0.5555555555555556,0.8384835255472188,1.0,24/124,9.78%,SORBS1;IGF1R;TBC1D4;PIK3R3;RAB31;PIK3C2A;GRB10;NAMPT;IGF2;PRKCI;INSR;LPIN2;ZFP36L1;ATP6V0C;ATP6V0D1;BCAR1;PARP1;GSK3B;SLC25A33;RHOQ;RPS6KB1;GSK3A;INSIG2;ZDHHC7
prerank,response to interferon-gamma (GO:0034341),0.3386054614839371,0.9819464252619877,0.4954954954954955,1.0,1.0,6/67,5.52%,CCL11;KYNU;EPRS1;CCL4;AQP4;WNT5A
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.40415663835021265,0.9818989772087833,0.4993160054719562,1.0,1.0,4/22,13.22%,FADD;FBXO38;ZBTB1;MALT1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.4789747236550956,0.9813229041518005,0.5007587253414264,1.0,1.0,5/10,19.62%,RNF157;PDE3B;PDE4D;APLNR;PDE11A
prerank,cellular response to retinoic acid (GO:0071300),-0.2681418899197516,-0.9812835787229454,0.5618556701030928,0.8395281918174098,1.0,8/42,8.69%,WNT5B;EPHA3;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,dephosphorylation (GO:0016311),0.31480203803867596,0.9811880501913665,0.5270833333333333,1.0,1.0,44/147,22.23%,PTPRH;PTEN;PTPN22;DUSP4;PSPH;PTPRT;ACP2;DUSP6;PTPN13;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;DUSP11;PTPRJ;PLPP4;PPP1CA;PLPPR4;PTPRA;PTPN18;HDHD2;PTPRZ1;PTPN21;PPP3CC;SSH1;PTPRF;PPM1E;DUSP16;NT5C;DAPP1;DUSP1;DUSP12;PTPRS;PLPPR2;CTDSP1;PPP4R1;PTPRN2;SSH2;PPM1A;PLPPR1;CTDSP2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.46895460667412786,0.9811519976974654,0.5047770700636943,1.0,1.0,4/10,18.77%,MEOX1;UFL1;TP53;BATF
prerank,zinc ion transport (GO:0006829),-0.3158826594568433,-0.9810062998353564,0.48161764705882354,0.8387837562664466,1.0,9/21,26.20%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC30A6;SLC39A3;TRPM2;SLC39A13;SLC39A1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4493505767985291,0.9808374787384382,0.47385103011093505,1.0,1.0,4/11,17.21%,EGFR;TGFB1;TP53;RIPK1
prerank,negative regulation of translation (GO:0017148),-0.23476800300031372,-0.9807040394680128,0.48314606741573035,0.8381382279718234,1.0,13/87,11.08%,DAPK1;ROCK2;SAMD4A;ROCK1;YBX1;YTHDF1;CAPRIN1;IGFBP5;METTL14;CNOT1;RACK1;EIF4A3;BTG2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.2909721944802882,-0.9806209705595379,0.5217391304347826,0.8368868828886404,1.0,6/35,9.00%,PLPP1;PPARGC1B;CALCOCO1;DDX5;EGLN2;NR3C2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.2647304576217879,-0.9801037343480541,0.4942528735632184,0.8368030551493382,1.0,10/47,7.97%,SOX13;LRP5;TMEM64;NOCT;CREBL2;PPARD;CDS1;ZFP36L1;SIX1;PTGS2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3121432941837198,0.9800760628206151,0.5426829268292683,1.0,1.0,49/190,22.07%,RORA;PYCARD;PTEN;RNF157;BCL2;VGLL4;NPRL2;THEM4;TLE1;DEPTOR;NF1;PDE3B;URI1;OTUD7B;NLRX1;TSC1;SPRED1;PPM1B;HERPUD1;PTPRJ;ESR1;MAPK14;BMP7;MAGI2;PDE4D;RHOH;RTKN2;DRD2;PER1;NDUFA13;APLNR;RIPK1;MDM2;PIK3IP1;OTUD7A;ZMYND11;MAPKBP1;FNIP1;CPNE1;PDE11A;DUSP1;LIMD1;ARHGAP12;P2RX7;PDE10A;DEPDC5;ARRB2;PRKAA1;PPM1A
prerank,microtubule anchoring at centrosome (GO:0034454),0.46117091024638907,0.9800399852221021,0.48440065681444994,1.0,1.0,6/10,24.42%,PCM1;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,regulation of fibrinolysis (GO:0051917),0.44362989684964743,0.9798572830965976,0.4956521739130435,1.0,1.0,1/13,1.18%,FAP
prerank,negative regulation of macrophage activation (GO:0043031),-0.353486266386425,-0.9794442680696238,0.4779874213836478,0.8371651918059128,1.0,2/16,1.53%,CD200;IL31RA
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.38539187163979427,0.9792361709720341,0.4877734877734878,1.0,1.0,2/28,3.35%,RELN;EPHB2
prerank,actin filament polymerization (GO:0030041),0.3770958453914446,0.9791735762689203,0.4920844327176781,1.0,1.0,10/29,23.01%,SPIRE1;GSN;GAS7;WASF1;COBL;DIAPH3;WASHC3;MICALL2;CORO7;WASF3
prerank,BMP signaling pathway (GO:0030509),0.3389806329538339,0.978788325333108,0.5087924970691676,1.0,1.0,6/62,4.73%,BMP5;RGMB;HIVEP1;ACVR1;TGFB1;GDF9
prerank,ketone body metabolic process (GO:1902224),0.46048549239092584,0.9786308925848302,0.5118858954041204,1.0,1.0,3/10,17.51%,ACSS3;HMGCLL1;HMGCS2
prerank,import into cell (GO:0098657),0.3599178490138423,0.9783749755160225,0.513317191283293,1.0,1.0,8/41,11.77%,SLC1A3;SLC27A1;SLC5A3;LRRC8D;SLC29A1;NEURL1B;SLC12A4;SLC7A8
prerank,regulation of cellular respiration (GO:0043457),0.4220332093205877,0.9778796010913815,0.48656294200848654,1.0,1.0,4/17,17.50%,PRDM16;CBFA2T3;PNPT1;TRAP1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.37643665437958623,-0.9778684238830904,0.484472049689441,0.8400919942614709,1.0,2/13,4.02%,IGF1;RAMP1
prerank,regulation of cell size (GO:0008361),0.39703515715409354,0.9778138115315621,0.49173553719008267,1.0,1.0,9/23,23.94%,PTEN;DEPTOR;RARG;VAV3;PRR16;RPTOR;RDX;VAV2;MTOR
prerank,regulation of osteoclast differentiation (GO:0045670),0.3729171780639635,0.9777174074325591,0.5107458912768648,1.0,1.0,1/33,0.55%,UBASH3B
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4312798104837705,0.9774626415032215,0.5070422535211268,1.0,1.0,3/16,8.27%,PTPN2;SOCS1;NF2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4355071234098754,0.9773351985462891,0.4942363112391931,1.0,1.0,3/13,6.38%,SEMA3E;VEGFA;TGFBR2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.33255922786732023,0.9773251326138721,0.5061590145576708,1.0,1.0,7/74,3.96%,LGALS3;BMP5;BCL2;FADD;ACVR1;MAPK7;TNFRSF10B
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.44042443347892263,0.9771165616608803,0.49554896142433236,1.0,1.0,6/14,22.57%,ELAVL4;MAPKAPK2;MAPK14;HNRNPC;ZFP36;YBX3
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.44078658522120745,0.9763121561063637,0.5073313782991202,1.0,1.0,2/13,7.55%,GLI2;ZC3H8
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3263286994498813,0.9762800067712362,0.5182403433476395,1.0,1.0,18/101,10.27%,TBC1D10A;VGLL4;ERBB2;FADD;UPF3A;PLD1;TGFB1;NIBAN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK;VPS11;AURKAIP1;HDAC2;EIF4G1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4584225459352212,0.9761243248928452,0.49921259842519683,1.0,1.0,6/11,21.39%,FADD;UNC93B1;TICAM1;RIPK1;SCARA3;TNIP2
prerank,regulation of endocytic recycling (GO:2001135),-0.39372461642925166,-0.9757299651989597,0.46397694524495675,0.8444987043991581,1.0,3/11,8.11%,RAB11B;ATP9A;ACTN2
prerank,regulation of actomyosin structure organization (GO:0110020),-0.36961577805618984,-0.9755938683819853,0.48656716417910445,0.8434144038634883,1.0,5/13,13.32%,ROCK2;ROCK1;FHOD1;ACTG1;CDC42
prerank,lamellipodium organization (GO:0097581),-0.29234859652836226,-0.9754128678801615,0.4791666666666667,0.8424154009453325,1.0,9/29,14.82%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.29378614365406913,-0.9750467336632079,0.48582995951417,0.8420011853512873,1.0,11/26,25.69%,NOS3;ACER2;SPTLC2;DDAH2;ASAH2;NOS1;SPR;SPHK1;AKT1;SPHK2;SPTLC1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4276795880397374,0.9743604923421592,0.4838235294117647,1.0,1.0,3/14,18.76%,PTGER3;IL6ST;PARK7
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.32782204851083646,0.9743158316765597,0.5113636363636364,1.0,1.0,16/71,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,membrane fusion (GO:0061025),0.3690984520697137,0.9741047370302016,0.5171537484116899,1.0,1.0,10/33,17.09%,DNM1;SNAP23;HACE1;SNAP29;HUWE1;VAPA;RIMS1;OTOF;OPA1;DYSF
prerank,protein import into nucleus (GO:0006606),0.33610269758508216,0.9740527478575699,0.5229885057471264,1.0,1.0,20/66,21.10%,CBLB;RANBP2;NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;IPO13;KPNA6;NXT1;EIF4ENIF1;KPNA1;POM121;TNPO3;IPO5;CSE1L;STAT3;KPNA3;PHB2;HEATR3
prerank,maturation of SSU-rRNA (GO:0030490),-0.2843376788526818,-0.9734605464685595,0.48058252427184467,0.844876834963503,1.0,16/34,26.89%,RPS14;RPS16;RPS19;NGDN;WDR3;RIOK3;HELB;RPS8;RIOK1;DHX37;MRPS11;DDX52;SNU13;TSR3;RIOK2;PWP2
prerank,response to unfolded protein (GO:0006986),0.3495807135338531,0.9732564318740781,0.5130641330166271,1.0,1.0,13/48,21.21%,HSPH1;PRKN;DNAJB4;PACRG;PTPN1;HERPUD1;HSPA4;TM7SF3;DNAJC4;DNAJA1;HSPA9;HSPD1;RHBDD1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4288762179318424,0.9728878725052011,0.5188536953242836,1.0,1.0,6/16,11.47%,IRAK3;ETF1;BNIP3;CLEC16A;HDAC6;UPF1
prerank,actin crosslink formation (GO:0051764),0.45236608943871826,0.9726779439838992,0.5037707390648567,1.0,1.0,3/12,8.56%,GAS2L3;BAIAP2;FLNA
prerank,establishment of skin barrier (GO:0061436),0.4264655929794561,0.9726216767463072,0.4985507246376812,1.0,1.0,3/15,15.00%,CLDN1;HRNR;MET
prerank,regulation of water loss via skin (GO:0033561),0.4264655929794561,0.9726216767463072,0.4985507246376812,1.0,1.0,3/15,15.00%,CLDN1;HRNR;MET
prerank,purine nucleotide catabolic process (GO:0006195),0.4449526159836617,0.9724514660631606,0.5262368815592204,1.0,1.0,3/13,10.38%,NUDT15;NT5C2;HINT1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4300023013699454,0.9723719086253239,0.5007518796992482,1.0,1.0,6/13,24.50%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36;TNRC6A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.31455314556662195,0.9722776111664457,0.5481171548117155,1.0,1.0,32/138,19.71%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;POLR2B;RORC;GTF2B;RARG;RARB;POLR2K;ESR1;TAF9;TAF11;TAF2;NR6A1;WWTR1;NR2C2AP;POLR2G;NCOR2;TAF7;GTF2E2;GTF2E1;TAF4;TAF4B;NR5A1;NRBF2;TAF1;POLR2A;PPARG;TAF8
prerank,icosanoid secretion (GO:0032309),-0.3689793955881745,-0.9721566264280703,0.48158640226628896,0.8470164693561139,1.0,2/12,6.81%,ABCC4;ACE
prerank,positive regulation of signal transduction (GO:0009967),0.30054466669977614,0.9720590816327692,0.5656565656565656,1.0,1.0,45/238,15.56%,RELN;SULF1;PRKCA;LGR6;NTRK3;MAML3;PTEN;KAT2B;STK36;DEPDC1B;MAML2;TRIM44;EVC;NRXN1;MT3;GLI1;NLGN1;AGPAT2;UCHL5;LMO3;DISC1;LOXL3;KLK6;RAB34;SPIN1;FLNA;SMO;ZMIZ1;LANCL2;HIF1A;PIH1D1;PIK3R1;PTPN11;RIMS1;IL6ST;LY86;GATA3;SMOC2;TRAF7;CITED2;TM2D3;DACT1;CRADD;HOMER1;STX1B
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3476662825437085,-0.971903622152252,0.5294117647058824,0.8461877834168005,1.0,5/16,15.26%,SNCAIP;CPLX1;CAMK2A;MCTP2;FLOT1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3296130222542617,-0.9717193918893215,0.5054151624548736,0.8452657367701367,1.0,8/18,24.03%,GSK3B;GSK3A;BID;HIP1R;BOK;SLC35F6;MUL1;BAK1
prerank,telomere maintenance via recombination (GO:0000722),0.4415349348551269,0.971305608323967,0.5015337423312883,1.0,1.0,4/11,22.69%,ERCC4;XRCC3;TPRKB;RAD50
prerank,regulation of mast cell activation (GO:0033003),-0.3979321938138227,-0.9711147063559709,0.5,0.8453688641807586,1.0,2/10,3.82%,PLSCR1;LYN
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3686370337449265,0.971028421571304,0.5131414267834794,1.0,1.0,9/36,11.98%,ANK3;GORASP1;VAMP4;BLZF1;RILPL2;SPTBN1;RAB34;GORASP2;SYS1
prerank,regulation of aerobic respiration (GO:1903715),-0.3431099027406557,-0.9705806744569455,0.5273311897106109,0.8454025981309624,1.0,7/15,28.53%,ATP7A;SLC25A33;NOP53;PINK1;AK4;COX7A2;VCP
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.39875572612427557,0.9704597714484601,0.5071428571428571,1.0,1.0,8/20,20.70%,HOXB8;ZBTB16;CDK6;PRMT1;CDC73;HSPA9;ZFP36;MEIS1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.41690441393996147,0.9702676124757421,0.522273425499232,1.0,1.0,5/15,20.76%,NGF;NTRK2;NGFR;GRB2;SOS1
prerank,negative regulation of ossification (GO:0030279),0.38768488741473295,0.9701777930401038,0.5145888594164456,1.0,1.0,3/23,8.60%,LRP4;SOX9;CHSY1
prerank,regulation of interleukin-10 production (GO:0032653),0.357484298835971,0.96944154315017,0.5099750623441397,1.0,1.0,2/44,1.88%,PYCARD;CD34
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.46367312028334906,0.9694115019830457,0.5147286821705427,1.0,1.0,2/10,8.10%,SESTD1;BIN1
prerank,regulation of embryonic development (GO:0045995),0.37055955743915714,0.9693991360428854,0.5231362467866324,1.0,1.0,4/34,4.92%,PHLDB1;WDPCP;RAB14;PLCB1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.35842403745868756,0.9692220997274057,0.5343980343980343,1.0,1.0,5/43,9.85%,PTPN22;CD34;IRAK3;SYT11;SELENOS
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3286409242115754,0.968660100414519,0.5440528634361234,1.0,1.0,13/75,12.07%,CCL11;PRKCA;FGF2;VEGFA;EGR3;WNT5A;FGFR1;AKT3;HIF1A;SP1;SIRT6;MYDGF;NRP2
prerank,vasculature development (GO:0001944),-0.33950374235201974,-0.9685379290317563,0.4857142857142857,0.8495369950503914,1.0,7/16,12.33%,CDH5;ERRFI1;ACVRL1;BMPR2;PDGFRB;STRA6;NOTCH4
prerank,regulation of phosphorylation (GO:0042325),0.3148087083537375,0.968520552735437,0.5406546990496304,1.0,1.0,19/120,11.41%,DYNLL1;GLMN;CDKN2B;EGFR;CADM4;PSEN1;RANBP2;SOCS1;NUP155;FZD7;EIF6;LDB2;HIF1A;DSCAM;GRM5;NUP205;NDC1;NUP160;BMP7
prerank,plasma membrane invagination (GO:0099024),0.37635091558216915,0.9682748158240692,0.5064599483204134,1.0,1.0,3/29,2.24%,SPIRE1;GULP1;GSN
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2584491728016443,-0.967985574844562,0.5539568345323741,0.849573032184575,1.0,16/53,19.43%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PPM1K;PSMA4
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.31892355652008453,0.9671340316858736,0.5290889132821076,1.0,1.0,23/83,23.30%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;PRKACA;ATF5;CKAP5;CEP76;DYNC1I2;CSNK1E;TP53;CEP63;TUBA1A;CEP78;SSNA1;PCNT;CDK5RAP2;DYNC1H1;PPP2R1A
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3740897751657322,0.9669389499683161,0.514030612244898,1.0,1.0,9/30,18.36%,TGFB1;SOX11;PCSK6;DKK3;SFRP4;BCL9;XIAP;NREP;EID2
prerank,endocytic recycling (GO:0032456),0.3462811333421495,0.966889678666681,0.5107655502392344,1.0,1.0,24/50,29.08%,RAB14;VPS29;EPS15;VPS39;DENND1C;ACAP2;RAB11FIP3;EHD2;WASHC1;ANKRD27;SNX12;RAB7A;MICALL2;SNX4;EIPR1;DENND1A;ENTR1;VPS35;DENND1B;VPS53;VPS26C;RAB13;STX6;SNF8
prerank,lipid droplet formation (GO:0140042),-0.38930974747502145,-0.9668786353495068,0.48520710059171596,0.8510608712092392,1.0,4/10,12.08%,ZFYVE1;CDS1;BSCL2;AUP1
prerank,chromatin assembly (GO:0031497),0.35786466341371104,0.9667576335371139,0.519546027742749,1.0,1.0,8/38,15.90%,SOX9;EZH1;ATRX;PRDM9;POLE3;ASF1A;RBBP4;TP53
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.36025099368960434,-0.9665786375012035,0.5236593059936908,0.8504904071809536,1.0,5/13,18.91%,GTPBP1;RHOQ;ENTPD7;GNAI3;AK4
prerank,iron ion transport (GO:0006826),0.347606966179932,0.9663411044503859,0.539833531510107,1.0,1.0,4/47,7.97%,SCARA5;STEAP3;ATP6V1B2;TTYH1
prerank,cortical cytoskeleton organization (GO:0030865),0.3573256559802269,0.9663398129995425,0.5333333333333333,1.0,1.0,8/41,12.13%,RHOD;RND3;RHOBTB3;FMNL2;NLGN1;EPB41L3;RHOH;RHOC
prerank,mRNA transport (GO:0051028),0.31640482449233504,0.9663386412255714,0.5296017222820237,1.0,1.0,37/101,26.36%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;KIF5C;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;ZFP36;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;THOC5;MAGOHB;FMR1;NUP35;HNRNPA2B1;RAE1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4318384040730963,0.9662332401631373,0.5263157894736842,1.0,1.0,2/15,3.14%,FGF2;VEGFA
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4120807107070896,0.965887246798347,0.5092724679029957,1.0,1.0,4/18,12.26%,COX20;COX18;SCO1;COX19
prerank,positive regulation of protein metabolic process (GO:0051247),0.31788621341936246,0.9658004427474856,0.526595744680851,1.0,1.0,20/110,16.25%,GPC3;PRKN;HACE1;MAPK7;TGFB1;PSEN1;WNT5A;ASB5;CARD9;IL18;HUWE1;EIF4G1;PRMT1;APC2;RAB1A;DDB1;NEDD4L;AREL1;DACT1;NDUFA13
prerank,monocarboxylic acid catabolic process (GO:0072329),0.40047289176561535,0.9657160929198098,0.5218579234972678,1.0,1.0,3/21,8.14%,CEL;ACBD5;ACOX1
prerank,necroptotic process (GO:0070266),0.4187116939216028,0.9656872753679185,0.5310245310245311,1.0,1.0,5/16,23.27%,ITPK1;TICAM1;RIPK1;MLKL;CYLD
prerank,glycerophospholipid catabolic process (GO:0046475),0.371983409214762,0.9656333960489556,0.5045045045045045,1.0,1.0,8/27,21.32%,PRDX6;PLA2G7;ENPP6;PNPLA8;LIPC;GDPD3;PLA2G4E;ABHD16A
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4247843110008297,0.9654572421851388,0.5394736842105263,1.0,1.0,2/15,4.87%,ARPC1B;IQGAP2
prerank,DNA modification (GO:0006304),0.39290421059910846,0.965184363815347,0.5358126721763086,1.0,1.0,9/22,23.59%,MBD4;MPG;MUTYH;NEIL1;SMUG1;TERF2IP;TDG;EXOSC3;ACD
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.38295359970597653,-0.965170682232252,0.5127478753541076,0.852832955883914,1.0,3/11,13.48%,CTNNB1;RYK;FZD1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.23998199984711402,-0.9649107445635189,0.5441176470588235,0.852124749279264,1.0,16/54,16.76%,CLIP4;CLIP3;CLIP1;FIGNL2;TUBGCP4;TUBGCP3;TUBGCP6;WDR73;RHOA;DCTN1;NUMA1;MAPT;TRPV4;CCDC88C;VPS4B;TUBGCP2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3923784283117214,-0.9646738063062957,0.5013262599469496,0.8512938800681317,1.0,5/10,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3571323585606766,-0.9645788950595742,0.5242424242424243,0.8487000801520149,1.0,2/14,6.99%,ABCG2;BLVRA
prerank,heme catabolic process (GO:0042167),-0.3571323585606766,-0.9645788950595742,0.5242424242424243,0.8487000801520149,1.0,2/14,6.99%,ABCG2;BLVRA
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.39337924546418174,0.9643535862456171,0.5316455696202531,1.0,1.0,8/22,22.07%,DUSP4;DUSP6;PPM1B;PPP1CA;PPM1E;DUSP16;DUSP1;PPM1A
prerank,negative regulation of heart contraction (GO:0045822),-0.3824263299645429,-0.963779192690282,0.5,0.8494346262822711,1.0,6/11,33.66%,ATP1A2;GRK2;SRI;PLN;SPX;PIK3CG
prerank,regulation of nervous system process (GO:0031644),-0.3286105585842653,-0.9636810730283647,0.47686832740213525,0.8482412267752862,1.0,4/18,6.89%,ROCK2;SLC8A3;NOS3;APP
prerank,protein tetramerization (GO:0051262),0.33127591184953514,0.9635082259271478,0.5239154616240267,1.0,1.0,20/67,23.18%,CTH;ACACA;FARSA;CPSF6;GRIN2B;AQP4;FARSB;SOD2;SNCA;PKD1;HOMER1;ALDH1A3;GLS;MS4A1;RYR3;HCN1;SSBP1;PKD2;KCNC1;TRPM4
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.42546491745804504,0.963308037268291,0.5127118644067796,1.0,1.0,4/15,15.34%,ZFAND2B;SPCS3;RAB3GAP2;SEC61G
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.397468844078423,0.9630571286108955,0.5100401606425703,1.0,1.0,4/20,12.99%,SLC27A1;GSS;PTDSS1;GGCT
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.38447149289740995,-0.9630190835750997,0.4945652173913043,0.8486170603617326,1.0,5/11,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,response to ketone (GO:1901654),-0.31098073722166253,-0.9627157014197913,0.4765625,0.8480593324462236,1.0,8/24,20.71%,SLIT2;THBS1;TGFB2;CAV1;ABHD2;ABCB4;CATSPER3;NR1H3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3521570891961573,0.9626992100802639,0.5319410319410319,1.0,1.0,9/43,11.37%,PRKCQ;PTPN2;SIK2;SLC27A4;SOCS1;GRB14;PTPN1;PTPN11;PID1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4042142523572574,0.9626453713897078,0.5237430167597765,1.0,1.0,9/17,26.74%,CPSF6;CPEB3;NCBP1;CPEB1;VIRMA;CDK9;CPSF7;RNF20;NELFE
prerank,lytic vacuole organization (GO:0080171),0.3640112887525258,0.9624425212095622,0.5132743362831859,1.0,1.0,15/32,23.94%,GNPTAB;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLVS2;HOOK1;HOOK3;TPP1;CLN6;MTOR
prerank,negative regulation of MAP kinase activity (GO:0043407),0.35102886064637795,0.9624019753788066,0.5190476190476191,1.0,1.0,7/44,11.41%,PTPN22;IRAK3;NF1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,macrophage activation (GO:0042116),-0.2785058066837065,-0.9621463282667597,0.49557522123893805,0.8481813949846382,1.0,9/34,19.43%,FOXP1;TLR4;APP;CD93;SBNO2;MAPT;NMI;IFI35;C1QA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3221188315766971,0.9620136985502484,0.515185601799775,1.0,1.0,16/73,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,retinal metabolic process (GO:0042574),0.43783047361677946,0.9616664110987325,0.5251908396946565,1.0,1.0,3/12,16.54%,CYP1B1;RDH10;ALDH1A3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4091541077961839,0.9615149888778363,0.5258741258741259,1.0,1.0,6/17,19.67%,PTEN;SOD2;TGFB3;TAFA5;PDCD4;PPARG
prerank,gonad development (GO:0008406),0.3537277097238728,0.9614695078506882,0.5250917992656059,1.0,1.0,12/41,21.61%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;IRX5;LRP2;NR5A1;CSDE1;MEA1;FGF9
prerank,negative regulation of hormone secretion (GO:0046888),-0.3752122810982096,-0.9612400759246421,0.5229885057471264,0.8492658757324073,1.0,1/10,1.42%,GJA1
prerank,vasoconstriction (GO:0042310),-0.39609456095080525,-0.9612272168747131,0.49728260869565216,0.8478811610592994,1.0,4/11,18.07%,PIK3C2A;ACTA2;EDNRB;EDN1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30664406516635845,0.9608170146271462,0.5708418891170431,1.0,1.0,40/166,19.97%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;TAF1A;POLR2B;RORC;GTF2B;TFAM;RARG;RARB;POLR2K;ESR1;TAF9;TAF11;TAF2;NR6A1;WWTR1;NR2C2AP;POLRMT;POLR1B;POLR2G;NCOR2;TAF7;GTF3C1;GTF2E2;GTF2E1;TAF4;TAF4B;POLR1C;NR5A1;POLR1G;NRBF2;TAF1;POLR2A;PPARG;TAF8;UBTF
prerank,vesicle transport along microtubule (GO:0047496),-0.3036051691580358,-0.9606068831822664,0.5435684647302904,0.8480960759615093,1.0,6/23,8.61%,KIF3B;KIF1C;TRAK1;PAFAH1B1;KIF5B;BICDL1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.37274070864387104,-0.9605087832838829,0.5,0.8469337121212122,1.0,3/12,8.35%,RBP4;TLR4;STRAP
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4284220632791417,0.9605010585117933,0.5137085137085137,1.0,1.0,4/14,16.67%,IRS2;TYSND1;MTLN;ABCD2
prerank,positive regulation of cholesterol transport (GO:0032376),0.3759091033950064,0.9601266170881436,0.5286458333333334,1.0,1.0,4/27,10.88%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.36900707453765236,0.9599872948817607,0.5115384615384615,1.0,1.0,6/32,23.35%,CXCL10;AKAP6;SNCA;APLNR;P2RX7;CEMIP
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3283695108638352,-0.95991379769837,0.5016501650165016,0.8471290599203647,1.0,4/16,12.70%,RIF1;PARP3;WRAP53;KDM4D
prerank,supramolecular fiber organization (GO:0097435),0.29721837223214426,0.959852555698177,0.6156156156156156,1.0,1.0,49/334,12.31%,COL15A1;TGFBI;HSPG2;LUM;FGF13;COL5A3;RHOD;COL20A1;GSN;COL28A1;PRKN;PPP1R9A;RND3;P4HA1;COL5A2;RHOBTB3;PXDN;COL4A2;COL27A1;COL26A1;PCM1;NF1;COLGALT2;TNXB;COL9A2;PLEC;LOXL3;CYP1B1;COL18A1;TLL2;HIP1;COL3A1;PLOD1;KATNAL1;BFSP1;TUBGCP5;SLK;NCSTN;COL1A2;MYO19;STMN4;COL14A1;DNAJB6;FIGN;SLAIN2;RHOH;RHOC;APH1A;KATNB1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.41044079438025255,0.9596841109395684,0.5287671232876713,1.0,1.0,4/16,9.87%,KMT2A;AUTS2;BRCA1;PIH1D1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3786933464965023,0.9596005601191179,0.5289473684210526,1.0,1.0,10/27,21.83%,EGFR;TGFB1;EIF4G1;EIF4ENIF1;TP53;RIPK1;STAT3;ZFP36;LIMD1;DDX6
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3694137315885615,0.9595218071283708,0.5307692307692308,1.0,1.0,5/30,13.66%,AKAP13;LPAR1;GPR65;COL3A1;ARHGEF3
prerank,cellular response to nitrogen compound (GO:1901699),0.4034211027627761,0.9590005276533456,0.5166204986149584,1.0,1.0,6/20,15.98%,DDX11;NSMCE3;AOC1;ATRX;BLM;SPIDR
prerank,negative regulation of viral entry into host cell (GO:0046597),0.44396444350125813,0.9584747711838101,0.5341614906832298,1.0,1.0,3/12,10.42%,GSN;TRIM11;MID2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.31556167509643196,0.9579827280628644,0.5449620801733478,1.0,1.0,29/96,22.56%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK
prerank,microtubule-based transport (GO:0099111),0.4349722828215435,0.9577947306644085,0.5124610591900312,1.0,1.0,4/13,18.46%,DYNC1I1;DYNC1I2;DNAAF2;HTT
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3960638627448496,0.9577839221789709,0.5317679558011049,1.0,1.0,8/22,18.76%,AKAP13;MAP1B;GBA2;ARL2;ABL1;MAPRE3;CAMSAP1;PARK7
prerank,nuclear migration (GO:0007097),0.4382822657561566,0.9576923911578047,0.4978102189781022,1.0,1.0,2/13,4.93%,DOCK7;PCM1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4067707653344201,0.9576736889914366,0.5070821529745042,1.0,1.0,6/17,22.45%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,cellular response to interleukin-7 (GO:0098761),0.4067707653344201,0.9576736889914366,0.5070821529745042,1.0,1.0,6/17,22.45%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35705009047911346,0.95767185824895,0.5200974421437271,1.0,1.0,15/38,23.86%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1;NDUFAF1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2861422886988336,-0.9574079470258219,0.50199203187251,0.8524872581010873,1.0,8/27,18.07%,MAP3K5;MAP3K20;MAP3K8;MAP3K7;IKBKB;CCDC88C;IKBKG;TAOK2
prerank,positive regulation of cell death (GO:0010942),0.33259965053339086,0.9572788338439209,0.5491525423728814,1.0,1.0,13/59,17.21%,LRP1;PRNP;MT3;GRIN2B;WNT5A;BNIP3;FYN;RARG;EIF4G1;SNCA;HTATIP2;EFNB2;RIPK1
prerank,regulation of intracellular pH (GO:0051453),-0.2760936060395269,-0.9571717962417075,0.46798029556650245,0.8517676264393346,1.0,8/34,11.85%,SLC4A10;SLC9A6;SLC9A2;SLC9A8;SLC4A3;SLC4A8;SLC9A9;SLC9A7
prerank,regulation of cytoskeleton organization (GO:0051493),0.3174085912815959,0.9568940018829578,0.5608974358974359,1.0,1.0,23/108,15.54%,DLC1;PHLDB1;RHOD;BICD1;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2;CAPN6;CLASP1;BICD2;MAPK1;RHOH;RHOC;ARHGAP44;IQGAP1;MAP6D1;ABL1
prerank,positive regulation of viral transcription (GO:0050434),0.3811990866137835,0.9568377956924913,0.5496083550913838,1.0,1.0,4/25,13.86%,MDFIC;POLR2B;POLR2K;POLR2G
prerank,regulation of coagulation (GO:0050818),0.4470928705993276,0.9568150581591971,0.5163690476190477,1.0,1.0,1/11,3.35%,EPHB2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.37235715627652,0.9566966583757646,0.5440414507772021,1.0,1.0,3/31,10.78%,IL16;PLCB1;MAPK14
prerank,negative regulation of cytokine production (GO:0001818),0.30728311328741587,0.9566252013587982,0.588053553038105,1.0,1.0,29/163,20.81%,APOD;FFAR4;PYCARD;PTPN22;CD34;IRAK3;RPS6KA4;PRNP;OTUD7B;NLRX1;SYT11;SELENOS;CHID1;TAX1BP1;TBK1;ATP2B1;HOMER2;NAV3;SSC5D;ABCD2;FOXJ1;N4BP1;IRF3;MAPKBP1;AXL;PDCD4;ZFP36;SIRPA;CD84
prerank,negative regulation of protein metabolic process (GO:0051248),0.3506309453442669,0.9561617718502318,0.5366146458583433,1.0,1.0,22/48,27.71%,EGFR;FMN2;IRAK3;PRNP;FLNA;CRYAB;MDM4;SNX12;AZIN2;SF3B3;CD84;NFKB1;AGAP2;PRKCG;INHBB;FLOT2;HMGCR;PFDN2;PIN1;CYP51A1;ITGAV;PFDN1
prerank,Golgi to lysosome transport (GO:0090160),0.45716340180688486,0.9560603257269638,0.5196374622356495,1.0,1.0,5/11,17.06%,CCDC91;AP1G1;GAK;AP4M1;RBSN
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3809227257898982,0.9559195958208618,0.5171467764060357,1.0,1.0,6/22,18.24%,EDEM3;UGGT2;DERL2;EDEM2;UBB;MAN1A2
prerank,RNA splicing (GO:0008380),0.3174772543930055,0.9558271235417062,0.5622222222222222,1.0,1.0,32/95,25.58%,DHX8;USB1;TRA2B;RSRC1;RP9;IVNS1ABP;RNPC3;SRSF11;TXNL4A;NCBP1;SFPQ;SNRNP40;PRPF6;PRPF18;NOVA1;KHSRP;RNPS1;FUS;DDX23;SYNCRIP;SRRM1;SF3B3;DBR1;HNRNPC;SNRPN;SF3B2;WBP4;PPP2R1A;MAGOHB;SCAF11;SNRPA1;NONO
prerank,central nervous system neuron development (GO:0021954),0.4192181493520208,0.9557807693292092,0.5351906158357771,1.0,1.0,3/15,4.78%,PTEN;NTRK2;GBA2
prerank,positive regulation of cellular process (GO:0048522),0.2936142383305123,0.9554409558595764,0.665,1.0,1.0,77/565,12.78%,OSR2;BMP5;PRKCA;PDGFRA;ERBB3;HAS2;NTRK3;EPB41L4B;FGF2;PYCARD;MYC;FGF10;KIF20B;PTEN;RHOD;BCL2;GAREM1;IRS2;SOX9;CRLF1;BST1;ERBB2;EGFR;LRP1;TGM1;VEGFA;ACACA;PTHLH;CAPN1;TGFB1;TIPIN;PTGFR;SOX11;NTRK2;GDF9;MT3;GLI1;NOX1;NOP2;WNT5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;FZD7;FOXM1;FGFR1;TSHR;PPP3CA;GAB2;PPP1R13L;ACLY;FASN;BTC;DERL2;NCBP1;CUL3;HDAC2;ERBB4;EIF4G1;EXOSC2;GDNF;PTPRJ;AKAP6;IL6ST;PRMT1;CDC25B;S1PR3;EDN3;FGF7;GRN;RTKN2;WWTR1;GLP2R;PRLR;PRDX3
prerank,lipid translocation (GO:0034204),-0.311686044934057,-0.9548601892059234,0.5197132616487455,0.8563889609687775,1.0,12/21,21.89%,ATP10A;ABCA1;ATP9A;ABCA4;ATP11A;ATP8B2;ATP11B;ABCB4;ATP10B;ATP8A1;ABCA7;TMEM30A
prerank,positive regulation of RNA splicing (GO:0033120),0.37629055477633916,0.9546603235264258,0.5436507936507936,1.0,1.0,5/29,12.97%,PRDX6;TRA2B;NCBP1;PIK3R1;DAZAP1
prerank,regulation of apoptotic process (GO:0042981),0.2959555499233333,0.9544931015258931,0.669,1.0,1.0,154/676,18.98%,FFAR4;BCL2L14;RTKN;HRK;CXCL10;PIP5KL1;SOX8;PYCARD;MYC;OLFM4;RNF157;BCL2;DPEP1;SOX9;NGF;PRKN;EGFR;AKAP13;STEAP3;FADD;FRZB;FGD4;FMN2;MAP4K4;VEGFA;EGR3;ANO6;ARAF;THOC6;WNK3;TNFRSF10B;ERCC5;PSEN1;SLC27A4;FANK1;MT3;NF1;DUSP6;GRID2;ACVR1C;WNT5A;YWHAZ;RASA1;APAF1;NAA35;BMF;SON;ITSN1;CASP6;TRIM2;NAA16;CYP1B1;SHQ1;GATA6;CBX4;PHLDA1;BNIP3;NAE1;BIN1;NF2;ARHGEF11;CTSB;RARG;FLNA;VAV3;HIP1;PPID;CRYAB;PRDM9;ASNS;HDAC2;UBE2Z;SLK;SFRP4;PIK3R1;GDNF;NGFR;NCSTN;CBL;ARF4;TAF9;IL6ST;ARL6IP5;ING4;ANP32E;MYDGF;TAX1BP1;APH1A;SCRIB;PRLR;PRDX3;ATF5;HSP90B1;YME1L1;MALT1;TRIO;ARHGEF3;DDX42;SNCA;RPS6KA2;PSEN2;ITGB3BP;RTN4;CITED2;OPA1;ZFAND6;UBB;ITGB1;CASP2;AREL1;CRADD;UBE2O;RASSF2;ATM;FZD9;ABL1;PIM2;BNIP1;IFT57;TP53;CCND2;BCL2L11;GPLD1;LRP2;XIAP;HTATIP2;TGFB3;QRICH1;GLS2;SGK1;PAX2;ARHGEF4;CD74;RIPK1;WRN;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;PCID2;CSRNP3;AIFM1;DNAJA1;HSPA9;CAT;IRF3;HTT;NAA15;AATF;CHM;MAP3K11;PARK7;SEMA4D;AXL
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3362956904369769,0.9541784540213198,0.5422374429223744,1.0,1.0,7/57,13.84%,CHRM3;LPAR1;FLNA;GPR37;DRD2;GNAI1;P2RY12
prerank,negative regulation of cellular metabolic process (GO:0031324),0.35600901670790186,0.9535174631627048,0.5372945638432364,1.0,1.0,10/37,22.41%,PRKN;MT3;ATXN2;BRCA1;PAX2;TRAP1;AP1AR;AATF;NFKB1;DLG4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.34684884435709,0.9535140593603473,0.5331695331695332,1.0,1.0,12/44,18.68%,DPEP1;NGF;VEGFA;MT3;NGFR;DNAJB6;SNCA;XIAP;PAX2;PCID2;CAST;FNIP1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.34165972788123455,-0.953466878673657,0.5095541401273885,0.8588457731296832,1.0,3/15,8.21%,XPO4;GSK3B;CAMK1
prerank,transcription by RNA polymerase II (GO:0006366),0.30025996324127374,0.9531699002494131,0.6238716148445336,1.0,1.0,70/305,19.74%,RORA;CSTF3;MAML3;CBFB;KAT2B;INTS11;TFCP2;MAML2;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;E2F2;TAF1A;RPRD1A;POLR2B;CDK13;RORC;TAF5L;INTS6;DRAP1;ZC3H8;GTF2B;RARG;TRIP11;RARB;SOX5;POLR2K;NCBP1;SETD2;FIP1L1;ELP2;INTS4;ESR1;SP1;TAF9;TAF11;TAF2;KLF13;ZBTB1;NR6A1;WWTR1;NR2C2AP;INTS2;ELP4;POLR2G;INTS8;NCOR2;TAF7;RNMT;ELL;GTF2E2;PAPOLA;GTF2E1;TAF4;TAF4B;CDC73;NFIX;NR5A1;PCID2;ELOC;NRBF2;TAF1;POLR2A;MLLT1;PRRX1;PPARG;TAF8;ELL2
prerank,regulation of interferon-beta production (GO:0032648),-0.2602631496388777,-0.9528430447722048,0.5172413793103449,0.8591211513584592,1.0,12/46,15.26%,TOMM70;REL;RELB;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;TIRAP;HSP90AA1;FLOT1
prerank,methylguanosine-cap decapping (GO:0110156),-0.3940152961885619,-0.9527726389521068,0.532133676092545,0.8579062208769286,1.0,5/10,18.97%,LSM1;DCP2;PATL1;PNRC2;EDC3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.45374864305808227,0.9526321153316046,0.5205696202531646,1.0,1.0,3/10,16.10%,IRS2;SNCA;GPLD1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2576660078979187,-0.9525478372839524,0.5753424657534246,0.8571175077289765,1.0,15/50,19.43%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4
prerank,negative regulation of multicellular organismal process (GO:0051241),0.302514383356563,0.9522181244836143,0.618421052631579,1.0,1.0,21/199,9.88%,FFAR4;PTCH1;SOSTDC1;BMP5;DOCK7;LRP4;PTEN;SOX9;EGFR;HOXA7;RPS6KA4;TGFB1;ACVR1C;SPRED2;ACOT11;SPRED1;TBX18;CHSY1;SYT11;LNPEP;SPRED3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3057544038026559,0.9521681237558555,0.5806451612903226,1.0,1.0,28/158,17.26%,ROR1;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TNFRSF10B;SLC44A2;TMEM106A;CARD9;PELI1;FLNA;VAPA;MID2;RHOC;TBK1;MALT1;NDFIP1;GOLT1B;TICAM1;PIM2;TERF2IP;CD74;RIPK1;CHUK
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.37370197353076634,0.9521056596350931,0.5467532467532468,1.0,1.0,5/30,7.70%,ANK3;VAMP4;BLZF1;SPTBN1;RAB34
prerank,glucan biosynthetic process (GO:0009250),0.44014046842603366,0.9520520806072197,0.5399698340874811,1.0,1.0,7/12,30.97%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.44014046842603366,0.9520520806072197,0.5399698340874811,1.0,1.0,7/12,30.97%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,protein maturation (GO:0051604),0.31809777643270265,0.9520283910955148,0.5758547008547008,1.0,1.0,20/95,17.33%,PTCH1;ADAM19;PSEN1;TSPAN32;PCSK4;PCSK6;NAA35;NAA16;LMF1;MMP16;NCSTN;TSPAN17;APH1A;CPD;TYSND1;GLRX3;PSEN2;CASP2;CIAO2B;NAA10
prerank,glycogen metabolic process (GO:0005977),-0.2814173610485523,-0.9518775867967311,0.5045045045045045,0.857482338255898,1.0,6/27,10.00%,PRKAG2;PYGB;GSK3B;AGL;PYGM;GAA
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3804193026083457,-0.9517940792181274,0.5059523809523809,0.8563016855572311,1.0,2/11,0.40%,IGF1;IGF1R
prerank,translational termination (GO:0006415),0.3135797527943785,0.9515455341552503,0.5818965517241379,1.0,1.0,28/95,22.43%,MRPL47;MRPS18A;ETF1;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;GSPT2;MRPL30;MRPL28;TRMT112;MRPL46;MRPL51;MRPS30;N6AMT1;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.39585222860255076,-0.9514805772255509,0.5257142857142857,0.855658302490489,1.0,3/10,13.48%,CTNNB1;RYK;FZD1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3887192963944527,0.9513349113755635,0.54,1.0,1.0,5/22,14.07%,MLIP;PRKCA;PDE9A;IL6ST;GLRX3
prerank,regulation of activated T cell proliferation (GO:0046006),0.3698735788943195,0.9513191209164356,0.5489690721649485,1.0,1.0,5/30,12.72%,PYCARD;FADD;PRNP;IL18;SCRIB
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.29231374072884975,-0.9512736236014105,0.5451127819548872,0.8548328237868298,1.0,9/25,20.36%,ETS1;ARNT;STAT5B;ACVR1B;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2
prerank,cellular response to interferon-gamma (GO:0071346),-0.22313772848085572,-0.9511691595679286,0.5609756097560976,0.8537205359905052,1.0,18/88,15.57%,DAPK1;SP100;CCL25;PRKCD;TLR4;TRIM25;CCL15;IRF2;CAMK2G;TRIM5;ICAM1;GBP3;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9
prerank,synaptic vesicle exocytosis (GO:0016079),0.3483454437227828,0.9511405777306403,0.5428921568627451,1.0,1.0,11/40,18.28%,SNAP23;SYT1;SNAP29;RIMS1;RAB3A;OTOF;SNCA;DOC2B;STX1B;SYT2;RIMS2
prerank,membrane organization (GO:0061024),0.29780106798334904,0.9510624648337835,0.6176470588235294,1.0,1.0,33/227,11.39%,ANK3;SGIP1;DNM1;ANK2;REPS2;SNAP23;EGFR;SPAG4;STON2;HACE1;VAMP4;PACSIN2;NPC1;WNT5A;SPTBN1;SYT1;SNAP29;SGCZ;NUP155;ITSN1;EPS15;BIN1;GAK;CNTN2;HIP1;BTC;COX18;HUWE1;VAPA;CBL;TMEM33;RIMS1;EMD
prerank,RNA polyadenylation (GO:0043631),0.38166364805304376,0.9502124327315674,0.5348226018396847,1.0,1.0,10/26,23.42%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,mRNA polyadenylation (GO:0006378),0.38166364805304376,0.9502124327315674,0.5348226018396847,1.0,1.0,10/26,23.42%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29297275650675647,0.9500539756684279,0.642,1.0,1.0,87/497,14.80%,NKX6-2;MDFIC;TSHZ3;SCML4;CREB3L1;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;NAB1;VGLL4;SUV39H1;HOXA7;EPRS1;KDM8;EIF2AK3;TLE1;FOXP2;TGFB1;GATAD2A;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;EED;CIPC;RFX3;ZBTB16;TSC1;MLXIPL;MLX;TWIST2;LOXL3;CBFA2T3;KAT8;GATA6;CBX4;ZC3H8;MEN1;FOXM1;CPEB3;KCTD1;BRCA1;MBD2;CRYAB;PASK;DKK3;LANCL2;SELENOS;SNX6;HDAC2;ZBTB38;MBTD1;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;JARID2;ZGPAT;PATZ1;XRCC6;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;PUS7;SUMO1;CRY1;NCOR2;CITED2;TAF7
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.2943220162455247,-0.949964736150702,0.5655430711610487,0.8556167012580302,1.0,9/25,28.37%,KIT;SLC7A5;CD55;MAP3K7;LAPTM5;SPHK2;LACC1;NOD2;TRIM6
prerank,negative regulation of cell adhesion (GO:0007162),0.3247287469665671,0.9498830709048641,0.5607580824972129,1.0,1.0,11/72,9.77%,TGFBI;ERBB3;PLXNC1;EPHB2;TGFB1;PDE3B;RASA1;CYP1B1;FZD7;NF2;DSCAM
prerank,Fc receptor signaling pathway (GO:0038093),0.3120854258020642,0.9497611455256014,0.5760517799352751,1.0,1.0,32/110,22.71%,PRKCQ;TEC;PAK1;PPP3CB;PPP3CA;GAB2;VAV3;PSMB7;MAPK9;NFATC3;PIK3R1;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;PSMB2;CHUK;PSMD9;TAB3;GRB2;PSME4;BCL10;JUN;PSMA8;SOS1;NFKB1;VAV2;CARD11;TAB2
prerank,positive regulation of viral genome replication (GO:0045070),0.3791784657471713,0.9490739625021982,0.5337662337662338,1.0,1.0,7/29,17.81%,FKBP6;PABPC1;PPID;ADARB1;DDB1;PPIH;PKN2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.32092060998267585,0.9489506499843682,0.5557986870897156,1.0,1.0,13/88,12.07%,CCL11;SULF1;PRKCA;FGF2;VEGFA;EGR3;NF1;WNT5A;AKT3;HIF1A;SPARC;MYDGF;NRP2
prerank,cellular response to osmotic stress (GO:0071470),0.38762810582581353,0.9489193529925427,0.5401360544217687,1.0,1.0,4/21,9.18%,SCN2A;WNK3;LRRC8D;STK39
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.32571770677336626,0.9485320950979005,0.5682574916759157,1.0,1.0,18/77,18.93%,LGALS3;BCL2;PRKN;ACVR1;URI1;HERPUD1;PIH1D1;RTKN2;OPA1;FZD9;NDUFA13;MPV17L;RIPK1;HTT;ZMYND11;PARK7;ACAA2;CSNK2A2
prerank,positive regulation of heart contraction (GO:0045823),-0.3247522908067192,-0.9483344406711043,0.558303886925795,0.8584413469573057,1.0,6/19,25.41%,ATP1A2;GSK3A;TGFB2;EDN1;ATP2A2;SCN3B
prerank,mesenchymal cell development (GO:0014031),0.4003491290866592,0.9483301555239199,0.5396383866481224,1.0,1.0,6/18,22.34%,SOX8;SOX11;KLHL12;HEYL;PEF1;NRG1
prerank,neutrophil mediated immunity (GO:0002446),0.29470828405170313,0.9481436597597243,0.673,1.0,1.0,59/432,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;CARD9;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,regulation of microtubule polymerization (GO:0031113),-0.26336163158022985,-0.9480592133008859,0.5628415300546448,0.8577634746390648,1.0,12/40,16.42%,CDH5;MAP2;OCLN;DRG1;CLIP3;CLIP1;EML2;DCTN1;NUMA1;MAPT;PRUNE1;TBCD
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3089587871975394,-0.9480028238121055,0.5335570469798657,0.8565306382991746,1.0,6/21,10.93%,MFHAS1;PPP1R16B;PTPA;GSK3B;ARPP19;PPP1R11
prerank,regulation of insulin secretion (GO:0050796),0.30952765087642636,0.9477247438241188,0.5662778366914104,1.0,1.0,11/101,7.97%,PRKCA;CACNA1E;IRS2;STXBP4;PRKN;EFNA5;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.35894340067855734,0.9476339171907054,0.5399484536082474,1.0,1.0,8/29,15.72%,EPHB2;SHISA9;GRIK2;SLC8A2;MCTP1;RAB3A;DRD2;NETO1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.3630047331280299,-0.9474102520161114,0.5103857566765578,0.8567574585560598,1.0,2/12,1.73%,ROCK2;ROCK1
prerank,regulation of G0 to G1 transition (GO:0070316),0.3458073511616325,0.947397302358343,0.5551282051282052,1.0,1.0,15/38,27.14%,CDKN2B;EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RHNO1;RBBP8;EZH2
prerank,neutrophil degranulation (GO:0043312),0.29473533981810507,0.9473830393639775,0.674,1.0,1.0,58/425,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,protein K63-linked ubiquitination (GO:0070534),0.34943691787034903,0.9473203175623978,0.5498783454987834,1.0,1.0,4/41,7.91%,UBE2T;PRKN;UBE2E2;PELI1
prerank,engulfment of apoptotic cell (GO:0043652),0.4318623473470587,0.9472478351794469,0.5288035450516987,1.0,1.0,2/15,2.81%,XKR7;XKR8
prerank,regulation of epithelial cell migration (GO:0010632),0.33726810666015405,0.9471646313902228,0.5420219244823387,1.0,1.0,11/51,14.55%,RHOJ;GLIPR2;FGF10;SOX9;DOCK5;DOCK1;HIF1A;CLASP1;HDAC6;BMPER;RTN4
prerank,response to metal ion (GO:0010038),0.32525806843792676,0.946839294547197,0.5476718403547672,1.0,1.0,16/67,18.62%,BCL2;MT3;SLC30A4;PPP3CA;ANXA11;HIF1A;PPP1CA;AHCYL1;GPHN;SNCA;NEDD4L;CALM1;HOMER1;CALM2;KCNMA1;SNCB
prerank,positive regulation of protein phosphorylation (GO:0001934),0.29269323700064576,0.9465687993996805,0.6405622489959839,1.0,1.0,74/348,19.08%,RELN;BMP5;CLDN19;DOCK7;NTRK3;FGF2;FGF10;SOX9;NGF;ERBB2;EGFR;ACVR1;EFNA5;WDFY2;VEGFA;ARAF;WNK3;RPS6KA4;TGFB1;TEC;NTRK2;TRAF4;GDF9;PRNP;MT3;MRNIP;TNIK;NIBAN1;PAK1;ALS2;RALB;RAP1A;UBE2K;ERBB4;EIF4G1;PTPRJ;FBH1;PTPN11;HDAC6;MAPK1;BMP7;MMD2;MYDGF;FGF7;TBK1;XRCC6;AKTIP;BRAT1;SNCA;P2RY1;SH2D3C;CALM1;BMPR1A;IQGAP1;RASSF2;ABL1;CALM2;TP53;CCND2;TGFB3;TERF2IP;APLNR;CD74;RIPK1;CSPG4;JTB;RPTOR;KRAS;MAPRE3;FNIP1;PARK7;SEMA4D;TESK1;S1PR2
prerank,JNK cascade (GO:0007254),-0.26910266764163304,-0.9464641242975279,0.5076142131979695,0.8577426597194411,1.0,15/40,25.17%,MAP3K5;TNFRSF19;GPS2;ARHGEF6;MAP3K7;UBE2N;IKBKG;MINK1;MAPK10;NOD1;CRKL;MAP3K13;GPS1;MAPK8;UBA52
prerank,negative regulation of JUN kinase activity (GO:0043508),0.45681545452385214,0.9462911948407657,0.5396341463414634,1.0,1.0,4/10,23.71%,PTPN22;DNAJA1;PDCD4;AIDA
prerank,phagosome acidification (GO:0090383),0.3677135868573099,0.946057814759852,0.5169270833333334,1.0,1.0,11/26,27.43%,RAB38;ATP6V1B2;RAB39A;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4178936394232693,0.9459055437116197,0.5406626506024096,1.0,1.0,2/14,7.90%,CARD9;IL18
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24662804369755723,-0.94579520997354,0.5620437956204379,0.858152215294517,1.0,7/59,4.37%,ROCK2;ROCK1;BIRC3;NFKBIA;REL;RELB;TLR4
prerank,phospholipid homeostasis (GO:0055091),-0.3765662346962281,-0.9457749298734365,0.5264705882352941,0.8568314363260178,1.0,5/11,25.85%,ABCA1;ABCG1;TLCD1;TLCD2;ANGPTL3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.41808509393043086,0.9456977832511801,0.5171919770773639,1.0,1.0,3/14,10.21%,CPSF6;NCBP1;FIP1L1
prerank,neutrophil activation involved in immune response (GO:0002283),0.29405309805964697,0.945668246119966,0.679,1.0,1.0,58/428,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.31659549171733964,0.9456665044661391,0.5798687089715536,1.0,1.0,11/78,11.37%,LGALS3;EGFR;LRP1;EPHB2;WNK3;TGFB1;SPTBN1;DPP10;ZDHHC8;PIK3R1;PID1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.30941249418850986,0.9455610115109326,0.5682062298603652,1.0,1.0,25/95,23.43%,DYNLL1;CC2D2A;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;CEP89;PRKACA;CKAP5;FBF1;CEP76;DYNC1I2;CSNK1E;CEP63;TUBA1A;CEP78;SSNA1;PCNT;CDK5RAP2;DYNC1H1;PPP2R1A;CEP97
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.31254087037225203,0.945194906749604,0.576307363927428,1.0,1.0,22/95,17.14%,PRDM16;HTRA3;CDKN2B;TGFB1;SOX11;TGFBR2;SPRED2;SPRED1;MEN1;PEG10;DKK3;BCL9L;SPRED3;SNX6;DAND5;BCL9;LDLRAD4;CITED2;ZEB2;UBB;RNF111;NREP
prerank,negative regulation of interleukin-6 production (GO:0032715),0.36866548550081674,0.9450441945595373,0.5308804204993429,1.0,1.0,4/27,9.85%,PTPN22;IRAK3;SYT11;SELENOS
prerank,immunoglobulin mediated immune response (GO:0016064),0.4455303810959156,0.9449459168406326,0.5472560975609756,1.0,1.0,2/10,17.14%,CARD9;CD74
prerank,RNA metabolic process (GO:0016070),0.3056548031864604,0.9448522284419528,0.5727748691099477,1.0,1.0,46/127,26.12%,BICD1;DHX8;ELAVL4;RNASE6;RNGTT;ATXN2;POLR2B;METTL3;XRN2;DDX54;PPP1R8;DDX24;POLR2K;APOBEC1;NCBP1;ADARB2;DUSP11;SNRNP40;HNRNPA3;RNASEH2C;ADARB1;POLR2G;NOVA1;PAPOLA;PNPT1;HNRNPU;TP53RK;TENT2;POLR2A;SYNCRIP;HNRNPUL1;HNRNPC;HNRNPH2;HNRNPL;RBFOX2;RBMS1;ALKBH1;PCBP2;POLR2F;TFIP11;SUPV3L1;DROSHA;RBM4;RNASE3;SND1;HNRNPA2B1
prerank,cellular response to gamma radiation (GO:0071480),0.40344468307433734,0.9442114825116849,0.5482093663911846,1.0,1.0,7/17,18.13%,CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,negative regulation of reproductive process (GO:2000242),0.40341023061740355,0.9438968610490306,0.5407303370786517,1.0,1.0,2/17,5.43%,SULF1;ACVR1C
prerank,regulation of anoikis (GO:2000209),0.39599592925588417,0.9437726134416506,0.5370629370629371,1.0,1.0,2/19,3.82%,BCL2;TLE1
prerank,endothelial cell development (GO:0001885),0.3713961963568051,0.9436106797591991,0.5440210249671484,1.0,1.0,5/25,15.00%,COL15A1;RAP1A;COL18A1;PDE4D;MET
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.34086491234122734,0.9434690217833631,0.5574162679425837,1.0,1.0,19/48,25.51%,OLFM4;IL1RAPL1;DOCK5;OBSL1;CDKL5;CDKL3;FLNA;DOCK1;MYOC;ABL1;RAC3;MDK;TESK1;TRIOBP;CRK;CIB1;PRKDC;FBXW8;ARHGEF7
prerank,negative regulation of autophagy (GO:0010507),0.33316344791421343,0.9432487241894376,0.5577830188679245,1.0,1.0,17/54,22.71%,PTPN22;BCL2;MT3;TSC1;BMF;TLK2;EIF4G1;SNCA;WASHC1;MET;KLHL22;TAB3;STAT3;RRAGA;EIF4G3;NRBP2;TAB2
prerank,cellular response to superoxide (GO:0071451),-0.3746984380546264,-0.9432394190182237,0.5043227665706052,0.8620268684343602,1.0,4/10,11.34%,NOS3;ATP7A;ADPRS;SOD1
prerank,DNA replication initiation (GO:0006270),0.35398770647708727,0.9427492222555355,0.5661310259579728,1.0,1.0,11/37,20.11%,LRWD1;POLE2;RPA3;POLE3;MCM4;RPA2;ORC1;TOPBP1;ORC4;DBF4;ORC2
prerank,organic acid transport (GO:0015849),0.31432084170248475,0.942505537595883,0.5828877005347594,1.0,1.0,17/94,13.24%,SLC27A1;ATP8B1;SLC1A5;NCOA1;SLC38A4;SLC16A10;LRRC8D;SLC27A4;SLC36A2;SLCO2B1;SLC43A1;GOT2;NCOA2;SLC7A7;SLC7A8;SLC25A10;SLC16A1
prerank,protein autoubiquitination (GO:0051865),0.3289550886654735,0.9420571460862485,0.5596330275229358,1.0,1.0,9/61,9.99%,UBE2T;RNF157;PRKN;NFX1;DDB2;BRCA1;RNFT1;CUL3;UHRF2
prerank,long-chain fatty acid import into cell (GO:0044539),0.45226727648477777,0.9419876347477283,0.5650224215246636,1.0,1.0,2/10,4.35%,SLC27A1;SLC27A4
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3763579499750004,0.9418183614468799,0.536813922356091,1.0,1.0,7/24,16.41%,ZRANB3;KMT2A;ERCC4;MSH6;RTEL1;BLM;TERF2IP
prerank,regulation of cellular senescence (GO:2000772),-0.2773428665639398,-0.9416275777284999,0.537117903930131,0.8650593525935273,1.0,12/28,22.02%,NUAK1;SLC30A10;YBX1;TERF2;ING2;HMGA2;TERT;ABI3;RBL1;TWIST1;EEF1E1;VASH1
prerank,regulation of histone deacetylation (GO:0031063),-0.3566491216388384,-0.9416193785325451,0.5471698113207547,0.8636945035985281,1.0,6/13,26.49%,SAP30BP;ING2;ZBTB7B;SPHK2;NIPBL;PRMT6
prerank,cellular response to oxidative stress (GO:0034599),0.30924714737699893,0.9415739012207887,0.5974842767295597,1.0,1.0,30/118,18.84%,PRDX6;PDGFRA;SRXN1;EGFR;NCF1;MT3;GPX3;MAPK9;HIF1A;MGAT3;NCF2;SELENOS;NFE2L2;FANCC;MAPK1;ERCC6L2;PRDX3;SOD2;SNCA;ABL1;VKORC1L1;RAD52;TP53;PNPT1;SLC25A24;CHUK;TXNRD1;CAT;PARK7;ERMP1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3671337856827508,0.9415393169741529,0.5479274611398963,1.0,1.0,4/29,12.73%,FADD;AP1G1;CADM1;NECTIN2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3537245351783773,0.9414808124337595,0.5677339901477833,1.0,1.0,10/37,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.27259823715776416,-0.9413015809885378,0.5299145299145299,0.8631376369031561,1.0,6/29,14.82%,SMAD7;ENG;TPM1;FGFR2;PROX1;S1PR1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4317471489933945,0.9406944937049154,0.5413416536661466,1.0,1.0,1/11,1.25%,BACE2
prerank,endocardial cushion development (GO:0003197),-0.3070897287904578,-0.9403952296935818,0.5627376425855514,0.8641622500303802,1.0,5/21,3.78%,ACVRL1;NOS3;BMP4;ENG;BMPR2
prerank,positive regulation of DNA recombination (GO:0045911),-0.2898719878676346,-0.9403467064885426,0.5469387755102041,0.8628997082548686,1.0,11/27,24.28%,RIF1;MMS19;PARP1;TFRC;WRAP53;ERCC2;PAXIP1;ERCC6;FANCB;TIMELESS;MAD2L2
prerank,regulation of biomineral tissue development (GO:0070167),0.3762146781235723,0.940270530118286,0.5478723404255319,1.0,1.0,3/26,4.08%,ANKH;SOX9;TGFB1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3604379260975577,0.9402370502158103,0.5471204188481675,1.0,1.0,4/30,8.59%,BMP5;FADD;TNFRSF10B;BRCA1
prerank,L-amino acid transport (GO:0015807),0.366780844153806,0.9400858914670005,0.5617529880478087,1.0,1.0,5/28,12.94%,SLC1A3;SLC36A2;ARL6IP5;SLC7A8;PRAF2
prerank,regulation of striated muscle contraction (GO:0006942),0.36687040012132716,0.9400624043171506,0.5455746367239102,1.0,1.0,6/27,15.54%,MYBPH;ANK2;TNNT3;PRKACA;CALM1;CALM2
prerank,negative regulation of B cell activation (GO:0050869),-0.3068718208536903,-0.9399938622422579,0.5427509293680297,0.8624089721374092,1.0,10/21,25.63%,LYN;PARP3;ID2;INHBA;CD300A;LAPTM5;TNFAIP3;TNFRSF21;TYROBP;INHA
prerank,growth hormone receptor signaling pathway (GO:0060396),0.42362317487589024,0.9399395375615287,0.5471976401179941,1.0,1.0,8/14,22.75%,PTPN1;PIK3R1;PRLR;STAT3;STAT5A;PXN;GHR;STAT6
prerank,amide transport (GO:0042886),-0.29339999526187016,-0.9396990665808876,0.5732217573221757,0.8617902612382451,1.0,7/26,12.63%,ABCG2;PLTP;PDPN;GLTP;AQP11;SLC38A5;SLC5A6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.37438930588586006,0.9394706528245675,0.5615183246073299,1.0,1.0,6/26,9.43%,ERLIN2;MLXIPL;PRKAB2;EIF6;BRCA1;ELOVL5
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3045092199852469,0.9392591424704456,0.6041450777202072,1.0,1.0,27/132,17.21%,DCN;IRS2;ZBTB20;VGLL4;NPRL2;PSEN1;DXO;MLXIPL;UFL1;BNIP3;VPS11;HIF1A;PTPN1;MID2;UPF1;ZC3H18;SNCA;MTLN;KHSRP;TICAM1;DACT1;PIM2;GPLD1;PNPT1;ZSWIM8;ABCD2;RC3H1
prerank,regulation of cell development (GO:0060284),-0.27290495447605045,-0.9390143507133747,0.585635359116022,0.8622170090048428,1.0,8/36,16.02%,NOTCH2;CTNNB1;CLOCK;RPS19;RHEB;PRUNE1;HEY2;ADGRA2
prerank,DNA repair (GO:0006281),0.29523983650813473,0.9389717341706227,0.65625,1.0,1.0,61/284,17.48%,UBE2T;RAD23B;POLN;ZRANB3;APTX;MBD4;POLE2;GTF2H2;CHRNA4;ERCC5;NSMCE3;ERCC4;MPG;KDM4B;DDB2;RPA3;NUDT1;MUTYH;MEN1;BRCA1;XPA;REXO4;TDP1;ALKBH5;SETD2;HUWE1;NEIL1;ENDOV;FBH1;FANCC;ASF1A;MSH6;NSD2;UPF1;ERCC6L2;ZBTB1;DDB1;HPF1;MDC1;XRCC3;EXD2;RPA2;TOPBP1;PDS5B;SUMO1;SMUG1;BAZ1B;UBB;ATM;TRRAP;ABL1;CSNK1E;RAD52;BLM;TP53;FANCI;USP1;FAM111A;CUL4B;WRN;NSMCE4A
prerank,respiratory electron transport chain (GO:0022904),-0.34794880471488143,-0.9389710834066349,0.5405405405405406,0.8609620157948491,1.0,7/14,23.06%,SDHB;SLC25A12;ETFRF1;ETFB;SDHA;UQCRFS1;SLC25A18
prerank,cellular amide metabolic process (GO:0043603),0.31040501326313746,0.9389418392837083,0.5889967637540453,1.0,1.0,26/102,20.99%,THEM4;MIPEP;OXSM;ALDH1L1;MCCC1;HLCS;ACOT11;MTRR;MCCC2;ACSF2;THOP1;PLAAT5;MTHFD2L;PLAAT3;CPD;ABCB9;GNE;ALDH1L2;ACSL6;GPAT4;GLYAT;DBI;PLA2G4E;SLC25A32;ACOT8;ACBD6
prerank,regulation of necroptotic process (GO:0060544),-0.29861061734863864,-0.9389315060413671,0.5362318840579711,0.8596968658337119,1.0,9/23,18.71%,BIRC3;OGT;STUB1;CASP8;HSP90AA1;FLOT1;ARHGEF2;SPATA2;CFLAR
prerank,inositol phosphate biosynthetic process (GO:0032958),0.44126887016760336,0.9387720266187553,0.5662100456621004,1.0,1.0,1/11,1.27%,FGF2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4091428073429152,0.9386667255771493,0.56,1.0,1.0,6/16,20.38%,CPEB3;ZFP36L2;UPF1;KHSRP;RC3H1;ZFP36
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.41533878865006457,0.9386393558520278,0.5444126074498568,1.0,1.0,2/15,4.08%,IRAK3;TGFB1
prerank,keratinocyte differentiation (GO:0030216),0.3672706839249355,0.9385258326934989,0.5609436435124509,1.0,1.0,3/29,5.52%,CERS3;TGM1;WNT5A
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.38009550879314524,-0.9380989910696547,0.5459610027855153,0.8606097895148199,1.0,7/11,29.99%,SERTAD2;SMARCD1;PADI2;SERTAD1;ELOF1;CDCA4;CHEK1
prerank,cellular protein modification process (GO:0006464),0.2881369861917221,0.93798427820858,0.764,1.0,1.0,161/983,14.08%,PTPRH;GPC3;CHRM3;WNK2;CCL11;VCAN;PRKCA;CTH;CEL;ST3GAL4;PTEN;PTPN22;MXRA8;PEAK1;FBXW9;CHRDL1;STK36;DUSP4;PGAP1;ERBB2;LAMC1;RAB38;PTPRT;TGM1;ACVR1;UBE2E2;MAP4K4;PAK4;ARAF;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;SOCS5;FBXW7;MAST2;SPSB4;PRKCSH;NEK1;TGFB1;TEC;ASB8;PAK5;NUCB1;NPC1;SETD3;SDC2;MT3;MAPKAPK2;KLHL13;TESK2;DUSP6;PRKAR1B;TNIK;PTPN13;HLCS;ACVR1C;OBSL1;FBXO7;PAK1;PKN1;WIPI1;FBXL15;YWHAZ;DDB2;CDKL5;ASB5;CDK8;FBXO32;CDKL3;ZBTB16;CDK13;MMP15;EVA1A;TGFBR2;B3GNT9;MAN2A2;CSK;UFL1;PPP3CB;DYRK1B;PDK3;RCN1;LIMK1;CDK6;MEN1;NAE1;FGFR1;ATG5;FYN;STT3A;VWA1;PPP3CA;CDK15;PPM1B;PPM1J;PPP2R3A;TBCK;FBXL16;CDK19;PSMB7;PPP2R2A;COL3A1;STK39;PASK;TLK2;MAPK9;AKT3;FBXO27;SGK3;SGK2;CKAP4;HIF1A;AMELX;PTPN1;CUL3;PXK;DUSP11;PTPRJ;TYK2;ST8SIA1;ARF4;DCLK1;UCHL3;LTBP1;STK19;CDC25B;MAPK1;SIRT6;CALU;UBA3;PPP1CA;SLC35A1;TAOK3;FBXO17;PTPRA;RAB1A;FBXL2;FUCA2;TBK1;PRKACA;ALG5;DCAF8;PTPN18;ATG3;RAB3A;BTBD1;CSNK1A1;HSP90B1;NEK7;PTPRZ1;CDK16;DDB1;PTPN21;PENK;TTBK1;SUMF1;NEDD8;PPP3CC;SSH1
prerank,regulation of protein phosphorylation (GO:0001932),0.293350077041466,0.937903486865142,0.6370967741935484,1.0,1.0,42/256,14.02%,CLDN19;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SOX9;BST1;ERBB2;PRKN;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;CADM4;EIF2AK3;TGFB1;NTRK2;PRNP;MT3;TNIK;PTPN13;NIBAN1;SOCS1;PAK1;RALB;MEN1;FYN;GRM5;ERBB4;FBH1;PID1;BMP7;MYDGF;FGF7;WWTR1;AKTIP;BRAT1;P2RY1;PDCL3;BMPER
prerank,regulation of cytokine production (GO:0001817),0.30604860363562075,0.9377316922306729,0.6153039832285115,1.0,1.0,16/126,13.20%,FFAR4;GLMN;DTX4;RPS6KA4;MAST2;MAPKAPK2;CCR2;AGPAT2;CARD9;CADM1;SYT11;MAPK14;TBK1;ATP2B1;PER1;GATA3
prerank,regulation of cell killing (GO:0031341),0.4098414405071793,0.9376908838116726,0.5595238095238095,1.0,1.0,3/16,7.26%,NOX1;WNT5A;FZD7
prerank,regulation of protein polymerization (GO:0032271),-0.27212987703533026,-0.9375048856314037,0.529126213592233,0.8608121283886992,1.0,9/35,15.01%,ARHGAP28;FCHSD2;MAP2;ESAM;PFN2;MAPT;HAX1;HSP90AA1;PRUNE1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3750949438165167,-0.9372428013614718,0.5163043478260869,0.8601156515976373,1.0,4/10,24.42%,USP7;OGT;PDK2;SIRT7
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.40502101048410577,0.9371646100359111,0.5499276410998553,1.0,1.0,9/17,26.20%,CARD9;ARL6IP5;TAOK3;KLHDC10;MID1;RNF13;TAOK1;EIF2AK2;SEMA4C
prerank,RNA export from nucleus (GO:0006405),0.3076920666148204,0.9370234000805273,0.5811688311688312,1.0,1.0,35/100,26.36%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;XPO5;THOC5;MAGOHB;NUP35;HNRNPA2B1;RAE1
prerank,positive regulation of biosynthetic process (GO:0009891),0.3476794603197726,0.936959919583973,0.5801435406698564,1.0,1.0,7/40,10.11%,CREB3L1;ZBTB20;SLC5A3;TGFB1;MLXIPL;AMELX;HDAC2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.39537001829731155,0.9367946378846793,0.5613275613275613,1.0,1.0,5/18,13.27%,NAALAD2;SMS;GOT2;ASNS;ADI1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36415843031109857,0.9365633382882749,0.5593869731800766,1.0,1.0,5/30,8.27%,PTPN2;CADM4;SOCS1;SAMSN1;NF2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.32147873012990813,0.9363267519832956,0.5735632183908046,1.0,1.0,17/67,15.23%,SULF1;VEGFA;MAPKAPK3;NCF1;MAPKAPK2;BAIAP2;FYN;BRK1;VAV3;DOCK1;NCF2;PIK3R1;MAPK14;NRP2;NCK1;CYFIP1;ELMO1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3764482366299821,-0.9360468813704103,0.5561643835616439,0.8618185911237113,1.0,2/10,14.78%,PTPRC;CEACAM1
prerank,cardiac myofibril assembly (GO:0055003),0.4176966416884662,0.9358564105553921,0.5589519650655022,1.0,1.0,2/15,5.55%,PDGFRA;OBSL1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4363879752156875,0.9358247839348365,0.5705329153605015,1.0,1.0,1/11,1.07%,SLC27A1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.35724354806634084,0.9351083329850979,0.5597014925373134,1.0,1.0,3/33,4.08%,MEOX2;FGF2;TGFB1
prerank,DNA replication checkpoint signaling (GO:0000076),0.41015559105241367,0.9348498647975513,0.5659259259259259,1.0,1.0,4/16,14.08%,TIPIN;NAE1;ORC1;TOPBP1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.29429216594033814,0.9347995837304715,0.6194415718717684,1.0,1.0,38/172,20.22%,PLEKHA4;INPP4B;SLC27A1;FGF2;PTEN;RAB14;PLD1;MTMR14;SLC44A2;PTPN13;AGPAT2;PI4KB;VAC14;PLA2G12A;PTDSS1;PIK3R1;PI4K2A;SELENOI;FAR1;MTMR12;PCYT1B;CHPT1;ETNK1;RAB4A;AGPAT5;CHAT;GPAT3;GPAT4;PIP5K1A;CPNE7;AGK;SLC44A1;CSNK2A2;LPCAT2;CPNE1;STARD7;DDHD1;INPP5J
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.30029002581274616,-0.9346214095138742,0.5519713261648745,0.8641382038902173,1.0,7/23,20.04%,SASH1;MAP3K5;TNFRSF11A;MAP3K7;ARHGEF5;EDN1;DVL2
prerank,positive regulation of telomerase activity (GO:0051973),0.35241533325763064,0.9343883847166148,0.5478589420654912,1.0,1.0,6/33,14.18%,PRKCQ;MYC;PARM1;MAPK1;NEK7;MAP3K4
prerank,positive regulation of ERAD pathway (GO:1904294),0.42494625162136274,0.9342706433767214,0.5411764705882353,1.0,1.0,7/13,23.05%,RNFT1;HERPUD1;NFE2L2;USP13;SGTA;UBQLN1;UBQLN2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3088625517675951,0.9342632775536851,0.5791710945802337,1.0,1.0,40/104,29.29%,SLC27A1;PYCARD;CDKN2B;CCNJ;KSR1;RALB;SLC8A2;PIH1D1;PKMYT1;CDK5R1;SNCA;CALM1;CDK5R2;ABL1;CALM2;BLM;CCND2;RPTOR;HTT;TESK1;CAB39;BCCIP;RB1;PPEF2;CIB1;CCNT2;CCNH;CDC37;CDK5RAP3;CDKN1A;CCND3;EZH2;CCNI;SIRT1;GTPBP4;TELO2;CCNE1;SNF8;CDKN2D;CDKN1B
prerank,histone H2A ubiquitination (GO:0033522),0.39750000459038703,0.9340448703500802,0.5482954545454546,1.0,1.0,8/17,27.83%,DDB2;DDB1;CUL4B;BCOR;RNF2;PCGF1;RNF168;TRIM37
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.44654291637677324,0.934028164465836,0.5536,1.0,1.0,4/10,19.23%,SHQ1;PIH1D1;TAF9;RUVBL2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.27808074306267716,-0.9338872112702321,0.5565610859728507,0.8645909088794984,1.0,5/28,15.46%,PRKAG2;PRKAA2;ADIPOR2;AVIL;FGFR4
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3047447088616205,0.9336925389770516,0.6104589114194237,1.0,1.0,21/119,14.51%,PLEKHA4;INPP4B;SLC27A1;FGF2;PTEN;RAB14;SOCS5;MTMR14;PTPN13;SOCS1;PI4KB;VAC14;PIGC;PIGP;PIK3R1;PI4K2A;MTMR12;RAB4A;PIGN;PIGA;TTC7A
prerank,regulation of DNA recombination at telomere (GO:0072695),0.39678037715392606,0.9333379914105626,0.5642076502732241,1.0,1.0,8/19,24.21%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.39678037715392606,0.9333379914105626,0.5642076502732241,1.0,1.0,8/19,24.21%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,myofibril assembly (GO:0030239),0.3389081762355708,0.9333139485784784,0.555421686746988,1.0,1.0,4/42,8.42%,PDGFRA;CSRP1;OBSL1;TNNT3
prerank,regulation of neuron death (GO:1901214),0.31722862138033747,0.933251221598131,0.6164079822616408,1.0,1.0,20/82,19.35%,CD34;PRKN;PRNP;GRIN2B;GRID2;WNT5A;TSC1;TRIM2;NAE1;FYN;DCC;EIF4G1;TBK1;SNCA;UBB;EFNB2;SNCB;PARK7;EGR1;BTBD10
prerank,ncRNA export from nucleus (GO:0097064),0.3451919467803723,0.933133684756232,0.5324189526184538,1.0,1.0,10/36,17.36%,RANBP2;TSC1;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,cell chemotaxis (GO:0060326),0.3261097815845909,0.9325765598357575,0.5853658536585366,1.0,1.0,7/60,7.06%,PDGFRA;PRKCQ;LPAR1;VEGFA;EGR3;CCR2;ACKR3
prerank,regulation of inflammatory response (GO:0050727),0.2972621378860129,0.9323748777149792,0.6234693877551021,1.0,1.0,35/190,19.67%,RORA;FFAR4;ADAMTS12;IL16;BST1;PTPN2;MAPK7;GPRC5B;TNFAIP8L2;CCR2;WNT5A;IL1RL2;UFL1;PLA2G7;OTULIN;IL18;SELENOS;SNX6;CASP12;GRN;SHPK;GATA3;SNCA;IL33;AREL1;XIAP;ABCC1;RIPK1;MDK;PTGES;LRFN5;PARK7;SETD4;PDCD4;PPARG
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3083233276969012,0.9323505630799691,0.5937161430119177,1.0,1.0,20/95,17.24%,POLN;MEIOB;AP5S1;ERCC5;REV3L;ERCC4;RPA3;BRCA1;GINS2;FBH1;MCM4;SFPQ;HELQ;XRCC3;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,reticulophagy (GO:0061709),-0.35696208643348315,-0.9323366849527195,0.5233918128654971,0.8672447665943508,1.0,5/12,21.18%,TEX264;UFM1;UFC1;UBA5;ULK1
prerank,protein polymerization (GO:0051258),0.33097690195066365,0.9323009479692996,0.5722748815165877,1.0,1.0,10/56,15.98%,FGF13;SPIRE1;GSN;PRKN;GAS7;UBE2K;WASF1;CKAP5;COBL;DIAPH3
prerank,regulation of macroautophagy (GO:0016241),0.30671603859442564,0.932100322643847,0.5922330097087378,1.0,1.0,16/105,12.48%,DCN;WAC;CAPN1;ATP6V1B2;TSC1;PRKAB2;BNIP3;LAMTOR2;UCHL1;SNX6;VPS26B;CLEC16A;HDAC6;CDK5R1;TBK1;PRKACA
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4218394478040075,0.932075949504199,0.5599415204678363,1.0,1.0,8/13,29.80%,UBA2;NAE1;UBA3;UBA1;SAE1;ATG10;DESI1;DESI2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.36149693890545187,-0.9317316377229469,0.5510204081632653,0.8674104260099137,1.0,3/13,1.46%,CACNA1C;GJA1;CACNB2
prerank,Notch signaling pathway (GO:0007219),0.3271848480775865,0.93127515102552,0.5975336322869955,1.0,1.0,15/59,18.42%,MAML3;MYC;KAT2B;DTX4;MAML2;PSEN1;HOXD3;NCSTN;APH1A;PSEN2;TRAF7;MIB1;HEYL;MDK;GALNT11
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.31268473253263085,-0.9312119002695829,0.5490909090909091,0.8673579141708964,1.0,9/20,30.18%,AGO1;ZC3H7B;AGO3;TERT;TARBP2;MRPL44;AGO2;DICER1;AGO4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3430624564752279,-0.9311451391123143,0.5468277945619335,0.8661616179123945,1.0,7/14,20.91%,NOS3;ACE;ENPEP;AGTR1;ECE1;EDN1;ACE2
prerank,RNA 3'-end processing (GO:0031123),0.31987335814106566,0.9311414992746144,0.5781071835803877,1.0,1.0,22/69,24.99%,CSTF3;THOC6;RPRD1A;TUT4;SRSF11;CASC3;NCBP1;FIP1L1;SRSF6;PAPOLA;PNPT1;RNPS1;TENT2;THOC7;SRRM1;SRSF3;SYMPK;TUT1;THOC5;SUPV3L1;MAGOHB;CPSF7
prerank,negative regulation of immune response (GO:0050777),0.297015888465374,0.9310694344447618,0.6105919003115264,1.0,1.0,16/154,12.74%,LGALS3;CRH;DPEP1;IRAK3;PTHLH;CCR2;PRKAR1B;PTH2R;SAMSN1;FYN;TSHR;PPM1B;COL3A1;MAPK14;PRKACA;GLP2R
prerank,cellular response to interleukin-4 (GO:0071353),-0.38165487044218577,-0.9307994307627132,0.5652173913043478,0.8656477478823007,1.0,1/10,0.63%,LEF1
prerank,cellular response to amyloid-beta (GO:1904646),0.3482009224394859,0.9305037753364983,0.5644555694618273,1.0,1.0,9/35,10.58%,CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR
prerank,myoblast fusion (GO:0007520),0.41834839351470354,0.9304903471746817,0.5385826771653544,1.0,1.0,4/12,21.90%,ADGRB3;CD9;ADAM12;CACNA1H
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2355297164599869,-0.9303073834885756,0.6074074074074074,0.8655652883917785,1.0,27/57,28.00%,NPM1;RPS16;RPL38;RPS19;NVL;RPL5;RPS25;RPS15;NAF1;RPS6;RPL11;EMG1;SURF6;BYSL;RIOK1;RPL35A;RPL26;PES1;DHX37;CUL4A;RPS17;NOC2L;RPF2;RIOK2;URB2;PAK1IP1;MRPL36
prerank,regulation of interleukin-4 production (GO:0032673),-0.30348861262823196,-0.9299316999826208,0.550185873605948,0.8651300755118642,1.0,8/21,20.70%,LEF1;SLC7A5;PRKCZ;CD86;RARA;ZFPM1;HAVCR2;FCER1G
prerank,endocrine system development (GO:0035270),0.3818218301271609,0.9296157049131856,0.5546448087431693,1.0,1.0,4/21,9.20%,GLI2;NF1;HOXD3;DKK3
prerank,regulation of epithelial cell differentiation (GO:0030856),0.39646355865447275,0.929108054995983,0.5724533715925395,1.0,1.0,4/17,13.20%,SOX9;PRKX;AJAP1;GATA3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.26882120139902194,-0.9289279829804816,0.5865384615384616,0.866277108574607,1.0,9/33,13.20%,ACER2;LYN;JAM3;DPP4;EPHA8;SERPINE1;TGFB2;NEXMIF;NCKAP1L
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.43434362554507444,0.9287348017971533,0.5622254758418741,1.0,1.0,3/11,14.37%,RASA1;PCBP4;NOVA1
prerank,transepithelial transport (GO:0070633),0.4058754141087244,0.9286815878256577,0.5643564356435643,1.0,1.0,4/15,17.07%,SLC1A3;SLC12A2;GPLD1;ABCC1
prerank,aerobic respiration (GO:0009060),-0.30370715559756906,-0.9286556712139762,0.5384615384615384,0.8656575564671709,1.0,10/20,28.40%,SDHB;SIRT3;OXA1L;UQCRB;ATP5F1D;UQCR10;UQCRH;UQCRC1;SURF1;MTFR2
prerank,negative regulation of interferon-beta production (GO:0032688),0.44131830740746064,0.9282962457233089,0.5634920634920635,1.0,1.0,4/10,20.80%,PYCARD;PPM1B;PTPRS;SIRPA
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4165657604948553,0.9282635554290168,0.565015479876161,1.0,1.0,4/13,12.68%,SHISA9;GRIK2;SLC8A2;RAB3A
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.30618109597143794,-0.9281581746641168,0.5488721804511278,0.8642453237804795,1.0,9/20,31.84%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5;GSTO2;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),-0.30618109597143794,-0.9281581746641168,0.5488721804511278,0.8642453237804795,1.0,9/20,31.84%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5;GSTO2;GSTK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.29641159839752174,0.9280240750547218,0.6359918200408998,1.0,1.0,32/166,16.10%,SLC27A1;GLI2;FGF2;MYC;IRS2;ERBB2;EGFR;PTPN2;UPF3A;PLD1;GLI1;NIBAN1;STN1;METTL3;MLXIPL;EIF3C;CPEB3;EIF6;NSUN5;PASK;ELOVL5;HIF1A;PAOX;SP1;PRMT1;DDB1;SMOC2;SNCA;ZEB2;PRR16;RPS27L;GPLD1
prerank,regulation of viral genome replication (GO:0045069),-0.2420475479622064,-0.9278334969484097,0.656934306569343,0.8637656927642091,1.0,18/56,22.46%,ZC3HAV1;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TNIP1;VAPB;IFITM2;OAS2;PROX1;PPIE;TARBP2;ISG15;IFIT1;BST2;RSAD2;PDE12
prerank,retrograde axonal transport (GO:0008090),-0.3207309939218633,-0.9277535501285441,0.5518394648829431,0.8626857500050761,1.0,4/16,11.34%,KIF1C;PAFAH1B1;KIF5B;SOD1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3582951735184094,-0.927608261734059,0.5431754874651811,0.8617631872051051,1.0,4/11,8.44%,P4HB;OGFOD1;P4HA2;EGLN2
prerank,negative regulation of cellular component organization (GO:0051129),0.317942413925695,0.9275591380415004,0.5951327433628318,1.0,1.0,9/74,11.57%,LGALS3;FAP;VEGFA;IRAK3;CRYAB;SYT11;MCTP1;HDAC6;DNAJB6
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4480900266271935,0.9275354800091753,0.5727848101265823,1.0,1.0,3/10,12.69%,VEGFA;DISC1;DRD2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.32857118850016304,-0.9272445717670061,0.5316455696202531,0.8614109166425342,1.0,3/17,1.14%,BAIAP2L1;NRP1;TEK
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3764875754778646,0.9271982010291316,0.5637860082304527,1.0,1.0,2/22,4.99%,LGALS3;PPP1R15A
prerank,phosphorylation (GO:0016310),0.2885470697369604,0.9267335751716289,0.7121364092276831,1.0,1.0,67/385,13.10%,WNK2;CCL11;PRKCA;PEAK1;STK36;ERBB2;ACVR1;MAP4K4;PAK4;EPHB2;GNPTAB;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAST2;NEK1;TGFB1;TEC;PAK5;MAPKAPK2;TESK2;PRKAR1B;TNIK;ACVR1C;PAK1;PKN1;YWHAZ;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;LIMK1;CDK6;FGFR1;FYN;CDK15;TBCK;CDK19;STK39;PASK;TLK2;MAPK9;AKT3;SGK3;SGK2;PXK;TYK2;DGKI;DCLK1;STK19;CDC25B;TOLLIP;MAPK1;TAOK3;TBK1;PRKACA;CSNK1A1;NEK7;CDK16;SHPK
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.444409330273622,0.926682225363226,0.573208722741433,1.0,1.0,2/10,4.45%,CACNA2D1;PDE4B
prerank,cellular calcium ion homeostasis (GO:0006874),0.29413703921380757,0.9266032549311471,0.613588110403397,1.0,1.0,23/133,15.53%,CCL11;BCL2;ANK2;LETM1;ATP2B3;PACS2;PSEN1;CCR2;PDZD8;SLC8A2;SLC24A5;SLC10A7;HTR2C;HERPUD1;ANXA6;EDN3;PRKACA;TPCN2;ATP2B1;CCDC47;TRPC5;CCL14;FZD9
prerank,regulation of monooxygenase activity (GO:0032768),0.3697244658955338,0.9265329334024152,0.5654520917678812,1.0,1.0,9/23,22.10%,POR;EGFR;LYPLA1;GDNF;SNCA;CALM1;NOS1AP;ZDHHC21;DDAH1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4170317385333977,0.9263029375870984,0.5468053491827637,1.0,1.0,1/12,2.53%,SLC5A3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.38294531006638954,-0.9260544360401791,0.5535714285714286,0.8630837786021818,1.0,2/10,4.91%,DSE;PXYLP1
prerank,negative regulation of protein transport (GO:0051224),0.36724965106546686,0.9255371653567528,0.5865384615384616,1.0,1.0,5/25,16.92%,PKDCC;CSK;DRD2;NDFIP1;SNX12
prerank,motor neuron axon guidance (GO:0008045),-0.3311246558773492,-0.9254677320389993,0.5490196078431373,0.8632468848907678,1.0,3/15,6.20%,EPHA4;SLIT2;TMEFF1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.27432045881130906,-0.9248356614753278,0.5854922279792746,0.8636017543852434,1.0,7/31,12.51%,SMAD7;ENG;TGFBR1;TPM1;FGFR2;PROX1;TGFB2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.39989717437149686,0.9248265836847424,0.5547445255474452,1.0,1.0,3/15,9.99%,PABPC1;CPEB3;ZFP36L2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.39989717437149686,0.9248265836847424,0.5547445255474452,1.0,1.0,3/15,9.99%,PABPC1;CPEB3;ZFP36L2
prerank,protein autophosphorylation (GO:0046777),0.29487668101665304,0.924713477823319,0.6553147574819401,1.0,1.0,23/157,10.25%,WNK2;PDGFRA;PEAK1;ERBB2;EGFR;PRKX;MAP3K3;WNK3;SIK2;EIF2AK3;MAPKAPK3;TEC;NTRK2;MAPKAPK2;TNIK;EEF2K;PAK1;CDKL5;FGFR1;STK39;PASK;ERBB4;SLK
prerank,synaptic vesicle membrane organization (GO:0048499),0.39067334819242217,0.9244769763960147,0.5628654970760234,1.0,1.0,2/17,5.65%,SNAP23;SNAP29
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.32859919531277215,-0.924193265666154,0.5594855305466238,0.8639572424377919,1.0,5/17,15.06%,GJA1;KDM1A;PTPRC;HMGA2;TERT
prerank,cardiac muscle tissue development (GO:0048738),0.3301169713029298,0.9240705224361767,0.589041095890411,1.0,1.0,7/50,7.60%,BMP5;AKAP13;SGCD;SCN5A;SGCZ;GATA6;TBX18
prerank,positive regulation of cell differentiation (GO:0045597),0.2913201440990788,0.9230437153093386,0.6697061803444783,1.0,1.0,38/237,11.65%,FFAR4;SOX6;GLIPR2;PKDCC;CD34;SOX9;NGF;ACVR1;FRZB;XKR8;WDFY2;NRCAM;GPRC5B;TGFB1;SOX11;PLCB1;CTNNA2;ZEB1;HOXD3;ZBTB16;TGFBR2;LMO3;RAP1A;FGFR1;IL18;PPP1R13L;SOX5;CARM1;MAPK9;BCL9L;GDNF;MAPK14;IL6ST;GPC1;BMP7;ATRAID;EDN3;MMD2
prerank,mRNA metabolic process (GO:0016071),0.30699700195778906,0.9229478999388426,0.6182019977802442,1.0,1.0,18/90,17.36%,CSTF3;DXO;CPSF6;METTL3;SON;SRSF11;AURKAIP1;ALKBH5;NCBP1;ZFP36L2;SFPQ;LSM3;PRKACA;PRPF18;TP53;PNPT1;SF3A1;SSB
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.32277087293776985,-0.9228057304099797,0.5576923076923077,0.8661639535570183,1.0,5/16,7.23%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,ureteric bud development (GO:0001657),0.396477889980394,0.9226557805933103,0.5669064748201439,1.0,1.0,1/17,0.27%,GPC3
prerank,mitochondrial translational elongation (GO:0070125),0.3081058741112942,0.9223686538571553,0.6032967032967033,1.0,1.0,25/88,22.43%,MRPL47;MRPS18A;TUFM;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3825763129307308,0.9222966507649576,0.593006993006993,1.0,1.0,4/20,11.37%,PKDCC;TGFB1;CSK;PID1
prerank,regulation of rRNA processing (GO:2000232),0.4016424197351093,0.9218574124105233,0.6029850746268657,1.0,1.0,4/16,12.65%,KAT2B;SHQ1;HEATR1;TRMT112
prerank,mammary gland development (GO:0030879),0.3838000401843074,0.9214427288499031,0.5786593707250342,1.0,1.0,6/21,17.72%,GLI2;VEGFA;ERBB4;PRLR;TGFB3;GPAT4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.326357926934449,-0.9208533382266471,0.5294117647058824,0.8698154467637611,1.0,6/14,21.64%,PRKCI;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,regulation of phosphatase activity (GO:0010921),0.37435788059571934,0.9207925975396992,0.58,1.0,1.0,12/24,28.22%,URI1;TSC1;HSP90B1;TIPRL;HTT;ZCCHC9;BMP2;PPP6R2;PPP6R1;CDK5RAP3;GPATCH2;CHP1
prerank,organic cation transport (GO:0015695),0.3811832333682154,0.9203064824601818,0.5891891891891892,1.0,1.0,3/20,9.03%,SLC22A3;SLC44A2;SEC14L1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2599457948562905,-0.9201312684148175,0.6073298429319371,0.870307030719932,1.0,14/40,18.11%,PRKCD;PARG;NPAS2;MCL1;POLH;ING2;ARMT1;ETAA1;SMYD2;MAPT;HMGA2;UBE2N;BCLAF1;FXR2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3224369023787672,-0.9199193350386499,0.5405405405405406,0.8695020093236535,1.0,5/17,12.22%,SLC9A6;SLC9A2;SLC9A9;SLC9A7;SLC6A1
prerank,tRNA export from nucleus (GO:0006409),0.34611149076987197,0.9192888545360757,0.5492424242424242,1.0,1.0,9/32,17.36%,RANBP2;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.34611149076987197,0.9192888545360757,0.5492424242424242,1.0,1.0,9/32,17.36%,RANBP2;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,mRNA export from nucleus (GO:0006406),0.3008115872132793,0.9186897875731236,0.6339381003201707,1.0,1.0,36/102,26.36%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;PCID2;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;THOC5;MAGOHB;ENY2;NUP35;HNRNPA2B1;RAE1
prerank,"phototransduction, visible light (GO:0007603)",0.40732359687570613,0.9183195505036016,0.5575757575757576,1.0,1.0,1/14,1.69%,RHO
prerank,meiosis I (GO:0007127),0.3723385318621796,0.9182454353823023,0.5818908122503329,1.0,1.0,7/23,22.34%,MEIOB;SGO1;BCL2L11;FOXJ3;ZSCAN21;PTTG1;DDX4
prerank,cellular response to interferon-beta (GO:0035458),-0.3340315550517024,-0.9180596857528881,0.597444089456869,0.8727205287294308,1.0,7/14,23.07%,AIM2;IRGM;IRF1;IFITM2;UBE2G2;HTRA2;CDC34
prerank,activation of protein kinase activity (GO:0032147),0.3017338866675257,0.9179851579048673,0.6291891891891892,1.0,1.0,15/106,7.90%,NTRK3;MAP4K4;VEGFA;PAK4;TNFRSF10B;PAK5;MT3;PRKAR1B;TNIK;WNT5A;PAK1;MAPKAP1;TGFBR2;PRRC1;IL18
prerank,B cell activation involved in immune response (GO:0002312),0.41221022147661124,0.9178200343298497,0.5701881331403763,1.0,1.0,5/13,27.55%,MSH6;BATF;EXOSC3;LIG4;RNF168
prerank,pore complex assembly (GO:0046931),-0.3066553057015915,-0.9177922569937648,0.5467128027681661,0.8720691734808509,1.0,7/19,19.33%,AFDN;NUP93;NUP107;ADAM10;PDZD11;GSDMD;NUP98
prerank,cell part morphogenesis (GO:0032990),0.4139096433022139,0.9176637928514426,0.5617469879518072,1.0,1.0,6/13,24.43%,PACSIN2;PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,striated muscle tissue development (GO:0014706),0.35754639662450877,0.9170724542249589,0.5919165580182529,1.0,1.0,3/29,5.87%,BMP5;SGCD;SGCZ
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3266780049102039,0.9169693261455155,0.5868814729574223,1.0,1.0,9/52,15.76%,DDX11;DNAJB9;CXXC1;WIPI1;EXTL3;MYDGF;ARFGAP1;LMNA;KDELR3
prerank,regulation of cellular protein localization (GO:1903827),0.3272698659085527,0.9168466633658584,0.5907429963459196,1.0,1.0,11/45,15.98%,GPC3;RALB;GBF1;PTPN1;SETD2;GPC1;DVL1;GPC4;KCNAB2;CSNK1E;SPIDR
prerank,regulation of interleukin-8 production (GO:0032677),0.3118576286935967,0.9167172929909742,0.6013667425968109,1.0,1.0,18/69,24.51%,PYCARD;PTPN22;FADD;OTUD7B;TLR1;RAB1A;SSC5D;CD74;RIPK1;MAPKBP1;LBP;PARK7;BCL10;STAT3;PRKD2;BCL3;MAVS;HSPA1A
prerank,blood vessel morphogenesis (GO:0048514),0.32285865654128915,0.9166918657652966,0.6,1.0,1.0,9/54,7.15%,HAS2;GLMN;VEGFA;TGFB1;ITGB8;NF1;RASA1;TGFBR2;CYP1B1
prerank,axonemal dynein complex assembly (GO:0070286),0.35017837134887075,0.9164858699137622,0.5896103896103896,1.0,1.0,2/28,2.93%,DNAI4;CCDC39
prerank,lung epithelium development (GO:0060428),0.4340873689749951,0.9164720921860305,0.563076923076923,1.0,1.0,4/10,16.83%,FGF10;RCN3;PKD1;FOXJ1
prerank,RNA catabolic process (GO:0006401),0.33086029727061717,0.9162099781002311,0.5822328931572629,1.0,1.0,8/46,12.38%,RNASE6;DXO;METTL3;XRN2;PPP1R8;NCBP1;ZFP36L2;RNASEH2C
prerank,negative regulation of apoptotic process (GO:0043066),0.2859272147604842,0.915735489856316,0.7477477477477478,1.0,1.0,97/444,18.98%,FFAR4;PRKCA;ERBB3;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;CRLF1;NGF;PRKN;EGFR;FMN2;MAP4K4;VEGFA;EGR3;ARAF;THOC6;WNK3;TLE1;ERCC5;PSEN1;FANK1;NTRK2;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;NAA16;GATA6;CBX4;BNIP3;FLNA;CRYAB;PRDM9;SNX6;ASNS;HDAC2;UBE2Z;PIK3R1;GDNF;NGFR;CBL;ARF4;TAF9;IL6ST;SFPQ;MAPK1;DNAJB6;MYDGF;GRN;TAX1BP1;PRLR;PRDX3;SOD2;ATF5;HSP90B1;PTPRZ1;YME1L1;MALT1;SNCA;PSEN2;CITED2;OPA1;ZFAND6;UBB;ITGB1;CASP2;AREL1;UBE2O;FZD9;PIM2;BNIP1;TP53;CCND2;LRP2;XIAP;HTATIP2;TGFB3;PAX2;CD74;RIPK1;PCID2;MDK;DNAJA1;HSPA9;CAT;NAA15;AATF;FNIP1;PARK7;SEMA4D;CSNK2A2;AXL
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.31404790151366374,0.9157229233551258,0.6118568232662193,1.0,1.0,7/70,6.95%,ERBB3;BCL2;NGF;FADD;TNFRSF10B;TGFB1;DEDD
prerank,phospholipid metabolic process (GO:0006644),-0.22119925877558075,-0.9153598029573661,0.6396396396396397,0.8766625732089404,1.0,20/71,23.46%,PLA2G4A;PLPP1;GPAM;PLCD1;GNPAT;MBOAT1;TNFAIP8L3;PIP4P1;ACP6;AGPAT4;PIP4K2B;GPX4;PLA2G15;PGP;ABHD12;PLPPR5;LPL;CLN8;PNPLA3;PLA2G4C
prerank,regulation of viral transcription (GO:0046782),0.3375401742957325,0.9152567996395973,0.5872235872235873,1.0,1.0,12/39,24.40%,MDFIC;POLR2B;TRIM11;POLR2K;MID2;POLR2G;POLR2A;ZFP36;CDK9;TRIM14;POLR2F;UBP1
prerank,regulation of exit from mitosis (GO:0007096),0.34200398234780965,0.914961822276158,0.5919610231425091,1.0,1.0,14/38,23.62%,ANAPC7;ANAPC2;BUB1B;UBB;CDC14A;CDC23;ANLN;ANAPC16;CDC27;PHB2;UBE2E1;ANAPC4;ANAPC5;CDC16
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3034018435754452,-0.9149583324921923,0.5806451612903226,0.8762808271690825,1.0,5/21,9.13%,MICU1;SLC8A3;SLC8B1;TGM2;MCUB
prerank,retina homeostasis (GO:0001895),-0.2892796271826462,-0.9147562268213356,0.5977011494252874,0.8754561210792665,1.0,9/23,39.29%,POC1B;SOD1;ACTG1;HSPB1;TULP1;CDH3;CNGB1;JCHAIN;CRB2
prerank,integrated stress response signaling (GO:0140467),0.41170814554499124,0.9144487227582798,0.5880640465793304,1.0,1.0,4/14,16.49%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,replicative senescence (GO:0090399),-0.35192786520667485,-0.9141524695042387,0.5504322766570605,0.8756094572082721,1.0,8/12,29.99%,SERPINE1;TERT;PLA2R1;WNT16;ROMO1;MME;CHEK2;CHEK1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.3229725634994371,-0.9140858885736677,0.5700636942675159,0.8744807878847106,1.0,5/17,21.17%,PODXL;TGFB2;NCKAP1L;SKAP1;FOXC2
prerank,embryonic hemopoiesis (GO:0035162),-0.35798084134258784,-0.9139538330816265,0.5626822157434402,0.8734889614162678,1.0,7/12,20.90%,KIT;KDR;KITLG;FLT3LG;TAL1;ZFPM1;ATF4
prerank,DNA metabolic process (GO:0006259),0.286292496329543,0.913863516428949,0.7063572149344097,1.0,1.0,63/270,19.45%,UBE2T;CBS;LRWD1;NUDT15;ZRANB3;MBD4;POLE2;CHRNA4;ERCC5;NSMCE3;ERCC4;MPG;DDB2;STN1;RPA3;NUDT1;SETMAR;MUTYH;MEN1;BRCA1;XPA;REXO4;TDP1;UHRF2;POLE3;NEIL1;ENDOV;MCM4;FANCC;HELLS;ASF1A;MSH6;UPF1;ZBTB1;XRCC6;DDB1;XRCC3;EXD2;RPA2;ORC1;TOPBP1;PDS5B;RTEL1;SUMO1;SMUG1;UBB;ATM;TRRAP;CSNK1E;RAD52;BLM;POLG;TERF2IP;WRN;NSMCE4A;ORC4;DDX23;PARK7;DBF4;LIG3;CNBP;TOP1;PSME4
prerank,regulation of p38MAPK cascade (GO:1900744),0.34411356122507974,0.9135684092876283,0.5763358778625954,1.0,1.0,12/35,23.34%,PTPN22;VEGFA;NCF1;PRMT1;PER1;MAP3K4;RELL2;EMC10;DUSP1;PJA2;CYLD;BMP2
prerank,protein modification by small protein removal (GO:0070646),0.2854971571370683,0.9132649194484649,0.7032193158953722,1.0,1.0,67/252,22.26%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;SENP3;DDB2;OTUD7B;UCHL5;INO80E;BRCA1;PSMB7;UCHL1;USP46;HIF1A;TOMM20;MYSM1;USP33;ESR1;UCHL3;NFRKB;USP32;USP48;GATA3;NEDD8;USP40;MDM4;SENP2;PSMD2;USP14;UBB;IL33;PSMC1;TRRAP;TP53;USP1;ASXL2;USP25;USP21;PSMB2;USP2;RIPK1;OTUD4;MDM2;USP37;RHOT1;OTUD7A;PSMD9;ATXN7;USP5;SENP1;PSME4;COPS6;MCRS1;MBD6;USP13;PSMA8;COPS7A;JOSD1;TNIP2;ARRB2;USP31;ACTR5;RNF123
prerank,superoxide metabolic process (GO:0006801),0.3556144776807345,0.9129630085406278,0.5939849624060151,1.0,1.0,6/29,12.83%,NCF1;MT3;NOX1;TAFA4;NCF2;SOD2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.41594377849263603,0.9127813260728219,0.5826086956521739,1.0,1.0,3/13,11.11%,CHRDL1;DAND5;LTBP1
prerank,positive regulation of protein maturation (GO:1903319),-0.3652022925145102,-0.9127091689710265,0.6071428571428571,0.8753337373021592,1.0,1/11,1.25%,CCBE1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35693386422146645,0.9125988488324737,0.5933075933075933,1.0,1.0,11/30,21.69%,FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3
prerank,response to hydrogen peroxide (GO:0042542),0.33542580144738904,0.9125955711017713,0.6074429771908764,1.0,1.0,14/45,20.80%,APTX;MAPK7;CYP1B1;FYN;NFE2L2;HDAC6;PRDX3;ABL1;PAX2;RIPK1;CAT;PARK7;OSER1;SIRPA
prerank,positive regulation of vacuole organization (GO:0044090),0.4441347892021889,0.9125858920570799,0.5782747603833865,1.0,1.0,4/10,20.52%,RALB;GRN;RAB3GAP2;RAB3GAP1
prerank,hexose biosynthetic process (GO:0019319),-0.24764115023829483,-0.9124959245522107,0.6593406593406593,0.874621381307447,1.0,13/42,23.62%,RBP4;CHST15;PGK1;PGAM1;GPI;SORD;CRTC2;SLC25A12;ENO1;GOT1;ATF4;GAPDHS;ENO3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.33864568599509215,0.912219646845162,0.5985401459854015,1.0,1.0,10/39,17.08%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,ERAD pathway (GO:0036503),0.30475665764189014,0.9119691524387747,0.6293859649122807,1.0,1.0,31/83,26.28%,PRKN;ERLIN2;DNAJB9;RHBDD2;UGGT2;RCN3;FBXO27;DERL2;SELENOS;HERPUD1;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;CCDC47;JKAMP;ERLIN1;DNAJC10;USP13;SGTA;UBXN6;RHBDD1;FBXO44;UBQLN1;UBQLN2;MAN1B1;UBXN8;ERLEC1;TMEM67;SGTB
prerank,mitochondrial genome maintenance (GO:0000002),0.42792809876423277,0.911826966460008,0.5914826498422713,1.0,1.0,8/11,27.58%,AKT3;OPA1;TOP3A;MGME1;MEF2A;SLC25A36;MPV17;LONP1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3734308921916419,0.9117445080153117,0.5833333333333334,1.0,1.0,5/23,12.38%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,positive regulation of cell growth (GO:0030307),0.3005933139383092,0.9116003686918656,0.6327433628318584,1.0,1.0,25/96,19.93%,RNF157;BCL2;NGF;ERBB2;EGFR;SYT1;CDKL5;LIMK1;DERL2;NCBP1;EIF4G1;EXOSC2;AKAP6;RIMS1;BRAT1;NEDD4L;KLHL22;PLAA;HYAL1;SYT2;RPTOR;RIMS2;SEMA4D;N6AMT1;SHTN1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3882722911803027,0.9115267485766734,0.5909090909090909,1.0,1.0,7/17,19.02%,CTNNA2;BRK1;WASF1;CORO1B;CYFIP1;ARFIP1;NCKAP1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3335985773198427,-0.9112071788104734,0.565625,0.8766333772094621,1.0,3/15,3.26%,ZDHHC3;STXBP1;NLGN2
prerank,cellular response to UV (GO:0034644),0.309151674457503,0.9110428745404145,0.6196388261851016,1.0,1.0,17/76,19.23%,MMP2;MYC;NSMCE3;ERCC4;DDB2;METTL3;BMF;XPA;PPID;ZBTB1;DDB1;TP53;HYAL1;N4BP1;CUL4B;TAF1;RUVBL2
prerank,phagosome maturation (GO:0090382),0.34220171943412653,0.9109752971701286,0.5957178841309824,1.0,1.0,14/35,27.43%,RAB38;RAB14;ATP6V1B2;RAB39A;RAB34;MREG;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3907043753001656,0.9108656161020198,0.5843971631205673,1.0,1.0,5/17,12.83%,MAPK7;BAG5;NFE2L2;SFPQ;SOD2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.3165098898249301,-0.910698908088054,0.5736677115987461,0.8766542385375085,1.0,7/17,15.61%,NPR3;MN1;FGFR2;CCN1;RHOA;PLXNB1;TMEM119
prerank,microtubule nucleation (GO:0007020),0.3810025294869205,0.91014665855293,0.5851216022889842,1.0,1.0,5/20,11.67%,CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3240016465543469,-0.9100823319001271,0.5684931506849316,0.8768820356707456,1.0,2/16,2.10%,ST6GALNAC3;ST8SIA4
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.32977657990128073,0.9099614170940862,0.6028880866425993,1.0,1.0,10/47,16.74%,SLC27A1;CD34;ERLIN2;FBXW7;FYN;BRCA1;CRY1;KHSRP;ERLIN1;MPV17L
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.33659297435880725,0.9097657942307531,0.5921052631578947,1.0,1.0,5/40,7.73%,HRK;PYCARD;PRKN;BMF;BNIP3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.2883420443769527,-0.9096101540744551,0.5840336134453782,0.876667665777458,1.0,3/22,4.65%,SORBS1;CREBL2;PPARD
prerank,cardiac muscle cell action potential (GO:0086001),0.35233189519958913,0.9094343799259302,0.6057068741893644,1.0,1.0,5/30,7.67%,CACNA2D1;ANK2;SCN5A;FGF12;KCND3
prerank,intestinal absorption (GO:0050892),-0.3466797737294747,-0.9093261126982467,0.5813253012048193,0.8760246487135325,1.0,4/13,20.92%,TJP2;UGCG;ADRA2A;SLC26A6
prerank,regulation of RNA export from nucleus (GO:0046831),0.4263161975906309,0.9093014143340411,0.572107765451664,1.0,1.0,2/11,9.87%,CPSF6;SETD2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.414334293842777,0.9089339151342731,0.5940298507462687,1.0,1.0,4/13,15.48%,SPRED2;SPRED1;SPRED3;ATM
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3155129064037355,0.9085376468167126,0.627039627039627,1.0,1.0,7/60,6.19%,PTEN;CBFB;SOX9;CCNC;MED31;ATF7IP;CDK8
prerank,telomere maintenance via telomerase (GO:0007004),-0.26845359134058017,-0.9082197463133478,0.6378600823045267,0.8775069840722113,1.0,11/28,18.96%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;GAR1;HSP90AB1;TINF2
prerank,stem cell development (GO:0048864),0.39040350346117175,0.9079148127368512,0.5925394548063128,1.0,1.0,2/16,4.44%,SOX8;SOX11
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3798815933979223,0.9077256583283436,0.6090534979423868,1.0,1.0,3/20,7.90%,PYCARD;ANO6;IL18
prerank,regulation of cell cycle (GO:0051726),0.28581426590849524,0.9074989861315729,0.7124117053481333,1.0,1.0,67/271,20.03%,FAP;CRLF3;MYC;FGF10;KIF20B;KAT2B;SOX9;CDKN2B;TGM1;TGFB1;NUPR2;PPP1R15A;CKS1B;APBB2;METTL3;TSC1;MLXIPL;SETMAR;SON;GBF1;GATA6;CDK6;MEN1;FOXM1;BIN1;NF2;BRCA1;UHRF2;LIN9;BMP7;MAGI2;ING4;PRKACA;TMEM8B;NEK7;ADARB1;GATA3;RBBP4;PRDM11;RPS6KA2;PKD1;CITED2;IQGAP1;MED25;CDC14A;ATM;FZD9;ABL1;PIM2;TP53;XIAP;TRNP1;PNPT1;HNRNPU;RNF167;NUDT6;CTBP1;MLF1;FBXO5;BOP1;MDM2;CSNK2A2;PDCD4;FBXL12;JUN;STAT3;DUSP1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3192165170657803,0.907155257276711,0.6156501726121979,1.0,1.0,15/57,17.87%,WAC;TIPIN;MRNIP;BRCA1;ATF2;TAOK3;STK33;MDC1;RPA2;TOPBP1;ATM;BLM;RPS27L;TP53;FBXO31
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4249191304512634,0.9069975338766825,0.5805946791862285,1.0,1.0,2/11,9.87%,DDX11;PIH1D1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.29579214708014745,-0.9064735754078665,0.6180555555555556,0.8805323859110525,1.0,4/20,11.62%,IL1R1;CD55;PRKCZ;MAP3K7
prerank,protein targeting to mitochondrion (GO:0006626),0.3178196663925273,0.9064345572699147,0.6089588377723971,1.0,1.0,16/52,20.89%,MIPEP;FBXO7;TOMM22;PMPCB;AIP;TOMM20;HSPA4;GDAP1;NDUFA13;DNAJC19;PAM16;AIFM1;AGK;PMPCA;TSPO;HSPD1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.302469221337073,0.9064010317935399,0.6488222698072805,1.0,1.0,20/94,16.49%,PYCARD;BCL2;SCN2A;TNFRSF10B;PPP1R15A;APAF1;CYP1B1;BNIP3;BRCA1;CUL3;HINT1;MSH6;ARL6IP5;TMEM117;CASP2;ATM;ABL1;TP53;BCL2L11;QRICH1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.28870487272594614,0.9063281723903591,0.6758974358974359,1.0,1.0,41/186,19.45%,SOSTDC1;TPBGL;TAX1BP3;RBMS3;LRP4;SOX9;VGLL4;PRKN;LRP1;FRZB;JADE1;TLE1;WIF1;GLI1;WNT5A;SHISA2;PSMB7;DKK3;CUL3;SFRP4;TMEM131L;EMD;PRICKLE1;APC2;DVL1;WWTR1;CSNK1A1;KLHL12;PSMD2;SCYL2;PSMC1;DACT1;WWOX;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;NKD2;PSME4
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4043972320623437,0.9061913201301154,0.6127167630057804,1.0,1.0,2/15,6.20%,PTPN2;METTL3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.34192562705358087,0.9061525607932136,0.6042713567839196,1.0,1.0,7/35,15.48%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;RTEL1;ATM
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.36872191771364465,0.9059961607412317,0.5768194070080862,1.0,1.0,6/21,15.54%,ANK2;AKAP6;PDE4D;PRKACA;CALM1;CALM2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.324291446459759,0.9058412319873951,0.6096385542168675,1.0,1.0,19/47,26.63%,OLFM4;EFNA5;DOCK5;FLNA;DOCK1;MYOC;ABL1;RAC3;AP1AR;MDK;TESK1;KANK1;TRIOBP;SPRY4;CRK;CIB1;ARHGEF7;CORO1C;LIMS1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.39637485782940035,0.9056407732238688,0.5985611510791367,1.0,1.0,4/15,13.00%,DERL2;SELENOS;HERPUD1;HSP90B1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.395424202126994,0.9053072617033397,0.5912305516265912,1.0,1.0,1/14,3.52%,IRAK3
prerank,response to glucose (GO:0009749),0.3279475566524469,0.9048449817227223,0.6183745583038869,1.0,1.0,11/46,17.89%,IRS2;ZBTB20;TRA2B;PDK3;EIF2B5;SELENOS;PRKACA;GPLD1;PAX2;EIF2B2;PCK2
prerank,proton transmembrane transport (GO:1902600),-0.2569167904593923,-0.9048305409932569,0.6256684491978609,0.8832349130113668,1.0,7/36,15.48%,ATP1A2;ATP6V0C;ATP6V0D1;ATP1A1;ATP6V0A4;ATP5MF;NNT
prerank,regulation of cholesterol efflux (GO:0010874),0.3443062423848171,0.9048080873346134,0.5780645161290323,1.0,1.0,4/30,10.88%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,sensory organ development (GO:0007423),-0.23542751900749057,-0.9047472620430438,0.668918918918919,0.8821609058379217,1.0,12/51,17.56%,SMOC1;RBP4;SIPA1L3;PBX3;STRA6;ECE1;TGFB2;PBX4;SHROOM2;SMG9;MAFB;PBX2
prerank,stress-activated MAPK cascade (GO:0051403),-0.23332190442794368,-0.9046465101274358,0.6575342465753424,0.8811310268662653,1.0,21/61,25.17%,MAP3K5;TNFRSF19;MAP3K20;MAP2K3;MAP3K8;ZFP36L1;GPS2;ARHGEF6;MAP3K7;UBE2N;IKBKB;IKBKG;TAOK2;MINK1;MAPK10;NOD1;CRKL;MAP3K13;GPS1;MAPK8;UBA52
prerank,acute-phase response (GO:0006953),-0.34484811223919654,-0.9043199902422746,0.5769230769230769,0.8806311393124049,1.0,2/12,10.10%,PLSCR1;IL6R
prerank,regulation of protein modification process (GO:0031399),0.3201025165097374,0.9041966211760704,0.5942376950780313,1.0,1.0,9/50,9.88%,KAT2B;CADM4;MT3;SOCS1;SPRED2;SPRED1;RABL3;GRM5;SPRED3
prerank,membrane depolarization during action potential (GO:0086010),0.3574478962454673,0.9041807477242779,0.596514745308311,1.0,1.0,4/26,6.94%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2772532139294387,0.9038470279911683,0.807,1.0,1.0,129/572,22.09%,OSR2;PTCH1;TENM2;MLIP;GLI2;SOX8;AASS;PRDM16;MYC;TGIF2;CBFB;ZNF25;SOX9;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;NFX1;FOXP2;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;ZEB1;URI1;EED;OTUD7B;ZBTB16;RORC;MTA2;MLX;TRPS1;DRAP1;E2F6;LRRFIP1;GATA6;CBX4;MEN1;FOXM1;CHD3;VPS72;CPEB3;ATRX;KCTD1;RARG;MBD2;RARB;PPID;LDB2;HDAC2;NFATC3;ESR1;SIN3B;SFPQ;SIRT6;DCAF1;EPC1;PER3;ZGPAT;FOXP4;ZBTB1;NR6A1;NRIP1;ZFPM2;PER1;GATA3;NACC2;SNCA;LCOR;MDM4;NEDD4L;SUMO1;CRY1;NCOR2;CITED2;TAF7;CREM;ZEB2;UBB;IL33;MED25;DACT1;RUNX1;TP53;MTA3;SREBF2;HNRNPU;WWOX;FOXJ1;USP2;CDC73;NFIX;CTBP1;SUFU;MDM2;KLF7;FNIP1;TAF1;SEMA4D;CGGBP1;CNBP;BCOR;PPARG;JUN;STAT3;PRDM2;YEATS2;ORC2;SMARCA4;JDP2;ZFP36;NR1D2;GATAD2B;DPF2;NFKB1;MITF;THRA;NSD1;ZMYM5;ZNF8;UBE2D3;CBX5;PPM1A;IRF8
prerank,steroid metabolic process (GO:0008202),0.31297302540843003,0.9030621402697545,0.6351039260969977,1.0,1.0,16/72,25.14%,HSD17B7;NPC1;GBA2;CYP39A1;CYP1B1;CYP7B1;PRLR;CYP27A1;LRP2;TSPO;SCP2;HSD17B4;GC;SULT1A1;STARD3;AMACR
prerank,response to cytokine (GO:0034097),0.29390311966012495,0.9027262999092737,0.6701352757544224,1.0,1.0,20/141,12.63%,AFF3;PRKCA;KYNU;BCL2;IL1RAPL1;PTPN2;IRAK3;MAPKAPK3;MAPKAPK2;PTPN13;IL1RL2;COL3A1;SETD2;AKAP6;PTPN11;TAF9;IL6ST;PID1;TBK1;PTPN18
prerank,negative regulation of hemostasis (GO:1900047),-0.34618826785569,-0.9027087037178266,0.5752212389380531,0.8832948161860688,1.0,6/12,18.75%,VTN;THBD;TFPI;SERPINE1;EDN1;APOE
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3109265159157008,0.9026154447256448,0.6096440872560276,1.0,1.0,11/64,15.26%,FADS2;SLC27A4;LTA4H;CYP1B1;AIG1;ACOX1;ELOVL6;ELOVL5;PNPLA8;ACAD9;ACSL3
prerank,brain morphogenesis (GO:0048854),0.41718551553344346,0.9022111268575944,0.5984962406015037,1.0,1.0,4/12,18.47%,PTEN;CTNNA2;PAX2;SLC6A4
prerank,nucleocytoplasmic transport (GO:0006913),0.327461976238025,0.9014909236237658,0.6198044009779952,1.0,1.0,9/40,17.77%,XPO1;RSRC1;NCBP1;NUP205;MALT1;NXT1;HTATIP2;AAAS;GEMIN7
prerank,DNA strand elongation (GO:0022616),-0.31185837857918,-0.9013501562803208,0.5874125874125874,0.8853306313959522,1.0,11/18,30.85%,POLD3;POLA1;TERT;DCLRE1B;NBN;RFC3;GINS4;POLD2;MRE11;GINS1;MCM3
prerank,tRNA transport (GO:0051031),0.3390289026518252,0.9013066054049423,0.592071611253197,1.0,1.0,10/35,17.36%,RANBP2;NUP155;TOMM20;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,post-translational protein modification (GO:0043687),0.2803202110444501,0.9011977710143297,0.757271815446339,1.0,1.0,77/332,21.35%,GPC3;VCAN;MXRA8;FBXW9;CHRDL1;LAMC1;RAB38;SOCS5;FBXW7;SPSB4;PRKCSH;ASB8;NUCB1;SDC2;KLHL13;OBSL1;FBXO7;FBXL15;DDB2;ASB5;FBXO32;ZBTB16;EVA1A;RCN1;MEN1;NAE1;ATG5;STT3A;VWA1;FBXL16;PSMB7;FBXO27;CKAP4;HIF1A;AMELX;CUL3;UCHL3;LTBP1;CALU;UBA3;FBXO17;RAB1A;FUCA2;DCAF8;RAB3A;BTBD1;HSP90B1;DDB1;PENK;SUMF1;NEDD8;DDA1;PSMD2;KLHL22;PSMC1;FBXL4;PSMB2;CUL4B;FBXO31;FBXO22;ELOC;PSMD9;CHM;FBXO11;PSME4;FBXL12;MBTPS1;FAM20C;DCAF7;COPS6;RBBP7;DCAF11;PSMA8;COPS7A;PDIA6;RHBDD1;DCAF6
prerank,positive regulation of dephosphorylation (GO:0035306),0.35756131569170574,0.9011120924557013,0.577247191011236,1.0,1.0,2/27,4.08%,DLC1;TGFB1
prerank,positive regulation of TOR signaling (GO:0032008),-0.25499551960337397,-0.9010883298572898,0.6243654822335025,0.8846931924018282,1.0,14/40,21.20%,SIK3;WDR59;RICTOR;RRAGC;FLCN;LARS1;PIP4P1;NCKAP1L;RHEB;SMCR8;GPR137;RRAGB;LAMTOR1;HDAC3
prerank,stem cell differentiation (GO:0048863),-0.2593566333807099,-0.9010404069142319,0.6082474226804123,0.8835255782339141,1.0,11/39,14.55%,KIT;OSR1;MLLT3;MTF2;ACE;FBXL17;FGFR2;TGFB2;PTPRC;EEF1AKMT4-ECE2;HMGA2
prerank,regulation of response to external stimulus (GO:0032101),0.29355683175105857,0.9009145215772958,0.672286617492097,1.0,1.0,24/121,17.78%,ADAMTS12;PDGFRA;RHO;PTPN22;BST1;EPHB2;ELMOD2;CCR2;WNT5A;IL1RL2;UFL1;GATA6;CASP12;GRN;SHPK;P2RY12;CALM1;USP14;AREL1;XIAP;N4BP1;EFNB2;SPAAR;PTGES
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.37021907941709975,0.9007142978108477,0.5708215297450425,1.0,1.0,4/19,13.26%,PAPSS2;BPNT1;BPNT2;SLC35B3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.34809935732297176,0.9006618483970601,0.6192893401015228,1.0,1.0,3/31,3.89%,PTEN;GORASP1;FBXW7
prerank,regulation of Rho protein signal transduction (GO:0035023),0.30658416011380496,0.900155369316457,0.6421404682274248,1.0,1.0,14/72,15.54%,DLC1;AKAP13;LPAR1;GPR65;ARHGEF28;EPS8L1;COL3A1;CUL3;MYO9B;OPHN1;MYOC;ARHGEF3;MET;ABL1
prerank,vascular transport (GO:0010232),0.30517208810932944,0.9000158678806807,0.6506550218340611,1.0,1.0,10/81,5.90%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;SLC5A3;LRP1;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,response to muscle stretch (GO:0035994),-0.3221459993122178,-0.8999250405252437,0.5899280575539568,0.8849494239428218,1.0,2/15,2.36%,CDH2;CTNNB1
prerank,positive regulation of histone modification (GO:0031058),0.33727457832744145,0.8995130044975272,0.6002587322121604,1.0,1.0,3/33,8.59%,FAM47E;RPS6KA4;BRCA1
prerank,mitotic spindle organization (GO:0007052),0.29016830289642037,0.8993922948166051,0.685890834191555,1.0,1.0,22/153,14.45%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;ARHGEF10;NDE1;STAG2;FLNA;DYNC1I1;RCC1;CLASP1;NUP160;SGO1;ZWINT;CKAP5;KPNB1;BUB1B;DYNC1I2;ITGB3BP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3771157817691181,0.8989301499581862,0.5910987482614742,1.0,1.0,4/19,15.90%,PYCARD;AEN;RPS27L;TP53
prerank,proteasome assembly (GO:0043248),-0.36666308781098633,-0.8989252172442865,0.6153846153846154,0.8862020352758138,1.0,5/11,29.15%,OTUD6B;PSMG2;PSMG1;ADRM1;PSMD10
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3401503206941593,0.8984974335476068,0.6123737373737373,1.0,1.0,3/29,4.08%,PDGFRA;FGF2;TGFB1
prerank,negative regulation of receptor binding (GO:1900121),-0.37290049115597146,-0.8984834612764151,0.6242774566473989,0.886012512905604,1.0,4/10,22.56%,ADAM15;ATP2A3;HFE;ATP2A2
prerank,regulation of sensory perception of pain (GO:0051930),-0.35340188986511556,-0.8984178324996983,0.5894428152492669,0.8848918125911417,1.0,6/11,34.08%,ATPSCKMT;MGLL;TMEM100;ACP3;SPX;F2R
prerank,regulation of keratinocyte differentiation (GO:0045616),0.36406625634718554,0.8983891963246694,0.6175675675675676,1.0,1.0,4/24,6.64%,ETV4;CBFB;HOXA7;CTSK
prerank,Rap protein signal transduction (GO:0032486),0.43454890234252597,0.8983383957205098,0.5901386748844376,1.0,1.0,2/10,7.42%,RAP2B;RAP1A
prerank,transport across blood-brain barrier (GO:0150104),0.30327536608997746,0.8981640997592152,0.6579804560260586,1.0,1.0,10/83,5.90%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;SLC5A3;LRP1;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,regulation of chemotaxis (GO:0050920),0.3467930087081923,0.8976961096327555,0.615485564304462,1.0,1.0,7/30,16.91%,PDGFRA;PTPN2;TGFB1;P2RY12;USP14;ZSWIM8;EFNB2
prerank,error-prone translesion synthesis (GO:0042276),0.37924285917180905,0.8969355532045806,0.6284916201117319,1.0,1.0,6/21,17.26%,POLE2;REV3L;RPA3;RPA2;UBB;REV1
prerank,actin polymerization or depolymerization (GO:0008154),0.3201035700208605,0.8968242350715648,0.6217494089834515,1.0,1.0,4/50,3.06%,ENAH;SPIRE1;GSN;GAS7
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2054439175627017,-0.8967393674899029,0.8103448275862069,0.8876525500119655,1.0,49/114,33.86%,PSMD14;BIRC3;NFKBIA;TNFRSF11B;PSMB3;AIM2;PSMD12;TNFRSF11A;TNFSF12;TNFRSF1A;COMMD7;PSMD6;TMSB4X;PSMA1;CDIP1;EIF5A;PSMD7;PSMA5;PSMC5;PTK2B;IKBKB;BAG4;PSMC4;PSMB6;PSMA4;EDA2R;CD40;TRADD;PSMB1;ACTN4;PSMB9;TRAF1;ILK;PSMC6;EDAR;TNFSF13;CD27;PSMD3;PSMD10;PSME3;TNFSF8;JAK2;TNFRSF1B;BIRC2;PSMA6;PSME2;TNFSF13B;TNFRSF9;TNFRSF12A
prerank,response to lipopolysaccharide (GO:0032496),0.28785208274039725,0.8967001057748566,0.677720207253886,1.0,1.0,33/138,23.11%,CXCL10;PYCARD;PTPN22;IRAK3;MAPKAPK3;PDE4B;MAPKAPK2;WNT5A;PELI1;ERBIN;SELENOS;MAPK14;TRIM41;UPF1;PRDX3;SHPK;SRR;SNCA;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;RPS6KA3;VIM;TAB2;CARD16
prerank,photoperiodism (GO:0009648),-0.26971033372314085,-0.8965227814120222,0.6346153846153846,0.8869036873295483,1.0,8/28,13.94%,SIK1;PPP1CB;CLOCK;MTA1;PPP1CC;FBXL17;ID2;PML
prerank,glycerolipid metabolic process (GO:0046486),-0.3560967712324351,-0.8964280159127245,0.5666666666666667,0.8858380911118976,1.0,6/11,29.07%,GAL3ST1;PLA2G15;PGP;DGKG;PNPLA3;DGKB
prerank,protein prenylation (GO:0018342),-0.374092743750011,-0.8962820645098374,0.5882352941176471,0.8849331751441506,1.0,6/10,30.34%,PGGT1B;CHML;FNTB;RCE1;FNTA;RABGGTA
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.31597234089431014,-0.8960165256122086,0.5947712418300654,0.8842862084758953,1.0,5/16,14.57%,ATP5MC3;ATP5PD;STOML2;ATP5F1D;ATP5MF
prerank,Golgi ribbon formation (GO:0090161),0.40520952644703023,0.895888825688971,0.5997045790251108,1.0,1.0,2/13,8.69%,VAMP4;TRIP11
prerank,exit from mitosis (GO:0010458),-0.3395282472084018,-0.8956895558315333,0.6047904191616766,0.8838287264851522,1.0,5/12,24.42%,PPP2R2D;EPS8;CTDP1;CHMP7;SIRT7
prerank,oogenesis (GO:0048477),0.38927609592208595,0.8955069956850615,0.5913173652694611,1.0,1.0,6/15,23.00%,FMN2;METTL3;MDK;MARF1;KMT2D;MEI4
prerank,neuron projection fasciculation (GO:0106030),0.4265053245112439,0.8950330028093383,0.6125,1.0,1.0,5/10,18.89%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,regulation of MAP kinase activity (GO:0043405),0.29649960140090614,0.8948674611964831,0.6387665198237885,1.0,1.0,14/92,11.59%,FGF2;ERBB2;EGFR;VEGFA;IRAK3;TGFB1;NF1;KSR1;FGFR1;UCHL1;PTPN1;PTPRJ;BMP7;EDN3
prerank,glycolytic process (GO:0006096),-0.27294159135074875,-0.8948579745731725,0.6349206349206349,0.8845623503403349,1.0,12/28,30.51%,PGK1;PGAM1;PGAM4;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3;PKM;PFKFB2;LDHA
prerank,intermediate filament organization (GO:0045109),0.3812577663662862,0.8946223741559174,0.5889487870619946,1.0,1.0,6/17,23.95%,BFSP1;DNAJB6;GFAP;PKP2;VIM;MTM1
prerank,positive regulation of developmental growth (GO:0048639),0.31860333456676954,0.8946052794656714,0.6111111111111112,1.0,1.0,16/49,23.56%,RNF157;NGF;PLCB1;SYT1;CDKL5;LIMK1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;SEMA4D;SHTN1;GHR;CPNE5;SYT3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.30040951832266954,0.8945503455582539,0.6558441558441559,1.0,1.0,13/85,16.12%,ROR1;PIEZO2;LHFPL5;PCDH15;LHFPL3;LHFPL4;HOMER2;LRTOMT;PAX3;COL1A1;CCDC50;CDC14A;LRP2
prerank,cilium movement (GO:0003341),0.3188888384770251,0.8943289251506372,0.6217183770883055,1.0,1.0,7/48,17.71%,DNAI4;CCDC39;DNHD1;CFAP91;CFAP61;DNAAF2;RSPH9
prerank,cellular senescence (GO:0090398),-0.27784776599260125,-0.8942843007225665,0.5952380952380952,0.8847006273657132,1.0,12/27,26.36%,PRKCD;TBX3;TERF2;MAP2K1;ID2;PML;HMGA2;ECRG4;ULK3;CALR;HRAS;SRF
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36597369283720527,0.8942364657732281,0.6101231190150479,1.0,1.0,14/24,31.27%,EED;CREBZF;EPC1;JARID2;RBBP4;PHF19;RBBP7;MPHOSPH8;AEBP2;EZH2;DNMT1;SMYD5;DNMT3B;PPHLN1
prerank,tRNA 5'-end processing (GO:0099116),0.39213813497142247,0.8940421939239888,0.6061946902654868,1.0,1.0,5/15,17.36%,RPP38;PRORP;POP1;RPP21;SSB
prerank,protein deubiquitination (GO:0016579),0.2798141006195861,0.8938095341923068,0.7374245472837022,1.0,1.0,63/242,22.26%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;DDB2;OTUD7B;UCHL5;OTULIN;INO80E;BRCA1;PSMB7;UCHL1;USP46;HIF1A;TOMM20;MYSM1;USP33;ESR1;UCHL3;NFRKB;USP32;USP48;GATA3;NEDD8;USP40;MDM4;PSMD2;USP14;UBB;IL33;PSMC1;TRRAP;TP53;USP1;ASXL2;USP25;USP21;PSMB2;USP2;RIPK1;OTUD4;MDM2;USP37;RHOT1;OTUD7A;PSMD9;ATXN7;USP5;PSME4;MCRS1;MBD6;USP13;PSMA8;JOSD1;TNIP2;ARRB2;USP31;ACTR5;RNF123
prerank,regulation of vasculature development (GO:1901342),0.3530418042504854,0.8936424899812391,0.6104252400548696,1.0,1.0,3/26,5.06%,FGF2;ERBB2;NF1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3673372440371174,0.8936182536202661,0.6246575342465753,1.0,1.0,3/20,10.31%,GSN;ANO6;SFRP4
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.31862883774925366,0.8931099630724235,0.6068075117370892,1.0,1.0,7/51,11.59%,CXCL10;VEGFA;ANO6;CCR2;PLA2G7;MAPK1;EDN3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.2657629584428279,-0.8930322473469091,0.6536964980544747,0.8863458453307029,1.0,2/26,0.58%,IGF1;FHL2
prerank,fatty acid oxidation (GO:0019395),-0.2417308386680366,-0.8930246927788936,0.6666666666666666,0.8851003651393117,1.0,20/57,27.48%,ACAD10;ECHDC1;PEX13;PPARD;PHYH;ACADM;ALDH3A2;BDH2;ECHDC2;ADIPOR2;ECI1;PECR;ECHS1;PEX2;ALOX12;CROT;SLC27A2;ECI2;CPT2;MCAT
prerank,cellular response to zinc ion (GO:0071294),0.3874708570087678,0.8927524481825982,0.6115942028985507,1.0,1.0,9/15,28.17%,MT3;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,regulation of organelle assembly (GO:1902115),0.30512046303763307,0.8926025147361731,0.6335195530726258,1.0,1.0,16/73,14.70%,TBC1D10A;GSN;NPRL2;IFT140;ATXN2;CDKL5;SDCCAG8;ATG5;VPS11;TBC1D19;CEP295NL;USP6NL;ATG3;TBC1D20;CEP76;PDCD6IP
prerank,toll-like receptor signaling pathway (GO:0002224),0.30292857994867706,0.892538802551512,0.6733111849390919,1.0,1.0,23/84,22.71%,FADD;IRAK3;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;TICAM1;UBB;RIPK1;CHUK;TRIL;LBP;TAB3;BCL10;SCARA3;HSPD1;TNIP2;RPS6KA3;UBE2D3;TAB2
prerank,histone H3-K4 trimethylation (GO:0080182),0.41061672272959804,0.8924102609507157,0.5922480620155038,1.0,1.0,5/11,23.88%,KMT2A;PRDM9;TET3;KMT2D;TET2
prerank,negative regulation of developmental process (GO:0051093),-0.21108006052246467,-0.8921978585302425,0.6952380952380952,0.8858120668111801,1.0,19/69,16.75%,ROCK2;ROCK1;NFIB;NOS3;BMP4;PARP3;TBX1;ARHGEF15;TFRC;IL17D;VAT1;NOTCH4;MAPT;SINHCAF;ARPIN;FUZ;HEY2;RPS6KA6;SUZ12
prerank,positive regulation of macroautophagy (GO:0016239),0.32567767966658795,0.8921747792848246,0.6425233644859814,1.0,1.0,4/48,7.73%,DCN;WAC;RALB;BNIP3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.42824779605699137,0.8921325439800751,0.600609756097561,1.0,1.0,1/10,0.88%,ETV4
prerank,regulation of histone modification (GO:0031056),-0.33355532534166693,-0.891698729800643,0.6149253731343284,0.8856695377652352,1.0,5/13,19.17%,PARG;IGF2;FLCN;UBE2N;MYOCD
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.35456147939718946,0.8914501580676099,0.622568093385214,1.0,1.0,6/26,19.41%,ANK2;STK39;NEDD4L;ITGB1;NETO1;CAB39
prerank,protein modification by small protein conjugation (GO:0032446),0.2769775118111191,0.8912660311538173,0.7853560682046138,1.0,1.0,83/361,19.98%,UBE2T;PDZRN3;RNF157;PRKN;DTX4;HACE1;WAC;NFX1;TRIM44;FBXW7;SPSB4;RANBP2;RNF6;KLHL13;UBA2;FBXO7;FBXL15;ASB5;FBXO32;NUP155;UFL1;OTULIN;TRIM11;NAE1;BRCA1;UBE2K;VPS11;HIF1A;PIAS2;CUL3;SELENOS;UHRF2;UBE2Z;HUWE1;ANAPC7;FBXO45;CBL;FBH1;NUP205;NFE2L2;UBE2J2;UCHL3;NDC1;TSPAN17;TRIM41;NUP160;UBA3;FBXL2;MYLIP;ATG3;DDB1;DET1;NEDD8;TRIM23;NEDD4L;SUMO1;TRAF7;UBB;AREL1;RCHY1;CDC23;POM121;RNF111;ZSWIM8;ANAPC16;AAAS;RNF182;MIB1;CUL4B;CDC73;UBA1;MDM2;ELOC;USP5;PCNP;FBXO11;BCL10;UBE2L3;RRAGA;CDC27;TRAIP;TRIM35;UBE2G1
prerank,mitochondrial translational termination (GO:0070126),0.296531588786809,0.8912498703273659,0.6579234972677596,1.0,1.0,24/88,22.43%,MRPL47;MRPS18A;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,response to interleukin-6 (GO:0070741),-0.3573394843644403,-0.8911624212505778,0.6167979002624672,0.8856020346727828,1.0,3/10,8.49%,PTGIS;ST3GAL6;SBNO2
prerank,steroid catabolic process (GO:0006706),0.4261475362932229,0.8909889619578215,0.6063492063492063,1.0,1.0,1/10,4.64%,HSD17B11
prerank,regulation of calcium-mediated signaling (GO:0050848),0.35453021302744664,0.8907396784036743,0.6148648648648649,1.0,1.0,3/25,7.96%,BST1;CCL4;SLC8A2
prerank,calcium import into the mitochondrion (GO:0036444),-0.37888284751191453,-0.8905976634845555,0.6063829787234043,0.8856663127345071,1.0,3/10,16.39%,MICU1;MCUB;MICU3
prerank,regulation of mRNA metabolic process (GO:1903311),0.42158206687859123,0.8904976857754205,0.6034755134281201,1.0,1.0,3/11,24.50%,NCBP1;SLTM;SAFB2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.36500890380202167,0.8902675721431991,0.6151724137931035,1.0,1.0,10/23,19.41%,WNK3;TGFB1;UBE2K;MAPK1;BMP7;CALM1;CALM2;RPTOR;S1PR2;CAB39
prerank,carboxylic acid transmembrane transport (GO:1905039),0.33013797103796766,0.8902380105951154,0.6245398773006134,1.0,1.0,10/40,17.07%,SLC27A1;SLC25A21;SLC38A4;SLC36A2;SLC7A7;SLC7A8;SLC25A10;SLC16A1;SLC25A11;ABCC1
prerank,regulation of protein binding (GO:0043393),-0.2073448699406382,-0.8901036678963032,0.746031746031746,0.8855245969385119,1.0,37/114,22.44%,DAB2;ROCK1;VTN;CLDN5;PRKCD;BMP4;EPB41;IFIT2;KDM1A;PRMT7;NVL;APP;GSK3B;CAMK1;RACK1;MARK2;HDAC4;SNAPIN;PRMT8;RPL11;STK3;PEX14;TERT;FLOT1;HIP1R;CAV1;TRIM21;GTF2F1;ZFPM1;CFHR2;HFE;ADD2;MARK3;IFIT1;GAS8;HDAC5;AKT1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2811137536656932,-0.8898213502669732,0.614406779661017,0.8849548524688382,1.0,10/24,22.04%,XRN1;TERF2;DCP2;PARP1;PINX1;EXOSC10;TEN1;TINF2;TENT4B;HNRNPA1
prerank,positive regulation of protein polymerization (GO:0032273),0.30651617559239086,0.8893221753078518,0.6353211009174312,1.0,1.0,15/65,16.91%,CCL11;PYCARD;PAK1;BAIAP2;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;TTBK1;NCK1;MET;CDC42EP1;NAV3;CTTN
prerank,regulation of cellular protein catabolic process (GO:1903362),0.37749359372077423,0.8892954896537841,0.6225071225071225,1.0,1.0,8/18,26.62%,VGLL4;VPS11;ATRAID;DACT1;RDX;PTTG1IP;CDK5RAP3;VPS35
prerank,negative regulation of inflammatory response (GO:0050728),0.2829026651321782,0.8892488132401821,0.7203302373581011,1.0,1.0,19/182,13.20%,RORA;FFAR4;CRH;DPEP1;PTPN2;MAPK7;PTHLH;TNFAIP8L2;PRKAR1B;PTH2R;OTULIN;FYN;TSHR;SELENOS;MAPK14;GRN;PRKACA;GLP2R;GATA3
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3630399558930355,0.8891954239774826,0.6091794158553546,1.0,1.0,7/23,17.98%,BMF;TOMM22;COX18;HSPA4;BCL2L11;NDUFA13;AGK
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34174720371105033,0.8887673599252098,0.6213468869123253,1.0,1.0,5/31,7.62%,PTCH1;SOX9;TWIST2;CDK6;MEN1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.38373570138710217,0.8885490269791738,0.6114369501466276,1.0,1.0,1/16,1.07%,SLC27A1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3646495226157911,0.8883234401324628,0.611716621253406,1.0,1.0,6/21,12.50%,NT5C2;PDE9A;HINT1;PDE4D;NUDT10;NUDT3
prerank,protein localization to cilium (GO:0061512),0.3364950477017955,0.8882207392534334,0.6204663212435233,1.0,1.0,5/32,11.71%,ARL3;IFT140;BBS9;WDR35;SNX10
prerank,detection of visible light (GO:0009584),0.3825574711660442,0.8880001044191335,0.6222222222222222,1.0,1.0,1/16,1.69%,RHO
prerank,cellular respiration (GO:0045333),-0.24398512711773218,-0.8873177009716703,0.6648936170212766,0.8894669341881198,1.0,18/41,28.40%,COQ10B;SDHB;SIRT3;OXA1L;UQCRB;ATP5F1D;ETFRF1;ETFB;SDHA;SDHAF4;UQCR10;UQCRH;UQCRFS1;UQCRC1;CYCS;SURF1;NR4A3;MTFR2
prerank,programmed necrotic cell death (GO:0097300),0.37820199303117524,0.8870651990174314,0.622478386167147,1.0,1.0,5/18,23.27%,ITPK1;TICAM1;RIPK1;MLKL;CYLD
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.32355488091583945,0.8870076679035979,0.6415981198589894,1.0,1.0,22/50,29.70%,CDKN2B;CCNJ;PKMYT1;CDK5R1;TTBK1;CDK5R2;BLM;CCND2;BCCIP;CCNT2;CCNH;CDC37;CDK5RAP3;CDKN1A;CCND3;CCNI;GTPBP4;CCNE1;CDKN1C;CDKN2D;CDKN1B;CAMK2N1
prerank,calcium ion transmembrane transport (GO:0070588),0.2932424158829985,0.8868498416093121,0.6545654565456546,1.0,1.0,25/86,21.50%,CACNA2D1;PARL;ANO6;LETM1;ATP2B3;CACNA1A;GRIN2B;SLC8A2;SLC24A5;PMPCB;SLC25A23;ATP2B1;YME1L1;GRIN2D;TRPC5;GRIN2A;PKD1;CACNA2D4;SLC24A4;SLC24A2;PMPCA;RYR3;PHB2;PKD2;P2RX7
prerank,positive regulation of autophagy (GO:0010508),0.30055006431469816,0.8867809437210159,0.6501103752759382,1.0,1.0,7/81,7.73%,DCN;PRKN;NPRL2;WAC;FBXO7;UFL1;BNIP3
prerank,regulation of interleukin-13 production (GO:0032656),-0.3323978026881876,-0.8867781111005891,0.6064516129032258,0.8894497202574455,1.0,5/13,24.24%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.29900673091723073,0.8867089032831622,0.6703296703296703,1.0,1.0,28/78,23.12%,PRKN;SOCS5;CBFA2T3;HERPUD1;NFE2L2;SIRT6;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;SGTA;ELOB;UBQLN1;ZYG11B;UBQLN2;COP1
prerank,lysosome localization (GO:0032418),-0.2447751753587394,-0.886312876194334,0.6740331491712708,0.8893034677275449,1.0,15/37,21.66%,KIT;MYH9;PLEKHM1;FAM98A;KIF5B;FLCN;BORCS5;SYTL4;SNAPIN;PIP4P1;TMEM106B;PLEKHM2;TFEB;LAMTOR1;DEF8
prerank,negative regulation of chemotaxis (GO:0050922),0.3403755396830776,0.8848347437828035,0.5901639344262295,1.0,1.0,4/31,3.81%,SEMA3E;PTPN2;SEMA6C;SEMA3A
prerank,response to ethanol (GO:0045471),0.3917384463188124,0.8847902087074268,0.6102189781021898,1.0,1.0,3/14,14.38%,GRIN2B;GOT2;GRIN2A
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3465762306177114,0.8845258476417379,0.6233595800524935,1.0,1.0,4/27,12.69%,LPAR1;GPR65;HTR2C;DRD2
prerank,positive regulation of macrophage migration (GO:1905523),-0.29360126084185667,-0.8839874473394933,0.6341463414634146,0.8934036434685805,1.0,3/19,7.52%,IL34;THBS1;AKIRIN1
prerank,negative regulation of protein binding (GO:0032091),-0.2182094180268345,-0.8839678078079722,0.7319587628865979,0.8921926226165041,1.0,22/71,22.56%,DAB2;MAP2;ROCK1;PRKCD;IFIT2;TTBK2;KDM1A;GSK3B;CAMK1;RACK1;ADAM15;PEX14;ATP2A3;CAV1;GTF2F1;ZFPM1;CFHR2;HFE;IFIT1;ADRB2;AKT1;ATP2A2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.29069955544336856,0.883681246993481,0.673202614379085,1.0,1.0,21/95,21.96%,CXCL10;PYCARD;PDE4B;WNT5A;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;VIM
prerank,calcium ion transport into cytosol (GO:0060402),0.36562149981084124,0.8835436492369585,0.6210670314637483,1.0,1.0,6/21,18.22%,CACNA2D1;GRIN2B;JPH3;GRIN2D;GRIN2A;MS4A1
prerank,DNA conformation change (GO:0071103),0.3741127746895758,0.8834459465310375,0.6122733612273361,1.0,1.0,5/17,21.72%,HAT1;ABL1;NAA10;TOP1;TOP3A
prerank,mRNA 3'-end processing (GO:0031124),0.29864835914796617,0.8833760029883323,0.6707317073170732,1.0,1.0,23/78,24.99%,CSTF3;THOC6;PABPC1;CPSF6;RPRD1A;SRSF11;CASC3;NCBP1;FIP1L1;AHCYL1;SRSF6;PAPOLA;CDC73;RNPS1;TENT2;THOC7;SRRM1;SRSF3;SYMPK;TUT1;THOC5;MAGOHB;CPSF7
prerank,regulation of DNA replication (GO:0006275),0.31566756003125174,0.8833440792834801,0.6304604486422668,1.0,1.0,16/49,24.73%,GLI2;EGFR;GLI1;STN1;ZBTB38;BLM;FBXO5;USP37;CCDC88A;BCAR3;CTC1;PPP2R1A;KAT7;ORC3;ATR;EHMT2
prerank,receptor-mediated endocytosis (GO:0006898),0.28557889070162235,0.8830029679625732,0.703239289446186,1.0,1.0,23/132,16.91%,HSPG2;SGIP1;DNM1;HSPH1;LRP1;PI4KB;AP1G1;ACKR3;EPS15;GAK;AP1S1;SPARC;GPR107;WASF1;TPCN2;HSP90B1;CD9;SNCA;SNX1;ITGB1;LRP2;IGF2R;CTTN
prerank,neural crest cell differentiation (GO:0014033),0.3774740226781715,0.8827083191546093,0.6251728907330567,1.0,1.0,2/18,4.44%,SOX8;SOX11
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.35696289834045836,0.8826099092430421,0.6196990424076607,1.0,1.0,7/22,24.67%,HMGN1;CDK13;ELL;CDC73;KAT7;THOC5;CCNT2
prerank,negative regulation of programmed cell death (GO:0043069),0.2768722578255811,0.8825511949907721,0.8106212424849699,1.0,1.0,81/355,18.98%,FFAR4;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;NGF;EGFR;FMN2;MAP4K4;VEGFA;EGR3;ARAF;THOC6;WNK3;ERCC5;PSEN1;FANK1;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;NAA16;GATA6;CBX4;BNIP3;FLNA;CRYAB;PRDM9;ASNS;HDAC2;UBE2Z;PIK3R1;GDNF;NGFR;CBL;ARF4;TAF9;IL6ST;MYDGF;TAX1BP1;PRLR;PRDX3;ATF5;HSP90B1;YME1L1;MALT1;TM7SF3;SNCA;PSEN2;CITED2;OPA1;ZFAND6;MET;UBB;CASP2;AREL1;UBE2O;PIM2;BNIP1;TP53;CCND2;LRP2;XIAP;HTATIP2;PAX2;CD74;RIPK1;PCID2;DNAJA1;HSPA9;CAT;RAB7A;NAA15;AATF;PARK7;SEMA4D;AXL
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3342343847161813,0.8825300307683518,0.6297709923664122,1.0,1.0,14/34,26.63%,OLFM4;DOCK5;FLNA;DOCK1;MYOC;ABL1;RAC3;MDK;TESK1;TRIOBP;CRK;CIB1;ARHGEF7;LIMS1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3462181275700751,0.8824210080528081,0.6319702602230484,1.0,1.0,3/28,6.20%,EGFR;FBXW7;METTL3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.33666725769045747,0.8822263489477866,0.648171500630517,1.0,1.0,14/36,24.93%,WAC;UCHL5;BAG5;TLK2;TAF9;OPHN1;GABARAPL2;USP25;N4BP1;PARK7;CAMLG;PRKCG;ALAD;FHIT
prerank,organelle assembly (GO:0070925),0.2739525433466027,0.8819133868862572,0.814629258517034,1.0,1.0,80/385,19.67%,DYNLL1;PTPDC1;RHO;BICD1;CD34;WDPCP;GSN;STK36;RAB38;SQLE;CC2D2A;HAUS3;ARL3;PACS2;NEK1;CCDC57;RFX2;STARD9;TTC39C;IFT140;PCM1;RILPL2;SNAP29;WIPI1;ATXN2;BBS9;RFX3;DISC1;GBF1;CPLANE1;ATG5;BBS5;FLNA;WDR35;TUBGCP5;VPS37B;FARP2;RCC1;ARF4;HDAC6;POGZ;GORASP2;VPS36;SNX10;RAB1A;LSM3;CEP89;ATG3;MVB12A;NEK7;CFAP20;FBF1;TRAPPC14;CCDC28B;RAB11FIP3;PKD1;PDCD6IP;EHD2;GABARAPL2;CCDC65;CHMP4C;EIF4ENIF1;CDC14A;TRAPPC6A;ANLN;FOXJ1;HPS1;CEP63;MYH6;RC3H1;RAB7A;GALNT11;KIF3A;MAPRE3;FLII;UBAP2L;IFT81;CENPC;CCDC66;CHMP1B
prerank,regulation of mitotic cell cycle (GO:0007346),0.281616842475846,0.8816708453925176,0.7173469387755103,1.0,1.0,52/171,25.90%,PRKCA;KIF20B;TGFB1;CCDC57;OBSL1;CKS1B;CDK13;GBF1;PSMB7;ASNS;ANAPC7;RCC1;PKMYT1;CDC25B;ANAPC2;SCRIB;TMEM8B;NEK7;DDB1;SMOC2;BUB1B;PSMD2;IQGAP1;PSMC1;PIM2;CDC23;ANAPC16;HNRNPU;PSMB2;USP2;PKN2;FBXO5;MDM2;PSMD9;PSME4;CDC27;TRIM35;UBE2E1;PSMA8;ANAPC4;HECA;ANAPC5;CDK9;RB1;CYLD;CDC16;BTG3;CUL1;RNF20;PSMD8;PSMD13;DAPK3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4195091036460019,0.8816701530054134,0.6236044657097288,1.0,1.0,3/10,15.16%,TUT4;NEDD8;UBB
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.34256386206909895,0.8814878144343054,0.6377952755905512,1.0,1.0,8/26,16.02%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;MET;NAV3
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.32482771797789084,-0.881446416468295,0.6360655737704918,0.8968446946332933,1.0,12/16,51.69%,TNFRSF21;TYROBP;DLL1;VSIR;AGER;LILRB1;PDCD1LG2;IL23A;FOXP3;IL23R;TRIB2;IL12B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.33237130713587326,-0.8811775332771417,0.6329479768786127,0.8962270973644116,1.0,5/13,14.08%,NFKBIA;GOPC;KEAP1;GET4;MDFI
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3103902191061019,0.8810700496723697,0.6551724137931034,1.0,1.0,8/57,11.09%,CRLF1;PTPN2;VEGFA;SOCS1;IL18;NF2;ERBB4;IL6ST
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2717561681601901,0.8808733351928069,0.834,1.0,1.0,86/532,19.48%,RORA;MMP2;CCL11;EDA;CXCL10;IL16;SLC27A1;IL2RA;FGF2;PYCARD;MYC;BCL2;IRS2;CRLF1;IL20RB;HNRNPDL;VEGFA;MAP3K3;IRAK3;RPS6KA4;SOCS5;TGFB1;CCL4;TEC;MT3;PLCB1;CCR2;ZEB1;NUMBL;SOCS1;YWHAZ;RORC;CSK;IL1RL2;CSF3R;ACKR3;IL18;PELI1;FYN;GAB2;PSMB7;HIF1A;AIP;NDN;PIK3R1;PTPRJ;TYK2;CBL;PTPN11;COL1A2;IL6ST;TOLLIP;PRKACA;PRLR;SOD2;HSP90B1;PTPRZ1;GATA3;TXLNA;PSMD2;UBB;CCL14;ITGB1;IL33;PSMC1;TP53;BCL2L11;IL1RAP;PYDC1;FSCN1;PSMB2;MTAP;RIPK1;CHUK;PTAFR;HSPA9;IRF3;LBP;PSMD9;MID1;BATF;TAB3;EGR1;GRB2;PSME4;PDCD4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.33784463103216167,0.8808410334566634,0.6268844221105527,1.0,1.0,9/37,16.07%,BCL2;BMF;FBH1;SFPQ;NACC2;NCK1;UBB;TP53;BCL2L11
prerank,cellular zinc ion homeostasis (GO:0006882),-0.27462628277281703,-0.8808303005033378,0.6406926406926406,0.8958066312578444,1.0,8/26,24.09%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC39A10;MT2A;SLC39A13;ATP13A2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3663704497853394,0.8802803692624761,0.6085164835164835,1.0,1.0,7/19,16.83%,DLG2;PATJ;ERBIN;SCRIB;PARD3B;FSCN1;FOXJ1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.34274000756553713,0.880016018971369,0.6426701570680629,1.0,1.0,3/27,4.08%,PDGFRA;FGF2;TGFB1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3450568087779839,0.8797833330056273,0.6336898395721925,1.0,1.0,9/26,24.18%,STXBP4;EFNA5;PPP3CB;CDK16;GPLD1;KLF7;ADCY8;TRPM4;ADCY5
prerank,regulation of ATP metabolic process (GO:1903578),-0.23573247014468313,-0.8797779718851265,0.7142857142857143,0.896962413766433,1.0,15/54,19.33%,PRKAG2;NUP93;NUP107;ATP7A;OGT;SLC25A33;PGAM1;NUP214;NUP43;NUP210;NUP88;PINK1;AK4;BEND3;NUP98
prerank,positive regulation of vasculogenesis (GO:2001214),0.4255986176448082,0.8797250222197838,0.6024844720496895,1.0,1.0,2/10,7.42%,CD34;RAP1A
prerank,negative regulation of coagulation (GO:0050819),-0.3266504763019855,-0.8796157890982735,0.6339869281045751,0.8960666480296223,1.0,3/14,2.71%,VTN;THBD;TFPI
prerank,regulation of histone acetylation (GO:0035065),0.32768204295273895,0.8794461457490427,0.6386010362694301,1.0,1.0,9/33,19.23%,KMT2A;RPS6KA4;BRCA1;SETD5;SNCA;TAF7;CTBP1;PARK7;RUVBL2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.40506885947596283,0.8790804478923654,0.618421052631579,1.0,1.0,7/12,26.56%,SEC61G;SEC63;SGTA;SEC61A2;SGTB;CHMP4A;CHMP4B
prerank,negative regulation of DNA recombination (GO:0045910),0.3224953786456472,0.878954548926819,0.6464285714285715,1.0,1.0,11/43,16.41%,ZRANB3;POLR2B;ATRX;POLR2K;FBH1;MSH6;POLR2G;RTEL1;CGAS;BLM;TERF2IP
prerank,body fluid secretion (GO:0007589),0.3879055003971803,0.8785982460650972,0.6197387518142236,1.0,1.0,4/15,17.72%,VEGFA;ERBB4;PRLR;GPAT4
prerank,protein-containing complex subunit organization (GO:0043933),0.2892831711448363,0.8785799079132944,0.7009544008483564,1.0,1.0,33/109,23.86%,REPS2;SOX9;LAMC1;WIPF1;EPRS1;KMT2A;PPID;MAGI1;NUP205;RIMS1;FANCC;NDC1;WASF1;DET1;MDM4;NIFK;TP53;LPXN;PPIH;IL1RAP;CD74;MDM2;SKAP2;KPNA3;NAPG;MITF;LLGL1;DLG4;ELOB;KIFAP3;WASF3;PPP2R1A;NDUFAF1
prerank,response to hexose (GO:0009746),0.35454809705308404,0.8784259302147843,0.6415343915343915,1.0,1.0,5/25,17.18%,IRS2;EIF2B5;SELENOS;GPLD1;EIF2B2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.3495902163143517,-0.8777986598002745,0.5911602209944752,0.8989327364754156,1.0,3/10,9.67%,BMP4;GLI3;IRF1
prerank,purine ribonucleotide transport (GO:0015868),-0.31026018304204417,-0.8772681848939622,0.6198083067092651,0.898859052699365,1.0,4/16,13.05%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,eye development (GO:0001654),0.3063516814767084,0.8772541825759209,0.6457345971563981,1.0,1.0,4/54,3.76%,EFEMP1;CHRDL1;COL5A2;MAB21L2
prerank,mitotic DNA replication (GO:1902969),-0.3571025911466843,-0.8771819368961228,0.6131805157593123,0.8977765536238811,1.0,7/10,33.48%,POLA1;MCM6;LIG1;CDC45;GINS1;MCM3;MCM2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.21257119621169757,-0.8771517626189981,0.7710843373493976,0.8965776974118036,1.0,24/87,19.43%,KANK2;DCUN1D3;PSMD14;BRD7;FBXL7;USP47;ZFP36L1;PSMB3;PSMD12;RGCC;KLF4;PRMT2;PSMD6;PSMA1;FAM107A;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;CDK4;PSMB6;RBL1;PSMA4
prerank,positive regulation of reproductive process (GO:2000243),0.3418366290125108,0.876942582163338,0.6514360313315927,1.0,1.0,8/31,23.25%,VEGFA;PLCB1;PRDM9;LHFPL2;CFAP69;CACNA1H;TAC4;INHBB
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.39603952920026947,0.8768110289405728,0.6207906295754027,1.0,1.0,8/13,31.85%,UNC93B1;TNIP2;IRAK2;IRAK1;PIK3C3;TRAF6;IRAK4;EPG5
prerank,positive regulation of proteolysis (GO:0045862),-0.22542698476265766,-0.8766941997899881,0.704225352112676,0.8964301849370704,1.0,15/55,18.89%,CTSH;CCBE1;SNX9;CTSC;OGT;STUB1;CASP8;TNIP1;MAPK12;ADRA2A;PERP;FGFR4;NRDC;APOE;PINK1
prerank,response to organic cyclic compound (GO:0014070),0.31095295186522964,0.8759431269862373,0.6643192488262911,1.0,1.0,8/52,12.69%,KYNU;TGFB1;HLCS;CYP1B1;IL18;ESR1;ARL6IP5;DRD2
prerank,regulation of RNA metabolic process (GO:0051252),0.3067142606048675,0.8759059397867975,0.6590126291618829,1.0,1.0,16/59,23.89%,PRX;TRA2B;ZNF326;RASA1;SON;PCBP4;NOVA1;RC3H1;FUS;HNRNPH2;HNRNPL;MITF;AHNAK;PTBP2;AFF2;PCBP2
prerank,sensory perception (GO:0007600),0.3155380422350962,0.8757785030818344,0.6351674641148325,1.0,1.0,8/45,17.78%,KCNA2;CHRNA4;PCDH15;CCR2;PENK;NIPSNAP1;OPRK1;PTGES
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2976756836241388,0.8752242250598498,0.698876404494382,1.0,1.0,24/76,23.12%,PTEN;PRKN;SOCS5;FBXW7;CBFA2T3;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;ELOB;ZYG11B;COP1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2833046980943502,-0.8750668973890448,0.6945454545454546,0.8987827831152713,1.0,4/23,7.14%,ACSL1;ELOVL7;FAR2;ACSL5
prerank,glycerolipid catabolic process (GO:0046503),0.356612323875551,0.8750496826540732,0.6307053941908713,1.0,1.0,6/19,19.94%,PRDX6;ENPP6;LYPLA2;ABHD6;GDPD3;PLA2G4E
prerank,regulation of establishment of protein localization (GO:0070201),-0.3285329913338419,-0.8747940372460518,0.6443768996960486,0.8981355411111496,1.0,8/14,36.01%,CENPJ;SCFD1;GAPVD1;CEP295;CORO2B;CTSD;TREM2;PTP4A3
prerank,cellular macromolecule catabolic process (GO:0044265),0.30811818200685687,0.8745630211238529,0.6343457943925234,1.0,1.0,17/49,26.06%,PRKN;RNASE6;XRN2;PPP1R8;FBXO27;NCBP1;FBXO17;RNASEH2C;PNPT1;RIPK1;MAGEC2;UBE2G1;FBXO44;OGA;SUPV3L1;RNASE3;SND1
prerank,striated muscle contraction (GO:0006941),-0.22436322066894218,-0.8745224075832133,0.7593984962406015,0.8975286275256459,1.0,15/53,26.03%,ATP1A2;RCSD1;TPM1;GRK2;GAA;NOS1;ATP1B1;STAC;SCN4B;MYH14;STAC3;DMD;SCN3B;MYL4;CASQ2
prerank,regulation of fibroblast migration (GO:0010762),0.36710377621916446,0.8740762610587102,0.6530898876404494,1.0,1.0,2/20,4.08%,FGF2;TGFB1
prerank,peptidyl-lysine acetylation (GO:0018394),0.42342833569837457,0.8738581915801708,0.6328125,1.0,1.0,1/10,2.04%,KAT2B
prerank,RNA stabilization (GO:0043489),-0.25070495701334233,-0.8736719857314765,0.6558139534883721,0.8982735225993693,1.0,7/33,10.91%,YBX1;NOCT;ZCCHC17;NAF1;ELAVL1;TAF15;DKC1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3526908334533501,0.8732962450162866,0.6472148541114059,1.0,1.0,1/25,0.13%,ARHGAP24
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.33026418171522637,0.873284418923351,0.6284224250325945,1.0,1.0,3/32,4.99%,DLC1;TGFB1;PPP1R15A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.40123812853833507,0.8732819341079612,0.6283464566929133,1.0,1.0,1/11,1.66%,PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.40123812853833507,0.8732819341079612,0.6283464566929133,1.0,1.0,1/11,1.66%,PTEN
prerank,regulation of vesicle-mediated transport (GO:0060627),0.29085377821176733,0.8732607082691949,0.7056892778993435,1.0,1.0,25/91,19.82%,OLFM4;STON2;PLD1;PACSIN2;SYT1;STON1;RAB21;HIP1;RAB3D;PTPN1;MAPK1;OPHN1;BET1L;STXBP5;RAB4B;RAB3A;RAB4A;ARFGAP1;ABL1;SNX12;DENND10;RIMS2;RAB3B;MBTPS1;RINT1
prerank,negative regulation of protein catabolic process (GO:0042177),0.31791827779601434,0.8729178495571731,0.6424167694204685,1.0,1.0,16/40,27.46%,EGFR;FMN2;IRAK3;FLNA;ATRAID;SNCA;MDM4;SNX12;AZIN2;SF3B3;AGAP2;PRKCG;HMGCR;CDK5RAP3;PIN1;CYP51A1
prerank,cellular protein-containing complex assembly (GO:0034622),0.28033252406203085,0.8728295763237435,0.7448347107438017,1.0,1.0,23/160,15.07%,STXBP6;SGIP1;DNAI4;CCDC39;VAMP4;TBCE;TGFB1;SHQ1;EPS15;GTF2B;BIN1;HIP1;ARL2;HSPA4;NUP205;NDC1;POGZ;TBCC;PRLR;SNCA;NCK1;RTN4;CCDC65
prerank,endocardial cushion morphogenesis (GO:0003203),0.36865126466859643,0.8727721559809336,0.6335227272727273,1.0,1.0,6/18,17.57%,SOX9;ACVR1;TGFBR2;MDM4;BMPR1A;HEYL
prerank,phosphatidylserine metabolic process (GO:0006658),0.3336319834205117,0.8724430734823231,0.6448362720403022,1.0,1.0,6/32,12.35%,SLC27A1;MBOAT2;OSBPL5;PLA2G12A;PTDSS1;PLAAT3
prerank,establishment of spindle localization (GO:0051293),0.39587845502328745,0.8723557041090907,0.6373134328358209,1.0,1.0,5/14,23.71%,CLASP1;KPNB1;LLGL1;DYNC1H1;ZBED3
prerank,neuromuscular process (GO:0050905),0.37829171966546027,0.8722280111571518,0.6278089887640449,1.0,1.0,2/16,4.74%,KCNA1;NRXN1
prerank,protein modification process (GO:0036211),0.2985190486218815,0.8720263338305944,0.6727066817667045,1.0,1.0,23/76,21.75%,CHRM3;TGM1;ARAF;CDKL3;MMP15;UBA3;SLC35A1;FBXL2;ATG3;NEDD8;ABL1;USP25;FBXO22;CSNK1G3;FBXO11;RPN1;UBE2L3;MCRS1;DUSP12;YES1;PLAT;UBE2D3;ERO1A
prerank,regulation of cell differentiation (GO:0045595),0.2803178765719988,0.871988933166146,0.7373319544984488,1.0,1.0,23/148,13.20%,LGALS3;PHLDB1;CBFB;NGF;MBOAT2;PTHLH;TGFB1;NF1;NLGN1;RORC;TRPS1;CDK6;KLK6;FGFR1;BIN1;PPP1R13L;GDNF;CLASP1;EDN3;APC2;CDK5R1;PRKACA;GATA3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.36150652196676936,-0.8717141771437545,0.6147540983606558,0.9013654691332977,1.0,5/10,31.45%,CDC42;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2671639673043793,-0.8716602641750403,0.6719367588932806,0.900260729264572,1.0,15/28,34.77%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;NBN;E2F1;RAD9A;CHEK2;CHEK1;PRPF19;ATRIP;FBXO6
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.28560098391195954,-0.8713924331432819,0.6426116838487973,0.8996281676409645,1.0,8/20,26.48%,OSR1;ACTN2;GOPC;ADRA2A;HECW2;TCAF2;CASQ2;PLN
prerank,protein ubiquitination (GO:0016567),0.27049073553956676,0.8709794637585077,0.8498498498498499,1.0,1.0,112/471,20.49%,UBE2T;PDZRN3;RNF157;BCL2;CBFB;FBXW9;PRKN;DTX4;UBE2E2;HACE1;WAC;NFX1;TRIM44;FBXW7;SPSB4;RNF6;KLHL13;SPOP;FBXO7;ZNRF2;FBXL15;DDB2;ASB5;FBXO32;TRIM2;OTULIN;TRIM11;PELI1;BRCA1;UBE2K;HECTD2;FBXL16;PSMB7;RNFT1;VPS11;FBXO27;HIF1A;LNPEP;CUL3;SELENOS;UHRF2;UBE2Z;HUWE1;ANAPC7;THOP1;FBXO45;CBL;FBH1;NFE2L2;UBE2J2;UCHL3;TSPAN17;TRIM41;FBXO17;FBXL2;MYLIP;ATG3;AKTIP;KLHL12;DDB1;DET1;NEDD8;TRIM23;DDA1;NEDD4L;TRAF7;PSMD2;KLHL22;UBB;AREL1;PSMC1;UBE2O;RNF19A;RCHY1;UBOX5;CDC23;RNF111;FBXL4;ZSWIM8;ANAPC16;UBE2Q1;RNF182;PSMB2;MIB1;CUL4B;RNF10;RC3H1;CDC73;RNF167;UBA1;FBXO31;FBXO22;MDM2;ELOC;RNF4;PSMD9;TAF1;USP5;PCNP;FBXO11;PSME4;BCL10;FBXL12;UBE2L3;RRAGA;CDC27;TRAIP;TRIM35;UBE2G1;RNF13;UBE2E1;NPEPPS
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3485449894210769,0.8708367751944841,0.6344086021505376,1.0,1.0,2/24,3.80%,PTPN22;TRIM44
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3041659953097632,0.8706754277388197,0.6685979142526072,1.0,1.0,18/59,23.21%,PTEN;CBFB;SOX9;CCNC;MED31;CDK8;MED13;MED12;MED25;TP53;MED30;MED8;JUN;NFKB1;MITF;THRA;MED24;CEBPB
prerank,histone lysine demethylation (GO:0070076),0.34957229224952685,0.870600075675837,0.6373193166885677,1.0,1.0,5/25,13.88%,KDM8;KDM5B;KDM4B;PHF8;KDM6A
prerank,7-methylguanosine mRNA capping (GO:0006370),0.33834397634403646,0.8705796819290123,0.6426735218508998,1.0,1.0,9/31,19.18%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.33834397634403646,0.8705796819290123,0.6426735218508998,1.0,1.0,9/31,19.18%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3571643908343326,-0.8699166850806592,0.6305555555555555,0.9016965733830224,1.0,2/11,6.74%,NRP1;BCAR1
prerank,calcium ion import into cytosol (GO:1902656),0.3818429532125507,0.8698777909352177,0.6202143950995406,1.0,1.0,4/15,18.22%,CACNA2D1;SLC8A2;SLC24A2;MS4A1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2938172335322432,-0.8694043253147054,0.6666666666666666,0.9016034963471551,1.0,6/18,12.28%,RAP1B;RAB5A;DTNBP1;GSK3B;SLC4A8;SNAPIN
prerank,regulation of transport (GO:0051049),0.3223524753913102,0.8692608161593941,0.6495726495726496,1.0,1.0,2/36,2.35%,CLDN19;PRKN
prerank,regulation of stem cell differentiation (GO:2000736),0.2939951903273585,0.8692099588705863,0.6952277657266811,1.0,1.0,20/89,20.75%,PDGFRA;CBFB;KMT2A;METTL3;PSMB7;ZFP36L2;GDNF;GATA3;PUS7;BMPR1A;PSMD2;PSMC1;RUNX1;ABL1;HNRNPU;PSMB2;PSMD9;PSME4;NSUN2;PSMA8
prerank,positive regulation of nervous system process (GO:0031646),-0.29180606416971355,-0.8689180519452305,0.7092198581560284,0.9014633414359715,1.0,4/18,10.71%,NLGN2;PARD3;ATPSCKMT;UNC13B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.40979656121582364,0.8689009118193878,0.625748502994012,1.0,1.0,5/11,18.76%,FYN;ABCD2;MPV17L;TRAP1;PARK7
prerank,relaxation of muscle (GO:0090075),-0.3287751794920363,-0.8687237674939063,0.6128048780487805,0.9006770669800599,1.0,3/13,6.72%,ATP1A2;KCNJ2;ATP1A1
prerank,mRNA processing (GO:0006397),0.2717487197086034,0.8685829921170284,0.8030150753768844,1.0,1.0,93/287,26.12%,CSTF3;DHX8;THOC6;TRA2B;GTF2H2;PABPC1;CPSF6;RNGTT;RPRD1A;RSRC1;POLR2B;METTL3;DHX35;SON;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;AURKAIP1;ALKBH5;NCBP1;SNRPB2;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRKACA;PRPF6;PRPF18;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;RNMT;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;THOC7;CMTR2;PRMT9;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WBP4;CTNNBL1;PCBP2;THOC5;POLR2F;TFIP11;CCNH;MAGOHB;CPSF7;U2SURP;SCAF11;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1
prerank,nitric oxide metabolic process (GO:0046209),0.38317231080212805,0.8683237711825559,0.6410998552821997,1.0,1.0,2/14,7.15%,NQO1;CYP1B1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3449163149630807,0.8682430353343443,0.6485411140583555,1.0,1.0,3/25,5.82%,SULF1;SOX11;FBXL15
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.355476941994552,-0.8682343766692929,0.6385224274406333,0.9005020138147989,1.0,4/10,22.11%,HSP90AA1;NAB2;HSP90AB1;CLU
prerank,protein O-linked glycosylation (GO:0006493),0.28848165508146145,0.8680645745224521,0.7139784946236559,1.0,1.0,23/96,18.61%,ST3GAL4;GALNTL6;TMTC2;GALNT9;GALNT1;PLOD1;POMGNT2;RXYLT1;GALNT15;GALNT7;C1GALT1;GALNT13;GALNT6;TMTC3;GALNT3;MUC3B;MUC3A;TET3;DPM1;FKTN;POGLUT2;GALNT11;FKRP
prerank,adenine nucleotide transport (GO:0051503),-0.29824211521770716,-0.8679301820339408,0.653125,0.8999776961106795,1.0,4/17,13.05%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,barbed-end actin filament capping (GO:0051016),0.3696613016200232,0.8672529317191099,0.637466307277628,1.0,1.0,2/18,2.24%,ADD3;GSN
prerank,actin filament capping (GO:0051693),0.3696613016200232,0.8672529317191099,0.637466307277628,1.0,1.0,2/18,2.24%,ADD3;GSN
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3053129359116151,0.86708571038836,0.6618531889290012,1.0,1.0,12/50,18.76%,DPEP1;NGF;VEGFA;MT3;PIH1D1;NGFR;DNAJB6;SNCA;XIAP;PAX2;FNIP1;PARK7
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.34748235936996985,0.8669668393704609,0.6418109187749668,1.0,1.0,12/24,26.79%,SLC25A38;UROS;RSAD1;SUCLA2;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,protein localization to synapse (GO:0035418),0.40004643168416987,0.8669541497624336,0.62,1.0,1.0,2/12,5.72%,NRXN1;NLGN1
prerank,negative regulation of potassium ion transport (GO:0043267),0.4013534754953421,0.8669092088667903,0.6666666666666666,1.0,1.0,5/13,19.41%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,fatty acid beta-oxidation (GO:0006635),0.31102241750025167,0.8668513507720446,0.6686320754716981,1.0,1.0,15/51,22.24%,GCDH;IVD;ETFA;HADHA;ACOX1;MTLN;ABCD2;AUH;CRAT;EHHADH;ACAA2;DECR1;ACOT8;ACADS;SCP2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38991888678797787,0.8666253727544799,0.6436950146627566,1.0,1.0,3/13,12.93%,XPO1;EIF6;SDAD1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3677334251824915,0.8665697301211971,0.6430594900849859,1.0,1.0,5/18,11.46%,FGF2;FGFR1;AKT3;SP1;SIRT6
prerank,in utero embryonic development (GO:0001701),0.34877521368544373,0.8665337887514026,0.631439894319683,1.0,1.0,6/25,17.16%,SOX8;VEGFA;EGFL8;PKD1;TGFB3;MYH6
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2932920764343895,-0.8664046782736186,0.6431372549019608,0.9020591122880228,1.0,6/18,14.55%,PTN;WDR43;CNOT1;ELAVL1;TAF6L;HMGA2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2804580964720372,0.8661469209866544,0.7124600638977636,1.0,1.0,28/124,20.11%,CDNF;DOCK7;WDPCP;PPP1R9A;ATXN10;GPM6B;PLP1;NLGN1;CNTNAP2;GPM6A;VAPA;GDNF;PRMT1;OPHN1;STMN4;CDK5R1;MYOC;CDK16;CORO1B;CYFIP1;CFAP61;CTTN;CAMSAP1;CNTN4;LRP12;MICALL2;CEP78;NPY
prerank,diacylglycerol metabolic process (GO:0046339),-0.27403121555516163,-0.8658166638358266,0.683206106870229,0.9021043014244498,1.0,10/23,30.52%,GPAM;DGKH;PLA2G15;DAGLA;PNPLA2;DGKG;LIPE;DGKB;ANG;DGAT1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.266569004272338,-0.8656670475683066,0.711864406779661,0.9012346548884925,1.0,12/25,33.35%,AMPD3;PRPSAP2;PRPS2;DCK;GART;PRPS1;PRPS1L1;APRT;GMPS;PNP;ADA;SHMT2
prerank,regulation of hydrolase activity (GO:0051336),0.29324875337489176,0.8655776240914964,0.6823793490460157,1.0,1.0,9/71,8.66%,SIPA1L1;PLXNC1;FGD4;EFNA5;NTRK2;NF1;CHN1;ARHGAP9;VAV3
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.36512183410470855,0.8654129007697929,0.6554149085794655,1.0,1.0,6/19,15.54%,MAP4K4;VEGFA;TSC1;PTPRJ;MYOC;ABL1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.27656202282883013,-0.8653050137954265,0.6468253968253969,0.9007515079871597,1.0,7/22,21.64%,ERI1;EXOSC7;URB1;NOP9;EXOSC10;RPS21;PES1
prerank,relaxation of cardiac muscle (GO:0055119),-0.32864359501592,-0.8652016939551045,0.6320754716981132,0.8997697504228004,1.0,3/13,6.72%,ATP1A2;KCNJ2;ATP1A1
prerank,purine-containing compound catabolic process (GO:0072523),0.3963261009724729,0.8649698371523082,0.6394658753709199,1.0,1.0,2/13,6.34%,NUDT15;NT5C2
prerank,regulation of BMP signaling pathway (GO:0030510),0.29478780548774125,0.8649368993715606,0.6729281767955801,1.0,1.0,14/73,16.36%,SOSTDC1;SULF1;HTRA3;SOX11;FBXL15;PCSK6;SFRP4;DAND5;BMPER;BMPR1A;UBE2O;LRP2;XIAP;VWC2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.22999786071304057,-0.8648190161006029,0.7298850574712644,0.8994120600908435,1.0,11/47,12.50%,PRKCD;TLR4;THBS1;AGTR1;DHRS4;PDGFRB;XDH;RNF41;CYBA;SOD1;MAPT
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.261639131811915,-0.8647849833339265,0.6780487804878049,0.898281122412389,1.0,10/29,22.08%,RPS14;RPS16;RPS19;NGDN;HELB;RPS8;NOP9;RPS21;DHX37;MRPS11
prerank,mitochondrial translation (GO:0032543),0.2843395682844717,0.8646810344259371,0.729903536977492,1.0,1.0,28/104,22.43%,MRPL47;IARS2;MRPS18A;TUFM;MRPL14;MRPL32;MRPL16;GATB;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;HARS1;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,early endosome to late endosome transport (GO:0045022),0.3623077167944001,0.8642180910738786,0.6411347517730497,1.0,1.0,13/20,29.68%,AKTIP;STX8;ANKRD27;RAB7A;SNX16;HOOK2;WDR81;HOOK1;HOOK3;PIK3C3;EEA1;SNF8;EMP2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.38191731217380864,0.8640956591141824,0.6224489795918368,1.0,1.0,1/14,0.94%,MEOX2
prerank,double-strand break repair (GO:0006302),0.27817801515574503,0.8639604004309012,0.7505133470225873,1.0,1.0,30/158,15.98%,POLN;MEIOB;APTX;AP5S1;ERCC5;REV3L;ERCC4;KDM4B;RPA3;SETMAR;ATP23;BRCA1;TDP1;NHEJ1;FBH1;SFPQ;NSD2;XRCC6;HPF1;MDC1;HELQ;XRCC3;EXD2;RPA2;SUMO1;BAZ1B;ATM;RAD52;BLM;SPIDR
prerank,ganglioside metabolic process (GO:0001573),-0.28580652671555185,-0.8635099552158052,0.6853932584269663,0.8998141992238767,1.0,2/20,2.10%,ST6GALNAC3;ST8SIA4
prerank,keratan sulfate catabolic process (GO:0042340),0.40569119245539065,0.8634297031021745,0.6274217585692996,1.0,1.0,2/11,7.19%,LUM;GALNS
prerank,cellular response to acid chemical (GO:0071229),0.3323646676899712,0.863380195601728,0.6424802110817942,1.0,1.0,11/27,26.28%,VEGFA;CPEB3;LAMTOR2;CPEB1;SPAAR;RPTOR;IPO5;RRAGA;MTOR;SLC38A9;CPEB4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.32494849036230716,-0.8625048155049722,0.6594427244582043,0.9008339048637023,1.0,3/13,4.65%,NFIB;BMP4;PPARD
prerank,activation of protein kinase B activity (GO:0032148),0.3351509644355862,0.8623661055974733,0.6688396349413298,1.0,1.0,5/29,7.90%,NTRK3;MT3;WNT5A;MAPKAP1;IL18
prerank,B cell mediated immunity (GO:0019724),0.4010727981588116,0.8618480855664515,0.6298003072196621,1.0,1.0,2/10,17.14%,CARD9;CD74
prerank,myeloid cell differentiation (GO:0030099),0.310058216350255,0.8617079564767363,0.6766109785202864,1.0,1.0,7/47,7.38%,CDKN2B;PTPN2;PRKX;SLC25A38;ZBTB16;UFL1;KAT8
prerank,mitotic sister chromatid cohesion (GO:0007064),0.37695227208379334,0.8615307505175641,0.6428571428571429,1.0,1.0,6/16,27.25%,POGZ;SGO1;PDS5B;RB1;SMC1A;NAA50
prerank,regulation of cilium movement (GO:0003352),0.41099407733409454,0.8612673625061515,0.6330708661417322,1.0,1.0,2/10,15.07%,CCDC39;CCDC65
prerank,mitotic cytokinetic process (GO:1902410),-0.28659211957564745,-0.8611437657914673,0.6588235294117647,0.9026534640218593,1.0,7/20,23.97%,CHMP3;RHOA;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,transition metal ion homeostasis (GO:0055076),0.33656426475580387,0.8606314758660801,0.6522875816993464,1.0,1.0,3/28,5.56%,PRKN;MT3;CYBRD1
prerank,regulation of protein localization to centrosome (GO:1904779),0.4109176250911529,0.8605778496317096,0.6423017107309487,1.0,1.0,1/10,1.79%,BICD1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3290468431414108,0.8605337141931516,0.6602809706257982,1.0,1.0,6/32,15.48%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;ATM
prerank,positive regulation of cyclase activity (GO:0031281),-0.31639289357212647,-0.8605220601214476,0.6547619047619048,0.9027527415030153,1.0,6/14,24.40%,CACNA1C;NOS3;STIM1;NOS1;CACNA1D;MAPK8
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.39105316410749724,0.860447077891314,0.6228209191759112,1.0,1.0,3/12,13.51%,PRNP;RCAN1;HOMER2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.39105316410749724,0.860447077891314,0.6228209191759112,1.0,1.0,3/12,13.51%,PRNP;RCAN1;HOMER2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.405042820890395,0.8603724926284501,0.6395534290271132,1.0,1.0,6/11,28.27%,ATF7IP;SIRT6;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3600425429647909,0.8602775726450691,0.6331444759206799,1.0,1.0,7/18,22.65%,SLC43A1;BIN1;STK39;NEDD4L;KCNH2;CAB39;CAMK2D
prerank,dendritic spine organization (GO:0097061),0.33887623358517727,0.8602363267154806,0.6675461741424802,1.0,1.0,6/26,11.37%,PTEN;EPHB2;PRNP;DOCK10;FYN;DIP2A
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.32318493749704685,0.860079230253419,0.6592398427260813,1.0,1.0,5/35,6.44%,PDGFRA;NTRK3;SEMA3E;IQGAP2;BAIAP2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.32392523643278837,-0.8597498941605031,0.653125,0.9032751646945746,1.0,5/13,25.56%,TM9SF4;HSP90AB1;ABCA7;SNX33;TYROBP
prerank,glucan catabolic process (GO:0009251),0.37849822519586196,0.859474789583283,0.6422651933701657,1.0,1.0,3/15,14.50%,PYGL;PHKB;CALM1
prerank,sarcomere organization (GO:0045214),0.3376494747118524,0.8593655455229464,0.6551264980026631,1.0,1.0,2/27,8.42%,CSRP1;TNNT3
prerank,nuclear export (GO:0051168),0.28623579368740654,0.8590890254282324,0.7157190635451505,1.0,1.0,17/80,19.63%,CCHCR1;XPO1;THOC6;TGFB1;NUP155;SRSF11;CASC3;NCBP1;MALT1;SRSF6;PKD1;POM121;NXF1;RNPS1;THOC7;CSE1L;SRRM1
prerank,negative regulation of dephosphorylation (GO:0035305),0.36327782704158973,0.8589211015268823,0.632183908045977,1.0,1.0,4/18,8.53%,PPP1R15A;URI1;ENSA;PPP1R8
prerank,sterol transport (GO:0015918),0.3628960034346677,0.8587593088067731,0.6437414030261348,1.0,1.0,2/19,5.43%,NPC1;OSBPL5
prerank,negative regulation of cell growth (GO:0030308),0.28078967076469685,0.8586369730961676,0.7393617021276596,1.0,1.0,11/121,6.26%,DCBLD2;FGF13;CRLF3;VGLL4;FRZB;JADE1;TGFB1;RNF6;MT3;APBB2;CDKL3
prerank,regulation of tissue remodeling (GO:0034103),0.3638054614544281,0.8585855205471807,0.6115007012622721,1.0,1.0,4/18,17.76%,TGFB1;IL18;RUNX1;MDK
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2702724192582676,0.8585764297048976,0.768762677484787,1.0,1.0,52/198,23.94%,ITPK1;GFPT2;INPP4B;PLBD1;PTEN;DUSP4;PSPH;EPHB2;TGFB1;PLCB1;ACP2;PAK1;AGPAT2;PPP3CB;PPP3CA;TOLLIP;PPP1CA;PLPPR4;ACYP2;NUDT10;PLAAT3;NUDT3;HDHD2;SHPK;CALM1;PLAA;MINPP1;AGK;DUSP16;NUDT5;NT5C;HK2;BCKDK;TOP1;STAT3;CERKL;PLA2G4E;DUSP12;PLPPR2;INPP5J;PFKFB1;NUDT11;LIMD1;LIMK2;PPM1A;PLPPR1;HK1;SLC20A1;PRKCG;TAOK1;INPP5B;MTOR
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.40559918300988157,0.85813085115199,0.6170839469808542,1.0,1.0,3/10,21.30%,DLGAP1;BEGAIN;DLGAP3
prerank,regulation of monocyte differentiation (GO:0045655),0.3822398145759033,0.8579999154857041,0.6322674418604651,1.0,1.0,3/14,7.57%,MYC;HOXA7;CDK6
prerank,regulation of gene silencing by miRNA (GO:0060964),0.29960423792776036,0.8578652679719003,0.6753688989784336,1.0,1.0,25/62,27.82%,TGFB1;RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;PPARG;STAT3;ZFP36;LIMD1;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1;AJUBA;PUM2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2854644464298991,0.8578647101443582,0.7664543524416136,1.0,1.0,13/117,9.83%,CYP2S1;KYNU;THEM4;SLC27A4;NPC1;GBA2;MCCC1;HLCS;ACOT11;GOT2;FASN;MCCC2;ACSF2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.28260905405232917,-0.8578072462481319,0.6580882352941176,0.9063870489601605,1.0,6/21,19.70%,NPM1;VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.33507808686848284,0.8578041471129367,0.6371911573472041,1.0,1.0,9/25,24.67%,HMGN1;ZNF326;SETD5;ELL;TCEA2;ZMYND11;KAT7;THOC5;CCNT2
prerank,anion transmembrane transport (GO:0098656),0.2949150456230175,0.8577920138924471,0.6963470319634704,1.0,1.0,11/67,13.11%,SLC1A3;SLC27A1;SLC25A21;LRRC8D;SLC35C2;SLC25A38;ARL6IP5;SLC35A1;SLC7A8;PRAF2;SLC25A10
prerank,epithelial to mesenchymal transition (GO:0001837),0.31177755246273403,0.8573395573244496,0.6623222748815166,1.0,1.0,10/47,11.41%,S100A4;SOX9;TGFB1;WNT5A;HNRNPAB;LOXL3;FGFR1;HIF1A;AMELX;BMP7
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3789432023688323,0.8570049721386226,0.657185628742515,1.0,1.0,2/15,6.38%,PDGFRA;TGFBR2
prerank,nitric oxide biosynthetic process (GO:0006809),0.38715265143566124,0.8569732131989803,0.6537890044576523,1.0,1.0,2/13,7.15%,NQO1;CYP1B1
prerank,piRNA metabolic process (GO:0034587),0.3567767104898676,0.8568205634309776,0.6647727272727273,1.0,1.0,4/19,22.34%,FKBP6;TEX15;TDRKH;DDX4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.21829860751500046,-0.8565169384335088,0.7423312883435583,0.9079059444914881,1.0,19/50,27.62%,SASH1;NFAT5;TLR4;APP;NR3C2;RHOA;NMI;SPHK1;IFI35;CD86;LAPTM5;NOD1;TCIM;TRADD;ACTN4;ILK;CCL19;NOD2;CD27
prerank,neutral amino acid transport (GO:0015804),0.3364471034375769,0.8562016701203606,0.6510695187165776,1.0,1.0,6/28,19.24%,SLC1A5;SLC36A2;SLC43A1;SLC7A8;SLC6A15;SLC6A9
prerank,bile acid metabolic process (GO:0008206),0.3413427524303745,0.8560863287401709,0.6599496221662469,1.0,1.0,10/27,25.14%,NPC1;GBA2;CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,response to insulin (GO:0032868),0.29048092022006283,0.8560567934453241,0.6997767857142857,1.0,1.0,10/80,10.37%,SLC27A1;IRS2;KAT2B;C2CD5;EPRS1;PDE3B;TSC1;EIF6;SELENOS;PIK3R1
prerank,protein stabilization (GO:0050821),0.27368547125458476,0.8560482110326921,0.75,1.0,1.0,41/168,21.45%,PTEN;ANK2;STXBP4;PRKN;CCT7;TRIM44;FBXW7;MT3;ATF7IP;TSC1;NAA16;RAB21;RABL3;FLNA;BAG5;HIP1;CRYAB;PIK3R1;USP33;TAF9;GRN;DVL1;PER3;PDCL3;MDM4;SUMO1;RTN4;RASSF2;PIM2;USP2;NAA15;PARK7;TAF1;PHB2;USP13;NAPG;LAMP2;HSPD1;TNIP2;WDR81;DVL3
prerank,mesenchyme morphogenesis (GO:0072132),0.36885241933419555,0.855621801209817,0.6647646219686163,1.0,1.0,7/17,23.45%,SOX9;ACVR1;MDM4;BMPR1A;HEYL;BMP2;TBX2
prerank,protein import (GO:0017038),0.28699651120738645,0.855561410747029,0.7032115171650055,1.0,1.0,23/84,21.10%,ACBD5;PEX3;PXMP2;NUP155;FAM53B;TOMM22;HSPA4;IPO9;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;GDAP1;POM121;ABCD2;TNPO3;IPO5;CSE1L;STAT3;PHB2;LAMP2;HEATR3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2931039853837047,0.8555361212797816,0.7171717171717171,1.0,1.0,15/69,15.46%,ERLIN2;DNAJB9;RHBDD2;FBXO27;DERL2;SELENOS;HERPUD1;EDEM2;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;JKAMP;ERLIN1
prerank,calcium ion import (GO:0070509),-0.2659176222912103,-0.8550620089678249,0.7023809523809523,0.9097873641791249,1.0,4/28,4.38%,CACNA1C;MICU1;CACNB2;CACNA1G
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.30751750317984894,-0.8550495018121566,0.6411149825783972,0.9085936606420285,1.0,3/16,9.33%,ETS1;NFAT5;RHOA
prerank,receptor internalization (GO:0031623),0.3106332430164341,0.8549386027863184,0.6744759556103576,1.0,1.0,9/44,15.19%,DNM1;LRP1;GTF2H2;ACKR3;CD9;SNCA;SNX1;SCYL2;ITGB1
prerank,negative regulation of cell division (GO:0051782),0.39836424482609833,0.8545150374273067,0.6391752577319587,1.0,1.0,3/11,15.80%,MYC;CHMP4C;BLM
prerank,cellular response to fluid shear stress (GO:0071498),0.39148973362483164,0.8543793892406272,0.6594516594516594,1.0,1.0,4/12,16.26%,HAS2;MAPK7;NFE2L2;SREBF2
prerank,regulation of centriole replication (GO:0046599),0.3619562424844852,0.8543699653460554,0.6609929078014184,1.0,1.0,5/18,13.91%,KAT2B;BRCA1;CEP295NL;CEP76;MDM1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.37703871895631597,0.8541938728937223,0.6300148588410104,1.0,1.0,7/14,25.14%,ACOX1;CRAT;EHHADH;ACOT8;SCP2;HSD17B4;AMACR
prerank,acylglycerol catabolic process (GO:0046464),-0.25023755679679516,-0.8536645617263531,0.7090163934426229,0.9103651205819631,1.0,9/30,25.43%,MGLL;ABHD2;DAGLA;ABHD12;PNPLA2;LPL;PNPLA3;FAAH;LIPE
prerank,synaptic membrane adhesion (GO:0099560),0.38079740412113455,0.8535036060745939,0.6507246376811594,1.0,1.0,6/14,20.12%,LRRC4C;NTNG1;GPC4;PTPRF;LRFN5;PTPRS
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41165670054133596,0.8534704317728268,0.656786271450858,1.0,1.0,7/10,27.66%,EMC10;EMC1;EMC8;EMC3;EMC6;EMC2;EMC7
prerank,positive regulation of protein modification process (GO:0031401),0.26698660570671245,0.8532038350223151,0.7806122448979592,1.0,1.0,18/203,6.54%,DLC1;CLDN19;NTRK3;FGF2;FGF10;SOX9;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;TGFB1;NTRK2;MT3;TNIK;NIBAN1;PAK1;RALB
prerank,positive regulation of cell cycle (GO:0045787),0.297064057754829,0.8531755067714804,0.6898954703832753,1.0,1.0,14/62,18.56%,PRKCA;EGFR;TGM1;CCDC57;ASNS;CDC25B;SMOC2;PKD1;CITED2;CCND2;USP2;PKN2;MDM2;MAPRE3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.3317719486084699,-0.8531638048306679,0.672463768115942,0.910181607252524,1.0,4/12,22.44%,WNK1;ASS1;SKAP1;AKT1
prerank,triglyceride biosynthetic process (GO:0019432),0.3619919471129084,0.8529294726799265,0.6542185338865837,1.0,1.0,5/18,17.89%,AGMO;MOGAT3;GPAT3;GPAT4;PCK2
prerank,positive regulation of vasculature development (GO:1904018),0.28508370137278727,0.852892593678946,0.7222222222222222,1.0,1.0,23/94,16.89%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;HSPB6;WNT5A;CYP1B1;GATA6;BRCA1;HIF1A;SP1;MYDGF;GRN;SMOC2;PDCL3;ITGB1;JUP;RUNX1;GAB1;HYAL1;APLNR
prerank,positive regulation of rRNA processing (GO:2000234),-0.35244464531621505,-0.8528063949765802,0.6353887399463807,0.9096932385555342,1.0,7/10,26.42%,WDR43;UTP15;BUD23;DIMT1;RIOK1;SIRT7;RIOK2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.30804726815180444,0.852664962925787,0.671875,1.0,1.0,5/44,8.63%,ACVR1;CCDC39;TGFBR2;BBS5;SMO
prerank,response to iron ion (GO:0010039),-0.3234248808220967,-0.8524089776192738,0.6569767441860465,0.9093497524934904,1.0,1/12,0.02%,BMP6
prerank,regulation of receptor recycling (GO:0001919),-0.29834611896509494,-0.8522809567959057,0.6506410256410257,0.9083921951846962,1.0,6/16,21.55%,NSF;OPTN;ECE1;TBC1D16;LAMTOR1;INPP5F
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3749428269851089,0.852277863647343,0.6555716353111433,1.0,1.0,5/14,21.52%,ADSS1;ADK;RFK;ADSL;PFAS
prerank,response to nutrient levels (GO:0031667),-0.29957979381001454,-0.8522000259430871,0.6313993174061433,0.907327920115383,1.0,6/17,21.18%,RPS6KB1;PRKAA2;KCNB1;FAM107A;ATF4;ULK1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.38456939492983516,0.852125476037142,0.6580547112462006,1.0,1.0,3/14,13.22%,SOCS5;IL18;MALT1
prerank,regulation of trophoblast cell migration (GO:1901163),0.37794827425661714,0.8520398995976612,0.6508172362555721,1.0,1.0,2/14,5.43%,VEGFA;ACVR1C
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4119751114801903,0.8519812246160676,0.6682170542635659,1.0,1.0,2/10,9.64%,KYNU;IL4I1
prerank,regulation of microglial cell activation (GO:1903978),0.3771922773593459,0.8519582104203174,0.6506024096385542,1.0,1.0,3/15,13.71%,SYT11;GRN;TTBK1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.307404233984045,-0.851949810954074,0.6830065359477124,0.9066188418925386,1.0,4/14,14.08%,NFKBIA;KEAP1;TMSB4X;MDFI
prerank,negative regulation of cell aging (GO:0090344),0.36642991152319876,0.851473694926761,0.6538461538461539,1.0,1.0,4/16,9.25%,MAP3K3;CDK6;FOXM1;AKT3
prerank,positive regulation of filopodium assembly (GO:0051491),0.34239993208771125,0.8514292225715238,0.6666666666666666,1.0,1.0,6/24,16.62%,TENM2;NLGN1;GPM6A;PIK3R1;TGFB3;FSCN1
prerank,positive regulation of DNA binding (GO:0043388),0.3299331812047945,0.8512672394465667,0.6780735107731305,1.0,1.0,3/31,4.08%,NGF;PRKN;TGFB1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2974840431410341,0.8509395930661567,0.6833527357392316,1.0,1.0,11/59,13.71%,PRKCA;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;STK39;MAPK1;CDK5R1;TBK1;TTBK1
prerank,signal release from synapse (GO:0099643),0.30713071799170516,0.8508900522090611,0.6959706959706959,1.0,1.0,8/43,13.88%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,response to UV (GO:0009411),0.2849594992307095,0.8508810779014317,0.7302275189599133,1.0,1.0,24/95,19.97%,MYC;EGFR;ZRANB3;GTF2H2;ERCC5;NSMCE3;ERCC4;DDB2;METTL3;BMF;MEN1;XPA;MSH6;ZBTB1;MAP3K4;TP53;USP1;N4BP1;WRN;REV1;CAT;TAF1;RUVBL2;SCARA3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.33263432202371374,-0.8508676536713171,0.6696428571428571,0.907659455512035,1.0,5/12,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,regulation of axon extension (GO:0030516),0.3198468827470946,0.8507873992031179,0.6741293532338308,1.0,1.0,13/37,20.12%,NRCAM;SEMA3A;RNF6;MT3;CDKL5;CDKL3;LIMK1;RTN4;ABL1;DIP2B;CTTN;SHTN1;PTPRS
prerank,regulation of protein kinase C signaling (GO:0090036),0.3794876748995041,0.8507416104025031,0.6483357452966715,1.0,1.0,2/14,5.52%,VEGFA;WNT5A
prerank,negative regulation of cholesterol transport (GO:0032375),0.4002598102632757,0.8503168882641498,0.6482649842271293,1.0,1.0,2/10,21.17%,SREBF2;NFKB1
prerank,positive regulation of chromatin organization (GO:1905269),-0.3222783624464776,-0.8502054693269834,0.6636363636363637,0.9078914770794705,1.0,5/12,18.96%,TERF2;UBE2N;TAL1;SIN3A;TINF2
prerank,mismatch repair (GO:0006298),0.33537441837567317,0.8498400788756714,0.6573705179282868,1.0,1.0,7/27,15.54%,RPA3;MUTYH;SETD2;MSH6;RPA2;MSH5;ABL1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.403806303038851,0.8497216691571483,0.6621621621621622,1.0,1.0,3/11,14.61%,CD34;GATA6;BMPR1A
prerank,negative regulation of proteolysis (GO:0045861),-0.23451461841474366,-0.8493629592524023,0.7606382978723404,0.9084268870770803,1.0,4/34,6.64%,EPHA4;ROCK1;GAS1;TIMP3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.20748354168853878,-0.8492989140239308,0.8269230769230769,0.907369559029389,1.0,14/76,12.94%,PTGIS;CD200;USP7;MAP2K5;NFKBIA;COMMD1;AIM2;PARP10;ANXA4;KLF4;COMMD7;PRMT2;TMSB4X;LRRC14
prerank,ion transport (GO:0006811),0.2791944979111381,0.8491061997771343,0.7524012806830309,1.0,1.0,9/111,5.24%,PIEZO2;SLC1A3;VDAC2;SLC12A3;SLC17A5;ANO6;CHRNA4;SLC36A2;SLC12A2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27600733276845446,-0.8490362134681769,0.68561872909699,0.906738315890983,1.0,4/20,6.57%,PPIC;PPIL2;CWC27;PPIA
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3077546513214987,-0.848928098143745,0.6613418530351438,0.905785444172249,1.0,8/16,29.90%,DFFA;H1-0;DNASE2;HMGB2;CASP3;FOXL2;DICER1;CECR2
prerank,negative regulation of viral life cycle (GO:1903901),0.37408406634896874,0.8488723915066273,0.662704309063893,1.0,1.0,3/15,10.42%,GSN;TRIM11;MID2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.3851906336248399,0.8484859934562187,0.6754002911208151,1.0,1.0,7/13,31.11%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),0.3851906336248399,0.8484859934562187,0.6754002911208151,1.0,1.0,7/13,31.11%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,protein export from nucleus (GO:0006611),0.3308829467822665,0.8483664641701518,0.6742323097463284,1.0,1.0,3/27,4.08%,CCHCR1;XPO1;TGFB1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.23773756419903785,-0.8480316988036102,0.7305699481865285,0.906494655293438,1.0,10/39,14.04%,MYO1D;WASL;FNBP1L;TRAK1;PAFAH1B1;KIF5B;BICDL1;MYO1E;MYO5B;MYO1C
prerank,regulation of autophagosome assembly (GO:2000785),-0.24564177164754122,-0.8478512704086331,0.7259615384615384,0.9056729848669978,1.0,11/33,22.35%,RAB5A;TBC1D14;FEZ2;SCFD1;NUPR1;LRSAM1;PIP4K2B;SMCR8;PINK1;ADPRH;SH3GLB1
prerank,calcium ion import across plasma membrane (GO:0098703),0.3796247571082795,0.8475457462570554,0.6447574334898278,1.0,1.0,2/14,7.96%,CACNA2D1;SLC8A2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.302493494258648,-0.847111768245132,0.654485049833887,0.9060031045280926,1.0,4/16,13.95%,PPARGC1B;DDX5;EGLN2;PADI2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2849133907531599,0.8470481568379771,0.7319474835886215,1.0,1.0,21/87,18.25%,NDUFAF4;COX20;NDUFS5;NDUFAF6;COX18;SCO1;NDUFB2;NDUFA8;COX19;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;SDHAF1;NDUFA6;NDUFA12;AIFM1;UQCC1;NDUFC1
prerank,neuron projection extension (GO:1990138),0.3221433895502563,0.8460487680767323,0.6875800256081946,1.0,1.0,9/32,14.94%,MAP1B;SEMA3A;AUTS2;CDKL3;PPP3CB;SPG11;NRP2;IQGAP1;CYFIP1
prerank,sensory perception of smell (GO:0007608),0.39791536736646793,0.8457938436569172,0.6471494607087828,1.0,1.0,4/11,24.42%,DRD2;SLC24A4;UBR3;BBS4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3426603561655942,0.845391300050941,0.6838046272493573,1.0,1.0,10/23,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;NFKB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.33578609669468684,0.84503234801764,0.6693989071038251,1.0,1.0,8/24,22.65%,JPH3;AKAP6;PDE4D;PRKACA;CALM1;CALM2;PKD2;CAMK2D
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.34879760314199415,0.8446293716991398,0.654178674351585,1.0,1.0,4/18,15.16%,UGGT2;DERL2;EDEM2;UBB
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.356982083919269,0.8438547796229362,0.665283540802213,1.0,1.0,7/18,24.75%,TGFB1;CLASP1;RUNX1;FSCN1;RB1;BMP2;COLGALT1
prerank,androgen receptor signaling pathway (GO:0030521),-0.3379078961119757,-0.8436738888560559,0.6868131868131868,0.9120207057439871,1.0,2/11,7.09%,PLPP1;DDX5
prerank,cellular response to fatty acid (GO:0071398),0.37984957302784506,0.8436689096752343,0.6148036253776435,1.0,1.0,2/12,11.37%,PDK3;PID1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2653594271137677,0.8432963842360691,0.8296146044624746,1.0,1.0,41/234,20.22%,RELN;ROR1;EDA;PRKCQ;PYCARD;PTEN;STK36;VEGFA;IRAK3;CRTC1;RPS6KA4;FANK1;WNT5A;CARD9;IL18;SMO;MID2;ATF2;ESR1;TRIM41;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;JUP;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;PARK7;TAB3;TAF1;BCL10;PPARG;STAT3;PHB2;ADCY8;SMARCA4
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2519871465427281,-0.8429938232383146,0.7440758293838863,0.912177477962582,1.0,13/29,30.18%,DGCR8;AGO1;ZC3H7B;TUT7;AGO3;SRRT;TARBP2;LIN28B;MRPL44;PUS10;AGO2;DICER1;AGO4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3930507712180428,0.8429350506644441,0.6583850931677019,1.0,1.0,3/11,17.14%,BCL2;TAF9;CD74
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2958272371731404,0.8429287066768254,0.6925714285714286,1.0,1.0,12/59,10.12%,TENM3;PTPRT;DSG2;OBSL1;CADM3;KIRREL3;HMCN1;CNTN6;CADM1;CNTN2;DSCAM;PALLD
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3638709751574512,0.8427922566023522,0.6487252124645893,1.0,1.0,3/16,10.58%,FGF2;VEGFA;NGFR
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2685558547550509,0.8424114216517568,0.7842535787321063,1.0,1.0,23/175,17.26%,CCL11;ADAMTS12;EDA;HAS2;PYCARD;CCL4;BRCA1;ERBIN;PSMB7;ZFP36L2;NFE2L2;PID1;GATA3;PSMD2;ZFAND6;CCL14;PSMC1;TP53;HYAL1;PYDC1;PSMB2;RIPK1;CHUK
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4077797006186575,0.8423645714314355,0.6635367762128326,1.0,1.0,1/10,1.74%,PTPN22
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.30031970615386294,0.8421853858332402,0.7048611111111112,1.0,1.0,28/51,31.22%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4A;CHMP4B;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,mitotic nuclear membrane organization (GO:0101024),0.30031970615386294,0.8421853858332402,0.7048611111111112,1.0,1.0,28/51,31.22%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4A;CHMP4B;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.33472621446837936,-0.8416135322409473,0.672972972972973,0.9126405510459329,1.0,5/11,13.59%,DKC1;LARP7;CCT8;CCT6A;CCT4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.33472621446837936,-0.8416135322409473,0.672972972972973,0.9126405510459329,1.0,5/11,13.59%,DKC1;LARP7;CCT8;CCT6A;CCT4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2859008248392904,0.8414242211522173,0.6983050847457627,1.0,1.0,22/73,24.87%,GLMN;KAT2B;TAF1A;EED;POLR2K;HDAC6;CREBZF;EPC1;JARID2;RBBP4;POLR1B;BAZ1B;PHF19;POLR1C;POLR1G;CGGBP1;RBBP7;TDG;MPHOSPH8;AEBP2;POLR2F;TBP
prerank,regulation of autophagy (GO:0010506),0.2646302898966909,0.841182529045358,0.8253319713993871,1.0,1.0,37/216,15.59%,DCN;PTPN22;BCL2;PRKN;NPRL2;CAPN1;FBXW7;ATP6V1B2;MT3;VPS29;PRKAB2;UFL1;BMF;KAT8;BNIP3;LAMTOR2;UCHL1;TLK2;SNX6;VPS26B;EIF4G1;MID2;USP33;HDAC6;CDK5R1;FBXL2;PRKACA;TPCN2;DRAM1;GFAP;WASHC1;TICAM1;MET;KLHL22;ATM;ABL1;PIM2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.41127143206664196,0.8410996529298127,0.6646153846153846,1.0,1.0,3/10,12.25%,ATRX;BRCA1;JARID2
prerank,lipid homeostasis (GO:0055088),0.29589144433480874,0.8410221863608208,0.6895348837209302,1.0,1.0,7/57,9.74%,IRS2;ZBTB20;FBXW7;MLXIPL;ACOX1;RCN3;THADA
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.35324834825379187,0.8409838542283967,0.6820728291316527,1.0,1.0,6/18,17.76%,NF1;TMEM98;DAAM2;PTPRZ1;OPALIN;MDK
prerank,phospholipid translocation (GO:0045332),0.3248294694286091,0.8405763456452019,0.6770428015564203,1.0,1.0,4/28,3.64%,ATP8B1;PLSCR4;ANO6;ATP9B
prerank,inorganic anion transmembrane transport (GO:0098661),0.29187131161672575,0.8405442013258537,0.7181286549707603,1.0,1.0,10/63,16.03%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;SLC12A4;SLC25A10;XPR1;GABRG2;SLC25A11
prerank,glycogen catabolic process (GO:0005980),0.3734277820635905,0.8401852506369051,0.6590909090909091,1.0,1.0,3/15,14.50%,PYGL;PHKB;CALM1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.36645544524076473,0.840170777669464,0.6566091954022989,1.0,1.0,3/17,5.51%,CACNA2D1;ANK2;SCN5A
prerank,striated muscle cell differentiation (GO:0051146),-0.30151606628564787,-0.8400532296969763,0.6749116607773852,0.9146430999367762,1.0,7/16,19.72%,SIK1;KDM6B;MYEF2;SORT1;CBY1;MYOCD;SDC1
prerank,macroautophagy (GO:0016236),0.2735694084094811,0.8400267485395595,0.757607555089192,1.0,1.0,21/118,15.22%,DYNLL1;PRKN;MTMR14;VPS33A;LIX1;ACBD5;SNAP29;WIPI1;PRKAB2;VPS39;ATG5;TOMM22;TOMM20;VPS37B;VPS36;ATG3;MVB12A;GABARAPL2;PLAA;VPS41;CHMP4C
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.26894793566987557,0.8391110200242248,0.7865284974093264,1.0,1.0,35/161,19.45%,TPBGL;RBMS3;LRP4;SOX9;PRKN;FRZB;JADE1;TLE1;GLI1;WNT5A;TBX18;PSMB7;DKK3;CUL3;SFRP4;TMEM131L;EMD;PRICKLE1;APC2;DVL1;WWTR1;CSNK1A1;KLHL12;PSMD2;SCYL2;PSMC1;DACT1;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;NKD2;PSME4
prerank,electron transport chain (GO:0022900),0.3674893841593204,0.8390061711750837,0.6676300578034682,1.0,1.0,2/15,5.93%,POR;ETFA
prerank,cellular response to nutrient levels (GO:0031669),0.2942206310064514,0.8389132235979968,0.7274774774774775,1.0,1.0,20/62,24.73%,CDKN2B;NUPR2;WIPI1;TSC1;RALB;EIF4G1;USP33;CLEC16A;VPS41;SREBF2;WRN;RPTOR;FNIP1;RRAGA;LAMP2;PRKAA1;INHBB;MTOR;WDR45B;EHMT2
prerank,histone modification (GO:0016570),0.2761146205121054,0.838876499486411,0.7724867724867724,1.0,1.0,25/109,19.23%,RCOR2;RPS6KA4;MT3;HLCS;MTA2;UFL1;KAT8;CARM1;BRD8;MORF4L2;HDAC2;HUWE1;PHF20;SIN3B;PRMT1;HDAC6;MIDEAS;BAZ1B;TRRAP;MSL3;MTA3;USP21;ATXN7;PARK7;RUVBL2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3498684535076055,0.8388132181559235,0.6593567251461988,1.0,1.0,6/18,20.36%,DLC1;CUL3;MYOC;MET;KANK1;HEG1
prerank,early endosome to Golgi transport (GO:0034498),0.3917085303848816,0.8386849839429266,0.6439942112879884,1.0,1.0,6/11,24.03%,SNX1;SURF4;RBSN;LMAN1;RAB6A;TRAPPC10
prerank,establishment of mitotic spindle localization (GO:0040001),0.32824300624055497,0.838624498959843,0.6727037516170763,1.0,1.0,7/28,18.46%,GPSM2;INSC;NDE1;CLASP1;KPNB1;ITGB1;HTT
prerank,cGMP metabolic process (GO:0046068),0.3823208271018995,0.8382504720722999,0.661144578313253,1.0,1.0,3/12,17.11%,NPR2;PDE9A;NPPC
prerank,negative regulation of centrosome duplication (GO:0010826),0.39282328632624597,0.838209232484894,0.6771653543307087,1.0,1.0,3/11,13.91%,KAT2B;BRCA1;MDM1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3614295469283828,0.8382047774232093,0.6556671449067432,1.0,1.0,1/17,1.04%,PRKCQ
prerank,protein transport (GO:0015031),0.261450672635464,0.8380013132317522,0.8580060422960725,1.0,1.0,95/332,24.29%,TMED6;ANK3;TBC1D10A;RAB38;LRP1;STEAP3;VAMP4;RAB14;ATP6V1B2;BLZF1;VPS33A;COPZ2;SNX15;VPS29;SCAMP2;SPTBN1;ARL1;RAB21;COPB2;RAB34;SEC31B;COPG2;RABL3;TBCK;MTTP;RCN3;TMED10;RAB3D;NEURL1B;SLC10A7;SNX6;VPS26B;ARL5C;NGFR;ARF4;NDC1;HDAC6;ARL6IP5;RAB22A;SYS1;RAB1A;USP6NL;RAB3A;HSP90B1;STX8;SYNDIG1;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;SEC23IP;UNC93B1;SGSM1;COPG1;STX1B;LRP2;TANGO6;CTTN;AP4M1;CD74;DENND10;ATP6V1C1;RAB7A;KIF3A;STX17;RAB3B;ARFIP1;CHMP1B;PPARG;TBC1D12;NAPG;ATP6V0E2;LAMP2;VMP1;TANGO2;TBC1D8B;TBC1D9B;KIF13A;ATP6V0E1;RAB18;FAM91A1;SNX4;RAB6A;UNC119B;TVP23A;SCFD2;STX2;ACD;STX7;ATP6V1G2;MIA3;ARRDC2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.32970043688375317,0.8379989052339083,0.6759628154050464,1.0,1.0,11/27,23.59%,SYT1;PPP3CB;SYT11;SYT12;RIMS1;DOC2B;SYT2;RIMS2;SYT13;SYT3;ARL8B
prerank,DNA replication (GO:0006260),0.27524685460435594,0.8378962010504578,0.7540279269602578,1.0,1.0,33/105,24.74%,POLE2;BAZ1A;TIPIN;REV3L;RPA3;BRCA1;POLE3;MCM4;UPF1;ING4;RPA2;ORC1;TOPBP1;POLG2;ATM;BLM;POLG;FAM111A;WRN;REV1;ORC4;DBF4;TOP1;WRNIP1;ORC2;TOP3A;RBMS1;RAD50;KAT7;BARD1;ORC3;ATR;RHNO1
prerank,sterol biosynthetic process (GO:0016126),0.31968991850470907,0.8370588471032371,0.706766917293233,1.0,1.0,4/33,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,dendrite morphogenesis (GO:0048813),0.31340464177963623,0.836863886692837,0.7175,1.0,1.0,8/35,12.17%,LRP4;PTEN;EPHB2;SDC2;CTNNA2;DOCK10;DIP2A;DVL1
prerank,base-excision repair (GO:0006284),0.3019909380500746,0.8366645608439782,0.6995249406175772,1.0,1.0,12/48,17.24%,MBD4;ERCC5;MPG;RPA3;MUTYH;XPA;HUWE1;NEIL1;RPA2;SMUG1;POLG;WRN
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.31363680827110835,-0.8364504407770298,0.688622754491018,0.9206177641795175,1.0,2/13,2.11%,ABCA1;CDH13
prerank,genitalia development (GO:0048806),0.3844804487758592,0.8364421863713888,0.6818873668188736,1.0,1.0,4/12,16.71%,WNT5A;PTPN11;PKD1;DNAJC19
prerank,histone H3-K9 demethylation (GO:0033169),-0.33425306985563824,-0.8361897850738461,0.6911764705882353,0.9199913601797376,1.0,5/11,19.85%,KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.26940963838339527,-0.8361622523774527,0.6946308724832215,0.9188402336455439,1.0,9/20,29.16%,PSMG2;PSMG1;HSP90AA1;HSP90AB1;PSMG3;CLU;HOPX;PFDN6;PTGES3L
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.27597202780514724,-0.8360612489536219,0.6934865900383141,0.9178576972945691,1.0,4/21,10.70%,ADCY9;NPR1;ADCY4;GUCY1B1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.37855603711494634,0.8356612210384783,0.6646616541353384,1.0,1.0,2/13,8.26%,AP1G1;GAB2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3220760751153849,0.8354741706404119,0.7054263565891473,1.0,1.0,4/31,7.57%,PTEN;CDKN2B;JADE1;CDK6
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.19529739576252794,-0.835122311863913,0.8823529411764706,0.9185547673459795,1.0,22/84,22.29%,DAPK1;IGF1;SAMD4A;ROCK1;YBX1;CAPRIN1;IGFBP5;CNOT1;RACK1;EIF4A3;BTG2;ORMDL3;SPHK1;FXR2;CNOT9;IGF2BP3;APOE;ABCA7;CHRNA7;PCIF1;CLU;ORMDL1
prerank,regulation of protein metabolic process (GO:0051246),-0.22394094326639932,-0.8346909914841206,0.8314606741573034,0.918313469352045,1.0,17/44,24.54%,ROCK2;MAP2K5;MTPN;KLF2;ACE;APP;KLF4;CENATAC;ODC1;TMEM9;APOE;HSP90AB1;ABCA7;CHRNA7;PLAUR;MAPK8;ZDHHC2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22857093861660707,-0.834414658903463,0.7621621621621621,0.9176624913402908,1.0,9/41,12.51%,SMAD7;BMP4;ENG;TPM1;FGFR2;JAG1;GSK3A;PROX1;TGFB2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.24116170403765022,-0.8343754589618188,0.7407407407407407,0.9165647261036522,1.0,14/35,22.58%,NUAK1;PTPA;PPP1R15B;GSK3B;PDGFRB;PPP1R11;ITGA1;CD300A;HSP90AB1;MASTL;CSNK2B;PPP1R2;BOD1;STYXL1
prerank,carbohydrate transport (GO:0008643),0.40314854714120846,0.8343614265167605,0.65284178187404,1.0,1.0,2/11,10.56%,SLC50A1;SLC2A2
prerank,regulation of inclusion body assembly (GO:0090083),-0.3378115876666804,-0.8342854847225865,0.6994047619047619,0.9155584938058974,1.0,1/11,0.33%,SNCAIP
prerank,reverse cholesterol transport (GO:0043691),-0.3065959714121016,-0.833961116199306,0.6578171091445427,0.9150550253232369,1.0,4/13,22.11%,ABCA1;ABCG1;APOE;CLU
prerank,regulation of chromosome organization (GO:0033044),0.34098861376541084,0.833202636460829,0.7050561797752809,1.0,1.0,6/22,17.73%,MYC;SETMAR;UPF1;SMG6;TERF2IP;CENPV
prerank,positive regulation of growth (GO:0045927),0.28597942038211077,0.8330055683900394,0.7370892018779343,1.0,1.0,13/64,18.03%,BCL2;ERBB2;EGFR;PLCB1;DERL2;NCBP1;EIF4G1;EXOSC2;AKAP6;BRAT1;KLHL22;HYAL1;RPTOR
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.32604788348185865,0.8325179149997647,0.6918158567774936,1.0,1.0,4/29,9.43%,SLC27A1;ZBTB20;MLXIPL;ELOVL5
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.30293357792979975,0.8323195436860864,0.7129186602870813,1.0,1.0,10/49,16.25%,PYCARD;BCL2;EIF2AK3;URI1;BMF;HERPUD1;RTKN2;TP53;BCL2L11;NDUFA13
prerank,carboxylic acid metabolic process (GO:0019752),0.3181339718688101,0.8323068199618392,0.6961394769613948,1.0,1.0,3/33,7.77%,CYP2S1;DAO;CSGALNACT1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.37734734280907756,0.8320431958185612,0.6923076923076923,1.0,1.0,2/13,5.19%,NUDT15;ENTPD2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3192480831811505,0.8320058315099343,0.6982323232323232,1.0,1.0,2/33,2.66%,PRKCA;FADD
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.27682157725888523,-0.8315997530010292,0.7269372693726938,0.9184136323275865,1.0,3/18,5.73%,NUP93;DDX19B;DDX19A
prerank,axon extension (GO:0048675),0.33439103503402084,0.8315639147297175,0.6868279569892473,1.0,1.0,7/23,14.94%,MAP1B;SEMA3A;AUTS2;PPP3CB;SPG11;NRP2;CYFIP1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.3913167924818353,0.8313568516341238,0.669710806697108,1.0,1.0,2/11,5.52%,CD34;WNT5A
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.34639845754126974,-0.8310543541647105,0.6684931506849315,0.9183354400790192,1.0,6/10,31.84%,RIOK3;UFD1;GPATCH3;RNF125;TKFC;TSPAN6
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3621629471025609,0.8307947049851699,0.6873278236914601,1.0,1.0,3/16,14.50%,PYGL;PHKB;CALM1
prerank,regulation of chromatin binding (GO:0035561),0.40255436849253123,0.8306399542519214,0.679160419790105,1.0,1.0,1/10,1.37%,DDX11
prerank,acidic amino acid transport (GO:0015800),0.35305857252157813,0.8303520077701076,0.6810966810966811,1.0,1.0,4/17,12.94%,SLC1A3;LRRC8D;ARL6IP5;PRAF2
prerank,negative regulation of bone mineralization (GO:0030502),-0.31293312530194667,-0.8302116381533071,0.637223974763407,0.9188183603964919,1.0,8/13,40.39%,SRGN;ENPP1;PTK2B;RFLNA;GREM1;ECM1;AHSG;RFLNB
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.29794882451495536,0.82984189586065,0.7231503579952268,1.0,1.0,15/52,21.69%,BCL2;FBXW7;YWHAZ;VPS11;HUWE1;UBE2J2;PPP3CC;TP53;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3
prerank,histone deubiquitination (GO:0016578),-0.28175425301095003,-0.8295360784057917,0.7132352941176471,0.9189417507590218,1.0,6/18,28.16%,USP7;USP3;USP15;KAT2A;TAF10;UIMC1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3355639733578805,0.8295160329186726,0.692722371967655,1.0,1.0,12/23,24.26%,DYNC1I1;KIF5C;CCDC186;DYNC1I2;MAP6D1;TUBA1A;HOOK2;MAP6;CCDC88A;HOOK1;HOOK3;TUBA1B
prerank,histone H4 deacetylation (GO:0070933),-0.3470707376354561,-0.8293234766222457,0.7046783625730995,0.9182099782338757,1.0,4/10,22.11%,HDAC8;HDAC4;HDAC3;SMARCAD1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.28906948363674,-0.8293162930205655,0.7181208053691275,0.9170588568486626,1.0,7/17,18.89%,PTPA;PPP1R15B;PDGFRB;ITGA1;PTPRC;CD300A;HSP90AB1
prerank,modulation by symbiont of host process (GO:0044003),-0.34813363130586655,-0.8292705318816731,0.6551724137931034,0.9159885596806152,1.0,4/10,25.17%,PGK1;ENO1;MRC1;UBA52
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.29015912502322694,-0.8291615437079726,0.745819397993311,0.9150256571081395,1.0,3/18,7.14%,ACSL1;ELOVL7;ACSL5
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.33066630430794774,0.827907520193838,0.6784741144414169,1.0,1.0,7/24,15.54%,MAP4K4;VEGFA;TSC1;PIK3R1;PTPRJ;MYOC;ABL1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3494943493180992,0.8278672912004715,0.7033557046979866,1.0,1.0,9/20,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,positive regulation of glycolytic process (GO:0045821),0.3494943493180992,0.8278672912004715,0.7033557046979866,1.0,1.0,9/20,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3576849553168651,0.8277892074737266,0.6758720930232558,1.0,1.0,5/15,20.38%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36
prerank,positive regulation of chemokine production (GO:0032722),0.29987740620087006,0.827599656718615,0.7142857142857143,1.0,1.0,7/44,19.03%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.29600406094136006,0.8273532620990668,0.7137724550898203,1.0,1.0,11/48,16.73%,PRDM16;RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;PNPT1;AAAS
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3108256135856306,-0.8273179779884383,0.6973293768545994,0.9164118086293843,1.0,3/12,16.88%,IGF1;CHERP;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3108256135856306,-0.8273179779884383,0.6973293768545994,0.9164118086293843,1.0,3/12,16.88%,IGF1;CHERP;PTBP1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3288053412562847,0.8272057450679615,0.7169559412550067,1.0,1.0,2/26,1.60%,LUM;ST3GAL4
prerank,cytosolic calcium ion transport (GO:0060401),0.32196444494342596,0.8271783588598621,0.6973684210526315,1.0,1.0,6/28,12.92%,CACNA2D1;ATP2B3;JPH3;SLC8A2;SLC25A23;ATP2B1
prerank,cellular response to alkaloid (GO:0071312),0.34933318589486173,0.8271364426981528,0.6814404432132964,1.0,1.0,5/17,19.09%,CASP6;BLM;SPIDR;CASP7;RYR3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3611859069755253,0.8269780408611398,0.6794326241134752,1.0,1.0,4/17,15.53%,BCL2;SOD2;GGCT;FZD9
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.3785929787973267,0.8268728504023553,0.682370820668693,1.0,1.0,3/12,14.88%,KLF15;MAGI2;IQGAP1
prerank,intracellular protein transport (GO:0006886),0.2576059605020458,0.8263800249046466,0.873991935483871,1.0,1.0,75/304,21.17%,TMED6;CCHCR1;TBC1D10A;XPO1;RAB38;C2CD5;RAB14;TGFB1;VPS33A;COPZ2;SNX15;VPS29;NLGN1;NUP155;ARL1;RAB21;COPB2;SEC31B;FAM53B;RABL3;TBCK;TMED10;SNX6;COX18;VPS26B;ARL5C;NGFR;AKAP6;ARF4;IPO9;HDAC6;RAB22A;PRICKLE1;VPS36;RAB1A;KATNB1;USP6NL;KPNB1;STX8;SYNDIG1;IPO13;NXT1;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;PKD1;SEC23IP;UNC93B1;SGSM1;EIF4ENIF1;STX1B;POM121;CTTN;AP4M1;SURF4;CD74;TRAK2;RAB7A;TNPO3;STX17;ARFIP1;IPO5;CSE1L;STAT3;TBC1D12;PHB2;NAPG;LAMP2;HEATR3;TBC1D8B;TBC1D9B
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.3289692797061703,0.8262096845102319,0.6916890080428955,1.0,1.0,3/23,12.73%,AP1G1;CADM1;NECTIN2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.27556945903404056,0.8260499133095753,0.7522222222222222,1.0,1.0,17/86,16.91%,CCL11;PYCARD;PSEN1;PAK1;BAIAP2;LIMK1;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;NCK1;MET;CDC42EP1;NAV3;CTTN
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2177494589603462,-0.8260444560153947,0.7894736842105263,0.9177603821803141,1.0,25/54,27.61%,NSA2;RPL24;NPM1;NVL;RPL5;RPL3;MAK16;MRPL20;NOP53;LAS1L;RPL11;SURF6;RPL7A;RPL35A;RPL26;PES1;RSL24D1;NLE1;SNU13;PPAN;NOC2L;RPF2;RPL6;RPF1;PAK1IP1
prerank,cellular response to hexose stimulus (GO:0071331),0.3341414738074486,0.826030967076561,0.6772908366533864,1.0,1.0,8/23,21.94%,ZBTB20;TRA2B;PDK3;PRKACA;PAX2;PCK2;ADCY8;PRKAA1
prerank,fatty acid elongation (GO:0030497),-0.3075236066956459,-0.8259343216340643,0.6949685534591195,0.9168057322110685,1.0,2/13,3.24%,ELOVL7;HACD4
prerank,lymphocyte proliferation (GO:0046651),0.33093425319377784,0.8254473539383679,0.6845827439886846,1.0,1.0,7/22,25.16%,BCL2;PPP3CB;HELLS;MS4A1;HSPD1;CR2;LMBR1L
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3344673353649714,0.8251945996021675,0.6898395721925134,1.0,1.0,3/23,10.17%,CRLF3;CYP1B1;ERBB4
prerank,regulation of catabolic process (GO:0009894),0.3557512370297199,0.8250245893100325,0.6842105263157895,1.0,1.0,6/18,21.62%,FAP;NEDD4L;ITGB1;MDM2;FURIN;RARRES2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2756840066399792,0.824704555922281,0.7613259668508288,1.0,1.0,16/86,16.29%,BMP5;SULF1;CDKN2B;ACVR1;TGFB1;SOX11;GDF9;FBXL15;MEN1;BMP7;BMPR1A;CITED2;ZEB2;UBE2O;TGFB3;RNF111
prerank,inositol phosphate catabolic process (GO:0071545),0.376974781266822,0.8246800927266971,0.6972049689440993,1.0,1.0,4/12,23.62%,PTEN;NUDT3;INPP5J;INPP5B
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2816610217215862,0.8246779515075711,0.767260579064588,1.0,1.0,16/85,21.86%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;MAGI2;PRICKLE1;DVL1;PSMD2;PSMC1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,negative regulation of transmembrane transport (GO:0034763),0.3966258944897498,0.8243663014448447,0.6828528072837633,1.0,1.0,1/10,1.98%,IRS2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3876860963533421,0.8241871181951449,0.6828908554572272,1.0,1.0,7/11,27.82%,STAT3;ZFP36;LIMD1;XPO5;FMR1;AJUBA;PUM2
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3122673699471927,0.8240770445307463,0.6972010178117048,1.0,1.0,10/35,18.85%,SEMA3E;SEMA6C;SEMA3A;FLNA;FARP2;NRP2;SEMA6D;MET;SEMA4B;SEMA4D
prerank,endodermal cell differentiation (GO:0035987),0.31567274127381656,0.824037556912091,0.6935897435897436,1.0,1.0,4/31,9.87%,MMP2;COL4A2;MMP15;SETD2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3917562093240009,0.8239943268766172,0.6887096774193548,1.0,1.0,2/10,7.41%,LAPTM4B;GATA6
prerank,nucleotide metabolic process (GO:0009117),-0.26541955806783885,-0.8238190440715951,0.7489711934156379,0.9198471015078695,1.0,10/23,25.12%,RNASEH2B;NMNAT2;ME1;NMNAT1;GUK1;DCK;AK4;AK1;NME2;ENPP3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3197562920094995,0.8238048757634278,0.7155963302752294,1.0,1.0,7/30,16.10%,CACNA2D1;ANK2;SCN5A;FGF12;NEDD4L;PKP2;KCNH2
prerank,sensory perception of light stimulus (GO:0050953),0.2736059781635888,0.8237603652503379,0.7655398037077427,1.0,1.0,15/87,20.71%,EFEMP1;CRYBG3;PCDH15;RDH10;DHRS3;COL18A1;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;ATXN7;RGS16;COL11A1
prerank,cellular response to radiation (GO:0071478),0.3056708175290526,0.8237443026069591,0.7001223990208079,1.0,1.0,7/40,15.98%,RHO;NSMCE3;MAPK14;GPR88;BLM;TP53;SPIDR
prerank,cellular response to unfolded protein (GO:0034620),0.3271029359161993,0.823334337653245,0.7208387942332897,1.0,1.0,7/26,21.21%,PRKN;PACRG;PTPN1;TM7SF3;HSPA9;HSPD1;RHBDD1
prerank,autophagy of peroxisome (GO:0030242),0.38407030225410765,0.8231354371090601,0.6807228915662651,1.0,1.0,3/12,18.07%,ACBD5;ATM;NBR1
prerank,regulation of vasoconstriction (GO:0019229),0.32216162650769636,0.8228463429053863,0.6982872200263505,1.0,1.0,3/27,12.92%,CHRM3;KCNMB2;ATP2B1
prerank,establishment of protein localization to organelle (GO:0072594),0.28097059157350274,0.8226996921869832,0.727683615819209,1.0,1.0,20/72,21.10%,NUP155;LAMP5;FAM53B;NEURL1B;IPO9;TSPAN17;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;POM121;TNPO3;HK2;IPO5;CSE1L;STAT3;PHB2;LAMP2;HEATR3
prerank,primary alcohol metabolic process (GO:0034308),-0.2576601358780182,-0.8226884373515241,0.773109243697479,0.9208408959422341,1.0,3/25,8.09%,IGF1;RBP4;ALDH3A2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.319461593715196,0.8225824867814086,0.7247706422018348,1.0,1.0,8/28,16.02%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;CKAP5;MET;NAV3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.32966035422529705,0.8224430763047351,0.7015915119363395,1.0,1.0,5/24,12.11%,FBXW7;PRNP;NF1;CDK5R1;GRN
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3321847141468873,0.8219998731842396,0.716931216931217,1.0,1.0,6/23,18.36%,TGFB1;SOX11;DKK3;BCL9;NREP;EID2
prerank,fatty acid metabolic process (GO:0006631),0.27041311513261324,0.8216548075847278,0.781414994720169,1.0,1.0,19/115,18.04%,CEL;ACACA;THEM4;SLC27A4;OXSM;ACBD5;ACOT11;ACOX1;ACLY;FASN;ACSF2;ALOX5AP;PNPLA8;ACAD9;LIPC;ACSL3;ABCD2;ACSL6;CRAT
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2742988383690945,-0.8213625615077298,0.7275985663082437,0.9222079764210858,1.0,7/19,30.00%,TLR4;TIRAP;NMI;PIK3AP1;NR1H4;ITGB2;ITGAM
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.29586425584231935,-0.8213431319782883,0.7151702786377709,0.9210830868995853,1.0,1/15,0.23%,OSBPL8
prerank,UV-damage excision repair (GO:0070914),0.38419110654234967,0.82111724565237,0.674591381872214,1.0,1.0,5/12,22.04%,DDB2;XPA;DDB1;CUL4B;ACTR5
prerank,ceramide catabolic process (GO:0046514),0.3659548716754709,0.8210869936693878,0.6737891737891738,1.0,1.0,2/14,6.02%,NAGA;GM2A
prerank,neurotransmitter secretion (GO:0007269),0.2939227388246293,0.8209275078319606,0.7454545454545455,1.0,1.0,8/44,13.88%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,microtubule depolymerization (GO:0007019),0.34883852461897247,0.8204894246568728,0.6976401179941003,1.0,1.0,4/17,13.07%,KIF19;STMN4;KATNB1;CKAP5
prerank,regulation of chromatin organization (GO:1902275),-0.3054325544886375,-0.8203659369817915,0.6993670886075949,0.9217862695246344,1.0,3/14,5.00%,MLLT3;PARG;IGF2
prerank,nucleosome assembly (GO:0006334),0.3157426711721284,0.8197837291442803,0.712258064516129,1.0,1.0,5/31,13.34%,SOX9;HAT1;ATRX;ASF1A;RBBP4
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.31269533886291273,0.8197445123179538,0.7345360824742269,1.0,1.0,7/31,15.90%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;POLR2G;NT5C3B
prerank,microtubule bundle formation (GO:0001578),0.2975272720664733,0.8195560951794238,0.7233250620347395,1.0,1.0,11/42,19.59%,RSPH1;NAV1;CFAP46;CAPN6;CFAP74;CLASP1;AAAS;FOXJ1;RSPH9;DCX;CCDC66
prerank,translational elongation (GO:0006414),0.2711279643428737,0.8195516217308011,0.7736051502145923,1.0,1.0,26/101,22.43%,MRPL47;MRPS18A;EEF2K;TUFM;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,regulation of establishment of planar polarity (GO:0090175),0.27730282843054516,0.8194960373701191,0.7819383259911894,1.0,1.0,16/88,21.86%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;PRICKLE1;DVL1;PSMD2;PSMC1;DACT1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3298534941726412,0.8193237258262985,0.6870748299319728,1.0,1.0,4/22,12.69%,HPCA;PDE4B;CACNB4;DRD2
prerank,positive regulation of intracellular transport (GO:0032388),0.30668314330693036,0.8191366091241405,0.7254658385093168,1.0,1.0,10/38,23.73%,KIF20B;PGAP1;PCM1;TBC1D20;EHD2;PLA2G4E;PCNT;DYNC1H1;EIPR1;STX18
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.28129792385278896,0.8188631061061018,0.7379077615298087,1.0,1.0,8/66,9.48%,SULF1;SOX9;CDKN2B;FBXW7;TGFB1;NF1;CDK6;SPARC
prerank,positive regulation of macrophage activation (GO:0043032),0.35040559083168826,0.8186547384180413,0.7117903930131004,1.0,1.0,6/17,21.39%,WNT5A;TTBK1;IL33;LBP;HSPD1;TNIP2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.29747157407073493,-0.8180680251703738,0.7207792207792207,0.9249546362748418,1.0,6/16,20.00%,SIK3;FLCN;LARS1;PIP4P1;GPR137;RRAGB
prerank,postreplication repair (GO:0006301),-0.22288012889462872,-0.8174067700580592,0.7745664739884393,0.9250819943687618,1.0,23/45,31.35%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;UBE2A;PCNA;UBE2N;RAD18;POLK;ISG15;FAAP20;NSMCE1;RFC3;UBA52;USP43;POLD2;VCP;PCLAF;MSH2;POLD4;POLD1
prerank,steroid biosynthetic process (GO:0006694),-0.2071923647656724,-0.8173675306166613,0.8790322580645161,0.9240120843011519,1.0,19/56,29.42%,PRKAG2;OSBP;LBR;OSBPL9;OSBPL2;INSIG2;DHRS11;OSBPL7;OSBPL3;FDXR;EBP;SLC27A2;OSBPL6;STAR;TM7SF2;HSD11B1;SRD5A1;HSD17B10;CH25H
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.26081934594725065,0.8173019182593318,0.8181818181818182,1.0,1.0,18/152,14.52%,CXCL10;GNA14;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;PTH2R;LGR5;TSHR;ADGRB3;GPR37;S1PR3;ADGRL3;GLP2R;GNAI1;P2RY12;ADGRG2
prerank,regulation of RNA splicing (GO:0043484),0.2770548842416089,0.817215923077977,0.7555555555555555,1.0,1.0,17/69,22.97%,PRX;QKI;TRA2B;ZNF326;SON;KHDRBS3;PIK3R1;YTHDC1;SF1;FUS;POLR2A;HNRNPH2;HNRNPL;SRSF3;AHNAK;PTBP2;AFF2
prerank,N-glycan processing (GO:0006491),0.34539412618131554,0.8170440843595894,0.7069701280227596,1.0,1.0,6/18,18.24%,GNPTAB;PRKCSH;MAN2A2;ST8SIA1;GANC;MAN1A2
prerank,protein polyubiquitination (GO:0000209),0.25640746441017354,0.8166780518667296,0.8734939759036144,1.0,1.0,90/297,26.04%,UBE2T;BCL2;CBFB;FBXW9;PRKN;UBE2E2;HACE1;FBXW7;RNF6;SPOP;FBXO7;FBXO38;ZNRF2;FBXL15;DDB2;FBXO32;TRIM2;PELI1;BRCA1;UBE2K;HECTD2;FBXL16;PSMB7;FBXO27;LNPEP;CUL3;HUWE1;ANAPC7;THOP1;UBE2J2;FBXO17;ANAPC2;MYLIP;AKTIP;DDA1;NEDD4L;PSMD2;UBB;AREL1;PSMC1;UBE2O;RNF19A;UBOX5;CDC23;FBXL4;UBE2Q1;PSMB2;RC3H1;RNF167;FBXO31;FBXO22;MDM2;ANKRD39;RNF4;PSMD9;TAF1;FBXO11;PSME4;FBXL12;UBE2L3;CDC27;UBE2G1;UBE2E1;NPEPPS;PSMA8;ANAPC4;MKRN1;RNF114;UBE2D3;TTC3;FBXO44;TPP2;ANAPC5;SIAH1;RNF187;UBE3C;CDC16;BARD1;TRIM14;WSB1;ANAPC13;UBE2Q2;FBXW8;CUL1;PELI2;RNF20;PSMD8;PSMD13;TOPORS;UBE2R2
prerank,cellular response to virus (GO:0098586),0.31512781109180216,0.8165770633869435,0.699614890885751,1.0,1.0,4/30,10.78%,CXCL10;GBF1;HIF1A;MAPK14
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2740468848831779,0.8164472189147509,0.7653061224489796,1.0,1.0,7/76,8.10%,CCL11;NTRK3;PYCARD;GPSM2;BAIAP2;LIMK1;BIN1
prerank,cellular metal ion homeostasis (GO:0006875),0.26491629668467304,0.8161595511399696,0.7902702702702703,1.0,1.0,20/102,18.10%,CCL11;ANK2;LETM1;ATP2B3;MT3;CCR2;SLC12A2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1;NEDD4L;CCL14;KCNMA1;SLC9A1;SLC24A4;SLC24A2
prerank,positive regulation of angiogenesis (GO:0045766),0.26934319839417076,0.8157963673721271,0.7859391395592865,1.0,1.0,27/108,17.94%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;HSPB6;WNT5A;CYP1B1;GATA6;BRCA1;HIF1A;SP1;SIRT6;MYDGF;GRN;SMOC2;PDCL3;BMPER;ITGB1;JUP;RUNX1;GAB1;HYAL1;APLNR;MDK;EMC10
prerank,actin filament network formation (GO:0051639),0.381046224580179,0.8157072666272646,0.6869158878504673,1.0,1.0,2/11,14.10%,SPIRE1;COBL
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.39624534271174516,0.8156308089595952,0.7072784810126582,1.0,1.0,4/10,18.76%,GPR37;NFE2L2;RIPK1;PARK7
prerank,endothelial cell proliferation (GO:0001935),0.3437504138602329,0.815284346138577,0.6736401673640168,1.0,1.0,2/17,2.85%,CD34;PRKX
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.33237159786681164,0.8150263783864097,0.7098092643051771,1.0,1.0,4/24,12.77%,CRLF3;CYP1B1;ERBB4;PRLR
prerank,positive regulation of protein processing (GO:0010954),-0.2725380753935013,-0.8150181649723044,0.7574750830564784,0.9273328262160891,1.0,2/19,1.47%,CCBE1;MYH9
prerank,negative regulation of TORC1 signaling (GO:1904262),0.36138891470218215,0.8145176839202422,0.6970149253731344,1.0,1.0,6/13,24.79%,CASTOR2;ATM;SPAAR;DEPDC5;SESN1;ITFG2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3168120031152633,-0.8138624857205805,0.6833333333333333,0.9283365866334131,1.0,4/11,15.30%,BMP4;JAG1;TGFB2;HEY2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2910426404315162,0.8137931273817856,0.7377622377622378,1.0,1.0,3/51,2.11%,SOSTDC1;HTRA3;CHRDL1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.39237642202134393,0.8136318668791446,0.7045101088646968,1.0,1.0,3/10,16.67%,MLXIPL;ELOVL5;ABCD2
prerank,transferrin transport (GO:0033572),-0.2399181510238818,-0.8135430452575858,0.7990430622009569,0.9277802634386739,1.0,9/33,15.42%,RAB11B;ATP6V0C;ATP6V0D1;MCOLN1;TFRC;DNM2;ATP6V0A4;ATP6AP1;ATP6V0A2
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2680588928477742,-0.8134185950664928,0.75,0.9268537406987285,1.0,10/22,26.32%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,glycoprotein metabolic process (GO:0009100),0.29196185765246513,0.8130040019688276,0.7288528389339514,1.0,1.0,9/53,11.73%,ST3GAL4;PRKCSH;PCSK6;MAN2A2;ST6GALNAC6;FBXO27;HIF1A;ST8SIA1;FBXO17
prerank,lipoprotein localization (GO:0044872),0.38107095562418913,0.812733995050053,0.6976401179941003,1.0,1.0,6/11,25.41%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3011891221845557,0.8127197797745223,0.733890214797136,1.0,1.0,5/43,7.90%,MMP2;FGF2;NOX1;ADAMTS1;IL18
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.271792436790562,0.8125231425361503,0.8002171552660152,1.0,1.0,20/93,18.73%,PYCARD;VEGFA;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;PRMT1;ARL6IP5;TAOK3;MAP3K4;RASSF2;KLHDC10;RELL2;RIPK1;EMC10;MAP3K11;MID1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3186136243975563,0.8122348745161017,0.7244094488188977,1.0,1.0,10/30,22.66%,WAC;UCHL5;BAG5;TLK2;TAF9;USP14;N4BP1;PARK7;SGTA;CAMLG
prerank,negative regulation of viral release from host cell (GO:1902187),-0.30648281311502246,-0.8121188608386173,0.7476635514018691,0.9279609873949157,1.0,4/13,17.26%,CHMP3;TRIM5;PML;TRIM21
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3031975215337989,0.8111105742079867,0.7314356435643564,1.0,1.0,12/37,22.66%,WAC;UCHL5;BAG5;TLK2;TAF9;PDCL3;N4BP1;PARK7;TAF1;CSNK2A2;SGTA;CAMLG
prerank,vitamin D metabolic process (GO:0042359),-0.30601653594609457,-0.8110516738556023,0.7427745664739884,0.9287598331165561,1.0,3/13,18.62%,CUBN;LGMN;CYP2R1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2700597483297799,0.8109610636997518,0.7731843575418994,1.0,1.0,16/80,16.98%,PYCARD;MYC;DPEP1;NGF;VEGFA;MT3;ACVR1C;CARD9;NGFR;ARL6IP5;DNAJB6;MALT1;SNCA;XIAP;NDUFA13;PAX2
prerank,positive regulation of actin nucleation (GO:0051127),0.37670909382516876,0.8104401084671735,0.6973478939157566,1.0,1.0,5/11,19.02%,GSN;BRK1;WASF1;CYFIP1;NCKAP1
prerank,catecholamine biosynthetic process (GO:0042423),0.3702110297982749,0.809523679943545,0.6879875195007801,1.0,1.0,3/11,13.88%,DAO;GATA3;SNCA
prerank,fatty acid biosynthetic process (GO:0006633),0.2787856813201704,0.809352035686699,0.7627314814814815,1.0,1.0,7/63,9.43%,ACACA;OXSM;LTA4H;SCD5;ELOVL6;ACLY;ELOVL5
prerank,negative regulation of telomere maintenance (GO:0032205),0.35071417866684057,0.8093046889700631,0.7122507122507122,1.0,1.0,7/15,25.07%,ERCC4;RTEL1;ATM;SMG6;TERF2IP;RAD50;SLX4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27679671984591525,0.8090384694124234,0.7993311036789298,1.0,1.0,30/78,29.29%,PTEN;CDKN2B;EGFR;CCNJ;MEN1;PKMYT1;CDK5R1;PKD1;CDK5R2;BLM;CCND2;MAPRE3;IPO5;BCCIP;PKD2;NR2F2;CCNY;CCNT2;CCNH;CDC37;APC;CDK5RAP3;CDKN1A;CCND3;CCNI;GTPBP4;CCNE1;CDKN1C;CDKN2D;CDKN1B
prerank,regulation of protein processing (GO:0070613),0.33446232513103547,0.8090257172705909,0.70042194092827,1.0,1.0,6/21,21.21%,PRNP;SERPINE2;RUNX1;SNX12;NKD2;RHBDD1
prerank,protein targeting to membrane (GO:0006612),-0.1968023662263652,-0.8090093125286252,0.9150943396226415,0.9313013478647568,1.0,31/83,27.26%,ZDHHC14;ZDHHC3;PEX13;PRKCI;PARD3;VPS37C;PEX19;ALDH3A2;ZDHHC18;ZDHHC7;SRPRA;AQP11;SRP14;ZDHHC20;MYO1C;SSR2;PEX14;ZDHHC4;PEX26;MICALL1;TAOK2;PEX2;ATAD1;ICMT;SIL1;ZDHHC2;RTP4;GET3;SRP19;VPS37D;PEX16
prerank,positive regulation of insulin secretion (GO:0032024),-0.22937825324254957,-0.8082796020794357,0.8472222222222222,0.9314925650966684,1.0,10/36,19.65%,MYRIP;RBP4;ANO1;NLGN2;NNAT;AACS;LRRC8A;C2CD2L;GPER1;BAIAP3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3558714124110142,0.8081392723729866,0.7098214285714286,1.0,1.0,3/15,13.42%,TIPIN;ATF2;MDC1
prerank,purine nucleotide metabolic process (GO:0006163),-0.24810657987048657,-0.8078975925762074,0.7717842323651453,0.9309970959179663,1.0,10/24,22.68%,PRPSAP2;ITPA;XDH;GPX1;PRPS2;GUK1;GART;PRPS1;PRPS1L1;NT5C1A
prerank,melanosome localization (GO:0032400),0.3293628617312844,0.8078759122407321,0.719562243502052,1.0,1.0,8/21,25.46%,VPS33A;BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,positive regulation of receptor internalization (GO:0002092),0.3173966281485482,0.8076634059584578,0.7093333333333334,1.0,1.0,8/22,25.96%,VEGFA;SFRP4;MAGI2;SCYL2;CD63;ARRB2;FMR1;AHI1
prerank,response to X-ray (GO:0010165),0.3637523383810453,0.8076328651930328,0.724822695035461,1.0,1.0,6/14,29.33%,XRCC6;ATM;BLM;LIG4;XRCC4;NUCKS1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.35720723395518145,0.8074565050963569,0.7219020172910663,1.0,1.0,3/15,15.00%,FGF2;SMOC2;MET
prerank,synaptic vesicle cycle (GO:0099504),0.3131723388522484,0.8070719469760695,0.7411764705882353,1.0,1.0,6/30,13.88%,NLGN1;RIMS1;RAB3A;OTOF;SYNDIG1;SNCA
prerank,cardiolipin metabolic process (GO:0032048),0.36572035650900947,0.807071284436078,0.697289156626506,1.0,1.0,3/13,13.50%,SLC27A1;HADHA;PNPLA8
prerank,lipid droplet organization (GO:0034389),-0.25946145246323515,-0.8066908834912785,0.7817460317460317,0.932060753691237,1.0,9/22,26.24%,ZFYVE1;CDS1;PPIA;BSCL2;AUP1;PNPLA3;FAF2;PLA2G4C;FITM2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.21258173912174563,-0.8066020070701749,0.8490566037735849,0.931065470265946,1.0,14/48,19.64%,ADCY9;SLC26A2;AMPD3;NPR1;PANK1;PANK2;ADCY4;GUCY1B1;PANK3;PPCDC;PANK4;ADCY3;IMPDH1;IMPDH2
prerank,coenzyme A metabolic process (GO:0015936),-0.29451003907992934,-0.8065503475836427,0.7586206896551724,0.9300149753250972,1.0,6/14,22.43%,PANK1;PANK2;PANK3;PPCDC;PANK4;CROT
prerank,canonical Wnt signaling pathway (GO:0060070),0.2789026549606496,0.8064760447167602,0.7912946428571429,1.0,1.0,15/68,15.64%,PTEN;FRZB;WNT5A;FZD7;RARG;BCL9L;SFRP4;PPP1CA;BCL9;DVL1;CSNK1A1;GATA3;SCYL2;FZD9;CSNK1E
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3043145293806714,-0.806275019343352,0.7018072289156626,0.9293715563357458,1.0,1/12,0.34%,EPHA4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3318588609113522,0.8060970225626597,0.7038043478260869,1.0,1.0,3/19,16.67%,IRS2;MTLN;ABCD2
prerank,UV protection (GO:0009650),0.39568685571900397,0.8059221580493565,0.7101226993865031,1.0,1.0,4/10,19.97%,ERCC5;XPA;CAT;SCARA3
prerank,positive regulation of exocytosis (GO:0045921),0.30528255649223834,0.8058032372481381,0.7399497487437185,1.0,1.0,9/35,18.12%,SDC4;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;PDCD6IP;UNC13D;RAB7A
prerank,positive regulation of translational initiation (GO:0045948),-0.27108650486193886,-0.805786646029083,0.7518796992481203,0.9291391928055196,1.0,6/18,22.88%,YTHDF1;HABP4;RPS6KB1;RPS6KB2;KHDRBS1;POLR2D
prerank,dendrite self-avoidance (GO:0070593),0.34637601066837864,0.8053415902092318,0.723314606741573,1.0,1.0,4/16,10.12%,CNTN6;CNTN2;DSCAM;PALLD
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2555369331685168,-0.8053258404057543,0.7301587301587301,0.9288444796080018,1.0,12/24,31.35%,POLD3;XRCC1;RFC1;PCNA;LIG1;POLK;RFC3;UBA52;POLD2;POLE;POLD4;POLD1
prerank,protein-DNA complex assembly (GO:0065004),0.2648907405266469,0.8051583624082259,0.8029818956336529,1.0,1.0,25/116,20.75%,RAD23B;SOX9;GTF2H2;ERCC5;DDB2;RPA3;ATRX;XPA;PSMB7;MCM4;ASF1A;DDB1;RPA2;ORC1;PSMD2;UBB;PSMC1;PSMB2;CUL4B;CENPV;ORC4;PSMD9;PSME4;ORC2;PSMA8
prerank,endothelial cell migration (GO:0043542),0.30311734004804247,0.8048541154007565,0.7527950310559006,1.0,1.0,5/37,7.15%,FAP;PRKX;VEGFA;EGR3;CYP1B1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3570074295752561,0.8046413065625118,0.6920777279521674,1.0,1.0,2/13,9.10%,BPNT1;BPNT2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.2882492935658345,-0.8046048351321281,0.7161716171617162,0.9289685249283586,1.0,7/17,25.13%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,negative regulation of actin filament polymerization (GO:0030837),0.32444934697102024,0.8044488847764598,0.7174825174825175,1.0,1.0,3/22,6.02%,KANK4;GSN;SSH3
prerank,nucleotide catabolic process (GO:0009166),0.3538578554466366,0.8042906059575217,0.71671388101983,1.0,1.0,4/16,18.57%,NUDT15;NT5C2;NUDT3;NT5C
prerank,regulation of actin nucleation (GO:0051125),0.3685192235305476,0.8042005276120822,0.7111111111111111,1.0,1.0,3/12,18.99%,GSN;CORO1B;ARFIP1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2512444619033992,-0.8040724021450918,0.7872340425531915,0.9287934493191037,1.0,10/26,21.82%,MFHAS1;WDFY1;CYBA;TIRAP;FLOT1;CAV1;IFI35;NINJ1;NR1H3;RSAD2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3216277760061182,-0.8039910466730733,0.7335329341317365,0.927797033991396,1.0,6/11,33.95%,DCK;SLC19A3;SLC25A19;ENPP3;TPK1;DCTD
prerank,acylglycerol biosynthetic process (GO:0046463),-0.25535972618713565,-0.8036301546687858,0.7837837837837838,0.9272862522781553,1.0,3/23,6.03%,PLA2G4A;GPAM;LPIN2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3911209387134475,0.803080807027279,0.7071651090342679,1.0,1.0,6/10,22.75%,PTPN1;PRLR;STAT3;STAT5A;GHR;STAT6
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.29623423654041336,0.8030498298448593,0.741421568627451,1.0,1.0,11/38,20.09%,HAT1;ATRX;ASF1A;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.28645549288401445,0.8030408607266549,0.7561837455830389,1.0,1.0,18/50,26.36%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1
prerank,regulation of gene silencing by RNA (GO:0060966),0.28645549288401445,0.8030408607266549,0.7561837455830389,1.0,1.0,18/50,26.36%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.2563201679642935,0.8028022893601747,0.8452012383900929,1.0,1.0,33/163,21.48%,PRKCQ;PTPN22;BCL2;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;LAX1;VAV3;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;LAT2;PSMB2;EIF2B2;RC3H1;CHUK;MS4A1;PSMD9;PSME4;BCL10;CD38;PSMA8;NFKB1;PRKD2
prerank,response to acidic pH (GO:0010447),-0.3063388780824978,-0.8027534270964738,0.7239263803680982,0.9277419444136863,1.0,4/13,14.94%,RAB11B;GPR4;LGMN;CTSS
prerank,response to zinc ion (GO:0010043),0.3134897090899627,0.8024179559216219,0.7265725288831836,1.0,1.0,12/25,30.15%,MT3;SLC30A4;D2HGDH;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CRIP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3367810647436066,0.8020735283420481,0.7130681818181818,1.0,1.0,6/18,18.76%,POR;GDNF;EDN3;RFK;ABL1;PARK7
prerank,atrial septum development (GO:0003283),-0.2958601790437102,-0.801400956473518,0.744927536231884,0.9290302319803988,1.0,2/13,3.78%,NOTCH2;BMPR2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3083048511701635,0.8013453861571022,0.7357992073976222,1.0,1.0,6/28,19.29%,TGFB1;PSEN1;FLNA;PIK3R1;JUP;IPO5
prerank,synaptic vesicle localization (GO:0097479),0.3628074294875419,0.8010463775873693,0.7,1.0,1.0,4/13,13.45%,NLGN1;SPG11;KIF5C;SYNDIG1
prerank,regulation of mitotic nuclear division (GO:0007088),0.2782182906347853,0.8007091649342213,0.7731591448931117,1.0,1.0,9/55,11.59%,KIF20B;OBSL1;CDK13;BTC;AURKAIP1;RCC1;PKMYT1;BMP7;EDN3
prerank,negative regulation of nuclear division (GO:0051784),0.3766058134771457,0.8004426391829664,0.7206349206349206,1.0,1.0,3/11,17.87%,AURKAIP1;BMP7;FBXO5
prerank,defense response to virus (GO:0051607),0.26221699136944004,0.800430291416156,0.7967914438502673,1.0,1.0,10/100,10.48%,CXCL10;PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.269919372862652,0.8002702395226146,0.7798882681564245,1.0,1.0,10/75,11.41%,PYCARD;PTEN;IRAK3;NF1;PRKAR1B;MEN1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3153541557070315,-0.8001395898413537,0.7162534435261708,0.9301784152080347,1.0,4/11,19.84%,SMAD7;PTPRC;CEACAM1;HFE
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.32492889355977495,0.7999159002085096,0.738950276243094,1.0,1.0,7/24,21.75%,FGF2;HTR2C;ANXA6;DRD2;RYR3;PKD2;ERO1A
prerank,visual perception (GO:0007601),0.2672636501710095,0.7998455334841438,0.7993384785005513,1.0,1.0,15/84,20.71%,EFEMP1;CRYBG3;RDH10;DHRS3;COL18A1;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;CACNA2D4;ATXN7;RGS16;COL11A1
prerank,lipid modification (GO:0030258),0.2988714459551283,0.7998044754155985,0.7440699126092385,1.0,1.0,15/37,28.51%,MBOAT2;PLA2G7;DGKI;PLPP4;PLPPR4;PLPPR2;PLPPR1;PORCN;EPHX2;DGKA;DGKK;SGPP1;DGKD;DGKZ;DGKQ
prerank,ethanol metabolic process (GO:0006067),0.3617383656901414,0.7997958153345689,0.7237237237237237,1.0,1.0,2/12,7.11%,ACSS2;ACSS1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3567190796344848,0.7996754051350627,0.7203007518796992,1.0,1.0,5/12,26.38%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3567190796344848,0.7996754051350627,0.7203007518796992,1.0,1.0,5/12,26.38%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.28545060860264854,0.7993944310336442,0.7779083431257344,1.0,1.0,13/54,19.89%,PYCARD;PRKN;FADD;PTPN2;OTULIN;UBE2K;TAX1BP1;PYDC1;RIPK1;CHUK;CPNE1;SPPL2B;TRAIP
prerank,regulation of oxidoreductase activity (GO:0051341),-0.29767431236271513,-0.7992398804687715,0.7292307692307692,0.9305503756996079,1.0,5/13,16.87%,ABL2;ATP7A;ECSIT;OXA1L;SIRT4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3871301274007256,0.7991403019737875,0.7242472266244057,1.0,1.0,2/11,8.06%,PRKN;FYN
prerank,arachidonic acid metabolic process (GO:0019369),0.3010485071943119,0.7991172462566349,0.7251243781094527,1.0,1.0,3/35,7.30%,CYP2S1;CYP1B1;PTGES2
prerank,regulation of transferase activity (GO:0051338),0.33968037901294307,0.7989678852659461,0.7206946454413893,1.0,1.0,5/17,16.25%,BAG5;LDB2;PPP1R3F;ATM;SMG6
prerank,phosphate ion homeostasis (GO:0055062),0.37814717252413566,0.7987379645052409,0.7111459968602826,1.0,1.0,2/10,14.89%,SFRP4;XPR1
prerank,protein oxidation (GO:0018158),-0.32372071744907094,-0.7984347260932253,0.7320954907161804,0.9308375554847095,1.0,3/11,10.29%,LOXL1;LOX;TMX3
prerank,centromere complex assembly (GO:0034508),0.2980562918871167,0.7982802846042046,0.7565543071161048,1.0,1.0,12/36,22.38%,HELLS;POGZ;HJURP;OIP5;RBBP4;ITGB3BP;CENPV;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.260064729193651,-0.7982089684150949,0.7714285714285715,0.9301119544464991,1.0,7/22,17.86%,CACNA1C;ADGRV1;STIM1;CAP1;GNAI3;GRM3;EDNRB
prerank,negative regulation of cell death (GO:0060548),0.26854530393048054,0.7981334252439354,0.8060344827586207,1.0,1.0,15/88,14.38%,FGF2;CD34;PRKN;SOX11;MT3;BNIP3;ATG5;FYN;PACRG;EIF4G1;BMP7;TM7SF3;SNCA;NCK1;SRSF6
prerank,regulation of actin filament polymerization (GO:0030833),0.2698549921473544,0.7980432842936132,0.7754868270332188,1.0,1.0,8/69,8.10%,CCL11;PYCARD;KANK4;GBA2;RASA1;SSH3;BAIAP2;BIN1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3624866457749717,0.7973026598208266,0.7245508982035929,1.0,1.0,5/13,19.74%,ALG9;ALG1;ALG8;DPAGT1;ALG6
prerank,mitotic metaphase plate congression (GO:0007080),-0.20189956726601996,-0.7971908920301888,0.8757763975155279,0.9307269263124863,1.0,25/51,34.94%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;PINX1;VPS4B;PIBF1;CHMP7;BOD1;CHMP2B;EML4;DCTN2;CENPE;EML3;ZW10;KIFC1;NUP62;NDC80;KIF14;SPDL1;MAD1L1;CDCA8;CEP55
prerank,regulation of neuron projection arborization (GO:0150011),0.3452699849864407,0.7970234594699439,0.7149187592319055,1.0,1.0,5/15,12.17%,WNT5A;NTNG2;NTNG1;MYO9A;DVL1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3652489439962322,0.7969939382479798,0.7129770992366412,1.0,1.0,1/11,4.10%,CCL4
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.30337538468362524,0.7968762300833337,0.742749054224464,1.0,1.0,7/33,17.23%,PTEN;CDKN2B;JADE1;CDK6;NACC2;DACT1;CDC73
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.31819897478840486,0.7968550323899194,0.7432065217391305,1.0,1.0,7/24,15.16%,NUDT15;UCHL5;TMF1;PRKACA;PKD1;USP14;UBB
prerank,regulation of defense response (GO:0031347),0.26940001461440793,0.795652142009485,0.7929125138427464,1.0,1.0,8/76,6.81%,ADAMTS12;PTPN22;BST1;ELMOD2;CCR2;WNT5A;IL1RL2;UFL1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.38081479330167095,0.795195567096987,0.7087227414330218,1.0,1.0,3/10,16.76%,NAGK;GNE;GNPDA1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23363515161351142,-0.7946076263036936,0.8209606986899564,0.9340525587118769,1.0,12/33,24.69%,ETS1;ARNT;STAT5B;ACVR1B;PITHD1;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2;FES;ACVR2A
prerank,regulation of primary metabolic process (GO:0080090),0.2611596650984779,0.7945977119492361,0.8446088794926004,1.0,1.0,29/126,20.75%,IRS2;NQO1;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;PRKAB2;ELOVL6;FASN;PSMB7;CARM1;NCOA2;CHD9;SIN3B;TGS1;SP1;NCOR2;PSMD2;PSMC1;SREBF2;PSMB2;PSMD9;SC5D;PSME4;PPARG;CERS2;NR1D2;PSMA8
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3031898841348779,0.794515431722329,0.7440993788819876,1.0,1.0,5/36,10.17%,CRLF3;SOCS1;CYP1B1;NF2;ERBB4
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.31578176431466026,0.7944595245701117,0.7445945945945946,1.0,1.0,7/26,21.75%,FGF2;LETM1;HTR2C;DRD2;RYR3;PKD2;ERO1A
prerank,histone H3 deacetylation (GO:0070932),0.3470306653568105,0.7944368785987653,0.7088068181818182,1.0,1.0,4/15,13.12%,HDAC2;SFPQ;SIRT6;PER1
prerank,positive regulation of organelle assembly (GO:1902117),0.2890524232335186,0.7943770202559162,0.753309265944645,1.0,1.0,16/44,26.22%,GPSM2;RALB;SDC4;RAB3GAP2;PDCD6IP;FSCN1;HTT;CCDC88A;RAB3GAP1;CNOT6L;DYNC1H1;STX18;G3BP2;BBS4;ENTR1;TAPT1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2699608984911363,0.7938897448102397,0.7883720930232558,1.0,1.0,19/66,25.61%,CCT7;EIF2AK3;TGFB1;PSEN1;FLNA;PIK3R1;NGFR;WWTR1;JUP;MEPCE;PARK7;TESK1;IPO5;MCRS1;LIMK2;KAT7;MAVS;TCP1;CARD10
prerank,I-kappaB phosphorylation (GO:0007252),-0.3263371012363496,-0.793821609977072,0.713903743315508,0.9343085474193348,1.0,2/10,11.62%,TLR4;MAP3K7
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2797676051035528,-0.7932753577299974,0.7800687285223368,0.934105363997127,1.0,8/16,28.93%,RIF1;HELB;POLQ;KLHL15;FANCB;MAD2L2;RMI2;PARPBP
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3295565001328518,0.7928117180811574,0.710926694329184,1.0,1.0,8/20,28.91%,KPNB1;SREBF2;MBTPS1;SEC14L2;EPHX2;LDLRAP1;DGKQ;MBTPS2
prerank,visual system development (GO:0150063),-0.22187818704991852,-0.7927080298392806,0.8298969072164949,0.9339161007713964,1.0,9/37,19.43%,SMOC1;RBP4;SIPA1L3;PBX3;TGFB2;PBX4;SMG9;PBX2;C1QA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3790489787804282,0.7925582474394323,0.7080062794348508,1.0,1.0,6/10,28.81%,NCK1;CITED2;JUN;HSPA1A;HIF1AN;SIRT2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.25625502898358454,0.792543852571105,0.825668449197861,1.0,1.0,12/110,12.69%,CXCL10;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;LGR5;TSHR;ADGRB3;S1PR3;ADGRL3;DRD2
prerank,calcium ion homeostasis (GO:0055074),0.2576777471957496,0.7924807427706597,0.8034934497816594,1.0,1.0,14/95,15.17%,CCL11;ANK2;TMTC2;ATP2B3;CCR2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1;SNCA;CCL14
prerank,regulation of translation (GO:0006417),0.250338633367191,0.7918785725886976,0.8572884811416922,1.0,1.0,58/173,26.79%,ERBB2;EPRS1;EIF2AK3;UPF3A;PLD1;ETF1;NIBAN1;ATXN2;METTL3;TSC1;EIF1B;EIF3C;CPEB3;EIF6;NSUN5;PASK;GRM5;NCBP1;EIF4G1;UPF1;MTG1;DDX25;RBM4B;PUS7;EIF1;CYFIP1;EIF4ENIF1;PRR16;RPS27L;EIF4A2;EIF2B2;TRAP1;GIGYF2;SYNCRIP;CSDE1;PYM1;RPS6KA3;EIF4G3;DDX6;METAP1;VIM;RIDA;GLE1;BCL3;PAIP2B;ALKBH1;MTOR;FMR1;PRKDC;SOX4;CIRBP;EIF2AK2;RBM4;YTHDF3;DAPK3;KLHL25;DDX1;MTG2
prerank,negative regulation of gene expression (GO:0010629),0.2489028265403785,0.7916648735102497,0.9185929648241206,1.0,1.0,49/302,16.92%,FFAR4;CLDN19;CREB3L1;FGF2;RBMS3;PTPN22;CD34;KAT2B;PRKN;EPRS1;VEGFA;EIF2AK3;RPS6KA4;FBXW7;TGFB1;PSEN1;DXO;SOX11;ITGB8;EED;METTL3;TSC1;SHQ1;CPEB3;SMO;HIF1A;SYT11;ZFP36L2;ESR1;HELLS;DIP2A;CREBZF;EPC1;JARID2;ATP2B1;NDFIP1;RBBP4;TTBK1;PUS7;NCOR2;BMPR1A;CITED2;EIF4ENIF1;RUNX1;PHF19;PNPT1;APLNR;N4BP1;SNX12
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.37253926953544125,0.7912709274134725,0.7151607963246555,1.0,1.0,3/11,9.28%,PRKN;RAB21;VPS11
prerank,regulation of GTPase activity (GO:0043087),0.2500412452369833,0.7912512328496955,0.8549540347293156,1.0,1.0,20/177,9.96%,SIPA1L1;CCL11;ERBB2;PLXNC1;FGD4;EFNA5;MAP4K4;CCL4;NTRK2;NF1;CHN1;ALS2;CDKL5;DOCK10;RAP1A;ARHGAP9;ZC3H15;VAV3;ARHGAP11A;ARL2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3479719091106336,0.7909186211193819,0.7240398293029872,1.0,1.0,5/15,18.76%,LIMK1;BAG5;ABL1;FBXO5;PARK7
prerank,negative regulation of protein kinase activity (GO:0006469),0.26395546157069105,0.7908925402185233,0.8231441048034934,1.0,1.0,18/88,18.98%,UBASH3B;PYCARD;PTPRT;DEPTOR;NF1;SPRED1;PTPN1;DVL1;WWTR1;ADARB1;SNCA;TAF7;ABL1;PYDC1;DBNDD2;PPM1E;PARK7;TESK1
prerank,regulation of JNK cascade (GO:0046328),0.2615509411304865,0.790762127409254,0.8154825026511134,1.0,1.0,20/101,18.70%,PYCARD;PRKN;EGFR;MAP4K4;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MEN1;MTURN;TAOK3;PER1;DACT1;RASSF2;RIPK1;FKTN;ZMYND11;MAP3K11
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3029730047836624,0.7904405569752903,0.7390745501285347,1.0,1.0,12/32,24.87%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;POLR2F;CCNH;TBP
prerank,establishment of mitotic spindle orientation (GO:0000132),0.32322383761355594,0.790241802109491,0.7438692098092643,1.0,1.0,3/23,6.12%,GPSM2;INSC;NDE1
prerank,protein localization to centrosome (GO:0071539),0.33669514678776824,0.7901038156079674,0.7279305354558611,1.0,1.0,3/17,11.71%,PCM1;GOLGB1;SNX10
prerank,peptidyl-lysine methylation (GO:0018022),0.3111287765453495,0.7896714248571928,0.7389033942558747,1.0,1.0,6/26,19.52%,SUV39H1;SETD3;SETD2;TRMT112;SETD4;N6AMT1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.37638292702902654,0.7891883968994741,0.7178294573643411,1.0,1.0,1/10,4.81%,PRNP
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.29970049214572375,0.788350384966238,0.7712833545108005,1.0,1.0,5/33,10.65%,FBXW7;NCF1;HIP1;BTC;CBL
prerank,protein hydroxylation (GO:0018126),-0.2894094513444441,-0.7879865439397545,0.7649006622516556,0.9408144601364881,1.0,6/15,23.85%,OGFOD1;PLOD3;VIPAS39;EGLN3;JMJD4;VPS33B
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2772856221414597,0.7878885278702717,0.7839080459770115,1.0,1.0,15/56,19.87%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2772856221414597,0.7878885278702717,0.7839080459770115,1.0,1.0,15/56,19.87%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3206956370858194,0.7877971245878513,0.7572815533980582,1.0,1.0,5/23,15.84%,SETMAR;REXO4;FBH1;KPNB1;KPNA1
prerank,chromatin remodeling at centromere (GO:0031055),0.30209479300723574,0.78763663006499,0.7509677419354839,1.0,1.0,11/31,22.38%,HELLS;HJURP;OIP5;RBBP4;ITGB3BP;CENPV;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.2783591796949846,0.7873646286275201,0.786697247706422,1.0,1.0,8/53,10.68%,MYC;FGF10;EGFR;SPRED2;SPRED1;BRCA1;SPRED3;FBH1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.28541196962047866,0.7871124100675169,0.7680473372781065,1.0,1.0,9/42,15.54%,UTRN;MAP4K4;VEGFA;TSC1;CDK6;PTPRJ;MYOC;JUP;ABL1
prerank,protein palmitoylation (GO:0018345),-0.23343018780291153,-0.7870800564734208,0.8326359832635983,0.9412084904099218,1.0,7/30,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,skeletal muscle contraction (GO:0003009),-0.27051634650526163,-0.7869233973667895,0.7814814814814814,0.9403368942288844,1.0,8/19,37.75%,RCSD1;STAC;MYH14;STAC3;TNNI1;TNNC1;TNNI3;CCDC78
prerank,response to glucocorticoid (GO:0051384),-0.23653815435415929,-0.7867564617764109,0.8152610441767069,0.9395061495568345,1.0,6/26,20.37%,SLIT2;ZFP36L1;FAM107A;ANXA1;PDCD7;GOT1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2946119779449797,0.7867016836980413,0.7772337821297429,1.0,1.0,5/38,12.69%,PTEN;THEM4;PTPRJ;MAGI2;DRD2
prerank,intracellular pH reduction (GO:0051452),0.29828140077407345,0.7866507442975277,0.7672634271099744,1.0,1.0,12/33,27.43%,RAB38;ATP6V1B2;RAB39A;DMXL1;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,protein import into peroxisome membrane (GO:0045046),0.3165228682140271,0.786582178308693,0.7412868632707775,1.0,1.0,5/22,16.67%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2
prerank,telomere organization (GO:0032200),-0.21582058568781254,-0.7861250382042732,0.8457142857142858,0.9393809824746406,1.0,10/43,15.13%,SP100;POLD3;RIF1;PARP3;TERF2;PARP1;DOT1L;HUS1;TERT;PCNA
prerank,axonal fasciculation (GO:0007413),0.3599355129283258,0.7859175244597466,0.7346326836581709,1.0,1.0,5/12,18.89%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,regulation of cell cycle process (GO:0010564),0.2584781851436807,0.7852766043472962,0.8358695652173913,1.0,1.0,15/104,15.54%,KIF20B;SOX9;CDKN2B;TIPIN;KLHL13;OBSL1;CDK13;SETD2;RCC1;PKMYT1;MYO19;ATF5;RAB11FIP3;CALM1;CALM2
prerank,protein secretion (GO:0009306),0.27289698636516696,0.7849738768236438,0.7902097902097902,1.0,1.0,23/56,28.75%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RIMS2;PARK7;RAB3B;TANGO2;PORCN;TVP23A;MIA3;SNX19;MON1A;SCG2;SEL1L;LTBP2;PREB;RAB13
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.24474964011330544,-0.7848980968464568,0.7838983050847458,0.9402468980027131,1.0,12/25,28.53%,POMT2;RNF185;STUB1;FBXL17;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;OMA1;VCP
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.2885851198197462,-0.7847808590176243,0.7467105263157895,0.9393126828041898,1.0,6/13,23.94%,CACNA1G;SYT10;KCNB1;STX1A;SYT4;CACNA1I
prerank,liver development (GO:0001889),0.2965951596902402,0.7846763729364759,0.7632600258732212,1.0,1.0,10/32,23.88%,CCDC39;PRKCSH;NF1;COBL;CITED2;MET;PCK2;PKD2;CEBPB;TGFBR3
prerank,GPI anchor biosynthetic process (GO:0006506),0.3069838898026869,0.7846598382308876,0.7560050568900126,1.0,1.0,8/30,19.95%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;DPM1;PIGO
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.27210234591968496,-0.7843889467651575,0.7482014388489209,0.9388622674687228,1.0,6/16,19.64%,AMPD3;LHPP;ATIC;IMPDH1;GART;IMPDH2
prerank,regulation of regulated secretory pathway (GO:1903305),0.29707697002923994,0.7843326879617883,0.7657068062827225,1.0,1.0,11/34,20.02%,SYT1;RAB3D;SYN1;SYT11;SYT12;RIMS1;RAB3A;UNC13D;SYT2;RIMS2;SYT13
prerank,transcription by RNA polymerase III (GO:0006383),0.31121428169810317,0.7839987498262847,0.7489986648865153,1.0,1.0,11/27,25.20%,SNAPC2;IVNS1ABP;ZC3H8;POLR2K;ELL;GTF3C1;POLR3G;SNAPC3;POLR3K;TBP;GTF3C5
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2877974794648018,0.7839510782229514,0.76,1.0,1.0,5/41,9.43%,FADS2;CYP1B1;SCD5;ACOX1;ELOVL5
prerank,regulation of store-operated calcium entry (GO:2001256),-0.318539885237224,-0.7839012957707132,0.7730870712401056,0.9385232089868589,1.0,3/10,13.35%,SLC8B1;SARAF;STIM1
prerank,B cell proliferation (GO:0042100),0.3321809109250082,0.7838364315555241,0.7529239766081871,1.0,1.0,1/17,1.76%,BCL2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2817449130824348,0.7837202979802461,0.7825030376670717,1.0,1.0,7/46,17.72%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,regulation of protein localization to nucleus (GO:1900180),-0.21176596947676418,-0.783687620909674,0.8571428571428571,0.9377934481058589,1.0,12/43,18.78%,MFHAS1;BMP4;LATS2;NVL;GSK3B;FLCN;TFRC;SESN2;SUMO3;ORMDL3;BYSL;SIN3A
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28805964237698833,0.7833081983430779,0.7551813471502591,1.0,1.0,13/36,27.14%,EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.36111302117229194,0.7829842035907941,0.7375776397515528,1.0,1.0,3/12,17.14%,BCL2;TAF9;CD74
prerank,regulation of cellular localization (GO:0060341),0.2809966677130703,0.7825160784562587,0.7836835599505563,1.0,1.0,4/46,2.90%,STXBP4;GSN;PRKN;EFNA5
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3570527701550388,0.782437549537327,0.736517719568567,1.0,1.0,4/13,21.01%,GOT2;ASPA;ACOT8;GLUD1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24521951075687132,0.7824264429656952,0.90625,1.0,1.0,76/241,26.12%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;DHX35;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;NCBP1;SNRPB2;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;MAGOHB;CPSF7;U2SURP;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1
prerank,positive regulation of leukocyte activation (GO:0002696),0.3285758878568398,0.7823156013761572,0.7591549295774648,1.0,1.0,6/18,21.39%,WNT5A;NECTIN2;IL33;LBP;HSPD1;TNIP2
prerank,rRNA catabolic process (GO:0016075),-0.27197469138756636,-0.7814187351351776,0.7785016286644951,0.9402414911892311,1.0,5/16,18.23%,XRN1;EXOSC7;DIS3;EXOSC10;DEDD2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.36400877842775786,0.7808671655112958,0.745269286754003,1.0,1.0,2/13,10.78%,BMS1;RCL1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3457809775838326,0.7807811323965802,0.7310443490701002,1.0,1.0,4/16,13.94%,PIGC;PIGP;PIGN;PIGA
prerank,cardiac ventricle development (GO:0003231),0.322009380753478,0.7807192415675442,0.762550881953867,1.0,1.0,6/20,17.57%,SCN5A;TMEM65;DAND5;GATA3;MDM4;HEYL
prerank,cell junction organization (GO:0034330),0.2663903197479038,0.7804459655542136,0.8035714285714286,1.0,1.0,13/71,12.17%,LRP4;SEMA3E;TGFB1;PSEN1;CLDN1;APBB2;SLC8A2;FLNA;GRM5;PPFIA2;MYO9A;OPHN1;DVL1
prerank,cellular response to glucose stimulus (GO:0071333),0.3072139436273413,0.7803643504181379,0.7599486521181001,1.0,1.0,10/30,21.94%,ZBTB20;TRA2B;MLXIPL;PDK3;PRKACA;PAX2;PCK2;ADCY8;PTPRN2;PRKAA1
prerank,receptor metabolic process (GO:0043112),0.2747995012726105,0.7801742903820248,0.7867132867132867,1.0,1.0,10/53,15.19%,DNM1;LRP1;TGFB1;ACKR3;PHETA2;MVB12A;CD9;SNCA;SNX1;ITGB1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20467044658226086,-0.7800419543478825,0.9,0.9412789627907319,1.0,8/49,13.32%,SMAD6;JAM3;GSK3B;RIOK3;PRKCZ;NOP53;LCMT1;CDC42
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3199018103828092,0.7799607139564406,0.7621023513139695,1.0,1.0,4/24,9.75%,CADM4;MT3;HIF1A;PTPN1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.2842509096594915,0.7799180449778056,0.777509068923821,1.0,1.0,15/44,21.49%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,positive regulation of immune system process (GO:0002684),0.3399202016576576,0.7798124255348211,0.7449856733524355,1.0,1.0,1/16,3.14%,VEGFA
prerank,regulation of defense response to virus by host (GO:0050691),0.30144747491071666,0.779595922043913,0.7557544757033248,1.0,1.0,2/30,3.80%,PTPN22;TRIM44
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3491098522424552,0.779362800870469,0.7458646616541353,1.0,1.0,2/13,10.09%,DERL2;EDEM2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24323389179139354,0.7793025410611168,0.919436052366566,1.0,1.0,86/264,27.00%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;CDK13;DHX35;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;NCBP1;SNRPB2;FIP1L1;TGS1;CLNS1A;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;CELF4;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WDR77;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;MAGOHB;CPSF7;U2SURP;SCAF11;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1;DDX1;PPWD1;PRPF40A;UBL5
prerank,positive regulation of binding (GO:0051099),0.26457036141828305,0.7790150840086661,0.8197802197802198,1.0,1.0,14/84,15.38%,DDX11;NGF;PRKN;LRP1;PSEN1;RALB;MEN1;NCBP1;USP33;AKTIP;PKD1;MET;MED25;DACT1
prerank,cellular protein metabolic process (GO:0044267),0.23992936332829545,0.7789348790915527,0.954,1.0,1.0,52/396,14.33%,GPC3;CHRM3;MMP2;VCAN;MXRA8;CHRDL1;HM13;PRKN;LAMC1;TGM1;MRPS18A;PARL;ARAF;PRKCSH;PSEN1;NUCB1;SDC2;RPL23A;LTA4H;MRPL32;CDKL3;MMP15;EVA1A;ATP23;RCN1;GATA6;MEN1;FARSB;SRBD1;VWA1;SPCS3;CKAP4;AMELX;MRPL35;EIF4G1;NCSTN;LTBP1;GSPT2;MRPL28;CALU;UBA3;SLC35A1;FBXL2;FUCA2;APH1A;ATG3;HSP90B1;YME1L1;PENK;NEDD8;HARS1;PSEN2
prerank,cholesterol transport (GO:0030301),0.28517629389835314,0.7787830962831281,0.7910628019323671,1.0,1.0,7/45,16.66%,CEL;NPC1;OSBPL5;RELCH;ABCA5;LIPC;ABCG4
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.28336018589815093,-0.7787819337244368,0.740506329113924,0.9421499945025231,1.0,2/14,4.93%,PKIA;PRKAR1A
prerank,response to amino acid (GO:0043200),0.2904649304585672,0.7786727543855911,0.7717948717948718,1.0,1.0,12/31,27.61%,CPEB3;LAMTOR2;CPEB1;SPAAR;RPTOR;IPO5;RRAGA;GLRB;MTOR;SLC38A9;CPEB4;GLRA3
prerank,fatty acid transmembrane transport (GO:1902001),0.3336358047496601,0.7780310051336996,0.7524613220815752,1.0,1.0,3/19,6.74%,SLC27A1;ACACA;PRKAB2
prerank,ether lipid metabolic process (GO:0046485),0.34907663349326623,0.7780073040171953,0.7464183381088825,1.0,1.0,4/14,12.35%,AGMO;PLA2G7;FAR1;PLAAT3
prerank,regulation of protein localization to cell surface (GO:2000008),0.29439327329086934,0.7775365466511414,0.7701005025125628,1.0,1.0,6/33,15.31%,TAX1BP3;GPM6B;GBF1;KCNAB2;NEDD4L;RIC3
prerank,regulation of protein acetylation (GO:1901983),-0.29591774212852734,-0.7772933942636252,0.7402234636871509,0.9433280472095811,1.0,4/12,20.83%,GSK3B;CAMK1;KAT5;CEP295
prerank,regulation of intracellular protein transport (GO:0033157),0.2978186026181589,0.7772847532551471,0.76875,1.0,1.0,4/32,9.75%,KIF20B;TGFB1;PCM1;PTPN1
prerank,negative regulation of peptidase activity (GO:0010466),-0.20126435325780448,-0.7761608256567791,0.89171974522293,0.9439346946643019,1.0,8/47,13.74%,VTN;TIMP3;SERPIND1;SPOCK2;SERPINB9;SERPINE1;TIMP2;SERPINI1
prerank,positive regulation of inflammatory response (GO:0050729),0.25905515294783293,0.7761113391260424,0.8295081967213115,1.0,1.0,16/86,19.48%,IL16;GPRC5B;CCR2;WNT5A;PLA2G7;IL18;IL6ST;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;LBP;SETD4;PDCD4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.29286938408107543,-0.7760595687887818,0.8050314465408805,0.9429836505427525,1.0,6/14,23.35%,MMS19;PARP1;WRAP53;ERCC6;FANCB;TIMELESS
prerank,heart trabecula morphogenesis (GO:0061384),0.32608368307744123,0.7759075508201903,0.7589041095890411,1.0,1.0,1/18,0.52%,BMP5
prerank,vacuolar acidification (GO:0007035),-0.25461777138965264,-0.775408198612196,0.8352059925093633,0.9429035368133212,1.0,11/21,30.51%,ATP6V0D1;ATP6V0A4;DMXL2;TMEM9;ATP6V0A2;CLN5;TMEM199;ATP6AP2;CCDC115;PPT1;SLC11A1
prerank,water transport (GO:0006833),0.3594093190338137,0.7742907435521819,0.7350299401197605,1.0,1.0,1/12,5.26%,AQP4
prerank,negative regulation of translational initiation (GO:0045947),-0.2930320462417846,-0.7742806466124351,0.75,0.9435269456473492,1.0,5/13,28.83%,EIF2AK1;EIF4EBP2;EIF3E;EIF2AK4;AGO2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3215182275157701,0.7737783751222735,0.7561307901907357,1.0,1.0,8/19,25.23%,ACVR1;TGFBR2;MDM4;BMPR1A;HEYL;BMP2;EFNA1;SOX4
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3714635280527867,0.7736534406188822,0.7196850393700788,1.0,1.0,3/10,18.86%,SETD3;SETD2;SETD4
prerank,ganglion development (GO:0061548),0.3658283170427704,0.7733453535764012,0.7470588235294118,1.0,1.0,3/11,12.09%,SEMA3A;NRP2;UNC5C
prerank,establishment of spindle orientation (GO:0051294),0.3065859849087808,0.7726632767036886,0.771353482260184,1.0,1.0,8/28,22.48%,GPSM2;INSC;NDE1;CLASP1;ITGB1;HTT;LLGL1;CDK5RAP2
prerank,positive regulation of locomotion (GO:0040017),-0.230265234494026,-0.77237612662951,0.8571428571428571,0.945427843190149,1.0,7/27,19.57%,CCDC25;THBS1;SPOCK2;PDGFRB;PPM1F;CAVIN1;TWIST1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.30367301368883065,0.7722898232288041,0.765399737876802,1.0,1.0,9/28,23.21%,BCL2;TNFRSF10B;PPP1R15A;TMEM117;QRICH1;AIFM1;DNAJC10;ERO1A;CEBPB
prerank,membrane repolarization during action potential (GO:0086011),-0.2921383005371131,-0.7712092331056178,0.7653958944281525,0.9460323935375541,1.0,5/13,24.77%,KCNJ2;ATP1A1;ATP1B1;KCNIP2;KCNE4
prerank,smooth muscle cell differentiation (GO:0051145),-0.2957586991546901,-0.7710887684512774,0.7470238095238095,0.9450831585593048,1.0,6/12,19.17%,BMP4;TMEM204;HEY2;EDNRB;MRTFB;MYOCD
prerank,negative regulation of lyase activity (GO:0051350),0.333314000125545,0.7708308512918407,0.7768115942028986,1.0,1.0,3/16,12.69%,CCR2;MTRR;DRD2
prerank,protein localization to cell surface (GO:0034394),0.30524722632588264,0.77059455340501,0.7608142493638677,1.0,1.0,6/26,15.87%,FGF10;ANK2;FLNA;FGF7;RIC3;PIGU
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3523337199468338,0.7702318934219967,0.7628398791540786,1.0,1.0,5/13,22.10%,DAO;GLS2;GLS;GLUD1;DDAH1
prerank,innate immune response in mucosa (GO:0002227),-0.31130971528944834,-0.7701730043596947,0.7610389610389611,0.9454236914667633,1.0,1/10,6.08%,DEFA6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.32837844134096567,0.7699423293079948,0.7310443490701002,1.0,1.0,3/16,13.74%,ACKR3;FBH1;NACC2
prerank,positive regulation of transmembrane transport (GO:0034764),0.3536959733503833,0.7698077152525546,0.7537764350453172,1.0,1.0,2/13,3.48%,C2CD5;ANO6
prerank,neuron remodeling (GO:0016322),0.3684924884983182,0.7696982090403224,0.739268680445151,1.0,1.0,3/10,12.08%,ADGRB3;FARP2;ANKS1A
prerank,positive regulation of phagocytosis (GO:0050766),-0.20462170664598772,-0.7693395937793651,0.9415584415584416,0.9455059585668989,1.0,25/47,37.83%,APPL2;RAB31;CAMK1D;CYBA;DOCK2;GATA2;NCKAP1L;PTPRC;C2;ABCA7;TUB;FCER1G;CALR;TULP1;LYAR;RAB27A;C4B;SLC11A1;GAS6;CD300LF;CCL2;TREM2;IL2RG;AHSG;PLA2G5
prerank,cell cycle G1/S phase transition (GO:0044843),0.2680852239077275,0.7693377802563434,0.8028004667444574,1.0,1.0,13/61,19.25%,CRLF3;MYC;ACVR1;CDK6;CUL3;RCC1;PHF8;PIM2;CUL4B;NASP;USP37;MAP3K11;DBF4
prerank,long-chain fatty acid transport (GO:0015909),0.299434029312023,0.7689490594694954,0.7716436637390214,1.0,1.0,4/30,6.74%,SLC27A1;ACACA;SLC27A4;PRKAB2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3029921955230309,0.7689294040819359,0.771978021978022,1.0,1.0,9/25,20.24%,TRA2B;TXNL4A;SNRNP40;PRPF6;KHSRP;DDX23;SRRM1;SF3B3;DBR1
prerank,positive regulation of response to stimulus (GO:0048584),0.28720093146817977,0.7688924775848555,0.7788819875776397,1.0,1.0,8/40,17.48%,MYC;WNT5A;TAF9;YPEL3;GATA3;CGAS;HOMER1;NSMCE4A
prerank,eye photoreceptor cell development (GO:0042462),0.3356225177715344,0.7681998681764278,0.7514285714285714,1.0,1.0,1/15,3.14%,VEGFA
prerank,phosphatidic acid metabolic process (GO:0046473),0.2746678335715822,0.7677702882912159,0.793939393939394,1.0,1.0,7/48,17.72%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3710079772095306,0.7673869243691218,0.765793528505393,1.0,1.0,2/10,13.20%,IL18;GATA3
prerank,tRNA modification (GO:0006400),0.26899906038676025,0.7672977744301874,0.816917728852839,1.0,1.0,20/62,23.76%,THUMPD3;DTWD1;PUSL1;TRMT12;THADA;DTWD2;TRMT112;PUS7;THUMPD2;ELP5;PUS1;SSB;TPRKB;TRIT1;NSUN2;LCMT2;ALKBH8;ALKBH1;TRMT1;MOCS3
prerank,cellular response to cAMP (GO:0071320),-0.2289792779667169,-0.7667201788077052,0.8492462311557789,0.9482758870920669,1.0,4/30,7.01%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,transcription by RNA polymerase I (GO:0006360),0.291159590804693,0.7661594994633392,0.7841634738186463,1.0,1.0,13/34,26.50%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;POLR2F;CCNH;TBP;TTF1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.23626269162258623,-0.7661437470293805,0.8326530612244898,0.9480690776038765,1.0,5/23,18.12%,UACA;C1QTNF3;TMSB4X;NMI;IFI35
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32773729993619155,0.766108054077513,0.7475728155339806,1.0,1.0,5/18,22.46%,NAGA;FBXO27;FBXO17;FBXO44;OGA
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3102186114183208,0.7659361765794668,0.7684069611780455,1.0,1.0,5/23,17.45%,SLC12A3;SLC12A2;SLC12A4;KCNH2;SLC9A1
prerank,mesenchymal to epithelial transition (GO:0060231),0.35710437029182646,0.7659147109134173,0.7402402402402403,1.0,1.0,3/10,16.98%,FZD7;GATA3;PAX2
prerank,cellular response to pH (GO:0071467),-0.2692574710995498,-0.765809166213152,0.7927272727272727,0.9474694348167819,1.0,10/17,36.96%,RAB11B;MCOLN1;GPR68;PKD2L1;PKD1L3;IMPACT;HVCN1;RAB11FIP5;KCNK4;ASIC1
prerank,miRNA metabolic process (GO:0010586),-0.2575047276101532,-0.7656525576984818,0.8070175438596491,0.9465928073140778,1.0,9/20,29.54%,DGCR8;TUT7;TENT4B;TARBP2;LIN28B;DDX17;BCDIN3D;AGO2;DICER1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2663848064984365,0.7653671955677485,0.8151549942594719,1.0,1.0,14/63,18.13%,WAC;CARM1;PCBP4;PRMT1;CNOT3;RPA2;MDM4;CASP2;CRADD;ATM;RPS27L;TP53;FBXO31;MDM2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.25046548041585887,0.7649946030617316,0.8624454148471615,1.0,1.0,17/101,16.02%,SLC27A1;FGF2;ERBB2;EGFR;VEGFA;TGFB1;WNT5A;RALB;FGFR1;SLC8A2;PIH1D1;EDN3;SNCA;CALM1;PKD1;CALM2;CCND2
prerank,heterochromatin organization (GO:0070828),0.33895290593317806,0.764714251140192,0.751412429378531,1.0,1.0,3/14,10.06%,PRDM16;EZH1;POLE3
prerank,response to progesterone (GO:0032570),-0.26122352214434297,-0.764494127252371,0.8,0.9471955685574879,1.0,6/18,20.71%,THBS1;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,glucose homeostasis (GO:0042593),0.25588935960893017,0.7643639288638129,0.8397790055248618,1.0,1.0,15/83,20.07%,PYGL;BACE2;PTPN2;LRRC8D;MLXIPL;HIF1A;PIK3R1;NGFR;CRY1;KLF7;PARK7;HK2;PPARG;STAT3;ADCY8
prerank,rRNA methylation (GO:0031167),0.30940372389221027,0.7640933310963938,0.7698519515477793,1.0,1.0,5/22,12.65%,NOP2;NSUN5;FDXACB1;FBL;TRMT112
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3354403649114418,0.7639241232398203,0.7510791366906475,1.0,1.0,7/15,28.67%,IRS2;GPLD1;PPARG;PRKCE;LDLRAP1;PPARA;ADM
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.25463970786818413,-0.7637196384984289,0.8397212543554007,0.9472739035514206,1.0,6/21,18.17%,SAMD4A;CNOT1;TUT7;PAN2;CNOT11;CNOT9
prerank,midbody abscission (GO:0061952),-0.2707845593080202,-0.7634716485092201,0.7963636363636364,0.9465600049753629,1.0,6/17,23.97%,CHMP3;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,protein N-linked glycosylation (GO:0006487),0.26276105140464534,0.7634226229838726,0.8222477064220184,1.0,1.0,15/66,19.74%,GFPT2;UGGT2;ALG9;STT3A;MGAT3;MAGT1;ALG5;TUSC3;ALG1;MOGS;ALG8;DPM1;DPAGT1;RPN1;ALG6
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.31491850125133425,0.7631322529202506,0.7868162692847125,1.0,1.0,3/21,6.11%,EPHB2;SYNGAP1;MAPKAP1
prerank,keratan sulfate metabolic process (GO:0042339),0.29331310631441054,0.7629146836467503,0.7916666666666666,1.0,1.0,3/31,7.19%,LUM;ST3GAL4;GALNS
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.23960024120664014,0.7627491119077442,0.9456740442655935,1.0,1.0,82/314,23.24%,ZFAND2B;RAD23B;PRKN;ERLIN2;HACE1;DNAJB9;FBXW7;SPSB4;RHBDD2;SPOP;FBXO38;FBXL15;TRIM2;HECTD3;PELI1;UBE2K;FBXL16;PSMB7;UCHL1;FBXO27;DERL2;CUL3;SELENOS;HERPUD1;HUWE1;ANAPC7;FBXO45;NFE2L2;UBE2J2;RNF121;FBXO17;ANAPC2;FBXL2;TMUB2;HSP90B1;DDB1;BUB1B;NEDD4L;JKAMP;PSMD2;KLHL22;PLAA;UBB;AREL1;PSMC1;ERLIN1;CDC23;FBXL4;ZSWIM8;ANAPC16;PSMB2;CUL4B;FBXO5;FBXO31;TRIM9;MDM2;RNF4;PSMD9;TAF1;DNAJC10;PCNP;PSME4;FBXL12;CDC27;UBE2G1;UBE2E1;DCAF11;SGTA;PSMA8;PTTG1;ANAPC4;UBE2D3;ARRB2;UBR3;FBXO44;ANAPC5;UBQLN1;SIAH1;RNF187;UBQLN2;COP1;RB1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3187717514603605,-0.762659998808863,0.782967032967033,0.9466816244679127,1.0,2/10,5.34%,OSR1;COMMD1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.3450588524225897,0.7625902878350393,0.7666195190947667,1.0,1.0,1/14,1.85%,ANK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.35671714511616803,0.7624392129146236,0.742998352553542,1.0,1.0,2/10,14.50%,DRD2;CALM1
prerank,Golgi localization (GO:0051645),0.35901253287585416,0.7622507876046095,0.7660550458715596,1.0,1.0,5/11,24.92%,YWHAZ;ARHGAP21;COPG1;HOOK3;ARCN1
prerank,embryonic heart tube development (GO:0035050),0.32933823498937187,0.7620836996391267,0.763235294117647,1.0,1.0,2/14,14.77%,ACVR1;CITED2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2550590066716717,0.7619233272163002,0.8544652701212789,1.0,1.0,23/85,20.32%,PRKN;SOCS5;FBXW7;CBFA2T3;RNFT1;PRICKLE1;DVL1;CSNK1A1;DET1;TMTC3;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;USP13
prerank,mesoderm development (GO:0007498),0.32600597019117483,0.7617686555080548,0.7524204702627939,1.0,1.0,2/18,5.00%,VEGFA;MEST
prerank,positive regulation of cell aging (GO:0090343),0.36096556241406874,0.7615532029787933,0.7664670658682635,1.0,1.0,3/11,15.21%,YPEL3;LMNA;CGAS
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.33406739727988327,0.76076891050285,0.7847919655667145,1.0,1.0,5/15,20.38%,ZFP36L2;BCL2L11;HNRNPU;UBE2L3;ZFP36
prerank,protein depolymerization (GO:0051261),-0.22764257974521274,-0.7607570719713956,0.8379446640316206,0.9483652877444289,1.0,7/27,16.59%,NCKAP5;MICAL3;MICAL2;NCKAP5L;DSTN;KIF18A;VPS4B
prerank,megakaryocyte differentiation (GO:0030219),0.3604392759694553,0.7607355961863633,0.7530120481927711,1.0,1.0,1/11,2.40%,CDKN2B
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.30726234618404985,0.7605300453068112,0.7831978319783198,1.0,1.0,5/23,17.04%,DERL2;SELENOS;HERPUD1;HSP90B1;SURF4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.26362521354588286,0.7603290019104298,0.8350398179749715,1.0,1.0,10/65,13.38%,MVB12B;EGFR;PTPN2;EPS15;HIP1;BTC;PTPRJ;CBL;MVB12A;SH3KBP1
prerank,cell junction maintenance (GO:0034331),-0.2786391536256315,-0.7600110271241571,0.7936507936507936,0.9483915252924897,1.0,8/14,34.62%,NLGN2;DCTN1;CSF1R;CBLN2;MYADM;F2R;CBLN1;PRTN3
prerank,regulation of glycogen metabolic process (GO:0070873),-0.2898275504503665,-0.7599650440401832,0.7784090909090909,0.9473647964871957,1.0,8/12,42.40%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2952838743824821,0.7597700203247216,0.7874015748031497,1.0,1.0,10/30,24.45%,SLC27A4;ACOX1;ELOVL6;ELOVL5;ABCD2;ACSL6;HACD2;TECRL;ELOVL1;HACD3
prerank,mammary gland epithelium development (GO:0061180),-0.28363854796373805,-0.7596294129899774,0.7819767441860465,0.9467502886057275,1.0,7/14,30.91%,WNT4;ID2;EPHA2;AKT1;CSF1R;LATS1;JAK2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.33895641269034993,0.7595220906043179,0.7724637681159421,1.0,1.0,6/13,24.45%,ELOVL6;ELOVL5;HACD2;TECRL;ELOVL1;HACD3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.3525091744684532,0.75865585304776,0.7515527950310559,1.0,1.0,4/12,25.10%,TSPOAP1;TSPO;CACNA1H;STARD3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.2923460101532163,0.7586538980814073,0.7971391417425228,1.0,1.0,8/29,16.35%,KANK4;PRKN;SSH3;CLASP1;FKBP4;PLEKHH2;SSH1;ARFGEF1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.30750738982888337,-0.7584594683046665,0.746031746031746,0.9473125479741715,1.0,5/10,37.46%,LYN;CCL19;RAPGEF2;GAS6;LILRB1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.32695059579050206,0.7580594769350073,0.7635036496350365,1.0,1.0,1/16,2.66%,FADD
prerank,regulation of chemokine production (GO:0032642),0.2812145353150619,0.7577236793468655,0.7957658779576587,1.0,1.0,7/36,19.03%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.24440723249552349,0.7575609236345537,0.8961578400830738,1.0,1.0,35/149,24.51%,ROR1;EDA;PRKCQ;PYCARD;IRAK3;RPS6KA4;WNT5A;CARD9;IL18;MID2;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;TAB3;BCL10;STAT3;NFKB1;PRKD2;CARD11;TAB2;CARD16;ERC1;FLOT2;IRAK2;TRIM14;CIB1;HSPA1A
prerank,positive regulation of peptidase activity (GO:0010952),0.316639500875358,0.7575504807416888,0.7889182058047494,1.0,1.0,5/20,16.25%,RCN3;NCSTN;GRN;APH1A;NDUFA13
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.32895747979366674,0.7573666654908001,0.7651296829971181,1.0,1.0,3/15,15.38%,ACVR1;MAGI2;DACT1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2689717730720191,0.7571227994124199,0.8134777376654633,1.0,1.0,8/46,15.90%,TGFB1;PSEN1;CPSF6;FLNA;PIK3R1;EMD;JUP;TP53
prerank,plasma membrane tubulation (GO:0097320),-0.29188085272394615,-0.7568245304913459,0.7900874635568513,0.9485717370238644,1.0,4/13,17.03%,SNX9;FNBP1L;WHAMM;MICALL1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.21417319108469973,-0.756766796964199,0.9237668161434978,0.947590627224394,1.0,12/33,18.96%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;DCLRE1B;GAR1;HSP90AB1;TINF2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.31111115393371724,0.7567405303886566,0.7818181818181819,1.0,1.0,9/20,24.48%,PARL;LETM1;PMPCB;SLC25A23;YME1L1;PMPCA;PHB2;MCUR1;SMDT1
prerank,regulation of ERAD pathway (GO:1904292),-0.2924706225276188,-0.7567168499651199,0.7987987987987988,0.9465732855517209,1.0,4/11,12.56%,USP19;RNF185;AQP11;TMEM259
prerank,positive regulation of protein depolymerization (GO:1901881),0.3483068358748471,0.7567144083593862,0.7421383647798742,1.0,1.0,4/11,26.15%,KATNB1;NES;CFL2;WDR1
prerank,protein localization to mitochondrion (GO:0070585),0.36318397177492134,0.7556158778639074,0.7698289269051322,1.0,1.0,5/11,27.44%,COX18;DNAJA1;HK2;HK1;RALA
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.2780895671998549,0.7554733895240164,0.7967781908302355,1.0,1.0,3/34,4.08%,PDGFRA;FGF2;TGFB1
prerank,regulation of TORC1 signaling (GO:1903432),-0.21878013102111388,-0.7554039719300357,0.8686440677966102,0.9473202558104459,1.0,13/33,26.39%,SIK3;RRAGC;FLCN;SESN2;LARS1;PIP4P1;SMCR8;KPTN;GPR137;RRAGB;CASTOR1;SZT2;STK11
prerank,positive regulation of cellular metabolic process (GO:0031325),0.24972274416946055,0.7553197566106243,0.853448275862069,1.0,1.0,22/98,19.67%,VEGFA;ACACA;TGFB1;MT3;TGFBR2;ACLY;FASN;EIF4G1;SFRP4;MAPK14;PID1;MAGI2;RAB1A;SCRIB;GATA3;SNCA;SCYL2;TP53;RIPK1;CD63;GRB2;PPARG
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3420648981368134,0.754018858439097,0.7609682299546142,1.0,1.0,4/12,22.65%,PDE4D;CALM1;CALM2;CAMK2D
prerank,microglial cell activation (GO:0001774),-0.2519940721018225,-0.7539612037108756,0.8480565371024735,0.9482319086070737,1.0,11/21,35.28%,APP;MAPT;C1QA;CLU;TYROBP;ITGB2;ITGAM;JAK2;AGER;AIF1;TREM2
prerank,regulation of centrosome duplication (GO:0010824),-0.2221157907092829,-0.7539530817596748,0.8761467889908257,0.9471521248151001,1.0,14/30,32.46%,CHMP3;CENPJ;NPM1;CHMP1A;CENATAC;VPS4B;SPICE1;CEP295;CHMP2B;STIL;CCNF;GEN1;CEP131;PLK2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.27124090620449015,0.753948726236594,0.8184019370460048,1.0,1.0,15/45,24.51%,EGFR;TGFB1;DXO;HEATR1;PIK3R1;ZC3H18;TRMT112;TP53;PNPT1;RIPK1;POLR2A;NFKB1;WDR75;SUPV3L1;HSPA1A
prerank,clathrin-dependent endocytosis (GO:0072583),0.3001507845809503,0.7538596435579028,0.7941567065073041,1.0,1.0,4/26,11.35%,SGIP1;ITSN1;GAK;GPR107
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2499192434895788,-0.7536564053123562,0.8191489361702128,0.9465243294737706,1.0,4/18,20.29%,ROCK1;SLC39A8;VCAM1;ADD2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.23813024920326017,-0.7533854300250191,0.8333333333333334,0.945834190142202,1.0,9/24,27.18%,RNF34;CASP8;MAP3K7;UBE2N;IKBKG;NOD1;TNFAIP3;UBA52;NOD2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.34952449859819135,0.7533581754407954,0.7711738484398217,1.0,1.0,2/13,9.60%,NAGK;MGAT3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2825617846060611,0.7530729188943719,0.7905236907730673,1.0,1.0,6/37,11.45%,PHLDB1;BICD1;EFNA5;CLASP1;BICD2;STMN4
prerank,positive regulation by host of viral transcription (GO:0043923),-0.26989496806986424,-0.7528855334886285,0.8145695364238411,0.945404273415838,1.0,3/15,12.14%,LEF1;SNW1;CTDP1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2858378865940491,0.7527795303734589,0.8063694267515924,1.0,1.0,8/35,16.11%,MBD4;MPG;RPA3;MUTYH;NEIL1;RPA2;SMUG1;POLG
prerank,T cell proliferation (GO:0042098),0.3334154359702697,0.7526853963265419,0.7795031055900621,1.0,1.0,2/13,8.17%,PPP3CB;CADM1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2549012795296259,0.7526233170702727,0.8566629339305711,1.0,1.0,15/78,19.15%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2549012795296259,0.7526233170702727,0.8566629339305711,1.0,1.0,15/78,19.15%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,negative regulation of interleukin-8 production (GO:0032717),0.31882919172356494,0.7524844731565302,0.7660818713450293,1.0,1.0,2/17,6.17%,PTPN22;OTUD7B
prerank,prostaglandin metabolic process (GO:0006693),0.2997544578544677,0.7518906657196613,0.7938420348058902,1.0,1.0,6/26,17.78%,CYP2S1;ACOX1;PNPLA8;PLAA;CD74;PTGES
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.324310147734453,0.7509817243404423,0.7717717717717718,1.0,1.0,2/15,4.19%,EGFR;TEC
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.23831638918696207,0.750835767310955,0.9193054136874361,1.0,1.0,47/185,23.70%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CUL3;ZFP36L2;ANAPC7;CLASP1;ANAPC2;PRKACA;CKAP5;DDB1;CEP76;BUB1B;DYNC1I2;PKD1;PSMD2;UBB;PSMC1;CDC14A;CSNK1E;CDC23;ANLN;ANAPC16;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;CDC27;CEP78;SSNA1;UBE2E1;PSMA8;PCNT;ANAPC4;CDK5RAP2;ANAPC5;DYNC1H1;PPP2R1A;CDC16;PLK5
prerank,negative regulation of platelet activation (GO:0010544),0.32708217752786295,0.7505786895601196,0.7892376681614349,1.0,1.0,3/16,13.83%,PDGFRA;SERPINE2;CD9
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3220218853862076,0.7504724007370018,0.776824034334764,1.0,1.0,6/17,20.38%,ALG9;ALG1;ALG8;DPAGT1;ALG6;DHDDS
prerank,antibacterial humoral response (GO:0019731),0.3269569579662937,0.7501964385363391,0.7714701601164483,1.0,1.0,1/16,3.93%,RNASE6
prerank,regulation of DNA biosynthetic process (GO:2000278),0.2950008490345323,0.750055397733174,0.7957559681697612,1.0,1.0,2/27,1.47%,FGF2;MYC
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2527427207196152,0.7499807913096079,0.8562019758507134,1.0,1.0,16/83,19.25%,CRLF3;MYC;ACVR1;CDK6;CDK15;CUL3;RCC1;PHF8;CDK16;ORC1;PIM2;CUL4B;FBXO5;NASP;USP37;DBF4
prerank,negative regulation of TOR signaling (GO:0032007),0.2840308308631518,0.749872936073999,0.7944162436548223,1.0,1.0,11/36,24.79%,NPRL2;DEPTOR;TSC1;CASTOR2;ATM;SPAAR;FNIP1;DEPDC5;PRKAA1;SESN1;ITFG2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3172878732500468,0.7494593701268948,0.7794943820224719,1.0,1.0,7/19,25.41%,SETD2;TBK1;CHUK;IRF3;HSPD1;MAVS;IRF5
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.1841110056482401,-0.7492222725548151,0.9242424242424242,0.9493393227518957,1.0,20/67,23.98%,ITGB5;PSMD14;TAPBP;PSMB3;PSMD12;CYBA;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;IKBKB;IKBKG;PSMC4;PSMB6;PSMA4;VAMP8;CALR;PSMB1;PSMB9
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3254396308889602,0.7490395342915199,0.7903930131004366,1.0,1.0,4/16,15.54%,ANK2;PRKACA;CALM1;CALM2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2536257831220192,0.7490309653126673,0.8651059085841695,1.0,1.0,15/79,19.15%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,peptidyl-lysine modification (GO:0018205),0.24669048103290325,0.7489295643078903,0.8832432432432432,1.0,1.0,13/99,11.29%,CTH;KAT2B;SENP3;RANBP2;UBA2;NUP155;LOXL3;PLOD1;PIAS2;NUP205;NDC1;HDAC6;NUP160
prerank,vitamin transport (GO:0051180),0.29254716436076034,0.7487738103939292,0.8015364916773368,1.0,1.0,2/29,3.90%,SLC27A1;CD320
prerank,peptide catabolic process (GO:0043171),0.3041242044298822,0.7485597962367637,0.7730769230769231,1.0,1.0,4/23,9.81%,DPEP1;LTA4H;TRHDE;LNPEP
prerank,regulation of mitochondrion organization (GO:0010821),0.2719064319893373,0.7484501327848958,0.8293269230769231,1.0,1.0,7/47,11.37%,PRKN;PARL;FBXW7;RHOT2;MYO19;HDAC6;PID1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.26404155509411065,-0.7482539795188545,0.8156996587030717,0.9495725127244952,1.0,7/15,25.53%,IGF1;GPX1;FXN;HGF;CLU;AKT1;PPIF
prerank,ventricular septum development (GO:0003281),0.27659340097395085,0.7479930238359878,0.8172959805115713,1.0,1.0,11/37,17.57%,ACVR1;SOX11;TGFBR2;DAND5;ZFPM2;GATA3;MDM4;BMPR1A;CITED2;APLNR;HEYL
prerank,cellular glucan metabolic process (GO:0006073),0.3524895037774614,0.7476300649471403,0.7798449612403101,1.0,1.0,2/11,9.06%,PYGL;PHKB
prerank,cellular response to starvation (GO:0009267),0.24091429868785147,0.7475657050840641,0.9045643153526971,1.0,1.0,54/147,27.99%,MIOS;NPRL2;SIK2;EIF2AK3;ATP6V1B2;NUPR2;AOC1;WIPI1;RALB;TBL2;ATG5;LAMTOR2;CASTOR2;ASNS;ATF2;USP33;CLEC16A;MAPK1;XPR1;GABARAPL2;VPS41;GCN1;TP53;SREBF2;WRN;ATP6V1C1;RPTOR;FNIP1;RRAGA;ATP6V0E2;LAMP2;DEPDC5;PRKAA1;ATP6V0E1;CEBPB;INHBB;RRP8;MTOR;ATP6V1G2;WDR45B;EHMT2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CPEB4;CDKN1A;TCIRG1;PPARA;SIRT1;ATP6V1D;PIK3C3;PRKAG1
prerank,Wnt signaling pathway (GO:0016055),0.2504288088084637,0.7473064930938809,0.876210979547901,1.0,1.0,19/92,15.83%,PTEN;FRZB;VPS29;WNT5A;FZD7;RARG;BCL9L;SFRP4;BCL9;DVL1;CSNK1G1;GPC4;CSNK1A1;STRN;KLHL12;UBB;FZD9;CSNK1E;CSNK1G2
prerank,maintenance of protein localization in organelle (GO:0072595),0.31126485216839367,0.7471081471966577,0.7861111111111111,1.0,1.0,9/19,26.22%,ARL2;HNRNPU;HK2;TAF8;BCL3;HK1;BBS4;TOPORS;TAPT1
prerank,melanosome transport (GO:0032402),0.3140742253253756,0.7470556496964686,0.786723163841808,1.0,1.0,7/18,25.46%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,pigment granule transport (GO:0051904),0.3140742253253756,0.7470556496964686,0.786723163841808,1.0,1.0,7/18,25.46%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,sulfation (GO:0051923),-0.2939618086557064,-0.7466202418752793,0.7859154929577464,0.9507486144498632,1.0,5/11,44.32%,UST;SULT4A1;CHST5;SULT2B1;SULT6B1
prerank,peptidyl-methionine modification (GO:0018206),-0.282650460091184,-0.7462141231975866,0.7994350282485876,0.9501996491588396,1.0,2/12,5.31%,NAA25;NAA30
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2660114258663605,0.7458375090873813,0.8483080513418904,1.0,1.0,10/55,17.21%,PYCARD;BCL2;FADD;BMF;TRAF7;CRADD;TP53;BCL2L11;WWOX;RIPK1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.29495463561776086,-0.7456342556704926,0.7813411078717201,0.9499002408854984,1.0,3/11,9.07%,BIRC3;NUPR1;CASP8
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.18086435536439163,-0.7453417031884843,0.9805825242718447,0.9492142821970079,1.0,18/74,19.43%,PSMD14;ARNT;PSMB3;PSMD12;EGLN2;HIGD1A;PSMD6;PSMA1;VHL;PSMD7;PSMA5;PSMC5;PSMC4;CREBBP;PSMB6;CUL2;EGLN3;PSMA4
prerank,positive regulation of translation (GO:0045727),0.248177261997137,0.7450759449547455,0.8683351468988031,1.0,1.0,12/94,9.18%,ERBB2;UPF3A;PLD1;NIBAN1;NGRN;METTL3;EIF3C;EIF2B5;CPEB3;EIF6;NSUN5;PASK
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.32641351292463716,0.7449672261992593,0.7714701601164483,1.0,1.0,4/14,14.00%,PPP3CA;PPP2R2A;PPP1CA;NCK1
prerank,positive regulation of JNK cascade (GO:0046330),0.257808071762811,0.7445763351363608,0.8439635535307517,1.0,1.0,9/70,11.66%,PYCARD;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;TAOK3
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.31289133037571926,0.7444873001180343,0.7741007194244605,1.0,1.0,4/17,21.03%,PCSK6;LMF1;LIPC;FURIN
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.33023194640855297,0.7444205903958905,0.7801204819277109,1.0,1.0,6/15,30.81%,ZC3H12B;POP1;ZC3H12C;RPP30;KHNYN;ZC3H12A
prerank,negative regulation of hydrolase activity (GO:0051346),0.2694304803051299,0.7443993804121178,0.8483080513418904,1.0,1.0,10/49,20.82%,MAPK7;CSTB;URI1;ARL2;NEIL1;TMED2;ARFGEF1;FICD;RDX;ZCCHC9
prerank,receptor catabolic process (GO:0032801),-0.2357213730898459,-0.7438217850774733,0.8062015503875969,0.9501326574162133,1.0,6/24,16.17%,ZNRF3;BECN1;LGMN;UVRAG;RNF43;CLTA
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28523751749806675,0.7437627227105839,0.8220230473751601,1.0,1.0,6/29,15.90%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;NT5C3B
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2658988370026666,0.7436483233883611,0.8295042321644498,1.0,1.0,15/51,21.49%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,T cell activation (GO:0042110),0.25331095471513254,0.7435437676742018,0.8696629213483146,1.0,1.0,11/69,17.76%,PTPN22;PTPN2;PPP3CB;PPP3CA;NHEJ1;RHOH;SCRIB;GATA3;NCK1;CD74;MDK
prerank,negative regulation of protein processing (GO:0010955),0.34414406146022825,0.7434675680697079,0.7809667673716012,1.0,1.0,3/12,16.92%,PRNP;SERPINE2;SNX12
prerank,regulation of blood circulation (GO:1903522),-0.21493933208503496,-0.743364148902508,0.9153439153439153,0.9496588406793067,1.0,11/34,26.48%,TPM1;ACE;AGTR1;ECE1;DES;SRI;ACE2;DMPK;AGT;KCNIP2;PLN
prerank,response to estrogen (GO:0043627),-0.22050607237807218,-0.7433621186163863,0.9090909090909091,0.9485908245051734,1.0,8/31,19.29%,TRIM25;PELP1;SERPINB9;SRA1;CAV1;ARID5A;RBBP5;RARA
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.28392653485783914,-0.7432085168876786,0.8137931034482758,0.9476889856966351,1.0,8/14,28.37%,ITPA;ENPP1;AK4;SMPDL3A;AK1;NME2;ENPP3;AK7
prerank,spindle assembly (GO:0051225),0.2549784890909643,0.743043791022346,0.8573021181716833,1.0,1.0,15/67,20.14%,HAUS3;STARD9;ARHGEF10;STAG2;FLNA;TUBGCP5;RCC1;CLASP1;NEK7;KPNB1;AAAS;CEP63;MAPRE3;KIF2A;BCCIP
prerank,regulation of interferon-alpha production (GO:0032647),0.3042166794063598,0.7429186485263064,0.8024523160762943,1.0,1.0,8/23,25.41%,SETD2;TBK1;CHUK;IRF3;PTPRS;HSPD1;MAVS;IRF5
prerank,ribosomal large subunit assembly (GO:0000027),0.30405908866484443,0.7428312658199528,0.8013698630136986,1.0,1.0,4/24,7.70%,RPL23A;NOP2;BRIX1;DHX30
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3423235755514774,0.7427238384960163,0.8035143769968051,1.0,1.0,5/12,18.28%,SYT1;RIMS1;DOC2B;SYT2;RIMS2
prerank,embryonic organ development (GO:0048568),0.25871925899204745,0.7427208195123959,0.8546712802768166,1.0,1.0,11/61,14.61%,GLI2;PKDCC;KMT2A;TGFB1;TGFBR2;RARB;GDNF;GATA3;COBL;NES;BMPR1A
prerank,cellular response to light stimulus (GO:0071482),0.254660567326583,0.7424758464881005,0.8395348837209302,1.0,1.0,6/66,6.89%,MYC;RHO;NSMCE3;ERCC4;METTL3;BMF
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.2947813267055312,-0.7424064869686419,0.8294314381270903,0.9476561642269159,1.0,7/12,27.40%,IFIH1;FLOT1;CAV1;IFIT1;COLEC12;MUL1;ZCCHC3
prerank,regulation of vasculogenesis (GO:2001212),0.3322349500166141,0.7421615691279779,0.7611510791366907,1.0,1.0,2/14,7.42%,CD34;RAP1A
prerank,epithelial cell development (GO:0002064),-0.24551294664388837,-0.741625860817195,0.8586206896551725,0.9475919940543457,1.0,3/20,7.45%,WNT5B;RILPL1;SIPA1L3
prerank,carbohydrate catabolic process (GO:0016052),-0.20693965327609956,-0.7414900363899554,0.9086294416243654,0.9467231984119061,1.0,12/38,23.62%,MANBA;MAN2B1;PGK1;PGAM1;PGAM4;GPI;PFKM;PFKL;ENO1;MAN2B2;GAPDHS;ENO3
prerank,protein glycosylation (GO:0006486),0.2420833260547598,0.7413721573813384,0.8918629550321199,1.0,1.0,26/125,19.74%,GFPT2;ST3GAL4;NPC1;ALG9;B3GNT9;GALNT9;GALNT1;STT3A;PLOD1;MGAT3;MAGT1;ST8SIA1;POMGNT2;GALNT7;ALG5;GALNT6;TUSC3;ALG1;MOGS;TET3;ALG8;DPM1;FKTN;DPAGT1;RPN1;ALG6
prerank,regulation of Notch signaling pathway (GO:0008593),0.2519057302902513,0.7412741456750156,0.8678223185265439,1.0,1.0,11/76,16.26%,MAML3;KAT2B;EGFR;MAML2;FBXW7;METTL3;ZMIZ1;IL6ST;RFNG;TM2D3;SREBF2
prerank,glucose transmembrane transport (GO:1904659),0.31380692186714065,0.7406707112184343,0.7791842475386779,1.0,1.0,3/18,12.41%,SLC5A3;SLC2A2;RAB4B
prerank,polyol biosynthetic process (GO:0046173),0.3260471866807094,0.7406318356831737,0.81169757489301,1.0,1.0,1/16,1.27%,FGF2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.22498718302079548,-0.7405389662663079,0.8502024291497976,0.9469223235421599,1.0,6/25,19.84%,EPHA4;RPL5;RPL11;PML;HSP90AB1;HFE
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.3262412180936537,0.740127024798172,0.8014492753623188,1.0,1.0,5/15,23.62%,ANAPC7;CDC23;CDC27;PTTG1;CDC16
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.26830944878331364,-0.7399193474857731,0.8448275862068966,0.9466913348634868,1.0,8/15,28.37%,ENTPD1;ENTPD7;AK4;AK1;NME2;ENTPD3;ENTPD5;AK7
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.29517074901070045,0.739687934329796,0.8067567567567567,1.0,1.0,9/27,19.57%,CRTC1;PPP1CA;PER3;PER1;RBM4B;CRY1;TP53;USP2;FBXL12
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.30814302489522005,-0.7390647747390802,0.815028901734104,0.9466798361117797,1.0,7/10,37.88%,TLR4;AKT1;MYD88;CD68;TREM2;CD36;TLR6
prerank,tRNA methylation (GO:0030488),0.28279767756101687,0.7386758697360659,0.8256997455470738,1.0,1.0,11/34,23.37%,THUMPD3;TRMT12;THADA;PRORP;TRMT112;DALRD3;THUMPD2;NSUN2;LCMT2;ALKBH8;TRMT1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.30241065961390623,0.7386083699585807,0.8258503401360544,1.0,1.0,5/22,15.09%,MVB12B;VPS37B;VPS36;MVB12A;PLAA
prerank,triglyceride metabolic process (GO:0006641),0.26637154739188595,0.7384131297328527,0.8455188679245284,1.0,1.0,7/48,17.72%,AGMO;LMF1;MOGAT3;PLAAT3;LIPC;GPAT3;GPAT4
prerank,protein mannosylation (GO:0035268),0.29922370203147586,0.7382898415905222,0.8029490616621984,1.0,1.0,9/22,19.08%,TMTC2;POMGNT2;RXYLT1;TMTC3;DPY19L2;DPM1;FKTN;FKRP;DPY19L3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2872100110346871,0.7380611811845853,0.8115183246073299,1.0,1.0,9/27,23.17%,DTYMK;AK5;AK6;AK2;TXNRD1;CTPS2;AK8;GLRX;CMPK1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.30018856847984965,0.7377249683711105,0.8088235294117647,1.0,1.0,5/22,15.48%,SPRED2;SPRED1;SPRED3;UBB;ATM
prerank,regulation of protein secretion (GO:0050708),0.2395276988991207,0.737313180050377,0.9020021074815595,1.0,1.0,15/119,12.69%,PRKCA;CACNA1E;FRMD4A;CACNA1A;TGFB1;SLC12A2;RFX3;PPP3CB;RAP1A;ENSA;PPID;TMED10;SLC2A2;STXBP5;DRD2
prerank,histone exchange (GO:0043486),0.27276290477190945,0.7367215623331104,0.8260869565217391,1.0,1.0,11/37,22.38%,VPS72;ANP32E;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,B cell receptor signaling pathway (GO:0050853),0.2774765948575231,0.7366012114421435,0.7969348659003831,1.0,1.0,9/32,26.09%,BCL2;TEC;VAV3;LAT2;MS4A1;CD38;PLEKHA1;NFAM1;SYK
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.252407659934454,0.7364222087759219,0.843680709534368,1.0,1.0,17/72,20.96%,HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;RPA3;XPA;POLR2K;DDB1;RPA2;POLR2G;UBB;CUL4B;POLR2A;LIG3;COPS6;COPS7A
prerank,regulation of TOR signaling (GO:0032006),0.25252950260109963,0.7362683749745351,0.8484500574052812,1.0,1.0,8/67,9.87%,MIOS;NPRL2;ARAF;DEPTOR;TSC1;LAMTOR2;TBCK;PIH1D1
prerank,positive regulation of T cell proliferation (GO:0042102),0.2606362602379781,0.7360506989714501,0.8394495412844036,1.0,1.0,6/55,14.00%,PYCARD;FADD;CCR2;IL18;IL6ST;NCK1
prerank,fibrinolysis (GO:0042730),-0.27578461576474345,-0.7360131316417544,0.8012422360248447,0.949503062515123,1.0,9/13,52.54%,SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,positive regulation of secretion (GO:0051047),0.34736429285286297,0.7355657875753858,0.7791411042944786,1.0,1.0,2/11,16.10%,ACSL3;GPLD1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.25938159955765283,-0.7354942716458928,0.81875,0.9491076612117229,1.0,2/15,7.86%,PRKCH;AGTR1
prerank,organophosphate biosynthetic process (GO:0090407),0.27551423586840695,0.7353522692517699,0.8249370277078085,1.0,1.0,6/37,17.75%,FGF2;PNPO;GPHN;AGPAT5;NFS1;PIP5K1A
prerank,T cell receptor signaling pathway (GO:0050852),0.23803497055613063,0.7353505617728001,0.9058577405857741,1.0,1.0,29/138,22.71%,PRKCQ;PTPN22;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;PSMB2;EIF2B2;RC3H1;CHUK;PSMD9;PSME4;BCL10;PSMA8;NFKB1;PRKD2;CARD11;TAB2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.30870480666376987,0.7349219003483419,0.7923497267759563,1.0,1.0,4/18,19.13%,VGLL4;VPS11;DACT1;RDX
prerank,DNA dealkylation (GO:0035510),0.35103912995650194,0.7347586207014049,0.7892234548335975,1.0,1.0,2/10,9.78%,MPG;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.35103912995650194,0.7347586207014049,0.7892234548335975,1.0,1.0,2/10,9.78%,MPG;ALKBH5
prerank,sodium ion homeostasis (GO:0055078),0.30468857570496305,0.7347094782861734,0.8049113233287858,1.0,1.0,4/21,17.45%,SLC12A3;SLC12A2;NEDD4L;SLC9A1
prerank,cellular response to amino acid starvation (GO:0034198),0.24668420517454465,0.7342020418931489,0.8790960451977401,1.0,1.0,26/71,27.43%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;ATP6V1C1;RPTOR;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;MTOR;ATP6V1G2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CDKN1A;TCIRG1;ATP6V1D
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.28834504819431866,0.7341737277747403,0.8202396804260985,1.0,1.0,5/27,12.94%,SLC1A3;SLC25A38;ARL6IP5;SLC7A8;PRAF2
prerank,cellular iron ion homeostasis (GO:0006879),0.25628797352542465,0.7339542578495888,0.8569753810082064,1.0,1.0,3/55,5.56%,SCARA5;MYC;CYBRD1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.23880216534515172,0.7338783175103736,0.8969505783385909,1.0,1.0,16/124,15.53%,ROR2;FRZB;PLCB1;WNT5A;PPP3CB;FZD7;PPP3CA;PRICKLE2;PSMB7;SFRP4;PRICKLE1;DVL1;CALM1;PSMD2;PSMC1;FZD9
prerank,nuclear membrane reassembly (GO:0031468),0.2594749048743947,0.7338239604287722,0.8540229885057471,1.0,1.0,28/54,31.22%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4A;CHMP4B;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23657554021066035,0.7337801083898593,0.9190325972660357,1.0,1.0,27/132,18.60%,CELF5;CPSF6;RPL23A;NOP2;BRIX1;LUC7L2;SHQ1;EIF6;TXNL4A;NCBP1;TGS1;CLNS1A;PRPF6;PRPF18;CELF6;SRSF6;YTHDC1;TRAF7;LUC7L;RPS27L;CDC73;SF1;GEMIN7;BOP1;SART1;DDX23;RPSA
prerank,response to amino acid starvation (GO:1990928),0.2457744218349239,0.7336736965233027,0.8783783783783784,1.0,1.0,26/72,27.43%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;ATP6V1C1;RPTOR;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;MTOR;ATP6V1G2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CDKN1A;TCIRG1;ATP6V1D
prerank,positive regulation of histone acetylation (GO:0035066),0.28456630546899087,0.7332885675612508,0.8021534320323015,1.0,1.0,3/23,9.87%,RPS6KA4;BRCA1;PIH1D1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2917422129347095,-0.7327218630715406,0.8079268292682927,0.9515489908115856,1.0,4/11,25.56%,LYN;CD300A;TNFRSF21;TYROBP
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2595239207387895,0.7325529453957135,0.8343057176196033,1.0,1.0,16/51,25.04%,PRKCQ;CCT7;STN1;MAPK1;NEK7;MAP3K4;ATM;SMG6;HNRNPU;HNRNPC;CTC1;GNL3L;ACD;ATR;TCP1;PKIB
prerank,translesion synthesis (GO:0019985),0.2766603553109811,0.7323849615849837,0.8253968253968254,1.0,1.0,9/42,17.26%,POLN;POLE2;REV3L;RPA3;ZBTB1;RPA2;UBB;RCHY1;REV1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2901465869524815,0.7322721559214166,0.8113975576662144,1.0,1.0,3/24,11.05%,BCL2;ACKR3;TAF9
prerank,negative regulation of phagocytosis (GO:0050765),-0.2534846802180462,-0.7322601951646235,0.8322368421052632,0.9510463056741107,1.0,4/17,17.73%,PLSCR1;RACK1;CD300A;APPL1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.298164889298863,0.732235817538244,0.7890410958904109,1.0,1.0,2/22,5.52%,CCR2;WNT5A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3393575087570524,0.7320520421455609,0.8022151898734177,1.0,1.0,3/11,16.10%,KCND3;KCNJ3;KCNH2
prerank,actin filament depolymerization (GO:0030042),0.3516746491831996,0.7317056326524853,0.7875,1.0,1.0,1/11,2.24%,GSN
prerank,regulation of plasminogen activation (GO:0010755),0.33919293818991436,0.7315869736779522,0.8015037593984963,0.9999640099874012,1.0,3/12,15.48%,SERPINE2;PLGRKT;RUNX1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.1950619117009835,-0.7306308774593049,0.9235294117647059,0.9519893665874829,1.0,24/49,32.86%,MAP3K20;ACER2;CLOCK;NDRG1;DOT1L;SESN2;HUS1;BID;CLSPN;PAXIP1;DONSON;ERCC6;NBN;E2F1;MAD2L2;CASP9;RAD9A;CHEK2;CHEK1;GADD45A;PRPF19;E2F7;TRIAP1;ATRIP
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.342871754409955,0.7305427433270064,0.7951070336391437,1.0,1.0,6/12,28.27%,ATF7IP;APOBEC1;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,synaptonemal complex organization (GO:0070193),0.32326711878675907,0.7304970194660874,0.8063583815028902,1.0,1.0,3/15,22.23%,TEX11;SYCE2;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.32326711878675907,0.7304970194660874,0.8063583815028902,1.0,1.0,3/15,22.23%,TEX11;SYCE2;SYCP2
prerank,regulation of protein sumoylation (GO:0033233),0.3188999113312895,0.730179609898425,0.8011695906432749,1.0,1.0,7/17,25.95%,UBA2;ZMIZ1;PARK7;EGR1;GNL3L;GNL3;SAE1
prerank,cGMP biosynthetic process (GO:0006182),0.35089737085537315,0.7300227427787296,0.7652733118971061,0.9998479236998237,1.0,1/10,3.33%,NPR2
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.27941673680235596,-0.7300110986325202,0.8194070080862533,0.9517122770200002,1.0,2/11,9.45%,ATL2;VAPB
prerank,sensory perception of taste (GO:0050909),-0.2933721080550456,-0.7292650959221684,0.7855072463768116,0.9515972022386172,1.0,8/10,50.77%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,modification-dependent protein catabolic process (GO:0019941),0.23260948211484164,0.7291809596538791,0.930327868852459,1.0,1.0,57/193,23.62%,PRKN;HACE1;SPSB4;RNF6;FBXO7;UBE2K;CUL3;HERPUD1;ANAPC7;FBXO45;CBL;USP33;TOLLIP;ANAPC2;PCYOX1L;MYLIP;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;UBB;AREL1;RNF19A;RCHY1;CDC23;RNF111;FBXL4;ANAPC16;MIB1;RC3H1;RNF167;UBA1;FBXO22;MDM2;ELOC;PSMD9;TAF1;FBXO11;UBE2L3;CDC27;UBE2G1;RNF13;UBE2E1;PTTG1;ANAPC4;WDR81;RNF114;UBQLN4;TTC3;UBR3;ANAPC5;UBQLN1;SIAH1;UBQLN2;UBE3C;CDC16
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3070628539218501,0.7291026662115478,0.7954545454545454,1.0,1.0,1/18,1.40%,PYCARD
prerank,protein sumoylation (GO:0016925),0.258787331606547,0.7289316806400167,0.8450536352800954,0.9999663859519873,1.0,10/49,16.73%,RANBP2;UBA2;NUP155;PIAS2;NUP205;NDC1;NUP160;SUMO1;POM121;AAAS
prerank,hexose transmembrane transport (GO:0008645),0.29878785160260124,0.7283990159558669,0.8119079837618404,1.0,1.0,3/21,10.56%,SLC5A3;SLC50A1;SLC2A2
prerank,central nervous system neuron differentiation (GO:0021953),0.2819556703175332,0.728246867206309,0.8305304010349288,1.0,1.0,5/33,11.42%,NTRK2;GBA2;GRID2;MDGA2;OPHN1
prerank,tRNA processing (GO:0008033),-0.18639340891936615,-0.7280729079086744,0.9477611940298507,0.9519710008092798,1.0,21/61,22.84%,TRMT9B;FTSJ1;SARS1;URM1;TSEN15;METTL1;AARS1;KARS1;TYW5;PUS3;WDR4;ZBTB8OS;TRMT10A;CDKAL1;CPSF4;POP5;QTRT2;TRNT1;CLP1;NSUN6;ANKRD16
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.35144056781136546,0.7279360657026089,0.8021472392638037,0.9991197615149889,1.0,4/10,25.07%,XRCC3;BLM;WRN;SLX4
prerank,t-circle formation (GO:0090656),0.35144056781136546,0.7279360657026089,0.8021472392638037,0.9991197615149889,1.0,4/10,25.07%,XRCC3;BLM;WRN;SLX4
prerank,telomere maintenance via telomere trimming (GO:0090737),0.35144056781136546,0.7279360657026089,0.8021472392638037,0.9991197615149889,1.0,4/10,25.07%,XRCC3;BLM;WRN;SLX4
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.31669571247441763,0.727630920542377,0.814327485380117,0.9991004172101319,1.0,6/16,23.15%,PSIP1;PRPF39;SART1;DDX23;SNRNP200;WBP4
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2929452339266244,0.7275879674216134,0.7942446043165468,0.9987248950913002,1.0,6/20,21.94%,RPS6KA4;BRCA1;DIP2A;DIP2B;RUVBL2;PRKAA1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.22108341679260274,-0.727534504750276,0.9082125603864735,0.9516130954216563,1.0,7/31,12.58%,SYT9;STXBP1;CACNA1G;ADRA2A;SYT10;KCNB1;SYT6
prerank,response to cAMP (GO:0051591),-0.2029763431757758,-0.7271763539141051,0.9157303370786517,0.9510382018318553,1.0,4/37,7.01%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,monoacylglycerol metabolic process (GO:0046462),-0.2754260847450001,-0.7271310176062019,0.8461538461538461,0.9500443326369763,1.0,6/13,31.03%,PLA2G4A;MGLL;ABHD12;FAAH;DGAT1;AWAT2
prerank,protein K63-linked deubiquitination (GO:0070536),0.27703173393084707,0.726890402958065,0.8121059268600253,0.9992083592230472,1.0,7/31,20.32%,USP50;OTUD7B;USP33;USP25;OTUD4;OTUD7A;USP13
prerank,C4-dicarboxylate transport (GO:0015740),0.3202862073075387,0.7266796556044084,0.8120411160058737,0.9990266673278418,1.0,6/14,28.84%,LRRC8D;SLC25A10;SLC25A11;SLC1A6;SLC1A2;SLC25A13
prerank,regulation of receptor internalization (GO:0002090),0.2726305282150812,0.72653435717458,0.8455598455598455,0.9987760659101984,1.0,9/35,22.41%,VEGFA;ATXN2;MKLN1;SFRP4;MAGI2;SCYL2;CD63;ARRB2;DLG4
prerank,histone H2B ubiquitination (GO:0033523),0.339879392222268,0.7264390737035099,0.803125,0.9984603871001925,1.0,4/10,25.74%,WAC;CDC73;UBE2E1;RNF20
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.32022527172872195,0.7262913320182764,0.7913669064748201,0.9982206385919106,1.0,2/15,10.31%,ETV4;SFRP4
prerank,intracellular protein transmembrane transport (GO:0065002),0.2672753019604251,0.7260726431833041,0.8506172839506173,0.9980704345039911,1.0,9/42,18.29%,ZFAND2B;C2CD5;TOMM20;SEC61G;SEC63;DNAJC19;PAM16;AIFM1;PEX1
prerank,nucleotide-excision repair (GO:0006289),0.2410525855809964,0.725545322381512,0.8869752421959096,0.998329475013145,1.0,21/101,19.81%,RAD23B;HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;DDB2;RPA3;XPA;POLR2K;FANCC;DDB1;RPA2;POLR2G;UBB;TP53;RNF111;CUL4B;POLR2A;LIG3;COPS6
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2781349777467546,0.7252965237331227,0.8242894056847545,0.9982391374002202,1.0,9/32,18.72%,FGF13;CLASP1;FKBP4;APC2;KATNB1;SNCA;NAV3;ATXN7;CAMSAP1
prerank,calcium ion transport (GO:0006816),0.233730947122473,0.7250807434935836,0.9117021276595745,0.9980924392295862,1.0,11/113,9.38%,CACNA1E;CACNA2D1;ANK2;CACNG7;ANO6;CACNA1A;CHRNA4;PSEN1;SLC8A2;FYN;SLC24A5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.344158022390733,0.7249101284923103,0.80370942812983,0.9978944309660764,1.0,3/10,15.20%,PLA2G7;PNPLA8;LIPC
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3095704534672762,0.7247052693926427,0.8245125348189415,0.9977260318172197,1.0,5/18,20.32%,RNFT1;PIK3R1;NCK1;BCL2L11;USP13
prerank,hepaticobiliary system development (GO:0061008),0.29945407625071946,0.7246359944285674,0.8141843971631205,0.9973849507668144,1.0,5/20,15.00%,PRKCSH;NF1;COBL;CITED2;MET
prerank,protein-containing complex disassembly (GO:0032984),0.26107681587992404,0.724578635017154,0.8708189158016147,0.9970333917326549,1.0,15/54,22.79%,MYC;VPS33A;LIX1;SNAP29;PPP1CA;DVL1;CSNK1A1;GABARAPL2;STX17;SNX14;LAMP2;PYM1;DVL3;VPS16;UBQLN1
prerank,ncRNA 3'-end processing (GO:0043628),0.325130750695569,0.7240132229998096,0.7953890489913544,0.9973426185726905,1.0,4/14,17.36%,INTS6;INTS2;INTS8;SSB
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.23188023811757538,-0.7239905103377424,0.869198312236287,0.9527813321365224,1.0,6/23,19.17%,IGF1;MAML1;PROX1;ATP11A;EDN1;MYOCD
prerank,neutrophil activation (GO:0042119),-0.288597424919168,-0.7239828761638534,0.8254437869822485,0.9517482677985654,1.0,1/12,2.60%,PRKCD
prerank,mitochondrion localization (GO:0051646),-0.24106341310767193,-0.7232541852363518,0.8681318681318682,0.9514972977857654,1.0,6/19,23.11%,MARK1;TRAK1;MARK2;ATCAY;MSTO1;MUL1
prerank,regulation of protein transport (GO:0051223),0.28580326317565047,0.7231518591053538,0.8430311231393776,0.9980460443471849,1.0,9/27,22.49%,PTPN1;STXBP5;NDFIP1;SNX12;DNAJA1;ARFIP1;DISP1;LLGL1;P3H1
prerank,RNA modification (GO:0009451),0.25634689645072606,0.7229864402373553,0.8463329452852154,0.9978287063197565,1.0,15/54,23.37%,DTWD1;NOP2;METTL3;NSUN5;DTWD2;ADARB1;PUS7;ELP5;MEPCE;SSB;TRIT1;NSUN2;LCMT2;ALKBH1;TRMT1
prerank,determination of bilateral symmetry (GO:0009855),-0.2271395929171413,-0.7229335802557728,0.8955823293172691,0.9508051047081878,1.0,11/25,34.70%,KIF3B;TBX1;ZIC3;DNAH11;DNAH5;STIL;NPHP3;CFAP53;DLL1;ODAD2;ODAD3
prerank,phospholipid biosynthetic process (GO:0008654),0.2705735243588857,0.7228601511323774,0.8591022443890274,0.9975664763455744,1.0,12/36,21.53%,IDI1;FAR1;AGPAT5;SGMS2;PIP5K1A;CPNE7;AGK;DPAGT1;CPNE1;DHDDS;CPNE3;FDPS
prerank,ncRNA processing (GO:0034470),0.22854587714410804,0.7227720900954594,0.9312436804853387,0.9972499042939329,1.0,37/200,17.36%,WDR55;C1D;INTS11;WDR36;SENP3;RPL23A;METTL3;NOB1;XRN2;NOL8;INTS6;BMS1;TUT4;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;FARS2;PIH1D1;EXOSC2;INTS4;RCL1;FBL;EBNA1BP2;INTS2;HELQ;INTS8;WDR46;TEX10;DDX10;DDX27;NOP56;NOC4L;POP1;RPP21;SSB
prerank,positive regulation of DNA metabolic process (GO:0051054),0.2511463782885587,0.7227084997225764,0.8542141230068337,0.9969071582538264,1.0,9/61,14.20%,FGF2;MYC;FGF10;EGFR;ATRX;BRCA1;SIRT6;SMOC2;RTEL1
prerank,positive regulation of histone deacetylation (GO:0031065),0.334554487128484,0.7220851609989156,0.8141321044546851,0.9972367088798441,1.0,4/12,21.48%,VEGFA;APLNR;CTBP1;PRKD2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.26472958927016393,-0.7217615679572249,0.8365384615384616,0.9511432933169656,1.0,6/14,22.04%,NMNAT2;ME1;NMNAT1;AK4;AK1;NME2
prerank,positive regulation of lipid transport (GO:0032370),0.32968175876019884,0.7217385075749412,0.8068862275449101,0.9972629416262629,1.0,1/12,2.55%,LRP1
prerank,leukotriene biosynthetic process (GO:0019370),0.32740401615242554,0.7211576323668533,0.7871720116618076,0.9975825661969417,1.0,3/14,13.16%,LTA4H;ALOX5AP;GGTA1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3227546278422817,0.721151292299931,0.8061674008810573,0.9971647766367793,1.0,5/14,19.55%,GPRC5B;WNT5A;TICAM1;CD74;BCL10
prerank,nucleus organization (GO:0006997),0.25941329803002994,0.7211396523227983,0.8534583821805393,0.9967494060936698,1.0,10/47,19.67%,SPAG4;PITPNB;NUP155;BIN1;NUP205;NDC1;PDCD6IP;CHMP4C;ATXN7;CHMP1B
prerank,cellular defense response (GO:0006968),-0.2004401056328801,-0.7206000547630529,0.9481132075471698,0.9514389903382029,1.0,7/40,15.38%,CCR9;DCDC2;LSP1;BECN1;ADORA2A;LGALS3BP;PTK2B
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24907427301874122,0.720325477926626,0.8626126126126126,0.9973713576457218,1.0,19/68,24.99%,CSTF3;GTF2H2;TAF1A;POLR2K;NCBP1;FIP1L1;POLR1B;PAPOLA;POLR1C;POLR1G;POLR2A;UBTF;MTERF2;SYMPK;POLR3K;POLR2F;CCNH;TBP;CPSF7
prerank,regulation of glycolytic process (GO:0006110),0.24938759175789882,0.7198940895982561,0.8737083811710677,0.9975029418555045,1.0,11/68,11.29%,ZBTB20;PSEN1;RANBP2;NUP155;MLXIPL;CBFA2T3;EIF6;HIF1A;NUP205;NDC1;NUP160
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2612100585042284,0.719718339100324,0.8573141486810552,0.9973020935474858,1.0,10/45,17.21%,ATXN2;TSC1;GRM5;DDX25;PER1;SPOUT1;RBM4B;YTHDC1;CYFIP1;RC3H1
prerank,negative regulation of GTPase activity (GO:0034260),0.2922487731573812,0.7195993773842964,0.8214765100671141,0.9970297946916181,1.0,5/22,19.13%,ARL2;TMED2;ARFGEF1;FICD;RDX
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.29870846952912805,0.7190468969589081,0.8326417704011065,0.9973045391957595,1.0,7/20,23.69%,EGFR;TTBK1;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25263433252882395,-0.7187748252501353,0.8636363636363636,0.9524172081627572,1.0,5/17,15.65%,NSA2;URB1;MAK16;LAS1L;EXOSC10
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.33422969812983483,0.7175035569514072,0.8208722741433022,0.9988617999669938,1.0,2/11,16.91%,TGFB1;EFNB2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.27821208973610706,0.7172349241787519,0.8309305373525557,0.9987951426811208,1.0,7/29,18.16%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2742659516019699,0.717070508662802,0.8367875647668394,0.9985744475045261,1.0,7/32,14.94%,ATXN2;TSC1;TMED10;GRM5;DDX25;RBM4B;CYFIP1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.26580306814998866,-0.7164690316222727,0.8520900321543409,0.9540193412824168,1.0,5/14,18.96%,TERF2;BRCA2;TERT;PINX1;TINF2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.31968363312820736,0.716093785357648,0.8328530259365994,0.9993664247547768,1.0,4/15,19.75%,CARD9;HIF1A;TICAM1;STAT3
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2602496822921388,-0.7155425906287327,0.84,0.9539804783446679,1.0,7/15,29.86%,TSEN15;ERN1;ZBTB8OS;CPSF4;CLP1;TRPT1;TSEN54
prerank,stress granule assembly (GO:0034063),0.29875384210815703,0.7155360684574884,0.819327731092437,0.9996445158713604,1.0,8/20,25.84%,BICD1;ATXN2;UBAP2L;CSDE1;DDX6;DYNC1H1;CIRBP;YTHDF3
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2941149547124325,-0.7154515578243641,0.8408408408408409,0.9530248344581208,1.0,2/10,6.15%,RIF1;TERF2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3114079025729129,0.7153964644994165,0.8222222222222222,0.999383111913966,1.0,5/17,17.76%,TGFB1;BIN1;SERPINE2;PTPRZ1;MDK
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.20433321501921387,-0.7153601457912261,0.9186602870813397,0.9520993681597121,1.0,18/36,32.86%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;DNA2;NBN;TIMELESS;E2F1;RAD9B;RAD9A;CDC45;CHEK2;CHEK1;PRPF19;ATRIP
prerank,positive regulation of protein binding (GO:0032092),0.25267211052630584,0.7152483440446614,0.8645833333333334,0.99912849394496,1.0,10/56,15.54%,PRKN;LRP1;PSEN1;RALB;MEN1;USP33;AKTIP;PKD1;DACT1;ABL1
prerank,regulation of B cell differentiation (GO:0045577),-0.2522430751380638,-0.7152466651591116,0.8642857142857143,0.9511832436344768,1.0,4/17,13.28%,ZFP36L1;ID2;NCKAP1L;INHBA
prerank,histone methylation (GO:0016571),0.27941477550353183,0.7145447883564776,0.8201342281879195,0.9995535376769699,1.0,5/26,12.65%,SUV39H1;CARM1;FBL;PRMT1;TRMT112
prerank,positive regulation of cytokinesis (GO:0032467),0.27088158614897323,0.7137345511207459,0.8482932996207333,1.0,1.0,8/32,20.27%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;CENPV;PKN2;SVIL
prerank,regulation of cell division (GO:0051302),0.24570139579158273,0.7135294816737288,0.8922902494331065,0.999973998462891,1.0,11/72,17.40%,EFHC1;MYC;INSC;KLHL13;SETD2;MYO19;RAB11FIP3;CALM1;CALM2;BLM;NCOA3
prerank,positive regulation of neuron death (GO:1901216),0.2567708937401272,0.7126115776972003,0.8590361445783132,1.0,1.0,8/46,13.88%,PRNP;GRIN2B;NF1;WNT5A;FYN;CDK5R1;GRN;SNCA
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.2829983806967491,0.7118421078277725,0.8648275862068966,1.0,1.0,6/24,19.02%,AUTS2;BRK1;PIK3R1;CYFIP1;FSCN1;NCKAP1
prerank,neuron projection organization (GO:0106027),0.3138857245634218,0.7116587064583171,0.8369723435225619,1.0,1.0,2/15,4.81%,PSEN1;PRNP
prerank,long-term memory (GO:0007616),0.30255412450855057,0.7112873124659482,0.7943661971830986,1.0,1.0,6/19,25.33%,PRNP;CPEB3;SGK1;PJA2;NFATC4;SHANK1
prerank,cardiocyte differentiation (GO:0035051),0.3446021588351771,0.7110676483076516,0.8111455108359134,1.0,1.0,2/10,7.41%,AKAP13;GATA6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.24694291940985588,0.7107972880757246,0.8888888888888888,1.0,1.0,14/70,20.75%,CBFB;KMT2A;METTL3;PSMB7;GATA3;PUS7;PSMD2;PSMC1;RUNX1;ABL1;PSMB2;PSMD9;PSME4;PSMA8
prerank,cellular response to topologically incorrect protein (GO:0035967),0.27371616291042933,0.7106680781287098,0.8595360824742269,1.0,1.0,5/31,13.47%,PRKN;PACRG;PTPN1;HDAC6;TM7SF3
prerank,cellular response to interleukin-6 (GO:0071354),0.28227698099191,0.7103419171880705,0.8443579766536965,1.0,1.0,8/26,21.17%,PTPRT;CBL;PTPN11;IL6ST;PID1;SELPLG;STAT3;NFKB1
prerank,"transcription, DNA-templated (GO:0006351)",0.22429251709222206,0.7102839848153777,0.9543147208121827,1.0,1.0,62/207,24.87%,CBFB;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;TAF1A;HOXD3;POLR2B;TAF5L;DRAP1;IVNS1ABP;GTF2B;TFAM;TRIP11;SOX5;POLR2K;NCBP1;TAF9;TAF11;TAF2;EPC1;KLF13;POLRMT;POLR2G;TAF7;RNMT;ELL;GTF3C1;GTF2E2;GTF2E1;TAF4;TP53;TAF4B;CDC73;NFIX;RNPS1;POLR1C;TCEA2;MLF1;ELOC;TAF1;POLR2A;MLLT1;UBTF;POLR3G;FUBP3;SSRP1;NFKB1;THRA;ARRB2;BCL3;ELOB;CDK9;SNAPC3;PKNOX1;POLR3K;MEF2A;POLR2F;CCNT2;CCNH;TBP
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.28989370605742343,0.7101541886788478,0.8308525033829499,0.9999499302067879,1.0,8/22,23.34%,VEGFA;NCF1;PRMT1;MAP3K4;RELL2;EMC10;PJA2;BMP2
prerank,apoptotic nuclear changes (GO:0030262),-0.23147957843890998,-0.7099859730002678,0.8859315589353612,0.9558717103131925,1.0,11/24,29.90%,ACIN1;DFFA;H1-0;DNASE2;DEDD2;GPER1;HMGB2;CASP3;FOXL2;DICER1;CECR2
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.1948040737030396,-0.7094189290035784,0.9385474860335196,0.9554318122247426,1.0,20/42,31.35%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;POLA1;PCNA;POLK;ISG15;FAAP20;RFC3;UBA52;USP43;POLD2;VCP;PCLAF;POLE;POLD4;POLD1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.2734838094144158,0.7092999639731744,0.8737113402061856,1.0,1.0,10/33,20.80%,MAPK7;CYP1B1;NFE2L2;HDAC6;ABL1;PAX2;RIPK1;PARK7;OSER1;SIRPA
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3327754334785127,0.7090547181457049,0.8037676609105181,1.0,1.0,3/10,18.00%,NDFIP1;SNX12;DNAJA1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.27382692652105983,0.7086680010335176,0.8450520833333334,1.0,1.0,7/30,18.16%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,multivesicular body assembly (GO:0036258),-0.2126128118577118,-0.7084371746579134,0.9136363636363637,0.9554974418355898,1.0,5/30,9.91%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2506969226760012,0.7083033033759958,0.8766006984866124,1.0,1.0,11/59,18.76%,ACACA;OXSM;CYP39A1;ACLY;CYP7B1;SRR;CYP27A1;LIPC;ALDH1A3;OSBPL1A;PARK7
prerank,chromatin assembly or disassembly (GO:0006333),0.3300154172272707,0.707908135435076,0.8201892744479495,1.0,1.0,3/11,15.90%,MTA2;RBBP4;TP53
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.30499058649875277,0.7074629528559417,0.8441558441558441,1.0,1.0,6/17,23.69%,EGFR;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,positive regulation of isotype switching (GO:0045830),-0.25128027598705,-0.7068088952225859,0.8526645768025078,0.9562272637744137,1.0,7/15,26.84%,RIF1;TFRC;PAXIP1;CD40;MAD2L2;CLCF1;TNFSF13
prerank,response to exogenous dsRNA (GO:0043330),0.30845463428224745,0.7065159108200174,0.828125,1.0,1.0,4/18,15.21%,IRAK3;RALB;TICAM1;CGAS
prerank,amide biosynthetic process (GO:0043604),0.25629486407240004,0.7064152831748662,0.8541176470588235,1.0,1.0,9/47,21.03%,SLC25A2;CERS3;CERS6;SPTSSA;SLC25A15;SGMS2;AGK;CERS2;FURIN
prerank,regulation of mitotic spindle organization (GO:0060236),-0.20479883550258565,-0.7062820331203471,0.9473684210526315,0.9557350334560936,1.0,6/35,10.62%,CHMP3;DRG1;PARP3;CHMP1A;DCTN1;NUMA1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.22817481529701952,0.7061428569750524,0.9191489361702128,1.0,1.0,11/116,12.74%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;SELENOS;MAPK14;PRKACA;GLP2R
prerank,male meiosis I (GO:0007141),-0.24780994201012696,-0.7056641217698353,0.8682432432432432,0.9553541521498635,1.0,5/16,26.85%,ING2;MYBL1;FOXJ2;BRDT;HSF2BP
prerank,membrane raft organization (GO:0031579),-0.25379721258768323,-0.7043347486346091,0.8745519713261649,0.9556629028039232,1.0,8/15,31.82%,RFTN1;FLOT1;ABCA7;NAXE;S100A10;YJEFN3;PPT1;MYADM
prerank,positive regulation of immunoglobulin production (GO:0002639),0.26653134440569826,0.7042381441018386,0.8772845953002611,1.0,1.0,2/31,3.65%,EPHB2;DNAJB9
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.22589037147553398,-0.7041559040472043,0.9029850746268657,0.9548125292812257,1.0,7/23,25.63%,TLR4;INHBA;RARA;HAVCR2;LAPTM5;NR1H4;INHA
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.305548822928028,0.7035056889887406,0.830703012912482,1.0,1.0,2/15,10.02%,SMOX;PAOX
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.33195392766681997,0.7033379623746385,0.8101851851851852,1.0,1.0,3/11,21.47%,AKAP6;NOS1AP;LRRC55
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2536900009581729,0.7027839554543669,0.8758949880668258,1.0,1.0,9/47,14.94%,TGFB1;ATXN2;TSC1;GRM5;EIF4G1;DDX25;RBM4B;SSH1;CYFIP1
prerank,negative regulation of neuron differentiation (GO:0045665),0.2829354379907031,0.7026295741824097,0.8393574297188755,1.0,1.0,2/22,11.41%,SOX9;BMP7
prerank,termination of RNA polymerase I transcription (GO:0006363),0.27379156980039715,0.7021259113252882,0.8533685601056803,1.0,1.0,11/30,26.50%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;UBTF;POLR2F;CCNH;TBP;TTF1
prerank,lipid biosynthetic process (GO:0008610),0.23481042830499663,0.70137330639349,0.8916201117318435,1.0,1.0,11/77,17.75%,ACSS2;ACACA;OXSM;SCD5;ACLY;PRLR;AGPAT5;LIPC;ACSL6;GPAT4;PIP5K1A
prerank,defense response to symbiont (GO:0140546),0.23106210230871993,0.7007122842210398,0.9069264069264069,1.0,1.0,9/92,10.48%,PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3290197735354021,0.7006043478472381,0.8355048859934854,1.0,1.0,4/11,17.23%,NCBP1;AHCYL1;PAPOLA;CDC73
prerank,oligosaccharide biosynthetic process (GO:0009312),0.29129361811719623,0.6994550234788495,0.8347457627118644,1.0,1.0,2/20,8.85%,ST3GAL4;ST6GALNAC6
prerank,cellular response to leucine starvation (GO:1990253),-0.2837751340083947,-0.6992019896367443,0.8309859154929577,0.9589189444446391,1.0,5/10,31.38%,SESN2;LARS1;RRAGB;EIF2AK4;IMPACT
prerank,regulation of translational initiation (GO:0006446),0.23878560148335765,0.6990746804049283,0.875995449374289,1.0,1.0,23/63,27.36%,EIF2AK3;EIF1B;EIF2B5;NCBP1;EIF4G1;POLR2G;NCK1;EIF1;EIF4A2;EIF2B2;CSDE1;EIF4G3;GLE1;PAIP2B;ALKBH1;CEBPB;NCK2;FMR1;RBM4;YTHDF3;KLHL25;DDX1;PAIP2
prerank,glycerophospholipid metabolic process (GO:0006650),0.23644320530589516,0.6987491318187877,0.917686318131257,1.0,1.0,17/75,19.94%,PRDX6;PLCB1;PLA2G7;PIGC;PIGP;FAR1;ENPP6;PIGN;PIGA;GPLD1;ABHD6;PIP5K1A;CPNE7;AGK;CPNE1;GDPD3;PLA2G4E
prerank,positive regulation of myelination (GO:0031643),-0.2776595791392396,-0.6986832318007737,0.851963746223565,0.9584192251328749,1.0,5/11,31.42%,PARD3;MYRF;TPPP;DICER1;TNFRSF1B
prerank,mitochondrion morphogenesis (GO:0070584),0.330576405701251,0.698662701476115,0.8304821150855366,1.0,1.0,5/11,24.43%,PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,negative regulation of cellular senescence (GO:2000773),0.31482409767327924,0.6983527742689216,0.8473837209302325,1.0,1.0,3/13,9.25%,MAP3K3;CDK6;AKT3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.33026514508981697,0.6979947666784445,0.8433544303797469,1.0,1.0,3/11,21.49%,CALM1;CALM2;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.33026514508981697,0.6979947666784445,0.8433544303797469,1.0,1.0,3/11,21.49%,CALM1;CALM2;PKD2
prerank,positive regulation of phosphatase activity (GO:0010922),0.287452782766915,0.6979732130619278,0.8383977900552486,1.0,1.0,5/21,16.10%,PPP1R15A;MAGI2;CALM1;CALM2;GPLD1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2272601900968309,-0.6974083387064706,0.8982456140350877,0.9586076208049567,1.0,1/22,0.09%,PDGFD
prerank,positive regulation of ruffle assembly (GO:1900029),0.31951015045587866,0.6967459692521868,0.8601190476190477,1.0,1.0,3/13,13.84%,NLGN1;EPS8L1;P2RY12
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.29241120037668417,0.6964372226481154,0.8358620689655173,1.0,1.0,7/20,24.51%,PRKN;ZMIZ1;HIF1A;WASHC1;EGR1;UBQLN1;HSPA1A
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.24058476564717146,-0.6963770761073156,0.8713826366559485,0.9585716612700134,1.0,3/17,11.53%,ADCY9;ADRA1B;ADRA2A
prerank,positive regulation of protein import (GO:1904591),0.2660680188917137,0.6963690738003547,0.8649006622516556,1.0,1.0,4/30,10.37%,TGFB1;PSEN1;FLNA;PIK3R1
prerank,carbohydrate biosynthetic process (GO:0016051),0.2880600049884281,0.6963527615951306,0.8561354019746121,1.0,1.0,2/21,8.85%,ST3GAL4;ST6GALNAC6
prerank,zinc ion homeostasis (GO:0055069),0.2687886835335673,0.6962147057479793,0.8654592496765847,1.0,1.0,2/28,4.84%,PRKN;MT3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23850074873587504,0.696077470044058,0.9205069124423964,1.0,1.0,14/63,19.79%,PTPN22;BCL2;MT3;BMF;TLK2;EIF4G1;ATRAID;WASHC1;MET;KLHL22;GPLD1;TAB3;STAT3;RRAGA
prerank,multivesicular body organization (GO:0036257),-0.20576953855391802,-0.6951350411238761,0.9444444444444444,0.9587173911716417,1.0,5/31,9.91%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2953705895762101,0.6948768542234043,0.8484005563282336,1.0,1.0,8/17,23.28%,EMC10;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC6;EMC2
prerank,determination of heart left/right asymmetry (GO:0061371),0.25288052326032223,0.6942725624446576,0.8650306748466258,1.0,1.0,5/43,10.98%,CCDC39;TGFBR2;BBS5;SMO;DAND5
prerank,mesenchyme development (GO:0060485),0.3039139081324783,0.6942563381246819,0.8345864661654135,1.0,1.0,1/15,0.85%,MEOX1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.31917900562317053,0.6941738984144613,0.8451327433628318,1.0,1.0,1/13,2.58%,PTPRT
prerank,protein targeting to peroxisome (GO:0006625),0.2682445834800004,0.6939241040670903,0.8704663212435233,1.0,1.0,7/29,18.29%,ACBD5;PEX3;PXMP2;ZFAND6;GDAP1;ABCD2;PEX1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.26161683272169467,0.6928016265466526,0.8740359897172236,1.0,1.0,7/32,19.02%,AUTS2;BRK1;PIK3R1;CORO1B;CYFIP1;FSCN1;NCKAP1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.2886459357299822,0.6927943315930151,0.8422496570644719,1.0,1.0,5/20,17.45%,ANK2;PRKACA;CALM1;CALM2;SLC9A1
prerank,sensory perception of sound (GO:0007605),0.23068586012912537,0.6927604579094536,0.9229946524064171,1.0,1.0,12/88,16.12%,ROR1;LHFPL5;PCDH15;LHFPL3;LHFPL4;HOMER2;LRTOMT;PAX3;COL1A1;CCDC50;CDC14A;LRP2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2753364780430428,0.6923207883298055,0.8540829986613119,1.0,1.0,2/25,5.90%,PSEN1;ATXN2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.269084206986878,-0.692015082198102,0.8364197530864198,0.9606541445605339,1.0,5/12,24.31%,INSIG2;RER1;GPAA1;KDELR1;OS9
prerank,nuclear envelope organization (GO:0006998),0.2901811887833701,0.6911272489643959,0.8497854077253219,1.0,1.0,3/20,11.39%,SPAG4;NUP155;EMD
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.2694816918688838,-0.6911050784431825,0.8525641025641025,0.9604948861642171,1.0,3/13,12.50%,PRKCD;SOD1;MAPT
prerank,mitochondrial membrane organization (GO:0007006),0.2665935960896273,0.6909963235783844,0.859514687100894,1.0,1.0,6/32,18.00%,BCL2;APOOL;BNIP3;RCC1L;OPA1;HSPA9
prerank,negative regulation of growth (GO:0045926),0.2241950509010441,0.6902889665704796,0.9310344827586207,1.0,1.0,8/121,5.87%,DCBLD2;CRLF3;VGLL4;FRZB;JADE1;TGFB1;MT3;APBB2
prerank,protein lipidation (GO:0006497),0.24076881438959444,0.6902826409002336,0.8895216400911162,1.0,1.0,23/59,28.06%,WIPI1;ATG5;ZDHHC8;PIGC;PIGP;HHAT;PIGN;PIGA;PIGU;GPLD1;DPM1;PIGO;ZDHHC21;PORCN;ZDHHC13;WDR45B;ATG12;ZDHHC15;ZDHHC17;ATG10;PIK3C3;ZDHHC5;PIGM
prerank,regulation of presynapse organization (GO:0099174),0.2925858060442795,0.6900067301406316,0.8551532033426184,1.0,1.0,6/18,21.78%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),0.2925858060442795,0.6900067301406316,0.8551532033426184,1.0,1.0,6/18,21.78%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,nucleosome disassembly (GO:0006337),0.302087374846,0.6896856987895461,0.8204747774480712,1.0,1.0,4/14,20.22%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,chromatin disassembly (GO:0031498),0.302087374846,0.6896856987895461,0.8204747774480712,1.0,1.0,4/14,20.22%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,positive regulation of organelle organization (GO:0010638),0.2650796731024844,0.6893645120254761,0.8662420382165605,1.0,1.0,13/32,27.57%,C2CD5;ATL3;RAB3GAP2;DOC2B;SURF4;RAB3GAP1;P2RX7;LMAN1;STX18;SORBS3;PFDN2;LIG4;FYCO1
prerank,negative regulation by host of viral transcription (GO:0043922),0.32056114052646,0.6883678833250176,0.8398203592814372,1.0,1.0,1/12,4.10%,CCL4
prerank,establishment of epithelial cell polarity (GO:0090162),0.2916954628290853,0.6881667595364548,0.8563611491108071,1.0,1.0,5/19,15.75%,CLASP1;MYO9A;OPHN1;FBF1;CYTH3
prerank,glutathione biosynthetic process (GO:0006750),0.31909601148511085,0.6881356640417015,0.8544668587896254,1.0,1.0,2/11,12.99%,GSS;GGCT
prerank,ribosome biogenesis (GO:0042254),0.21679611732178786,0.6878867507422868,0.9673135852911133,1.0,1.0,31/187,16.32%,WDR55;XPO1;C1D;WDR36;SENP3;RPL23A;NOB1;TSC1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;SDAD1;HELQ;WDR46;TEX10;DDX10;DDX27;NIP7;NOP56;NOC4L
prerank,nucleoside salvage (GO:0043174),-0.28344563372309783,-0.6870127622275186,0.871875,0.963520122032315,1.0,4/10,32.00%,TK2;DCK;CDA;TK1
prerank,aminoglycan metabolic process (GO:0006022),-0.27771799713095585,-0.6867939194860571,0.8595988538681948,0.9626671346460878,1.0,4/10,29.55%,B4GALT7;B3GAT1;B3GALT6;CHST9
prerank,mitotic sister chromatid segregation (GO:0000070),-0.1606164558703682,-0.6866522231051682,1.0,0.9617729095702896,1.0,46/98,34.94%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;NCAPH2;PINX1;VPS4B;TENT4A;PIBF1;TUBG1;KIF23;CHMP7;CENPK;CSNK2B;BOD1;MCPH1;CHMP2B;NCAPD3;EML4;DCTN2;DSN1;NUSAP1;NIPBL;CENPE;EML3;KMT5A;NCAPD2;ZW10;KNSTRN;NCAPH;SPAG5;KIF18B;TTN;KIFC1;NUP62;NSL1;NDC80;REC8;KIF14;SPDL1;TUBG2;RAD21;CDCA8;CEP55
prerank,regulation of complement activation (GO:0030449),0.2539910306831325,0.6865271332794953,0.8968058968058968,1.0,1.0,1/40,0.78%,C7
prerank,positive regulation of innate immune response (GO:0045089),0.2683887888490049,0.6862317076323985,0.8690629011553274,1.0,1.0,3/30,8.77%,FADD;WNT5A;UBE2K
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.26723531086801905,0.6857696727271643,0.8875968992248062,1.0,1.0,2/29,2.66%,PYCARD;FADD
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2385139753951246,0.6856918744650131,0.9049255441008018,1.0,1.0,22/64,24.77%,GTF2H2;POLR2B;CDK13;POLR2K;NCBP1;SETD2;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;TCEA2;ELOC;POLR2A;MLLT1;SSRP1;ELOB;CDK9;POLR2F;CCNT2;CCNH
prerank,alanine transport (GO:0032328),0.32836236667656704,0.6847383450083903,0.8467741935483871,1.0,1.0,1/10,5.20%,SLC36A2
prerank,oxoacid metabolic process (GO:0043436),0.26841430675098604,0.6846187411193082,0.856760374832664,1.0,1.0,3/27,9.10%,DAO;BPNT1;BPNT2
prerank,positive regulation of protein acetylation (GO:1901985),0.305268821284678,0.6845143962043294,0.8258859784283513,1.0,1.0,5/12,23.26%,DIP2A;TERF2IP;DIP2B;PRKAA1;TAOK1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2832465944425324,0.6845080891519532,0.8647887323943662,1.0,1.0,2/20,7.62%,PTEN;MEN1
prerank,regulation of immune effector process (GO:0002697),0.2525720744363907,0.6836545477878152,0.8931203931203932,1.0,1.0,1/41,0.78%,C7
prerank,pseudouridine synthesis (GO:0001522),0.3044512628614239,0.6836415281675721,0.8425787106446777,1.0,1.0,3/13,15.71%,PUSL1;PUS7;PUS1
prerank,fluid transport (GO:0042044),0.3175645642898166,0.683617937537477,0.8594674556213018,1.0,1.0,1/12,5.26%,AQP4
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.29792792867981066,0.6835920737912541,0.8623595505617978,1.0,1.0,5/17,17.35%,NLGN1;RAB3D;RAB3A;DOC2B;UNC13D
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.29607958671207535,0.6835196480037985,0.8394495412844036,1.0,1.0,2/15,7.29%,CCT7;SHQ1
prerank,histone H2A monoubiquitination (GO:0035518),-0.23743379547686388,-0.6833648950756704,0.8918918918918919,0.963835838673174,1.0,6/17,18.34%,PCGF3;PCGF2;PCGF5;BMI1;RING1;PCGF6
prerank,protein localization to nucleus (GO:0034504),0.2264743191384185,0.6833395877644818,0.9343544857768052,1.0,1.0,28/102,22.58%,NUP155;NOL8;FAM53B;XPA;ARL2;IPO9;BMP7;PRICKLE1;DVL1;KPNB1;IPO13;NXT1;COL1A1;LMNA;EIF4ENIF1;POM121;HNRNPU;WRN;MDM2;TNPO3;IPO5;CSE1L;TAF8;STAT3;PHB2;HEATR3;GBP2;BCL3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.25071315966100133,-0.6831744813517392,0.8910614525139665,0.9629673446247813,1.0,4/14,24.28%,RIF1;TFRC;PAXIP1;MAD2L2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.3184584839666408,0.6828877890060411,0.8233532934131736,1.0,1.0,2/12,9.77%,VEGFA;DSCAM
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.2967128682026856,0.6828625716815186,0.844062947067239,1.0,1.0,4/17,14.55%,NTRK2;PRNP;BIN1;RTN4
prerank,heme biosynthetic process (GO:0006783),0.2806993078013973,0.6827499371155408,0.8656716417910447,1.0,1.0,10/22,26.79%,SLC25A38;UROS;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.23814608114044672,0.6816429844596569,0.9209039548022598,1.0,1.0,12/58,19.25%,ERCC4;SETMAR;ATP23;BRCA1;NHEJ1;NSD2;XRCC6;MDC1;SUMO1;ATM;CYREN;LIG3
prerank,mitochondrial transport (GO:0006839),0.23913777336497063,0.6807190093651913,0.916083916083916,1.0,1.0,10/53,16.71%,BCL2;FBXO7;BNIP3;TOMM22;AIP;TOMM20;COX18;GDAP1;SLC25A24;DNAJC19
prerank,aerobic electron transport chain (GO:0019646),0.235645785120493,0.6805694125671834,0.9186176142697882,1.0,1.0,16/68,18.25%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,pre-replicative complex assembly (GO:0036388),-0.16836644728664224,-0.6802823795369732,0.9705882352941176,0.9644951425923236,1.0,26/64,34.32%,PSMD14;PSMB3;PSMD12;MCM6;PSMD6;PSMA1;ORC6;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4;PSMB1;PSMB9;UBA52;PSMC6;MCM8;PSMD3;PSMD10;PSME3;MCM3;PSMA6;PSME2;MCM2;MCM5
prerank,response to molecule of bacterial origin (GO:0002237),0.23283434929185137,0.6800833374319694,0.9155555555555556,1.0,1.0,9/69,13.88%,PTPN22;IRAK3;MAPKAPK3;MAPKAPK2;PELI1;ERBIN;PRDX3;SRR;SNCA
prerank,axonal transport of mitochondrion (GO:0019896),0.312238557659305,0.6799291364931838,0.8460342146189735,1.0,1.0,6/11,29.61%,HIF1A;OPA1;TRAK2;SYBU;SPAST;ACTR10
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.22006301504286252,-0.6794403200051595,0.92,0.9642210041920749,1.0,5/21,20.04%,CTNNB1;GSK3B;FZD1;CAV1;DVL2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.2423692018566408,-0.6793191127399798,0.8734177215189873,0.9632918122114388,1.0,3/15,18.75%,PLTP;ABCG1;APOE
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3018070976323473,0.6788269668880074,0.8705882352941177,1.0,1.0,7/14,27.87%,UMPS;NT5C;DHODH;DPYD;NT5C3A;NT5E;CAD
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.26167551758311663,0.6784268375373634,0.8660598179453837,1.0,1.0,8/29,19.65%,FBXW7;LIMK1;BAG5;ABL1;FBXO5;PARK7;MAGEC2;UBE2L3
prerank,maintenance of protein location in nucleus (GO:0051457),-0.22722618205045975,-0.677752250560909,0.9075342465753424,0.9635924630114342,1.0,4/20,17.77%,SP100;SUPT7L;PML;TAF3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.27138463648986777,-0.6777448650780322,0.8644501278772379,0.9625744888910571,1.0,1/10,2.50%,SMAD7
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.23142208588080135,0.6777113575746886,0.9305711086226204,1.0,1.0,15/76,16.40%,FBXW7;NSMCE3;UBA2;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.31406045721172127,0.6770410848991811,0.850381679389313,1.0,1.0,1/11,3.97%,GTF2H2
prerank,rRNA metabolic process (GO:0016072),0.2150941084304913,0.6769868294720226,0.9639917695473251,1.0,1.0,27/160,16.32%,WDR55;C1D;WDR36;SENP3;RPL23A;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;WDR46;TEX10;DDX10;DDX27;NIFK;NOP56;NOC4L
prerank,RNA methylation (GO:0001510),0.2375246340375055,0.6767690923303183,0.9125874125874126,1.0,1.0,11/60,15.73%,THUMPD3;NOP2;METTL3;TRMT12;NSUN5;THADA;TGS1;FBL;TRMT112;THUMPD2;MEPCE
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.27322301222689876,0.6757487599579222,0.868632707774799,1.0,1.0,5/22,18.17%,MED13;ESR1;MED12;TP53;MED30
prerank,regulation of humoral immune response (GO:0002920),0.24640182320935017,0.6755482668047142,0.9045346062052506,1.0,1.0,3/44,12.85%,C7;GATA6;PROS1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.19128569011483826,-0.6753359682719032,0.9532710280373832,0.9635857442349212,1.0,15/35,37.51%,ADCY9;LGR4;ADCY4;CAP1;ADCY3;ADCYAP1;ADRB2;CAP2;ADRB1;LHCGR;ADCY7;ACR;GIPR;CRHR1;GLP1R
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.22878557914281034,-0.6745482779125606,0.9106529209621993,0.9632464896846902,1.0,3/19,9.91%,CHMP3;DRG1;CHMP1A
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.23019275743376325,-0.674435676356698,0.8975265017667845,0.962329175893476,1.0,6/18,24.54%,VTI1B;ZDHHC7;VPS4A;APPL1;VAMP8;ZDHHC2
prerank,regulation of T cell cytokine production (GO:0002724),-0.2473085972496862,-0.674033223056097,0.9158576051779935,0.9616999325314453,1.0,3/15,11.62%,SMAD7;CD55;MAP3K7
prerank,protein neddylation (GO:0045116),0.30411893999524864,0.6736884681998732,0.866464339908953,1.0,1.0,3/13,13.90%,NAE1;UBA3;NEDD8
prerank,receptor signaling pathway via STAT (GO:0097696),-0.20869373167156732,-0.673659342603503,0.9348837209302325,0.9609976121252086,1.0,7/25,21.10%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.27697466541585797,0.6730646044708841,0.8688741721854305,1.0,1.0,6/22,17.76%,TAFA1;SHCBP1;PTPRZ1;NES;FZD9;MDK
prerank,protein O-linked mannosylation (GO:0035269),0.2819171677544116,0.6729386305805585,0.8524137931034482,1.0,1.0,7/18,18.61%,TMTC2;POMGNT2;RXYLT1;TMTC3;DPM1;FKTN;FKRP
prerank,positive regulation of cilium assembly (GO:0045724),-0.22303054443657278,-0.6728893822980685,0.9059233449477352,0.9606436504333553,1.0,4/18,18.15%,ARHGAP35;CCP110;FUZ;CROCC
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2874001025330408,0.6727764673898686,0.8715846994535519,1.0,1.0,3/18,11.09%,CBL;PTPN11;IL6ST
prerank,negative regulation of catalytic activity (GO:0043086),0.2706151943431847,0.6726672554741725,0.8620236530880421,1.0,1.0,4/24,15.90%,MT3;HDAC6;NES;TP53
prerank,regulation of phagocytosis (GO:0050764),0.23715626963358882,0.672436298778028,0.9097303634232122,1.0,1.0,2/53,1.52%,PYCARD;OLFM4
prerank,regulation of vacuole organization (GO:0044088),0.27975843083302754,0.6720593326707943,0.8732782369146006,1.0,1.0,2/20,6.24%,NPRL2;LAPTM4B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.32039141873525223,0.6719873881249279,0.8343949044585988,1.0,1.0,4/10,15.90%,FOXM1;ING4;RPS27L;TP53
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.22993283530889644,0.6715965120254477,0.9243792325056434,1.0,1.0,16/72,19.38%,FGF13;KANK4;PRKN;SSH3;CRYAB;CLASP1;APC2;PLEKHH2;KATNB1;SNCA;SSH1;NAV3;ARFGEF1;ATXN7;CAMSAP1;KANK1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.27115442224193065,0.671463118789046,0.8804627249357326,1.0,1.0,2/23,5.68%,PTPN2;SOCS1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2488998335562247,0.6713954350937648,0.8910891089108911,1.0,1.0,10/42,17.91%,MRNIP;SETD2;FBH1;SIRT6;RPA2;RTEL1;CGAS;SPIDR;TERF2IP;FUS
prerank,regulation of cellular response to stress (GO:0080135),0.22087738343535365,0.6713298786905142,0.9472016895459345,1.0,1.0,21/115,16.73%,HSPH1;PRKN;RANBP2;MAPKAPK2;RPA3;NUP155;BAG5;CRYAB;EIF4G1;NUP205;FKBP4;NDC1;NUP160;MAPK1;DNAJB6;RPA2;ATM;ABL1;POM121;PNPT1;AAAS
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.21459515624541645,0.6691360494211985,0.9655891553701773,1.0,1.0,27/146,21.16%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CLASP1;CDC25B;PRKACA;CKAP5;CEP76;DYNC1I2;PSMD2;PSMC1;CSNK1E;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;CEP78;SSNA1;PSMA8;PCNT
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3099054496696322,0.669097890581624,0.8629518072289156,1.0,1.0,2/12,12.11%,VPS33A;GRN
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3193738179979506,0.6690601705626454,0.8704581358609794,1.0,1.0,2/11,15.20%,PLA2G7;LIPC
prerank,carbohydrate homeostasis (GO:0033500),0.23271624243141692,0.6690167413585936,0.9322617680826636,1.0,1.0,4/67,6.40%,PYGL;BACE2;PTPN2;MLXIPL
prerank,neuromuscular synaptic transmission (GO:0007274),-0.22921486038307687,-0.6689381602716274,0.9263157894736842,0.9629281370414544,1.0,2/18,7.47%,FCHSD2;KIF1B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.23152153698290334,0.6685647840501069,0.9343715239154616,1.0,1.0,16/69,18.25%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,negative regulation of viral transcription (GO:0032897),0.3010113332680311,0.6684865258721635,0.8724727838258165,1.0,1.0,5/13,24.40%,TRIM11;MID2;ZFP36;TRIM14;UBP1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2449246070347017,0.6682964342062823,0.9174876847290641,1.0,1.0,9/41,16.73%,RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;AAAS
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.27709048570845346,0.6680423368258072,0.85578231292517,1.0,1.0,5/20,21.52%,ADSS1;NT5C2;AK3;ADSL;PFAS
prerank,AMP metabolic process (GO:0046033),0.30125880937771243,0.6679172510600879,0.8583941605839416,1.0,1.0,5/13,26.67%,ADSS1;AK3;ADSL;NUDT2;NT5E
prerank,DNA-dependent DNA replication (GO:0006261),0.21814356672776425,0.6679019244402066,0.939873417721519,1.0,1.0,29/128,20.98%,LRWD1;POLE2;BAZ1A;REV3L;RPA3;PSMB7;GINS2;POLE3;MCM4;RPA2;ORC1;TOPBP1;POLG2;PSMD2;UBB;PSMC1;BLM;POLG;PSMB2;WRN;ORC4;DDX23;PSMD9;DBF4;PSME4;WRNIP1;ORC2;PSMA8;SSBP1
prerank,autophagosome maturation (GO:0097352),0.25685715935433884,0.6678814180496,0.8916562889165629,1.0,1.0,11/32,22.79%,VPS33A;LIX1;SNAP29;CALM1;GABARAPL2;STX17;SNX14;LAMP2;VMP1;VPS16;UBQLN1
prerank,heart looping (GO:0001947),0.24556069498404481,0.667822932247938,0.8879310344827587,1.0,1.0,4/40,8.63%,CCDC39;TGFBR2;BBS5;SMO
prerank,lipid phosphorylation (GO:0046834),0.31866567165679516,0.6676064266327241,0.8694968553459119,1.0,1.0,6/10,28.51%,DGKI;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.21592649700432665,0.6673004836458734,0.9579741379310345,1.0,1.0,12/107,12.92%,CCL11;ANK2;ATP2B3;MT3;CCR2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1
prerank,peroxisomal membrane transport (GO:0015919),0.26076535295862213,0.6668347268288488,0.8809831824062095,1.0,1.0,6/27,18.29%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2;PEX1
prerank,melanosome organization (GO:0032438),0.2643763386008189,0.6665287346787182,0.8697916666666666,1.0,1.0,6/26,23.23%,RAB38;AP1G1;TRAPPC6A;HPS1;KIF13A;BLOC1S6
prerank,positive regulation of ATP metabolic process (GO:1903580),0.25767186301026845,0.6657686006646123,0.8923654568210263,1.0,1.0,10/32,22.02%,ZBTB20;PSEN1;MLXIPL;HIF1A;PID1;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,response to leucine (GO:0043201),0.3132000710588288,0.6657357258783403,0.8363047001620746,1.0,1.0,5/10,29.14%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,cellular response to leucine (GO:0071233),0.3132000710588288,0.6657357258783403,0.8363047001620746,1.0,1.0,5/10,29.14%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2636346265272435,0.6657250047544342,0.8854860186418109,1.0,1.0,3/26,10.49%,POR;HIF1A;GDNF
prerank,rRNA processing (GO:0006364),0.21092747291216674,0.6652316951408622,0.9623217922606925,1.0,1.0,29/172,16.52%,WDR55;C1D;WDR36;SENP3;RPL23A;NOP2;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;WDR46;TEX10;DDX10;DDX27;NOP56;NOC4L;RRP15
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.23320835979817364,0.6651623909323104,0.9241379310344827,1.0,1.0,21/62,24.77%,GTF2H2;POLR2B;CDK13;POLR2K;NCBP1;SETD2;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;ELOC;POLR2A;MLLT1;SSRP1;ELOB;CDK9;POLR2F;CCNT2;CCNH
prerank,termination of RNA polymerase II transcription (GO:0006369),0.25458899692158327,0.6634548238785062,0.88875,1.0,1.0,3/33,10.21%,CSTF3;NCBP1;FIP1L1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2076571785729539,-0.6631464064194632,0.9563492063492064,0.9665853083002962,1.0,8/24,23.41%,ERAP1;TAPBP;ACE;SAR1B;HFE;TAPBPL;FCER1G;CALR
prerank,ovarian follicle development (GO:0001541),0.3031341908446407,0.6626647875735993,0.8670694864048338,1.0,1.0,5/13,23.25%,VEGFA;EIF2B5;EIF2B2;CEBPB;INHBB
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2671139593936788,0.6624470583272125,0.8732970027247956,1.0,1.0,4/23,15.22%,SETMAR;ZWINT;BUB1B;CHMP4C
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2963038450933826,0.6622317582736688,0.871244635193133,1.0,1.0,4/14,23.11%,PTPN2;PYDC1;TRAIP;CARD16
prerank,double-strand break repair via break-induced replication (GO:0000727),0.30011858800987534,0.6620626801901316,0.8657616892911011,1.0,1.0,2/12,10.84%,GINS2;MCM4
prerank,mitochondrial fusion (GO:0008053),-0.22386824555771695,-0.6615476278127689,0.9372822299651568,0.9668263954248264,1.0,3/18,11.42%,SPG7;STOML2;MFF
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.21403528258538507,0.6610024677125406,0.9674027339642481,1.0,1.0,23/136,17.79%,PTCH1;PYCARD;IRAK3;PRNP;UFL1;CYP1B1;OTULIN;MEN1;FLNA;ERBIN;HDAC2;SFRP4;ESR1;MTURN;BMP7;TAX1BP1;SUMO1;PKD1;PYDC1;FOXJ1;CHUK;HEYL;SUFU
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.28774908792624043,0.6608608688390908,0.8626865671641791,1.0,1.0,5/14,27.54%,NECTIN2;BCL10;PRKD2;CARD11;RELA
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3074617080528557,0.6602431512886969,0.8696319018404908,1.0,1.0,4/12,23.18%,PPP3CB;GPLD1;ADCY8;TRPM4
prerank,establishment of melanosome localization (GO:0032401),0.274349928666552,0.6598333035995252,0.8938547486033519,1.0,1.0,7/19,25.46%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,response to chemokine (GO:1990868),0.30085835481572565,0.6596411511602346,0.8785607196401799,1.0,1.0,2/13,9.18%,SLC12A2;STK39
prerank,regulation of type I interferon production (GO:0032479),0.2241057293387846,0.659460301284055,0.9498910675381264,1.0,1.0,28/84,27.86%,PTPN22;DTX4;NLRX1;LRRFIP1;POLR2K;TAX1BP1;TBK1;XRCC6;DHX33;CGAS;POLR1C;IRF3;POLR3G;NFKB1;IRF8;STAT6;CYLD;PCBP2;POLR3K;MAVS;POLR2F;PRKDC;IRF5;POLR3F;IRAK1;PIN1;RELA;ACOD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26867455613696356,0.6589969448940224,0.9020979020979021,1.0,1.0,2/22,7.62%,PTEN;MEN1
prerank,response to ionizing radiation (GO:0010212),0.22682669868564656,0.6589098050920719,0.9260089686098655,1.0,1.0,13/70,15.98%,MYC;MRNIP;MEN1;BRCA1;NHEJ1;MAPK14;BRAT1;TOPBP1;AEN;ATM;BLM;TP53;SPIDR
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2841893901237282,0.658828336712669,0.8731988472622478,1.0,1.0,7/17,23.34%,ACVR1;TGFB1;BMPR1A;HEYL;GALNT11;SNAI1;BMP2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.2892964236282214,0.658543415532483,0.8838612368024132,1.0,1.0,4/15,19.16%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,cell differentiation in hindbrain (GO:0021533),0.3074135156876942,0.6580773841662311,0.8614457831325302,1.0,1.0,4/11,23.47%,GRID2;OPHN1;FAIM2;KNDC1
prerank,mitotic chromosome condensation (GO:0007076),-0.21253745167296842,-0.6576037006243564,0.9488188976377953,0.9688997806425965,1.0,11/26,31.76%,CHMP1A;NCAPH2;TENT4A;CSNK2B;MCPH1;NCAPD3;NUSAP1;KMT5A;NCAPD2;NCAPH;TTN
prerank,negative regulation of stem cell differentiation (GO:2000737),0.304169061063056,0.6574116291851051,0.8501483679525222,1.0,1.0,2/12,16.44%,ZFP36L2;HNRNPU
prerank,heterotypic cell-cell adhesion (GO:0034113),0.26305844159359215,0.6571659521356595,0.8908355795148248,1.0,1.0,6/25,17.05%,DSG2;CTNNA3;PKP2;ITGB1;JUP;ITGB7
prerank,nuclear pore complex assembly (GO:0051292),0.31886514735692134,0.6567664431038643,0.8672985781990521,1.0,1.0,4/10,20.91%,NUP205;NDC1;RTN4;AHCTF1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.2765180480981519,0.656475742180718,0.8743243243243243,1.0,1.0,3/19,8.10%,NTRK2;PRNP;BIN1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2415273477230618,0.6563599597923377,0.917910447761194,1.0,1.0,9/41,16.73%,RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;AAAS
prerank,mitochondrion organization (GO:0007005),0.20873940657469395,0.6563339033152231,0.9733333333333334,1.0,1.0,42/165,22.66%,DNM1;PRKN;RAB38;FBXO7;ATP23;BNIP3;TFAM;TOMM22;AKT3;AIP;TOMM20;RHOT2;AFG1L;PID1;WASF1;PRDX3;YME1L1;POLRMT;POLG2;OPA1;GDAP1;PNPT1;DNAJC19;GABPB1;TRAK2;ADCK1;AIFM1;RHOT1;CLUH;PARK7;HK2;TSPO;PHB2;HSPD1;SSBP1;WDR81;AIFM2;MTFR1;BNIP3L;MIGA2;MGME1;IMMP2L
prerank,response to glucagon (GO:0033762),-0.22863915417288583,-0.6558315897989063,0.9315068493150684,0.9692670274244566,1.0,7/19,25.13%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3148129953301485,0.6550100777421167,0.8693009118541033,1.0,1.0,2/10,8.79%,RARG;RARB
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.20963524810762715,0.65487617934195,0.9647668393782384,1.0,1.0,30/151,21.48%,SLC27A1;SLC25A2;CERS3;ST3GAL4;SLC44A2;CERS6;ELOVL6;ELOVL5;SPTSSA;VAPA;PCYT1B;CHPT1;GPHN;SLC25A15;NFS1;CHAT;CSNK1G2;SGMS2;GSTZ1;GPAT4;SLC44A1;GSTT1;CSNK2A2;LPCAT2;STARD7;HACD2;CERS2;LCMT2;FURIN;PRKD2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.25744069726786456,-0.6543575123100938,0.8873626373626373,0.9683466781458521,1.0,6/11,30.18%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.25744069726786456,-0.6543575123100938,0.8873626373626373,0.9683466781458521,1.0,6/11,30.18%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,positive regulation of viral life cycle (GO:1903902),0.266306098960664,0.653677034413316,0.8740053050397878,1.0,1.0,6/22,18.98%,TRIM11;VPS37B;DDB1;KPNA6;CD74;AXL
prerank,oligosaccharide metabolic process (GO:0009311),0.23582194511583968,0.6536659190124465,0.9215686274509803,1.0,1.0,5/46,10.57%,ST3GAL4;NAGA;MAN2C1;ST6GALNAC6;ST8SIA1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2796059231388055,0.6531458980026589,0.8823529411764706,1.0,1.0,3/17,11.37%,MLXIPL;CBFA2T3;PID1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2972261597802871,0.6525982361868166,0.8823529411764706,1.0,1.0,1/12,2.71%,ADSS1
prerank,membrane lipid metabolic process (GO:0006643),0.2705493521757599,0.6525545512634287,0.8825100133511349,1.0,1.0,3/22,8.13%,AGMO;CYP1B1;TEX2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.20913392363437577,0.6524668081093894,0.9813664596273292,1.0,1.0,53/148,26.99%,NOP2;MAPKAP1;MTA2;RPA3;PRKAB2;CHD3;PPP1R13L;BRCA1;HDAC2;PHF20;MAPK14;TAF9;TAF11;TAF2;CDK5R1;RBBP4;RPA2;TOPBP1;MDM4;TAF7;ATM;TAF4;BLM;TP53;TAF4B;SGK1;USP2;WRN;TP53RK;BOP1;MDM2;TAF1;CSNK2A2;RBBP7;TTC5;SSRP1;TOP3A;PRKAA1;RAD50;BARD1;MTOR;ATR;EHMT2;RHNO1;TBP;BRPF1;RBBP8;RFC2;PPP2R5C;CDK5RAP3;MAP2K6;HDAC1;PIN1
prerank,secondary palate development (GO:0062009),0.29332774152803065,0.6522005183447306,0.890190336749634,1.0,1.0,2/14,6.38%,WNT5A;TGFBR2
prerank,filopodium assembly (GO:0046847),0.2820602997616515,0.6521919003687445,0.8674521354933726,1.0,1.0,4/16,19.08%,FGD4;SPATA13;ARHGEF4;S1PR2
prerank,maturation of LSU-rRNA (GO:0000470),-0.20036920833539612,-0.6518549343801167,0.94921875,0.9691076227534853,1.0,12/26,30.82%,NSA2;URB1;MAK16;LAS1L;RPL7A;PES1;SNU13;RPF2;RPF1;NHP2;DDX18;ZNHIT3
prerank,protein targeting (GO:0006605),0.21007493696906182,0.6513001135350993,0.9683210137275607,1.0,1.0,27/118,20.73%,ZFAND2B;NCF1;FBXO7;NLGN1;GOLGA7B;TOMM22;SPCS3;AIP;TOMM20;VPS37B;NACA;AKAP6;KATNB1;ATG3;ZDHHC24;ZFAND6;SEC61G;GDAP1;SEC63;DNAJC19;AP4M1;TRAK2;PEX1;CHM;TSPO;ZDHHC21;LAMP2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.19523280630290074,-0.6512511600772561,0.970873786407767,0.9685544964458072,1.0,7/29,21.10%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2
prerank,establishment of vesicle localization (GO:0051650),0.2711403741078884,0.6511809860999379,0.8832630098452883,1.0,1.0,6/18,21.99%,SPG11;SYT11;KIF5C;CCDC186;TESK1;LIMK2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.2676557786028038,-0.6511011900305261,0.8672086720867209,0.967639434271699,1.0,5/10,27.98%,LYN;MAP2K1;MAP2K2;FAS;GREM1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.24441915258283586,-0.6510105269532842,0.9120234604105572,0.9666854645916859,1.0,8/14,29.34%,FASTKD1;SLC25A33;EARS2;MRPL12;TEFM;TFB2M;TWNK;FASTKD5
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.27544529623342756,0.6509336801191458,0.8840782122905028,1.0,1.0,4/20,18.76%,TGFB1;GTF2B;GATA3;PARK7
prerank,T cell activation involved in immune response (GO:0002286),-0.24226292055421872,-0.6505209405466814,0.8855421686746988,0.9660177621979069,1.0,5/12,30.51%,ICAM1;FCER1G;LCP1;EIF2AK4;SLC11A1
prerank,regulation of exosomal secretion (GO:1903541),0.2758908228499177,0.6502831534847217,0.8820301783264746,1.0,1.0,4/19,18.12%,PRKN;SDC4;PDCD6IP;RAB7A
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.23766272653465179,0.6502650349272302,0.9192037470725996,1.0,1.0,15/44,26.17%,SQLE;PSAT1;CYP39A1;PNPO;CYP7B1;CYP27A1;OSBPL1A;SC5D;PARK7;ACOT8;SCP2;HMGCR;HSD17B4;AMACR;PER2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.2353902465455438,0.649980644908118,0.9258823529411765,1.0,1.0,4/47,8.22%,RECK;MT3;BIN1;SERPINE2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2606810461417915,0.6498143299580993,0.8981233243967829,1.0,1.0,7/23,24.19%,PTEN;MTMR12;INPP5J;MTMR7;INPP5B;MTM1;MTMR1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2097124679019325,-0.6490505081157132,0.925764192139738,0.9660928244144255,1.0,10/24,26.32%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,positive regulation of defense response (GO:0031349),0.2176896336210753,0.648840636848536,0.9631635969664138,1.0,1.0,15/89,20.08%,IL16;GPRC5B;CCR2;WNT5A;PLA2G7;IL18;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;SETD4;PDCD4;POLR3G
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.30499733726242595,0.6486873870926619,0.8914027149321267,1.0,1.0,1/11,3.88%,SOCS5
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.26264963144636444,-0.6485446215888675,0.9121212121212121,0.9653992271097473,1.0,5/11,30.00%,CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2566413660159874,0.6484422526310125,0.9034013605442177,1.0,1.0,4/25,13.07%,FGF13;STMN4;KATNB1;CKAP5
prerank,tyrosine metabolic process (GO:0006570),0.30906887226545826,0.6484128207850832,0.8726993865030674,0.9997084605647948,1.0,2/11,17.25%,IL4I1;GSTZ1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.29364251074925646,0.6481680494536355,0.8638426626323752,0.9995400825066417,1.0,4/13,18.76%,GPR37;NFE2L2;MET;PARK7
prerank,negative regulation of type I interferon production (GO:0032480),0.23892541787760962,0.6481608688197669,0.9392466585662211,0.999149724687636,1.0,11/40,24.08%,PYCARD;NLRX1;PPM1B;TAX1BP1;TBK1;IRF3;PTPRS;SIRPA;CYLD;PCBP2;MAVS
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2279622462355319,0.6479883525216728,0.9388235294117647,0.9989050221995136,1.0,14/52,23.06%,TUT4;EXOSC8;DCP1B;PNLDC1;EXOSC2;EDC4;LSM3;CNOT3;NT5C3B;RC3H1;ZFP36;CNOT6L;DDX6;EXOSC3
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2171788933142396,0.6478769440196046,0.9488574537540805,0.9986052196343517,1.0,33/94,29.38%,MAP3K3;IRAK3;RPS6KA4;PLCB1;PELI1;PSMB7;TOLLIP;PSMD2;UBB;PSMC1;IL1RAP;PSMB2;CHUK;PSMD9;TAB3;EGR1;PSME4;PSMA8;NFKB1;TNIP2;TAB2;IRAK2;CUL1;PELI2;PSMD8;PSMD13;IRAK1;RELA;TRAF6;TAB1;PSMD4;PSMD5;IRAK4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.2898624380299337,0.6478140230546776,0.884393063583815,0.9982602931608046,1.0,3/15,16.76%,NAGK;MGAT3;GNPDA1
prerank,lipoprotein catabolic process (GO:0042159),0.30222150264660574,0.6476792506570361,0.8725490196078431,0.9979910841298757,1.0,3/11,17.88%,LYPLA1;LYPLA2;ABHD10
prerank,rRNA 3'-end processing (GO:0031125),0.30949909940290865,0.647213955762363,0.8697674418604651,0.9980165108994676,1.0,2/10,10.32%,EXOSC8;EXOSC2
prerank,import into nucleus (GO:0051170),0.21973364547721386,0.6462272868107765,0.9425028184892897,0.9985201185273178,1.0,17/73,21.10%,NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;POM121;HTATIP2;GEMIN7;TNPO3;IPO5;CSE1L;STAT3;PHB2;HEATR3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2082119976241645,0.645642229376432,0.9628450106157113,0.9986427455925404,1.0,10/117,12.74%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;MAPK14;PRKACA;GLP2R
prerank,female gonad development (GO:0008585),0.2733222543684227,0.644530132889776,0.9033613445378151,0.9992354907325541,1.0,7/19,23.54%,VEGFA;EIF2B5;EIF2B2;NR5A1;CEBPB;INHBB;NR2F2
prerank,regulation of biosynthetic process (GO:0009889),-0.2514237254551253,-0.643925431369121,0.908256880733945,0.9675641844731134,1.0,3/11,24.24%,SLC25A33;MID1IP1;SPHK2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.22058397817194658,0.6436615099104611,0.9435840707964602,0.9996030211699017,1.0,14/73,20.75%,CBFB;KMT2A;METTL3;PSMB7;GATA3;PUS7;PSMD2;PSMC1;RUNX1;ABL1;PSMB2;PSMD9;PSME4;PSMA8
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.221148653349457,-0.6430219453578301,0.9298245614035088,0.9671825988591568,1.0,5/18,19.70%,VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,positive regulation of type I interferon production (GO:0032481),0.2211769647196841,0.6417469882817959,0.9523269012485811,1.0,1.0,23/73,26.58%,PTPN22;LRRFIP1;POLR2K;SETD2;PTPN11;TBK1;XRCC6;DHX33;CGAS;CHUK;POLR1C;IRF3;POLR3G;HSPD1;NFKB1;STAT6;POLR3K;MAVS;POLR2F;PRKDC;IRF5;POLR3F;IRAK1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.20080511729310818,0.6416289256876214,0.9899699097291875,1.0,1.0,85/341,23.12%,ZFAND2B;RAD23B;PRKN;MVB12B;HACE1;FBXW7;SPSB4;RNF6;SPOP;FBXO7;OTUD7B;TRIM2;HECTD3;PELI1;UBE2K;PSMB7;UCHL1;CUL3;HERPUD1;HUWE1;VPS37B;ANAPC7;FBXO45;CBL;USP33;NFE2L2;TOLLIP;ANAPC2;MYLIP;MVB12A;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;PSMD2;KLHL22;PLAA;AREL1;PSMC1;RNF19A;RCHY1;CDC23;RNF111;FBXL4;ZSWIM8;ANAPC16;PSMB2;MIB1;RC3H1;RNF167;UBA1;TRIM9;FBXO22;MDM2;ELOC;OTUD7A;RNF4;PSMD9;TAF1;PCNP;FBXO11;PSME4;UBE2L3;CDC27;UBE2G1;RNF13;UBE2E1;DCAF11;PSMA8;PTTG1;ANAPC4;WDR81;RNF114;UBE2D3;UBQLN4;ARRB2;TTC3;UBR3;ANAPC5;UBQLN1;SIAH1;RNF187;UBQLN2;COP1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.25397424715164946,0.6394858344287021,0.908256880733945,1.0,1.0,4/26,19.74%,ST3GAL4;SCCPDH;ALG8;ALG6
prerank,telomere capping (GO:0016233),0.2798430219887299,0.6393982317058376,0.9005763688760807,1.0,1.0,7/16,25.22%,STN1;TERF2IP;CTC1;RAD50;ACD;TFIP11;PRKDC
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.2655745655263304,-0.6392562706026281,0.9335260115606936,0.9686608661282113,1.0,3/11,17.46%,PDPN;ARPIN;RREB1
prerank,arachidonic acid secretion (GO:0050482),0.3063075921840881,0.6392092957245376,0.89171974522293,1.0,1.0,2/10,13.50%,DRD2;PNPLA8
prerank,arachidonate transport (GO:1903963),0.3063075921840881,0.6392092957245376,0.89171974522293,1.0,1.0,2/10,13.50%,DRD2;PNPLA8
prerank,mucosal immune response (GO:0002385),0.2749340972934442,0.6384990718316486,0.8935860058309038,1.0,1.0,1/15,6.17%,OTUD7B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22982128627932408,0.638427259027776,0.938949938949939,1.0,1.0,9/48,17.82%,KAT2B;TAF1A;ZMIZ1;POLR2K;ASF1A;POLR1B;BAZ1B;POLR1C;POLR1G
prerank,autophagosome assembly (GO:0000045),0.22664272236111735,0.6383911245928318,0.9376470588235294,1.0,1.0,15/52,24.67%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;STX17;VMP1;TMEM41B;UBQLN1;UBQLN2;EMC6;WDR45B;ATG12
prerank,regulation of multicellular organismal development (GO:2000026),0.25462226723366804,0.6383054825306369,0.9198369565217391,1.0,1.0,5/25,17.52%,RAB14;DUSP6;MYSM1;GATA3;SPAAR
prerank,regulation of viral entry into host cell (GO:0046596),0.24808606546841594,0.6379991948348884,0.9263565891472868,1.0,1.0,4/30,12.73%,GSN;TRIM11;MID2;NECTIN2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2343425249979263,0.6376122459811989,0.9253365973072215,1.0,1.0,8/43,15.80%,MRNIP;NAE1;BRCA1;TAOK3;ORC1;TOPBP1;ATM;BLM
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22842344390288977,0.6374278687800261,0.9471788715486195,0.9998489845037276,1.0,19/50,26.17%,UFL1;LIMK1;IVNS1ABP;BAG5;SENP2;CRY1;ABL1;N4BP1;FBXO5;DNAJA1;PARK7;TAF1;ARRB2;CAMLG;PRKCG;GNL3L;HSPA1A;SOX4;PER2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.2938636341641791,0.6361844757750085,0.8748114630467572,1.0,1.0,1/12,6.46%,B3GNT9
prerank,regulation of JUN kinase activity (GO:0043506),0.24245263489546087,0.6355943902972679,0.9338422391857506,1.0,1.0,10/33,24.03%,PTPN22;PAK1;TAOK3;MAP3K4;DNAJA1;MAP3K11;PDCD4;DVL3;AIDA;PPEF2
prerank,fatty acid catabolic process (GO:0009062),0.22044668639161083,0.6348103986529663,0.9427917620137299,1.0,1.0,19/67,24.82%,CEL;SLC27A4;ACBD5;HADHA;AIG1;ACOX1;MTLN;ABCD2;ILVBL;AUH;EHHADH;ACAA2;DECR1;ACOT8;ACADS;SCP2;ABHD3;HSD17B4;NUDT19
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.29726890727364547,0.6344608999292424,0.8875,1.0,1.0,4/11,15.90%,FOXM1;ING4;RPS27L;TP53
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2626217948458457,0.6341100654976113,0.8988603988603988,1.0,1.0,3/20,12.69%,AKAP13;PDE4D;DRD2
prerank,phospholipid dephosphorylation (GO:0046839),0.23579210813725665,0.6340214310290593,0.928311057108141,1.0,1.0,13/37,26.71%,PTEN;MTMR12;PLPP4;PLPPR4;PLPPR2;INPP5J;PLPPR1;MTMR7;INPP5B;MTM1;MTMR1;EPHX2;SGPP1
prerank,error-free translesion synthesis (GO:0070987),0.2644243273221157,0.6335882410858436,0.9068493150684932,1.0,1.0,5/22,17.26%,RPA3;RPA2;UBB;RCHY1;REV1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24019415381962816,-0.6334815271614919,0.9164086687306502,0.9714640778576362,1.0,2/13,7.08%,MMS19;ISCA1
prerank,positive regulation of wound healing (GO:0090303),0.23804984389774222,0.6332369791353628,0.935881627620222,1.0,1.0,10/36,24.01%,ST3GAL4;CLDN1;SMOC2;ITGB1;ARFGEF1;HBEGF;KANK1;INSL3;MTOR;PRKCE
prerank,regulation of immune response (GO:0050776),0.20275850669623252,0.6330181127123483,0.9852786540483701,0.9999762145427974,1.0,17/135,17.58%,PTPN22;CD34;FGL1;ELMOD2;CSK;COL3A1;IL4I1;COL1A2;NECTIN2;AHR;COL1A1;ITGB1;CD300LB;XIAP;N4BP1;ITGB7;CLEC2D
prerank,DNA recombination (GO:0006310),0.2350947891066628,0.6325312128876672,0.935031847133758,0.9999840148927698,1.0,12/37,26.07%,FBH1;XRCC3;RTEL1;RAD52;BLM;WRN;RAD50;SUPV3L1;RECQL;RHNO1;LIG4;TSN
prerank,regulation of mRNA catabolic process (GO:0061013),0.20695340449920624,0.6324763399763091,0.9768421052631578,0.9996418398712933,1.0,24/121,20.75%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;EXOSC8;PSMB7;ZFP36L2;EIF4G1;EXOSC2;PCBP4;UPF1;PSMD2;KHSRP;UBB;PSMC1;PNPT1;PSMB2;RC3H1;PCID2;PSMD9;PSME4;ZFP36;PSMA8
prerank,lipoprotein biosynthetic process (GO:0042158),0.29727628959737895,0.6322692650082022,0.8924731182795699,0.9994249530703649,1.0,5/11,27.77%,WIPI1;PORCN;WDR45B;ATG10;PIK3C3
prerank,protein targeting to lysosome (GO:0006622),0.26440424352641595,0.632009692894714,0.8988919667590027,0.9992503949016849,1.0,5/20,20.73%,GNPTAB;AP4M1;RAB7A;SNX16;LAMP2
prerank,glycosphingolipid metabolic process (GO:0006687),0.23269817165838205,0.631892291108263,0.9317365269461078,0.9989506734251312,1.0,6/42,13.72%,GBA2;GM2A;ST6GALNAC6;GALC;ST8SIA1;SUMF1
prerank,positive regulation of protein sumoylation (GO:0033235),0.30630188168223316,0.6315769029979321,0.8892307692307693,0.998812920953416,1.0,1/10,5.36%,UBA2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2751801207942352,0.6312870868625696,0.9130434782608695,0.998652717043304,1.0,4/16,16.25%,ERCC4;RTEL1;ATM;SMG6
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2557774348372663,0.6312585691820332,0.9122807017543859,0.9982911905355646,1.0,2/23,4.54%,TGFB1;DSG2
prerank,proteasomal protein catabolic process (GO:0010498),0.1995825148883473,0.6312542054936953,0.9867751780264497,0.9979077801917269,1.0,46/201,23.12%,ZFAND2B;RAD23B;PRKN;HACE1;FBXW7;SPSB4;SPOP;TRIM2;HECTD3;PELI1;UBE2K;PSMB7;UCHL1;RCN3;CUL3;HUWE1;FBXO45;NFE2L2;DDB1;CCDC47;NEDD4L;PSMD2;KLHL22;PLAA;AREL1;PSMC1;ZSWIM8;PSMB2;CUL4B;TRIM9;MDM2;RNF4;PSMD9;PCNP;PSME4;UBE2G1;DCAF11;PSMA8;UBXN6;RHBDD1;UBE2D3;ARRB2;FBXO44;SIAH1;RNF187;COP1
prerank,mitochondrion distribution (GO:0048311),-0.2438869308683425,-0.6300169064219835,0.9204892966360856,0.9725693548544905,1.0,5/12,20.06%,TRAK1;MAPT;ATCAY;DNM1L;MSTO1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.2535425522362201,0.6299732062335649,0.9249658935879945,0.9981152567688104,1.0,4/23,15.90%,BCL2;YWHAZ;PPP3CC;TP53
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.2535425522362201,0.6299732062335649,0.9249658935879945,0.9981152567688104,1.0,4/23,15.90%,BCL2;YWHAZ;PPP3CC;TP53
prerank,cellular response to ionizing radiation (GO:0071479),0.22926238280425976,0.6298963131609061,0.9352179034157833,0.9977920273499354,1.0,20/47,30.08%,CRYAB;TLK2;MAPK14;XRCC6;ATM;BLM;TP53;SPIDR;WRN;MDM2;GRB2;ATR;RHNO1;TNKS1BP1;LIG4;CDKN1A;SIRT1;INTS7;NUCKS1;RAD1
prerank,activation of protein kinase A activity (GO:0034199),0.26910742787900727,0.6298161662603122,0.9114285714285715,0.9974690494714642,1.0,3/16,12.48%,PRKAR1B;PRRC1;PRKACA
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.26164128948575266,0.6297572260850718,0.9048275862068965,0.9971316994849851,1.0,6/19,26.13%,ZC3H8;ELL;RPTOR;POLR3G;MTOR;POLR3F
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2523234431229461,0.6295383871670605,0.9148099606815203,0.9969179249825199,1.0,6/25,24.51%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A
prerank,CENP-A containing chromatin organization (GO:0061641),0.24355485336401037,0.6294415116234707,0.91796875,0.9962156014954032,1.0,9/29,22.38%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.24355485336401037,0.6294415116234707,0.91796875,0.9962156014954032,1.0,9/29,22.38%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,positive regulation of cell development (GO:0010720),0.2403119737152364,0.6292245207867138,0.9396984924623115,0.9960091705732852,1.0,3/31,6.19%,SOX11;NUMBL;RFX3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.21457794244027567,0.6286328990006111,0.967032967032967,0.9960873147442391,1.0,23/84,23.62%,PSMB7;CUL3;ANAPC7;ANAPC2;BUB1B;PSMD2;UBB;PSMC1;CDC23;ANAPC16;PSMB2;FBXO5;FBXO31;PSMD9;PSME4;CDC27;UBE2E1;PSMA8;PTTG1;ANAPC4;ANAPC5;RB1;CDC16
prerank,regulation of chromosome segregation (GO:0051983),-0.2230622830744845,-0.6278271178309898,0.9261538461538461,0.972876262021211,1.0,9/16,43.91%,NUMA1;RAD18;RMI2;SMC6;MKI67;CDC6;BUB1;IHO1;KIF2C
prerank,protein homotetramerization (GO:0051289),0.22579187074154802,0.6275505578437232,0.9599528857479388,0.9965286346162372,1.0,10/49,21.49%,CTH;ACACA;AQP4;SOD2;ALDH1A3;GLS;RYR3;HCN1;SSBP1;PKD2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.2147855115823486,-0.6274648062264327,0.9616724738675958,0.9720687112254994,1.0,2/18,6.74%,LYN;BCAR1
prerank,icosanoid biosynthetic process (GO:0046456),0.3029277974089706,0.6257264282328057,0.8786482334869432,0.997545105314659,1.0,2/10,12.51%,LTA4H;ALOX5AP
prerank,regulation of superoxide anion generation (GO:0032928),-0.23448389830043714,-0.6251010248975318,0.9037267080745341,0.9724123983941483,1.0,3/14,12.50%,PRKCD;SOD1;MAPT
prerank,dendritic cell chemotaxis (GO:0002407),0.279377556124531,0.6249476731462354,0.9039881831610044,0.9977369442110915,1.0,1/14,5.23%,CCR2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.28225042783384874,0.6248660170259838,0.9096296296296297,0.9974070192387544,1.0,2/14,13.22%,TNFRSF10B;MALT1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.2724817934573402,0.6243021399142749,0.9165467625899281,0.9974713977573385,1.0,1/16,2.55%,LRP1
prerank,telomere maintenance (GO:0000723),0.22162126640965465,0.6232972637970777,0.9498806682577565,0.9979042331224347,1.0,12/50,17.92%,ERCC4;STN1;RPA3;XRCC6;XRCC3;RPA2;RTEL1;ATM;BLM;TERF2IP;WRN;TPRKB
prerank,cellular response to interleukin-12 (GO:0071349),0.22351096955287253,0.6231393425480604,0.9389221556886228,0.9976332214618812,1.0,14/48,26.12%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;SIRPA;BOLA2;TCP1;SNRPA1;HNRNPA2B1
prerank,purine-containing compound salvage (GO:0043101),0.2872196356327189,0.6228038534100799,0.8789237668161435,0.9974956060596978,1.0,2/12,12.60%,ADK;DGUOK
prerank,response to peptide hormone (GO:0043434),0.22483813651998594,0.6225516015046662,0.93681652490887,0.9972954453772144,1.0,13/43,25.02%,SLC27A1;TSC1;EIF2B5;EIF6;GNAI1;CRY1;EIF2B2;STAT3;STAT5A;STAT6;ZBED3;TGFBR3;EPM2AIP1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2463473487020155,-0.622528982716316,0.9197707736389685,0.972846371450771,1.0,6/12,30.01%,VBP1;APOE;CLU;PFDN5;PFDN6;LDLR
prerank,defense response to Gram-negative bacterium (GO:0050829),0.22587196144702285,0.6221032937184365,0.935687263556116,0.9972546177914684,1.0,2/42,3.93%,PYCARD;RNASE6
prerank,regulation of cytokinesis (GO:0032465),0.21106322998027408,0.6220453435681311,0.959731543624161,0.9969175739312801,1.0,20/78,24.42%,KIF20B;KLHL13;CUL3;SETD2;MYO19;CDC25B;DRD2;RAB11FIP3;CALM1;CHMP4C;CDC14A;CALM2;CENPV;PKN2;SVIL;AHCTF1;KIF13A;PLK5;PRKCE;BBS4
prerank,sterol metabolic process (GO:0016125),0.22276014761717935,0.6203272620921337,0.9497716894977168,0.9978174732833485,1.0,7/60,10.88%,SQLE;GBA2;CYP39A1;OSBPL5;CYP1B1;CYP7B1;ABCA5
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20889995053561894,0.6198163225622692,0.9664053751399776,0.9978081412022729,1.0,19/80,20.75%,FBXW7;SPSB4;NSMCE3;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI;MAGEC2;BCL10;UBE2L3;PEF1
prerank,negative regulation of transposition (GO:0010529),0.2628338583129303,0.6184051223937009,0.9073529411764706,0.9984472012038428,1.0,2/16,9.32%,TUT4;TEX15
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.24691126730627838,0.6167393894136595,0.917900403768506,0.9992621260161575,1.0,12/27,30.56%,IRAK3;TLR1;UBB;TAB3;HSPD1;TAB2;IRAK2;IRAK1;TRAF6;TAB1;IRAK4;BTK
prerank,pancreas development (GO:0031016),0.27568869285972963,0.6166911460645377,0.9023668639053254,0.9989156598169758,1.0,1/12,2.93%,CCDC39
prerank,polarized epithelial cell differentiation (GO:0030859),0.2792538086471348,0.6155748038216129,0.9098837209302325,0.9993174752339746,1.0,3/13,12.72%,MYO9A;OPHN1;SCRIB
prerank,positive regulation of immune response (GO:0050778),0.21721188913066458,0.6139528833712722,0.9622857142857143,1.0,1.0,2/64,2.66%,PYCARD;FADD
prerank,regulation of amyloid fibril formation (GO:1905906),0.2719632548724621,0.6135938464711241,0.9010339734121122,0.9999463196950067,1.0,2/15,8.98%,PSEN1;CRYAB
prerank,regulation of secretion by cell (GO:1903530),0.21528595921382881,0.6124457990668588,0.95,1.0,1.0,14/54,22.49%,SYT1;RAB21;RAB3D;SYN1;MCTP1;RIMS1;STXBP5;RAB3A;RIMS2;RAB3B;ARFIP1;DISP1;LLGL1;P3H1
prerank,negative regulation of cell cycle (GO:0045786),0.20605474003317767,0.6119336671256395,0.9730337078651685,1.0,1.0,20/73,23.54%,PTEN;TGFB1;NUPR2;CDK6;MEN1;BMP7;SCRIB;GATA3;RPS6KA2;NPPC;RNF167;NUDT6;IPO5;PDCD4;TRIM35;DUSP1;HECA;RB1;BMP2;NR2F2
prerank,gene expression (GO:0010467),0.18985062016597348,0.6117801284747064,0.9979939819458375,1.0,1.0,78/348,22.58%,BICD1;DHX8;MRPS18A;THOC6;ELAVL4;RANBP2;TSPAN32;RPL23A;RNGTT;HOXD3;MRPL32;POLR2B;NUP155;XRN2;FARSB;SRBD1;DDX54;MCM3AP;SRSF11;LMF1;POLR2K;CASC3;APOBEC1;ALKBH5;NCBP1;ADARB2;MRPL35;FIP1L1;EIF4G1;DUSP11;NUP205;NDC1;TSPAN17;GSPT2;MRPL28;NUP160;UPF1;SNRNP40;DDX25;EPC1;ADARB1;NXT1;POLR2G;HARS1;NOVA1;SRSF6;YTHDC1;MRPL51;POM121;SMG6;HNRNPU;AAAS;ABCF1;NXF1;RNPS1;MLF1;RPSA;POLR2A;THOC7;SYNCRIP;SRRM1;HNRNPUL1;MRPS14;FUBP3;HSPD1;HNRNPL;MRPS6;HARS2;SRSF3;RBMS1;FYTTD1;MRPL52;RPS11;NUP42;MRPL18;GLE1;SYMPK;BCL3
prerank,mitochondrial transcription (GO:0006390),0.29234407112260086,0.611732132885358,0.8931552587646077,0.999692209671922,1.0,3/10,21.09%,TFAM;POLRMT;MTERF2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.24192521261934619,0.6115289646572258,0.9151436031331592,0.9994615845405865,1.0,11/26,28.00%,ALPK1;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;IRAK1;MAP2K6;TRAF6;TAB1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.28880645560563567,0.6113159150360675,0.8971061093247589,0.9992248359832283,1.0,2/10,12.48%,ZDHHC8;PRKACA
prerank,peptide cross-linking (GO:0018149),0.24440754234900317,0.610574308659877,0.9213630406290957,0.9993480157760039,1.0,2/25,9.11%,TGM1;COL3A1
prerank,regulation of mRNA stability (GO:0043488),0.19748059936465462,0.6086391391289753,0.9906054279749478,1.0,1.0,33/145,22.18%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;METTL3;EXOSC8;PSMB7;ZFP36L2;EIF4G1;EXOSC2;GDNF;PCBP4;PSMD2;KHSRP;UBB;EIF4ENIF1;PSMC1;HNRNPU;PSMB2;RC3H1;PCID2;FUS;PSMD9;TENT5D;GIGYF2;PSME4;TENT5A;ZFP36;PSMA8;VIM;TENT5C;RIDA
prerank,histone ubiquitination (GO:0016574),0.2524643372445894,0.6085699343649084,0.9266304347826086,0.9999676294399235,1.0,4/21,20.32%,WAC;HUWE1;CDC73;UBE2E1
prerank,negative regulation of receptor internalization (GO:0002091),-0.23465841518216674,-0.6084971367786615,0.9219219219219219,0.9794043659390566,1.0,4/12,20.36%,RIN3;MTMR2;ANKRD13B;ANKRD13A
prerank,regulation of cell aging (GO:0090342),0.28744368454691505,0.6083329104342641,0.9,0.999742522134917,1.0,3/11,16.29%,FOXM1;LMNA;PNPT1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2680983921303687,0.6073554305897452,0.9186390532544378,1.0,1.0,2/14,12.06%,NGRN;RCC1L
prerank,negative regulation of cell cycle process (GO:0010948),0.20716606463420204,0.6054129813656209,0.9616724738675958,1.0,1.0,18/61,27.21%,EED;APAF1;E2F6;BRCA1;AURKAIP1;BMP7;EPC1;RBBP4;CHMP4C;FBXO5;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2;NME6
prerank,regulation of acute inflammatory response (GO:0002673),0.25639840720797774,0.6048751034435187,0.9298998569384835,1.0,1.0,2/18,17.78%,IL6ST;PTGES
prerank,cardiac cell development (GO:0055006),0.2857224779085714,0.6039677188199944,0.9117647058823529,1.0,1.0,1/11,3.14%,VEGFA
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.2744631826123228,0.6030460638178224,0.9059180576631259,1.0,1.0,1/13,6.46%,B3GNT9
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.23974175317797752,0.6029961192370055,0.9349804941482445,1.0,1.0,1/23,1.69%,RHO
prerank,regulation of spindle assembly (GO:0090169),0.2398933563655491,0.6015362391890147,0.9410977242302544,1.0,1.0,9/25,24.51%,GPSM2;PDCD6IP;CHMP4C;HNRNPU;RNF4;CHMP1B;DYNC1H1;CEP97;HSPA1A
prerank,regulation of protein ubiquitination (GO:0031396),0.19839364170596702,0.601499531301526,0.9870967741935484,1.0,1.0,36/108,26.59%,PRKN;FBXW7;NSMCE3;UFL1;IVNS1ABP;BAG5;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;WASHC1;UBB;RCHY1;XIAP;FANCI;N4BP1;DNAJA1;PARK7;BCL10;UBE2L3;ARRB2;CAMLG;UBQLN1;PRKCG;GNL3L;HSPA1A;SOX4;MYCBP2;PER2;CENPX;PTTG1IP;CDK5RAP3
prerank,mitotic recombination (GO:0006312),0.257344241365007,0.6012594801798463,0.9272997032640949,1.0,1.0,4/15,22.69%,XRCC3;RAD52;TPRKB;RAD50
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2154714853754342,0.6010932966608757,0.9647058823529412,1.0,1.0,5/49,11.09%,CRLF1;VEGFA;IL18;ERBB4;IL6ST
prerank,negative regulation of insulin secretion (GO:0046676),0.25820164811683344,0.599737096231369,0.9422799422799423,1.0,1.0,1/17,2.35%,PRKN
prerank,regulation of organelle organization (GO:0033043),0.20417603844166707,0.5995430482118662,0.9748358862144421,1.0,1.0,22/80,24.08%,PRKN;PARL;VPS11;SYT11;RHOT2;CAPN6;CLEC16A;TMEM33;MAPK1;USP6NL;ZEB2;SURF4;RBSN;CENPV;RHOT1;RDX;MYO5A;LMAN1;TAOK1;STX18;MTM1;MAVS
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.22066008666262732,-0.5984704277630438,0.935064935064935,0.9834027851669274,1.0,8/14,38.00%,TSEN15;ZBTB8OS;CPSF4;CLP1;TRPT1;TSEN54;CSTF2;RTRAF
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.2807281858129317,0.5984572455045502,0.9072327044025157,1.0,1.0,11/11,71.95%,IL6ST;STAT3;EBI3;IL12A;IL27RA;STAT1;STAT4;JAK1;IL12RB2;JAK2;CANX
prerank,regulation of cholesterol transport (GO:0032374),0.2440385988425284,0.5983514395168982,0.9476661951909476,1.0,1.0,4/20,21.17%,LRP1;ABCA5;TSPO;NFKB1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.272351601646141,0.5974382025995839,0.9239940387481371,1.0,1.0,2/12,15.26%,MTTP;ACSL3
prerank,tRNA metabolic process (GO:0006399),0.25903873895902774,0.5960186462826018,0.9127906976744186,1.0,1.0,7/17,24.16%,FARS2;POP1;RPP21;SSB;DTD1;RPP30;DARS2
prerank,regulation of cell cycle phase transition (GO:1901987),0.19991119062196508,0.5955642934479085,0.9751619870410367,1.0,1.0,33/91,29.29%,FBXW7;PSMB7;ANAPC7;ANAPC2;DDB1;BUB1B;PSMD2;PSMC1;TP53;CDC23;ANAPC16;PSMB2;FBXO5;PSMD9;TAF1;DBF4;PSME4;CDC27;UBE2E1;PSMA8;ANAPC4;ANAPC5;CDC16;CUL1;PSMD8;PSMD13;CDKN1A;TRIM39;PSMD4;UBE2S;ATP2B4;PSMD5;CDKN1B
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.23780002802020028,0.5955414902925888,0.9470899470899471,1.0,1.0,10/27,27.41%,SPRED2;SPRED1;SPRED3;ATM;CD74;MDM2;SNAI1;ATR;PTTG1IP;SIRT1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.23504512414857343,0.5950861619920863,0.9398692810457516,1.0,1.0,5/26,18.76%,SLC5A3;SNCA;ABCD2;TRAP1;PARK7
prerank,ncRNA metabolic process (GO:0034660),0.2204165946813935,0.5950681708400191,0.9605095541401274,1.0,1.0,9/37,23.25%,FKBP6;TUT4;KHSRP;MEPCE;NIFK;DTD1;TDRKH;DDX4;XPO5
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2151470817947738,0.5950412321570442,0.9574726609963548,1.0,1.0,13/46,26.12%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;BOLA2;TCP1;SNRPA1;HNRNPA2B1
prerank,acute inflammatory response (GO:0002526),0.23974414898961321,0.5941611376352979,0.927916120576671,1.0,1.0,1/23,3.48%,ANO6
prerank,positive regulation of hormone secretion (GO:0046887),0.24975333240482647,0.5940846703483876,0.9316860465116279,1.0,1.0,2/17,11.59%,SOX11;EDN3
prerank,protein catabolic process (GO:0030163),0.20628299193002914,0.592704885702113,0.967741935483871,1.0,1.0,17/59,23.94%,PRKN;FBXO27;UCHL3;FBXO17;DDB1;CUL4B;RIPK1;MAGEC2;UBE2G1;LAMP2;PSMA8;FBXO44;OGA;SIAH1;TPP1;CLN6;MTOR
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.27089531740098705,0.5922975730514679,0.9319148936170213,1.0,1.0,2/12,12.99%,GSS;GGCT
prerank,regulation of centrosome cycle (GO:0046605),-0.1966344319483954,-0.5919541434350805,0.9553903345724907,0.9854282639839432,1.0,3/21,9.91%,CHMP3;NPM1;CHMP1A
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.236244806456951,0.5917963326466629,0.9406332453825857,1.0,1.0,2/26,8.38%,IRAK3;PPM1B
prerank,renal water homeostasis (GO:0003091),0.24046398851442824,0.5914643171759896,0.9491758241758241,1.0,1.0,3/23,12.48%,PRKAR1B;AQP4;PRKACA
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.22456748558110465,0.5905643494448405,0.9541511771995044,1.0,1.0,9/32,24.95%,PYCARD;HINT1;AEN;RPS27L;TP53;BCL3;RRP8;FHIT;USP28
prerank,heart contraction (GO:0060047),0.21629379480252048,0.5897911476336093,0.959902794653706,1.0,1.0,3/41,5.87%,SGCD;SCN5A;SGCZ
prerank,ncRNA catabolic process (GO:0034661),0.227802936237509,0.5896715999679332,0.963855421686747,1.0,1.0,5/28,16.60%,TUT4;EXOSC8;EXOSC2;RBM7;POP1
prerank,thyroid hormone generation (GO:0006590),0.28035092846642207,0.5892350644099248,0.9183673469387755,1.0,1.0,1/10,6.64%,CTSK
prerank,protein deacylation (GO:0035601),0.23289866838143272,0.5889255756956308,0.9351351351351351,0.9998182308728043,1.0,5/23,17.88%,LYPLA1;HDAC6;SIRT6;LYPLA2;ABHD10
prerank,cristae formation (GO:0042407),0.23300231281479675,0.5873576029489833,0.9609882964889467,1.0,1.0,10/27,27.65%,LETM1;APOOL;ATP5MG;DMAC2L;CHCHD6;ATP5MC2;ATP5PO;ATP5ME;ATP5PF;ATP5F1B
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.24086003212417195,0.5868329850194879,0.9442176870748299,1.0,1.0,5/21,17.87%,ZWINT;BUB1B;KLHL22;ATM;FBXO5
prerank,autophagosome organization (GO:1905037),0.2081579965869147,0.586438033548236,0.966824644549763,1.0,1.0,14/50,24.67%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;VMP1;TMEM41B;UBQLN1;UBQLN2;EMC6;WDR45B;ATG12
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23661242614711894,0.5861245103120216,0.9479305740987984,0.9998968735461033,1.0,2/23,8.18%,LTA4H;ELOVL6
prerank,leukocyte tethering or rolling (GO:0050901),-0.19807958644249896,-0.5858175603905984,0.9754385964912281,0.9871364201944545,1.0,1/17,1.73%,ROCK1
prerank,positive regulation of heart rate (GO:0010460),-0.1996526719092357,-0.5856371488781146,0.9791666666666666,0.9862031479098592,1.0,2/17,6.22%,ADRA1B;TPM1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24297115559239083,0.5852622870380971,0.9349930843706777,1.0,1.0,6/21,22.78%,MED13;MED12;MED30;JUN;MITF;MED24
prerank,acylglycerol metabolic process (GO:0006639),0.21590057444991778,0.5826165806311224,0.9650872817955112,1.0,1.0,14/37,28.51%,LMF1;DGKI;PLAAT3;LYPLA2;ABHD6;DGAT2;DGKA;DGKK;PGS1;DGKD;GK;DGKZ;SEL1L;DGKQ
prerank,positive regulation of cell division (GO:0051781),0.2149416758322818,0.5825568204356799,0.9692118226600985,1.0,1.0,8/38,20.27%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;CENPV;PKN2;SVIL
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.2677338355304455,0.5817118407605457,0.9307692307692308,1.0,1.0,11/11,73.25%,SELENOS;AXL;MERTK;CCR7;CXCL12;LILRB1;GAS6;IRF7;HCLS1;NOD2;CCL19
prerank,negative regulation of mitochondrion organization (GO:0010823),0.22339888919318804,0.5810155027547353,0.9612015018773467,1.0,1.0,8/33,18.80%,PRKN;BNIP3;HUWE1;OPA1;FZD9;MPV17L;ADCK1;ACAA2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.268386247964683,0.5795656608026801,0.9220183486238532,1.0,1.0,2/11,11.12%,EXOSC2;FBL
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.2598138746390486,0.5774598989103276,0.9304084720121029,1.0,1.0,1/13,6.38%,TGFBR2
prerank,regulation of lipid catabolic process (GO:0050994),0.24396651743791092,0.5765062430613911,0.9532967032967034,1.0,1.0,4/19,21.94%,PDE3B;TYSND1;RARRES2;PRKAA1
prerank,mitotic spindle assembly (GO:0090307),0.21409145019975662,0.5762558025458195,0.9702734839476813,1.0,1.0,11/42,24.00%,ARHGEF10;STAG2;FLNA;CLASP1;KPNB1;AAAS;KIF2A;BCCIP;SMC1A;WRAP73;KIFC2
prerank,cholesterol efflux (GO:0033344),0.23839592511356011,0.5754273433429036,0.9396067415730337,1.0,1.0,3/20,16.66%,NPC1;ABCA5;ABCG4
prerank,protein acylation (GO:0043543),0.21474432035395735,0.5746073170830664,0.9563046192259675,1.0,1.0,5/38,12.19%,KAT2B;GTF2B;ZDHHC8;ING4;HHAT
prerank,innate immune response (GO:0045087),0.18103364768196537,0.574067311701742,0.9979654120040692,1.0,1.0,39/217,24.36%,CXCL10;KYNU;ALPK1;RNASE6;NCF1;ANKHD1;CARD9;OTULIN;TRIM11;FYN;NCF2;SETD2;MID2;STYK1;TBK1;MALT1;SNCA;CD300LB;CLPB;PYDC1;CD74;AKAP1;CHUK;LBP;MASP2;BCL10;PPARG;TRIM35;PHB2;YES1;RARRES2;CR2;PJA2;RNF187;CYLD;MAVS;TRIM14;HCK;RPL39
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.20697686014144073,0.5740358314356766,0.9731379731379731,1.0,1.0,7/45,13.93%,TGFB1;AURKAIP1;ZFP36L2;BMP7;ZWINT;SCRIB;BUB1B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.20277691584530977,0.573839883253448,0.9775413711583925,1.0,1.0,10/54,18.13%,CARM1;PCBP4;PRMT1;CNOT3;MDM4;CASP2;CRADD;ATM;TP53;MDM2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.2735318014847632,0.5727646865570309,0.9308755760368663,1.0,1.0,2/10,11.42%,MYO9A;OPHN1
prerank,modulation by host of symbiont process (GO:0051851),0.2173580449647483,0.5726954159294487,0.9595959595959596,1.0,1.0,4/31,11.32%,CCL4;CARD9;SP1;TAF11
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.19275217166204772,0.5721943289436716,0.99457111834962,1.0,1.0,18/88,20.75%,FBXW7;FBXO38;FBXL15;FBXL16;PSMB7;FBXO27;FBXO17;FBXL2;PSMD2;PSMC1;FBXL4;PSMB2;CUL4B;FBXO31;PSMD9;PSME4;FBXL12;PSMA8
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.22597806206944382,0.5720781453228604,0.9677835051546392,1.0,1.0,7/25,21.00%,LAPTM4B;TMEM50B;MVB12A;CHMP4C;DENND10;CHMP1B;UBXN6
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20449313098491007,0.5717597321358033,0.975093399750934,1.0,1.0,18/46,29.24%,FBXO7;TOMM22;AIP;TOMM20;GDAP1;DNAJC19;PAM16;AIFM1;HK2;TSPO;HSPD1;HK1;CHCHD4;TIMM13;RALA;TOMM34;TIMM50;FIS1
prerank,regulation of lipid kinase activity (GO:0043550),-0.22463222622954562,-0.5691285877622339,0.9584487534626038,0.9915461669883034,1.0,1/11,1.96%,PIK3R3
prerank,response to prostaglandin E (GO:0034695),0.26771702969054056,0.5667641634290904,0.9358372456964006,1.0,1.0,10/10,73.25%,TGFBR3;ADCY6;GNG2;PTGER4;TNFSF4;CCR7;PTGER2;SFRP1;GNB1;CCL19
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.24452749461485979,0.5657268678201282,0.9541547277936963,1.0,1.0,3/16,15.22%,VPS36;TMEM50B;CHMP4C
prerank,glutathione metabolic process (GO:0006749),0.21389171290326126,0.5651292938633087,0.9740420271940667,1.0,1.0,6/38,18.76%,DPEP1;GSS;GGCT;GSTZ1;GSTT1;PARK7
prerank,bile acid biosynthetic process (GO:0006699),0.23003214470835925,0.5637587888208221,0.9665809768637532,1.0,1.0,8/24,25.14%,CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,negative regulation of biosynthetic process (GO:0009890),0.24396987861057157,0.5633404444536627,0.9393939393939394,1.0,1.0,4/16,18.76%,ASXL3;ABCD2;TRAP1;PARK7
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.236347817256616,0.5620116297282953,0.9508426966292135,1.0,1.0,1/18,3.89%,FBXW7
prerank,negative regulation of defense response to virus (GO:0050687),0.2718267150168814,0.5618781498902506,0.9352409638554217,1.0,1.0,1/10,8.38%,PPM1B
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.1647160000542493,-0.5614128592253291,1.0,0.9932828295880192,1.0,12/32,32.17%,POLA1;TFDP2;ID2;PCNA;NPAT;ZPR1;E2F1;KLF11;CDC45;CDK14;CDK18;E2F7
prerank,glycine metabolic process (GO:0006544),0.26246514365151496,0.5606732964967426,0.9491778774289985,1.0,1.0,3/12,22.18%,GLYAT;AMT;RIDA
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.1992887106106339,-0.5597193024156607,0.9604863221884499,0.9928739239630465,1.0,6/15,29.56%,CAMK1;FLOT1;CD53;RIPOR2;TYROBP;EHD1
prerank,cellular response to lectin (GO:1990858),0.1853034480706083,0.5597089853501267,0.9946178686759957,1.0,1.0,28/104,26.09%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.1853034480706083,0.5597089853501267,0.9946178686759957,1.0,1.0,28/104,26.09%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,sensory perception of chemical stimulus (GO:0007606),0.24413287640696385,0.5593643813677006,0.9488636363636364,1.0,1.0,4/15,24.42%,DRD2;SLC24A4;UBR3;BBS4
prerank,negative regulation of cyclase activity (GO:0031280),0.24842227187482635,0.5591421108152842,0.9453471196454948,1.0,1.0,2/14,12.69%,CCR2;DRD2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.2526179283972326,0.559032372826416,0.9357249626307922,1.0,1.0,2/13,12.69%,CCR2;DRD2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.19596859134822747,-0.5587743193458043,0.9636363636363636,0.9921634262377649,1.0,6/15,28.84%,ATL2;ZFYVE27;REEP1;RAB10;REEP2;REEP4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.21442521726571012,0.5582961748244804,0.9653401797175867,1.0,1.0,6/32,15.80%,MRNIP;BRCA1;TAOK3;TOPBP1;ATM;BLM
prerank,gluconeogenesis (GO:0006094),0.20850919915395358,0.557926967212803,0.9813200498132005,1.0,1.0,7/39,20.51%,PGM1;GOT2;SLC25A10;CRY1;SLC25A11;PCK2;PFKFB1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2603093190282708,0.5576973455930476,0.9466019417475728,1.0,1.0,2/10,14.47%,RPA2;CRY1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.18433243315778292,0.5576133244987769,0.9946351931330472,1.0,1.0,28/105,26.09%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.18928813101835362,0.5571967356973071,0.9898305084745763,1.0,1.0,15/72,18.77%,FOXM1;ATRX;CARM1;PCBP4;PRMT1;ING4;CNOT3;MDM4;CASP2;CRADD;ATM;RPS27L;TP53;MDM2;BATF
prerank,inorganic ion transmembrane transport (GO:0098660),-0.21495385774373785,-0.5568467846386433,0.9593023255813954,0.991780440918308,1.0,12/12,78.53%,ABCC9;KCNJ8;PKD2L1;ABCC8;P2RX3;KCNJ11;RHAG;ATP1B4;ASIC2;TRPM4;CACNA1H;PKD2
prerank,signal transduction by p53 class mediator (GO:0072331),0.21239919535326998,0.556330487016711,0.9714285714285714,1.0,1.0,9/30,24.93%,PYCARD;ATRX;HINT1;MDM4;TP53;BATF;BCL3;RRP8;FHIT
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.26582621149023633,0.5560888652969818,0.950479233226837,1.0,1.0,3/10,20.98%,ATRX;DBF4;SSBP1
prerank,positive regulation of lipid storage (GO:0010884),0.2294654607042353,0.5560094088049686,0.9713467048710601,0.9998473298729303,1.0,1/21,3.85%,PLIN3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22844199872034343,0.5554413825593582,0.9643347050754458,0.9997340459874493,1.0,5/22,20.75%,PSMB7;NFE2L2;PSMB2;PSME4;PSMA8
prerank,regulation of mitochondrial translation (GO:0070129),0.22471487360303488,0.5547404807616083,0.9543010752688172,0.9996470758462518,1.0,3/21,12.06%,NGRN;MTG1;RCC1L
prerank,positive regulation of cellular senescence (GO:2000774),0.2677803310591781,0.5547034793181841,0.9426356589147287,0.9992907918182704,1.0,2/10,15.21%,YPEL3;CGAS
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2215371930178345,0.5526348724580548,0.9658792650918635,0.9997386588603957,1.0,2/25,4.44%,TGFB1;SOX11
prerank,macromolecule catabolic process (GO:0009057),0.21975256776770444,0.5520585168175679,0.9721854304635762,0.9996047676951909,1.0,7/26,23.94%,TGFB1;UCHL3;MVB12A;SIAH1;TPP1;CLN6;MTOR
prerank,protein localization to microtubule organizing center (GO:1905508),0.2407268398638278,0.5520428198342295,0.9549418604651163,0.9992384928522816,1.0,2/15,11.71%,PCM1;SNX10
prerank,cellular response to ketone (GO:1901655),0.20541935702669334,0.5510365943673363,0.969097651421508,0.9993024964293841,1.0,6/35,20.07%,PTGFR;GNAI1;AHR;KLF9;PCK2;ADCY8
prerank,negative regulation of inclusion body assembly (GO:0090084),0.26501788964911177,0.5496361386163727,0.9468085106382979,0.9994876266657297,1.0,10/10,73.51%,DNAJB6;HSPA1A;DNAJB2;SACS;DNAJB8;DNAJA4;HSPA2;SORL1;HSPA1B;DNAJB1
prerank,cAMP metabolic process (GO:0046058),0.24666297396065656,0.5494924324692811,0.9518950437317785,0.9991694671264234,1.0,2/13,12.05%,PTHLH;PDE4D
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.22358986753231241,-0.5492663911527634,0.9657894736842105,0.9921113271115313,1.0,3/10,18.16%,NUPR1;HDAC4;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),-0.22358986753231241,-0.5492663911527634,0.9657894736842105,0.9921113271115313,1.0,3/10,18.16%,NUPR1;HDAC4;GIT1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.26154104259136085,0.5487238084544355,0.9549689440993789,0.9991166396443413,1.0,5/10,26.55%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,regulation of microtubule nucleation (GO:0010968),0.25953287573236,0.547597747993156,0.9520865533230294,0.9992010053248027,1.0,2/10,13.07%,PAK1;CKAP5
prerank,regulation of membrane depolarization (GO:0003254),0.2292761273068226,0.5461678870494532,0.958041958041958,0.9993740852172989,1.0,2/18,14.27%,SCN5A;NEDD4L
prerank,regulation of spindle organization (GO:0090224),0.2294642208532856,0.5456951608596812,0.9615931721194879,0.999194565829388,1.0,4/18,22.85%,GPSM2;GNAI1;RNF4;DYNC1H1
prerank,kinetochore organization (GO:0051383),0.25202749187617657,0.5445407277536024,0.9561270801815431,0.9992770201532721,1.0,3/13,19.45%,POGZ;NUF2;CENPC
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.20752498069961617,0.543070007136513,0.9753246753246754,0.9994727639199101,1.0,12/30,30.42%,ACKR3;RTEL1;CD74;FBXO5;MDM2;SNAI1;THOC5;PTTG1IP;SIRT1;CDKN2D;BCL2L1;TMEM161A
prerank,tetrahydrofolate metabolic process (GO:0046653),0.25279960930985007,0.5418707724303673,0.959546925566343,0.9995532667460235,1.0,1/10,11.94%,MTHFD2L
prerank,positive regulation of exosomal secretion (GO:1903543),0.2424961195688337,0.541110590696637,0.9629080118694362,0.9994393344317417,1.0,3/15,18.12%,SDC4;PDCD6IP;RAB7A
prerank,mitotic nuclear division (GO:0140014),0.1848914606983335,0.5409555400158718,0.9955703211517165,0.9991226108852616,1.0,13/71,20.14%,ARHGEF10;NDE1;STAG2;FLNA;CLASP1;SGO1;ZWINT;KPNB1;KLHL22;AAAS;SMC4;KIF2A;BCCIP
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.23611253214890587,0.5403551801657639,0.9738651994497937,0.9989707188486286,1.0,2/15,9.43%,MLXIPL;ELOVL5
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.18591783203071016,0.5400327212604796,0.9909604519774011,0.9987093676129066,1.0,13/70,20.95%,SNAP23;NCF1;PSMB7;NCF2;LNPEP;PSMD2;PSMC1;PSMB2;CHUK;PSMD9;PSME4;PSMA8;TAP1
prerank,regulation of myoblast fusion (GO:1901739),0.25203820789354847,0.539293280799002,0.9566563467492261,0.9986066196527649,1.0,2/11,14.86%,MAPK14;EHD2
prerank,regulation of DNA metabolic process (GO:0051052),0.1952689860120229,0.5385983535735039,0.9864197530864197,0.9984843321386746,1.0,17/44,30.99%,MYC;UPF1;KPNA1;SMG6;TERF2IP;USP1;WRNIP1;CDK9;MPHOSPH8;KAT7;WDR18;SMG1;MPV17;NUCKS1;HNRNPD;UBE2V1;ALYREF
prerank,phosphate ion transmembrane transport (GO:0035435),0.24673976551984145,0.5385295184384612,0.9476047904191617,0.998139313201268,1.0,4/12,23.00%,SLC25A10;XPR1;SLC25A11;SLC20A1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.21230542841366928,0.5378235920934301,0.9712722298221614,0.998027623972363,1.0,7/26,25.00%,THADA;DRD2;CALM1;CALM2;PKD2;UBQLN1;FMR1
prerank,response to UV-B (GO:0010224),-0.20306654056942947,-0.5377824593110002,0.976878612716763,0.9943471322488362,1.0,6/12,36.08%,MFAP4;STK11;HYAL2;MME;MSH2;HYAL3
prerank,regulation of response to stress (GO:0080134),-0.21592870882960843,-0.5367610428051477,0.9779005524861878,0.9935899261000537,1.0,5/10,29.80%,OPRM1;SLC38A2;MLC1;STOX1;CORO2B
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2225558109021236,0.5360854733606173,0.9766162310866575,0.9975374842909837,1.0,4/20,15.48%,ZWINT;BUB1B;KLHL22;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2225558109021236,0.5360854733606173,0.9766162310866575,0.9975374842909837,1.0,4/20,15.48%,ZWINT;BUB1B;KLHL22;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2225558109021236,0.5360854733606173,0.9766162310866575,0.9975374842909837,1.0,4/20,15.48%,ZWINT;BUB1B;KLHL22;ATM
prerank,primary miRNA processing (GO:0031053),0.26238986768601086,0.5360540631487676,0.9561270801815431,0.9971767263962832,1.0,1/10,6.20%,METTL3
prerank,protein autoprocessing (GO:0016540),-0.1829942293590982,-0.5357901039919132,0.9863013698630136,0.9928365275484088,1.0,5/17,26.14%,CASP4;FXN;MYRF;HTRA2;OMA1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.2267782908239731,0.5354464180965542,0.9682320441988951,0.9970168640181589,1.0,3/18,10.84%,GINS2;POLE3;MCM4
prerank,rRNA transcription (GO:0009303),0.2269721080561015,0.5346307898418466,0.9723032069970845,0.9969300164380728,1.0,4/17,17.82%,SPIN1;GTF3C1;NIFK;POLR1G
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.23143346709234608,0.5341319717429419,0.9598893499308437,0.9967234417627988,1.0,5/16,24.62%,MCM4;BLM;WRN;SSBP1;RECQL
prerank,TOR signaling (GO:0031929),0.21382168883250477,0.533426556737342,0.9706666666666667,0.9965987458032727,1.0,8/26,23.94%,MAPKAP1;GATA3;TIPRL;RPTOR;FNIP1;CCDC88A;CARD11;MTOR
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20697465901958392,0.5312855960629729,0.9803664921465969,0.9969984189740119,1.0,12/28,28.00%,OTULIN;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;IRAK1;MAP2K6;RELA;TRAF6;TAB1
prerank,cellular response to purine-containing compound (GO:0071415),0.2558594436772016,0.5310279988702497,0.9629629629629629,0.9967107362072344,1.0,2/10,19.09%,P2RY1;RYR3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.18033936420554786,0.5307049880943869,0.994535519125683,0.9964356881771208,1.0,16/86,20.97%,VEGFA;MAPK7;PSMB7;HIF1A;NFE2L2;PSMD2;UBB;PSMC1;GCN1;TP53;PSMB2;ELOC;PSMD9;PSME4;PSMA8;LIMD1
prerank,cell cycle checkpoint signaling (GO:0000075),0.23964861522919065,0.5284668449166555,0.9564541213063764,0.9967704047876966,1.0,2/12,13.93%,ZWINT;BUB1B
prerank,phosphate ion transport (GO:0006817),0.22562042796757087,0.5283887116770939,0.9622377622377623,0.9964324043961413,1.0,3/16,16.03%,SLC25A10;XPR1;SLC25A11
prerank,nuclear pore organization (GO:0006999),0.2365845867501663,0.5278020201626525,0.9629080118694362,0.9962605811822713,1.0,4/14,20.91%,NUP205;NDC1;RTN4;AHCTF1
prerank,cardiac muscle contraction (GO:0060048),0.20080160633803681,0.5276095212093557,0.9785353535353535,0.9959520790192009,1.0,2/34,5.51%,GSN;SCN5A
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.2507061703596759,0.5267708171547105,0.9589905362776026,0.9954983129771792,1.0,10/10,74.95%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.2507061703596759,0.5267708171547105,0.9589905362776026,0.9954983129771792,1.0,10/10,74.95%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.18580847723704866,-0.5264884053623202,0.9771241830065359,0.9941537515114086,1.0,16/16,81.44%,UPB1;NT5M;DPYSL5;NT5C1A;UPP1;DPYSL4;DPYS;CRMP1;DPYSL3;UPP2;DPYSL2;NT5E;TET2;NT5C3A;DPYD;NT5C
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.2255175724120405,0.5242163921856707,0.9684813753581661,0.9959409686769213,1.0,1/17,2.35%,PRKN
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.25022392365909507,0.5235630423549307,0.9513343799058085,0.995768579568095,1.0,3/10,19.13%,SERPINE2;CD9;RDX
prerank,organelle fusion (GO:0048284),0.21767971978075176,0.5234887171987512,0.977027027027027,0.9954247397258839,1.0,7/22,29.24%,VPS11;OPA1;GDAP1;MIGA2;VPS18;EEA1;FIS1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.17349847324342668,0.523193900607455,1.0,0.9951494042394361,1.0,17/88,22.70%,EPRS1;EIF2AK3;CSTB;TSC1;CPEB3;SERPINE2;HDAC6;ATRAID;PUS7;EIF4ENIF1;GIGYF2;SYNCRIP;PLAT;NFKB1;DDX6;RIDA;PAIP2B
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.17714585256062718,0.5211647061102557,0.9978094194961665,0.9953826153132008,1.0,15/76,23.27%,PTPN22;EGFR;TRIM44;PPM1B;TRIP6;BMP7;RTKN2;RASSF2;TERF2IP;CPNE1;PDCD4;PHB2;PPM1A;BCL3;CYLD
prerank,B cell homeostasis (GO:0001782),0.24497765740788602,0.5204443441931165,0.9703125,0.9952198714903336,1.0,1/10,6.74%,DOCK10
prerank,dendritic cell migration (GO:0036336),0.22526455882454624,0.5204288213408528,0.9644381223328592,0.9948611937365254,1.0,1/16,5.23%,CCR2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2445034895501572,0.5194074358237646,0.9639498432601881,0.9947912774760357,1.0,1/10,9.30%,DERL2
prerank,mRNA methylation (GO:0080009),-0.1924120164982374,-0.5191326208822814,0.9774193548387097,0.9947857200701923,1.0,2/15,6.60%,WTAP;METTL14
prerank,heterocycle biosynthetic process (GO:0018130),0.2281784094270214,0.5180653893108992,0.971342383107089,0.9947951873932998,1.0,2/14,14.15%,GPHN;NFS1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.19202303346113408,-0.5145774570399135,0.9848942598187311,0.9947413010627228,1.0,2/13,11.03%,KDM1A;YJU2
prerank,macrophage activation involved in immune response (GO:0002281),0.23306230996611332,0.5132310466387303,0.9745889387144993,0.9957888698590914,1.0,3/13,18.61%,GRN;DYSF;LBP
prerank,regulation of peptidase activity (GO:0052547),0.21727853651479653,0.511027593793837,0.9820936639118457,0.9959835926405405,1.0,4/19,21.03%,CSTB;RCN3;NDUFA13;FURIN
prerank,negative regulation of macroautophagy (GO:0016242),0.20425272203980308,0.510663626447866,0.9773635153129161,0.9957141474537362,1.0,12/26,29.23%,TSC1;CLEC16A;UBQLN4;NRBP2;MTOR;MTM1;CHMP4A;CHMP4B;SMG1;PIK3CA;TMEM39A;SEC22B
prerank,protein kinase A signaling (GO:0010737),0.23103359342017046,0.5043840465590586,0.962852897473997,0.9969383318874852,1.0,2/12,19.13%,PRKACA;RDX
prerank,response to purine-containing compound (GO:0014074),-0.1787674762570212,-0.5001476542628822,0.9897610921501706,0.9964875272899831,1.0,4/17,25.43%,ABCC9;TRPC3;TRPM2;VGF
prerank,chromosome condensation (GO:0030261),0.1849007323333311,0.49859987596329663,0.9897172236503856,0.9979213220025624,1.0,5/36,18.93%,BANF2;PHF8;SMC4;AIFM1;CSNK2A2
prerank,peptidyl-amino acid modification (GO:0018193),0.2374673223994908,0.49757746909704215,0.9739663093415007,0.9978018606202875,1.0,3/10,23.09%,TTLL4;METAP1;METAP1D
prerank,negative regulation of phosphatase activity (GO:0010923),0.19569817140768764,0.4936113470418579,0.9933598937583001,0.9982606147594395,1.0,2/25,5.64%,PPP1R15A;URI1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.19019845747470476,-0.4927637317450897,0.9859550561797753,0.9967326421497001,1.0,2/12,13.73%,MTPN;LIMA1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.22852271764388893,0.4924024995935787,0.9678899082568807,0.998139004976547,1.0,4/12,22.67%,UMPS;CTPS2;ALDH6A1;DPYD
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.22582687776786106,0.4914943236845651,0.9736456808199122,0.9979640056695611,1.0,5/12,27.87%,UMPS;DHODH;UCK1;UCK2;CAD
prerank,nucleoside catabolic process (GO:0009164),-0.19521892455644993,-0.4904864880529376,0.9831460674157303,0.9960618083996152,1.0,3/11,22.68%,UPB1;NT5M;NT5C1A
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.1997103598300929,-0.4897711540562117,0.9755434782608695,0.9951738324989648,1.0,3/10,22.68%,UPB1;NT5M;NT5C1A
prerank,non-motile cilium assembly (GO:1905515),0.1855379893585413,0.4895782259293029,0.9974160206718347,0.9979734261621923,1.0,4/30,15.65%,PCM1;DISC1;CEP89;IFT57
prerank,regulation of phosphate metabolic process (GO:0019220),0.21249021403304497,0.48828942656535,0.9838945827232797,0.9978699844544238,1.0,1/16,4.32%,PSEN1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.1994174321197455,-0.48698197776913404,0.9805013927576601,0.9945993086314471,1.0,1/10,8.11%,ACTN2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.18855656408733024,0.4864132604251182,0.9948652118100129,0.9978706462035198,1.0,7/30,25.39%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A;CHCHD4
prerank,regulation of Golgi organization (GO:1903358),0.20506667724708377,0.48546733329915853,0.983402489626556,0.9977012695657209,1.0,5/17,23.73%,MAPK1;USP6NL;RBSN;MYO5A;STX18
prerank,triglyceride catabolic process (GO:0019433),0.2029895741740988,0.4838424284731578,0.98989898989899,0.9976500161752938,1.0,19/19,79.73%,LIPC;FABP7;APOC3;FABP6;PNPLA5;PNLIPRP2;LIPI;PNPLA1;FABP2;CPS1;LIPG;FABP5;FABP12;FABP4;LIPH;FABP3;PNPLA3;LPL;PNPLA2
prerank,ruffle organization (GO:0031529),0.20659217045561012,0.4835431779400786,0.9886845827439887,0.997338663091975,1.0,4/16,23.92%,CORO1B;CYFIP1;PIP5K1A;PLEKHA1
prerank,mRNA modification (GO:0016556),0.19658104072943777,0.48148915441391654,0.9850136239782016,0.9973514490627903,1.0,5/22,20.16%,METTL3;PUS7;PUS1;VIRMA;NSUN2
prerank,defense response to protozoan (GO:0042832),0.21646054366250234,0.47654607548583316,0.9790419161676647,0.997827641252837,1.0,12/12,78.37%,BATF;GBP2;GBP4;LYST;GBP7;IRF4;GBP6;PF4;BATF2;SLC11A1;MYD88;CD40
prerank,homeostasis of number of cells (GO:0048872),0.2183511316042761,0.4764753018292834,0.9896296296296296,0.9974776379684037,1.0,1/12,6.84%,CARD9
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2045381884897226,0.47593659155694545,0.9830747531734838,0.9972074644161126,1.0,3/17,21.94%,PDE3B;GPLD1;PRKAA1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2124221154823482,0.47298682088820904,0.9820359281437125,0.9973366202703711,1.0,4/13,22.48%,XRCC3;PCID2;DUSP1;CDK5RAP2
prerank,regulation of protein kinase A signaling (GO:0010738),0.1989895530940095,0.4729766656896452,0.9875173370319001,0.9969756171620605,1.0,2/20,10.70%,PRKAR1B;AKAP6
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.21671165798229636,0.46831243227475755,0.9830508474576272,0.9973582860993767,1.0,12/12,78.35%,NUF2;CENPC;MIS12;CDT1;CHAMP1;KIF2C;RMDN1;SEH1L;MAD1L1;NDC80;CENPE;BOD1
prerank,protein deneddylation (GO:0000338),0.21717129209529698,0.46590636911051486,0.989329268292683,0.9973598310918332,1.0,5/10,31.90%,COPS6;COPS7A;COPS2;TOR1A;COPS4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.1798026081957145,0.45700220270436764,0.9986859395532195,0.9981889245599633,1.0,9/28,26.92%,MRNIP;SETMAR;CYREN;TFIP11;PRKDC;SMCHD1;ACTR2;KMT5B;KMT5C
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.17718928197193876,0.4509490678578512,0.9907407407407407,0.9985752839548043,1.0,5/25,20.44%,HIP1;CBL;RTN4;CCDC88A;BCAR3
prerank,sister chromatid segregation (GO:0000819),0.1723540374781144,0.4507867416015144,0.9973614775725593,0.9982305706952973,1.0,7/31,23.57%,SGO1;ZWINT;KLHL22;SMC4;RB1;SMC1A;WRAP73
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.16611298021605092,-0.45014749940105275,0.9938461538461538,0.9974608848125168,1.0,5/14,30.82%,URB1;PES1;RPF2;DDX18;ZNHIT3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.20936076489058203,0.4444928033863417,0.9872,0.9981862020949259,1.0,1/10,12.50%,MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.20936076489058203,0.4444928033863417,0.9872,0.9981862020949259,1.0,1/10,12.50%,MYLIP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.1633633376853467,0.44383563236797796,0.9962406015037594,0.9978902053229268,1.0,10/40,26.37%,RNASE6;MR1;LBP;RARRES2;GBP2;RPL39;DROSHA;RNASE3;GBP4;RNASE7
prerank,C21-steroid hormone metabolic process (GO:0008207),0.18466176747691732,0.43877576149555747,0.9901685393258427,0.9980402937112826,1.0,20/20,81.56%,TSPOAP1;TSPO;STARD3;STARD3NL;FDX1;DHRS2;HSD3B1;CYP17A1;AKR1B1;CYP11A1;CYP11B1;AKR1D1;DHRS9;AKR1C1;HSD3B2;FDX2;CYP46A1;HSD17B10;STAR;FDXR
prerank,regulation of transposition (GO:0010528),0.19654547755706253,0.4347654362558768,0.9984639016897081,0.9980736979199005,1.0,1/13,9.32%,TEX15
prerank,positive regulation of type 2 immune response (GO:0002830),0.19290214593881017,0.4320888062433653,0.9985358711566618,0.9979444895622276,1.0,2/14,17.14%,IL18;CD74
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.16044029477842847,0.42598380197919294,0.9960106382978723,0.9980947441832699,1.0,7/31,28.36%,PRLR;GPHN;NFS1;SCP2;MOCS3;CYP51A1;PYCR2
prerank,regulation of mast cell degranulation (GO:0043304),0.1842784146815261,0.4155931243128935,0.9984848484848485,0.9984861557458221,1.0,3/14,20.81%,GAB2;UNC13D;CD84
prerank,dendritic cell differentiation (GO:0097028),0.1605768407366746,0.39821907661975986,1.0,0.9991184626913792,1.0,4/22,22.09%,TGFBR2;BATF;AXL;IRF8
prerank,ATP transport (GO:0015867),0.1923740303937213,0.39735782399021247,0.9984,0.9988016255533754,1.0,4/10,31.28%,SLC25A24;SLC17A9;SLC25A17;CD47
prerank,natural killer cell activation (GO:0030101),0.15741640364729315,0.3970995928642857,1.0,0.9984522797876935,1.0,4/23,23.66%,RABL3;AXL;PBX1;KAT7
